data_2lfg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lfg _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.644 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 37.7 Cg_endo . . . . . 0 N--CA 1.461 -0.384 0 CA-C-O 121.568 0.57 . . . . 0.0 111.349 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.17 178.91 6.24 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.2 -175.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 57.34 49.09 13.72 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.665 -175.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.68 96.28 0.54 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.69 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.33 125.11 39.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.543 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.2 t -120.38 120.44 62.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.662 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -127.77 142.88 51.19 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.3 p -97.99 117.14 42.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.118 0.485 . . . . 0.0 109.839 176.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -107.16 128.09 54.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.584 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -120.68 89.28 44.7 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.494 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -72.93 152.15 51.55 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 123.196 2.597 . . . . 0.0 111.989 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -73.81 -33.78 64.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.075 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -104.52 -49.3 3.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.473 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -76.4 167.02 22.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.772 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -75.16 143.28 76.83 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.588 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.6 138.13 63.01 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.596 2.198 . . . . 0.0 111.251 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -145.17 160.23 41.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.015 0.436 . . . . 0.0 111.232 -173.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 29.5 tp -93.98 121.88 35.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -102.82 104.42 14.7 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.034 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.2 mp -98.58 121.37 49.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.88 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -134.27 144.13 48.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.425 0.631 . . . . 0.0 110.476 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -132.56 164.13 27.32 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.766 -173.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 52.3 m -97.44 131.36 27.37 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 C--O 1.235 0.343 0 C-N-CA 122.458 2.106 . . . . 0.0 111.504 177.583 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.443 HD22 ' SG ' ' A' ' 184' ' ' CYS . 32.9 tp . . . . . 0 N--CA 1.445 -0.684 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 43.5 mt -92.31 144.69 25.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.913 0.387 . . . . 0.0 110.576 -177.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.479 ' CD1' ' HB3' ' A' ' 184' ' ' CYS . 46.2 m-85 -115.45 146.0 42.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.942 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 36.2 tt0 -126.3 133.87 51.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.604 176.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 181' ' ' GLN . 4.6 mp -118.64 125.65 74.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.309 -176.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -113.16 137.18 51.85 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -148.38 159.9 43.56 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.702 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -170.17 145.53 2.35 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.453 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -70.38 175.16 9.0 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.196 1.931 . . . . 0.0 112.537 173.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -62.16 -43.37 98.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -86.07 17.06 3.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.136 0.493 . . . . 0.0 111.298 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -94.11 121.97 36.15 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.056 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.09 -22.68 33.37 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.894 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -121.01 156.04 33.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.91 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -90.92 140.61 29.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.36 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -104.41 107.35 18.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.836 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.03 129.57 39.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.124 0.487 . . . . 0.0 110.576 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 66.6 m-70 -128.2 114.11 16.55 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.961 175.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -83.43 115.89 22.25 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.59 -44.42 19.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.767 0.317 . . . . 0.0 111.053 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 143' ' ' LEU . . . 102.93 -127.96 9.38 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.313 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -86.23 -19.74 29.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.983 0.42 . . . . 0.0 111.018 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -75.0 146.29 41.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.202 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.5 p -104.98 30.02 5.87 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.206 0.527 . . . . 0.0 111.658 -174.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -157.16 142.4 17.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.603 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 34.3 t80 -136.52 150.7 48.79 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 0.0 OUTLIER -122.8 136.65 54.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.766 0.317 . . . . 0.0 110.669 -177.404 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 29.0 mm -109.92 128.52 65.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 175.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.55 -34.97 9.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.025 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.0 m -80.15 82.81 6.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.836 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.433 HD13 ' CZ ' ' A' ' 206' ' ' PHE . 73.7 mt -125.87 147.56 49.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.224 0.535 . . . . 0.0 111.687 -176.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -105.25 119.09 54.16 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.11 176.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.39 126.3 20.39 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.858 2.372 . . . . 0.0 112.66 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.55 45.41 7.94 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.628 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -146.98 149.05 32.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.96 0.41 . . . . 0.0 111.15 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -80.82 134.24 35.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.948 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -123.47 142.66 50.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.616 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.8 mm? -106.9 132.54 52.73 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 175.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.28 141.98 43.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.028 0.442 . . . . 0.0 111.521 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.63 ' OE1' ' HB3' ' A' ' 194' ' ' TRP . 36.9 mt-30 -143.77 139.37 29.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.526 175.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 145' ' ' GLU . 7.1 p -133.36 139.06 49.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 174.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 37.1 ttt-85 -146.76 147.11 30.59 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.8 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . 0.644 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 21.9 p -109.57 169.39 8.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.328 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.261 0.553 . . . . 0.0 111.502 -177.398 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.63 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 81.9 m95 . . . . . 0 C--O 1.233 0.23 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 48.1 t -171.43 -54.96 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -75.52 69.92 5.79 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.114 1.876 . . . . 0.0 113.669 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.419 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -74.48 105.85 5.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.872 0.368 . . . . 0.0 110.879 178.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 27.6 m -98.0 132.34 43.64 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.565 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -96.3 120.33 36.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.317 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.1 tp -126.91 131.84 70.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.207 0.527 . . . . 0.0 110.473 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -95.41 119.91 34.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.621 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.9 mm -79.98 117.99 70.21 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 172.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.91 149.59 91.03 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.529 2.153 . . . . 0.0 112.158 -176.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 39.1 m -69.92 -17.46 63.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.341 0.591 . . . . 0.0 109.639 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.87 9.58 7.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.529 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.433 ' CZ ' HD13 ' A' ' 172' ' ' LEU . 64.5 t80 -57.76 -46.17 84.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.167 0.508 . . . . 0.0 110.359 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.445 -0.723 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.617 174.482 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.507 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 7.9 Cg_endo . . . . . 0 C--O 1.235 0.354 0 CA-C-O 121.22 0.425 . . . . 0.0 111.906 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -122.27 178.57 4.89 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.78 -176.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 56.51 47.34 18.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.071 0.462 . . . . 0.0 111.126 178.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.2 tp -74.05 95.94 2.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.035 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -102.65 125.36 49.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.346 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.1 t -110.39 118.86 58.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.904 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -128.62 145.97 50.99 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.134 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.0 p -101.9 117.71 47.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.296 0.57 . . . . 0.0 110.343 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -98.1 129.88 44.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.246 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -120.08 86.44 37.23 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.101 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.466 ' HG2' ' HG3' ' A' ' 119' ' ' ARG . 6.4 Cg_exo -76.04 164.47 31.41 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.432 2.755 . . . . 0.0 112.606 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -91.4 -36.45 13.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.384 -176.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -94.73 -51.79 4.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.712 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.466 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 10.5 ptm180 -90.77 162.52 14.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.289 177.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -79.71 152.04 74.65 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.387 -174.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.37 151.26 75.66 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.369 2.713 . . . . 0.0 113.188 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.447 ' CE2' ' HD2' ' A' ' 168' ' ' LYS . 35.7 p90 -161.58 158.67 26.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.711 -174.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 8.3 mt -82.93 139.7 33.23 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.214 173.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.568 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 10.2 t90 -118.06 94.31 4.46 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.14 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.6 mp -88.81 119.35 35.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.648 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.481 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 9.9 mtmp? -122.84 141.31 52.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.045 0.45 . . . . 0.0 110.985 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 40.2 p90 -138.45 152.06 47.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.04 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.2 t -89.09 126.16 59.89 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo . . . . . 0 C--N 1.346 0.438 0 C-N-CA 123.374 2.716 . . . . 0.0 112.803 -178.949 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 N--CA 1.454 -0.254 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -98.88 145.58 26.85 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.901 0.382 . . . . 0.0 110.334 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -102.43 148.73 25.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.567 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -132.57 133.55 43.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.832 -168.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 181' ' ' GLN . 4.5 mp -126.85 120.42 55.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.877 0.37 . . . . 0.0 110.753 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.607 ' HB2' ' CZ2' ' A' ' 194' ' ' TRP . 5.4 ttp-105 -104.22 120.13 40.48 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.2 pp -143.3 159.34 42.52 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.937 0.399 . . . . 0.0 111.719 -175.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -169.54 148.33 3.35 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.305 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -71.16 166.9 27.74 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.247 1.965 . . . . 0.0 112.187 172.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.485 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 11.1 pt-20 -57.98 -41.15 82.37 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.485 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 95.0 mttt -85.25 16.84 3.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.904 0.383 . . . . 0.0 111.595 -176.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.15 128.17 47.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.59 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -85.53 -34.11 21.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.269 0.557 . . . . 0.0 110.333 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -103.12 147.49 26.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.705 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.475 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 76.3 m95 -90.7 148.6 22.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.5 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -107.42 114.14 27.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.719 174.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.1 mp -91.29 112.05 24.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -106.79 148.64 28.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.253 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -109.48 123.23 49.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.62 -174.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -79.24 -51.63 9.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.615 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 82.04 79.98 0.95 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.651 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 72.6 -46.18 0.64 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.078 0.951 . . . . 0.0 112.595 175.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -66.5 148.28 52.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.003 0.43 . . . . 0.0 110.81 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 56.9 p -104.14 36.41 2.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.35 0.595 . . . . 0.0 111.308 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -157.77 140.36 14.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.186 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -131.88 149.72 52.36 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.568 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 42.1 mmtm -116.6 143.85 45.1 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.439 ' HB ' ' HB2' ' A' ' 123' ' ' LEU . 29.8 mm -123.76 122.29 64.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 175.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.81 -32.82 13.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.311 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.6 m -77.96 83.81 4.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.838 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 86.9 mt -133.03 145.63 50.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.784 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -102.49 122.13 47.45 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.283 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.65 112.93 1.41 Allowed 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.468 2.112 . . . . 0.0 111.682 175.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 89.27 44.76 4.92 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.658 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -141.29 147.41 38.15 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.763 0.316 . . . . 0.0 110.17 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -91.55 137.82 32.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.469 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -125.19 140.49 52.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.023 0.44 . . . . 0.0 110.498 176.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.4 mp -104.64 132.1 51.29 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.62 147.23 28.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.948 0.404 . . . . 0.0 111.699 -175.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.574 ' OE1' ' HB3' ' A' ' 194' ' ' TRP . 53.6 mt-30 -143.46 153.28 42.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.392 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.9 p -124.67 140.44 47.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.113 0.482 . . . . 0.0 111.012 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . 0.629 ' HG3' ' CE3' ' A' ' 194' ' ' TRP . 26.2 mtp-105 -133.34 163.99 28.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.912 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . 0.507 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 31.5 p -140.7 125.72 18.38 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 167.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.411 ' HD3' HH12 ' A' ' 183' ' ' ARG . 23.4 pttm . . . . . 0 C--N 1.318 -0.781 0 CA-C-O 121.328 0.585 . . . . 0.0 110.984 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.629 ' CE3' ' HG3' ' A' ' 183' ' ' ARG . 69.0 m95 . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 120.726 0.298 . . . . 0.0 111.624 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.481 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 42.0 m -159.64 -57.58 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -176.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.491 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 9.2 Cg_endo -90.03 91.9 0.31 Allowed 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.539 2.159 . . . . 0.0 113.595 -170.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.549 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -79.48 116.55 19.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.023 0.44 . . . . 0.0 111.0 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 27.0 m -109.48 140.96 42.6 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.812 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -115.61 127.82 55.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.731 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.9 tp -125.45 135.52 63.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.033 0.444 . . . . 0.0 111.141 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -96.67 118.9 34.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.404 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 50.8 mm -84.21 119.88 73.82 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.44 151.1 86.56 Favored 'Trans proline' 0 N--CA 1.466 -0.147 0 C-N-CA 122.558 2.172 . . . . 0.0 112.251 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 19.2 m -69.94 -20.4 63.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.047 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -88.2 26.82 1.32 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.775 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -66.18 -43.98 85.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.635 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 28.8 m . . . . . 0 C--N 1.319 -0.723 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.922 178.602 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.674 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 39.4 Cg_endo . . . . . 0 N--CA 1.461 -0.414 0 CA-C-O 121.545 0.56 . . . . 0.0 111.44 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -90.41 175.01 7.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.675 -177.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 53.38 51.96 14.39 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 123.556 0.535 . . . . 0.0 110.888 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 57.0 tp -78.84 96.37 5.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.148 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.83 128.71 45.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.387 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -116.62 115.74 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -125.0 130.18 51.83 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.965 0.412 . . . . 0.0 110.786 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.5 p -77.52 117.42 22.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.2 0.524 . . . . 0.0 109.874 176.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -102.23 122.38 44.09 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.282 0.563 . . . . 0.0 111.388 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -124.91 75.82 66.31 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.753 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.459 ' HG2' ' HB2' ' A' ' 119' ' ' ARG . 6.7 Cg_exo -76.03 -179.06 4.84 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 123.38 2.72 . . . . 0.0 112.782 -175.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -89.76 -64.21 1.17 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -71.96 -36.83 69.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.442 -177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.459 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 56.9 mtt85 -88.01 156.35 19.36 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.592 -178.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.416 ' O ' ' HD1' ' A' ' 122' ' ' TYR . 50.6 mtmt -75.35 153.56 85.98 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.04 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.25 133.76 39.26 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.329 2.019 . . . . 0.0 111.503 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.416 ' HD1' ' O ' ' A' ' 120' ' ' LYS . 55.1 p90 -151.12 166.23 31.44 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.432 -176.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 169' ' ' ILE . 38.9 tp -95.98 123.21 39.48 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 176.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.402 ' HE1' ' HB2' ' A' ' 166' ' ' GLU . 17.5 t90 -103.24 106.68 17.25 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.221 -176.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.4 mp -106.28 118.36 53.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.708 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -131.54 141.45 49.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.48 0.657 . . . . 0.0 111.24 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . 0.45 ' CH2' HD11 ' A' ' 146' ' ' ILE . 28.7 p90 -129.07 155.44 45.44 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.439 -176.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 22.6 t -83.36 130.53 56.17 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 C--N 1.346 0.432 0 C-N-CA 123.045 2.497 . . . . 0.0 112.492 -178.91 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.415 HD11 ' H ' ' A' ' 185' ' ' LYS . 42.2 tp . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 120.967 0.413 . . . . 0.0 110.463 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.6 mp -106.18 144.8 32.37 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.557 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -113.61 165.31 12.64 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.151 -176.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.452 ' HB3' ' NE ' ' A' ' 183' ' ' ARG . 40.3 tt0 -154.07 139.37 17.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.527 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.523 ' CD1' ' HB2' ' A' ' 161' ' ' ALA . 4.3 mp -121.92 130.19 74.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.042 0.449 . . . . 0.0 110.968 -172.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.463 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 27.8 ttp180 -108.18 121.15 44.26 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 1.7 pp -146.98 166.0 28.13 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.9 0.381 . . . . 0.0 111.413 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -172.45 149.89 2.13 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.751 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.35 162.45 42.34 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.34 2.026 . . . . 0.0 111.153 172.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -67.31 -14.53 63.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.546 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -93.93 2.97 56.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.289 0.566 . . . . 0.0 110.06 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -102.76 130.93 49.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.272 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -88.22 -35.85 17.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.24 0.543 . . . . 0.0 110.315 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -95.84 150.44 20.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.333 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.463 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 84.3 m95 -85.91 148.02 25.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.238 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -115.82 119.23 35.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.947 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.0 mp -99.05 131.68 45.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.103 0.478 . . . . 0.0 110.847 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -125.54 126.41 44.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.976 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -83.28 124.79 30.93 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.523 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -82.3 -36.43 27.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.895 0.379 . . . . 0.0 111.286 -176.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 88.34 -136.97 14.08 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.487 -0.863 . . . . 0.0 110.965 -175.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -99.85 70.99 1.65 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.088 0.47 . . . . 0.0 110.353 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -160.24 147.17 15.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.821 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.2 p -102.43 13.62 34.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.35 0.595 . . . . 0.0 111.074 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 166' ' ' GLU . 1.0 OUTLIER -140.08 113.41 8.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.89 175.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -109.03 152.08 25.48 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.519 -173.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' A' ' 168' ' ' LYS . 10.4 mptt -123.23 129.11 50.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.276 -176.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.403 ' HB ' ' HB3' ' A' ' 123' ' ' LEU . 28.9 mm -108.54 137.58 39.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 175.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.77 -23.18 12.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.997 0.427 . . . . 0.0 110.58 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 7.0 m -87.17 67.5 9.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.78 -175.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.01 140.43 39.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.968 0.413 . . . . 0.0 110.887 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 32.5 m-70 -103.74 115.81 62.86 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.474 173.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 35.8 Cg_exo -59.02 126.09 20.06 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.822 2.348 . . . . 0.0 112.878 -177.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 88.86 29.45 18.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.752 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -133.95 145.51 49.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.095 0.474 . . . . 0.0 110.734 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -82.44 132.05 35.21 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.441 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -114.71 136.7 52.78 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.872 0.368 . . . . 0.0 110.532 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.9 mm? -101.36 129.26 47.32 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 174.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.24 141.7 44.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.176 0.512 . . . . 0.0 111.655 -176.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -144.59 134.06 23.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.959 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 6.5 p -117.71 135.73 57.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . 0.452 ' NE ' ' HB3' ' A' ' 145' ' ' GLU . 7.8 ppt_? -116.12 155.73 27.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.83 0.348 . . . . 0.0 110.731 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . 0.674 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 26.4 p -136.77 175.26 9.78 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.794 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.415 ' H ' HD11 ' A' ' 142' ' ' LEU . 37.1 mtmt . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.337 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 29.9 m95 . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.516 0.198 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.474 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 36.4 t -116.0 -59.67 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 195' ' ' SER . 95.4 Cg_endo -76.8 87.37 1.48 Allowed 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.857 1.705 . . . . 0.0 113.397 -173.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.61 101.75 5.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.101 0.477 . . . . 0.0 109.927 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 18.6 m -91.03 131.26 36.73 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.917 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -94.33 132.46 38.91 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.458 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.651 HG12 ' N ' ' A' ' 201' ' ' GLN . 0.0 OUTLIER -147.49 150.24 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.367 0.603 . . . . 0.0 111.297 174.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.651 ' N ' HG12 ' A' ' 200' ' ' ILE . 7.6 mm-40 -91.81 136.01 33.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.741 176.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 49.0 mm -100.89 114.75 65.83 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 165.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.64 148.95 79.51 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.905 2.403 . . . . 0.0 112.555 -175.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 17.1 m -69.79 -23.98 63.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.856 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -92.21 32.92 1.11 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.202 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -65.93 -32.44 73.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.135 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 C--N 1.321 -0.637 0 CA-C-O 121.119 0.485 . . . . 0.0 110.662 -178.829 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.477 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 7.1 Cg_endo . . . . . 0 C--O 1.233 0.24 0 CA-C-O 121.18 0.409 . . . . 0.0 111.692 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -73.15 163.02 28.74 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.384 -173.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 60.61 54.46 3.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.382 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -75.58 93.92 3.1 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -97.21 131.46 43.92 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.407 -176.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.57 114.39 43.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -129.39 140.36 51.37 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.367 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.9 p -87.16 115.56 28.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.413 0.625 . . . . 0.0 109.351 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.508 ' O ' ' HD3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -102.06 113.2 26.24 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.4 -174.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -105.49 98.89 18.4 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.316 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 114' ' ' LYS . 5.5 Cg_exo -80.79 146.08 16.36 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.295 2.663 . . . . 0.0 112.092 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.0 -23.99 58.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.831 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -118.15 3.27 12.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.774 0.321 . . . . 0.0 111.376 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -137.86 151.64 48.26 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.461 ' HD2' ' N ' ' A' ' 120' ' ' LYS . 12.7 mptt -63.42 139.04 97.52 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.236 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.18 145.12 98.78 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.476 2.784 . . . . 0.0 112.752 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.517 ' CE1' ' HD2' ' A' ' 168' ' ' LYS . 35.4 p90 -149.28 155.04 39.93 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.26 -176.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 9.3 mt -80.43 127.41 32.38 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 173.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.563 ' CZ2' ' HD2' ' A' ' 126' ' ' LYS . 14.4 t90 -101.69 102.18 12.8 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.789 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.5 mp -93.62 114.27 29.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.563 ' HD2' ' CZ2' ' A' ' 124' ' ' TRP . 64.1 tttm -127.84 126.56 41.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.568 -175.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 39.9 p90 -126.04 158.98 33.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.338 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.42 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 37.7 m -99.61 131.74 24.26 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.195 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 128' ' ' SER . 33.5 Cg_exo . . . . . 0 C--O 1.233 0.267 0 C-N-CA 122.664 2.243 . . . . 0.0 111.725 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.518 HD22 ' SG ' ' A' ' 184' ' ' CYS . 56.7 tp . . . . . 0 C--O 1.233 0.189 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -93.88 152.7 18.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.035 0.445 . . . . 0.0 111.141 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.595 ' CD1' ' HB3' ' A' ' 184' ' ' CYS . 63.7 m-85 -129.78 149.84 51.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.012 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -128.73 139.7 52.09 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.42 124.34 69.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.847 0.356 . . . . 0.0 110.448 -176.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.497 ' HB2' ' CZ2' ' A' ' 194' ' ' TRP . 16.3 ttp180 -113.76 120.18 39.91 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.412 HD22 ' C ' ' A' ' 148' ' ' LEU . 0.0 OUTLIER -143.42 160.22 40.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.542 0.211 . . . . 0.0 110.786 -177.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -165.23 148.65 7.21 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.241 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 178' ' ' TYR . 56.9 Cg_endo -73.47 169.37 22.47 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.57 2.18 . . . . 0.0 111.946 172.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -68.9 -11.54 60.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.667 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -93.76 -1.57 54.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.289 0.566 . . . . 0.0 110.004 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -100.19 122.6 43.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.771 -173.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -84.45 -28.38 26.87 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.562 0.696 . . . . 0.0 109.437 173.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -106.85 146.32 31.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.173 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.467 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 80.0 m95 -86.69 155.22 20.47 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.08 0.466 . . . . 0.0 111.582 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -111.62 127.39 55.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.74 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.87 126.99 67.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.164 0.507 . . . . 0.0 111.222 -176.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -125.26 137.98 54.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -96.57 138.21 34.49 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.4 -23.16 50.73 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.514 -177.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 83.86 -46.06 3.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.994 177.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -179.52 -33.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.128 0.489 . . . . 0.0 109.895 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -72.28 160.08 32.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.385 -177.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.406 HG22 ' HG3' ' A' ' 129' ' ' PRO . 67.5 p -110.03 30.33 6.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.401 -174.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -153.19 140.6 19.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.711 175.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -135.65 153.25 51.69 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.672 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 22.5 mmtt -118.86 140.98 49.07 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 31.8 mm -114.89 123.79 70.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.691 0.281 . . . . 0.0 110.561 176.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.416 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.8 mm? -95.72 -16.76 21.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.5 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.8 m -80.8 71.15 7.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.709 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 59.4 mt -129.63 137.22 50.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.98 0.419 . . . . 0.0 111.34 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -111.7 125.19 30.8 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.263 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.84 122.52 11.35 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.742 2.295 . . . . 0.0 112.46 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 95.43 22.26 22.34 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.749 177.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -131.24 148.73 52.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.935 0.398 . . . . 0.0 110.895 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -90.26 134.18 34.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.116 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.492 ' CZ ' ' HB3' ' A' ' 150' ' ' PRO . 12.1 m-85 -119.9 149.59 41.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.021 0.438 . . . . 0.0 110.652 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.9 mp -112.49 136.21 52.27 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.3 m -132.6 148.12 31.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.056 0.455 . . . . 0.0 111.372 -177.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 93.2 mt-30 -150.29 144.33 25.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.384 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.419 HG13 ' HG2' ' A' ' 106' ' ' PRO . 12.0 p -138.83 145.01 28.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 171.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -155.53 161.22 40.93 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.223 0.535 . . . . 0.0 110.182 171.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . 0.595 ' HB3' ' CD1' ' A' ' 144' ' ' TYR . 5.7 p -116.69 -174.45 2.57 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.077 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.412 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.955 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.497 ' CZ2' ' HB2' ' A' ' 147' ' ' ARG . 61.8 m95 . . . . . 0 C--O 1.236 0.346 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.438 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 50.7 m -156.07 -53.89 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.525 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 1.1 Cg_endo -82.95 81.27 2.44 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.128 1.886 . . . . 0.0 113.057 -173.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.4 ' HA ' ' CG ' ' A' ' 181' ' ' GLN . . . -82.83 103.94 12.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.115 0.484 . . . . 0.0 110.66 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 53.9 m -96.7 138.06 34.83 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.257 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -102.76 130.87 49.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.495 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.2 tp -135.91 137.09 49.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.207 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -102.46 147.05 27.22 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.93 0.395 . . . . 0.0 111.566 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 21.8 mm -96.47 118.16 65.52 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.789 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.51 153.28 72.35 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.968 2.445 . . . . 0.0 112.11 -177.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 28.0 m -70.81 -23.03 62.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.889 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -94.2 34.56 1.25 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.643 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -69.66 -50.97 38.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.838 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 6.4 t . . . . . 0 C--N 1.324 -0.502 0 CA-C-O 121.371 0.605 . . . . 0.0 111.098 -176.869 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.487 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 35.8 Cg_exo . . . . . 0 C--O 1.233 0.263 0 CA-C-O 120.867 0.278 . . . . 0.0 111.672 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -122.3 -179.45 4.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.427 -172.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 54.78 41.22 32.08 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 123.576 0.548 . . . . 0.0 110.731 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.6 tt -64.53 103.97 0.74 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.792 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -109.74 132.42 54.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.705 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.3 t -114.42 126.35 71.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.84 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -126.52 132.61 51.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.947 0.404 . . . . 0.0 110.615 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.8 p -87.22 126.36 41.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.1 0.476 . . . . 0.0 110.196 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 114' ' ' LYS . 55.1 mmtt -106.68 127.29 53.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.032 0.444 . . . . 0.0 110.957 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -132.94 85.09 47.22 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.158 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.71 168.7 22.99 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.982 2.455 . . . . 0.0 111.5 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.17 -6.24 23.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.859 0.362 . . . . 0.0 111.354 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -132.88 2.62 3.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.481 0.658 . . . . 0.0 110.534 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -136.82 149.14 47.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.531 -176.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -56.97 130.63 79.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 O-C-N 123.513 0.508 . . . . 0.0 111.289 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.27 137.04 63.41 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.573 2.182 . . . . 0.0 111.361 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -140.9 163.89 31.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.468 -175.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.0 tp -100.19 124.99 46.26 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.456 ' CZ2' ' HD3' ' A' ' 126' ' ' LYS . 25.9 t90 -107.49 115.94 31.05 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.418 -177.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.4 mp -101.06 122.55 53.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.735 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.456 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 39.7 ttpt -129.72 120.36 24.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.189 0.519 . . . . 0.0 110.555 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . 0.439 ' CE2' HG21 ' A' ' 182' ' ' VAL . 40.3 p90 -116.28 160.78 19.98 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.931 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.3 m -95.61 129.37 34.86 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo . . . . . 0 C--O 1.233 0.271 0 C-N-CA 122.905 2.404 . . . . 0.0 111.945 -178.884 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 41.8 tp . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.6 mp -99.84 143.19 30.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.01 0.434 . . . . 0.0 110.872 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -115.3 133.78 55.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.662 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -116.75 139.35 50.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 181' ' ' GLN . 4.7 mp -120.26 119.72 60.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.088 0.47 . . . . 0.0 110.859 -176.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.414 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 21.4 ttp180 -104.18 121.68 43.78 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.2 pp -143.88 162.75 35.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.678 0.275 . . . . 0.0 111.316 -176.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -171.51 150.42 2.71 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.416 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.16 156.37 55.57 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.096 1.864 . . . . 0.0 110.904 170.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -61.95 -18.57 60.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.246 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -91.62 -3.85 55.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.984 0.421 . . . . 0.0 110.553 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -87.6 127.12 35.27 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.099 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.72 -14.27 52.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.285 0.564 . . . . 0.0 110.475 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -119.95 139.02 53.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.794 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.414 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 78.2 m95 -81.4 147.98 29.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.354 177.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -116.08 117.62 30.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.279 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mp -93.05 123.18 45.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.392 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 59.8 m-70 -119.04 155.87 30.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.524 176.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -122.6 129.79 52.29 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.518 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -97.88 -34.74 10.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.943 0.401 . . . . 0.0 110.953 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.58 -140.93 15.24 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.49 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -91.67 52.99 2.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.211 0.529 . . . . 0.0 109.906 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -150.1 149.92 30.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.329 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.428 ' HA ' ' CE2' ' A' ' 127' ' ' TRP . 61.3 p -101.4 33.08 3.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.954 -174.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -146.59 134.09 20.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.975 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 39.9 t80 -136.89 149.33 47.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.105 176.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.97 140.84 49.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.945 0.402 . . . . 0.0 111.224 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 34.7 mm -117.67 136.41 54.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.886 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -103.84 -23.85 13.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.833 0.349 . . . . 0.0 110.67 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 69.5 m -89.54 80.53 6.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.867 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -116.57 132.16 56.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.982 0.42 . . . . 0.0 110.691 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 52.9 m170 -100.09 118.62 61.17 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.657 176.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.02 118.46 5.33 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.875 2.383 . . . . 0.0 112.813 -178.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 97.22 5.64 58.06 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.96 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -109.03 151.4 26.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.157 0.503 . . . . 0.0 110.66 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.431 ' HE3' ' HB3' ' A' ' 199' ' ' PHE . 37.8 tttp -93.51 136.72 33.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.07 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -120.88 139.42 53.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.879 0.371 . . . . 0.0 110.21 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.7 mp -104.08 126.06 50.9 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.9 m -123.76 139.15 51.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.117 0.484 . . . . 0.0 111.312 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.485 ' HG3' ' HA ' ' A' ' 197' ' ' ALA . 0.0 OUTLIER -141.63 134.64 29.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.14 179.415 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.439 HG21 ' CE2' ' A' ' 127' ' ' TRP . 7.8 p -129.45 137.65 56.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -143.39 149.56 37.85 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . 0.487 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 28.3 p -118.21 158.85 24.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.638 -174.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 121.137 0.494 . . . . 0.0 111.279 -178.856 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 80.4 m95 . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.525 ' H ' ' HD2' ' A' ' 196' ' ' PRO . 20.0 m -137.02 -57.88 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.569 0 CA-C-O 119.242 -0.409 . . . . 0.0 111.947 -177.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.525 ' HD2' ' H ' ' A' ' 195' ' ' SER . 59.3 Cg_endo -71.42 83.06 1.05 Allowed 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.627 1.551 . . . . 0.0 112.874 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.485 ' HA ' ' HG3' ' A' ' 181' ' ' GLN . . . -88.24 115.14 25.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.143 0.497 . . . . 0.0 110.662 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 85.7 m -107.12 138.39 43.39 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.053 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.431 ' HB3' ' HE3' ' A' ' 177' ' ' LYS . 62.1 m-85 -106.61 140.04 40.11 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.347 -176.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.9 tp -136.54 134.06 49.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.147 0.499 . . . . 0.0 110.533 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.81 123.1 45.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.25 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.9 mm -79.34 123.52 84.51 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.96 149.63 87.85 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.904 2.402 . . . . 0.0 112.371 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 13.3 m -66.03 -26.48 67.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.94 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -91.91 27.78 2.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.55 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -62.71 -46.93 85.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.137 0.494 . . . . 0.0 110.433 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 C--N 1.32 -0.674 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.9 177.774 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo . . . . . 0 N--CA 1.449 -1.116 0 CA-C-O 121.009 0.337 . . . . 0.0 111.412 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.5 mp -91.52 178.24 6.0 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.835 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 128' ' ' SER . 39.6 mt-10 50.2 47.41 23.68 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 124.839 1.337 . . . . 0.0 111.727 165.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.2 tp -64.86 112.94 3.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.92 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -114.16 128.12 56.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.407 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.5 t -116.44 126.34 73.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.82 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -141.38 126.44 18.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.913 0.387 . . . . 0.0 110.609 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.31 133.96 28.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.318 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -124.19 117.71 25.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.356 0.598 . . . . 0.0 111.088 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.447 ' NE2' ' HA ' ' A' ' 206' ' ' PHE . 46.6 mt-30 -108.59 99.64 34.52 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.476 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' A' ' 117' ' ' GLU . 16.0 Cg_exo -68.1 -83.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.769 2.313 . . . . 0.0 112.66 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.422 ' H ' ' HB2' ' A' ' 116' ' ' PRO . 12.2 tp10 -175.17 -77.44 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 120.704 0.288 . . . . 0.0 110.64 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -87.27 -34.89 18.76 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -66.92 134.79 52.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.923 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -58.35 135.11 85.15 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.004 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.406 ' HB3' ' HG2' ' A' ' 115' ' ' GLN . 28.1 Cg_endo -62.12 140.37 83.5 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.654 2.236 . . . . 0.0 111.367 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.513 ' CE2' ' HD2' ' A' ' 168' ' ' LYS . 23.2 p90 -144.03 155.85 44.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.064 0.459 . . . . 0.0 111.594 -172.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 6.6 mt -83.12 130.51 35.12 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.839 172.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -107.91 106.65 17.01 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.706 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 166' ' ' GLU . 4.0 mp -100.88 131.17 49.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.776 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -138.87 156.72 47.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.965 0.412 . . . . 0.0 110.577 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 20.1 p90 -143.53 156.21 44.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.911 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 15.0 m -114.22 105.38 54.12 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.076 -178.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo . . . . . 0 C--O 1.235 0.343 0 C-N-CA 122.496 2.13 . . . . 0.0 111.033 173.824 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 55.5 tp . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.984 0.421 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.3 mp -89.4 139.84 30.11 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.786 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -114.49 149.68 35.98 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.914 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -133.22 133.42 42.71 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.37 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.467 HD13 ' N ' ' A' ' 146' ' ' ILE . 4.2 mp -113.72 131.5 65.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.749 0.309 . . . . 0.0 110.632 -174.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.49 ' HB2' ' CH2' ' A' ' 194' ' ' TRP . 18.6 ttp180 -118.23 120.18 36.92 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 157' ' ' GLU . 0.0 OUTLIER -145.58 160.41 41.7 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.798 -178.128 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -169.72 147.66 3.06 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.532 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -70.08 167.37 25.04 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.102 1.868 . . . . 0.0 111.789 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -61.78 -29.65 70.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.221 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -86.53 7.03 27.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -177.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -94.72 130.95 41.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.113 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -87.32 -26.63 23.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.842 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -123.69 150.08 44.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.294 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.447 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 77.6 m95 -82.34 145.83 29.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.542 -177.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 148' ' ' LEU . 43.2 mt-10 -98.71 118.96 36.62 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.445 175.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mp -98.16 116.18 40.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -119.84 114.66 22.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.12 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -81.28 133.68 35.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.854 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -101.11 -51.64 3.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.876 0.37 . . . . 0.0 111.481 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 127.59 -142.39 13.47 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -175.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.3 20.3 11.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.322 0.561 . . . . 0.0 111.127 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -103.41 143.75 32.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.806 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 38.8 p -96.48 36.49 1.36 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.039 0.447 . . . . 0.0 111.787 -175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 125' ' ' ILE . 9.2 pt-20 -156.45 145.04 20.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.177 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -140.71 151.2 44.33 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.513 ' HD2' ' CE2' ' A' ' 122' ' ' TYR . 45.8 mmtt -116.41 137.67 51.97 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 41.0 mm -112.74 120.83 63.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 175.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.447 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.9 mm? -89.71 -38.96 13.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 -177.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 50.4 m -76.72 84.5 3.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.066 0.46 . . . . 0.0 111.206 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 90.2 mt -126.38 133.21 51.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.75 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -102.49 124.57 38.87 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.031 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.44 124.8 15.86 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.656 2.237 . . . . 0.0 112.387 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 88.16 27.56 25.38 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.549 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -126.82 146.95 50.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.027 0.442 . . . . 0.0 111.038 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -85.42 131.71 34.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.577 177.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -121.13 136.17 55.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.888 0.375 . . . . 0.0 110.471 176.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 8.5 mp -103.65 126.62 50.91 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.2 142.71 38.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.147 0.499 . . . . 0.0 111.813 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.557 ' NE2' ' HB3' ' A' ' 197' ' ' ALA . 89.4 mt-30 -143.25 157.91 44.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.899 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.46 144.39 24.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.142 178.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . 0.648 ' HG2' ' CZ3' ' A' ' 194' ' ' TRP . 1.9 ptm180 -138.82 175.6 9.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.213 0.53 . . . . 0.0 110.673 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 10.6 p -160.78 -172.66 3.59 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.369 176.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt . . . . . 0 C--N 1.324 -0.515 0 CA-C-O 121.199 0.523 . . . . 0.0 111.176 177.332 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.648 ' CZ3' ' HG2' ' A' ' 183' ' ' ARG . 14.4 m95 . . . . . 0 C--O 1.233 0.236 0 CA-C-O 120.577 0.227 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.556 ' OG ' ' HD3' ' A' ' 196' ' ' PRO . 3.5 p -103.75 -50.59 0.14 Allowed Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.556 ' HD3' ' OG ' ' A' ' 195' ' ' SER . 4.7 Cg_exo -78.97 80.53 3.06 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.085 1.857 . . . . 0.0 113.078 -173.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.557 ' HB3' ' NE2' ' A' ' 181' ' ' GLN . . . -83.96 101.08 11.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.324 0.583 . . . . 0.0 110.104 176.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 25.2 m -95.97 131.45 42.33 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.605 -176.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -95.58 114.82 26.61 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.571 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.3 tp -118.23 134.92 60.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.056 0.455 . . . . 0.0 110.153 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -102.37 134.78 45.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.987 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 40.4 mm -92.16 116.48 66.54 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.614 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.97 150.24 84.89 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.557 2.171 . . . . 0.0 112.074 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 30.2 p -67.84 -18.21 64.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.596 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -86.18 10.24 15.13 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.636 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.447 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 57.5 t80 -64.71 -37.98 89.42 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 173.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 C--N 1.321 -0.658 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.134 176.653 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 C--O 1.235 0.346 0 CA-C-O 121.301 0.459 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 pp -122.77 178.92 4.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.76 -175.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 53.07 46.17 27.26 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 123.659 0.599 . . . . 0.0 110.702 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.7 tp -70.28 99.17 1.49 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.909 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.94 130.22 46.09 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.342 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.1 t -123.8 127.07 73.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.812 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -143.41 159.17 42.88 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.976 0.417 . . . . 0.0 110.848 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.79 129.65 60.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.408 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -111.28 132.92 54.0 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -122.52 83.72 47.7 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.832 0.349 . . . . 0.0 111.448 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -83.43 163.78 14.7 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.334 2.689 . . . . 0.0 111.376 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -97.62 -31.09 12.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.078 0.466 . . . . 0.0 111.006 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -86.37 -22.12 26.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.615 0.722 . . . . 0.0 109.965 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -123.07 135.47 54.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.064 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -56.66 134.71 78.03 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -49.79 141.12 28.79 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.419 2.746 . . . . 0.0 112.445 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -144.55 162.22 37.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.931 -173.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 31.4 tp -95.77 128.49 42.69 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.582 176.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -105.75 114.37 28.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.373 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.3 mp -104.29 120.9 55.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -128.94 128.67 44.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.096 0.474 . . . . 0.0 110.913 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . 0.439 ' CH2' HD12 ' A' ' 146' ' ' ILE . 32.6 p90 -121.41 160.79 23.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.907 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.3 t -123.74 123.66 26.25 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.459 -0.521 0 C-N-CA 122.326 2.017 . . . . 0.0 111.181 175.478 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.4 pt? . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 121.435 0.636 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 56.4 mt -91.95 149.58 21.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.688 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -108.0 150.61 26.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.245 0.545 . . . . 0.0 111.575 -174.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -140.91 130.12 23.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.171 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.466 HD11 ' N ' ' A' ' 146' ' ' ILE . 4.3 mp -110.73 129.12 66.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.962 0.41 . . . . 0.0 110.82 -173.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.487 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 15.9 ttp180 -111.15 120.08 41.11 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -146.22 161.11 40.98 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.621 0.248 . . . . 0.0 110.969 -177.384 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -167.84 147.46 4.3 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.684 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -71.96 178.01 6.4 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.411 2.074 . . . . 0.0 112.339 172.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.405 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 11.0 pt-20 -70.5 -30.84 67.74 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -176.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.405 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 88.5 mttt -91.67 13.01 19.25 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.152 0.501 . . . . 0.0 110.825 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -98.71 119.79 38.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.719 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.79 -32.47 35.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.324 0.583 . . . . 0.0 110.43 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -101.28 156.99 17.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.604 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.487 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 81.5 m95 -96.15 139.93 31.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.076 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -94.97 115.14 27.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.54 175.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.69 119.02 40.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 34.8 m-70 -120.14 108.14 13.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.193 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -75.24 126.0 30.12 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -93.51 -43.43 8.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.017 0.437 . . . . 0.0 110.985 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 102.95 -134.94 12.03 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.098 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -94.97 60.95 2.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.267 0.556 . . . . 0.0 110.138 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -156.81 146.28 20.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.117 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 44.0 p -103.22 37.37 2.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.182 0.515 . . . . 0.0 111.26 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -149.09 140.96 23.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.936 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 22.0 t80 -142.09 145.18 34.0 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 174.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 0.7 OUTLIER -119.17 129.85 55.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.776 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 35.8 mm -101.46 126.46 55.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 174.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -100.16 -30.78 11.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.724 0.297 . . . . 0.0 110.763 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 13.3 m -79.65 81.44 5.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.466 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 74.1 mt -126.36 140.97 52.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.954 0.407 . . . . 0.0 111.367 -176.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -112.55 131.19 22.77 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.222 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.11 130.01 30.81 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.608 2.205 . . . . 0.0 112.13 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.64 26.77 60.27 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.275 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.417 ' HB3' ' CE1' ' A' ' 178' ' ' TYR . 0.6 OUTLIER -115.4 138.23 51.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.763 0.316 . . . . 0.0 110.23 179.003 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -82.71 129.9 35.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.365 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.417 ' CE1' ' HB3' ' A' ' 176' ' ' GLN . 66.5 m-85 -121.06 140.19 52.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.872 0.368 . . . . 0.0 110.311 177.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.7 mm? -107.78 129.38 55.05 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.4 m -127.46 138.08 55.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.059 0.457 . . . . 0.0 111.945 -175.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.503 ' OE1' ' HB3' ' A' ' 194' ' ' TRP . 78.6 mt-30 -144.0 153.2 41.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.727 177.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.19 137.99 45.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.888 0.375 . . . . 0.0 110.759 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . 0.479 ' HD2' ' C ' ' A' ' 183' ' ' ARG . 6.1 ppt_? -126.45 164.02 22.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.127 177.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 20.1 p -146.69 175.34 10.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.003 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 C--N 1.325 -0.48 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 173.447 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.503 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 70.5 m95 . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.579 ' H ' ' HD2' ' A' ' 196' ' ' PRO . 20.3 m -137.21 -54.01 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.579 ' HD2' ' H ' ' A' ' 195' ' ' SER . 66.4 Cg_endo -74.25 82.99 1.73 Allowed 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 121.686 1.59 . . . . 0.0 113.208 -175.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.446 ' HB3' ' NE2' ' A' ' 181' ' ' GLN . . . -82.3 104.03 12.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.805 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 34.7 m -95.21 135.79 36.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.738 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -98.72 119.48 37.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.068 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.3 tp -125.71 138.56 54.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.026 0.441 . . . . 0.0 110.627 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -106.78 140.86 38.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.361 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 41.0 mm -96.87 124.51 49.81 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.837 177.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.0 149.12 81.64 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.853 2.369 . . . . 0.0 112.04 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 3.0 p -75.24 -15.19 60.55 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.856 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -95.99 18.07 14.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.084 175.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -55.47 -60.58 3.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.27 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.7 m . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.144 179.7 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.499 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 9.7 Cg_endo . . . . . 0 C--O 1.232 0.189 0 CA-C-O 120.843 0.268 . . . . 0.0 111.446 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.86 175.34 6.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.485 -172.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 55.97 47.13 20.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.849 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.6 tp -68.92 98.9 0.99 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.631 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.63 130.39 41.11 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.457 -176.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -125.13 120.41 58.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.087 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -138.0 157.7 45.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.723 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.3 p -107.53 131.19 58.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.136 0.493 . . . . 0.0 110.295 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -103.04 123.88 47.46 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -123.38 80.36 53.39 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.006 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.443 ' HG2' ' HB2' ' A' ' 119' ' ' ARG . 1.0 OUTLIER -86.69 163.86 9.2 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.562 2.841 . . . . 0.0 111.798 177.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -97.45 -30.27 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.054 0.454 . . . . 0.0 111.169 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -93.76 -25.48 17.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.434 0.635 . . . . 0.0 110.177 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.443 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 23.3 mmt180 -110.91 151.74 27.55 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 175.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -73.78 138.3 76.82 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.63 132.93 55.04 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.946 2.431 . . . . 0.0 111.804 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.438 ' CD2' ' HD2' ' A' ' 168' ' ' LYS . 53.1 p90 -145.8 157.62 43.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.974 0.416 . . . . 0.0 110.957 -174.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 26.3 tp -91.21 131.17 36.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.624 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.564 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 12.4 t90 -110.47 109.38 19.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.207 -175.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.2 mp -108.05 123.37 63.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.082 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -123.23 148.42 45.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.834 0.35 . . . . 0.0 110.622 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -138.87 152.2 47.6 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.916 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 m -113.26 138.02 22.24 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.705 -175.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo . . . . . 0 C--N 1.346 0.445 0 C-N-CA 122.945 2.43 . . . . 0.0 111.556 175.767 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 29.7 tp . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.412 HD13 ' HG2' ' A' ' 163' ' ' GLN . 8.3 mp -98.01 153.28 18.49 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.848 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.53 ' CD2' ' HB3' ' A' ' 184' ' ' CYS . 75.2 m-85 -128.99 147.56 50.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.301 -173.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -128.12 139.82 52.29 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.453 HD11 ' N ' ' A' ' 146' ' ' ILE . 4.3 mp -117.44 129.52 73.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.039 0.447 . . . . 0.0 110.718 -175.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.468 HH22 ' NE2' ' A' ' 181' ' ' GLN . 7.7 ttp-105 -112.67 120.4 41.42 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.529 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -143.69 160.38 40.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.463 0.173 . . . . 0.0 110.821 -177.266 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -165.96 151.76 8.2 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.395 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.401 ' HG2' ' HB3' ' A' ' 153' ' ' ALA . 37.1 Cg_endo -70.54 157.12 59.8 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.52 2.147 . . . . 0.0 110.923 170.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.475 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 14.9 pt-20 -62.51 -27.64 69.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.473 -0.785 . . . . 0.0 113.013 -170.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.475 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 82.4 mttt -94.09 9.29 38.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.091 0.472 . . . . 0.0 110.777 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.401 ' HB3' ' HG2' ' A' ' 150' ' ' PRO . . . -90.21 131.71 35.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.263 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.96 -35.35 24.04 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.97 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -103.66 159.98 15.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.273 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.425 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 60.0 m95 -101.04 156.23 17.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.652 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -102.79 120.97 41.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.194 173.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.54 117.84 47.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.948 177.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -124.55 124.58 42.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.924 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -89.48 126.1 35.44 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.047 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.423 ' HB1' ' CD1' ' A' ' 146' ' ' ILE . . . -83.96 -47.67 10.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.159 0.504 . . . . 0.0 110.88 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.405 ' C ' ' HG ' ' A' ' 143' ' ' LEU . . . 107.57 -128.49 9.21 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.805 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.412 ' HG2' HD13 ' A' ' 143' ' ' LEU . 34.4 mt-30 -94.76 5.59 51.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.25 0.548 . . . . 0.0 110.464 -175.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -95.94 142.74 27.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.534 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.429 HG23 ' CE1' ' A' ' 144' ' ' TYR . 61.9 p -101.63 23.98 10.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.459 0.647 . . . . 0.0 111.0 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -148.69 137.74 21.61 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -130.1 149.52 51.78 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.71 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.564 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 42.5 mmtm -114.69 135.85 53.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.593 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 123' ' ' LEU . 31.9 mm -109.86 136.32 46.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 172.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -102.29 -31.39 10.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.925 0.393 . . . . 0.0 110.852 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 44.0 m -89.33 80.95 6.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.652 -177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.8 mm? -112.97 131.23 55.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.978 174.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -88.68 116.84 67.42 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.542 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.42 116.09 3.18 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.577 2.185 . . . . 0.0 112.066 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 108.27 -2.05 33.02 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.992 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -110.22 144.27 39.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.447 0.641 . . . . 0.0 111.766 -175.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -85.29 128.75 34.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.877 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -109.98 146.65 34.9 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.077 0.465 . . . . 0.0 110.886 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.8 mp -111.17 127.83 55.71 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.88 142.99 40.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.913 0.387 . . . . 0.0 111.447 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.551 ' HG2' ' HA ' ' A' ' 197' ' ' ALA . 62.4 mt-30 -143.41 139.19 29.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.574 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 12.6 p -125.65 141.18 46.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.803 0.335 . . . . 0.0 110.165 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -136.82 150.99 48.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.005 0.431 . . . . 0.0 110.639 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . 0.53 ' HB3' ' CD2' ' A' ' 144' ' ' TYR . 18.5 p -128.89 155.98 44.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.947 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt . . . . . 0 C--N 1.328 -0.358 0 CA-C-O 121.399 0.619 . . . . 0.0 112.415 -172.726 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.512 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 44.6 m95 . . . . . 0 C--O 1.233 0.201 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.557 ' OG ' ' HD3' ' A' ' 196' ' ' PRO . 13.9 p -168.16 -50.07 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -177.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.557 ' HD3' ' OG ' ' A' ' 195' ' ' SER . 94.8 Cg_endo -85.46 86.73 1.02 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 121.69 1.593 . . . . 0.0 113.516 -171.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.551 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -83.76 114.17 21.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.146 0.498 . . . . 0.0 111.505 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 86.2 m -106.07 139.56 40.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.022 175.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -104.09 148.69 25.97 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.384 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.8 tp -154.29 134.56 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.248 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -97.58 125.53 42.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.681 0.277 . . . . 0.0 110.276 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 44.6 mm -80.59 117.7 69.04 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -59.07 145.69 96.81 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.551 2.167 . . . . 0.0 111.874 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 26.8 m -70.1 -8.22 47.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.474 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.71 -15.24 60.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.984 176.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 9.7 t80 -61.62 131.82 51.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.197 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 49.8 m . . . . . 0 CA--C 1.539 0.521 0 O-C-N 123.314 0.384 . . . . 0.0 111.223 -179.784 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.524 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 9.8 Cg_endo . . . . . 0 C--O 1.236 0.421 0 CA-C-O 121.08 0.367 . . . . 0.0 112.664 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -136.97 171.89 13.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.777 -173.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 54.35 57.22 6.04 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 123.96 0.787 . . . . 0.0 111.236 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.421 HD23 ' OG1' ' A' ' 198' ' ' THR . 56.2 tp -80.29 94.33 6.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.004 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.29 129.72 35.79 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.216 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.06 114.45 44.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.956 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.482 ' OE1' ' HE3' ' A' ' 114' ' ' LYS . 38.9 tt0 -135.51 131.69 36.36 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.349 -175.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.31 133.48 31.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.996 0.427 . . . . 0.0 110.892 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.482 ' HE3' ' OE1' ' A' ' 112' ' ' GLU . 0.4 OUTLIER -108.57 131.43 54.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.45 178.175 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -124.54 85.45 56.24 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.688 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.21 156.16 65.59 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 123.27 2.647 . . . . 0.0 112.318 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.91 -17.7 56.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.233 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -117.05 -49.75 2.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.9 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.78 157.6 28.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.764 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -64.29 145.5 98.2 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.336 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.97 141.13 76.08 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.821 2.347 . . . . 0.0 111.971 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.451 ' HB3' HD13 ' A' ' 170' ' ' LEU . 21.4 p90 -148.5 151.11 34.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.607 -174.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 6.8 mt -79.07 134.04 36.77 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.059 173.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -111.6 100.58 9.1 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.151 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.4 mp -90.16 123.47 42.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.494 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -132.56 119.55 20.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.044 0.449 . . . . 0.0 110.534 -176.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . 0.441 ' CH2' HD11 ' A' ' 146' ' ' ILE . 39.4 p90 -118.45 166.44 12.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.535 -176.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.6 t -101.15 118.32 60.51 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo . . . . . 0 N--CA 1.462 -0.371 0 C-N-CA 122.723 2.282 . . . . 0.0 112.322 -178.221 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 22.6 tp . . . . . 0 N--CA 1.451 -0.414 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.48 141.44 32.27 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.914 0.388 . . . . 0.0 110.954 -176.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -107.64 139.55 42.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.138 -172.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -133.57 134.35 43.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.639 -175.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.441 HD11 ' CH2' ' A' ' 127' ' ' TRP . 4.5 mp -118.9 124.82 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.881 0.372 . . . . 0.0 110.681 -175.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.491 ' HB2' ' CZ2' ' A' ' 194' ' ' TRP . 25.4 ttp180 -113.46 126.35 55.24 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.447 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 4.1 pp -149.89 164.67 34.78 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.526 -176.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -169.33 148.9 3.64 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.588 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -68.23 167.35 22.31 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.377 2.051 . . . . 0.0 111.812 172.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.422 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 11.3 pt-20 -64.02 -24.21 67.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.97 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.422 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 89.6 mttt -96.15 18.78 12.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.198 0.523 . . . . 0.0 110.753 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -103.99 128.73 51.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.718 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -95.0 -11.24 28.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.075 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.67 162.67 27.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.239 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.462 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 86.5 m95 -98.81 137.73 36.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.17 0.51 . . . . 0.0 112.278 -171.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -104.14 115.04 29.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.548 176.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 158' ' ' ILE . 2.5 mp -95.98 120.02 44.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.363 -178.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 65.5 m-70 -113.56 130.1 56.43 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.341 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -97.41 129.89 44.59 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.845 -176.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -95.27 -37.96 10.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.888 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.68 -125.13 8.24 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.854 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -98.92 9.05 44.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.008 0.433 . . . . 0.0 110.577 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -103.82 144.88 30.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.459 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.6 p -97.01 33.58 1.89 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.305 0.574 . . . . 0.0 111.731 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -154.64 149.99 27.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.592 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 31.9 t80 -145.12 149.44 35.02 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 49.4 mmtt -113.03 144.34 42.77 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 123' ' ' LEU . 36.3 mm -127.18 123.18 61.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.593 0.235 . . . . 0.0 110.809 176.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.451 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.9 mm? -97.3 -28.74 13.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.184 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 9.7 t -81.65 79.46 8.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.095 0.474 . . . . 0.0 110.563 -176.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 67.5 mt -129.64 143.02 50.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.863 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 79.1 m-70 -105.95 128.53 26.23 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.974 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 22.2 Cg_exo -63.77 133.62 40.02 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.741 2.294 . . . . 0.0 112.484 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 79.52 28.93 50.75 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.769 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -128.38 155.67 44.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.067 0.46 . . . . 0.0 110.91 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -92.78 133.38 36.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.388 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -120.32 144.47 47.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.869 0.366 . . . . 0.0 110.144 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.2 mm? -105.12 129.1 53.61 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 23.1 m -128.61 139.64 51.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.834 0.349 . . . . 0.0 110.865 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.47 ' NE2' ' HB3' ' A' ' 197' ' ' ALA . 16.2 mt-30 -139.64 158.98 43.21 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.212 -178.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 12.6 p -136.29 138.45 46.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.208 0.527 . . . . 0.0 111.04 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -138.76 147.86 43.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.876 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . 0.524 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 25.5 p -137.93 154.61 49.4 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.453 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.491 ' CZ2' ' HB2' ' A' ' 147' ' ' ARG . 75.4 m95 . . . . . 0 N--CA 1.455 -0.191 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.498 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 7.4 m -131.41 -59.1 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -175.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.498 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 10.1 Cg_endo -90.08 95.11 0.29 Allowed 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.43 2.087 . . . . 0.0 113.16 -171.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.47 ' HB3' ' NE2' ' A' ' 181' ' ' GLN . . . -95.74 127.58 41.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.965 0.412 . . . . 0.0 110.567 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' THR . . . . . 0.421 ' OG1' HD23 ' A' ' 109' ' ' LEU . 30.9 m -121.77 144.21 48.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.639 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -104.08 127.5 51.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.204 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.7 tp -128.45 137.42 57.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.156 0.503 . . . . 0.0 110.985 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -99.59 124.98 45.3 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.686 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 51.0 mm -86.28 124.57 69.89 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 174.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.68 152.82 66.4 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.898 2.399 . . . . 0.0 112.226 -176.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 17.9 m -71.17 -23.92 62.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.7 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -100.46 54.71 0.88 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.344 176.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -87.95 -60.31 2.0 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.829 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 C--N 1.323 -0.581 0 CA-C-O 121.039 0.447 . . . . 0.0 110.976 -179.719 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.418 ' HG3' ' SG ' ' A' ' 184' ' ' CYS . 24.2 Cg_exo . . . . . 0 C--O 1.233 0.256 0 N-CA-C 111.162 -0.361 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' A' ' 128' ' ' SER . 1.2 pp -133.38 177.06 7.98 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.717 0.294 . . . . 0.0 111.582 -175.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 55.41 50.28 15.12 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.584 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.5 tp -73.66 105.18 4.86 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -112.13 128.86 56.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.828 -175.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.6 t -113.32 129.82 68.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.032 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -129.78 129.84 44.6 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.878 0.37 . . . . 0.0 110.401 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 p -85.66 118.73 32.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.183 0.516 . . . . 0.0 109.846 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.49 ' O ' ' HD3' ' A' ' 116' ' ' PRO . 31.2 mmmt -113.38 108.45 17.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.1 0.476 . . . . 0.0 110.762 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -107.36 96.14 15.22 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.364 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 114' ' ' LYS . 15.3 Cg_exo -69.37 146.11 61.54 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.798 2.332 . . . . 0.0 111.687 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -80.01 -3.89 50.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.104 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -126.77 -40.86 1.87 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.196 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 66.7 mtm-85 -99.44 165.58 11.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.41 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 120' ' ' LYS . 12.6 mptt -60.11 135.4 90.71 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.119 175.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.445 ' HA ' ' CD ' ' A' ' 116' ' ' PRO . 32.3 Cg_endo -64.18 136.86 53.79 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.909 2.406 . . . . 0.0 112.122 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -136.33 159.71 40.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.711 -175.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.5 tp -98.83 123.83 43.33 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.427 ' CZ2' ' HD3' ' A' ' 126' ' ' LYS . 21.6 t90 -104.62 115.24 30.0 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.401 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.7 mp -108.3 129.06 63.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.652 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.427 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 54.9 pttt -137.68 152.48 49.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.047 0.451 . . . . 0.0 110.347 175.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . 0.446 ' CD2' HG21 ' A' ' 182' ' ' VAL . 29.3 p90 -142.0 163.33 33.17 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.076 -174.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.408 ' HB2' HD12 ' A' ' 107' ' ' LEU . 42.4 m -106.94 105.59 55.83 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 121.004 0.43 . . . . 0.0 109.895 176.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.463 -0.278 0 C-N-CA 122.758 2.305 . . . . 0.0 112.013 -177.77 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 185' ' ' LYS . 30.1 tp . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 184' ' ' CYS . 2.0 mp -106.8 158.31 17.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.361 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -125.45 133.39 52.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.024 0.44 . . . . 0.0 111.247 -172.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -123.28 139.33 54.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.067 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.6 mp -126.99 122.34 60.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.679 0.276 . . . . 0.0 110.469 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -107.72 130.08 54.97 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 174.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.495 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.5 pp -144.25 157.71 44.13 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.724 -177.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -165.44 144.5 5.32 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.187 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -67.88 168.84 17.61 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.406 2.071 . . . . 0.0 111.835 172.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.86 -18.86 65.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.934 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -100.96 17.79 21.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.121 0.486 . . . . 0.0 110.578 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -108.21 120.5 42.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.166 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -79.57 -28.55 41.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.583 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -109.71 154.25 23.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.755 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -90.53 144.78 25.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.146 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -98.59 110.18 22.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.254 172.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.17 113.47 24.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.198 0.523 . . . . 0.0 109.733 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 49.4 m-70 -116.35 118.99 34.26 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.685 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -88.31 126.38 35.15 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -86.6 -30.6 21.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.987 0.422 . . . . 0.0 110.729 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 95.25 -127.89 9.31 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.589 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -104.8 53.13 0.73 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.372 0.606 . . . . 0.0 110.241 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -144.64 143.86 30.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.283 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.5 p -96.66 24.35 6.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.18 0.514 . . . . 0.0 111.538 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -147.43 136.24 22.07 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.446 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 24.5 t80 -134.05 142.1 47.45 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.4 136.38 54.74 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.689 0.281 . . . . 0.0 110.564 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 43.2 mm -108.52 131.95 57.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.616 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -112.71 41.96 1.94 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.203 0.525 . . . . 0.0 110.117 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 10.7 t -157.75 64.26 0.47 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.647 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.8 mm? -109.27 151.84 26.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.991 0.424 . . . . 0.0 110.694 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -116.61 122.96 31.04 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.232 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -59.84 117.61 4.38 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.862 2.375 . . . . 0.0 112.35 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.23 -5.76 49.7 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.69 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -101.63 142.18 33.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.05 0.452 . . . . 0.0 111.015 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.439 ' HE2' ' HB3' ' A' ' 199' ' ' PHE . 79.7 tttt -91.86 133.33 35.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.131 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -116.8 137.9 51.87 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.095 0.474 . . . . 0.0 110.496 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 7.6 mp -99.3 126.28 45.11 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 174.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.7 136.4 60.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.043 0.449 . . . . 0.0 111.226 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.558 ' HG2' ' HA ' ' A' ' 197' ' ' ALA . 55.4 mt-30 -138.3 139.06 38.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.0 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.446 HG21 ' CD2' ' A' ' 127' ' ' TRP . 12.6 p -125.08 152.69 31.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.857 0.36 . . . . 0.0 110.733 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -153.13 142.02 21.17 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.79 173.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . 0.418 ' SG ' ' HG3' ' A' ' 106' ' ' PRO . 25.1 p -105.09 157.08 17.5 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.659 174.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.424 ' O ' HD13 ' A' ' 142' ' ' LEU . 98.3 mttt . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 120.634 0.254 . . . . 0.0 111.441 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 23.6 m95 . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.517 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 3.3 m -134.84 -54.47 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.208 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 27.1 Cg_endo -95.36 131.69 0.51 Allowed 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 122.501 2.134 . . . . 0.0 112.969 -177.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.558 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -123.65 124.63 43.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.036 0.446 . . . . 0.0 110.705 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 61.0 m -117.02 144.02 45.08 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.629 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.439 ' HB3' ' HE2' ' A' ' 177' ' ' LYS . 55.7 m-85 -107.69 132.44 53.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.594 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.1 tp -133.28 135.31 56.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.1 0.476 . . . . 0.0 110.735 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -105.61 130.6 53.62 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.539 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 46.6 mm -85.9 124.64 70.48 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.913 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.41 156.73 61.84 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.908 2.405 . . . . 0.0 112.382 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 46.1 m -81.06 -3.67 52.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.15 0.5 . . . . 0.0 110.913 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -84.96 -15.09 45.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.039 174.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.457 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 30.0 t80 -58.92 141.31 53.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.722 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 206' ' ' PHE . 80.6 m . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 121.474 0.654 . . . . 0.0 111.626 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo . . . . . 0 C--O 1.233 0.236 0 N-CA-C 110.768 -0.512 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -127.75 -178.32 4.45 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.917 -171.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 55.78 40.8 30.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.822 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.475 HD23 ' OG1' ' A' ' 198' ' ' THR . 54.0 tp -70.22 94.61 0.93 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.7 123.58 40.43 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.322 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.416 HG11 HD11 ' A' ' 123' ' ' LEU . 3.2 t -112.29 113.56 44.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -124.06 133.27 53.67 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.141 -172.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.6 p -85.78 116.9 29.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.388 0.613 . . . . 0.0 109.841 175.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -103.05 123.49 46.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.403 -177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -121.04 84.68 39.77 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.436 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.98 146.87 42.5 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.736 2.29 . . . . 0.0 111.087 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -79.9 -16.77 54.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.351 -177.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -116.12 -39.55 3.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.581 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -91.37 163.07 14.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.634 176.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -72.97 141.52 81.78 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.012 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.38 138.68 67.13 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.944 2.429 . . . . 0.0 111.742 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -150.82 164.55 35.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.833 -174.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.416 HD11 HG11 ' A' ' 111' ' ' VAL . 29.7 tp -97.41 122.27 40.26 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 24.4 t90 -102.71 112.53 25.34 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.047 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.8 mp -106.89 120.15 57.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.666 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -128.11 134.78 49.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.93 0.395 . . . . 0.0 110.293 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 36.0 p90 -128.05 155.56 44.15 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.573 -177.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.9 m -108.88 100.27 38.87 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.909 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 CA--C 1.532 0.395 0 C-N-CA 123.021 2.481 . . . . 0.0 112.547 178.889 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 46.5 tp . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 121.068 0.461 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -91.62 166.04 13.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.456 174.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -131.32 131.92 44.12 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -119.87 134.6 55.19 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.51 121.96 61.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.133 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.566 ' HG3' ' NE2' ' A' ' 181' ' ' GLN . 22.5 ptt180 -103.74 148.08 26.5 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' A' ' 157' ' ' GLU . 3.6 pp -165.05 161.79 19.95 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.175 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -164.77 145.59 6.32 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-O 120.682 0.277 . . . . 0.0 110.484 176.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.75 165.71 28.67 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.76 2.307 . . . . 0.0 111.746 174.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.46 -5.4 19.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.897 -174.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -111.3 6.7 20.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.292 0.568 . . . . 0.0 110.437 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.2 127.72 41.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.187 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.36 -38.86 29.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.723 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -104.16 162.92 12.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.955 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -91.4 140.89 29.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.034 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 148' ' ' LEU . 36.1 mt-10 -91.88 116.25 28.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.3 172.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.75 109.41 21.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.54 0.686 . . . . 0.0 109.363 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.472 ' HB3' ' CE2' ' A' ' 167' ' ' PHE . 35.0 m-70 -105.8 126.42 52.15 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.195 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -98.28 117.27 32.28 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.866 0.365 . . . . 0.0 110.648 -176.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -78.0 -51.11 10.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.143 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 76.19 89.9 0.25 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.072 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 75.34 -25.59 0.2 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.733 0.813 . . . . 0.0 113.033 170.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -89.41 142.59 27.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.91 0.386 . . . . 0.0 110.57 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.1 p -101.75 32.6 3.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.5 0.667 . . . . 0.0 111.047 -177.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -156.9 109.94 2.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.769 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.472 ' CE2' ' HB3' ' A' ' 159' ' ' HIS . 17.8 t80 -110.94 146.56 36.38 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.497 -174.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.458 ' HD2' ' N ' ' A' ' 168' ' ' LYS . 9.6 mptt -121.83 130.19 53.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.369 -178.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 34.7 mm -107.84 124.21 63.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.551 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.17 -27.14 15.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.957 0.408 . . . . 0.0 110.482 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 34.7 m -82.33 84.55 7.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.663 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 68.9 mt -130.99 145.85 52.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.124 0.488 . . . . 0.0 111.323 -177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 63.6 m-70 -114.38 127.49 26.77 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.859 177.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 24.2 Cg_exo -62.88 129.53 26.36 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.836 2.357 . . . . 0.0 112.797 -178.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.14 33.34 32.86 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.487 176.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -126.21 145.53 50.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.318 0.58 . . . . 0.0 111.059 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -86.85 129.64 34.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.079 177.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -120.25 137.21 54.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.246 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -97.44 125.02 41.85 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 173.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.473 ' O ' ' HB ' ' A' ' 198' ' ' THR . 16.7 m -135.43 139.31 46.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.748 0.309 . . . . 0.0 110.788 -171.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.566 ' NE2' ' HG3' ' A' ' 147' ' ' ARG . 0.2 OUTLIER -166.63 142.95 4.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.907 0.384 . . . . 0.0 110.842 177.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 13.0 p -121.93 153.02 26.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.52 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -146.11 134.75 22.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.066 0.46 . . . . 0.0 109.76 173.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 3.3 m -111.93 152.66 27.78 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.682 -176.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.0 pttp . . . . . 0 C--N 1.327 -0.373 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.738 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 51.6 m95 . . . . . 0 C--O 1.232 0.15 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.408 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 16.1 m -92.2 -54.57 0.26 Allowed Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 94.9 Cg_endo -76.68 69.78 6.65 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.096 1.864 . . . . 0.0 113.762 -172.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.478 ' HA ' ' HB3' ' A' ' 181' ' ' GLN . . . -69.52 123.23 20.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.331 0.586 . . . . 0.0 111.128 178.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' THR . . . . . 0.475 ' OG1' HD23 ' A' ' 109' ' ' LEU . 90.4 m -108.07 148.02 30.37 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.566 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -111.86 133.14 54.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.362 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.9 tp -137.63 133.84 45.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.34 0.591 . . . . 0.0 111.017 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -100.7 121.17 41.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.517 176.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.4 mm -85.85 122.95 72.82 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.27 143.7 96.84 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.58 2.186 . . . . 0.0 112.384 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 14.9 m -66.28 -23.55 66.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.29 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.87 19.62 3.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.591 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -53.64 -48.86 68.97 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.095 0.474 . . . . 0.0 110.318 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.444 -0.746 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.776 174.779 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.425 ' HG3' ' SG ' ' A' ' 184' ' ' CYS . 18.3 Cg_endo . . . . . 0 N--CA 1.473 0.289 0 CA-C-O 120.884 0.285 . . . . 0.0 112.346 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 107' ' ' LEU . 2.4 pt? -146.82 -167.57 2.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.27 -174.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 59.14 57.16 3.59 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.241 0.543 . . . . 0.0 111.105 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.3 mt -72.37 99.95 2.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.796 177.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.53 122.9 37.58 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.9 t -114.64 122.64 69.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.14 -175.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -120.84 140.92 51.08 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.804 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 p -98.21 119.71 46.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.21 0.528 . . . . 0.0 110.145 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.527 ' HA ' ' HE2' ' A' ' 114' ' ' LYS . 9.9 mmpt? -111.51 126.69 55.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.652 -178.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -133.09 97.23 16.79 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.08 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.81 175.97 8.92 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.71 2.273 . . . . 0.0 112.7 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -59.76 -67.31 0.4 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.329 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -131.63 38.16 3.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.295 0.569 . . . . 0.0 111.017 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -122.23 154.6 37.31 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.189 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -55.33 118.38 18.34 Favored Pre-proline 0 C--N 1.328 -0.337 0 O-C-N 123.582 0.552 . . . . 0.0 111.071 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.91 144.57 83.36 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.628 2.219 . . . . 0.0 111.146 177.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -140.53 150.56 43.86 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.219 0.533 . . . . 0.0 111.215 -173.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 30.1 tp -91.52 126.27 36.54 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.288 175.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.428 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 22.5 t90 -102.98 105.89 16.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.195 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.7 mp -98.99 123.62 51.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -134.12 136.21 43.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.944 0.402 . . . . 0.0 110.555 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . 0.446 ' CH2' HD11 ' A' ' 146' ' ' ILE . 20.7 p90 -122.51 167.96 12.71 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.0 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.9 t -87.29 125.47 65.74 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo . . . . . 0 C--N 1.343 0.273 0 C-N-CA 122.652 2.235 . . . . 0.0 111.81 178.793 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 63.9 tp . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.99 148.27 26.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.2 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.48 ' CD2' ' HB3' ' A' ' 184' ' ' CYS . 92.6 m-85 -115.46 138.33 51.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.545 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -124.46 135.77 53.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.452 ' CD1' ' HB1' ' A' ' 161' ' ' ALA . 5.1 mp -118.73 130.84 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.043 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -111.79 134.26 53.48 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.5 pp -145.43 156.53 43.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.797 -177.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -165.66 151.05 8.08 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.419 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -70.05 164.11 36.03 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.453 2.102 . . . . 0.0 111.685 173.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.419 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 14.4 pt-20 -64.15 -23.69 67.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.976 -172.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.419 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 86.9 mttt -98.55 9.94 42.09 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.189 0.518 . . . . 0.0 110.875 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.85 131.52 42.08 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.006 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -84.96 -43.03 14.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.542 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -82.78 150.56 26.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.036 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -98.09 142.85 29.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.811 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -103.35 116.28 32.13 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.957 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.06 132.17 38.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.189 0.519 . . . . 0.0 111.079 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 67.6 m-70 -127.08 125.97 42.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.332 175.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -86.43 119.86 27.15 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.452 ' HB1' ' CD1' ' A' ' 146' ' ' ILE . . . -85.11 -39.19 18.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.905 0.383 . . . . 0.0 111.026 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 100.51 -143.78 16.45 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.443 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.08 62.74 4.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.978 0.418 . . . . 0.0 110.366 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -155.24 147.92 24.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.377 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.8 p -98.0 27.8 4.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.975 0.416 . . . . 0.0 111.909 -176.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -151.82 144.86 24.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.893 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.415 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 26.4 t80 -140.07 148.51 41.86 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.992 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 10.5 mptt -120.39 142.77 48.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.644 0.259 . . . . 0.0 110.782 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 32.9 mm -119.64 129.92 74.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.572 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.68 -29.17 11.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.102 0.477 . . . . 0.0 110.294 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.0 m -79.27 83.71 5.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.285 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 63.4 mt -132.12 172.19 12.7 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.958 -176.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -138.37 124.65 12.82 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.899 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.13 130.02 29.16 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.606 2.204 . . . . 0.0 112.08 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 79.65 39.69 17.11 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.839 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -133.24 146.39 51.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.957 0.408 . . . . 0.0 110.474 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.9 tttp -98.1 128.1 44.42 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.836 177.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -119.85 140.98 49.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.193 0.52 . . . . 0.0 110.898 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 5.5 mp -103.73 130.66 51.27 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.97 139.73 51.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.81 0.338 . . . . 0.0 111.452 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.515 ' HG2' ' HA ' ' A' ' 197' ' ' ALA . 78.1 mt-30 -143.72 142.47 30.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.299 177.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 13.5 p -132.06 150.15 33.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.684 0.278 . . . . 0.0 110.798 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -159.06 147.44 18.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.254 172.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . 0.48 ' HB3' ' CD2' ' A' ' 144' ' ' TYR . 27.9 p -123.4 -172.96 2.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.67 177.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 121.183 0.516 . . . . 0.0 111.044 179.764 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.478 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 81.0 m95 . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.507 ' H ' ' HD2' ' A' ' 196' ' ' PRO . 5.3 m -153.71 -56.9 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.507 ' HD2' ' H ' ' A' ' 195' ' ' SER . 68.4 Cg_endo -72.69 80.81 1.68 Allowed 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 122.019 1.813 . . . . 0.0 113.354 -173.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.515 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -80.35 103.0 9.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.273 0.559 . . . . 0.0 110.812 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.9 m -100.44 135.45 41.85 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.158 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -104.92 126.51 52.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.103 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.9 tp -126.75 137.98 56.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.003 0.43 . . . . 0.0 110.832 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -100.19 120.98 40.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.751 177.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.1 121.02 76.96 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.1 151.58 65.46 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.925 2.417 . . . . 0.0 112.362 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 16.8 t -71.75 -23.63 61.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.895 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -98.33 43.76 1.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.795 0.807 . . . . 0.0 109.28 175.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -80.85 -18.42 47.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.536 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 57.4 m . . . . . 0 C--N 1.319 -0.738 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.565 -178.171 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.612 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 72.6 Cg_endo . . . . . 0 N--CA 1.459 -0.553 0 CA-C-O 121.784 0.66 . . . . 0.0 111.872 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 pp -109.43 174.47 5.85 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.317 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 52.45 60.22 3.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.259 0.552 . . . . 0.0 110.626 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.408 HD12 ' CG2' ' A' ' 125' ' ' ILE . 43.1 tp -73.17 108.88 6.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.675 -177.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -98.44 119.68 37.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.576 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.447 ' CG1' HD13 ' A' ' 123' ' ' LEU . 2.6 t -109.24 115.28 49.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.394 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -127.72 125.58 40.25 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.933 -173.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.5 126.41 39.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.15 177.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 57.0 mmtt -108.28 129.72 55.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.936 0.398 . . . . 0.0 110.853 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.592 ' OE1' ' HA ' ' A' ' 206' ' ' PHE . 47.3 mt-30 -133.89 86.75 37.22 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.433 -174.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.05 167.69 24.62 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.078 2.519 . . . . 0.0 111.547 175.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -86.24 -46.28 10.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.779 0.323 . . . . 0.0 111.32 -178.429 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -88.53 -51.48 5.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.89 0.376 . . . . 0.0 110.24 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -72.65 138.72 46.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -66.52 144.84 98.84 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 120.732 0.301 . . . . 0.0 111.4 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.543 ' HG3' ' O ' ' A' ' 206' ' ' PHE . 36.1 Cg_endo -62.72 142.41 89.13 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 123.263 2.642 . . . . 0.0 112.56 -177.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -144.56 159.9 42.03 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.733 -176.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.447 HD13 ' CG1' ' A' ' 111' ' ' VAL . 2.7 tm? -98.22 126.38 43.67 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 21.7 t90 -111.68 109.25 19.03 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.703 -172.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.408 ' CG2' HD12 ' A' ' 109' ' ' LEU . 3.6 mp -96.67 132.56 40.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.45 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -146.91 143.17 28.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.313 0.578 . . . . 0.0 110.456 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 18.5 p90 -126.74 162.94 24.64 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.112 -173.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.1 t -102.9 112.98 66.16 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 120.852 0.358 . . . . 0.0 110.374 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo . . . . . 0 N--CA 1.456 -0.698 0 C-N-CA 122.436 2.091 . . . . 0.0 111.541 174.372 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 52.5 tp . . . . . 0 N--CA 1.451 -0.382 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.419 ' HG ' ' HA2' ' A' ' 162' ' ' GLY . 4.7 mp -99.95 139.13 36.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.049 -175.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -109.14 143.18 38.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.402 -175.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -127.64 135.17 49.87 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.544 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.47 HD13 ' N ' ' A' ' 146' ' ' ILE . 4.4 mp -114.75 128.19 71.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.009 0.433 . . . . 0.0 110.428 -176.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.465 ' HB2' ' CH2' ' A' ' 194' ' ' TRP . 26.6 ttp180 -114.97 123.13 48.31 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.528 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -142.6 160.35 40.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.632 0.253 . . . . 0.0 111.437 -177.16 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -171.69 150.22 2.57 Favored Pre-proline 0 C--O 1.234 0.275 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.996 176.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.18 160.32 50.32 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.282 1.988 . . . . 0.0 110.599 169.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -67.9 -21.37 65.14 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -173.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -86.04 -11.12 53.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.018 0.437 . . . . 0.0 110.289 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -82.12 131.26 35.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.57 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -86.03 -35.57 20.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.363 178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -94.96 143.19 26.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.325 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.445 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 67.7 m95 -88.46 145.76 25.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.77 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -96.43 116.94 29.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.577 174.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mp -95.67 111.66 26.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.009 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 51.3 m-70 -117.87 119.7 35.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.159 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -85.38 137.3 33.03 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.14 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.413 ' HB3' ' CD1' ' A' ' 146' ' ' ILE . . . -102.22 -41.05 6.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.992 0.425 . . . . 0.0 110.937 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.419 ' HA2' ' HG ' ' A' ' 143' ' ' LEU . . . 91.41 -125.64 8.11 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.152 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -97.23 64.06 1.89 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.217 0.532 . . . . 0.0 110.366 -177.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -157.64 142.95 17.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.03 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.6 p -99.31 31.6 3.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.04 0.447 . . . . 0.0 111.608 -176.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -158.86 156.44 29.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.941 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 33.1 t80 -146.01 154.03 41.43 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.05 131.94 54.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.711 0.291 . . . . 0.0 110.996 -178.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 29.0 mm -106.88 138.55 32.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -104.64 -28.15 11.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.965 0.412 . . . . 0.0 111.107 -176.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.9 m -90.59 75.15 6.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.928 -174.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -114.56 142.66 46.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.84 0.352 . . . . 0.0 110.737 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 26.3 m-70 -111.35 134.36 21.17 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.924 174.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 39.7 Cg_exo -61.22 131.14 35.07 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.834 2.356 . . . . 0.0 112.325 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 73.36 43.57 37.62 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.118 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -134.0 148.0 51.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.872 0.368 . . . . 0.0 110.041 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -95.03 126.29 40.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.74 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -120.29 136.8 54.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.184 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 7.3 mp -102.24 129.67 48.7 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.22 141.84 43.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.069 0.462 . . . . 0.0 111.544 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 98.5 mt-30 -141.42 149.02 40.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.066 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.15 136.58 37.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.618 0.247 . . . . 0.0 110.338 175.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . 0.4 ' HD2' ' HA ' ' A' ' 194' ' ' TRP . 65.7 mtp85 -143.47 160.93 39.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.354 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . 0.612 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 21.3 p -148.49 172.15 14.94 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 21.2 pttp . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 121.058 0.456 . . . . 0.0 111.907 -174.518 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.465 ' CH2' ' HB2' ' A' ' 147' ' ' ARG . 72.9 m95 . . . . . 0 N--CA 1.456 -0.165 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.475 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 13.1 m -148.69 -58.87 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.547 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 4.5 Cg_exo -79.56 75.69 4.93 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.332 2.021 . . . . 0.0 113.412 -168.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -77.91 103.02 7.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.988 0.423 . . . . 0.0 110.429 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.2 m -96.95 140.58 31.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.454 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -105.0 131.4 52.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.933 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.3 tp -126.49 140.06 49.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.121 0.486 . . . . 0.0 110.744 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -103.41 119.11 38.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.038 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 51.2 mm -83.29 124.31 76.14 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.636 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.99 164.92 25.57 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.211 2.608 . . . . 0.0 113.419 -174.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 10.3 p -68.63 -46.79 68.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.473 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -85.6 35.19 0.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.769 0.795 . . . . 0.0 110.609 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.592 ' HA ' ' OE1' ' A' ' 115' ' ' GLN . 89.2 t80 -68.76 -58.04 4.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 C--N 1.322 -0.626 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.814 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 0 N--CA 1.464 -0.226 0 CA-C-O 121.453 0.522 . . . . 0.0 112.179 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -94.53 -173.21 2.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.021 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 54.7 43.04 30.76 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 123.563 0.54 . . . . 0.0 110.217 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 48.6 tp -68.76 94.77 0.63 Allowed 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.604 178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.69 125.64 38.42 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.997 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.69 114.13 46.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -121.32 118.19 28.87 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.108 -173.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.509 HG22 ' CD1' ' A' ' 123' ' ' LEU . 7.1 t -80.39 123.84 37.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -102.73 120.5 40.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.956 0.408 . . . . 0.0 110.783 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -121.61 86.39 44.75 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.422 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.62 -177.85 2.71 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 123.211 2.607 . . . . 0.0 113.327 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -74.41 -64.71 0.97 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.17 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -119.32 15.26 13.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.096 0.474 . . . . 0.0 110.912 -176.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -110.29 150.19 29.09 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.556 177.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -61.71 138.22 95.22 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 123.634 0.584 . . . . 0.0 110.646 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.98 138.52 44.34 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.543 2.162 . . . . 0.0 111.47 178.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -148.39 157.25 43.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.624 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.509 ' CD1' HG22 ' A' ' 113' ' ' VAL . 30.7 tp -92.61 124.8 36.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.955 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.526 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 21.3 t90 -103.43 103.75 13.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.096 0.474 . . . . 0.0 110.429 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.2 mp -95.2 116.45 36.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.579 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.455 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 5.0 ttpm? -128.93 127.27 41.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.189 0.518 . . . . 0.0 110.566 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 22.5 p90 -116.27 160.56 20.28 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.27 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 39.3 t -86.33 118.62 70.64 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo . . . . . 0 C--O 1.235 0.338 0 C-N-CA 122.709 2.273 . . . . 0.0 111.876 -178.423 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 60.0 mt -104.31 141.51 36.18 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.018 0.437 . . . . 0.0 110.941 -175.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 184' ' ' CYS . 93.6 m-85 -104.29 141.24 36.64 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.477 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -126.84 136.57 52.53 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 161' ' ' ALA . 4.9 mp -118.16 128.07 75.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.949 0.404 . . . . 0.0 110.782 -176.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.524 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 15.3 ttp180 -113.07 120.3 40.86 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -144.58 160.41 41.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.692 0.282 . . . . 0.0 111.596 -175.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.403 ' HE2' ' CE2' ' A' ' 156' ' ' TRP . 56.7 pttt -170.93 144.55 1.82 Allowed Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.489 176.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.431 ' HG2' ' HB3' ' A' ' 153' ' ' ALA . 43.4 Cg_endo -74.2 167.09 28.0 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.553 2.169 . . . . 0.0 111.444 167.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.409 ' HG2' ' HG3' ' A' ' 152' ' ' LYS . 1.4 pm0 -59.47 -39.6 84.21 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.925 0.393 . . . . 0.0 111.426 -177.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.409 ' HG3' ' HG2' ' A' ' 151' ' ' GLU . 91.7 mttt -87.8 16.25 6.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.499 -175.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.431 ' HB3' ' HG2' ' A' ' 150' ' ' PRO . . . -88.96 -38.99 14.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.262 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 70.33 -54.38 0.63 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.126 0.891 . . . . 0.0 111.19 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -85.41 151.89 23.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.248 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.524 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 77.1 m95 -90.45 135.51 33.64 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.216 178.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -99.95 123.48 44.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.505 175.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.4 mp -103.66 120.07 53.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.994 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 41.2 m-70 -123.35 122.91 39.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.872 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -85.8 131.4 34.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.548 -176.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.446 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -96.6 -41.56 8.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.331 . . . . 0.0 111.387 -179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.35 -141.09 15.18 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.292 -176.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.49 44.03 1.06 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.461 0.648 . . . . 0.0 111.08 -177.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -128.46 149.68 50.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.593 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.3 p -101.47 26.18 7.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -174.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -151.66 140.42 20.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.931 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 33.5 t80 -130.7 146.99 52.32 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.526 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 39.1 mmtm -112.1 132.5 54.81 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.736 0.303 . . . . 0.0 110.901 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 26.4 mm -112.34 136.85 47.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -104.93 -25.5 12.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.068 0.461 . . . . 0.0 110.441 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 25.6 t -86.18 70.02 10.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.287 -175.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.9 mm? -110.62 139.83 45.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.968 0.414 . . . . 0.0 110.435 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -101.03 122.51 48.4 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.051 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.438 ' HB3' ' HB3' ' A' ' 206' ' ' PHE . 10.0 Cg_endo -58.35 116.96 3.61 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.527 2.152 . . . . 0.0 112.605 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 91.35 32.46 8.77 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.636 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.482 HE21 ' HA ' ' A' ' 176' ' ' GLN . 0.1 OUTLIER -133.13 159.3 40.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.826 0.346 . . . . 0.0 110.911 -179.6 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -106.88 126.63 52.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.691 -174.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -112.82 137.95 50.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.048 0.451 . . . . 0.0 110.67 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.9 mp -99.84 124.21 44.89 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 26.3 m -121.8 140.27 46.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.229 0.538 . . . . 0.0 111.877 -176.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.522 HE21 ' HB3' ' A' ' 197' ' ' ALA . 82.7 mt-30 -136.08 147.68 47.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.333 175.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.18 142.44 22.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.869 0.366 . . . . 0.0 110.128 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 27.0 ttt-85 -146.69 149.31 33.2 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . 0.608 ' HB3' ' CE2' ' A' ' 144' ' ' TYR . 9.0 p -103.67 154.03 19.98 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.527 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 73.7 mttt . . . . . 0 C--N 1.32 -0.679 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.676 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 73.1 m95 . . . . . 0 C--O 1.235 0.299 0 N-CA-C 110.448 -0.204 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.524 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 2.0 m -133.54 -60.85 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -176.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.524 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 14.8 Cg_endo -94.9 111.47 0.15 Allowed 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.674 2.249 . . . . 0.0 113.308 -172.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.522 ' HB3' HE21 ' A' ' 181' ' ' GLN . . . -103.53 122.47 45.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.039 0.447 . . . . 0.0 110.858 177.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 90.7 m -117.03 147.04 42.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.709 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.4 ' CD2' ' HG ' ' A' ' 179' ' ' LEU . 68.2 m-85 -110.66 140.37 45.08 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.1 tp -136.23 138.07 47.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.145 0.498 . . . . 0.0 110.794 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -104.39 124.37 49.09 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.551 177.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 40.8 mm -88.56 124.55 65.66 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.343 178.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.49 146.61 96.88 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.605 2.203 . . . . 0.0 111.908 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 49.6 m -70.91 -11.56 61.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.288 0.566 . . . . 0.0 110.57 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -96.26 15.59 20.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.614 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.5 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 83.7 t80 -53.13 -43.91 67.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.523 177.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.449 -0.479 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.229 177.143 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo . . . . . 0 C--O 1.235 0.339 0 N-CA-C 110.87 -0.473 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.16 174.68 8.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.971 -172.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 57.07 60.63 2.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.343 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.7 mt -69.45 97.76 1.03 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.7 174.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.6 122.02 39.07 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.0 t -115.09 119.55 62.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.896 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -118.88 132.7 56.11 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.158 -176.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.464 ' HA ' HD21 ' A' ' 123' ' ' LEU . 12.9 p -86.78 128.26 39.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.19 0.519 . . . . 0.0 109.984 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -116.69 107.84 15.17 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.21 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.418 ' HG2' ' HB3' ' A' ' 121' ' ' PRO . 50.5 mt-30 -111.24 97.95 37.58 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.421 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.91 -179.88 4.68 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.775 2.316 . . . . 0.0 112.374 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.66 -68.44 0.45 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.884 0.373 . . . . 0.0 110.855 -177.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -107.24 -18.28 13.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.334 0.588 . . . . 0.0 110.97 -176.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -80.12 141.93 35.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.845 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -60.06 135.39 90.54 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.268 -175.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.418 ' HB3' ' HG2' ' A' ' 115' ' ' GLN . 38.0 Cg_endo -65.52 149.36 87.77 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.978 2.452 . . . . 0.0 112.282 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -150.81 167.98 25.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.941 -175.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.464 HD21 ' HA ' ' A' ' 113' ' ' VAL . 11.1 mt -100.25 142.41 31.77 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 120.918 0.39 . . . . 0.0 110.822 176.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.504 ' CZ2' ' HD2' ' A' ' 126' ' ' LYS . 19.9 t90 -113.93 105.28 13.06 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.729 175.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.1 mp -94.87 118.48 41.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.504 ' HD2' ' CZ2' ' A' ' 124' ' ' TRP . 81.5 tttt -132.05 119.56 21.17 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.216 0.532 . . . . 0.0 110.866 -175.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . 0.442 ' CH2' HD11 ' A' ' 146' ' ' ILE . 35.5 p90 -116.08 162.46 17.39 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.829 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.6 m -102.9 134.94 19.54 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 C--N 1.347 0.464 0 C-N-CA 123.235 2.623 . . . . 0.0 112.279 -177.005 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 1.015 ' HG ' ' SG ' ' A' ' 184' ' ' CYS . 11.4 tp . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 120.889 0.376 . . . . 0.0 110.077 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.436 ' C ' ' HG ' ' A' ' 184' ' ' CYS . 2.5 mm? -96.16 133.67 40.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.948 -177.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -102.1 144.35 30.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.988 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 75.1 tt0 -136.64 137.35 39.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.926 -173.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 181' ' ' GLN . 4.7 mp -120.57 125.42 74.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.775 0.321 . . . . 0.0 110.858 -176.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.435 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 18.0 ttp180 -108.84 121.77 45.77 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.55 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 4.0 pp -145.25 159.28 43.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.79 0.328 . . . . 0.0 111.342 -176.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -168.61 149.33 4.34 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.426 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 31.3 Cg_endo -70.95 160.89 47.94 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.988 1.792 . . . . 0.0 112.311 174.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.438 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 6.0 pt-20 -50.93 -46.93 61.04 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.438 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 93.4 mttt -84.77 13.85 5.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.803 0.335 . . . . 0.0 111.59 -174.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.426 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -88.23 134.25 33.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.926 0.393 . . . . 0.0 111.185 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -89.95 -21.63 22.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.205 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -120.37 145.83 46.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.733 -177.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.435 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 66.4 m95 -84.06 137.7 33.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.433 176.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -109.9 116.7 32.1 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.423 0.63 . . . . 0.0 111.323 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.1 mp -91.03 130.79 39.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.935 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 67.6 m-70 -124.11 126.03 45.49 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.223 176.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -93.0 119.55 32.38 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.852 0.358 . . . . 0.0 110.836 -174.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.418 ' HB1' HD11 ' A' ' 146' ' ' ILE . . . -75.09 -51.5 13.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.054 177.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 77.8 81.76 0.63 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.368 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 74.3 -40.0 0.44 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.954 0.901 . . . . 0.0 112.563 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -68.56 145.65 53.78 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 55.5 p -104.94 30.31 5.63 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.26 0.552 . . . . 0.0 111.49 -176.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -154.14 144.76 22.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.639 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.449 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 32.4 t80 -142.27 146.14 34.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.081 -177.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.44 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 10.3 mptt -115.76 144.53 43.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.861 0.362 . . . . 0.0 110.661 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 35.8 mm -119.61 134.19 63.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.951 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -102.02 -29.52 11.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.878 0.371 . . . . 0.0 110.608 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 45.6 m -86.2 73.89 10.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.963 -175.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.25 144.3 41.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.854 0.359 . . . . 0.0 110.333 174.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 -110.16 122.11 39.72 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.887 175.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.25 124.35 15.96 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.984 2.456 . . . . 0.0 112.772 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 97.21 12.54 48.6 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.073 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -118.78 148.84 42.4 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.377 0.608 . . . . 0.0 111.873 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -89.47 129.97 35.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.547 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -115.59 135.52 53.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.998 0.427 . . . . 0.0 110.455 177.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.6 mp -101.5 121.94 42.88 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.8 m -119.49 137.56 52.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.175 0.512 . . . . 0.0 111.062 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.561 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 89.3 mt-30 -136.94 139.58 41.63 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.556 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 145' ' ' GLU . 10.4 p -123.55 137.35 57.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.206 0.527 . . . . 0.0 110.606 174.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -138.79 138.68 37.81 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.667 174.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . 1.015 ' SG ' ' HG ' ' A' ' 142' ' ' LEU . 4.6 t -125.53 156.23 39.36 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.424 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.22 -172.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 83.0 m95 . . . . . 0 C--O 1.23 0.078 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.525 ' OG ' ' HD3' ' A' ' 196' ' ' PRO . 3.1 p -110.72 -50.24 0.06 OUTLIER Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -176.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.525 ' HD3' ' OG ' ' A' ' 195' ' ' SER . 9.3 Cg_endo -86.92 83.05 1.13 Allowed 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.019 1.813 . . . . 0.0 113.12 -172.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.487 ' HB3' ' NE2' ' A' ' 181' ' ' GLN . . . -87.41 107.1 18.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.043 0.449 . . . . 0.0 110.464 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 28.8 m -100.27 139.8 35.43 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.19 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -108.19 120.41 42.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.831 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.1 tp -119.99 133.56 66.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.167 0.508 . . . . 0.0 110.508 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -95.94 135.58 37.51 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.452 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 43.1 mm -95.83 121.51 60.94 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.01 149.13 86.11 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.923 2.415 . . . . 0.0 112.071 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 7.5 p -72.76 -18.75 61.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.037 0.446 . . . . 0.0 110.523 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -91.32 16.78 9.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.363 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.416 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 54.5 t80 -67.1 -32.41 73.54 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.451 -0.382 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.058 175.757 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.458 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 32.8 Cg_endo . . . . . 0 N--CA 1.461 -0.383 0 N-CA-C 111.131 -0.373 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.16 178.82 4.55 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.382 -174.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 54.16 58.07 5.33 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.894 -178.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.0 96.15 3.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.012 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.57 129.87 41.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.84 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.407 HG11 HD12 ' A' ' 123' ' ' LEU . 3.1 t -120.35 120.25 62.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.786 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -132.16 141.53 49.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.686 0.279 . . . . 0.0 110.616 -176.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.2 p -95.82 120.28 45.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.049 0.452 . . . . 0.0 110.029 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -111.18 126.82 55.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.904 0.383 . . . . 0.0 111.109 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.405 ' HG2' ' HB3' ' A' ' 121' ' ' PRO . 78.0 mt-30 -114.02 106.47 53.26 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.098 175.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.53 170.37 5.61 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.054 2.503 . . . . 0.0 112.561 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -78.29 -8.68 58.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.382 -176.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -159.71 -40.13 0.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.243 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -69.05 167.37 16.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.295 -178.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -63.02 141.68 97.69 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.853 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.405 ' HB3' ' HG2' ' A' ' 115' ' ' GLN . 60.3 Cg_endo -72.36 147.26 46.68 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.819 2.346 . . . . 0.0 111.602 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.459 ' HB3' HD13 ' A' ' 170' ' ' LEU . 34.8 p90 -147.92 154.77 40.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.14 0.495 . . . . 0.0 111.336 -175.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 28.9 tp -90.16 124.36 34.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.531 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.525 ' CZ2' ' HD3' ' A' ' 126' ' ' LYS . 21.9 t90 -100.32 103.76 15.19 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.224 0.535 . . . . 0.0 110.232 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.9 mp -97.66 119.82 46.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.195 177.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.525 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 25.4 pttm -132.0 139.59 48.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.51 0.672 . . . . 0.0 110.458 176.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 19.1 p90 -122.52 145.3 48.45 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.143 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.6 t -88.11 121.15 70.71 Favored Pre-proline 0 C--N 1.317 -0.828 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo . . . . . 0 C--N 1.347 0.497 0 C-N-CA 123.58 2.854 . . . . 0.0 112.951 -179.116 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 39.2 tp . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.24 142.03 28.15 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.936 0.398 . . . . 0.0 111.063 -175.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.444 ' CE2' HG23 ' A' ' 165' ' ' THR . 86.8 m-85 -119.37 141.51 48.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.123 -175.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -120.29 129.82 54.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.057 175.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.42 HD11 ' N ' ' A' ' 146' ' ' ILE . 4.5 mp -106.6 125.38 62.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.005 0.431 . . . . 0.0 110.191 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.518 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 18.6 ttp180 -117.66 119.81 36.12 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.676 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -140.5 159.45 42.17 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.413 -176.32 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.439 ' HE2' ' CZ2' ' A' ' 156' ' ' TRP . 52.4 pttt -167.08 149.9 5.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.426 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.97 161.69 44.1 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.547 2.165 . . . . 0.0 111.196 170.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -67.47 -16.74 64.38 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -172.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -94.04 -1.15 54.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.021 0.439 . . . . 0.0 110.427 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -91.23 125.78 36.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.381 -176.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.09 -35.32 25.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.706 0.765 . . . . 0.0 109.415 173.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -88.16 150.25 23.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.388 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.518 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 65.4 m95 -101.41 153.4 19.72 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.786 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -105.24 117.78 34.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.592 174.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -94.82 118.8 41.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.227 0.537 . . . . 0.0 110.044 175.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.536 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 22.8 m-70 -122.68 114.8 21.07 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.328 177.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -82.71 142.22 31.82 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.508 -176.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -82.37 -46.36 13.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.944 0.402 . . . . 0.0 111.448 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 163' ' ' GLN . . . 108.28 -39.44 2.9 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.987 177.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 162' ' ' GLY . 63.8 tt0 174.93 -28.28 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.295 0.569 . . . . 0.0 110.017 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -70.78 160.3 32.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.809 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.444 HG23 ' CE2' ' A' ' 144' ' ' TYR . 60.7 p -110.91 28.09 9.04 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.254 0.549 . . . . 0.0 111.273 -174.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -152.29 143.95 23.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.411 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.536 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 19.8 t80 -131.86 147.7 52.5 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.428 ' HD2' ' CE2' ' A' ' 122' ' ' TYR . 43.2 mmtt -117.68 131.69 56.59 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 34.9 mm -106.91 125.01 62.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.459 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.8 mm? -93.95 -38.2 11.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.508 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 14.7 m -76.51 87.23 3.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.822 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.448 HD13 ' CZ ' ' A' ' 206' ' ' PHE . 49.1 mt -131.92 147.57 52.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.762 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -109.28 134.29 20.52 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.305 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.34 110.87 2.13 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.618 2.212 . . . . 0.0 111.852 178.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 90.17 46.61 4.08 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.6 -176.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -135.78 147.22 48.27 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.925 0.393 . . . . 0.0 110.29 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -98.29 129.1 45.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.028 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -122.38 138.82 54.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.93 0.395 . . . . 0.0 110.639 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 7.5 mp -97.09 132.97 42.36 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.455 ' CG2' ' HB ' ' A' ' 198' ' ' THR . 28.4 m -122.72 152.98 27.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.174 0.511 . . . . 0.0 110.988 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.577 ' NE2' ' HA ' ' A' ' 181' ' ' GLN . 0.8 OUTLIER -151.94 152.6 32.73 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.454 -177.871 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.9 p -135.85 139.91 45.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.029 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -136.49 133.59 36.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.449 176.852 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . 0.458 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 13.0 p -105.08 144.65 31.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.486 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 53.4 mttt . . . . . 0 C--N 1.327 -0.391 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.284 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.442 ' CE3' ' HB3' ' A' ' 181' ' ' GLN . 63.4 m95 . . . . . 0 C--O 1.231 0.126 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.494 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 6.9 m -102.0 -54.05 0.14 Allowed Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -176.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.494 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 73.5 Cg_endo -78.08 169.74 19.9 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.656 1.571 . . . . 0.0 112.333 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -154.93 117.89 4.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 172.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' THR . . . . . 0.455 ' HB ' ' CG2' ' A' ' 180' ' ' VAL . 7.0 m -99.01 134.57 41.65 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.312 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -104.91 130.07 53.15 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 8.4 tp -128.78 138.92 53.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.284 0.564 . . . . 0.0 111.124 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -100.14 123.29 44.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.936 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 50.6 mm -88.24 120.39 70.53 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 173.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.6 150.69 80.53 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.845 2.363 . . . . 0.0 112.425 -176.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 17.5 m -69.83 -12.53 61.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.52 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -91.6 17.31 8.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.711 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.448 ' CZ ' HD13 ' A' ' 172' ' ' LEU . 80.6 t80 -67.3 -34.11 76.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.232 -178.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.191 -176.927 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.426 ' HG3' ' SG ' ' A' ' 184' ' ' CYS . 14.6 Cg_endo . . . . . 0 C--O 1.235 0.35 0 N-CA-C 111.446 -0.251 . . . . 0.0 111.446 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.01 -172.13 3.61 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.498 -173.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 58.53 51.24 8.18 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.699 0.625 . . . . 0.0 111.403 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.422 HD22 ' OG1' ' A' ' 198' ' ' THR . 52.9 tp -80.23 93.62 5.91 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.76 127.45 45.91 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.306 -177.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.7 t -112.27 123.8 68.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.877 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -132.59 140.07 48.09 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.585 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.69 113.46 32.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.383 0.611 . . . . 0.0 109.753 176.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -96.26 121.26 37.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.223 -176.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -120.7 76.13 27.48 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.101 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.91 160.61 40.2 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.74 2.293 . . . . 0.0 111.891 -178.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -83.2 -25.59 31.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.295 0.569 . . . . 0.0 110.374 176.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -92.75 -44.55 8.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.324 -175.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -105.07 153.64 21.21 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.413 ' O ' ' HD2' ' A' ' 122' ' ' TYR . 18.7 ptpt -64.7 152.43 90.05 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.413 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.55 134.34 44.02 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.754 2.303 . . . . 0.0 112.565 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.413 ' HD2' ' O ' ' A' ' 120' ' ' LYS . 46.1 p90 -146.4 163.93 34.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.443 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.438 ' HB3' ' HB ' ' A' ' 169' ' ' ILE . 33.7 tp -97.44 125.77 42.29 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.453 ' CZ2' ' HD2' ' A' ' 126' ' ' LYS . 24.3 t90 -107.67 114.66 28.79 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.296 -176.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.2 mp -102.85 123.08 55.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.453 ' HD2' ' CZ2' ' A' ' 124' ' ' TRP . 51.2 tttm -132.38 121.12 22.97 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.991 0.424 . . . . 0.0 110.848 -177.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . 0.403 ' CD2' HG21 ' A' ' 182' ' ' VAL . 42.8 p90 -119.61 166.42 13.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.995 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 61.2 m -109.02 126.47 29.27 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.293 177.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo . . . . . 0 C--O 1.233 0.257 0 C-N-CA 122.822 2.348 . . . . 0.0 111.647 179.446 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 54.1 tp . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.532 ' CD1' ' HG2' ' A' ' 163' ' ' GLN . 2.8 mm? -100.55 157.22 16.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 -176.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -120.84 136.98 54.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.801 -176.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.438 ' C ' HG13 ' A' ' 146' ' ' ILE . 27.4 tt0 -127.54 140.42 52.14 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -174.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.438 HG13 ' C ' ' A' ' 145' ' ' GLU . 7.6 mt -132.65 150.15 32.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.98 0.419 . . . . 0.0 111.843 -166.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.465 ' HG3' ' CH2' ' A' ' 194' ' ' TRP . 43.6 mtm180 -126.75 154.71 43.82 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 174.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.618 HD12 ' NE2' ' A' ' 159' ' ' HIS . 0.0 OUTLIER -163.1 155.41 18.36 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 123.297 0.373 . . . . 0.0 110.255 170.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -173.43 141.38 0.91 Allowed Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.955 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.8 173.37 13.57 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.561 2.174 . . . . 0.0 112.108 173.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -65.78 -24.68 66.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.627 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -90.51 11.51 21.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.237 0.541 . . . . 0.0 110.467 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -111.52 130.6 55.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.751 178.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -92.92 -35.35 13.38 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.259 0.552 . . . . 0.0 110.341 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -91.92 149.46 21.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.002 -175.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -93.77 128.72 40.14 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.065 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -93.06 111.46 23.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.008 173.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.441 HG13 ' HG2' ' A' ' 147' ' ' ARG . 1.9 mp -88.72 126.21 41.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.618 ' NE2' HD12 ' A' ' 148' ' ' LEU . 3.2 p80 -130.36 132.96 46.06 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.828 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -97.72 116.57 30.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.199 -176.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.437 ' HB1' ' CD1' ' A' ' 146' ' ' ILE . . . -76.95 -48.74 17.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.191 0.52 . . . . 0.0 110.643 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 123.5 -125.61 5.96 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.257 -176.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.532 ' HG2' ' CD1' ' A' ' 143' ' ' LEU . 5.1 mt-30 -102.14 -7.0 22.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.921 0.391 . . . . 0.0 110.482 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -79.48 143.24 35.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.375 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 63.5 p -101.32 33.78 2.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.171 0.51 . . . . 0.0 111.76 -174.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -158.82 153.51 24.62 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.283 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -151.27 152.56 33.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.701 0.286 . . . . 0.0 110.547 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 168' ' ' LYS . 0.1 OUTLIER -118.33 128.92 55.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.437 -178.109 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 123' ' ' LEU . 23.6 mm -99.87 140.82 18.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.11 -19.82 13.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.777 0.323 . . . . 0.0 110.86 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 36.7 t -87.59 73.89 9.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.231 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.407 ' N ' HD22 ' A' ' 172' ' ' LEU . 2.7 mm? -117.7 143.26 46.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.995 0.426 . . . . 0.0 110.522 175.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 62.0 m-70 -119.15 132.26 24.03 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.575 175.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 24.3 Cg_exo -62.09 124.33 14.2 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.791 2.327 . . . . 0.0 112.732 -177.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 85.67 28.37 29.64 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.751 177.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -123.75 149.74 45.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.14 0.495 . . . . 0.0 111.125 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -87.38 128.34 35.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.361 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -121.1 142.39 49.89 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.752 0.311 . . . . 0.0 110.329 175.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.8 mp -104.93 146.89 28.39 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 172.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.414 HG22 ' HB ' ' A' ' 198' ' ' THR . 19.4 m -134.53 152.74 34.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.983 0.42 . . . . 0.0 110.484 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.559 ' NE2' ' HA ' ' A' ' 181' ' ' GLN . 0.3 OUTLIER -151.66 146.27 25.67 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.035 179.522 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.403 HG21 ' CD2' ' A' ' 127' ' ' TRP . 12.0 p -138.17 149.82 24.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -158.34 139.25 13.02 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . 0.426 ' SG ' ' HG3' ' A' ' 106' ' ' PRO . 26.3 p -104.41 177.9 4.71 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 56.3 mttm . . . . . 0 C--N 1.327 -0.395 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.684 -178.391 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.465 ' CH2' ' HG3' ' A' ' 147' ' ' ARG . 50.9 m95 . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 120.796 0.331 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.423 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 12.9 m -74.48 -51.24 4.35 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.099 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.437 ' HG2' ' OE1' ' A' ' 181' ' ' GLN . 59.2 Cg_endo -74.78 165.27 31.84 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.667 1.578 . . . . 0.0 112.722 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -154.11 130.67 10.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.965 172.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' THR . . . . . 0.422 ' OG1' HD22 ' A' ' 109' ' ' LEU . 12.8 m -115.9 135.45 53.98 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.582 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -106.22 131.64 53.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.252 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.0 tp -128.53 130.27 69.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.283 0.563 . . . . 0.0 110.4 177.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.406 ' HA ' HE21 ' A' ' 201' ' ' GLN . 0.0 OUTLIER -97.81 113.38 25.16 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.338 178.495 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 51.7 mm -74.27 122.05 86.64 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.14 155.05 71.63 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.776 2.318 . . . . 0.0 112.353 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 12.3 p -75.85 -5.18 44.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.299 0.571 . . . . 0.0 110.224 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -82.8 -6.43 59.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.148 177.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -53.32 -37.26 62.11 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.54 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.449 -0.506 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.231 174.176 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.666 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 73.4 Cg_endo . . . . . 0 N--CA 1.458 -0.609 0 N-CA-C 111.271 -0.319 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.403 HD23 ' N ' ' A' ' 107' ' ' LEU . 2.1 pt? -140.07 -174.61 3.97 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.094 -177.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 54.99 55.97 7.12 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 123.704 0.628 . . . . 0.0 110.925 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.4 tp -75.5 96.85 3.56 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.21 0.528 . . . . 0.0 110.491 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.09 123.18 38.44 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.253 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.435 HG13 HD12 ' A' ' 123' ' ' LEU . 3.5 t -119.04 118.1 56.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.43 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -136.1 121.37 19.14 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.838 -174.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.2 t -74.48 129.44 36.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.312 -0.403 . . . . 0.0 109.971 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 114' ' ' LYS . 24.3 mmtp -118.59 125.17 49.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.14 0.495 . . . . 0.0 111.642 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -117.26 97.13 50.41 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.884 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.437 ' HB2' ' HB2' ' A' ' 119' ' ' ARG . 15.2 Cg_exo -68.74 171.48 13.24 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.429 2.086 . . . . 0.0 111.968 177.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -76.18 -66.2 0.83 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.953 0.406 . . . . 0.0 110.706 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -92.69 -33.6 14.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.666 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.437 ' HB2' ' HB2' ' A' ' 116' ' ' PRO . 71.8 mtp180 -72.41 154.9 40.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.806 176.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -75.54 149.39 83.79 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.53 146.15 48.97 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.975 2.45 . . . . 0.0 112.468 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.472 ' CD2' ' HD2' ' A' ' 168' ' ' LYS . 49.0 p90 -151.41 161.37 42.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.461 -176.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 44.5 tp -91.52 125.46 36.27 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 175.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.598 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 22.4 t90 -102.03 108.93 20.52 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.127 0.489 . . . . 0.0 110.421 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.03 122.22 52.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.337 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -131.09 120.5 23.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.946 0.403 . . . . 0.0 110.491 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . 0.42 ' CH2' HD11 ' A' ' 146' ' ' ILE . 37.1 p90 -115.83 165.84 12.63 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.466 -178.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.0 t -104.34 121.27 47.94 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.756 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo . . . . . 0 C--N 1.346 0.442 0 C-N-CA 123.377 2.718 . . . . 0.0 112.526 177.914 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.47 HD22 ' SG ' ' A' ' 184' ' ' CYS . 48.0 tp . . . . . 0 N--CA 1.448 -0.538 0 CA-C-O 120.962 0.411 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 3.5 mp -95.71 134.84 38.16 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.318 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -102.83 153.17 20.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.718 -172.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -131.62 134.24 45.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.953 -171.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.42 HD11 ' CH2' ' A' ' 127' ' ' TRP . 4.5 mp -125.68 125.2 68.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.518 ' HB3' ' HB2' ' A' ' 181' ' ' GLN . 46.6 ttp180 -118.01 119.86 36.06 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -141.5 162.59 35.12 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.848 -176.251 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -167.07 150.25 6.06 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.164 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -68.32 159.48 53.13 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.282 1.988 . . . . 0.0 111.027 171.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 177' ' ' LYS . 15.8 pt-20 -63.06 -20.66 65.54 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -171.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -100.28 7.35 44.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.091 0.472 . . . . 0.0 110.852 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.75 124.24 31.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.899 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.96 -22.99 39.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.535 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -115.32 154.45 29.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.393 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -94.7 141.58 28.45 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.324 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -103.92 108.58 19.97 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.989 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.2 mp -87.99 133.4 30.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.033 0.444 . . . . 0.0 110.053 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -126.92 141.84 51.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.609 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.416 ' CZ ' ' HB3' ' A' ' 143' ' ' LEU . 5.3 t80 -106.14 124.66 49.93 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.073 -177.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -88.21 -44.06 11.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.138 0.494 . . . . 0.0 110.303 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 143' ' ' LEU . . . 103.71 -127.63 9.21 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.051 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -93.03 9.0 37.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.447 0.641 . . . . 0.0 110.519 -176.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -105.48 153.19 22.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.584 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.8 p -107.44 19.5 20.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.033 -175.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -146.57 140.66 26.27 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -133.87 151.39 51.51 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.598 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 40.7 mmtm -120.53 135.48 55.07 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.613 0.244 . . . . 0.0 110.66 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 33.9 mm -109.7 128.78 65.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.93 -25.06 12.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.368 . . . . 0.0 111.051 -178.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 13.8 m -80.62 65.4 5.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.712 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.447 HD12 ' CZ ' ' A' ' 206' ' ' PHE . 57.6 mt -114.55 157.59 22.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.949 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 75.3 m-70 -126.08 129.97 24.1 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.774 177.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 23.7 Cg_exo -63.75 121.85 9.73 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.615 2.21 . . . . 0.0 111.925 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 90.8 20.2 40.93 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.05 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -117.49 142.97 46.52 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.425 ' HB3' ' HB3' ' A' ' 151' ' ' GLU . 30.3 ttmt -90.77 135.13 33.92 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.064 177.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -122.12 133.17 54.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.112 0.482 . . . . 0.0 110.606 176.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.3 mp -100.68 124.71 46.66 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 34.7 m -115.02 161.27 13.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.364 0.602 . . . . 0.0 111.723 -176.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' A' ' 147' ' ' ARG . 12.2 mm-40 -145.63 148.67 33.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.901 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 9.0 p -136.37 145.69 30.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 120.891 0.377 . . . . 0.0 110.184 175.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . 0.552 ' HG2' ' CZ3' ' A' ' 194' ' ' TRP . 1.2 ptm180 -163.08 177.98 8.68 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.398 175.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . 0.666 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 27.9 p -155.25 170.46 21.81 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 21.7 pttm . . . . . 0 C--N 1.322 -0.619 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.797 -176.067 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.552 ' CZ3' ' HG2' ' A' ' 183' ' ' ARG . 71.9 m95 . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 120.717 0.294 . . . . 0.0 111.653 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.532 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 70.4 m -158.58 -63.97 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.532 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 76.9 Cg_endo -76.25 109.07 2.8 Favored 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 121.896 1.731 . . . . 0.0 113.456 -173.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.454 ' HB3' HE21 ' A' ' 181' ' ' GLN . . . -101.66 137.61 39.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.891 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 94.9 m -133.48 139.21 46.54 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.574 177.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -99.75 126.72 45.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.396 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.9 tp -129.25 137.68 56.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.029 0.443 . . . . 0.0 110.423 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -102.54 137.33 40.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.905 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 39.2 mm -96.98 113.08 62.39 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 176.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.8 147.44 72.39 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.921 2.414 . . . . 0.0 112.188 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 42.1 m -71.76 -7.51 48.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.974 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -95.16 7.77 45.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.773 175.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.447 ' CZ ' HD12 ' A' ' 172' ' ' LEU . 63.6 t80 -59.77 -36.19 76.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.114 177.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 24.9 m . . . . . 0 C--N 1.319 -0.754 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.225 177.85 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 27.0 Cg_exo . . . . . 0 C--O 1.232 0.185 0 CA-C-O 120.684 0.202 . . . . 0.0 112.415 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.93 174.26 5.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.154 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 54.74 47.53 22.25 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.694 0.621 . . . . 0.0 110.976 -178.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.453 HD23 ' OG1' ' A' ' 198' ' ' THR . 55.8 tp -70.34 94.39 0.94 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.002 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.17 130.79 43.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.541 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.0 t -117.38 113.88 43.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.667 178.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -111.94 148.43 33.76 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.18 -178.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.6 p -108.36 95.84 4.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 122.077 0.941 . . . . 0.0 109.92 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -87.36 122.06 30.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.456 -174.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -117.88 98.87 51.95 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.195 -173.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.6 155.39 49.83 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.977 2.451 . . . . 0.0 111.27 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.414 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -93.5 -4.93 50.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.958 0.408 . . . . 0.0 111.145 -176.317 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -132.49 -34.94 1.16 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.728 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -87.37 173.15 9.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.291 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -79.62 138.24 54.75 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.161 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.41 ' HG3' ' O ' ' A' ' 206' ' ' PHE . 38.3 Cg_endo -66.24 147.91 84.1 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.949 2.432 . . . . 0.0 111.847 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -149.09 156.99 43.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.958 0.408 . . . . 0.0 110.979 -174.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 16.3 mt -87.65 142.46 27.82 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.248 0.547 . . . . 0.0 110.602 174.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.495 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 19.5 t90 -117.03 102.1 9.05 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.701 177.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.2 mp -97.94 117.79 43.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -131.48 131.56 43.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.065 0.459 . . . . 0.0 110.897 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 29.0 p90 -123.48 151.92 42.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.897 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.2 m -127.54 78.09 75.18 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.4 -177.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 106' ' ' PRO . 19.0 Cg_exo . . . . . 0 CA--C 1.541 0.854 0 C-N-CA 122.091 1.861 . . . . 0.0 113.395 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 13.5 tp . . . . . 0 N--CA 1.448 -0.544 0 CA-C-O 120.717 0.294 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.489 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 4.1 mp -92.76 135.54 34.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.871 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.483 ' CE1' ' HB3' ' A' ' 184' ' ' CYS . 82.5 m-85 -122.61 144.42 49.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.17 -176.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -125.66 138.14 53.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.315 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 181' ' ' GLN . 4.4 mp -118.56 122.02 68.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.924 0.392 . . . . 0.0 110.148 -177.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.417 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 23.1 ttp180 -107.1 123.86 48.84 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.564 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.7 pp -143.18 162.09 36.52 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.161 -176.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -168.35 148.8 4.35 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.91 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -71.08 161.11 47.08 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.306 2.004 . . . . 0.0 111.067 170.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -63.35 -19.94 65.07 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.247 -175.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -97.02 10.37 39.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.0 0.428 . . . . 0.0 110.9 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -98.55 131.01 45.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.641 178.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -86.23 -37.13 18.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.206 0.527 . . . . 0.0 110.469 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -98.23 159.29 15.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.912 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.417 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 69.9 m95 -96.88 146.03 25.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.078 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -105.39 111.82 24.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.007 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.48 130.08 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.082 0.468 . . . . 0.0 110.959 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -126.46 133.64 51.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.791 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -102.78 130.09 49.64 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -94.11 -29.96 14.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.859 0.362 . . . . 0.0 111.4 -177.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 143' ' ' LEU . . . 100.33 -133.28 11.24 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.149 -176.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -106.81 31.6 5.18 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.34 0.591 . . . . 0.0 110.96 -177.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -115.69 151.97 34.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.385 177.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 34.9 p -102.17 21.81 14.27 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -175.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -147.74 138.83 23.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.109 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -129.51 150.22 50.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.892 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.495 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 42.9 mmtm -112.78 146.0 39.58 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 32.6 mm -125.04 132.62 71.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 173.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.75 -16.94 14.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.915 0.388 . . . . 0.0 110.969 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 8.7 t -96.33 69.95 2.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.828 0.347 . . . . 0.0 111.451 -173.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.546 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.1 mm? -115.98 159.8 21.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.815 0.34 . . . . 0.0 110.603 176.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 57.7 m-70 -126.52 136.36 28.56 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.548 178.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 24.6 Cg_exo -62.29 122.25 10.6 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.745 2.297 . . . . 0.0 111.986 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 83.98 38.34 10.42 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.81 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -133.38 144.43 49.57 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -101.83 132.66 47.46 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.635 177.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -120.66 142.64 49.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.63 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.1 mm? -103.85 127.39 51.35 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 174.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.2 m -122.36 141.46 42.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.182 0.515 . . . . 0.0 111.55 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 99.1 mt-30 -140.65 142.73 34.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.337 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.2 p -138.57 139.42 41.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -145.97 142.82 29.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . 0.483 ' HB3' ' CE1' ' A' ' 144' ' ' TYR . 23.5 p -108.14 163.4 13.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.98 -175.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 121.38 0.609 . . . . 0.0 111.516 -178.008 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.407 ' CZ2' ' HB2' ' A' ' 147' ' ' ARG . 61.0 m95 . . . . . 0 N--CA 1.456 -0.165 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.455 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 18.2 m -140.5 -55.75 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -176.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.536 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 8.4 Cg_endo -87.64 88.71 0.58 Allowed 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.312 2.008 . . . . 0.0 113.273 -171.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . 0.452 ' HB3' ' NE2' ' A' ' 181' ' ' GLN . . . -85.78 106.76 17.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.908 0.385 . . . . 0.0 110.47 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' THR . . . . . 0.453 ' OG1' HD23 ' A' ' 109' ' ' LEU . 17.4 m -92.33 136.32 33.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.814 -177.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -95.36 124.15 39.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.742 -177.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.2 tp -127.45 129.43 70.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.234 0.54 . . . . 0.0 110.464 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -101.11 132.79 46.4 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.409 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 36.5 mm -94.08 115.48 65.24 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.07 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.41 155.4 47.09 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.998 2.465 . . . . 0.0 112.562 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 18.7 m -70.06 -17.31 63.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.645 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -82.27 1.15 38.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.87 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.546 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 62.4 t80 -57.41 -51.24 70.24 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.109 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.807 176.805 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 C--O 1.232 0.195 0 CA-C-O 120.469 0.112 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.488 ' N ' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -134.91 -178.32 5.03 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -176.454 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 56.11 58.75 4.12 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.615 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.468 HD21 ' OG1' ' A' ' 198' ' ' THR . 33.9 tp -75.57 95.81 3.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.261 0.553 . . . . 0.0 109.735 175.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.72 128.83 40.13 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.01 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.9 t -125.7 122.09 61.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.04 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -139.21 155.35 47.86 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.176 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.477 HG21 ' CD1' ' A' ' 123' ' ' LEU . 21.8 t -100.18 94.21 3.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-O 121.375 0.607 . . . . 0.0 109.636 -177.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.44 ' O ' ' HD3' ' A' ' 116' ' ' PRO . 0.8 OUTLIER -78.86 108.14 12.09 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.794 -176.723 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -106.43 98.98 21.81 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.921 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 114' ' ' LYS . 14.6 Cg_exo -69.88 163.82 36.93 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.817 2.344 . . . . 0.0 112.881 -177.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -101.4 19.75 17.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.206 177.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -147.39 -55.25 0.23 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.673 -176.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -93.12 168.59 11.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.795 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.62 143.77 96.3 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.344 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.98 135.19 46.53 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.821 2.347 . . . . 0.0 112.024 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -139.44 160.49 39.71 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.047 0.451 . . . . 0.0 110.991 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.477 ' CD1' HG21 ' A' ' 113' ' ' VAL . 37.2 tp -91.12 123.76 34.82 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 176.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.511 ' CZ2' ' HD2' ' A' ' 126' ' ' LYS . 10.5 t90 -103.0 103.25 13.33 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.2 0.524 . . . . 0.0 110.49 -174.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.0 mp -95.73 113.61 30.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.081 178.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.511 ' HD2' ' CZ2' ' A' ' 124' ' ' TRP . 58.6 tttp -129.61 119.54 23.76 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.352 0.596 . . . . 0.0 110.656 -176.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' TRP . . . . . 0.42 ' CD2' HG23 ' A' ' 182' ' ' VAL . 29.2 p90 -109.76 163.61 13.35 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.752 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.1 t -103.25 122.81 43.93 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo . . . . . 0 C--N 1.347 0.452 0 C-N-CA 123.334 2.689 . . . . 0.0 112.202 177.899 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.3 tp . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.2 mt -101.29 150.39 23.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.297 -177.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.579 ' CD2' ' HB3' ' A' ' 184' ' ' CYS . 49.7 m-85 -116.54 143.98 44.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.178 -176.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -121.48 141.93 50.54 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.513 HD11 ' N ' ' A' ' 146' ' ' ILE . 4.1 mp -117.95 124.94 73.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.024 0.44 . . . . 0.0 110.734 -175.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.437 ' HB2' ' CH2' ' A' ' 194' ' ' TRP . 14.3 ttp180 -109.01 120.32 42.2 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.062 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -145.69 161.49 39.75 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.471 -175.611 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -172.69 147.29 1.62 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.72 175.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -70.9 164.73 34.64 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.093 1.862 . . . . 0.0 111.067 170.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -64.29 -23.96 67.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.608 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.512 ' HE2' ' OE1' ' A' ' 176' ' ' GLN . 67.8 mmtt -81.7 -13.66 57.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.21 0.528 . . . . 0.0 110.512 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -83.97 129.61 34.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.746 -178.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -88.22 -26.39 22.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.409 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -107.12 144.66 33.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.791 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' TRP . . . . . 0.421 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 77.1 m95 -85.22 134.56 34.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.261 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -93.37 131.22 38.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.685 177.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.38 122.44 65.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.038 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.557 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 46.3 m-70 -130.57 113.45 14.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.202 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -79.09 132.71 36.68 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.988 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.409 ' HB1' ' CD1' ' A' ' 146' ' ' ILE . . . -99.12 -49.49 4.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 111.804 -177.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 111.87 -137.75 14.49 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.02 13.58 22.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.066 0.46 . . . . 0.0 111.005 -177.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -68.75 -23.01 64.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.492 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 42.0 p 63.16 15.71 8.77 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.382 -1.281 . . . . 0.0 113.051 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -153.2 136.88 16.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 171.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 24.7 t80 -125.74 151.33 46.81 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.692 0.282 . . . . 0.0 110.525 -176.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.58 ' HD2' ' N ' ' A' ' 168' ' ' LYS . 0.0 OUTLIER -125.53 115.51 20.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.466 -175.087 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 34.5 mm -93.39 137.92 21.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -100.37 -32.53 10.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.851 0.358 . . . . 0.0 111.118 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 18.7 m -87.55 80.93 7.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.814 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.6 mm? -113.6 137.43 51.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 110.712 176.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 53.5 m-70 -100.05 125.93 38.31 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.18 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 22.9 Cg_exo -63.52 125.05 14.78 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.566 2.177 . . . . 0.0 112.448 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 86.6 26.93 31.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.409 178.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.512 ' OE1' ' HE2' ' A' ' 152' ' ' LYS . 77.4 mm-40 -125.18 152.47 44.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.294 0.568 . . . . 0.0 111.658 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -91.08 129.69 37.05 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.32 176.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -117.58 137.74 52.4 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.43 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.5 mm? -102.31 128.74 48.74 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 175.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.7 m -128.92 139.74 51.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 120.951 0.405 . . . . 0.0 111.33 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 98.9 mt-30 -139.19 136.58 35.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.355 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.42 HG23 ' CD2' ' A' ' 127' ' ' TRP . 13.5 p -120.05 137.42 53.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.99 0.424 . . . . 0.0 110.334 174.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -138.62 157.06 46.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.349 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . 0.579 ' HB3' ' CD2' ' A' ' 144' ' ' TYR . 24.3 p -136.34 174.75 10.27 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 121.17 0.509 . . . . 0.0 111.953 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' TRP . . . . . 0.437 ' CH2' ' HB2' ' A' ' 147' ' ' ARG . 72.2 m95 . . . . . 0 N--CA 1.457 -0.091 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.514 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 54.0 m -152.28 -63.77 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 97.5 Cg_endo -74.88 80.49 2.38 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 121.954 1.77 . . . . 0.0 113.952 -168.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.65 100.61 7.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.169 0.509 . . . . 0.0 110.312 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' THR . . . . . 0.468 ' OG1' HD21 ' A' ' 109' ' ' LEU . 20.0 m -94.17 138.9 31.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.713 -176.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -100.83 116.06 31.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.622 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.0 tp -123.73 137.49 56.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.061 0.458 . . . . 0.0 110.485 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -104.75 128.71 52.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.236 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 47.2 mm -87.09 124.39 68.66 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.86 151.47 80.81 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.049 2.499 . . . . 0.0 112.382 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 37.8 m -68.57 -30.12 68.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.757 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -92.56 39.8 1.04 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.681 0.753 . . . . 0.0 109.809 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' PHE . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 80.3 t80 -74.89 -35.19 62.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.863 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.514 -177.059 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.957 0.408 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.497 ' CE2' HG11 ' A' ' 101' ' ' VAL . 8.7 t80 -75.11 133.96 41.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.32 0.581 . . . . 0.0 109.912 175.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.3 mp -74.2 97.96 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.83 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.497 HG11 ' CE2' ' A' ' 99' ' ' TYR . 3.9 m -99.23 157.95 3.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -105.33 96.46 11.64 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.923 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -73.93 -82.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.033 1.822 . . . . 0.0 112.284 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 130' ' ' PRO . 14.0 m-20 -140.9 114.55 7.12 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 120.678 0.275 . . . . 0.0 110.573 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -75.93 169.22 22.6 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.848 2.366 . . . . 0.0 110.446 170.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.644 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 37.7 Cg_endo -69.11 92.19 0.45 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 121.923 1.749 . . . . 0.0 111.349 176.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.17 178.91 6.24 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.2 -175.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 57.34 49.09 13.72 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.665 -175.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.68 96.28 0.54 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.69 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.33 125.11 39.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.543 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.2 t -120.38 120.44 62.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.662 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -127.77 142.88 51.19 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.3 p -97.99 117.14 42.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.118 0.485 . . . . 0.0 109.839 176.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -107.16 128.09 54.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.584 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -120.68 89.28 44.7 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.494 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -72.93 152.15 51.55 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 123.196 2.597 . . . . 0.0 111.989 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -73.81 -33.78 64.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.075 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -104.52 -49.3 3.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.473 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -76.4 167.02 22.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.772 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -75.16 143.28 76.83 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.588 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.6 138.13 63.01 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.596 2.198 . . . . 0.0 111.251 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -145.17 160.23 41.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.015 0.436 . . . . 0.0 111.232 -173.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 29.5 tp -93.98 121.88 35.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -102.82 104.42 14.7 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.034 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.2 mp -98.58 121.37 49.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.88 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -134.27 144.13 48.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.425 0.631 . . . . 0.0 110.476 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -132.56 164.13 27.32 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.766 -173.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 52.3 m -97.44 131.36 27.37 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.73 149.27 87.12 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.458 2.106 . . . . 0.0 111.504 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.402 ' HB3' ' O ' ' A' ' 104' ' ' ASP . 12.5 Cg_endo -55.76 138.69 82.19 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.097 2.532 . . . . 0.0 112.192 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.6 m -68.04 148.35 51.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.744 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 62.9 mt 64.04 -170.57 0.19 Allowed 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.105 0.562 . . . . 0.0 111.361 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 34.0 mt 64.7 -70.58 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 123.574 0.749 . . . . 0.0 112.473 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 57.93 87.1 0.07 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.243 0.544 . . . . 0.0 110.611 -174.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.2 mp -77.77 47.12 0.6 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.702 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -100.0 -29.78 12.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.942 -176.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.2 t -81.1 132.2 35.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.998 0.428 . . . . 0.0 110.965 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.69 162.81 9.64 Favored Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.986 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 75.7 t-105 -79.76 71.87 6.43 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 122.119 0.961 . . . . 0.0 110.501 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -145.95 75.48 1.42 Allowed 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 169.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.8 t -86.3 155.45 20.65 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.321 -177.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.443 HD22 ' SG ' ' A' ' 184' ' ' CYS . 32.9 tp -92.88 110.68 22.14 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.013 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.441 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 43.5 mt -92.31 144.69 25.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.913 0.387 . . . . 0.0 110.576 -177.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.479 ' CD1' ' HB3' ' A' ' 184' ' ' CYS . 46.2 m-85 -115.45 146.0 42.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.942 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 36.2 tt0 -126.3 133.87 51.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.604 176.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 181' ' ' GLN . 4.6 mp -118.64 125.65 74.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.309 -176.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -113.16 137.18 51.85 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -148.38 159.9 43.56 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.702 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -170.17 145.53 2.35 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.453 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -70.38 175.16 9.0 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.196 1.931 . . . . 0.0 112.537 173.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -62.16 -43.37 98.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -86.07 17.06 3.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.136 0.493 . . . . 0.0 111.298 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -94.11 121.97 36.15 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.056 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.09 -22.68 33.37 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.894 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -121.01 156.04 33.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.91 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -90.92 140.61 29.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.36 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -104.41 107.35 18.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.836 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.03 129.57 39.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.124 0.487 . . . . 0.0 110.576 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 66.6 m-70 -128.2 114.11 16.55 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.961 175.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -83.43 115.89 22.25 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.59 -44.42 19.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.767 0.317 . . . . 0.0 111.053 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 143' ' ' LEU . . . 102.93 -127.96 9.38 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.313 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -86.23 -19.74 29.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.983 0.42 . . . . 0.0 111.018 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -75.0 146.29 41.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.202 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.5 p -104.98 30.02 5.87 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.206 0.527 . . . . 0.0 111.658 -174.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -157.16 142.4 17.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.603 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 34.3 t80 -136.52 150.7 48.79 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 0.0 OUTLIER -122.8 136.65 54.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.766 0.317 . . . . 0.0 110.669 -177.404 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 29.0 mm -109.92 128.52 65.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 175.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.55 -34.97 9.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.025 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.0 m -80.15 82.81 6.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.836 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.433 HD13 ' CZ ' ' A' ' 206' ' ' PHE . 73.7 mt -125.87 147.56 49.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.224 0.535 . . . . 0.0 111.687 -176.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -105.25 119.09 54.16 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.11 176.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.39 126.3 20.39 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.858 2.372 . . . . 0.0 112.66 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.55 45.41 7.94 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.628 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -146.98 149.05 32.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.96 0.41 . . . . 0.0 111.15 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -80.82 134.24 35.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.948 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -123.47 142.66 50.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.616 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.8 mm? -106.9 132.54 52.73 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 175.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.1 m -132.28 141.98 43.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.028 0.442 . . . . 0.0 111.521 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.63 ' OE1' ' HB3' ' A' ' 194' ' ' TRP . 36.9 mt-30 -143.77 139.37 29.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.526 175.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 145' ' ' GLU . 7.1 p -133.36 139.06 49.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 174.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.455 ' NH1' ' HB3' ' A' ' 191' ' ' TRP . 37.1 ttt-85 -146.76 147.11 30.59 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.8 177.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.644 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 21.9 p -109.57 169.39 8.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.328 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.457 ' HB3' ' CD1' ' A' ' 191' ' ' TRP . 17.2 ptpt -124.92 90.92 50.27 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.261 0.553 . . . . 0.0 111.502 -177.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.536 ' HD2' ' O ' ' A' ' 189' ' ' GLY . 31.6 Cg_exo -62.15 157.64 43.6 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.042 2.494 . . . . 0.0 112.549 176.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -54.1 -49.05 69.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.881 0.372 . . . . 0.0 111.992 -172.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -97.6 10.74 39.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.842 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.536 ' O ' ' HD2' ' A' ' 186' ' ' PRO . . . -149.32 75.79 0.25 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.145 -176.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -76.27 153.93 35.58 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.457 ' CD1' ' HB3' ' A' ' 185' ' ' LYS . 14.8 p-90 -117.29 156.2 28.21 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.14 0.495 . . . . 0.0 111.518 -175.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 43.7 m -146.38 14.8 1.27 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.515 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -149.09 158.27 44.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.437 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.63 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 81.9 m95 -106.88 -179.56 3.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.321 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 48.1 t -171.43 -54.96 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -75.52 69.92 5.79 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.114 1.876 . . . . 0.0 113.669 -174.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.419 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -74.48 105.85 5.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.872 0.368 . . . . 0.0 110.879 178.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 27.6 m -98.0 132.34 43.64 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.565 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -96.3 120.33 36.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.317 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.1 tp -126.91 131.84 70.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.207 0.527 . . . . 0.0 110.473 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -95.41 119.91 34.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.621 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.9 mm -79.98 117.99 70.21 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 172.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.91 149.59 91.03 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.529 2.153 . . . . 0.0 112.158 -176.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 39.1 m -69.92 -17.46 63.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.341 0.591 . . . . 0.0 109.639 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.87 9.58 7.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.529 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.433 ' CZ ' HD13 ' A' ' 172' ' ' LEU . 64.5 t80 -57.76 -46.17 84.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.167 0.508 . . . . 0.0 110.359 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.1 p -88.48 137.88 31.93 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.617 174.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 63.7 mtt -77.4 63.33 2.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.327 0.584 . . . . 0.0 111.016 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -85.97 65.73 9.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.305 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 31.7 t70 . . . . . 0 C--O 1.247 0.951 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.481 -175.278 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 84.5 mtp . . . . . 0 N--CA 1.478 0.929 0 CA-C-O 121.117 0.484 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.498 ' HD1' ' O ' ' A' ' 101' ' ' VAL . 37.0 t80 -137.4 141.13 41.71 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 46.1 mt -43.16 -53.62 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 123.869 0.731 . . . . 0.0 112.596 -175.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.498 ' O ' ' HD1' ' A' ' 99' ' ' TYR . 3.6 t -116.85 157.0 17.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.32 -174.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -118.77 74.35 12.44 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-O 121.484 0.659 . . . . 0.0 109.396 168.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.455 ' HD3' ' C ' ' A' ' 101' ' ' VAL . 54.0 Cg_endo -101.37 -161.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.637 2.891 . . . . 0.0 112.958 -174.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -144.71 99.29 4.79 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.84 174.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.28 170.4 4.12 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.457 2.771 . . . . 0.0 112.716 -176.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.507 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 7.9 Cg_endo -50.17 133.33 35.41 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.785 2.324 . . . . 0.0 111.906 178.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -122.27 178.57 4.89 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.78 -176.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 56.51 47.34 18.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.071 0.462 . . . . 0.0 111.126 178.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.2 tp -74.05 95.94 2.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.035 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -102.65 125.36 49.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.346 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.1 t -110.39 118.86 58.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.904 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -128.62 145.97 50.99 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.134 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.0 p -101.9 117.71 47.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.296 0.57 . . . . 0.0 110.343 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -98.1 129.88 44.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.246 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -120.08 86.44 37.23 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.101 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.466 ' HG2' ' HG3' ' A' ' 119' ' ' ARG . 6.4 Cg_exo -76.04 164.47 31.41 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.432 2.755 . . . . 0.0 112.606 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -91.4 -36.45 13.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.384 -176.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -94.73 -51.79 4.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.712 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.466 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 10.5 ptm180 -90.77 162.52 14.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.289 177.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -79.71 152.04 74.65 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.387 -174.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -60.37 151.26 75.66 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.369 2.713 . . . . 0.0 113.188 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.447 ' CE2' ' HD2' ' A' ' 168' ' ' LYS . 35.7 p90 -161.58 158.67 26.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.711 -174.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 8.3 mt -82.93 139.7 33.23 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.214 173.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.568 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 10.2 t90 -118.06 94.31 4.46 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.14 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.6 mp -88.81 119.35 35.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.648 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.481 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 9.9 mtmp? -122.84 141.31 52.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.045 0.45 . . . . 0.0 110.985 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 40.2 p90 -138.45 152.06 47.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.04 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.2 t -89.09 126.16 59.89 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.19 139.36 21.47 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.374 2.716 . . . . 0.0 112.803 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.417 ' HG3' ' SG ' ' A' ' 184' ' ' CYS . 9.6 Cg_endo -50.75 138.1 41.62 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.679 2.919 . . . . 0.0 112.674 -177.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.6 m -71.33 -39.49 71.33 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.708 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 72.8 mt -118.72 104.4 10.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.764 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.422 ' O ' ' HB3' ' A' ' 134' ' ' ASP . 20.2 mt -100.84 -20.97 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.025 -175.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 133' ' ' ILE . 26.8 t70 70.52 14.17 7.33 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.016 0.912 . . . . 0.0 110.534 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 71.8 mt -122.37 141.02 52.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.519 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -89.35 150.42 22.57 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 12.0 t -83.15 158.38 22.39 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 -174.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 143.28 -64.3 0.48 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.253 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 44.5 p-90 -139.01 1.11 2.02 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.425 ' C ' ' HG1' ' A' ' 141' ' ' THR . 2.7 p90 -77.56 157.36 30.36 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.959 0.409 . . . . 0.0 110.438 -177.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.425 ' HG1' ' C ' ' A' ' 140' ' ' PHE . 8.7 m -156.2 132.71 10.18 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.88 173.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -115.64 144.62 43.65 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -98.88 145.58 26.85 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.901 0.382 . . . . 0.0 110.334 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -102.43 148.73 25.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.567 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -132.57 133.55 43.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.832 -168.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 181' ' ' GLN . 4.5 mp -126.85 120.42 55.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.877 0.37 . . . . 0.0 110.753 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.607 ' HB2' ' CZ2' ' A' ' 194' ' ' TRP . 5.4 ttp-105 -104.22 120.13 40.48 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.2 pp -143.3 159.34 42.52 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.937 0.399 . . . . 0.0 111.719 -175.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -169.54 148.33 3.35 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.305 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -71.16 166.9 27.74 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.247 1.965 . . . . 0.0 112.187 172.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.485 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 11.1 pt-20 -57.98 -41.15 82.37 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.485 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 95.0 mttt -85.25 16.84 3.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.904 0.383 . . . . 0.0 111.595 -176.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.15 128.17 47.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.59 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -85.53 -34.11 21.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.269 0.557 . . . . 0.0 110.333 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -103.12 147.49 26.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.705 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.475 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 76.3 m95 -90.7 148.6 22.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.5 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -107.42 114.14 27.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.719 174.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.1 mp -91.29 112.05 24.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -106.79 148.64 28.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.253 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -109.48 123.23 49.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.62 -174.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -79.24 -51.63 9.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.615 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 82.04 79.98 0.95 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.651 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 72.6 -46.18 0.64 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.078 0.951 . . . . 0.0 112.595 175.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -66.5 148.28 52.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.003 0.43 . . . . 0.0 110.81 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 56.9 p -104.14 36.41 2.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.35 0.595 . . . . 0.0 111.308 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -157.77 140.36 14.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.186 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -131.88 149.72 52.36 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.568 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 42.1 mmtm -116.6 143.85 45.1 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.439 ' HB ' ' HB2' ' A' ' 123' ' ' LEU . 29.8 mm -123.76 122.29 64.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 175.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -94.81 -32.82 13.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.311 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.6 m -77.96 83.81 4.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.838 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 86.9 mt -133.03 145.63 50.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.784 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -102.49 122.13 47.45 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.283 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.65 112.93 1.41 Allowed 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.468 2.112 . . . . 0.0 111.682 175.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 89.27 44.76 4.92 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.658 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -141.29 147.41 38.15 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.763 0.316 . . . . 0.0 110.17 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -91.55 137.82 32.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.469 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -125.19 140.49 52.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.023 0.44 . . . . 0.0 110.498 176.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.4 mp -104.64 132.1 51.29 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.62 147.23 28.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.948 0.404 . . . . 0.0 111.699 -175.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.574 ' OE1' ' HB3' ' A' ' 194' ' ' TRP . 53.6 mt-30 -143.46 153.28 42.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.392 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.9 p -124.67 140.44 47.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.113 0.482 . . . . 0.0 111.012 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.629 ' HG3' ' CE3' ' A' ' 194' ' ' TRP . 26.2 mtp-105 -133.34 163.99 28.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.912 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.507 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 31.5 p -140.7 125.72 18.38 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 167.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.411 ' HD3' HH12 ' A' ' 183' ' ' ARG . 23.4 pttm -119.42 89.88 41.34 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 121.328 0.585 . . . . 0.0 110.984 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.41 166.85 18.22 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.769 2.313 . . . . 0.0 112.354 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.41 -24.37 65.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.281 -172.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 52.9 m170 -93.09 4.4 54.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.562 0.22 . . . . 0.0 111.111 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -132.57 174.29 20.48 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 119.927 -1.13 . . . . 0.0 113.535 -174.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.414 ' CG ' ' N ' ' A' ' 191' ' ' TRP . 66.6 t80 -129.53 178.95 6.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.588 ' HA ' ' NH2' ' A' ' 183' ' ' ARG . 50.7 m95 -48.24 142.02 5.84 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 174.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 17.7 p -119.4 9.61 11.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.903 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . 61.71 21.64 12.34 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.629 ' CE3' ' HG3' ' A' ' 183' ' ' ARG . 69.0 m95 69.2 171.96 0.3 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.624 172.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.481 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 42.0 m -159.64 -57.58 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -176.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.491 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 9.2 Cg_endo -90.03 91.9 0.31 Allowed 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.539 2.159 . . . . 0.0 113.595 -170.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.549 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -79.48 116.55 19.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.023 0.44 . . . . 0.0 111.0 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 27.0 m -109.48 140.96 42.6 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.812 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -115.61 127.82 55.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.731 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.9 tp -125.45 135.52 63.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.033 0.444 . . . . 0.0 111.141 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -96.67 118.9 34.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.404 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 50.8 mm -84.21 119.88 73.82 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.44 151.1 86.56 Favored 'Trans proline' 0 N--CA 1.466 -0.147 0 C-N-CA 122.558 2.172 . . . . 0.0 112.251 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 19.2 m -69.94 -20.4 63.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.047 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -88.2 26.82 1.32 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.775 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -66.18 -43.98 85.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.635 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 28.8 m -112.84 141.39 46.71 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.922 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 21.4 ptm -72.29 122.16 20.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.202 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -101.24 57.47 0.86 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.968 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 C--O 1.246 0.882 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.952 177.403 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.7 0.286 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -122.23 137.59 54.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.442 0.639 . . . . 0.0 110.703 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 91.2 mt -81.34 111.87 18.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.951 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.568 ' O ' ' HD3' ' A' ' 103' ' ' PRO . 13.9 m -107.85 158.89 7.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.678 -176.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -98.66 91.74 1.36 Allowed Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 173.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.568 ' HD3' ' O ' ' A' ' 101' ' ' VAL . 93.8 Cg_endo -83.4 -9.84 10.14 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.514 2.142 . . . . 0.0 112.401 -175.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.454 ' HB3' ' HB3' ' A' ' 130' ' ' PRO . 26.1 m-20 -127.18 78.73 74.04 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.974 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -85.31 153.19 10.72 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.159 2.573 . . . . 0.0 111.481 177.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.674 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 39.4 Cg_endo -69.5 94.82 0.51 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.268 1.979 . . . . 0.0 111.44 176.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -90.41 175.01 7.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.675 -177.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 53.38 51.96 14.39 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 123.556 0.535 . . . . 0.0 110.888 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 57.0 tp -78.84 96.37 5.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.148 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.83 128.71 45.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.387 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -116.62 115.74 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -125.0 130.18 51.83 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.965 0.412 . . . . 0.0 110.786 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.5 p -77.52 117.42 22.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.2 0.524 . . . . 0.0 109.874 176.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -102.23 122.38 44.09 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.282 0.563 . . . . 0.0 111.388 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -124.91 75.82 66.31 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.753 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.459 ' HG2' ' HB2' ' A' ' 119' ' ' ARG . 6.7 Cg_exo -76.03 -179.06 4.84 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 123.38 2.72 . . . . 0.0 112.782 -175.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -89.76 -64.21 1.17 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -71.96 -36.83 69.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.442 -177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.459 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 56.9 mtt85 -88.01 156.35 19.36 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.592 -178.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.416 ' O ' ' HD1' ' A' ' 122' ' ' TYR . 50.6 mtmt -75.35 153.56 85.98 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.04 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.25 133.76 39.26 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.329 2.019 . . . . 0.0 111.503 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.416 ' HD1' ' O ' ' A' ' 120' ' ' LYS . 55.1 p90 -151.12 166.23 31.44 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.432 -176.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 169' ' ' ILE . 38.9 tp -95.98 123.21 39.48 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 176.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.402 ' HE1' ' HB2' ' A' ' 166' ' ' GLU . 17.5 t90 -103.24 106.68 17.25 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.221 -176.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.4 mp -106.28 118.36 53.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.708 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -131.54 141.45 49.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.48 0.657 . . . . 0.0 111.24 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . 0.45 ' CH2' HD11 ' A' ' 146' ' ' ILE . 28.7 p90 -129.07 155.44 45.44 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.439 -176.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 22.6 t -83.36 130.53 56.17 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.7 139.26 76.93 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.045 2.497 . . . . 0.0 112.492 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.454 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 76.8 Cg_exo -49.66 129.71 24.39 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.011 2.474 . . . . 0.0 111.899 176.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.99 -67.87 0.26 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -167.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 97.0 mt -101.75 80.58 2.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.486 0.66 . . . . 0.0 112.024 -173.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.3 mt -97.08 -58.53 3.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 172.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.0 t70 56.99 79.36 0.19 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.033 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mp -84.76 51.34 2.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.49 -175.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -101.04 -37.17 8.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.207 0.527 . . . . 0.0 110.034 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 19.3 p -81.8 -53.84 5.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.889 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.41 105.91 2.86 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.567 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -84.76 69.34 10.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.191 0.519 . . . . 0.0 110.592 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -103.42 178.95 4.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.372 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.3 m -117.9 129.4 55.61 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.415 HD11 ' H ' ' A' ' 185' ' ' LYS . 42.2 tp -91.69 116.47 28.91 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.967 0.413 . . . . 0.0 110.463 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.6 mp -106.18 144.8 32.37 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.557 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -113.61 165.31 12.64 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.151 -176.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.452 ' HB3' ' NE ' ' A' ' 183' ' ' ARG . 40.3 tt0 -154.07 139.37 17.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.527 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.523 ' CD1' ' HB2' ' A' ' 161' ' ' ALA . 4.3 mp -121.92 130.19 74.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.042 0.449 . . . . 0.0 110.968 -172.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.463 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 27.8 ttp180 -108.18 121.15 44.26 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 1.7 pp -146.98 166.0 28.13 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.9 0.381 . . . . 0.0 111.413 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -172.45 149.89 2.13 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.751 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.35 162.45 42.34 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.34 2.026 . . . . 0.0 111.153 172.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -67.31 -14.53 63.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.546 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -93.93 2.97 56.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.289 0.566 . . . . 0.0 110.06 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -102.76 130.93 49.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.272 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -88.22 -35.85 17.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.24 0.543 . . . . 0.0 110.315 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -95.84 150.44 20.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.333 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.463 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 84.3 m95 -85.91 148.02 25.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.238 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -115.82 119.23 35.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.947 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.0 mp -99.05 131.68 45.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.103 0.478 . . . . 0.0 110.847 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -125.54 126.41 44.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.976 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -83.28 124.79 30.93 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.523 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -82.3 -36.43 27.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.895 0.379 . . . . 0.0 111.286 -176.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 88.34 -136.97 14.08 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.487 -0.863 . . . . 0.0 110.965 -175.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -99.85 70.99 1.65 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.088 0.47 . . . . 0.0 110.353 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -160.24 147.17 15.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.821 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.2 p -102.43 13.62 34.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.35 0.595 . . . . 0.0 111.074 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 166' ' ' GLU . 1.0 OUTLIER -140.08 113.41 8.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.89 175.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -109.03 152.08 25.48 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.519 -173.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' A' ' 168' ' ' LYS . 10.4 mptt -123.23 129.11 50.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.276 -176.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.403 ' HB ' ' HB3' ' A' ' 123' ' ' LEU . 28.9 mm -108.54 137.58 39.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 175.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.77 -23.18 12.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.997 0.427 . . . . 0.0 110.58 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 7.0 m -87.17 67.5 9.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.78 -175.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.01 140.43 39.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.968 0.413 . . . . 0.0 110.887 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 32.5 m-70 -103.74 115.81 62.86 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.474 173.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 35.8 Cg_exo -59.02 126.09 20.06 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.822 2.348 . . . . 0.0 112.878 -177.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 88.86 29.45 18.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.752 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -133.95 145.51 49.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.095 0.474 . . . . 0.0 110.734 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -82.44 132.05 35.21 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.441 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -114.71 136.7 52.78 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.872 0.368 . . . . 0.0 110.532 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.9 mm? -101.36 129.26 47.32 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 174.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.24 141.7 44.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.176 0.512 . . . . 0.0 111.655 -176.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -144.59 134.06 23.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.959 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 6.5 p -117.71 135.73 57.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.452 ' NE ' ' HB3' ' A' ' 145' ' ' GLU . 7.8 ppt_? -116.12 155.73 27.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.83 0.348 . . . . 0.0 110.731 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.674 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 26.4 p -136.77 175.26 9.78 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.794 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.415 ' H ' HD11 ' A' ' 142' ' ' LEU . 37.1 mtmt -124.72 83.85 58.47 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.337 174.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 190' ' ' TYR . 50.6 Cg_exo -56.48 146.97 71.69 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.079 2.52 . . . . 0.0 112.528 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -70.91 -29.25 65.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.401 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -92.49 24.04 3.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.503 177.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -170.17 -133.1 1.55 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.472 ' O ' ' HD2' ' A' ' 186' ' ' PRO . 31.5 p90 -163.17 -164.83 1.0 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -30.03 129.35 0.1 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.299 1.0 . . . . 0.0 112.717 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 35.8 p -98.17 -2.52 39.67 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.457 -177.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . 58.09 -157.83 0.3 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.785 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 29.9 m95 -117.73 106.32 12.93 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.56 -176.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.474 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 36.4 t -116.0 -59.67 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 195' ' ' SER . 95.4 Cg_endo -76.8 87.37 1.48 Allowed 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.857 1.705 . . . . 0.0 113.397 -173.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.61 101.75 5.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.101 0.477 . . . . 0.0 109.927 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 18.6 m -91.03 131.26 36.73 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.917 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -94.33 132.46 38.91 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.458 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.651 HG12 ' N ' ' A' ' 201' ' ' GLN . 0.0 OUTLIER -147.49 150.24 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.367 0.603 . . . . 0.0 111.297 174.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.651 ' N ' HG12 ' A' ' 200' ' ' ILE . 7.6 mm-40 -91.81 136.01 33.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.741 176.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 49.0 mm -100.89 114.75 65.83 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 165.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.64 148.95 79.51 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.905 2.403 . . . . 0.0 112.555 -175.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 17.1 m -69.79 -23.98 63.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.856 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -92.21 32.92 1.11 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.202 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -65.93 -32.44 73.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.135 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 8.3 t -100.86 141.84 33.17 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.119 0.485 . . . . 0.0 110.662 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -114.12 -71.13 0.76 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.733 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.3 t30 53.72 67.72 0.96 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.831 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.382 -0.818 . . . . 0.0 109.678 178.085 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.4 mmm . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 120.915 0.388 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.576 ' HD2' ' O ' ' A' ' 101' ' ' VAL . 83.2 t80 -135.26 161.02 36.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.58 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.428 HG21 HG21 ' A' ' 101' ' ' VAL . 4.4 mp -49.0 -48.31 16.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 123.53 0.732 . . . . 0.0 112.42 -177.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.576 ' O ' ' HD2' ' A' ' 99' ' ' TYR . 63.4 t -124.33 137.12 58.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.163 -176.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -62.91 135.74 96.22 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.8 99.19 0.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.563 2.175 . . . . 0.0 112.013 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -119.6 91.02 44.08 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.949 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.86 145.64 32.26 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.88 2.387 . . . . 0.0 111.618 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.477 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 7.1 Cg_endo -49.68 112.46 0.7 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.271 2.647 . . . . 0.0 111.692 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -73.15 163.02 28.74 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.384 -173.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 60.61 54.46 3.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.382 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -75.58 93.92 3.1 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -97.21 131.46 43.92 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.407 -176.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.57 114.39 43.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -129.39 140.36 51.37 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.367 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.9 p -87.16 115.56 28.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.413 0.625 . . . . 0.0 109.351 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.508 ' O ' ' HD3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -102.06 113.2 26.24 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.4 -174.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.454 ' HB3' ' SD ' ' A' ' 208' ' ' MET . 20.0 mp0 -105.49 98.89 18.4 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.316 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 114' ' ' LYS . 5.5 Cg_exo -80.79 146.08 16.36 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.295 2.663 . . . . 0.0 112.092 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.0 -23.99 58.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.831 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -118.15 3.27 12.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.774 0.321 . . . . 0.0 111.376 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -137.86 151.64 48.26 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.461 ' HD2' ' N ' ' A' ' 120' ' ' LYS . 12.7 mptt -63.42 139.04 97.52 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.236 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.18 145.12 98.78 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.476 2.784 . . . . 0.0 112.752 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.517 ' CE1' ' HD2' ' A' ' 168' ' ' LYS . 35.4 p90 -149.28 155.04 39.93 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.26 -176.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 9.3 mt -80.43 127.41 32.38 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 173.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.563 ' CZ2' ' HD2' ' A' ' 126' ' ' LYS . 14.4 t90 -101.69 102.18 12.8 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.789 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.5 mp -93.62 114.27 29.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.563 ' HD2' ' CZ2' ' A' ' 124' ' ' TRP . 64.1 tttm -127.84 126.56 41.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.568 -175.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 39.9 p90 -126.04 158.98 33.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.338 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.42 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 37.7 m -99.61 131.74 24.26 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.195 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 128' ' ' SER . 33.5 Cg_exo -62.23 141.92 89.72 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.664 2.243 . . . . 0.0 111.725 176.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.7 86.9 0.17 Allowed 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.986 2.457 . . . . 0.0 113.22 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.443 HG22 ' HG ' ' A' ' 132' ' ' LEU . 9.6 m 56.86 -95.22 0.05 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.243 176.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.443 ' HG ' HG22 ' A' ' 131' ' ' THR . 95.0 mt -117.12 -9.09 11.1 Favored 'General case' 0 CA--C 1.518 -0.255 0 O-C-N 122.409 -0.182 . . . . 0.0 111.125 -176.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.4 HD11 ' CB ' ' A' ' 129' ' ' PRO . 3.6 mp 67.9 -76.65 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 123.654 0.596 . . . . 0.0 110.137 -177.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.3 t70 45.91 62.06 2.4 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.977 0.911 . . . . 0.0 112.552 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 7.5 mp -79.19 -43.31 24.15 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 169.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -151.7 111.33 3.99 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.653 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.9 m -61.64 108.73 1.03 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.208 -174.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 165.22 -105.16 0.24 Allowed Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -128.1 7.92 6.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.844 0.354 . . . . 0.0 110.49 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -73.81 99.3 3.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.011 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 15.5 p -87.2 147.29 25.65 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.396 -178.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.518 HD22 ' SG ' ' A' ' 184' ' ' CYS . 56.7 tp -80.0 132.67 36.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.145 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -93.88 152.7 18.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.035 0.445 . . . . 0.0 111.141 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.595 ' CD1' ' HB3' ' A' ' 184' ' ' CYS . 63.7 m-85 -129.78 149.84 51.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.012 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -128.73 139.7 52.09 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.42 124.34 69.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.847 0.356 . . . . 0.0 110.448 -176.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.497 ' HB2' ' CZ2' ' A' ' 194' ' ' TRP . 16.3 ttp180 -113.76 120.18 39.91 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.412 HD22 ' C ' ' A' ' 148' ' ' LEU . 0.0 OUTLIER -143.42 160.22 40.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.542 0.211 . . . . 0.0 110.786 -177.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -165.23 148.65 7.21 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.241 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.492 ' HB3' ' CZ ' ' A' ' 178' ' ' TYR . 56.9 Cg_endo -73.47 169.37 22.47 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.57 2.18 . . . . 0.0 111.946 172.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -68.9 -11.54 60.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.667 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -93.76 -1.57 54.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.289 0.566 . . . . 0.0 110.004 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -100.19 122.6 43.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.771 -173.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -84.45 -28.38 26.87 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.562 0.696 . . . . 0.0 109.437 173.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -106.85 146.32 31.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.173 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.467 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 80.0 m95 -86.69 155.22 20.47 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.08 0.466 . . . . 0.0 111.582 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -111.62 127.39 55.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.74 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.87 126.99 67.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.164 0.507 . . . . 0.0 111.222 -176.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -125.26 137.98 54.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -96.57 138.21 34.49 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -77.4 -23.16 50.73 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.514 -177.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 83.86 -46.06 3.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.994 177.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -179.52 -33.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.128 0.489 . . . . 0.0 109.895 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -72.28 160.08 32.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.385 -177.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.406 HG22 ' HG3' ' A' ' 129' ' ' PRO . 67.5 p -110.03 30.33 6.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.401 -174.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -153.19 140.6 19.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.711 175.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -135.65 153.25 51.69 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.672 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 22.5 mmtt -118.86 140.98 49.07 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 31.8 mm -114.89 123.79 70.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.691 0.281 . . . . 0.0 110.561 176.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.416 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.8 mm? -95.72 -16.76 21.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.5 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.8 m -80.8 71.15 7.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.709 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 59.4 mt -129.63 137.22 50.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.98 0.419 . . . . 0.0 111.34 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -111.7 125.19 30.8 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.263 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.84 122.52 11.35 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.742 2.295 . . . . 0.0 112.46 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 95.43 22.26 22.34 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.749 177.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -131.24 148.73 52.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.935 0.398 . . . . 0.0 110.895 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -90.26 134.18 34.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.116 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.492 ' CZ ' ' HB3' ' A' ' 150' ' ' PRO . 12.1 m-85 -119.9 149.59 41.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.021 0.438 . . . . 0.0 110.652 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.9 mp -112.49 136.21 52.27 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.3 m -132.6 148.12 31.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.056 0.455 . . . . 0.0 111.372 -177.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 93.2 mt-30 -150.29 144.33 25.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.384 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.419 HG13 ' HG2' ' A' ' 106' ' ' PRO . 12.0 p -138.83 145.01 28.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 171.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.472 ' HD3' ' CZ3' ' A' ' 191' ' ' TRP . 7.6 ptm180 -155.53 161.22 40.93 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.223 0.535 . . . . 0.0 110.182 171.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.595 ' HB3' ' CD1' ' A' ' 144' ' ' TYR . 5.7 p -116.69 -174.45 2.57 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.077 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.43 134.96 6.47 Favored Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.955 -177.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.02 141.16 47.45 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.953 2.435 . . . . 0.0 111.446 177.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -71.92 -24.73 61.68 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.55 -176.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -84.15 10.21 10.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.58 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -151.36 -158.18 8.23 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.484 -0.647 . . . . 0.0 111.484 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -138.66 -171.44 3.07 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.024 0.44 . . . . 0.0 111.162 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.472 ' CZ3' ' HD3' ' A' ' 183' ' ' ARG . 17.8 m95 -70.65 157.63 37.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.571 176.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 15.6 t -142.63 41.05 1.57 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.392 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . 67.62 -172.27 0.19 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.917 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.497 ' CZ2' ' HB2' ' A' ' 147' ' ' ARG . 61.8 m95 -100.36 178.45 4.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.014 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.438 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 50.7 m -156.07 -53.89 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.525 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 1.1 Cg_endo -82.95 81.27 2.44 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.128 1.886 . . . . 0.0 113.057 -173.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.4 ' HA ' ' CG ' ' A' ' 181' ' ' GLN . . . -82.83 103.94 12.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.115 0.484 . . . . 0.0 110.66 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 53.9 m -96.7 138.06 34.83 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.257 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -102.76 130.87 49.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.495 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.2 tp -135.91 137.09 49.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.207 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -102.46 147.05 27.22 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.93 0.395 . . . . 0.0 111.566 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 21.8 mm -96.47 118.16 65.52 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.789 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.51 153.28 72.35 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.968 2.445 . . . . 0.0 112.11 -177.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 28.0 m -70.81 -23.03 62.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.889 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -94.2 34.56 1.25 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.643 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -69.66 -50.97 38.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.838 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 6.4 t -65.51 144.03 57.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.371 0.605 . . . . 0.0 111.098 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.454 ' SD ' ' HB3' ' A' ' 115' ' ' GLN . 85.8 mtp -115.55 8.78 15.22 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.679 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -135.33 86.16 2.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.698 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 34.8 t70 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.409 -0.805 . . . . 0.0 110.404 -177.352 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 14.6 t80 68.82 127.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 O-C-N 124.065 0.853 . . . . 0.0 111.671 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.0 mm -71.38 92.44 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.765 174.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.2 m -67.47 146.41 13.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.422 0.63 . . . . 0.0 111.243 -176.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.4 pm0 -83.17 139.42 42.22 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.796 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -78.78 -174.72 2.4 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.977 2.451 . . . . 0.0 111.749 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -105.03 106.75 56.73 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 28.1 Cg_exo -64.47 147.81 90.55 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 123.224 2.616 . . . . 0.0 112.775 -176.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.487 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 35.8 Cg_exo -58.48 132.94 51.41 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.068 2.512 . . . . 0.0 111.672 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -122.3 -179.45 4.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.427 -172.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 54.78 41.22 32.08 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 123.576 0.548 . . . . 0.0 110.731 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.6 tt -64.53 103.97 0.74 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.792 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -109.74 132.42 54.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.705 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.3 t -114.42 126.35 71.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.84 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -126.52 132.61 51.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.947 0.404 . . . . 0.0 110.615 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.8 p -87.22 126.36 41.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.1 0.476 . . . . 0.0 110.196 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 114' ' ' LYS . 55.1 mmtt -106.68 127.29 53.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.032 0.444 . . . . 0.0 110.957 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -132.94 85.09 47.22 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.158 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.71 168.7 22.99 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.982 2.455 . . . . 0.0 111.5 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.449 ' HA ' ' OD1' ' A' ' 209' ' ' ASN . 0.4 OUTLIER -102.17 -6.24 23.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.859 0.362 . . . . 0.0 111.354 -177.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -132.88 2.62 3.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.481 0.658 . . . . 0.0 110.534 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -136.82 149.14 47.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.531 -176.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -56.97 130.63 79.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 O-C-N 123.513 0.508 . . . . 0.0 111.289 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.27 137.04 63.41 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.573 2.182 . . . . 0.0 111.361 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -140.9 163.89 31.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.468 -175.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.0 tp -100.19 124.99 46.26 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.456 ' CZ2' ' HD3' ' A' ' 126' ' ' LYS . 25.9 t90 -107.49 115.94 31.05 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.418 -177.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.4 mp -101.06 122.55 53.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.735 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.456 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 39.7 ttpt -129.72 120.36 24.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.189 0.519 . . . . 0.0 110.555 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . 0.439 ' CE2' HG21 ' A' ' 182' ' ' VAL . 40.3 p90 -116.28 160.78 19.98 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.931 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.3 m -95.61 129.37 34.86 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.51 162.72 29.74 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.905 2.404 . . . . 0.0 111.945 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -38.57 135.63 0.72 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.862 3.041 . . . . 0.0 113.57 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.5 p -68.01 -30.09 69.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.374 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 73.8 mt -99.07 -178.91 4.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.945 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.4 mt 70.39 -53.03 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 123.143 0.577 . . . . 0.0 111.801 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 54.49 65.33 1.53 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.299 0.571 . . . . 0.0 110.422 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.97 54.42 2.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.355 -176.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -79.38 -20.29 48.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.941 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 16.6 p -84.96 -178.36 6.81 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.866 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -88.42 -159.55 35.01 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.534 175.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 70.9 t90 69.34 -65.92 0.28 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.285 0.634 . . . . 0.0 111.363 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -71.09 100.14 1.97 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.4 m -96.42 132.23 42.17 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.188 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 41.8 tp -128.5 116.89 20.38 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.6 mp -99.84 143.19 30.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.01 0.434 . . . . 0.0 110.872 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -115.3 133.78 55.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.662 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -116.75 139.35 50.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 181' ' ' GLN . 4.7 mp -120.26 119.72 60.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.088 0.47 . . . . 0.0 110.859 -176.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.414 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 21.4 ttp180 -104.18 121.68 43.78 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.2 pp -143.88 162.75 35.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.678 0.275 . . . . 0.0 111.316 -176.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -171.51 150.42 2.71 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.416 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.16 156.37 55.57 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.096 1.864 . . . . 0.0 110.904 170.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -61.95 -18.57 60.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.246 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -91.62 -3.85 55.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.984 0.421 . . . . 0.0 110.553 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -87.6 127.12 35.27 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.099 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.72 -14.27 52.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.285 0.564 . . . . 0.0 110.475 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -119.95 139.02 53.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.794 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.414 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 78.2 m95 -81.4 147.98 29.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.354 177.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -116.08 117.62 30.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.279 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mp -93.05 123.18 45.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.392 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 59.8 m-70 -119.04 155.87 30.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.524 176.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -122.6 129.79 52.29 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.518 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -97.88 -34.74 10.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.943 0.401 . . . . 0.0 110.953 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.58 -140.93 15.24 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.49 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -91.67 52.99 2.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.211 0.529 . . . . 0.0 109.906 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -150.1 149.92 30.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.329 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.428 ' HA ' ' CE2' ' A' ' 127' ' ' TRP . 61.3 p -101.4 33.08 3.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.954 -174.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -146.59 134.09 20.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.975 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 39.9 t80 -136.89 149.33 47.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.105 176.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.97 140.84 49.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.945 0.402 . . . . 0.0 111.224 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 34.7 mm -117.67 136.41 54.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.886 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -103.84 -23.85 13.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.833 0.349 . . . . 0.0 110.67 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 69.5 m -89.54 80.53 6.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.867 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -116.57 132.16 56.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.982 0.42 . . . . 0.0 110.691 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 52.9 m170 -100.09 118.62 61.17 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.657 176.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.02 118.46 5.33 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.875 2.383 . . . . 0.0 112.813 -178.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 97.22 5.64 58.06 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.96 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -109.03 151.4 26.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.157 0.503 . . . . 0.0 110.66 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.431 ' HE3' ' HB3' ' A' ' 199' ' ' PHE . 37.8 tttp -93.51 136.72 33.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.07 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -120.88 139.42 53.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.879 0.371 . . . . 0.0 110.21 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.7 mp -104.08 126.06 50.9 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.9 m -123.76 139.15 51.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.117 0.484 . . . . 0.0 111.312 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.485 ' HG3' ' HA ' ' A' ' 197' ' ' ALA . 0.0 OUTLIER -141.63 134.64 29.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.14 179.415 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.439 HG21 ' CE2' ' A' ' 127' ' ' TRP . 7.8 p -129.45 137.65 56.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -143.39 149.56 37.85 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.487 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 28.3 p -118.21 158.85 24.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.638 -174.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.477 ' HB3' ' CD1' ' A' ' 191' ' ' TRP . 20.8 ptmt -145.72 114.65 4.74 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.137 0.494 . . . . 0.0 111.279 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -89.57 -170.95 0.47 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.123 2.549 . . . . 0.0 111.472 176.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -88.51 10.72 19.31 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.145 0.498 . . . . 0.0 110.221 177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -98.72 -21.65 16.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.04 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -168.13 -163.34 21.91 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.382 -175.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -156.83 178.75 9.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.71 0.29 . . . . 0.0 110.341 -175.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.477 ' CD1' ' HB3' ' A' ' 185' ' ' LYS . 49.1 p-90 -139.5 137.18 35.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.195 176.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 12.5 p -113.5 6.48 17.11 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.232 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -155.99 167.02 31.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.207 0.527 . . . . 0.0 111.61 -176.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -106.99 148.17 29.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.416 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.525 ' H ' ' HD2' ' A' ' 196' ' ' PRO . 20.0 m -137.02 -57.88 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.569 0 CA-C-O 119.242 -0.409 . . . . 0.0 111.947 -177.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.525 ' HD2' ' H ' ' A' ' 195' ' ' SER . 59.3 Cg_endo -71.42 83.06 1.05 Allowed 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.627 1.551 . . . . 0.0 112.874 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.485 ' HA ' ' HG3' ' A' ' 181' ' ' GLN . . . -88.24 115.14 25.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.143 0.497 . . . . 0.0 110.662 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 85.7 m -107.12 138.39 43.39 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.053 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.431 ' HB3' ' HE3' ' A' ' 177' ' ' LYS . 62.1 m-85 -106.61 140.04 40.11 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.347 -176.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.9 tp -136.54 134.06 49.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.147 0.499 . . . . 0.0 110.533 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.81 123.1 45.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.25 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.9 mm -79.34 123.52 84.51 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.96 149.63 87.85 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.904 2.402 . . . . 0.0 112.371 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 13.3 m -66.03 -26.48 67.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.94 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -91.91 27.78 2.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.55 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -62.71 -46.93 85.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.137 0.494 . . . . 0.0 110.433 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.4 m -97.36 115.49 27.8 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.9 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 93.8 mmm -139.28 -61.65 0.55 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.908 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . 0.449 ' OD1' ' HA ' ' A' ' 117' ' ' GLU . 8.9 p30 -147.62 154.28 40.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.625 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 C--O 1.252 1.191 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.139 179.535 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.1 ptm . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 120.767 0.318 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -99.45 137.22 38.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.269 0.556 . . . . 0.0 110.259 175.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 188' ' ' HIS . 88.2 mt -77.36 111.05 13.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.596 177.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 31.2 m -103.5 139.42 24.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.6 -174.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.547 ' CD ' ' HA3' ' A' ' 189' ' ' GLY . 3.1 mp0 -112.3 89.85 13.08 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.162 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -72.79 -81.33 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.888 1.725 . . . . 0.0 111.921 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -135.46 87.69 26.48 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 174.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.505 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 38.1 Cg_exo -53.38 -46.45 33.75 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.547 2.165 . . . . 0.0 113.279 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' A' ' 105' ' ' PRO . 20.8 Cg_endo -96.66 104.54 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.128 1.885 . . . . 0.0 111.412 171.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.5 mp -91.52 178.24 6.0 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.835 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 128' ' ' SER . 39.6 mt-10 50.2 47.41 23.68 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 124.839 1.337 . . . . 0.0 111.727 165.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.2 tp -64.86 112.94 3.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.92 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -114.16 128.12 56.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.407 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.5 t -116.44 126.34 73.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.82 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -141.38 126.44 18.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.913 0.387 . . . . 0.0 110.609 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.31 133.96 28.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.318 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -124.19 117.71 25.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.356 0.598 . . . . 0.0 111.088 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.447 ' NE2' ' HA ' ' A' ' 206' ' ' PHE . 46.6 mt-30 -108.59 99.64 34.52 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.476 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' A' ' 117' ' ' GLU . 16.0 Cg_exo -68.1 -83.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.769 2.313 . . . . 0.0 112.66 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.422 ' H ' ' HB2' ' A' ' 116' ' ' PRO . 12.2 tp10 -175.17 -77.44 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 120.704 0.288 . . . . 0.0 110.64 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -87.27 -34.89 18.76 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -66.92 134.79 52.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.923 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -58.35 135.11 85.15 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.004 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.406 ' HB3' ' HG2' ' A' ' 115' ' ' GLN . 28.1 Cg_endo -62.12 140.37 83.5 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.654 2.236 . . . . 0.0 111.367 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.513 ' CE2' ' HD2' ' A' ' 168' ' ' LYS . 23.2 p90 -144.03 155.85 44.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.064 0.459 . . . . 0.0 111.594 -172.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 6.6 mt -83.12 130.51 35.12 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.839 172.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -107.91 106.65 17.01 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.706 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 166' ' ' GLU . 4.0 mp -100.88 131.17 49.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.776 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -138.87 156.72 47.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.965 0.412 . . . . 0.0 110.577 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 20.1 p90 -143.53 156.21 44.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.911 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 15.0 m -114.22 105.38 54.12 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.076 -178.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.75 167.72 23.63 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.496 2.13 . . . . 0.0 111.033 173.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 105' ' ' PRO . 73.3 Cg_exo -50.6 154.06 6.99 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.573 2.182 . . . . 0.0 112.562 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.7 m -46.32 -62.71 1.23 Allowed 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 122.901 0.48 . . . . 0.0 111.917 -175.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.467 ' O ' HD12 ' A' ' 132' ' ' LEU . 3.5 pp -147.28 125.16 11.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.249 0.547 . . . . 0.0 110.333 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 49.0 mt -111.18 -50.21 6.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.225 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.7 t70 58.69 79.52 0.21 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.527 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.435 HD22 ' H ' ' A' ' 187' ' ' ASP . 40.9 mt -70.49 -65.38 0.74 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 140' ' ' PHE . 99.5 mttt -142.89 118.89 10.65 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.372 170.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.6 m -61.07 107.73 0.78 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.757 -166.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.18 -56.77 4.58 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.451 173.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.516 ' NE1' ' HB3' ' A' ' 136' ' ' LYS . 24.2 p90 -81.27 11.25 4.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -173.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.523 ' HB3' ' HB2' ' A' ' 136' ' ' LYS . 43.7 t80 -153.18 138.74 17.75 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 173.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.4 m -135.66 149.64 49.35 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 176.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 55.5 tp -78.53 124.86 28.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.984 0.421 . . . . 0.0 110.535 -176.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.3 mp -89.4 139.84 30.11 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.786 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -114.49 149.68 35.98 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.914 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -133.22 133.42 42.71 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.37 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.467 ' N ' HD13 ' A' ' 146' ' ' ILE . 4.2 mp -113.72 131.5 65.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.749 0.309 . . . . 0.0 110.632 -174.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.49 ' HB2' ' CH2' ' A' ' 194' ' ' TRP . 18.6 ttp180 -118.23 120.18 36.92 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 157' ' ' GLU . 0.0 OUTLIER -145.58 160.41 41.7 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.798 -178.128 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -169.72 147.66 3.06 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.532 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -70.08 167.37 25.04 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.102 1.868 . . . . 0.0 111.789 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -61.78 -29.65 70.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.221 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -86.53 7.03 27.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -177.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -94.72 130.95 41.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.113 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -87.32 -26.63 23.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.842 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -123.69 150.08 44.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.294 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.447 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 77.6 m95 -82.34 145.83 29.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.542 -177.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 148' ' ' LEU . 43.2 mt-10 -98.71 118.96 36.62 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.445 175.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mp -98.16 116.18 40.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -119.84 114.66 22.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.12 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -81.28 133.68 35.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.854 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -101.11 -51.64 3.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.876 0.37 . . . . 0.0 111.481 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 127.59 -142.39 13.47 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -175.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.3 20.3 11.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.322 0.561 . . . . 0.0 111.127 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -103.41 143.75 32.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.806 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 38.8 p -96.48 36.49 1.36 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.039 0.447 . . . . 0.0 111.787 -175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 125' ' ' ILE . 9.2 pt-20 -156.45 145.04 20.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.177 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -140.71 151.2 44.33 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.513 ' HD2' ' CE2' ' A' ' 122' ' ' TYR . 45.8 mmtt -116.41 137.67 51.97 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 41.0 mm -112.74 120.83 63.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 175.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.447 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.9 mm? -89.71 -38.96 13.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 -177.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 50.4 m -76.72 84.5 3.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.066 0.46 . . . . 0.0 111.206 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 90.2 mt -126.38 133.21 51.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.75 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -102.49 124.57 38.87 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.031 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.44 124.8 15.86 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.656 2.237 . . . . 0.0 112.387 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 88.16 27.56 25.38 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.549 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -126.82 146.95 50.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.027 0.442 . . . . 0.0 111.038 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -85.42 131.71 34.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.577 177.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -121.13 136.17 55.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.888 0.375 . . . . 0.0 110.471 176.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 8.5 mp -103.65 126.62 50.91 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.2 142.71 38.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.147 0.499 . . . . 0.0 111.813 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.557 ' NE2' ' HB3' ' A' ' 197' ' ' ALA . 89.4 mt-30 -143.25 157.91 44.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.899 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.46 144.39 24.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.142 178.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.648 ' HG2' ' CZ3' ' A' ' 194' ' ' TRP . 1.9 ptm180 -138.82 175.6 9.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.213 0.53 . . . . 0.0 110.673 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 105' ' ' PRO . 10.6 p -160.78 -172.66 3.59 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.369 176.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -142.56 91.4 7.56 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 121.199 0.523 . . . . 0.0 111.176 177.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -69.17 149.84 71.12 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.714 2.276 . . . . 0.0 112.034 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.435 ' H ' HD22 ' A' ' 135' ' ' LEU . 17.5 t70 -61.46 -25.23 67.1 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.823 -176.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.403 ' O ' HG22 ' A' ' 100' ' ' ILE . 20.8 m-70 -74.76 -39.42 61.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.997 0.427 . . . . 0.0 110.252 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.547 ' HA3' ' CD ' ' A' ' 102' ' ' GLN . . . -118.39 -134.22 4.98 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.969 -175.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -163.81 -168.53 1.65 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -51.98 139.53 22.35 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.831 0.348 . . . . 0.0 111.043 173.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 50.1 m -135.69 25.81 3.38 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.985 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . 58.32 -152.72 0.39 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.051 -178.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.648 ' CZ3' ' HG2' ' A' ' 183' ' ' ARG . 14.4 m95 -117.16 115.35 25.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.694 -174.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.556 ' OG ' ' HD3' ' A' ' 196' ' ' PRO . 3.5 p -103.75 -50.59 0.14 Allowed Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.556 ' HD3' ' OG ' ' A' ' 195' ' ' SER . 4.7 Cg_exo -78.97 80.53 3.06 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.085 1.857 . . . . 0.0 113.078 -173.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.557 ' HB3' ' NE2' ' A' ' 181' ' ' GLN . . . -83.96 101.08 11.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.324 0.583 . . . . 0.0 110.104 176.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 25.2 m -95.97 131.45 42.33 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.605 -176.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -95.58 114.82 26.61 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.571 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.3 tp -118.23 134.92 60.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.056 0.455 . . . . 0.0 110.153 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -102.37 134.78 45.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.987 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 40.4 mm -92.16 116.48 66.54 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.614 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.97 150.24 84.89 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.557 2.171 . . . . 0.0 112.074 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 30.2 p -67.84 -18.21 64.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.596 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -86.18 10.24 15.13 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.636 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.447 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 57.5 t80 -64.71 -37.98 89.42 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 173.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 23.6 m -155.8 140.98 17.48 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.134 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 86.8 mtp -60.7 -19.55 58.92 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -175.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -128.78 148.35 50.86 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 172.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 C--O 1.246 0.897 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.242 179.46 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 89.5 mmm . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -67.33 133.74 50.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.12 0.486 . . . . 0.0 110.802 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.1 mt -69.08 105.24 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.192 175.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.42 134.38 31.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.565 -175.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -100.59 105.87 39.75 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.426 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -90.17 -171.42 0.47 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.742 2.294 . . . . 0.0 110.467 175.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.451 ' N ' ' HD3' ' A' ' 105' ' ' PRO . 2.1 p30 34.89 57.35 2.26 Favored Pre-proline 0 N--CA 1.468 0.442 0 O-C-N 124.181 0.925 . . . . 0.0 112.373 -177.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 104' ' ' ASP . 53.0 Cg_endo -91.94 175.97 1.99 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.204 2.603 . . . . 0.0 112.234 -173.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.01 111.44 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.414 2.076 . . . . 0.0 111.225 174.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 pp -122.77 178.92 4.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.76 -175.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 53.07 46.17 27.26 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 123.659 0.599 . . . . 0.0 110.702 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.7 tp -70.28 99.17 1.49 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.909 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.94 130.22 46.09 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.342 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.1 t -123.8 127.07 73.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.812 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -143.41 159.17 42.88 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.976 0.417 . . . . 0.0 110.848 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.79 129.65 60.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.408 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -111.28 132.92 54.0 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -122.52 83.72 47.7 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.832 0.349 . . . . 0.0 111.448 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -83.43 163.78 14.7 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.334 2.689 . . . . 0.0 111.376 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -97.62 -31.09 12.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.078 0.466 . . . . 0.0 111.006 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -86.37 -22.12 26.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.615 0.722 . . . . 0.0 109.965 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -123.07 135.47 54.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.064 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -56.66 134.71 78.03 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -49.79 141.12 28.79 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.419 2.746 . . . . 0.0 112.445 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -144.55 162.22 37.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.931 -173.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 31.4 tp -95.77 128.49 42.69 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.582 176.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -105.75 114.37 28.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.373 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.3 mp -104.29 120.9 55.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -128.94 128.67 44.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.096 0.474 . . . . 0.0 110.913 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . 0.439 ' CH2' HD12 ' A' ' 146' ' ' ILE . 32.6 p90 -121.41 160.79 23.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.907 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.3 t -123.74 123.66 26.25 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.78 171.63 17.05 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.326 2.017 . . . . 0.0 111.181 175.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -46.56 138.5 14.24 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.95 2.433 . . . . 0.0 111.683 175.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.8 m -57.49 -32.75 67.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.183 -176.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 96.0 mt -126.32 108.24 11.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.869 176.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 26.7 mt -97.28 -65.18 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.097 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.7 t70 64.12 87.28 0.11 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.514 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 69.8 mt -112.02 13.88 20.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.718 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -72.95 111.76 8.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.455 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.9 t 178.26 -23.99 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.702 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 179.63 -158.7 22.7 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -81.32 75.91 8.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.096 0.474 . . . . 0.0 110.657 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -138.74 116.59 11.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.007 0.432 . . . . 0.0 110.372 176.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.3 m -132.73 136.03 46.12 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.264 176.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -82.62 111.73 18.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.435 0.636 . . . . 0.0 110.347 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 56.4 mt -91.95 149.58 21.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.688 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -108.0 150.61 26.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.245 0.545 . . . . 0.0 111.575 -174.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -140.91 130.12 23.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.171 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.466 HD11 ' N ' ' A' ' 146' ' ' ILE . 4.3 mp -110.73 129.12 66.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.962 0.41 . . . . 0.0 110.82 -173.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.487 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 15.9 ttp180 -111.15 120.08 41.11 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -146.22 161.11 40.98 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.621 0.248 . . . . 0.0 110.969 -177.384 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -167.84 147.46 4.3 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.684 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -71.96 178.01 6.4 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.411 2.074 . . . . 0.0 112.339 172.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.405 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 11.0 pt-20 -70.5 -30.84 67.74 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -176.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.405 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 88.5 mttt -91.67 13.01 19.25 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.152 0.501 . . . . 0.0 110.825 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -98.71 119.79 38.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.719 178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.79 -32.47 35.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.324 0.583 . . . . 0.0 110.43 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -101.28 156.99 17.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.604 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.487 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 81.5 m95 -96.15 139.93 31.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.076 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -94.97 115.14 27.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.54 175.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.69 119.02 40.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 34.8 m-70 -120.14 108.14 13.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.193 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -75.24 126.0 30.12 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -93.51 -43.43 8.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.017 0.437 . . . . 0.0 110.985 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 102.95 -134.94 12.03 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.098 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -94.97 60.95 2.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.267 0.556 . . . . 0.0 110.138 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -156.81 146.28 20.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.117 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 44.0 p -103.22 37.37 2.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.182 0.515 . . . . 0.0 111.26 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -149.09 140.96 23.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.936 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 22.0 t80 -142.09 145.18 34.0 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 174.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 0.7 OUTLIER -119.17 129.85 55.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.776 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 35.8 mm -101.46 126.46 55.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 174.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -100.16 -30.78 11.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.724 0.297 . . . . 0.0 110.763 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 13.3 m -79.65 81.44 5.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.466 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 74.1 mt -126.36 140.97 52.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.954 0.407 . . . . 0.0 111.367 -176.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -112.55 131.19 22.77 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.222 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.11 130.01 30.81 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.608 2.205 . . . . 0.0 112.13 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.64 26.77 60.27 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.275 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.417 ' HB3' ' CE1' ' A' ' 178' ' ' TYR . 0.6 OUTLIER -115.4 138.23 51.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.763 0.316 . . . . 0.0 110.23 179.003 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -82.71 129.9 35.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.365 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.417 ' CE1' ' HB3' ' A' ' 176' ' ' GLN . 66.5 m-85 -121.06 140.19 52.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.872 0.368 . . . . 0.0 110.311 177.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.7 mm? -107.78 129.38 55.05 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.4 m -127.46 138.08 55.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.059 0.457 . . . . 0.0 111.945 -175.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.503 ' OE1' ' HB3' ' A' ' 194' ' ' TRP . 78.6 mt-30 -144.0 153.2 41.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.727 177.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.19 137.99 45.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.888 0.375 . . . . 0.0 110.759 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.479 ' HD2' ' C ' ' A' ' 183' ' ' ARG . 6.1 ppt_? -126.45 164.02 22.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.127 177.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 20.1 p -146.69 175.34 10.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.003 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -113.1 88.98 13.1 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.595 ' HD2' ' O ' ' A' ' 189' ' ' GLY . 2.3 Cg_endo -81.48 164.99 18.69 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.933 2.422 . . . . 0.0 111.955 177.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -82.44 -17.06 46.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.725 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -81.07 9.37 6.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.441 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.595 ' O ' ' HD2' ' A' ' 186' ' ' PRO . . . 143.59 109.88 0.71 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.429 ' O ' ' HB2' ' A' ' 191' ' ' TRP . 68.7 m-85 -64.77 135.03 55.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.462 0.173 . . . . 0.0 110.819 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.429 ' HB2' ' O ' ' A' ' 190' ' ' TYR . 84.1 m95 71.8 104.69 0.07 Allowed 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 124.261 0.976 . . . . 0.0 111.702 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 33.0 p -88.29 -1.87 58.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.517 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . 62.81 -169.57 0.18 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.744 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.503 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 70.5 m95 -110.96 112.69 24.7 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.13 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.579 ' H ' ' HD2' ' A' ' 196' ' ' PRO . 20.3 m -137.21 -54.01 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.579 ' HD2' ' H ' ' A' ' 195' ' ' SER . 66.4 Cg_endo -74.25 82.99 1.73 Allowed 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 121.686 1.59 . . . . 0.0 113.208 -175.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.446 ' HB3' ' NE2' ' A' ' 181' ' ' GLN . . . -82.3 104.03 12.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.805 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 34.7 m -95.21 135.79 36.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.738 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -98.72 119.48 37.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.068 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.3 tp -125.71 138.56 54.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.026 0.441 . . . . 0.0 110.627 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -106.78 140.86 38.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.361 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 41.0 mm -96.87 124.51 49.81 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.837 177.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.0 149.12 81.64 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.853 2.369 . . . . 0.0 112.04 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 3.0 p -75.24 -15.19 60.55 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.856 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -95.99 18.07 14.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.084 175.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -55.47 -60.58 3.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.27 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.7 m -72.75 131.4 42.3 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.144 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 20.5 ptp -90.44 54.87 2.86 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.869 0.842 . . . . 0.0 110.023 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -139.57 152.28 46.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.127 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.576 -0.726 . . . . 0.0 110.71 -179.152 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.862 0.363 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -146.28 132.58 19.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.26 0.553 . . . . 0.0 111.081 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 72.7 mt -72.24 95.64 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.63 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.1 p -114.56 133.37 60.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.427 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -71.82 127.83 90.27 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.27 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.66 -57.09 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.928 2.419 . . . . 0.0 112.217 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.444 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 6.1 t70 -165.14 128.5 1.65 Allowed Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 104' ' ' ASP . 11.4 Cg_exo -71.04 151.08 61.42 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.714 2.276 . . . . 0.0 112.249 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.499 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 9.7 Cg_endo -53.05 116.77 3.15 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.852 2.368 . . . . 0.0 111.446 177.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.86 175.34 6.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.485 -172.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 55.97 47.13 20.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.849 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.6 tp -68.92 98.9 0.99 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.631 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.63 130.39 41.11 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.457 -176.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -125.13 120.41 58.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.087 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -138.0 157.7 45.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.723 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.3 p -107.53 131.19 58.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.136 0.493 . . . . 0.0 110.295 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -103.04 123.88 47.46 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -123.38 80.36 53.39 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.006 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.443 ' HG2' ' HB2' ' A' ' 119' ' ' ARG . 1.0 OUTLIER -86.69 163.86 9.2 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.562 2.841 . . . . 0.0 111.798 177.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -97.45 -30.27 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.054 0.454 . . . . 0.0 111.169 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -93.76 -25.48 17.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.434 0.635 . . . . 0.0 110.177 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.443 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 23.3 mmt180 -110.91 151.74 27.55 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 175.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -73.78 138.3 76.82 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.63 132.93 55.04 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.946 2.431 . . . . 0.0 111.804 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.438 ' CD2' ' HD2' ' A' ' 168' ' ' LYS . 53.1 p90 -145.8 157.62 43.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.974 0.416 . . . . 0.0 110.957 -174.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 26.3 tp -91.21 131.17 36.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.624 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.564 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 12.4 t90 -110.47 109.38 19.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.207 -175.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.2 mp -108.05 123.37 63.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.082 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -123.23 148.42 45.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.834 0.35 . . . . 0.0 110.622 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -138.87 152.2 47.6 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.916 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 m -113.26 138.02 22.24 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.705 -175.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.42 130.62 41.04 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.945 2.43 . . . . 0.0 111.556 175.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -67.47 174.38 7.4 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.777 2.318 . . . . 0.0 112.783 -177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.9 m -70.59 -33.57 71.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.352 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 39.2 mt -81.47 -179.38 7.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.295 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 27.1 mt 69.51 -58.04 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 123.173 0.589 . . . . 0.0 111.008 -173.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.9 t70 52.82 82.54 0.07 Allowed 'General case' 0 C--O 1.237 0.404 0 O-C-N 123.778 0.673 . . . . 0.0 110.581 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.5 mp -73.03 67.86 0.89 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.397 -176.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -92.84 -14.66 27.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.43 0.633 . . . . 0.0 109.717 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.5 p -70.12 119.9 15.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.44 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -71.43 159.88 53.93 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.944 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 8.1 m-90 72.67 -44.26 0.59 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.7 0.8 . . . . 0.0 111.584 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -59.07 120.0 8.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.941 0.401 . . . . 0.0 110.489 176.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.0 m -118.74 128.81 54.84 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.612 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 29.7 tp -94.22 124.08 38.01 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.412 HD13 ' HG2' ' A' ' 163' ' ' GLN . 8.3 mp -98.01 153.28 18.49 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.848 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.53 ' CD2' ' HB3' ' A' ' 184' ' ' CYS . 75.2 m-85 -128.99 147.56 50.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.301 -173.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -128.12 139.82 52.29 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.453 HD11 ' N ' ' A' ' 146' ' ' ILE . 4.3 mp -117.44 129.52 73.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.039 0.447 . . . . 0.0 110.718 -175.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.468 HH22 ' NE2' ' A' ' 181' ' ' GLN . 7.7 ttp-105 -112.67 120.4 41.42 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.529 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -143.69 160.38 40.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.463 0.173 . . . . 0.0 110.821 -177.266 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -165.96 151.76 8.2 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.395 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.401 ' HG2' ' HB3' ' A' ' 153' ' ' ALA . 37.1 Cg_endo -70.54 157.12 59.8 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.52 2.147 . . . . 0.0 110.923 170.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.475 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 14.9 pt-20 -62.51 -27.64 69.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.473 -0.785 . . . . 0.0 113.013 -170.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.475 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 82.4 mttt -94.09 9.29 38.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.091 0.472 . . . . 0.0 110.777 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.401 ' HB3' ' HG2' ' A' ' 150' ' ' PRO . . . -90.21 131.71 35.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.263 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.96 -35.35 24.04 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.97 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -103.66 159.98 15.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.273 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.425 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 60.0 m95 -101.04 156.23 17.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.652 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -102.79 120.97 41.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.194 173.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.54 117.84 47.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.948 177.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -124.55 124.58 42.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.924 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -89.48 126.1 35.44 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.047 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.423 ' HB1' ' CD1' ' A' ' 146' ' ' ILE . . . -83.96 -47.67 10.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.159 0.504 . . . . 0.0 110.88 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.405 ' C ' ' HG ' ' A' ' 143' ' ' LEU . . . 107.57 -128.49 9.21 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.805 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.412 ' HG2' HD13 ' A' ' 143' ' ' LEU . 34.4 mt-30 -94.76 5.59 51.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.25 0.548 . . . . 0.0 110.464 -175.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -95.94 142.74 27.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.534 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.429 HG23 ' CE1' ' A' ' 144' ' ' TYR . 61.9 p -101.63 23.98 10.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.459 0.647 . . . . 0.0 111.0 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -148.69 137.74 21.61 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -130.1 149.52 51.78 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.71 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.564 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 42.5 mmtm -114.69 135.85 53.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.593 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 123' ' ' LEU . 31.9 mm -109.86 136.32 46.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 172.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -102.29 -31.39 10.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.925 0.393 . . . . 0.0 110.852 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 44.0 m -89.33 80.95 6.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.652 -177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.8 mm? -112.97 131.23 55.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.978 174.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -88.68 116.84 67.42 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.542 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.42 116.09 3.18 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.577 2.185 . . . . 0.0 112.066 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 108.27 -2.05 33.02 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.992 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -110.22 144.27 39.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.447 0.641 . . . . 0.0 111.766 -175.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -85.29 128.75 34.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.877 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -109.98 146.65 34.9 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.077 0.465 . . . . 0.0 110.886 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.8 mp -111.17 127.83 55.71 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.88 142.99 40.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.913 0.387 . . . . 0.0 111.447 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.551 ' HG2' ' HA ' ' A' ' 197' ' ' ALA . 62.4 mt-30 -143.41 139.19 29.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.574 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 12.6 p -125.65 141.18 46.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.803 0.335 . . . . 0.0 110.165 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -136.82 150.99 48.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.005 0.431 . . . . 0.0 110.639 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.53 ' HB3' ' CD2' ' A' ' 144' ' ' TYR . 18.5 p -128.89 155.98 44.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.947 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.523 ' HB3' ' CD1' ' A' ' 191' ' ' TRP . 17.9 ptpt -126.9 85.79 60.2 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.399 0.619 . . . . 0.0 112.415 -172.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -74.37 164.11 34.78 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.741 2.294 . . . . 0.0 110.77 172.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -72.28 -14.11 61.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.141 0.496 . . . . 0.0 110.775 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -86.37 -6.91 58.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.97 176.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -172.73 100.37 0.15 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.0 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -88.93 119.08 29.12 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.523 ' CD1' ' HB3' ' A' ' 185' ' ' LYS . 30.1 p-90 -81.19 145.74 30.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.188 0.518 . . . . 0.0 111.263 -174.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 41.6 m -126.51 3.17 6.9 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.554 174.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.05 174.46 11.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.371 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.512 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 44.6 m95 -114.49 -176.73 2.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.781 -177.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.557 ' OG ' ' HD3' ' A' ' 196' ' ' PRO . 13.9 p -168.16 -50.07 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -177.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.557 ' HD3' ' OG ' ' A' ' 195' ' ' SER . 94.8 Cg_endo -85.46 86.73 1.02 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 121.69 1.593 . . . . 0.0 113.516 -171.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.551 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -83.76 114.17 21.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.146 0.498 . . . . 0.0 111.505 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 86.2 m -106.07 139.56 40.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.022 175.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -104.09 148.69 25.97 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.384 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.8 tp -154.29 134.56 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.248 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -97.58 125.53 42.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.681 0.277 . . . . 0.0 110.276 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 44.6 mm -80.59 117.7 69.04 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -59.07 145.69 96.81 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.551 2.167 . . . . 0.0 111.874 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 26.8 m -70.1 -8.22 47.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.474 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.71 -15.24 60.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.984 176.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 9.7 t80 -61.62 131.82 51.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.197 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 208' ' ' MET . 49.8 m 70.21 153.42 0.11 Allowed 'General case' 0 CA--C 1.539 0.521 0 O-C-N 123.314 0.384 . . . . 0.0 111.223 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.422 ' HB2' ' O ' ' A' ' 207' ' ' THR . 62.9 mtt 75.2 -69.53 0.17 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.494 0.717 . . . . 0.0 111.489 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -159.82 133.02 6.89 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -177.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.202 -179.939 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.841 0.353 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -120.45 141.4 50.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.411 0.624 . . . . 0.0 111.108 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.438 HD13 ' CZ ' ' A' ' 190' ' ' TYR . 83.9 mt -79.84 99.98 4.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.385 176.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.1 m -83.43 116.15 27.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.171 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -130.08 94.36 31.09 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.209 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -68.06 -59.15 0.11 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.38 2.053 . . . . 0.0 112.046 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -155.25 121.79 2.7 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.919 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -62.37 160.22 32.3 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.95 2.433 . . . . 0.0 112.385 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.524 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 9.8 Cg_endo -52.09 147.38 27.21 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.247 2.631 . . . . 0.0 112.664 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -136.97 171.89 13.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.777 -173.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 54.35 57.22 6.04 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 123.96 0.787 . . . . 0.0 111.236 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.421 HD23 ' OG1' ' A' ' 198' ' ' THR . 56.2 tp -80.29 94.33 6.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.004 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.29 129.72 35.79 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.216 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.06 114.45 44.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.956 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.482 ' OE1' ' HE3' ' A' ' 114' ' ' LYS . 38.9 tt0 -135.51 131.69 36.36 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.349 -175.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.31 133.48 31.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.996 0.427 . . . . 0.0 110.892 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.482 ' HE3' ' OE1' ' A' ' 112' ' ' GLU . 0.4 OUTLIER -108.57 131.43 54.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.45 178.175 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -124.54 85.45 56.24 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.688 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.21 156.16 65.59 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 123.27 2.647 . . . . 0.0 112.318 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.91 -17.7 56.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.233 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -117.05 -49.75 2.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.9 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.78 157.6 28.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.764 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -64.29 145.5 98.2 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.336 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.97 141.13 76.08 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.821 2.347 . . . . 0.0 111.971 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.451 ' HB3' HD13 ' A' ' 170' ' ' LEU . 21.4 p90 -148.5 151.11 34.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.607 -174.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 6.8 mt -79.07 134.04 36.77 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.059 173.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -111.6 100.58 9.1 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.151 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.4 mp -90.16 123.47 42.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.494 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -132.56 119.55 20.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.044 0.449 . . . . 0.0 110.534 -176.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . 0.441 ' CH2' HD11 ' A' ' 146' ' ' ILE . 39.4 p90 -118.45 166.44 12.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.535 -176.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.6 t -101.15 118.32 60.51 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -76.67 136.96 17.64 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.723 2.282 . . . . 0.0 112.322 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -61.6 91.53 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.628 2.219 . . . . 0.0 110.97 173.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.1 m -83.63 -22.51 32.18 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.042 -173.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 92.0 mt -84.87 13.45 5.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.453 0.644 . . . . 0.0 111.397 -175.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 59.2 mt -69.78 -20.31 23.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.241 -0.891 . . . . 0.0 108.869 166.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 t70 69.32 70.75 0.26 Allowed 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 114.44 -1.255 . . . . 0.0 109.913 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.39 142.98 33.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.267 -176.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -133.44 165.74 24.15 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.99 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 13.6 p -82.85 43.6 0.86 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.152 0.501 . . . . 0.0 111.287 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.19 54.71 0.64 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 13.1 t90 66.13 62.62 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.598 0.713 . . . . 0.0 110.558 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -162.9 75.85 0.42 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.351 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 186' ' ' PRO . 4.2 m -98.93 136.12 39.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.393 -174.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 22.6 tp -99.9 110.89 23.23 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.48 141.44 32.27 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.914 0.388 . . . . 0.0 110.954 -176.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -107.64 139.55 42.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.138 -172.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -133.57 134.35 43.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.639 -175.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.441 HD11 ' CH2' ' A' ' 127' ' ' TRP . 4.5 mp -118.9 124.82 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.881 0.372 . . . . 0.0 110.681 -175.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.491 ' HB2' ' CZ2' ' A' ' 194' ' ' TRP . 25.4 ttp180 -113.46 126.35 55.24 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.447 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 4.1 pp -149.89 164.67 34.78 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.526 -176.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -169.33 148.9 3.64 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.588 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -68.23 167.35 22.31 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.377 2.051 . . . . 0.0 111.812 172.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.422 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 11.3 pt-20 -64.02 -24.21 67.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.97 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.422 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 89.6 mttt -96.15 18.78 12.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.198 0.523 . . . . 0.0 110.753 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -103.99 128.73 51.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.718 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -95.0 -11.24 28.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.075 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.67 162.67 27.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.239 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.462 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 86.5 m95 -98.81 137.73 36.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.17 0.51 . . . . 0.0 112.278 -171.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -104.14 115.04 29.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.548 176.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 158' ' ' ILE . 2.5 mp -95.98 120.02 44.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.363 -178.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 65.5 m-70 -113.56 130.1 56.43 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.341 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -97.41 129.89 44.59 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.845 -176.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -95.27 -37.96 10.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.888 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.68 -125.13 8.24 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.854 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -98.92 9.05 44.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.008 0.433 . . . . 0.0 110.577 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -103.82 144.88 30.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.459 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.6 p -97.01 33.58 1.89 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.305 0.574 . . . . 0.0 111.731 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -154.64 149.99 27.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.592 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 31.9 t80 -145.12 149.44 35.02 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 49.4 mmtt -113.03 144.34 42.77 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 123' ' ' LEU . 36.3 mm -127.18 123.18 61.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.593 0.235 . . . . 0.0 110.809 176.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.451 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.9 mm? -97.3 -28.74 13.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.184 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 9.7 t -81.65 79.46 8.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.095 0.474 . . . . 0.0 110.563 -176.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 67.5 mt -129.64 143.02 50.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.863 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 79.1 m-70 -105.95 128.53 26.23 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.974 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 22.2 Cg_exo -63.77 133.62 40.02 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.741 2.294 . . . . 0.0 112.484 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 79.52 28.93 50.75 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.769 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -128.38 155.67 44.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.067 0.46 . . . . 0.0 110.91 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -92.78 133.38 36.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.388 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -120.32 144.47 47.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.869 0.366 . . . . 0.0 110.144 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.2 mm? -105.12 129.1 53.61 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 23.1 m -128.61 139.64 51.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.834 0.349 . . . . 0.0 110.865 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.47 ' NE2' ' HB3' ' A' ' 197' ' ' ALA . 16.2 mt-30 -139.64 158.98 43.21 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.212 -178.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 12.6 p -136.29 138.45 46.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.208 0.527 . . . . 0.0 111.04 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -138.76 147.86 43.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.876 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.524 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 25.5 p -137.93 154.61 49.4 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.31 138.82 5.97 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' A' ' 141' ' ' THR . 89.8 Cg_endo -78.94 -165.64 0.35 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.761 2.307 . . . . 0.0 112.356 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -80.99 -35.49 31.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.72 0.295 . . . . 0.0 111.242 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -86.69 24.31 1.48 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -175.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -159.64 142.99 8.69 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.912 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.438 ' CZ ' HD13 ' A' ' 100' ' ' ILE . 37.6 p90 -119.23 153.3 35.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.135 0.493 . . . . 0.0 110.548 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -110.65 163.41 13.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.318 -174.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 20.6 p -148.58 10.36 0.84 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.518 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -162.25 160.81 27.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.146 0.498 . . . . 0.0 111.596 -177.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.491 ' CZ2' ' HB2' ' A' ' 147' ' ' ARG . 75.4 m95 -106.26 161.98 14.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.613 176.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.498 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 7.4 m -131.41 -59.1 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -175.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.498 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 10.1 Cg_endo -90.08 95.11 0.29 Allowed 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.43 2.087 . . . . 0.0 113.16 -171.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.47 ' HB3' ' NE2' ' A' ' 181' ' ' GLN . . . -95.74 127.58 41.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.965 0.412 . . . . 0.0 110.567 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.421 ' OG1' HD23 ' A' ' 109' ' ' LEU . 30.9 m -121.77 144.21 48.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.639 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -104.08 127.5 51.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.204 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.7 tp -128.45 137.42 57.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.156 0.503 . . . . 0.0 110.985 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -99.59 124.98 45.3 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.686 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 51.0 mm -86.28 124.57 69.89 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 174.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.68 152.82 66.4 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.898 2.399 . . . . 0.0 112.226 -176.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 17.9 m -71.17 -23.92 62.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.7 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -100.46 54.71 0.88 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.344 176.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -87.95 -60.31 2.0 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.829 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.8 p -89.86 106.37 18.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.039 0.447 . . . . 0.0 110.976 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.19 111.83 6.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.948 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -88.7 -23.59 22.93 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.825 0.821 . . . . 0.0 109.748 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 . . . . . 0 C--N 1.309 -1.185 0 CA-C-N 114.227 -1.351 . . . . 0.0 109.767 -178.333 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 93.3 mtp . . . . . 0 N--CA 1.485 1.282 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 76.9 t80 74.94 143.97 0.08 Allowed 'General case' 0 C--O 1.236 0.354 0 O-C-N 123.802 0.689 . . . . 0.0 111.595 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 58.5 mt -43.09 -56.75 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.578 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.0 t -85.12 97.61 5.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.405 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.584 ' HA ' HE21 ' A' ' 102' ' ' GLN . 0.1 OUTLIER -63.42 154.82 77.69 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.93 -177.305 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.412 ' O ' ' HD3' ' A' ' 105' ' ' PRO . 52.4 Cg_endo -70.36 1.71 4.57 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.129 2.553 . . . . 0.0 114.0 -174.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -110.27 95.14 20.64 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.797 0.332 . . . . 0.0 110.143 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 103' ' ' PRO . 72.9 Cg_endo -94.97 168.25 1.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.444 2.763 . . . . 0.0 112.616 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.418 ' HG3' ' SG ' ' A' ' 184' ' ' CYS . 24.2 Cg_exo -62.98 141.64 84.84 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.394 2.063 . . . . 0.0 111.162 174.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' A' ' 128' ' ' SER . 1.2 pp -133.38 177.06 7.98 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.717 0.294 . . . . 0.0 111.582 -175.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 55.41 50.28 15.12 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.584 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.5 tp -73.66 105.18 4.86 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -112.13 128.86 56.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.828 -175.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.6 t -113.32 129.82 68.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.032 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -129.78 129.84 44.6 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.878 0.37 . . . . 0.0 110.401 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 p -85.66 118.73 32.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.183 0.516 . . . . 0.0 109.846 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.49 ' O ' ' HD3' ' A' ' 116' ' ' PRO . 31.2 mmmt -113.38 108.45 17.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.1 0.476 . . . . 0.0 110.762 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -107.36 96.14 15.22 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.364 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 114' ' ' LYS . 15.3 Cg_exo -69.37 146.11 61.54 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.798 2.332 . . . . 0.0 111.687 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -80.01 -3.89 50.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.104 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -126.77 -40.86 1.87 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.196 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 66.7 mtm-85 -99.44 165.58 11.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.41 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 120' ' ' LYS . 12.6 mptt -60.11 135.4 90.71 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.119 175.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.445 ' HA ' ' CD ' ' A' ' 116' ' ' PRO . 32.3 Cg_endo -64.18 136.86 53.79 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.909 2.406 . . . . 0.0 112.122 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -136.33 159.71 40.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.711 -175.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.5 tp -98.83 123.83 43.33 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.427 ' CZ2' ' HD3' ' A' ' 126' ' ' LYS . 21.6 t90 -104.62 115.24 30.0 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.401 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.7 mp -108.3 129.06 63.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.652 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.427 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 54.9 pttt -137.68 152.48 49.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.047 0.451 . . . . 0.0 110.347 175.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . 0.446 ' CD2' HG21 ' A' ' 182' ' ' VAL . 29.3 p90 -142.0 163.33 33.17 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.076 -174.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.408 ' HB2' HD12 ' A' ' 107' ' ' LEU . 42.4 m -106.94 105.59 55.83 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 121.004 0.43 . . . . 0.0 109.895 176.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.83 148.68 65.14 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.758 2.305 . . . . 0.0 112.013 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.26 136.85 78.77 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.439 2.093 . . . . 0.0 111.767 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 26.9 m -90.13 -18.5 25.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.422 0.63 . . . . 0.0 110.092 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 97.4 mt -114.3 98.25 6.82 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.378 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 94.1 mt -133.19 -43.01 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.359 -177.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 5.3 m-20 66.66 77.43 0.28 Allowed 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.621 0.576 . . . . 0.0 110.239 -172.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -75.08 -25.92 58.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.934 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? 65.06 110.86 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 122.092 0.948 . . . . 0.0 111.745 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 40.9 m -59.17 133.88 56.49 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.787 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 171.66 -79.7 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.45 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -143.72 -35.0 0.39 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.739 0.304 . . . . 0.0 110.237 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -64.16 131.46 47.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.066 0.46 . . . . 0.0 110.294 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.0 m -125.35 154.86 41.19 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.342 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 185' ' ' LYS . 30.1 tp -78.12 109.18 11.99 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 184' ' ' CYS . 2.0 mp -106.8 158.31 17.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.361 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -125.45 133.39 52.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.024 0.44 . . . . 0.0 111.247 -172.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -123.28 139.33 54.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.067 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.6 mp -126.99 122.34 60.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.679 0.276 . . . . 0.0 110.469 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -107.72 130.08 54.97 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 174.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.495 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.5 pp -144.25 157.71 44.13 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.724 -177.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -165.44 144.5 5.32 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.187 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -67.88 168.84 17.61 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.406 2.071 . . . . 0.0 111.835 172.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.86 -18.86 65.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.934 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -100.96 17.79 21.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.121 0.486 . . . . 0.0 110.578 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -108.21 120.5 42.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.166 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -79.57 -28.55 41.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.583 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -109.71 154.25 23.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.755 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -90.53 144.78 25.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.146 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -98.59 110.18 22.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.254 172.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.17 113.47 24.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.198 0.523 . . . . 0.0 109.733 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 49.4 m-70 -116.35 118.99 34.26 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.685 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -88.31 126.38 35.15 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -86.6 -30.6 21.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.987 0.422 . . . . 0.0 110.729 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 95.25 -127.89 9.31 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.589 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -104.8 53.13 0.73 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.372 0.606 . . . . 0.0 110.241 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -144.64 143.86 30.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.283 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.5 p -96.66 24.35 6.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.18 0.514 . . . . 0.0 111.538 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -147.43 136.24 22.07 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.446 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 24.5 t80 -134.05 142.1 47.45 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.4 136.38 54.74 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.689 0.281 . . . . 0.0 110.564 -178.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 43.2 mm -108.52 131.95 57.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.616 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -112.71 41.96 1.94 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.203 0.525 . . . . 0.0 110.117 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 10.7 t -157.75 64.26 0.47 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.647 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.8 mm? -109.27 151.84 26.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.991 0.424 . . . . 0.0 110.694 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -116.61 122.96 31.04 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.232 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -59.84 117.61 4.38 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.862 2.375 . . . . 0.0 112.35 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.23 -5.76 49.7 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.69 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -101.63 142.18 33.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.05 0.452 . . . . 0.0 111.015 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.439 ' HE2' ' HB3' ' A' ' 199' ' ' PHE . 79.7 tttt -91.86 133.33 35.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.131 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -116.8 137.9 51.87 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.095 0.474 . . . . 0.0 110.496 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 7.6 mp -99.3 126.28 45.11 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 174.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.7 136.4 60.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.043 0.449 . . . . 0.0 111.226 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.558 ' HG2' ' HA ' ' A' ' 197' ' ' ALA . 55.4 mt-30 -138.3 139.06 38.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.0 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.446 HG21 ' CD2' ' A' ' 127' ' ' TRP . 12.6 p -125.08 152.69 31.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.857 0.36 . . . . 0.0 110.733 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -153.13 142.02 21.17 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.79 173.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.418 ' SG ' ' HG3' ' A' ' 106' ' ' PRO . 25.1 p -105.09 157.08 17.5 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.659 174.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.424 ' O ' HD13 ' A' ' 142' ' ' LEU . 98.3 mttt -102.96 103.33 33.11 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.634 0.254 . . . . 0.0 111.441 -176.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.26 161.53 28.94 Favored 'Trans proline' 0 CA--C 1.529 0.275 0 C-N-CA 123.021 2.481 . . . . 0.0 112.192 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -66.97 -18.16 65.25 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.141 0.495 . . . . 0.0 111.013 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -85.73 -13.75 47.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.698 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -151.88 103.58 0.24 Allowed Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -75.36 17.97 0.24 Allowed 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -167.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -145.21 172.72 12.72 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.2 m -94.25 75.25 3.98 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.35 -1.75 . . . . 0.0 110.039 -171.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -88.57 112.02 22.55 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.543 0.687 . . . . 0.0 109.737 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 23.6 m95 -69.88 149.31 47.98 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.58 -1.191 . . . . 0.0 112.622 -163.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.517 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 3.3 m -134.84 -54.47 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.208 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 27.1 Cg_endo -95.36 131.69 0.51 Allowed 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 122.501 2.134 . . . . 0.0 112.969 -177.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.558 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -123.65 124.63 43.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.036 0.446 . . . . 0.0 110.705 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 61.0 m -117.02 144.02 45.08 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.629 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.439 ' HB3' ' HE2' ' A' ' 177' ' ' LYS . 55.7 m-85 -107.69 132.44 53.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.594 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.1 tp -133.28 135.31 56.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.1 0.476 . . . . 0.0 110.735 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -105.61 130.6 53.62 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.539 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 46.6 mm -85.9 124.64 70.48 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.913 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.41 156.73 61.84 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.908 2.405 . . . . 0.0 112.382 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 46.1 m -81.06 -3.67 52.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.15 0.5 . . . . 0.0 110.913 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -84.96 -15.09 45.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.039 174.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.457 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 30.0 t80 -58.92 141.31 53.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.722 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.421 ' HB ' ' O ' ' A' ' 206' ' ' PHE . 80.6 m 74.87 138.11 0.06 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.474 0.654 . . . . 0.0 111.626 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 96.3 mmm -119.15 -72.03 0.71 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.168 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -141.9 61.67 1.45 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 . . . . . 0 C--O 1.25 1.125 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.492 -169.734 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -163.82 176.08 9.85 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 62.6 mt -65.45 95.89 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.92 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.3 p -152.9 139.77 12.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.639 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -97.82 115.92 65.74 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 120.904 0.383 . . . . 0.0 111.259 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -74.18 -50.6 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.671 2.247 . . . . 0.0 111.977 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -120.25 99.78 48.13 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.435 0.636 . . . . 0.0 110.289 176.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -63.14 161.1 31.45 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.455 2.77 . . . . 0.0 112.716 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -54.55 121.15 9.26 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.521 2.147 . . . . 0.0 110.768 174.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -127.75 -178.32 4.45 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.917 -171.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 55.78 40.8 30.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.822 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.475 HD23 ' OG1' ' A' ' 198' ' ' THR . 54.0 tp -70.22 94.61 0.93 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.7 123.58 40.43 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.322 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.416 HG11 HD11 ' A' ' 123' ' ' LEU . 3.2 t -112.29 113.56 44.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -124.06 133.27 53.67 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.141 -172.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.6 p -85.78 116.9 29.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.388 0.613 . . . . 0.0 109.841 175.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -103.05 123.49 46.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.403 -177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -121.04 84.68 39.77 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.436 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.98 146.87 42.5 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.736 2.29 . . . . 0.0 111.087 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -79.9 -16.77 54.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.351 -177.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -116.12 -39.55 3.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.581 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -91.37 163.07 14.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.634 176.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -72.97 141.52 81.78 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.012 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.38 138.68 67.13 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.944 2.429 . . . . 0.0 111.742 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -150.82 164.55 35.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.833 -174.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.416 HD11 HG11 ' A' ' 111' ' ' VAL . 29.7 tp -97.41 122.27 40.26 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 24.4 t90 -102.71 112.53 25.34 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.047 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.8 mp -106.89 120.15 57.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.666 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -128.11 134.78 49.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.93 0.395 . . . . 0.0 110.293 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 36.0 p90 -128.05 155.56 44.15 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.573 -177.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.9 m -108.88 100.27 38.87 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.909 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.13 161.82 18.44 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.021 2.481 . . . . 0.0 112.547 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -51.8 153.29 11.75 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.316 2.678 . . . . 0.0 113.238 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.4 p -57.42 -54.54 45.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.796 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 57.0 mt -102.57 100.02 10.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.246 0.546 . . . . 0.0 111.187 -175.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 75.1 mt -111.95 -69.05 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.604 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 57.9 55.36 5.41 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.797 0.685 . . . . 0.0 112.615 172.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.513 HD21 ' N ' ' A' ' 187' ' ' ASP . 3.4 mm? -99.56 74.54 1.89 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.14 0.495 . . . . 0.0 109.966 172.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.402 ' C ' ' HG1' ' A' ' 137' ' ' THR . 62.9 mttm -84.43 -84.12 0.15 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.326 -177.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.402 ' HG1' ' C ' ' A' ' 136' ' ' LYS . 70.0 p 46.49 -92.12 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.0 0.92 . . . . 0.0 113.419 176.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 152.19 -53.5 0.47 Allowed Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -178.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 40.2 m95 -75.92 -17.45 59.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.008 0.432 . . . . 0.0 110.184 176.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -118.6 136.67 53.75 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.001 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.415 ' O ' HD23 ' A' ' 143' ' ' LEU . 22.0 m -141.64 147.35 37.42 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 175.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 46.5 tp -80.09 111.16 16.17 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.002 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 141' ' ' THR . 2.6 mm? -91.62 166.04 13.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.456 174.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -131.32 131.92 44.12 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -119.87 134.6 55.19 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.51 121.96 61.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.133 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.566 ' HG3' ' NE2' ' A' ' 181' ' ' GLN . 22.5 ptt180 -103.74 148.08 26.5 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' A' ' 157' ' ' GLU . 3.6 pp -165.05 161.79 19.95 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.175 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -164.77 145.59 6.32 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-O 120.682 0.277 . . . . 0.0 110.484 176.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.75 165.71 28.67 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.76 2.307 . . . . 0.0 111.746 174.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.46 -5.4 19.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.897 -174.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -111.3 6.7 20.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.292 0.568 . . . . 0.0 110.437 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.2 127.72 41.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.187 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.36 -38.86 29.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.723 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -104.16 162.92 12.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.955 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -91.4 140.89 29.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.034 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 148' ' ' LEU . 36.1 mt-10 -91.88 116.25 28.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.3 172.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.75 109.41 21.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.54 0.686 . . . . 0.0 109.363 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.472 ' HB3' ' CE2' ' A' ' 167' ' ' PHE . 35.0 m-70 -105.8 126.42 52.15 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.195 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -98.28 117.27 32.28 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.866 0.365 . . . . 0.0 110.648 -176.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -78.0 -51.11 10.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.143 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 76.19 89.9 0.25 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.072 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 75.34 -25.59 0.2 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.733 0.813 . . . . 0.0 113.033 170.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -89.41 142.59 27.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.91 0.386 . . . . 0.0 110.57 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.1 p -101.75 32.6 3.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.5 0.667 . . . . 0.0 111.047 -177.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -156.9 109.94 2.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.769 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.472 ' CE2' ' HB3' ' A' ' 159' ' ' HIS . 17.8 t80 -110.94 146.56 36.38 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.497 -174.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.458 ' HD2' ' N ' ' A' ' 168' ' ' LYS . 9.6 mptt -121.83 130.19 53.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.369 -178.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 34.7 mm -107.84 124.21 63.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.551 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.17 -27.14 15.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.957 0.408 . . . . 0.0 110.482 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 34.7 m -82.33 84.55 7.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.663 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 68.9 mt -130.99 145.85 52.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.124 0.488 . . . . 0.0 111.323 -177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 63.6 m-70 -114.38 127.49 26.77 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.859 177.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 24.2 Cg_exo -62.88 129.53 26.36 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.836 2.357 . . . . 0.0 112.797 -178.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.14 33.34 32.86 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.487 176.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -126.21 145.53 50.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.318 0.58 . . . . 0.0 111.059 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -86.85 129.64 34.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.079 177.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -120.25 137.21 54.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.246 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -97.44 125.02 41.85 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 173.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.473 ' O ' ' HB ' ' A' ' 198' ' ' THR . 16.7 m -135.43 139.31 46.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.748 0.309 . . . . 0.0 110.788 -171.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.566 ' NE2' ' HG3' ' A' ' 147' ' ' ARG . 0.2 OUTLIER -166.63 142.95 4.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.907 0.384 . . . . 0.0 110.842 177.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 13.0 p -121.93 153.02 26.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.52 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -146.11 134.75 22.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.066 0.46 . . . . 0.0 109.76 173.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 3.3 m -111.93 152.66 27.78 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.682 -176.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.48 ' HB3' ' CD1' ' A' ' 191' ' ' TRP . 18.0 pttp -121.39 86.52 43.93 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.87 175.82 5.95 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.33 2.02 . . . . 0.0 111.842 172.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.513 ' N ' HD21 ' A' ' 135' ' ' LEU . 27.7 t70 -64.98 -28.31 69.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.186 0.517 . . . . 0.0 110.782 -178.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -92.5 1.94 56.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.308 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -164.9 113.88 0.57 Allowed Glycine 0 C--O 1.226 -0.375 0 C-N-CA 119.704 -1.236 . . . . 0.0 113.546 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -108.55 141.95 39.69 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.48 ' CD1' ' HB3' ' A' ' 185' ' ' LYS . 28.9 p-90 -106.8 149.54 27.26 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.058 0.456 . . . . 0.0 111.282 -176.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.4 p -128.74 7.62 5.69 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.202 177.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -155.4 171.28 20.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.99 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -114.67 103.31 10.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.843 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.408 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 16.1 m -92.2 -54.57 0.26 Allowed Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 94.9 Cg_endo -76.68 69.78 6.65 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.096 1.864 . . . . 0.0 113.762 -172.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.478 ' HA ' ' HB3' ' A' ' 181' ' ' GLN . . . -69.52 123.23 20.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.331 0.586 . . . . 0.0 111.128 178.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.475 ' OG1' HD23 ' A' ' 109' ' ' LEU . 90.4 m -108.07 148.02 30.37 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.566 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -111.86 133.14 54.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.362 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.9 tp -137.63 133.84 45.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.34 0.591 . . . . 0.0 111.017 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -100.7 121.17 41.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.517 176.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.4 mm -85.85 122.95 72.82 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.27 143.7 96.84 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.58 2.186 . . . . 0.0 112.384 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 14.9 m -66.28 -23.55 66.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.29 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.87 19.62 3.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.591 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -53.64 -48.86 68.97 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.095 0.474 . . . . 0.0 110.318 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.8 p -85.6 125.62 33.27 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.776 174.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -65.19 113.44 3.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.515 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -92.96 66.28 4.18 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 C--O 1.25 1.107 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.178 -178.403 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 120.258 0.075 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 26.4 t80 69.0 144.67 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.629 0.728 . . . . 0.0 111.751 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.4 mp -78.78 86.47 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.82 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.9 m -73.32 140.84 17.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -82.23 121.64 78.79 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -52.75 -67.85 0.08 OUTLIER 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.81 2.34 . . . . 0.0 112.322 -172.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -154.22 90.03 3.27 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.903 176.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.28 132.5 52.59 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.717 2.278 . . . . 0.0 112.007 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.425 ' HG3' ' SG ' ' A' ' 184' ' ' CYS . 18.3 Cg_endo -56.67 132.61 52.79 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.201 2.6 . . . . 0.0 112.346 -176.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 107' ' ' LEU . 2.4 pt? -146.82 -167.57 2.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.27 -174.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 59.14 57.16 3.59 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.241 0.543 . . . . 0.0 111.105 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.3 mt -72.37 99.95 2.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.796 177.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.53 122.9 37.58 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.9 t -114.64 122.64 69.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.14 -175.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -120.84 140.92 51.08 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.804 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 p -98.21 119.71 46.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.21 0.528 . . . . 0.0 110.145 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.527 ' HA ' ' HE2' ' A' ' 114' ' ' LYS . 9.9 mmpt? -111.51 126.69 55.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.652 -178.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -133.09 97.23 16.79 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.08 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.81 175.97 8.92 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.71 2.273 . . . . 0.0 112.7 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -59.76 -67.31 0.4 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.329 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -131.63 38.16 3.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.295 0.569 . . . . 0.0 111.017 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -122.23 154.6 37.31 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.189 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -55.33 118.38 18.34 Favored Pre-proline 0 C--N 1.328 -0.337 0 O-C-N 123.582 0.552 . . . . 0.0 111.071 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.91 144.57 83.36 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.628 2.219 . . . . 0.0 111.146 177.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -140.53 150.56 43.86 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.219 0.533 . . . . 0.0 111.215 -173.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 30.1 tp -91.52 126.27 36.54 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.288 175.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.428 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 22.5 t90 -102.98 105.89 16.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.195 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.7 mp -98.99 123.62 51.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -134.12 136.21 43.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.944 0.402 . . . . 0.0 110.555 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . 0.446 ' CH2' HD11 ' A' ' 146' ' ' ILE . 20.7 p90 -122.51 167.96 12.71 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.0 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.9 t -87.29 125.47 65.74 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -62.64 150.75 86.83 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.652 2.235 . . . . 0.0 111.81 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.69 -162.48 0.11 Allowed 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.845 2.363 . . . . 0.0 112.399 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.0 p -60.81 151.0 30.95 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.771 0.319 . . . . 0.0 110.793 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.453 ' O ' HD13 ' A' ' 132' ' ' LEU . 2.7 pp -66.14 112.74 4.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.644 0.735 . . . . 0.0 111.243 -174.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 68.3 mt -94.18 -41.21 12.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.597 177.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.0 t70 62.85 86.6 0.11 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.569 -172.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.3 mt -78.97 59.11 2.56 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.787 -174.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -74.68 -30.15 61.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.285 0.564 . . . . 0.0 109.769 173.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.4 p -86.74 95.36 9.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.352 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.53 -16.07 48.95 Favored Glycine 0 C--N 1.33 0.237 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.93 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 27.7 m-90 -57.27 -33.79 67.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.065 0.46 . . . . 0.0 110.155 175.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -110.6 112.78 24.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 171.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.8 m -112.54 138.16 49.72 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 63.9 tp -97.14 110.58 23.1 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.99 148.27 26.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.2 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.48 ' CD2' ' HB3' ' A' ' 184' ' ' CYS . 92.6 m-85 -115.46 138.33 51.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.545 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -124.46 135.77 53.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.452 ' CD1' ' HB1' ' A' ' 161' ' ' ALA . 5.1 mp -118.73 130.84 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.043 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -111.79 134.26 53.48 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.5 pp -145.43 156.53 43.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.797 -177.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -165.66 151.05 8.08 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.419 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -70.05 164.11 36.03 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.453 2.102 . . . . 0.0 111.685 173.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.419 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 14.4 pt-20 -64.15 -23.69 67.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.976 -172.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.419 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 86.9 mttt -98.55 9.94 42.09 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.189 0.518 . . . . 0.0 110.875 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -95.85 131.52 42.08 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.006 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -84.96 -43.03 14.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.542 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -82.78 150.56 26.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.036 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -98.09 142.85 29.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.811 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -103.35 116.28 32.13 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.957 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.06 132.17 38.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.189 0.519 . . . . 0.0 111.079 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 67.6 m-70 -127.08 125.97 42.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.332 175.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -86.43 119.86 27.15 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.452 ' HB1' ' CD1' ' A' ' 146' ' ' ILE . . . -85.11 -39.19 18.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.905 0.383 . . . . 0.0 111.026 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 100.51 -143.78 16.45 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.443 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.08 62.74 4.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.978 0.418 . . . . 0.0 110.366 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -155.24 147.92 24.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.377 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.8 p -98.0 27.8 4.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.975 0.416 . . . . 0.0 111.909 -176.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -151.82 144.86 24.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.893 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.415 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 26.4 t80 -140.07 148.51 41.86 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.992 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 10.5 mptt -120.39 142.77 48.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.644 0.259 . . . . 0.0 110.782 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 32.9 mm -119.64 129.92 74.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.572 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.68 -29.17 11.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.102 0.477 . . . . 0.0 110.294 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.0 m -79.27 83.71 5.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.285 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 63.4 mt -132.12 172.19 12.7 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.958 -176.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -138.37 124.65 12.82 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.899 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.13 130.02 29.16 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.606 2.204 . . . . 0.0 112.08 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 79.65 39.69 17.11 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.839 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -133.24 146.39 51.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.957 0.408 . . . . 0.0 110.474 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.9 tttp -98.1 128.1 44.42 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.836 177.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -119.85 140.98 49.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.193 0.52 . . . . 0.0 110.898 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 5.5 mp -103.73 130.66 51.27 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.97 139.73 51.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.81 0.338 . . . . 0.0 111.452 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.515 ' HG2' ' HA ' ' A' ' 197' ' ' ALA . 78.1 mt-30 -143.72 142.47 30.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.299 177.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 13.5 p -132.06 150.15 33.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.684 0.278 . . . . 0.0 110.798 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -159.06 147.44 18.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.254 172.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.48 ' HB3' ' CD2' ' A' ' 144' ' ' TYR . 27.9 p -123.4 -172.96 2.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.67 177.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -125.71 95.28 40.53 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.183 0.516 . . . . 0.0 111.044 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.23 159.23 19.57 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 123.435 2.756 . . . . 0.0 113.124 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -73.67 -39.61 64.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.456 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -94.18 24.07 4.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.252 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -160.85 -144.99 4.15 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -167.44 -166.12 0.74 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 9.3 m95 -54.85 115.58 2.26 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.405 0.622 . . . . 0.0 111.299 176.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.6 m -97.87 16.1 21.88 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.57 -175.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . 66.98 173.44 0.26 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.722 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.478 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 81.0 m95 -82.34 144.55 30.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.009 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.507 ' H ' ' HD2' ' A' ' 196' ' ' PRO . 5.3 m -153.71 -56.9 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.507 ' HD2' ' H ' ' A' ' 195' ' ' SER . 68.4 Cg_endo -72.69 80.81 1.68 Allowed 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 122.019 1.813 . . . . 0.0 113.354 -173.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.515 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -80.35 103.0 9.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.273 0.559 . . . . 0.0 110.812 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.9 m -100.44 135.45 41.85 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.158 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -104.92 126.51 52.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.103 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.9 tp -126.75 137.98 56.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.003 0.43 . . . . 0.0 110.832 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -100.19 120.98 40.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.751 177.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.1 121.02 76.96 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.1 151.58 65.46 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.925 2.417 . . . . 0.0 112.362 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 16.8 t -71.75 -23.63 61.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.895 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -98.33 43.76 1.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.795 0.807 . . . . 0.0 109.28 175.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -80.85 -18.42 47.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.536 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.404 ' C ' ' H ' ' A' ' 209' ' ' ASN . 57.4 m -145.23 149.15 34.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.565 -178.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 95.0 mmm -77.33 40.87 0.29 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.061 0.458 . . . . 0.0 111.464 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . 0.404 ' H ' ' C ' ' A' ' 207' ' ' THR . 20.2 m120 -137.11 41.48 2.45 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.424 -178.101 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.5 mpp? . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.963 0.411 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -103.34 139.37 38.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.334 0.587 . . . . 0.0 110.772 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.5 mp -81.57 95.21 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.107 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.541 ' O ' ' HD3' ' A' ' 103' ' ' PRO . 13.6 p -103.62 154.12 5.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.686 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -85.14 102.76 2.6 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 101' ' ' VAL . 70.1 Cg_endo -91.7 155.9 3.49 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.762 2.308 . . . . 0.0 113.185 -172.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -127.14 65.32 64.28 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.809 174.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.459 ' HD3' ' C ' ' A' ' 103' ' ' PRO . 36.6 Cg_exo -60.07 -49.08 10.38 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.619 2.212 . . . . 0.0 114.386 -177.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.612 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 72.6 Cg_endo -78.37 95.9 1.08 Allowed 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.128 1.219 . . . . 0.0 111.872 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 pp -109.43 174.47 5.85 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.317 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 52.45 60.22 3.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.259 0.552 . . . . 0.0 110.626 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.408 HD12 ' CG2' ' A' ' 125' ' ' ILE . 43.1 tp -73.17 108.88 6.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.675 -177.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -98.44 119.68 37.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.576 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.447 ' CG1' HD13 ' A' ' 123' ' ' LEU . 2.6 t -109.24 115.28 49.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.394 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -127.72 125.58 40.25 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.933 -173.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.5 126.41 39.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.15 177.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 57.0 mmtt -108.28 129.72 55.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.936 0.398 . . . . 0.0 110.853 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.592 ' OE1' ' HA ' ' A' ' 206' ' ' PHE . 47.3 mt-30 -133.89 86.75 37.22 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.433 -174.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.05 167.69 24.62 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.078 2.519 . . . . 0.0 111.547 175.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -86.24 -46.28 10.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.779 0.323 . . . . 0.0 111.32 -178.429 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -88.53 -51.48 5.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.89 0.376 . . . . 0.0 110.24 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -72.65 138.72 46.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -66.52 144.84 98.84 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 120.732 0.301 . . . . 0.0 111.4 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.543 ' HG3' ' O ' ' A' ' 206' ' ' PHE . 36.1 Cg_endo -62.72 142.41 89.13 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 123.263 2.642 . . . . 0.0 112.56 -177.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -144.56 159.9 42.03 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.733 -176.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.447 HD13 ' CG1' ' A' ' 111' ' ' VAL . 2.7 tm? -98.22 126.38 43.67 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 21.7 t90 -111.68 109.25 19.03 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.703 -172.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.408 ' CG2' HD12 ' A' ' 109' ' ' LEU . 3.6 mp -96.67 132.56 40.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.45 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -146.91 143.17 28.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.313 0.578 . . . . 0.0 110.456 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 18.5 p90 -126.74 162.94 24.64 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.112 -173.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.1 t -102.9 112.98 66.16 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 120.852 0.358 . . . . 0.0 110.374 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -83.27 137.61 8.36 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.436 2.091 . . . . 0.0 111.541 174.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 105' ' ' PRO . 52.9 Cg_exo -55.48 136.03 71.97 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.788 2.325 . . . . 0.0 111.559 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.2 m -67.12 -36.63 82.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.439 -176.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 94.8 mt -108.03 94.58 5.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.552 0.691 . . . . 0.0 110.988 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 78.4 mt -114.16 -57.72 3.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.1 175.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.3 t70 56.41 83.99 0.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.68 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.16 -28.76 69.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.826 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp 71.43 -44.75 0.6 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.822 0.849 . . . . 0.0 112.964 173.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 17.0 p -58.48 -33.45 69.8 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.06 -60.98 4.79 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.716 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -82.54 35.86 0.47 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.201 0.524 . . . . 0.0 111.065 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.404 ' HZ ' ' O ' ' A' ' 185' ' ' LYS . 76.1 t80 -142.46 132.5 24.49 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.793 -178.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.2 m -116.98 141.63 48.0 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.862 0.363 . . . . 0.0 110.409 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 52.5 tp -81.05 110.54 16.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.419 ' HG ' ' HA2' ' A' ' 162' ' ' GLY . 4.7 mp -99.95 139.13 36.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.049 -175.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -109.14 143.18 38.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.402 -175.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -127.64 135.17 49.87 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.544 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.47 ' N ' HD13 ' A' ' 146' ' ' ILE . 4.4 mp -114.75 128.19 71.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.009 0.433 . . . . 0.0 110.428 -176.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.465 ' HB2' ' CH2' ' A' ' 194' ' ' TRP . 26.6 ttp180 -114.97 123.13 48.31 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.528 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -142.6 160.35 40.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.632 0.253 . . . . 0.0 111.437 -177.16 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -171.69 150.22 2.57 Favored Pre-proline 0 C--O 1.234 0.275 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.996 176.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.18 160.32 50.32 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.282 1.988 . . . . 0.0 110.599 169.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -67.9 -21.37 65.14 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -173.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -86.04 -11.12 53.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.018 0.437 . . . . 0.0 110.289 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -82.12 131.26 35.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.57 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -86.03 -35.57 20.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.363 178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -94.96 143.19 26.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.325 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.445 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 67.7 m95 -88.46 145.76 25.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.77 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -96.43 116.94 29.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.577 174.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mp -95.67 111.66 26.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.009 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 51.3 m-70 -117.87 119.7 35.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.159 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -85.38 137.3 33.03 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.14 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.413 ' HB3' ' CD1' ' A' ' 146' ' ' ILE . . . -102.22 -41.05 6.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.992 0.425 . . . . 0.0 110.937 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.419 ' HA2' ' HG ' ' A' ' 143' ' ' LEU . . . 91.41 -125.64 8.11 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.152 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -97.23 64.06 1.89 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.217 0.532 . . . . 0.0 110.366 -177.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -157.64 142.95 17.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.03 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.6 p -99.31 31.6 3.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.04 0.447 . . . . 0.0 111.608 -176.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -158.86 156.44 29.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.941 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 33.1 t80 -146.01 154.03 41.43 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.05 131.94 54.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.711 0.291 . . . . 0.0 110.996 -178.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 29.0 mm -106.88 138.55 32.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -104.64 -28.15 11.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.965 0.412 . . . . 0.0 111.107 -176.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.9 m -90.59 75.15 6.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.928 -174.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -114.56 142.66 46.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.84 0.352 . . . . 0.0 110.737 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 26.3 m-70 -111.35 134.36 21.17 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.924 174.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 39.7 Cg_exo -61.22 131.14 35.07 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.834 2.356 . . . . 0.0 112.325 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 73.36 43.57 37.62 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.118 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -134.0 148.0 51.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.872 0.368 . . . . 0.0 110.041 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -95.03 126.29 40.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.74 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -120.29 136.8 54.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.184 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 7.3 mp -102.24 129.67 48.7 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.22 141.84 43.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.069 0.462 . . . . 0.0 111.544 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 98.5 mt-30 -141.42 149.02 40.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.066 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.15 136.58 37.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.618 0.247 . . . . 0.0 110.338 175.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.4 ' HD2' ' HA ' ' A' ' 194' ' ' TRP . 65.7 mtp85 -143.47 160.93 39.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.354 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.612 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 21.3 p -148.49 172.15 14.94 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.404 ' O ' ' HZ ' ' A' ' 140' ' ' PHE . 21.2 pttp -138.55 117.66 9.52 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.058 0.456 . . . . 0.0 111.907 -174.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.71 -160.87 0.13 Allowed 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 123.299 2.666 . . . . 0.0 112.586 175.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -79.9 -46.54 16.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.118 0.485 . . . . 0.0 111.343 -175.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -94.41 23.85 4.92 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -171.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -161.86 168.23 36.88 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.384 178.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -157.59 150.74 23.42 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 29.1 p-90 -124.94 144.22 50.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.82 0.343 . . . . 0.0 111.218 -177.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 49.0 m -133.08 12.5 4.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.429 176.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -145.6 163.56 34.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.332 -178.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.465 ' CH2' ' HB2' ' A' ' 147' ' ' ARG . 72.9 m95 -112.86 167.7 10.29 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.184 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.475 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 13.1 m -148.69 -58.87 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.547 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 4.5 Cg_exo -79.56 75.69 4.93 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.332 2.021 . . . . 0.0 113.412 -168.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -77.91 103.02 7.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.988 0.423 . . . . 0.0 110.429 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.2 m -96.95 140.58 31.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.454 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -105.0 131.4 52.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.933 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.3 tp -126.49 140.06 49.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.121 0.486 . . . . 0.0 110.744 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -103.41 119.11 38.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.038 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 51.2 mm -83.29 124.31 76.14 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.636 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.99 164.92 25.57 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.211 2.608 . . . . 0.0 113.419 -174.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 10.3 p -68.63 -46.79 68.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.473 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -85.6 35.19 0.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.769 0.795 . . . . 0.0 110.609 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.592 ' HA ' ' OE1' ' A' ' 115' ' ' GLN . 89.2 t80 -68.76 -58.04 4.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.5 t -155.62 157.16 36.28 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 20.2 ptp -114.03 -44.25 3.17 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.268 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 50.43 45.58 26.18 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.25 0.548 . . . . 0.0 110.582 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 27.0 t70 . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.167 -176.784 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 67.6 mtm . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -122.18 146.72 46.97 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.449 HG21 HG13 ' A' ' 101' ' ' VAL . 47.4 mt -41.76 -60.92 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 123.772 0.829 . . . . 0.0 113.177 -176.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.628 ' O ' ' HD3' ' A' ' 103' ' ' PRO . 1.5 m -129.76 157.41 42.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -174.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -92.51 88.2 0.3 Allowed Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 164.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.628 ' HD3' ' O ' ' A' ' 101' ' ' VAL . 90.1 Cg_endo -83.61 135.44 6.92 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.381 2.054 . . . . 0.0 113.28 -167.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -111.2 91.29 13.13 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.923 173.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 103' ' ' PRO . 37.5 Cg_exo -60.18 153.59 57.81 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.176 2.584 . . . . 0.0 112.088 -177.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.43 98.49 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.881 2.387 . . . . 0.0 112.179 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -94.53 -173.21 2.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.021 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 54.7 43.04 30.76 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 123.563 0.54 . . . . 0.0 110.217 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 48.6 tp -68.76 94.77 0.63 Allowed 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.604 178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.69 125.64 38.42 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.997 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.69 114.13 46.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -121.32 118.19 28.87 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.108 -173.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.509 HG22 ' CD1' ' A' ' 123' ' ' LEU . 7.1 t -80.39 123.84 37.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -102.73 120.5 40.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.956 0.408 . . . . 0.0 110.783 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -121.61 86.39 44.75 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.422 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.62 -177.85 2.71 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 123.211 2.607 . . . . 0.0 113.327 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -74.41 -64.71 0.97 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.17 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -119.32 15.26 13.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.096 0.474 . . . . 0.0 110.912 -176.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -110.29 150.19 29.09 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.556 177.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -61.71 138.22 95.22 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 123.634 0.584 . . . . 0.0 110.646 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.446 ' HD3' ' SD ' ' A' ' 208' ' ' MET . 43.2 Cg_endo -67.98 138.52 44.34 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.543 2.162 . . . . 0.0 111.47 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -148.39 157.25 43.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.624 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.509 ' CD1' HG22 ' A' ' 113' ' ' VAL . 30.7 tp -92.61 124.8 36.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.955 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.526 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 21.3 t90 -103.43 103.75 13.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.096 0.474 . . . . 0.0 110.429 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.2 mp -95.2 116.45 36.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.579 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.455 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 5.0 ttpm? -128.93 127.27 41.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.189 0.518 . . . . 0.0 110.566 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 22.5 p90 -116.27 160.56 20.28 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.27 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 39.3 t -86.33 118.62 70.64 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 21.1 Cg_endo -61.33 148.74 92.12 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.709 2.273 . . . . 0.0 111.876 -178.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 129' ' ' PRO . 38.9 Cg_exo -57.03 163.15 8.1 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.965 2.444 . . . . 0.0 112.386 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 36.3 p -69.09 174.35 4.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.513 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 58.1 mt -63.83 112.84 3.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.854 -175.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 133' ' ' ILE . 41.0 mt -99.55 7.59 8.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 122.005 0.907 . . . . 0.0 109.37 177.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 61.23 53.11 3.64 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.84 -176.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.73 70.0 5.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.391 -177.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -101.76 -4.32 26.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.985 -172.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.2 p -74.26 -175.72 2.38 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.473 174.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -108.18 13.03 37.2 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.555 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -133.84 38.48 3.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.633 0.73 . . . . 0.0 109.801 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -91.98 -1.43 57.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.368 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.28 106.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -168.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -97.68 132.9 42.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.095 175.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 60.0 mt -104.31 141.51 36.18 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.018 0.437 . . . . 0.0 110.941 -175.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 184' ' ' CYS . 93.6 m-85 -104.29 141.24 36.64 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.477 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -126.84 136.57 52.53 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 161' ' ' ALA . 4.9 mp -118.16 128.07 75.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.949 0.404 . . . . 0.0 110.782 -176.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.524 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 15.3 ttp180 -113.07 120.3 40.86 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -144.58 160.41 41.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.692 0.282 . . . . 0.0 111.596 -175.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.403 ' HE2' ' CE2' ' A' ' 156' ' ' TRP . 56.7 pttt -170.93 144.55 1.82 Allowed Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.489 176.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.431 ' HG2' ' HB3' ' A' ' 153' ' ' ALA . 43.4 Cg_endo -74.2 167.09 28.0 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.553 2.169 . . . . 0.0 111.444 167.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.409 ' HG2' ' HG3' ' A' ' 152' ' ' LYS . 1.4 pm0 -59.47 -39.6 84.21 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.925 0.393 . . . . 0.0 111.426 -177.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.409 ' HG3' ' HG2' ' A' ' 151' ' ' GLU . 91.7 mttt -87.8 16.25 6.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.499 -175.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.431 ' HB3' ' HG2' ' A' ' 150' ' ' PRO . . . -88.96 -38.99 14.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.262 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 70.33 -54.38 0.63 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.126 0.891 . . . . 0.0 111.19 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -85.41 151.89 23.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.248 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.524 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 77.1 m95 -90.45 135.51 33.64 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.216 178.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -99.95 123.48 44.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.505 175.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.4 mp -103.66 120.07 53.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.994 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 41.2 m-70 -123.35 122.91 39.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.872 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -85.8 131.4 34.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.548 -176.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.446 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -96.6 -41.56 8.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.331 . . . . 0.0 111.387 -179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.35 -141.09 15.18 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.292 -176.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.49 44.03 1.06 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.461 0.648 . . . . 0.0 111.08 -177.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -128.46 149.68 50.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.593 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.3 p -101.47 26.18 7.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -174.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -151.66 140.42 20.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.931 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 33.5 t80 -130.7 146.99 52.32 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.526 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 39.1 mmtm -112.1 132.5 54.81 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.736 0.303 . . . . 0.0 110.901 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 26.4 mm -112.34 136.85 47.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -104.93 -25.5 12.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.068 0.461 . . . . 0.0 110.441 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 25.6 t -86.18 70.02 10.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.287 -175.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.9 mm? -110.62 139.83 45.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.968 0.414 . . . . 0.0 110.435 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -101.03 122.51 48.4 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.051 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.438 ' HB3' ' HB3' ' A' ' 206' ' ' PHE . 10.0 Cg_endo -58.35 116.96 3.61 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.527 2.152 . . . . 0.0 112.605 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 91.35 32.46 8.77 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.636 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.482 HE21 ' HA ' ' A' ' 176' ' ' GLN . 0.1 OUTLIER -133.13 159.3 40.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.826 0.346 . . . . 0.0 110.911 -179.6 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -106.88 126.63 52.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.691 -174.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -112.82 137.95 50.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.048 0.451 . . . . 0.0 110.67 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.9 mp -99.84 124.21 44.89 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 26.3 m -121.8 140.27 46.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.229 0.538 . . . . 0.0 111.877 -176.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.522 HE21 ' HB3' ' A' ' 197' ' ' ALA . 82.7 mt-30 -136.08 147.68 47.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.333 175.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.18 142.44 22.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.869 0.366 . . . . 0.0 110.128 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.439 ' HD2' ' O ' ' A' ' 193' ' ' ALA . 27.0 ttt-85 -146.69 149.31 33.2 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.608 ' HB3' ' CE2' ' A' ' 144' ' ' TYR . 9.0 p -103.67 154.03 19.98 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.527 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.479 ' HE2' ' CE2' ' A' ' 191' ' ' TRP . 73.7 mttt -112.54 95.14 30.81 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.25 145.96 89.5 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.926 2.417 . . . . 0.0 112.442 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -64.87 -23.12 67.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.745 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -96.6 16.55 18.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.963 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -167.41 -148.9 5.81 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.174 -1.012 . . . . 0.0 112.967 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -162.43 -178.03 6.02 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.479 ' CE2' ' HE2' ' A' ' 185' ' ' LYS . 1.2 p-90 -118.48 135.48 54.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.019 0.438 . . . . 0.0 110.479 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 12.1 p -85.08 -38.57 18.96 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.044 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.439 ' O ' ' HD2' ' A' ' 183' ' ' ARG . . . -177.35 -154.78 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.767 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -94.32 157.03 16.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.448 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.524 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 2.0 m -133.54 -60.85 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -176.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.524 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 14.8 Cg_endo -94.9 111.47 0.15 Allowed 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.674 2.249 . . . . 0.0 113.308 -172.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.522 ' HB3' HE21 ' A' ' 181' ' ' GLN . . . -103.53 122.47 45.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.039 0.447 . . . . 0.0 110.858 177.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 90.7 m -117.03 147.04 42.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.709 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.4 ' CD2' ' HG ' ' A' ' 179' ' ' LEU . 68.2 m-85 -110.66 140.37 45.08 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.1 tp -136.23 138.07 47.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.145 0.498 . . . . 0.0 110.794 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -104.39 124.37 49.09 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.551 177.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 40.8 mm -88.56 124.55 65.66 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.343 178.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.49 146.61 96.88 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.605 2.203 . . . . 0.0 111.908 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 49.6 m -70.91 -11.56 61.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.288 0.566 . . . . 0.0 110.57 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -96.26 15.59 20.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.614 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.5 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 83.7 t80 -53.13 -43.91 67.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.523 177.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.5 m -57.52 119.81 7.18 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.229 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.485 ' HG3' ' O ' ' A' ' 208' ' ' MET . 20.5 ptm -80.8 83.46 6.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.278 0.561 . . . . 0.0 110.571 -175.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 60.37 -156.96 0.34 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.291 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.331 -0.843 . . . . 0.0 110.596 178.141 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 56.6 tpp . . . . . 0 N--CA 1.483 1.186 0 CA-C-O 120.536 0.208 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.584 ' CE2' ' HB ' ' A' ' 101' ' ' VAL . 35.5 p90 -162.34 178.68 8.46 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 177.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.603 ' O ' ' HA2' ' A' ' 189' ' ' GLY . 13.9 mt -41.09 -44.29 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.213 0.946 . . . . 0.0 113.079 -176.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.584 ' HB ' ' CE2' ' A' ' 99' ' ' TYR . 17.5 t -104.16 94.19 3.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.174 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -60.45 129.22 89.04 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.475 -177.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -82.47 -161.22 0.14 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.325 2.683 . . . . 0.0 112.736 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 67.79 85.19 0.15 Allowed Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.319 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.7 147.93 8.42 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.517 2.145 . . . . 0.0 111.822 175.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.43 141.06 96.83 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.341 2.028 . . . . 0.0 110.87 172.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.16 174.68 8.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.971 -172.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 57.07 60.63 2.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.343 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 9.7 mt -69.45 97.76 1.03 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.7 174.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.6 122.02 39.07 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.0 t -115.09 119.55 62.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.896 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -118.88 132.7 56.11 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.158 -176.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.464 ' HA ' HD21 ' A' ' 123' ' ' LEU . 12.9 p -86.78 128.26 39.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.19 0.519 . . . . 0.0 109.984 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -116.69 107.84 15.17 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.21 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.418 ' HG2' ' HB3' ' A' ' 121' ' ' PRO . 50.5 mt-30 -111.24 97.95 37.58 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.421 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.91 -179.88 4.68 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.775 2.316 . . . . 0.0 112.374 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.66 -68.44 0.45 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.884 0.373 . . . . 0.0 110.855 -177.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -107.24 -18.28 13.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.334 0.588 . . . . 0.0 110.97 -176.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -80.12 141.93 35.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.845 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -60.06 135.39 90.54 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.268 -175.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.418 ' HB3' ' HG2' ' A' ' 115' ' ' GLN . 38.0 Cg_endo -65.52 149.36 87.77 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.978 2.452 . . . . 0.0 112.282 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -150.81 167.98 25.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.941 -175.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.464 HD21 ' HA ' ' A' ' 113' ' ' VAL . 11.1 mt -100.25 142.41 31.77 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 120.918 0.39 . . . . 0.0 110.822 176.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.504 ' CZ2' ' HD2' ' A' ' 126' ' ' LYS . 19.9 t90 -113.93 105.28 13.06 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.729 175.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.1 mp -94.87 118.48 41.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.504 ' HD2' ' CZ2' ' A' ' 124' ' ' TRP . 81.5 tttt -132.05 119.56 21.17 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.216 0.532 . . . . 0.0 110.866 -175.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . 0.442 ' CH2' HD11 ' A' ' 146' ' ' ILE . 35.5 p90 -116.08 162.46 17.39 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.829 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.6 m -102.9 134.94 19.54 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.95 148.69 28.81 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.235 2.623 . . . . 0.0 112.279 -177.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -48.25 -82.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.464 2.776 . . . . 0.0 113.267 -174.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.1 p -149.5 -74.99 0.16 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.972 0.415 . . . . 0.0 111.143 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 95.5 mt -117.68 102.93 9.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.369 0.604 . . . . 0.0 111.471 -176.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.484 ' N ' HD13 ' A' ' 133' ' ' ILE . 3.5 mp -99.92 87.07 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 122.487 1.137 . . . . 0.0 109.617 177.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.78 -3.83 40.34 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.167 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.7 mp -78.71 57.4 2.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.228 -172.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -85.5 100.92 12.23 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 175.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.7 t 169.11 147.7 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.749 -173.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -66.77 -54.21 23.34 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.489 177.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 19.3 m-90 -82.97 136.44 34.53 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.9 t80 67.03 59.87 0.53 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.836 0.827 . . . . 0.0 109.696 -173.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 13.3 t -106.91 170.43 7.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.87 174.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 1.015 ' HG ' ' SG ' ' A' ' 184' ' ' CYS . 11.4 tp -96.1 110.63 22.86 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.889 0.376 . . . . 0.0 110.077 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.436 ' C ' ' HG ' ' A' ' 184' ' ' CYS . 2.5 mm? -96.16 133.67 40.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.948 -177.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -102.1 144.35 30.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.988 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 75.1 tt0 -136.64 137.35 39.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.926 -173.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 181' ' ' GLN . 4.7 mp -120.57 125.42 74.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.775 0.321 . . . . 0.0 110.858 -176.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.435 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 18.0 ttp180 -108.84 121.77 45.77 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.55 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 4.0 pp -145.25 159.28 43.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.79 0.328 . . . . 0.0 111.342 -176.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -168.61 149.33 4.34 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.426 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 31.3 Cg_endo -70.95 160.89 47.94 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.988 1.792 . . . . 0.0 112.311 174.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.438 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 6.0 pt-20 -50.93 -46.93 61.04 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.438 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 93.4 mttt -84.77 13.85 5.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.803 0.335 . . . . 0.0 111.59 -174.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.426 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -88.23 134.25 33.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.926 0.393 . . . . 0.0 111.185 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -89.95 -21.63 22.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.205 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -120.37 145.83 46.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.733 -177.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.435 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 66.4 m95 -84.06 137.7 33.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.433 176.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -109.9 116.7 32.1 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.423 0.63 . . . . 0.0 111.323 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.1 mp -91.03 130.79 39.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.935 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 67.6 m-70 -124.11 126.03 45.49 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.223 176.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -93.0 119.55 32.38 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.852 0.358 . . . . 0.0 110.836 -174.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.418 ' HB1' HD11 ' A' ' 146' ' ' ILE . . . -75.09 -51.5 13.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.054 177.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 77.8 81.76 0.63 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.368 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 74.3 -40.0 0.44 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.954 0.901 . . . . 0.0 112.563 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -68.56 145.65 53.78 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 55.5 p -104.94 30.31 5.63 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.26 0.552 . . . . 0.0 111.49 -176.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -154.14 144.76 22.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.639 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.449 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 32.4 t80 -142.27 146.14 34.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.081 -177.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.44 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 10.3 mptt -115.76 144.53 43.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.861 0.362 . . . . 0.0 110.661 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 35.8 mm -119.61 134.19 63.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.951 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -102.02 -29.52 11.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.878 0.371 . . . . 0.0 110.608 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 45.6 m -86.2 73.89 10.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.963 -175.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.25 144.3 41.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.854 0.359 . . . . 0.0 110.333 174.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 -110.16 122.11 39.72 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.887 175.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.25 124.35 15.96 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.984 2.456 . . . . 0.0 112.772 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 97.21 12.54 48.6 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.073 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -118.78 148.84 42.4 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.377 0.608 . . . . 0.0 111.873 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -89.47 129.97 35.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.547 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -115.59 135.52 53.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.998 0.427 . . . . 0.0 110.455 177.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.6 mp -101.5 121.94 42.88 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.8 m -119.49 137.56 52.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.175 0.512 . . . . 0.0 111.062 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.561 ' O ' ' HA ' ' A' ' 146' ' ' ILE . 89.3 mt-30 -136.94 139.58 41.63 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.556 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 145' ' ' GLU . 10.4 p -123.55 137.35 57.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.206 0.527 . . . . 0.0 110.606 174.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -138.79 138.68 37.81 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.667 174.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 1.015 ' SG ' ' HG ' ' A' ' 142' ' ' LEU . 4.6 t -125.53 156.23 39.36 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.07 126.16 1.57 Allowed Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.22 -172.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -55.44 163.74 4.71 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.799 2.333 . . . . 0.0 112.454 168.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -47.33 -51.45 19.39 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -172.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -74.57 -20.37 59.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -174.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.603 ' HA2' ' O ' ' A' ' 100' ' ' ILE . . . -75.61 99.15 1.21 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.487 -174.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -84.45 113.95 21.57 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.784 0.802 . . . . 0.0 110.46 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 14.4 p-90 -91.51 158.99 16.16 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.359 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 10.5 t -158.96 22.75 0.21 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.215 0.531 . . . . 0.0 109.722 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -160.99 166.3 28.51 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.823 -173.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -132.96 135.14 45.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.943 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.525 ' OG ' ' HD3' ' A' ' 196' ' ' PRO . 3.1 p -110.72 -50.24 0.06 OUTLIER Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -176.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.525 ' HD3' ' OG ' ' A' ' 195' ' ' SER . 9.3 Cg_endo -86.92 83.05 1.13 Allowed 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.019 1.813 . . . . 0.0 113.12 -172.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.487 ' HB3' ' NE2' ' A' ' 181' ' ' GLN . . . -87.41 107.1 18.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.043 0.449 . . . . 0.0 110.464 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 28.8 m -100.27 139.8 35.43 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.19 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -108.19 120.41 42.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.831 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.1 tp -119.99 133.56 66.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.167 0.508 . . . . 0.0 110.508 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -95.94 135.58 37.51 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.452 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 43.1 mm -95.83 121.51 60.94 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.01 149.13 86.11 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.923 2.415 . . . . 0.0 112.071 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 7.5 p -72.76 -18.75 61.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.037 0.446 . . . . 0.0 110.523 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -91.32 16.78 9.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.363 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.416 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 54.5 t80 -67.1 -32.41 73.54 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.9 m -63.93 134.25 54.75 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.058 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 82.6 mtp -77.85 161.52 27.55 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -79.67 59.36 3.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.667 0.27 . . . . 0.0 111.374 -176.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 33.3 t70 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.803 174.845 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.949 0.404 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.493 ' CE1' HG21 ' A' ' 101' ' ' VAL . 53.1 t80 -167.31 152.55 7.33 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.4 mt -48.87 -70.32 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.493 HG21 ' CE1' ' A' ' 99' ' ' TYR . 3.2 m -75.36 132.91 32.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.327 -172.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -134.13 72.74 71.25 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.638 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -82.76 116.22 2.51 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.63 2.22 . . . . 0.0 113.151 -173.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -153.29 87.34 3.9 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 171.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -62.16 138.63 73.55 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.953 2.436 . . . . 0.0 112.988 -174.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.458 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 32.8 Cg_endo -65.26 123.91 12.19 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.624 2.216 . . . . 0.0 111.131 176.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.16 178.82 4.55 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.382 -174.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 54.16 58.07 5.33 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.894 -178.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.0 96.15 3.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.012 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.57 129.87 41.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.84 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.407 HG11 HD12 ' A' ' 123' ' ' LEU . 3.1 t -120.35 120.25 62.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.786 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -132.16 141.53 49.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.686 0.279 . . . . 0.0 110.616 -176.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.2 p -95.82 120.28 45.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.049 0.452 . . . . 0.0 110.029 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -111.18 126.82 55.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.904 0.383 . . . . 0.0 111.109 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.405 ' HG2' ' HB3' ' A' ' 121' ' ' PRO . 78.0 mt-30 -114.02 106.47 53.26 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.098 175.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.53 170.37 5.61 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.054 2.503 . . . . 0.0 112.561 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -78.29 -8.68 58.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.382 -176.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -159.71 -40.13 0.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.243 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -69.05 167.37 16.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.295 -178.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -63.02 141.68 97.69 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.853 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.471 ' HD3' ' SD ' ' A' ' 208' ' ' MET . 60.3 Cg_endo -72.36 147.26 46.68 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.819 2.346 . . . . 0.0 111.602 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.459 ' HB3' HD13 ' A' ' 170' ' ' LEU . 34.8 p90 -147.92 154.77 40.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.14 0.495 . . . . 0.0 111.336 -175.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 28.9 tp -90.16 124.36 34.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.531 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.525 ' CZ2' ' HD3' ' A' ' 126' ' ' LYS . 21.9 t90 -100.32 103.76 15.19 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.224 0.535 . . . . 0.0 110.232 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.9 mp -97.66 119.82 46.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.195 177.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.525 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 25.4 pttm -132.0 139.59 48.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.51 0.672 . . . . 0.0 110.458 176.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 19.1 p90 -122.52 145.3 48.45 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.143 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.6 t -88.11 121.15 70.71 Favored Pre-proline 0 C--N 1.317 -0.828 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.02 151.88 3.7 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.58 2.854 . . . . 0.0 112.951 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -46.28 151.71 1.6 Allowed 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 123.824 3.016 . . . . 0.0 113.591 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.4 m -74.4 -31.64 62.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.714 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.431 ' O ' ' HB ' ' A' ' 133' ' ' ILE . 96.1 mt -84.05 155.52 22.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.3 174.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.431 ' HB ' ' O ' ' A' ' 132' ' ' LEU . 29.5 mt 70.45 -59.88 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.211 0 O-C-N 123.47 0.481 . . . . 0.0 111.526 -177.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.9 t70 56.05 54.75 7.57 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.672 0.748 . . . . 0.0 110.11 -177.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -69.78 151.3 45.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.917 -178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -135.31 -45.21 0.7 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.851 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 13.8 t -167.3 167.65 13.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.055 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 117.8 -160.13 13.87 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.798 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 56.1 t90 -74.63 -36.79 62.91 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.423 ' CE1' HG22 ' A' ' 133' ' ' ILE . 25.4 t80 -61.56 117.55 5.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.687 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 21.9 m -133.56 140.26 47.06 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.044 0.45 . . . . 0.0 111.014 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 39.2 tp -116.32 116.54 27.93 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.24 142.03 28.15 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.936 0.398 . . . . 0.0 111.063 -175.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.444 ' CE2' HG23 ' A' ' 165' ' ' THR . 86.8 m-85 -119.37 141.51 48.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.123 -175.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -120.29 129.82 54.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.057 175.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.42 HD11 ' N ' ' A' ' 146' ' ' ILE . 4.5 mp -106.6 125.38 62.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.005 0.431 . . . . 0.0 110.191 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.518 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 18.6 ttp180 -117.66 119.81 36.12 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.676 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -140.5 159.45 42.17 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.413 -176.32 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.439 ' HE2' ' CZ2' ' A' ' 156' ' ' TRP . 52.4 pttt -167.08 149.9 5.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.426 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.97 161.69 44.1 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.547 2.165 . . . . 0.0 111.196 170.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -67.47 -16.74 64.38 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -172.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -94.04 -1.15 54.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.021 0.439 . . . . 0.0 110.427 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -91.23 125.78 36.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.381 -176.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.09 -35.32 25.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.706 0.765 . . . . 0.0 109.415 173.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -88.16 150.25 23.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.388 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.518 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 65.4 m95 -101.41 153.4 19.72 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.786 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -105.24 117.78 34.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.592 174.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -94.82 118.8 41.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.227 0.537 . . . . 0.0 110.044 175.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.536 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 22.8 m-70 -122.68 114.8 21.07 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.328 177.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -82.71 142.22 31.82 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.508 -176.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -82.37 -46.36 13.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.944 0.402 . . . . 0.0 111.448 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 163' ' ' GLN . . . 108.28 -39.44 2.9 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.987 177.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 162' ' ' GLY . 63.8 tt0 174.93 -28.28 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.295 0.569 . . . . 0.0 110.017 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -70.78 160.3 32.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.809 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.444 HG23 ' CE2' ' A' ' 144' ' ' TYR . 60.7 p -110.91 28.09 9.04 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.254 0.549 . . . . 0.0 111.273 -174.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -152.29 143.95 23.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.411 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.536 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 19.8 t80 -131.86 147.7 52.5 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.428 ' HD2' ' CE2' ' A' ' 122' ' ' TYR . 43.2 mmtt -117.68 131.69 56.59 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 34.9 mm -106.91 125.01 62.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.459 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.8 mm? -93.95 -38.2 11.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.508 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 14.7 m -76.51 87.23 3.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.822 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.448 HD13 ' CZ ' ' A' ' 206' ' ' PHE . 49.1 mt -131.92 147.57 52.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.762 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -109.28 134.29 20.52 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.305 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.34 110.87 2.13 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.618 2.212 . . . . 0.0 111.852 178.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 90.17 46.61 4.08 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.6 -176.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -135.78 147.22 48.27 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.925 0.393 . . . . 0.0 110.29 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -98.29 129.1 45.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.028 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -122.38 138.82 54.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.93 0.395 . . . . 0.0 110.639 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 7.5 mp -97.09 132.97 42.36 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.455 ' CG2' ' HB ' ' A' ' 198' ' ' THR . 28.4 m -122.72 152.98 27.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.174 0.511 . . . . 0.0 110.988 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.577 ' NE2' ' HA ' ' A' ' 181' ' ' GLN . 0.8 OUTLIER -151.94 152.6 32.73 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.454 -177.871 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.9 p -135.85 139.91 45.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.029 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -136.49 133.59 36.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.449 176.852 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.458 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 13.0 p -105.08 144.65 31.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.486 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -131.74 106.06 14.15 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -76.18 -163.86 0.22 Allowed 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.742 2.295 . . . . 0.0 112.888 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -84.75 -54.38 4.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.788 0.328 . . . . 0.0 111.294 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -78.37 -40.01 37.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.03 0.443 . . . . 0.0 110.357 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -96.38 159.89 21.93 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.667 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -140.16 -157.69 0.79 Allowed 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -177.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -43.46 134.78 3.85 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 4.8 t -130.81 29.59 4.73 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.303 171.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . 68.6 162.95 0.21 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.444 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.442 ' CE3' ' HB3' ' A' ' 181' ' ' GLN . 63.4 m95 -86.34 115.11 23.66 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 175.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.494 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 6.9 m -102.0 -54.05 0.14 Allowed Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -176.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.494 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 73.5 Cg_endo -78.08 169.74 19.9 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.656 1.571 . . . . 0.0 112.333 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -154.93 117.89 4.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 172.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.455 ' HB ' ' CG2' ' A' ' 180' ' ' VAL . 7.0 m -99.01 134.57 41.65 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.312 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -104.91 130.07 53.15 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 8.4 tp -128.78 138.92 53.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.284 0.564 . . . . 0.0 111.124 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -100.14 123.29 44.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.936 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 50.6 mm -88.24 120.39 70.53 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 173.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.6 150.69 80.53 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.845 2.363 . . . . 0.0 112.425 -176.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 17.5 m -69.83 -12.53 61.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.52 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -91.6 17.31 8.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.711 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.448 ' CZ ' HD13 ' A' ' 172' ' ' LEU . 80.6 t80 -67.3 -34.11 76.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.232 -178.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.1 m -68.07 129.51 40.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.191 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.471 ' SD ' ' HD3' ' A' ' 121' ' ' PRO . 91.9 mtp -97.14 166.82 11.4 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 64.7 t30 58.91 37.18 24.76 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 122.137 0.97 . . . . 0.0 108.579 -171.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 16.7 t70 . . . . . 0 C--O 1.248 0.985 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.946 -174.581 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.1 ptm . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.607 0.242 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.462 ' CD2' ' HB ' ' A' ' 101' ' ' VAL . 24.1 t80 -148.1 136.85 21.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.117 0.484 . . . . 0.0 110.463 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 82.8 mt -67.4 106.22 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.697 176.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.462 ' HB ' ' CD2' ' A' ' 99' ' ' TYR . 14.4 p -149.44 148.73 15.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.177 -174.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -90.5 110.13 38.92 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.95 -39.97 22.65 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.241 1.961 . . . . 0.0 111.651 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' A' ' 130' ' ' PRO . 36.2 t70 -135.42 89.35 22.89 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.616 176.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -65.07 141.28 69.32 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.59 2.193 . . . . 0.0 111.798 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.426 ' HG3' ' SG ' ' A' ' 184' ' ' CYS . 14.6 Cg_endo -57.89 141.57 96.01 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.779 2.319 . . . . 0.0 111.446 178.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.01 -172.13 3.61 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.498 -173.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 58.53 51.24 8.18 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.699 0.625 . . . . 0.0 111.403 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.422 HD22 ' OG1' ' A' ' 198' ' ' THR . 52.9 tp -80.23 93.62 5.91 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.76 127.45 45.91 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.306 -177.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.7 t -112.27 123.8 68.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.877 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -132.59 140.07 48.09 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.585 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.69 113.46 32.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.383 0.611 . . . . 0.0 109.753 176.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -96.26 121.26 37.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.223 -176.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.438 ' HB3' ' SD ' ' A' ' 208' ' ' MET . 22.5 mt-30 -120.7 76.13 27.48 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.101 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.91 160.61 40.2 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.74 2.293 . . . . 0.0 111.891 -178.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -83.2 -25.59 31.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.295 0.569 . . . . 0.0 110.374 176.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -92.75 -44.55 8.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.324 -175.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -105.07 153.64 21.21 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.413 ' O ' ' HD2' ' A' ' 122' ' ' TYR . 18.7 ptpt -64.7 152.43 90.05 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.413 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.55 134.34 44.02 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.754 2.303 . . . . 0.0 112.565 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.413 ' HD2' ' O ' ' A' ' 120' ' ' LYS . 46.1 p90 -146.4 163.93 34.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.443 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.438 ' HB3' ' HB ' ' A' ' 169' ' ' ILE . 33.7 tp -97.44 125.77 42.29 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.453 ' CZ2' ' HD2' ' A' ' 126' ' ' LYS . 24.3 t90 -107.67 114.66 28.79 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.296 -176.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.2 mp -102.85 123.08 55.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.453 ' HD2' ' CZ2' ' A' ' 124' ' ' TRP . 51.2 tttm -132.38 121.12 22.97 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.991 0.424 . . . . 0.0 110.848 -177.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . 0.403 ' CD2' HG21 ' A' ' 182' ' ' VAL . 42.8 p90 -119.61 166.42 13.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.995 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 61.2 m -109.02 126.47 29.27 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.293 177.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.79 152.99 79.46 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.822 2.348 . . . . 0.0 111.647 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.453 ' HB3' ' O ' ' A' ' 104' ' ' ASP . 40.1 Cg_exo -56.81 146.02 80.42 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.716 2.277 . . . . 0.0 111.724 178.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.2 m -94.49 149.61 21.07 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.372 -173.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 74.2 mt 63.34 82.27 0.19 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.478 0.711 . . . . 0.0 112.366 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.419 HD12 ' HB2' ' A' ' 130' ' ' PRO . 77.0 mt -134.98 -59.57 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.995 176.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.2 t70 51.31 79.33 0.1 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.54 -174.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.495 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 1.7 pt? -85.34 86.89 7.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 122.176 0.988 . . . . 0.0 111.168 -176.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -132.92 -62.47 0.8 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.945 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.8 t -72.6 -18.09 61.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.196 -175.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -83.47 -12.01 79.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.487 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 52.34 64.99 1.64 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 122.757 0.423 . . . . 0.0 111.496 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -151.47 173.69 14.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.192 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.479 ' HA ' HD11 ' A' ' 135' ' ' LEU . 29.8 m -137.45 141.63 41.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.489 176.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 54.1 tp -97.79 111.36 23.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.532 ' CD1' ' HG2' ' A' ' 163' ' ' GLN . 2.8 mm? -100.55 157.22 16.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 -176.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -120.84 136.98 54.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.801 -176.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.438 ' C ' HG13 ' A' ' 146' ' ' ILE . 27.4 tt0 -127.54 140.42 52.14 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -174.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.438 HG13 ' C ' ' A' ' 145' ' ' GLU . 7.6 mt -132.65 150.15 32.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.98 0.419 . . . . 0.0 111.843 -166.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.465 ' HG3' ' CH2' ' A' ' 194' ' ' TRP . 43.6 mtm180 -126.75 154.71 43.82 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 174.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.618 HD12 ' NE2' ' A' ' 159' ' ' HIS . 0.0 OUTLIER -163.1 155.41 18.36 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 123.297 0.373 . . . . 0.0 110.255 170.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -173.43 141.38 0.91 Allowed Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.955 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.8 173.37 13.57 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.561 2.174 . . . . 0.0 112.108 173.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -65.78 -24.68 66.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.627 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -90.51 11.51 21.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.237 0.541 . . . . 0.0 110.467 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -111.52 130.6 55.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.751 178.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -92.92 -35.35 13.38 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.259 0.552 . . . . 0.0 110.341 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -91.92 149.46 21.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.002 -175.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -93.77 128.72 40.14 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.065 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -93.06 111.46 23.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.008 173.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.441 HG13 ' HG2' ' A' ' 147' ' ' ARG . 1.9 mp -88.72 126.21 41.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.618 ' NE2' HD12 ' A' ' 148' ' ' LEU . 3.2 p80 -130.36 132.96 46.06 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.828 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -97.72 116.57 30.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.199 -176.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.437 ' HB1' ' CD1' ' A' ' 146' ' ' ILE . . . -76.95 -48.74 17.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.191 0.52 . . . . 0.0 110.643 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 123.5 -125.61 5.96 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.257 -176.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.532 ' HG2' ' CD1' ' A' ' 143' ' ' LEU . 5.1 mt-30 -102.14 -7.0 22.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.921 0.391 . . . . 0.0 110.482 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -79.48 143.24 35.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.375 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 63.5 p -101.32 33.78 2.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.171 0.51 . . . . 0.0 111.76 -174.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -158.82 153.51 24.62 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.283 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -151.27 152.56 33.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.701 0.286 . . . . 0.0 110.547 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 168' ' ' LYS . 0.1 OUTLIER -118.33 128.92 55.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.437 -178.109 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 123' ' ' LEU . 23.6 mm -99.87 140.82 18.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.11 -19.82 13.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.777 0.323 . . . . 0.0 110.86 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 36.7 t -87.59 73.89 9.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.231 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.407 ' N ' HD22 ' A' ' 172' ' ' LEU . 2.7 mm? -117.7 143.26 46.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.995 0.426 . . . . 0.0 110.522 175.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 62.0 m-70 -119.15 132.26 24.03 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.575 175.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 24.3 Cg_exo -62.09 124.33 14.2 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.791 2.327 . . . . 0.0 112.732 -177.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 85.67 28.37 29.64 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.751 177.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -123.75 149.74 45.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.14 0.495 . . . . 0.0 111.125 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -87.38 128.34 35.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.361 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -121.1 142.39 49.89 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.752 0.311 . . . . 0.0 110.329 175.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.8 mp -104.93 146.89 28.39 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 172.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.414 HG22 ' HB ' ' A' ' 198' ' ' THR . 19.4 m -134.53 152.74 34.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.983 0.42 . . . . 0.0 110.484 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.559 ' NE2' ' HA ' ' A' ' 181' ' ' GLN . 0.3 OUTLIER -151.66 146.27 25.67 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.035 179.522 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.403 HG21 ' CD2' ' A' ' 127' ' ' TRP . 12.0 p -138.17 149.82 24.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -158.34 139.25 13.02 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.426 ' SG ' ' HG3' ' A' ' 106' ' ' PRO . 26.3 p -104.41 177.9 4.71 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -125.65 84.68 60.1 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.684 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.9 158.0 59.62 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.955 2.437 . . . . 0.0 111.701 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -79.45 -8.93 59.47 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.764 -176.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -88.65 -7.15 56.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.544 175.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -179.74 94.71 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.592 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -75.25 125.53 29.16 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 176.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 85.1 m95 62.85 98.6 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 O-C-N 123.626 0.579 . . . . 0.0 111.245 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 10.2 p -107.47 13.98 26.32 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.753 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . 67.38 163.64 0.2 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.801 -1.09 . . . . 0.0 112.196 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.465 ' CH2' ' HG3' ' A' ' 147' ' ' ARG . 50.9 m95 -88.92 79.36 7.35 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.191 -177.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.423 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 12.9 m -74.48 -51.24 4.35 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.099 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.437 ' HG2' ' OE1' ' A' ' 181' ' ' GLN . 59.2 Cg_endo -74.78 165.27 31.84 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.667 1.578 . . . . 0.0 112.722 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -154.11 130.67 10.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.965 172.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.422 ' OG1' HD22 ' A' ' 109' ' ' LEU . 12.8 m -115.9 135.45 53.98 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.582 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -106.22 131.64 53.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.252 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.0 tp -128.53 130.27 69.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.283 0.563 . . . . 0.0 110.4 177.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.406 ' HA ' HE21 ' A' ' 201' ' ' GLN . 0.0 OUTLIER -97.81 113.38 25.16 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.338 178.495 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 51.7 mm -74.27 122.05 86.64 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.14 155.05 71.63 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.776 2.318 . . . . 0.0 112.353 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 12.3 p -75.85 -5.18 44.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.299 0.571 . . . . 0.0 110.224 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -82.8 -6.43 59.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.148 177.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -53.32 -37.26 62.11 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.54 -179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.2 p -89.12 92.89 9.38 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.231 174.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' MET . . . . . 0.438 ' SD ' ' HB3' ' A' ' 115' ' ' GLN . 58.5 mtm -82.63 -26.32 32.31 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.011 -172.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 46.51 65.1 1.28 Allowed 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.756 0.66 . . . . 0.0 112.514 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 34.2 t70 . . . . . 0 C--O 1.253 1.252 0 O-C-N 123.643 0.589 . . . . 0.0 110.745 179.437 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 83.1 mtp . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.95 0.405 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -101.53 134.07 45.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.271 0.558 . . . . 0.0 110.642 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 76.9 mt -73.86 89.14 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.213 175.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.519 ' O ' ' HD3' ' A' ' 103' ' ' PRO . 10.4 p -84.99 144.78 9.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.59 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -85.88 101.79 2.14 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 101' ' ' VAL . 38.5 Cg_endo -69.2 -39.6 7.36 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.108 1.872 . . . . 0.0 110.977 -178.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -112.79 86.02 8.3 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.288 172.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 103' ' ' PRO . 89.8 Cg_endo -97.1 156.43 1.08 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.675 2.916 . . . . 0.0 113.131 -176.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.666 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 73.4 Cg_endo -77.6 146.24 23.96 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.457 2.105 . . . . 0.0 111.271 175.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.403 HD23 ' N ' ' A' ' 107' ' ' LEU . 2.1 pt? -140.07 -174.61 3.97 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.094 -177.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 54.99 55.97 7.12 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 123.704 0.628 . . . . 0.0 110.925 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.4 tp -75.5 96.85 3.56 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.21 0.528 . . . . 0.0 110.491 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.09 123.18 38.44 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.253 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.435 HG13 HD12 ' A' ' 123' ' ' LEU . 3.5 t -119.04 118.1 56.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.43 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -136.1 121.37 19.14 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.838 -174.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.2 t -74.48 129.44 36.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.312 -0.403 . . . . 0.0 109.971 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 114' ' ' LYS . 24.3 mmtp -118.59 125.17 49.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.14 0.495 . . . . 0.0 111.642 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -117.26 97.13 50.41 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.884 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.437 ' HB2' ' HB2' ' A' ' 119' ' ' ARG . 15.2 Cg_exo -68.74 171.48 13.24 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.429 2.086 . . . . 0.0 111.968 177.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -76.18 -66.2 0.83 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.953 0.406 . . . . 0.0 110.706 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -92.69 -33.6 14.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.666 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.437 ' HB2' ' HB2' ' A' ' 116' ' ' PRO . 71.8 mtp180 -72.41 154.9 40.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.806 176.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -75.54 149.39 83.79 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.53 146.15 48.97 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.975 2.45 . . . . 0.0 112.468 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.472 ' CD2' ' HD2' ' A' ' 168' ' ' LYS . 49.0 p90 -151.41 161.37 42.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.461 -176.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 44.5 tp -91.52 125.46 36.27 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 175.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.598 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 22.4 t90 -102.03 108.93 20.52 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.127 0.489 . . . . 0.0 110.421 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.03 122.22 52.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.337 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -131.09 120.5 23.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.946 0.403 . . . . 0.0 110.491 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . 0.42 ' CH2' HD11 ' A' ' 146' ' ' ILE . 37.1 p90 -115.83 165.84 12.63 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.466 -178.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.0 t -104.34 121.27 47.94 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.756 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.95 142.4 33.85 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.377 2.718 . . . . 0.0 112.526 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.451 ' C ' ' HG1' ' A' ' 131' ' ' THR . 97.1 Cg_exo -43.6 106.56 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 124.034 3.156 . . . . 0.0 113.175 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.451 ' HB ' HD22 ' A' ' 132' ' ' LEU . 52.7 p 48.87 -98.48 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.715 0.806 . . . . 0.0 112.353 -176.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.451 HD22 ' HB ' ' A' ' 131' ' ' THR . 0.9 OUTLIER -143.68 124.1 13.92 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 176.033 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 59.3 mt -121.98 -66.32 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.742 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 52.75 57.99 5.81 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 123.713 0.633 . . . . 0.0 110.756 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.3 pp -71.92 138.61 48.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.791 -177.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -145.64 179.72 7.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.014 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 69.2 p 58.22 18.06 5.09 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.358 1.063 . . . . 0.0 113.123 176.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.87 -30.22 2.33 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.259 176.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -62.58 112.78 2.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.698 0.249 . . . . 0.0 110.698 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 88.4 t80 70.47 133.37 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 O-C-N 123.915 0.759 . . . . 0.0 111.41 -177.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.9 m -148.68 135.5 19.86 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.597 174.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.47 HD22 ' SG ' ' A' ' 184' ' ' CYS . 48.0 tp -107.94 117.19 33.48 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.159 -176.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 3.5 mp -95.71 134.84 38.16 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.318 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -102.83 153.17 20.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.718 -172.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -131.62 134.24 45.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.953 -171.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.42 HD11 ' CH2' ' A' ' 127' ' ' TRP . 4.5 mp -125.68 125.2 68.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.518 ' HB3' ' HB2' ' A' ' 181' ' ' GLN . 46.6 ttp180 -118.01 119.86 36.06 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -141.5 162.59 35.12 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.848 -176.251 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -167.07 150.25 6.06 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.164 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -68.32 159.48 53.13 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.282 1.988 . . . . 0.0 111.027 171.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 177' ' ' LYS . 15.8 pt-20 -63.06 -20.66 65.54 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -171.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -100.28 7.35 44.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.091 0.472 . . . . 0.0 110.852 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.75 124.24 31.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.899 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.96 -22.99 39.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.535 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -115.32 154.45 29.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.393 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -94.7 141.58 28.45 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.324 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -103.92 108.58 19.97 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.989 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.2 mp -87.99 133.4 30.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.033 0.444 . . . . 0.0 110.053 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -126.92 141.84 51.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.609 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.416 ' CZ ' ' HB3' ' A' ' 143' ' ' LEU . 5.3 t80 -106.14 124.66 49.93 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.073 -177.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -88.21 -44.06 11.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.138 0.494 . . . . 0.0 110.303 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 143' ' ' LEU . . . 103.71 -127.63 9.21 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.051 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -93.03 9.0 37.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.447 0.641 . . . . 0.0 110.519 -176.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -105.48 153.19 22.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.584 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.8 p -107.44 19.5 20.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.033 -175.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -146.57 140.66 26.27 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -133.87 151.39 51.51 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.598 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 40.7 mmtm -120.53 135.48 55.07 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.613 0.244 . . . . 0.0 110.66 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 33.9 mm -109.7 128.78 65.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.93 -25.06 12.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.368 . . . . 0.0 111.051 -178.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 13.8 m -80.62 65.4 5.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.712 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.447 HD12 ' CZ ' ' A' ' 206' ' ' PHE . 57.6 mt -114.55 157.59 22.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.949 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 75.3 m-70 -126.08 129.97 24.1 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.774 177.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 23.7 Cg_exo -63.75 121.85 9.73 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.615 2.21 . . . . 0.0 111.925 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 90.8 20.2 40.93 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.05 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -117.49 142.97 46.52 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.425 ' HB3' ' HB3' ' A' ' 151' ' ' GLU . 30.3 ttmt -90.77 135.13 33.92 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.064 177.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -122.12 133.17 54.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.112 0.482 . . . . 0.0 110.606 176.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.3 mp -100.68 124.71 46.66 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 34.7 m -115.02 161.27 13.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.364 0.602 . . . . 0.0 111.723 -176.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' A' ' 147' ' ' ARG . 12.2 mm-40 -145.63 148.67 33.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.901 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 9.0 p -136.37 145.69 30.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 120.891 0.377 . . . . 0.0 110.184 175.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.552 ' HG2' ' CZ3' ' A' ' 194' ' ' TRP . 1.2 ptm180 -163.08 177.98 8.68 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.398 175.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.666 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 27.9 p -155.25 170.46 21.81 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -147.35 89.69 5.44 Favored Pre-proline 0 C--N 1.322 -0.619 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.797 -176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.49 -169.33 0.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.721 2.28 . . . . 0.0 112.252 -178.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.5 -24.03 64.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.236 0.541 . . . . 0.0 110.259 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -61.51 -24.3 66.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.108 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -159.41 -147.64 4.95 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 119.979 -1.105 . . . . 0.0 113.539 -177.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -150.36 -141.22 0.11 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 -176.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 40.5 m95 -66.1 136.5 56.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.123 0.487 . . . . 0.0 111.709 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 16.5 m -120.94 10.79 10.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.881 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . 62.25 24.44 14.55 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.552 ' CZ3' ' HG2' ' A' ' 183' ' ' ARG . 71.9 m95 70.83 164.29 0.27 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.653 173.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.532 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 70.4 m -158.58 -63.97 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.532 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 76.9 Cg_endo -76.25 109.07 2.8 Favored 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 121.896 1.731 . . . . 0.0 113.456 -173.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.454 ' HB3' HE21 ' A' ' 181' ' ' GLN . . . -101.66 137.61 39.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.891 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 94.9 m -133.48 139.21 46.54 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.574 177.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -99.75 126.72 45.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.396 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.9 tp -129.25 137.68 56.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.029 0.443 . . . . 0.0 110.423 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -102.54 137.33 40.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.905 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 39.2 mm -96.98 113.08 62.39 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 176.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.8 147.44 72.39 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.921 2.414 . . . . 0.0 112.188 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 42.1 m -71.76 -7.51 48.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.974 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -95.16 7.77 45.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.773 175.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.447 ' CZ ' HD12 ' A' ' 172' ' ' LEU . 63.6 t80 -59.77 -36.19 76.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.114 177.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 24.9 m -138.14 142.62 40.12 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.225 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 21.4 ptp -57.79 117.16 3.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.415 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -79.99 105.17 11.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.946 -177.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 C--O 1.252 1.198 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.406 -179.309 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 55.7 ttp . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 120.549 0.214 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -140.58 151.33 44.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.993 0.425 . . . . 0.0 110.805 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.455 ' HA ' ' O ' ' A' ' 188' ' ' HIS . 4.5 mp -75.0 88.5 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.364 177.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.0 p -154.04 143.63 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.381 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -109.23 98.87 33.48 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 173.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.61 -18.71 25.26 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.553 2.169 . . . . 0.0 112.438 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -131.26 76.69 75.66 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.686 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -69.7 159.5 53.22 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.878 2.386 . . . . 0.0 111.271 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 129' ' ' PRO . 27.0 Cg_exo -60.24 105.34 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.772 2.315 . . . . 0.0 112.415 -178.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.93 174.26 5.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.154 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 54.74 47.53 22.25 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.694 0.621 . . . . 0.0 110.976 -178.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.453 HD23 ' OG1' ' A' ' 198' ' ' THR . 55.8 tp -70.34 94.39 0.94 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.002 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.17 130.79 43.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.541 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.0 t -117.38 113.88 43.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.667 178.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -111.94 148.43 33.76 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.18 -178.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.6 p -108.36 95.84 4.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 122.077 0.941 . . . . 0.0 109.92 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -87.36 122.06 30.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.456 -174.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -117.88 98.87 51.95 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.195 -173.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.6 155.39 49.83 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.977 2.451 . . . . 0.0 111.27 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.414 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -93.5 -4.93 50.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.958 0.408 . . . . 0.0 111.145 -176.317 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -132.49 -34.94 1.16 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.728 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -87.37 173.15 9.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.291 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -79.62 138.24 54.75 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.161 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.41 ' HG3' ' O ' ' A' ' 206' ' ' PHE . 38.3 Cg_endo -66.24 147.91 84.1 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.949 2.432 . . . . 0.0 111.847 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -149.09 156.99 43.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.958 0.408 . . . . 0.0 110.979 -174.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 16.3 mt -87.65 142.46 27.82 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.248 0.547 . . . . 0.0 110.602 174.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.495 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 19.5 t90 -117.03 102.1 9.05 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.701 177.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.2 mp -97.94 117.79 43.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -131.48 131.56 43.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.065 0.459 . . . . 0.0 110.897 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 29.0 p90 -123.48 151.92 42.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.897 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.2 m -127.54 78.09 75.18 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.4 -177.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.468 ' CB ' ' HD3' ' A' ' 130' ' ' PRO . 19.0 Cg_exo -61.88 -56.67 0.69 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.091 1.861 . . . . 0.0 113.395 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.52 ' HB2' ' HB ' ' A' ' 133' ' ' ILE . 28.9 Cg_endo -98.08 73.04 0.08 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.466 2.111 . . . . 0.0 112.196 -177.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.8 p -55.93 -53.47 56.42 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -174.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 89.9 mt -113.56 28.78 8.5 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.698 0.761 . . . . 0.0 111.452 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 130' ' ' PRO . 70.7 mt -102.64 -52.97 7.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.221 177.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.9 t70 55.33 29.88 13.8 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.388 0.613 . . . . 0.0 111.133 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.459 ' HB3' ' HA ' ' A' ' 139' ' ' TRP . 2.6 mm? 42.1 46.35 3.67 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.549 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -73.53 -69.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 0.0 111.149 -178.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.4 p -84.21 74.78 10.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.365 0.602 . . . . 0.0 110.979 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 108.43 93.04 2.27 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.704 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.459 ' HA ' ' HB3' ' A' ' 135' ' ' LEU . 29.8 p90 -93.43 145.5 24.45 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.992 0.425 . . . . 0.0 110.624 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -162.84 148.85 12.31 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.553 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.12 105.46 17.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.607 0.718 . . . . 0.0 110.938 178.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 13.5 tp -83.56 136.73 34.14 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.414 -177.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.489 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 4.1 mp -92.76 135.54 34.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.871 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.483 ' CE1' ' HB3' ' A' ' 184' ' ' CYS . 82.5 m-85 -122.61 144.42 49.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.17 -176.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -125.66 138.14 53.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.315 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.447 ' HA ' ' O ' ' A' ' 181' ' ' GLN . 4.4 mp -118.56 122.02 68.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.924 0.392 . . . . 0.0 110.148 -177.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.417 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 23.1 ttp180 -107.1 123.86 48.84 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.564 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.7 pp -143.18 162.09 36.52 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.161 -176.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -168.35 148.8 4.35 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.91 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -71.08 161.11 47.08 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.306 2.004 . . . . 0.0 111.067 170.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -63.35 -19.94 65.07 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.247 -175.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -97.02 10.37 39.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.0 0.428 . . . . 0.0 110.9 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -98.55 131.01 45.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.641 178.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -86.23 -37.13 18.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.206 0.527 . . . . 0.0 110.469 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -98.23 159.29 15.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.912 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.417 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 69.9 m95 -96.88 146.03 25.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.078 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -105.39 111.82 24.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.007 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.48 130.08 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.082 0.468 . . . . 0.0 110.959 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -126.46 133.64 51.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.791 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -102.78 130.09 49.64 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -94.11 -29.96 14.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.859 0.362 . . . . 0.0 111.4 -177.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 143' ' ' LEU . . . 100.33 -133.28 11.24 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.149 -176.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -106.81 31.6 5.18 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.34 0.591 . . . . 0.0 110.96 -177.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -115.69 151.97 34.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.385 177.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 34.9 p -102.17 21.81 14.27 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -175.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -147.74 138.83 23.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.109 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -129.51 150.22 50.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.892 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.495 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 42.9 mmtm -112.78 146.0 39.58 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 32.6 mm -125.04 132.62 71.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 173.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.75 -16.94 14.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.915 0.388 . . . . 0.0 110.969 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 8.7 t -96.33 69.95 2.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.828 0.347 . . . . 0.0 111.451 -173.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.546 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.1 mm? -115.98 159.8 21.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.815 0.34 . . . . 0.0 110.603 176.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 57.7 m-70 -126.52 136.36 28.56 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.548 178.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 24.6 Cg_exo -62.29 122.25 10.6 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.745 2.297 . . . . 0.0 111.986 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 83.98 38.34 10.42 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.81 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -133.38 144.43 49.57 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -101.83 132.66 47.46 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.635 177.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -120.66 142.64 49.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.63 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.1 mm? -103.85 127.39 51.35 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 174.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.2 m -122.36 141.46 42.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.182 0.515 . . . . 0.0 111.55 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 99.1 mt-30 -140.65 142.73 34.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.337 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.2 p -138.57 139.42 41.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -145.97 142.82 29.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.483 ' HB3' ' CE1' ' A' ' 144' ' ' TYR . 23.5 p -108.14 163.4 13.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.98 -175.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.456 ' HB3' ' CD1' ' A' ' 191' ' ' TRP . 18.0 ptmt -147.61 87.83 5.84 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.38 0.609 . . . . 0.0 111.516 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -85.38 -162.59 0.16 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.925 2.416 . . . . 0.0 111.895 176.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -77.73 -21.21 52.2 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.168 0.508 . . . . 0.0 110.187 176.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.455 ' O ' ' HA ' ' A' ' 100' ' ' ILE . 38.7 m170 -74.89 -29.26 60.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.823 -177.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -163.8 163.54 35.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.026 -1.083 . . . . 0.0 113.101 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -136.07 -176.87 4.46 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . 0.456 ' CD1' ' HB3' ' A' ' 185' ' ' LYS . 42.4 p-90 -151.07 147.57 27.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.048 0.451 . . . . 0.0 111.441 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 22.9 t -121.35 -3.05 9.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.039 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -149.85 172.37 15.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.969 -176.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.407 ' CZ2' ' HB2' ' A' ' 147' ' ' ARG . 61.0 m95 -110.82 163.46 13.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.678 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.455 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 18.2 m -140.5 -55.75 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -176.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.536 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 8.4 Cg_endo -87.64 88.71 0.58 Allowed 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.312 2.008 . . . . 0.0 113.273 -171.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . 0.452 ' HB3' ' NE2' ' A' ' 181' ' ' GLN . . . -85.78 106.76 17.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.908 0.385 . . . . 0.0 110.47 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.453 ' OG1' HD23 ' A' ' 109' ' ' LEU . 17.4 m -92.33 136.32 33.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.814 -177.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -95.36 124.15 39.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.742 -177.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.2 tp -127.45 129.43 70.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.234 0.54 . . . . 0.0 110.464 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -101.11 132.79 46.4 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.409 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 36.5 mm -94.08 115.48 65.24 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.07 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.41 155.4 47.09 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.998 2.465 . . . . 0.0 112.562 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 18.7 m -70.06 -17.31 63.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.645 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -82.27 1.15 38.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.87 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.546 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 62.4 t80 -57.41 -51.24 70.24 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.109 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 28.7 m -153.46 134.99 14.33 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.807 176.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -116.23 -18.42 10.55 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.093 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -76.84 144.38 39.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.134 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 30.7 t70 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.834 -1.079 . . . . 0.0 110.873 -179.421 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.3 mmm . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.418 ' CE2' ' HB ' ' A' ' 101' ' ' VAL . 19.8 t80 -144.33 144.89 31.67 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.265 -178.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 43.5 mm -64.68 91.32 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.298 175.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.418 ' HB ' ' CE2' ' A' ' 99' ' ' TYR . 8.3 p -152.01 144.7 15.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.284 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.427 ' HG2' ' HD3' ' A' ' 186' ' ' PRO . 26.6 mt-30 -98.05 156.23 36.14 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.83 178.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.18 -42.23 44.69 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.173 1.915 . . . . 0.0 110.581 172.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 132' ' ' LEU . 0.3 OUTLIER -150.18 127.32 5.46 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.432 178.183 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 104' ' ' ASP . 5.3 Cg_exo -77.03 145.8 25.11 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.93 2.42 . . . . 0.0 111.908 174.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.11 144.84 43.08 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.704 2.269 . . . . 0.0 111.814 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.488 ' N ' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -134.91 -178.32 5.03 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -176.454 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 56.11 58.75 4.12 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.615 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.468 HD21 ' OG1' ' A' ' 198' ' ' THR . 33.9 tp -75.57 95.81 3.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.261 0.553 . . . . 0.0 109.735 175.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.72 128.83 40.13 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.01 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.9 t -125.7 122.09 61.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.04 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -139.21 155.35 47.86 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.176 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.477 HG21 ' CD1' ' A' ' 123' ' ' LEU . 21.8 t -100.18 94.21 3.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-O 121.375 0.607 . . . . 0.0 109.636 -177.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.44 ' O ' ' HD3' ' A' ' 116' ' ' PRO . 0.8 OUTLIER -78.86 108.14 12.09 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.794 -176.723 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -106.43 98.98 21.81 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.921 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 114' ' ' LYS . 14.6 Cg_exo -69.88 163.82 36.93 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.817 2.344 . . . . 0.0 112.881 -177.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -101.4 19.75 17.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.206 177.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -147.39 -55.25 0.23 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.673 -176.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -93.12 168.59 11.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.795 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.62 143.77 96.3 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.344 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.98 135.19 46.53 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.821 2.347 . . . . 0.0 112.024 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -139.44 160.49 39.71 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.047 0.451 . . . . 0.0 110.991 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.477 ' CD1' HG21 ' A' ' 113' ' ' VAL . 37.2 tp -91.12 123.76 34.82 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 176.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.511 ' CZ2' ' HD2' ' A' ' 126' ' ' LYS . 10.5 t90 -103.0 103.25 13.33 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.2 0.524 . . . . 0.0 110.49 -174.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.0 mp -95.73 113.61 30.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.081 178.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.511 ' HD2' ' CZ2' ' A' ' 124' ' ' TRP . 58.6 tttp -129.61 119.54 23.76 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.352 0.596 . . . . 0.0 110.656 -176.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' TRP . . . . . 0.42 ' CD2' HG23 ' A' ' 182' ' ' VAL . 29.2 p90 -109.76 163.61 13.35 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.752 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.1 t -103.25 122.81 43.93 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -49.71 137.53 33.98 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.334 2.689 . . . . 0.0 112.202 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.402 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 39.0 Cg_exo -57.59 152.12 50.2 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.006 2.471 . . . . 0.0 112.735 -178.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.6 m -54.16 -66.82 0.33 Allowed 'General case' 0 C--O 1.236 0.369 0 O-C-N 123.343 0.402 . . . . 0.0 111.669 -176.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 104' ' ' ASP . 99.6 mt -112.69 101.51 9.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.297 0.57 . . . . 0.0 111.3 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.4 mt -96.49 87.01 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.748 0.785 . . . . 0.0 109.153 175.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -69.22 84.65 0.37 Allowed 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.419 175.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 140' ' ' PHE . 1.6 pt? -129.55 153.14 48.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.8 177.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -72.5 113.2 9.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.09 0.471 . . . . 0.0 110.451 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 24.7 p -75.38 133.42 41.19 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.564 -175.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.29 -17.3 52.64 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.219 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -96.57 -47.49 5.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.686 0.243 . . . . 0.0 110.402 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.48 ' CZ ' ' HB2' ' A' ' 135' ' ' LEU . 22.2 p90 -151.73 162.42 41.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.786 0.327 . . . . 0.0 110.498 178.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.9 m -122.86 151.6 41.56 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.01 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.3 tp -79.42 110.63 14.9 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.2 mt -101.29 150.39 23.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.297 -177.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.579 ' CD2' ' HB3' ' A' ' 184' ' ' CYS . 49.7 m-85 -116.54 143.98 44.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.178 -176.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -121.48 141.93 50.54 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.513 HD11 ' N ' ' A' ' 146' ' ' ILE . 4.1 mp -117.95 124.94 73.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.024 0.44 . . . . 0.0 110.734 -175.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.437 ' HB2' ' CH2' ' A' ' 194' ' ' TRP . 14.3 ttp180 -109.01 120.32 42.2 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.062 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -145.69 161.49 39.75 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.471 -175.611 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -172.69 147.29 1.62 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.72 175.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -70.9 164.73 34.64 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.093 1.862 . . . . 0.0 111.067 170.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -64.29 -23.96 67.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.608 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.512 ' HE2' ' OE1' ' A' ' 176' ' ' GLN . 67.8 mmtt -81.7 -13.66 57.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.21 0.528 . . . . 0.0 110.512 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -83.97 129.61 34.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.746 -178.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -88.22 -26.39 22.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.409 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -107.12 144.66 33.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.791 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' TRP . . . . . 0.421 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 77.1 m95 -85.22 134.56 34.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.261 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -93.37 131.22 38.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.685 177.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.38 122.44 65.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.038 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.557 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 46.3 m-70 -130.57 113.45 14.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.202 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -79.09 132.71 36.68 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.988 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.409 ' HB1' ' CD1' ' A' ' 146' ' ' ILE . . . -99.12 -49.49 4.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 111.804 -177.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 111.87 -137.75 14.49 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.02 13.58 22.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.066 0.46 . . . . 0.0 111.005 -177.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -68.75 -23.01 64.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.492 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 42.0 p 63.16 15.71 8.77 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.382 -1.281 . . . . 0.0 113.051 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -153.2 136.88 16.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 171.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.557 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 24.7 t80 -125.74 151.33 46.81 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.692 0.282 . . . . 0.0 110.525 -176.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.58 ' HD2' ' N ' ' A' ' 168' ' ' LYS . 0.0 OUTLIER -125.53 115.51 20.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.466 -175.087 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 34.5 mm -93.39 137.92 21.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -100.37 -32.53 10.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.851 0.358 . . . . 0.0 111.118 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 18.7 m -87.55 80.93 7.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.814 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.6 mm? -113.6 137.43 51.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 110.712 176.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 53.5 m-70 -100.05 125.93 38.31 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.18 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 22.9 Cg_exo -63.52 125.05 14.78 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.566 2.177 . . . . 0.0 112.448 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 86.6 26.93 31.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.409 178.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.512 ' OE1' ' HE2' ' A' ' 152' ' ' LYS . 77.4 mm-40 -125.18 152.47 44.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.294 0.568 . . . . 0.0 111.658 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -91.08 129.69 37.05 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.32 176.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -117.58 137.74 52.4 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.43 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.5 mm? -102.31 128.74 48.74 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 175.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.7 m -128.92 139.74 51.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 120.951 0.405 . . . . 0.0 111.33 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 98.9 mt-30 -139.19 136.58 35.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.355 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.42 HG23 ' CD2' ' A' ' 127' ' ' TRP . 13.5 p -120.05 137.42 53.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.99 0.424 . . . . 0.0 110.334 174.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -138.62 157.06 46.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.349 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.579 ' HB3' ' CD2' ' A' ' 144' ' ' TYR . 24.3 p -136.34 174.75 10.27 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.31 132.86 3.11 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.17 0.509 . . . . 0.0 111.953 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.427 ' HD3' ' HG2' ' A' ' 102' ' ' GLN . 93.9 Cg_endo -86.33 -163.35 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.216 2.61 . . . . 0.0 110.493 168.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -91.24 -31.58 16.09 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.485 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -62.72 -39.27 93.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.318 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -118.16 102.92 1.0 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.494 -178.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -80.39 107.07 12.88 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 3.1 p-90 -67.4 158.8 30.86 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.068 -174.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 15.8 m -153.98 16.5 0.49 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.432 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -152.01 162.15 41.54 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.295 0.569 . . . . 0.0 112.499 -172.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' TRP . . . . . 0.437 ' CH2' ' HB2' ' A' ' 147' ' ' ARG . 72.2 m95 -120.22 173.05 7.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.946 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.514 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 54.0 m -152.28 -63.77 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 97.5 Cg_endo -74.88 80.49 2.38 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 121.954 1.77 . . . . 0.0 113.952 -168.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -78.65 100.61 7.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.169 0.509 . . . . 0.0 110.312 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' THR . . . . . 0.468 ' OG1' HD21 ' A' ' 109' ' ' LEU . 20.0 m -94.17 138.9 31.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.713 -176.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -100.83 116.06 31.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.622 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.0 tp -123.73 137.49 56.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.061 0.458 . . . . 0.0 110.485 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -104.75 128.71 52.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.236 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 47.2 mm -87.09 124.39 68.66 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.86 151.47 80.81 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.049 2.499 . . . . 0.0 112.382 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 37.8 m -68.57 -30.12 68.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.757 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -92.56 39.8 1.04 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.681 0.753 . . . . 0.0 109.809 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 80.3 t80 -74.89 -35.19 62.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.863 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 12.8 t -73.89 152.49 40.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.514 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -70.26 129.86 40.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.36 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -95.53 -4.1 45.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.373 0.606 . . . . 0.0 111.143 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 . . . . . 0 C--O 1.248 0.994 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.078 179.431 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.652 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 37.7 Cg_endo . . . . . 0 N--CA 1.461 -0.384 0 CA-C-O 121.568 0.57 . . . . 0.0 111.349 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.17 178.91 6.24 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.2 -175.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 57.34 49.09 13.72 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.665 -175.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.68 96.28 0.54 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.69 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.33 125.11 39.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.543 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.428 HG12 HD11 ' A' ' 123' ' ' LEU . 5.2 t -120.38 120.44 62.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.662 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -127.77 142.88 51.19 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.3 p -97.99 117.14 42.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.118 0.485 . . . . 0.0 109.839 176.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -107.16 128.09 54.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.584 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -120.68 89.28 44.7 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.494 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -72.93 152.15 51.55 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 123.196 2.597 . . . . 0.0 111.989 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -73.81 -33.78 64.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.075 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -104.52 -49.3 3.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.473 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -76.4 167.02 22.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.772 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -75.16 143.28 76.83 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.588 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.6 138.13 63.01 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.596 2.198 . . . . 0.0 111.251 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -145.17 160.23 41.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.015 0.436 . . . . 0.0 111.232 -173.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.546 ' HB2' HD11 ' A' ' 172' ' ' LEU . 29.5 tp -93.98 121.88 35.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -102.82 104.42 14.7 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.034 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.2 mp -98.58 121.37 49.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.88 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -134.27 144.13 48.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.425 0.631 . . . . 0.0 110.476 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' TRP . . . . . 0.429 ' CH2' HD11 ' A' ' 146' ' ' ILE . 22.9 p90 -132.56 164.13 27.32 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.766 -173.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 52.3 m -97.44 131.36 27.37 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 C--O 1.235 0.343 0 C-N-CA 122.458 2.106 . . . . 0.0 111.504 177.583 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.448 HD21 ' SG ' ' A' ' 184' ' ' CYS . 32.9 tp . . . . . 0 N--CA 1.445 -0.684 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 43.5 mt -92.31 144.69 25.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.913 0.387 . . . . 0.0 110.576 -177.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.492 ' CD1' ' HB3' ' A' ' 184' ' ' CYS . 46.2 m-85 -115.45 146.0 42.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.942 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 36.2 tt0 -126.3 133.87 51.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.604 176.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 181' ' ' GLN . 4.6 mp -118.64 125.65 74.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.309 -176.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -113.16 137.18 51.85 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -148.38 159.9 43.56 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.702 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -170.17 145.53 2.35 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.453 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.465 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 37.4 Cg_endo -70.38 175.16 9.0 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.196 1.931 . . . . 0.0 112.537 173.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -62.16 -43.37 98.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -86.07 17.06 3.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.136 0.493 . . . . 0.0 111.298 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.465 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -94.11 121.97 36.15 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.056 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.09 -22.68 33.37 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.894 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -121.01 156.04 33.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.91 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -90.92 140.61 29.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.36 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -104.41 107.35 18.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.836 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.03 129.57 39.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.124 0.487 . . . . 0.0 110.576 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 66.6 m-70 -128.2 114.11 16.55 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.961 175.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -83.43 115.89 22.25 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.59 -44.42 19.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.767 0.317 . . . . 0.0 111.053 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 143' ' ' LEU . . . 102.93 -127.96 9.38 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.313 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -86.23 -19.74 29.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.983 0.42 . . . . 0.0 111.018 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -75.0 146.29 41.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.202 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.5 p -104.98 30.02 5.87 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.206 0.527 . . . . 0.0 111.658 -174.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -157.16 142.4 17.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.603 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 34.3 t80 -136.52 150.7 48.79 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 0.0 OUTLIER -122.8 136.65 54.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.766 0.317 . . . . 0.0 110.669 -177.404 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 29.0 mm -109.92 128.52 65.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 175.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.55 -34.97 9.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.025 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.0 m -80.15 82.81 6.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.836 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 123' ' ' LEU . 73.7 mt -125.87 147.56 49.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.224 0.535 . . . . 0.0 111.687 -176.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -105.25 119.09 54.16 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.11 176.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.39 126.3 20.39 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.858 2.372 . . . . 0.0 112.66 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.55 45.41 7.94 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.628 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -146.98 149.05 32.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.96 0.41 . . . . 0.0 111.15 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -80.82 134.24 35.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.948 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -123.47 142.66 50.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.616 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.8 mm? -106.9 132.54 52.73 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 175.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.409 HG23 ' HB ' ' A' ' 198' ' ' THR . 27.1 m -132.28 141.98 43.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.028 0.442 . . . . 0.0 111.521 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.638 ' OE1' ' HB3' ' A' ' 194' ' ' TRP . 36.9 mt-30 -143.77 139.37 29.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.526 175.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 145' ' ' GLU . 7.1 p -133.36 139.06 49.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 174.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 37.1 ttt-85 -146.76 147.11 30.59 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.8 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' CYS . . . . . 0.652 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 21.9 p -109.57 169.39 8.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.328 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.261 0.553 . . . . 0.0 111.502 -177.398 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.638 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 81.9 m95 . . . . . 0 C--O 1.233 0.23 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.473 ' H ' ' HD2' ' A' ' 196' ' ' PRO . 48.1 t -171.43 -54.96 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -176.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.473 ' HD2' ' H ' ' A' ' 195' ' ' SER . 77.8 Cg_endo -75.52 69.92 5.79 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.114 1.876 . . . . 0.0 113.669 -174.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.45 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -74.48 105.85 5.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.872 0.368 . . . . 0.0 110.879 178.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.409 ' HB ' HG23 ' A' ' 180' ' ' VAL . 27.6 m -98.0 132.34 43.64 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.565 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -96.3 120.33 36.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.317 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.1 tp -126.91 131.84 70.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.207 0.527 . . . . 0.0 110.473 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -95.41 119.91 34.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.621 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.9 mm -79.98 117.99 70.21 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 172.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.91 149.59 91.03 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.529 2.153 . . . . 0.0 112.158 -176.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 39.1 m -69.92 -17.46 63.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.341 0.591 . . . . 0.0 109.639 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.87 9.58 7.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.529 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -57.76 -46.17 84.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.167 0.508 . . . . 0.0 110.359 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.445 -0.723 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.617 174.482 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.539 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 7.9 Cg_endo . . . . . 0 C--O 1.235 0.354 0 CA-C-O 121.22 0.425 . . . . 0.0 111.906 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.41 ' H ' HD23 ' A' ' 107' ' ' LEU . 1.1 pt? -122.27 178.57 4.89 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.78 -176.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 56.51 47.34 18.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.071 0.462 . . . . 0.0 111.126 178.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.2 tp -74.05 95.94 2.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.035 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -102.65 125.36 49.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.346 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.438 HG21 HG21 ' A' ' 180' ' ' VAL . 8.1 t -110.39 118.86 58.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.904 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -128.62 145.97 50.99 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.134 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.0 p -101.9 117.71 47.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.296 0.57 . . . . 0.0 110.343 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -98.1 129.88 44.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.246 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -120.08 86.44 37.23 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.101 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.484 ' HG2' ' HG3' ' A' ' 119' ' ' ARG . 6.4 Cg_exo -76.04 164.47 31.41 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.432 2.755 . . . . 0.0 112.606 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -91.4 -36.45 13.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.384 -176.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -94.73 -51.79 4.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.712 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.484 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 10.5 ptm180 -90.77 162.52 14.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.289 177.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -79.71 152.04 74.65 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.387 -174.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.405 ' HG3' ' O ' ' A' ' 206' ' ' PHE . 28.9 Cg_endo -60.37 151.26 75.66 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.369 2.713 . . . . 0.0 113.188 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.449 ' CE2' ' HD2' ' A' ' 168' ' ' LYS . 35.7 p90 -161.58 158.67 26.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.711 -174.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 8.3 mt -82.93 139.7 33.23 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.214 173.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.56 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 10.2 t90 -118.06 94.31 4.46 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.14 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.406 ' H ' HD12 ' A' ' 125' ' ' ILE . 4.6 mp -88.81 119.35 35.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.648 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.487 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 9.9 mtmp? -122.84 141.31 52.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.045 0.45 . . . . 0.0 110.985 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 40.2 p90 -138.45 152.06 47.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.04 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.2 t -89.09 126.16 59.89 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo . . . . . 0 C--N 1.346 0.438 0 C-N-CA 123.374 2.716 . . . . 0.0 112.803 -178.949 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 N--CA 1.454 -0.254 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -98.88 145.58 26.85 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.901 0.382 . . . . 0.0 110.334 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -102.43 148.73 25.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.567 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -132.57 133.55 43.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.832 -168.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.414 HD11 ' HB2' ' A' ' 161' ' ' ALA . 4.5 mp -126.85 120.42 55.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.877 0.37 . . . . 0.0 110.753 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.62 ' HB2' ' CZ2' ' A' ' 194' ' ' TRP . 5.4 ttp-105 -104.22 120.13 40.48 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.572 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.2 pp -143.3 159.34 42.52 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.937 0.399 . . . . 0.0 111.719 -175.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -169.54 148.33 3.35 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.305 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.472 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 35.0 Cg_endo -71.16 166.9 27.74 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.247 1.965 . . . . 0.0 112.187 172.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.514 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 11.1 pt-20 -57.98 -41.15 82.37 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.514 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 95.0 mttt -85.25 16.84 3.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.904 0.383 . . . . 0.0 111.595 -176.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.472 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -101.15 128.17 47.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.59 176.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -85.53 -34.11 21.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.269 0.557 . . . . 0.0 110.333 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -103.12 147.49 26.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.705 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.482 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 76.3 m95 -90.7 148.6 22.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.5 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -107.42 114.14 27.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.719 174.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.1 mp -91.29 112.05 24.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -106.79 148.64 28.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.253 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -109.48 123.23 49.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.62 -174.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.414 ' HB2' HD11 ' A' ' 146' ' ' ILE . . . -79.24 -51.63 9.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.615 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 82.04 79.98 0.95 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.651 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 72.6 -46.18 0.64 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.078 0.951 . . . . 0.0 112.595 175.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -66.5 148.28 52.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.003 0.43 . . . . 0.0 110.81 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 56.9 p -104.14 36.41 2.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.35 0.595 . . . . 0.0 111.308 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -157.77 140.36 14.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.186 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -131.88 149.72 52.36 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.56 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 42.1 mmtm -116.6 143.85 45.1 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 123' ' ' LEU . 29.8 mm -123.76 122.29 64.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 175.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.408 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.7 mm? -94.81 -32.82 13.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.311 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.6 m -77.96 83.81 4.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.838 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 86.9 mt -133.03 145.63 50.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.784 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -102.49 122.13 47.45 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.283 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.65 112.93 1.41 Allowed 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.468 2.112 . . . . 0.0 111.682 175.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 89.27 44.76 4.92 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.658 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -141.29 147.41 38.15 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.763 0.316 . . . . 0.0 110.17 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -91.55 137.82 32.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.469 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -125.19 140.49 52.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.023 0.44 . . . . 0.0 110.498 176.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.4 mp -104.64 132.1 51.29 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.438 HG21 HG21 ' A' ' 111' ' ' VAL . 34.5 m -135.62 147.23 28.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.948 0.404 . . . . 0.0 111.699 -175.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.591 ' HG2' ' HA ' ' A' ' 197' ' ' ALA . 53.6 mt-30 -143.46 153.28 42.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.392 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.9 p -124.67 140.44 47.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.113 0.482 . . . . 0.0 111.012 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.624 ' HG3' ' CE3' ' A' ' 194' ' ' TRP . 26.2 mtp-105 -133.34 163.99 28.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.912 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' CYS . . . . . 0.539 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 31.5 p -140.7 125.72 18.38 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 167.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.449 ' HD3' HH12 ' A' ' 183' ' ' ARG . 23.4 pttm . . . . . 0 C--N 1.318 -0.781 0 CA-C-O 121.328 0.585 . . . . 0.0 110.984 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.624 ' CE3' ' HG3' ' A' ' 183' ' ' ARG . 69.0 m95 . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 120.726 0.298 . . . . 0.0 111.624 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.47 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 42.0 m -159.64 -57.58 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -176.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.487 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 9.2 Cg_endo -90.03 91.9 0.31 Allowed 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.539 2.159 . . . . 0.0 113.595 -170.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.591 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -79.48 116.55 19.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.023 0.44 . . . . 0.0 111.0 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 27.0 m -109.48 140.96 42.6 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.812 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -115.61 127.82 55.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.731 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.9 tp -125.45 135.52 63.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.033 0.444 . . . . 0.0 111.141 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -96.67 118.9 34.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.404 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.401 HD11 HD11 ' A' ' 123' ' ' LEU . 50.8 mm -84.21 119.88 73.82 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.44 151.1 86.56 Favored 'Trans proline' 0 N--CA 1.466 -0.147 0 C-N-CA 122.558 2.172 . . . . 0.0 112.251 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 19.2 m -69.94 -20.4 63.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.047 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -88.2 26.82 1.32 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.775 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.405 ' O ' ' HG3' ' A' ' 121' ' ' PRO . 85.7 t80 -66.18 -43.98 85.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.635 176.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 28.8 m . . . . . 0 C--N 1.319 -0.723 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.922 178.602 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.685 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 39.4 Cg_endo . . . . . 0 N--CA 1.461 -0.414 0 CA-C-O 121.545 0.56 . . . . 0.0 111.44 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.683 ' H ' HD23 ' A' ' 107' ' ' LEU . 2.7 pt? -90.41 175.01 7.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.675 -177.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 53.38 51.96 14.39 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 123.556 0.535 . . . . 0.0 110.888 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 57.0 tp -78.84 96.37 5.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.148 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.83 128.71 45.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.387 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.448 HG21 HG21 ' A' ' 180' ' ' VAL . 2.4 t -116.62 115.74 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -125.0 130.18 51.83 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.965 0.412 . . . . 0.0 110.786 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.5 p -77.52 117.42 22.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.2 0.524 . . . . 0.0 109.874 176.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -102.23 122.38 44.09 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.282 0.563 . . . . 0.0 111.388 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -124.91 75.82 66.31 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.753 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.47 ' HG2' ' HB2' ' A' ' 119' ' ' ARG . 6.7 Cg_exo -76.03 -179.06 4.84 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 123.38 2.72 . . . . 0.0 112.782 -175.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -89.76 -64.21 1.17 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -71.96 -36.83 69.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.442 -177.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.47 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 56.9 mtt85 -88.01 156.35 19.36 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.592 -178.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.417 ' O ' ' HD1' ' A' ' 122' ' ' TYR . 50.6 mtmt -75.35 153.56 85.98 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.04 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.25 133.76 39.26 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.329 2.019 . . . . 0.0 111.503 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.417 ' HD1' ' O ' ' A' ' 120' ' ' LYS . 55.1 p90 -151.12 166.23 31.44 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.432 -176.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.437 ' HB3' ' HB ' ' A' ' 169' ' ' ILE . 38.9 tp -95.98 123.21 39.48 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 176.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.432 ' HE1' ' HB2' ' A' ' 166' ' ' GLU . 17.5 t90 -103.24 106.68 17.25 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.221 -176.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.4 mp -106.28 118.36 53.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.708 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -131.54 141.45 49.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.48 0.657 . . . . 0.0 111.24 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' TRP . . . . . 0.492 ' CH2' HD11 ' A' ' 146' ' ' ILE . 28.7 p90 -129.07 155.44 45.44 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.439 -176.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 22.6 t -83.36 130.53 56.17 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 128' ' ' SER . 50.4 Cg_exo . . . . . 0 C--N 1.346 0.432 0 C-N-CA 123.045 2.497 . . . . 0.0 112.492 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.596 HD11 ' H ' ' A' ' 185' ' ' LYS . 42.2 tp . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 120.967 0.413 . . . . 0.0 110.463 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.6 mp -106.18 144.8 32.37 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.557 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -113.61 165.31 12.64 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.151 -176.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.467 ' HB3' ' NE ' ' A' ' 183' ' ' ARG . 40.3 tt0 -154.07 139.37 17.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.527 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.531 ' CD1' ' HB2' ' A' ' 161' ' ' ALA . 4.3 mp -121.92 130.19 74.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.042 0.449 . . . . 0.0 110.968 -172.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.476 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 27.8 ttp180 -108.18 121.15 44.26 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 1.7 pp -146.98 166.0 28.13 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.9 0.381 . . . . 0.0 111.413 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -172.45 149.89 2.13 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.751 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.35 162.45 42.34 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.34 2.026 . . . . 0.0 111.153 172.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -67.31 -14.53 63.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.546 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -93.93 2.97 56.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.289 0.566 . . . . 0.0 110.06 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -102.76 130.93 49.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.272 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -88.22 -35.85 17.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.24 0.543 . . . . 0.0 110.315 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -95.84 150.44 20.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.333 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.476 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 84.3 m95 -85.91 148.02 25.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.238 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -115.82 119.23 35.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.947 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.0 mp -99.05 131.68 45.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.103 0.478 . . . . 0.0 110.847 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -125.54 126.41 44.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.976 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -83.28 124.79 30.93 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.531 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -82.3 -36.43 27.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.895 0.379 . . . . 0.0 111.286 -176.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 88.34 -136.97 14.08 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.487 -0.863 . . . . 0.0 110.965 -175.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -99.85 70.99 1.65 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.088 0.47 . . . . 0.0 110.353 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -160.24 147.17 15.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.821 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.2 p -102.43 13.62 34.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.35 0.595 . . . . 0.0 111.074 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.432 ' HB2' ' HE1' ' A' ' 124' ' ' TRP . 1.0 OUTLIER -140.08 113.41 8.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.89 175.929 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -109.03 152.08 25.48 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.519 -173.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 168' ' ' LYS . 10.4 mptt -123.23 129.11 50.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.276 -176.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.437 ' HB ' ' HB3' ' A' ' 123' ' ' LEU . 28.9 mm -108.54 137.58 39.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 175.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.77 -23.18 12.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.997 0.427 . . . . 0.0 110.58 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 7.0 m -87.17 67.5 9.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.78 -175.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.01 140.43 39.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.968 0.413 . . . . 0.0 110.887 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 32.5 m-70 -103.74 115.81 62.86 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.474 173.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 35.8 Cg_exo -59.02 126.09 20.06 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.822 2.348 . . . . 0.0 112.878 -177.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 88.86 29.45 18.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.752 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -133.95 145.51 49.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.095 0.474 . . . . 0.0 110.734 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -82.44 132.05 35.21 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.441 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -114.71 136.7 52.78 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.872 0.368 . . . . 0.0 110.532 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.9 mm? -101.36 129.26 47.32 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 174.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.448 HG21 HG21 ' A' ' 111' ' ' VAL . 35.8 m -125.24 141.7 44.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.176 0.512 . . . . 0.0 111.655 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 94.4 mt-30 -144.59 134.06 23.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.959 177.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 6.5 p -117.71 135.73 57.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.467 ' NE ' ' HB3' ' A' ' 145' ' ' GLU . 7.8 ppt_? -116.12 155.73 27.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.83 0.348 . . . . 0.0 110.731 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' CYS . . . . . 0.685 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 26.4 p -136.77 175.26 9.78 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.794 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.596 ' H ' HD11 ' A' ' 142' ' ' LEU . 37.1 mtmt . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.337 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.404 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 29.9 m95 . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.516 0.198 . . . . 0.0 110.56 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.495 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 36.4 t -116.0 -59.67 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 195' ' ' SER . 95.4 Cg_endo -76.8 87.37 1.48 Allowed 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.857 1.705 . . . . 0.0 113.397 -173.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.61 101.75 5.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.101 0.477 . . . . 0.0 109.927 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 18.6 m -91.03 131.26 36.73 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.917 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -94.33 132.46 38.91 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.458 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.653 HG12 ' N ' ' A' ' 201' ' ' GLN . 0.0 OUTLIER -147.49 150.24 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.367 0.603 . . . . 0.0 111.297 174.67 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.653 ' N ' HG12 ' A' ' 200' ' ' ILE . 7.6 mm-40 -91.81 136.01 33.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.741 176.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 49.0 mm -100.89 114.75 65.83 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 165.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.64 148.95 79.51 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.905 2.403 . . . . 0.0 112.555 -175.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 17.1 m -69.79 -23.98 63.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.856 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -92.21 32.92 1.11 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.202 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -65.93 -32.44 73.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.135 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 C--N 1.321 -0.637 0 CA-C-O 121.119 0.485 . . . . 0.0 110.662 -178.829 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.486 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 7.1 Cg_endo . . . . . 0 C--O 1.233 0.24 0 CA-C-O 121.18 0.409 . . . . 0.0 111.692 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.517 ' H ' HD23 ' A' ' 107' ' ' LEU . 2.7 pt? -73.15 163.02 28.74 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.384 -173.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 60.61 54.46 3.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.382 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -75.58 93.92 3.1 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -97.21 131.46 43.92 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.407 -176.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.467 HG12 HD22 ' A' ' 123' ' ' LEU . 2.6 t -120.57 114.39 43.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -129.39 140.36 51.37 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.367 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.9 p -87.16 115.56 28.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.413 0.625 . . . . 0.0 109.351 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.515 ' O ' ' HD3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -102.06 113.2 26.24 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.4 -174.843 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -105.49 98.89 18.4 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.316 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 114' ' ' LYS . 5.5 Cg_exo -80.79 146.08 16.36 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.295 2.663 . . . . 0.0 112.092 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.0 -23.99 58.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.831 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -118.15 3.27 12.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.774 0.321 . . . . 0.0 111.376 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -137.86 151.64 48.26 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' A' ' 120' ' ' LYS . 12.7 mptt -63.42 139.04 97.52 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.236 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.18 145.12 98.78 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.476 2.784 . . . . 0.0 112.752 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.524 ' CE1' ' HD2' ' A' ' 168' ' ' LYS . 35.4 p90 -149.28 155.04 39.93 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.26 -176.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 9.3 mt -80.43 127.41 32.38 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 173.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.569 ' CZ2' ' HD2' ' A' ' 126' ' ' LYS . 14.4 t90 -101.69 102.18 12.8 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.789 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.5 mp -93.62 114.27 29.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.569 ' HD2' ' CZ2' ' A' ' 124' ' ' TRP . 64.1 tttm -127.84 126.56 41.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.568 -175.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 39.9 p90 -126.04 158.98 33.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.338 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.451 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 37.7 m -99.61 131.74 24.26 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.195 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.567 ' HG3' HG21 ' A' ' 165' ' ' THR . 33.5 Cg_exo . . . . . 0 C--O 1.233 0.267 0 C-N-CA 122.664 2.243 . . . . 0.0 111.725 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.524 HD21 ' SG ' ' A' ' 184' ' ' CYS . 56.7 tp . . . . . 0 C--O 1.233 0.189 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -93.88 152.7 18.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.035 0.445 . . . . 0.0 111.141 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.596 ' CD1' ' HB3' ' A' ' 184' ' ' CYS . 63.7 m-85 -129.78 149.84 51.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.012 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -128.73 139.7 52.09 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.404 HD11 ' HB2' ' A' ' 161' ' ' ALA . 4.0 mp -113.42 124.34 69.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.847 0.356 . . . . 0.0 110.448 -176.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.514 ' HB2' ' CZ2' ' A' ' 194' ' ' TRP . 16.3 ttp180 -113.76 120.18 39.91 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.414 HD22 ' C ' ' A' ' 148' ' ' LEU . 0.0 OUTLIER -143.42 160.22 40.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.542 0.211 . . . . 0.0 110.786 -177.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -165.23 148.65 7.21 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.241 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 178' ' ' TYR . 56.9 Cg_endo -73.47 169.37 22.47 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.57 2.18 . . . . 0.0 111.946 172.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -68.9 -11.54 60.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.667 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -93.76 -1.57 54.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.289 0.566 . . . . 0.0 110.004 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -100.19 122.6 43.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.771 -173.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -84.45 -28.38 26.87 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.562 0.696 . . . . 0.0 109.437 173.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -106.85 146.32 31.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.173 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.476 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 80.0 m95 -86.69 155.22 20.47 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.08 0.466 . . . . 0.0 111.582 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -111.62 127.39 55.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.74 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.87 126.99 67.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.164 0.507 . . . . 0.0 111.222 -176.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -125.26 137.98 54.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -96.57 138.21 34.49 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.404 ' HB2' HD11 ' A' ' 146' ' ' ILE . . . -77.4 -23.16 50.73 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.514 -177.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 83.86 -46.06 3.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.994 177.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -179.52 -33.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.128 0.489 . . . . 0.0 109.895 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -72.28 160.08 32.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.385 -177.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.567 HG21 ' HG3' ' A' ' 129' ' ' PRO . 67.5 p -110.03 30.33 6.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.401 -174.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -153.19 140.6 19.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.711 175.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -135.65 153.25 51.69 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.672 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 22.5 mmtt -118.86 140.98 49.07 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 31.8 mm -114.89 123.79 70.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.691 0.281 . . . . 0.0 110.561 176.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.479 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.8 mm? -95.72 -16.76 21.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.5 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.8 m -80.8 71.15 7.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.709 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 59.4 mt -129.63 137.22 50.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.98 0.419 . . . . 0.0 111.34 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -111.7 125.19 30.8 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.263 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.84 122.52 11.35 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.742 2.295 . . . . 0.0 112.46 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 95.43 22.26 22.34 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.749 177.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -131.24 148.73 52.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.935 0.398 . . . . 0.0 110.895 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -90.26 134.18 34.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.116 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 150' ' ' PRO . 12.1 m-85 -119.9 149.59 41.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.021 0.438 . . . . 0.0 110.652 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.9 mp -112.49 136.21 52.27 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.3 m -132.6 148.12 31.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.056 0.455 . . . . 0.0 111.372 -177.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 93.2 mt-30 -150.29 144.33 25.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.384 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.459 HG13 ' HG2' ' A' ' 106' ' ' PRO . 12.0 p -138.83 145.01 28.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 171.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -155.53 161.22 40.93 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.223 0.535 . . . . 0.0 110.182 171.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' CYS . . . . . 0.596 ' HB3' ' CD1' ' A' ' 144' ' ' TYR . 5.7 p -116.69 -174.45 2.57 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.077 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.412 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.955 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.514 ' CZ2' ' HB2' ' A' ' 147' ' ' ARG . 61.8 m95 . . . . . 0 C--O 1.236 0.346 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.424 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 50.7 m -156.07 -53.89 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.539 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 1.1 Cg_endo -82.95 81.27 2.44 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.128 1.886 . . . . 0.0 113.057 -173.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.409 ' HA ' ' CG ' ' A' ' 181' ' ' GLN . . . -82.83 103.94 12.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.115 0.484 . . . . 0.0 110.66 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 53.9 m -96.7 138.06 34.83 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.257 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -102.76 130.87 49.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.495 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.2 tp -135.91 137.09 49.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.207 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -102.46 147.05 27.22 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.93 0.395 . . . . 0.0 111.566 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 21.8 mm -96.47 118.16 65.52 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.789 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.51 153.28 72.35 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.968 2.445 . . . . 0.0 112.11 -177.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 28.0 m -70.81 -23.03 62.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.889 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -94.2 34.56 1.25 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.643 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -69.66 -50.97 38.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.838 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 6.4 t . . . . . 0 C--N 1.324 -0.502 0 CA-C-O 121.371 0.605 . . . . 0.0 111.098 -176.869 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.478 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 35.8 Cg_exo . . . . . 0 C--O 1.233 0.263 0 CA-C-O 120.867 0.278 . . . . 0.0 111.672 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.462 HD23 ' H ' ' A' ' 107' ' ' LEU . 1.6 pt? -122.3 -179.45 4.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.427 -172.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 54.78 41.22 32.08 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 123.576 0.548 . . . . 0.0 110.731 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.6 tt -64.53 103.97 0.74 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.792 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -109.74 132.42 54.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.705 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.3 t -114.42 126.35 71.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.84 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -126.52 132.61 51.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.947 0.404 . . . . 0.0 110.615 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.8 p -87.22 126.36 41.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.1 0.476 . . . . 0.0 110.196 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 114' ' ' LYS . 55.1 mmtt -106.68 127.29 53.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.032 0.444 . . . . 0.0 110.957 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -132.94 85.09 47.22 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.158 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.71 168.7 22.99 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.982 2.455 . . . . 0.0 111.5 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.17 -6.24 23.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.859 0.362 . . . . 0.0 111.354 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -132.88 2.62 3.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.481 0.658 . . . . 0.0 110.534 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -136.82 149.14 47.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.531 -176.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -56.97 130.63 79.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 O-C-N 123.513 0.508 . . . . 0.0 111.289 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.27 137.04 63.41 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.573 2.182 . . . . 0.0 111.361 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -140.9 163.89 31.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.468 -175.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.417 ' HB3' ' HB ' ' A' ' 169' ' ' ILE . 28.0 tp -100.19 124.99 46.26 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.457 ' CZ2' ' HD3' ' A' ' 126' ' ' LYS . 25.9 t90 -107.49 115.94 31.05 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.418 -177.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.4 mp -101.06 122.55 53.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.735 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.457 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 39.7 ttpt -129.72 120.36 24.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.189 0.519 . . . . 0.0 110.555 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' TRP . . . . . 0.45 ' CE2' HG21 ' A' ' 182' ' ' VAL . 40.3 p90 -116.28 160.78 19.98 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.931 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.3 m -95.61 129.37 34.86 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo . . . . . 0 C--O 1.233 0.271 0 C-N-CA 122.905 2.404 . . . . 0.0 111.945 -178.884 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 41.8 tp . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.6 mp -99.84 143.19 30.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.01 0.434 . . . . 0.0 110.872 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -115.3 133.78 55.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.662 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -116.75 139.35 50.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 181' ' ' GLN . 4.7 mp -120.26 119.72 60.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.088 0.47 . . . . 0.0 110.859 -176.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.422 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 21.4 ttp180 -104.18 121.68 43.78 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.533 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.2 pp -143.88 162.75 35.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.678 0.275 . . . . 0.0 111.316 -176.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -171.51 150.42 2.71 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.416 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.474 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 45.6 Cg_endo -72.16 156.37 55.57 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.096 1.864 . . . . 0.0 110.904 170.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -61.95 -18.57 60.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.246 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -91.62 -3.85 55.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.984 0.421 . . . . 0.0 110.553 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.474 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -87.6 127.12 35.27 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.099 -177.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.72 -14.27 52.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.285 0.564 . . . . 0.0 110.475 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -119.95 139.02 53.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.794 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.422 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 78.2 m95 -81.4 147.98 29.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.354 177.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -116.08 117.62 30.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.279 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mp -93.05 123.18 45.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.392 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 59.8 m-70 -119.04 155.87 30.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.524 176.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -122.6 129.79 52.29 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.518 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -97.88 -34.74 10.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.943 0.401 . . . . 0.0 110.953 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.58 -140.93 15.24 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.49 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -91.67 52.99 2.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.211 0.529 . . . . 0.0 109.906 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -150.1 149.92 30.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.329 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.422 ' HA ' ' CE2' ' A' ' 127' ' ' TRP . 61.3 p -101.4 33.08 3.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.954 -174.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -146.59 134.09 20.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.975 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 39.9 t80 -136.89 149.33 47.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.105 176.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.97 140.84 49.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.945 0.402 . . . . 0.0 111.224 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' A' ' 123' ' ' LEU . 34.7 mm -117.67 136.41 54.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.886 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -103.84 -23.85 13.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.833 0.349 . . . . 0.0 110.67 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 69.5 m -89.54 80.53 6.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.867 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.7 mm? -116.57 132.16 56.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.982 0.42 . . . . 0.0 110.691 176.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 52.9 m170 -100.09 118.62 61.17 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.657 176.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 32.5 Cg_exo -57.02 118.46 5.33 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.875 2.383 . . . . 0.0 112.813 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 97.22 5.64 58.06 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.96 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -109.03 151.4 26.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.157 0.503 . . . . 0.0 110.66 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.441 ' HE3' ' HB3' ' A' ' 199' ' ' PHE . 37.8 tttp -93.51 136.72 33.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.07 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -120.88 139.42 53.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.879 0.371 . . . . 0.0 110.21 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.7 mp -104.08 126.06 50.9 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.9 m -123.76 139.15 51.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.117 0.484 . . . . 0.0 111.312 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.533 ' HG3' ' HA ' ' A' ' 197' ' ' ALA . 0.0 OUTLIER -141.63 134.64 29.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.14 179.415 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.45 HG21 ' CE2' ' A' ' 127' ' ' TRP . 7.8 p -129.45 137.65 56.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -143.39 149.56 37.85 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' CYS . . . . . 0.478 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 28.3 p -118.21 158.85 24.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.638 -174.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 121.137 0.494 . . . . 0.0 111.279 -178.856 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 80.4 m95 . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.613 ' H ' ' HD2' ' A' ' 196' ' ' PRO . 20.0 m -137.02 -57.88 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.569 0 CA-C-O 119.242 -0.409 . . . . 0.0 111.947 -177.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.613 ' HD2' ' H ' ' A' ' 195' ' ' SER . 59.3 Cg_endo -71.42 83.06 1.05 Allowed 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.627 1.551 . . . . 0.0 112.874 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.533 ' HA ' ' HG3' ' A' ' 181' ' ' GLN . . . -88.24 115.14 25.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.143 0.497 . . . . 0.0 110.662 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 85.7 m -107.12 138.39 43.39 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.053 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.441 ' HB3' ' HE3' ' A' ' 177' ' ' LYS . 62.1 m-85 -106.61 140.04 40.11 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.347 -176.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.9 tp -136.54 134.06 49.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.147 0.499 . . . . 0.0 110.533 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -101.81 123.1 45.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.25 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.9 mm -79.34 123.52 84.51 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.96 149.63 87.85 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.904 2.402 . . . . 0.0 112.371 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 13.3 m -66.03 -26.48 67.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.94 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -91.91 27.78 2.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.55 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 82.6 t80 -62.71 -46.93 85.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.137 0.494 . . . . 0.0 110.433 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 C--N 1.32 -0.674 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.9 177.774 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo . . . . . 0 N--CA 1.449 -1.116 0 CA-C-O 121.009 0.337 . . . . 0.0 111.412 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.5 mp -91.52 178.24 6.0 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.835 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 128' ' ' SER . 39.6 mt-10 50.2 47.41 23.68 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 124.839 1.337 . . . . 0.0 111.727 165.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.2 tp -64.86 112.94 3.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.92 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -114.16 128.12 56.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.407 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.497 HG12 HD22 ' A' ' 123' ' ' LEU . 4.5 t -116.44 126.34 73.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.82 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -141.38 126.44 18.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.913 0.387 . . . . 0.0 110.609 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.31 133.96 28.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.318 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -124.19 117.71 25.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.356 0.598 . . . . 0.0 111.088 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.454 ' NE2' ' HA ' ' A' ' 206' ' ' PHE . 46.6 mt-30 -108.59 99.64 34.52 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.476 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.1 -83.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.769 2.313 . . . . 0.0 112.66 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -175.17 -77.44 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 120.704 0.288 . . . . 0.0 110.64 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -87.27 -34.89 18.76 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -66.92 134.79 52.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.923 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -58.35 135.11 85.15 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.004 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.435 ' HB3' ' HG2' ' A' ' 115' ' ' GLN . 28.1 Cg_endo -62.12 140.37 83.5 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.654 2.236 . . . . 0.0 111.367 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.518 ' CE2' ' HD2' ' A' ' 168' ' ' LYS . 23.2 p90 -144.03 155.85 44.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.064 0.459 . . . . 0.0 111.594 -172.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.497 HD22 HG12 ' A' ' 111' ' ' VAL . 6.6 mt -83.12 130.51 35.12 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.839 172.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -107.91 106.65 17.01 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.706 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 166' ' ' GLU . 4.0 mp -100.88 131.17 49.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.776 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -138.87 156.72 47.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.965 0.412 . . . . 0.0 110.577 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 20.1 p90 -143.53 156.21 44.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.911 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 15.0 m -114.22 105.38 54.12 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.076 -178.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo . . . . . 0 C--O 1.235 0.343 0 C-N-CA 122.496 2.13 . . . . 0.0 111.033 173.824 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.437 HD11 ' H ' ' A' ' 185' ' ' LYS . 55.5 tp . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.984 0.421 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.3 mp -89.4 139.84 30.11 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.786 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -114.49 149.68 35.98 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.914 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -133.22 133.42 42.71 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.37 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.2 mp -113.72 131.5 65.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.749 0.309 . . . . 0.0 110.632 -174.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.506 ' HB2' ' CH2' ' A' ' 194' ' ' TRP . 18.6 ttp180 -118.23 120.18 36.92 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.421 HD22 ' C ' ' A' ' 148' ' ' LEU . 0.0 OUTLIER -145.58 160.41 41.7 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.798 -178.128 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -169.72 147.66 3.06 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.532 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.426 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 39.3 Cg_endo -70.08 167.37 25.04 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.102 1.868 . . . . 0.0 111.789 173.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -61.78 -29.65 70.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.221 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -86.53 7.03 27.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -177.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.426 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -94.72 130.95 41.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.113 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -87.32 -26.63 23.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.842 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -123.69 150.08 44.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.294 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.454 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 77.6 m95 -82.34 145.83 29.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.542 -177.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 148' ' ' LEU . 43.2 mt-10 -98.71 118.96 36.62 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.445 175.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mp -98.16 116.18 40.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -119.84 114.66 22.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.12 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -81.28 133.68 35.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.854 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -101.11 -51.64 3.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.876 0.37 . . . . 0.0 111.481 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 127.59 -142.39 13.47 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -175.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.3 20.3 11.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.322 0.561 . . . . 0.0 111.127 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -103.41 143.75 32.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.806 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 38.8 p -96.48 36.49 1.36 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.039 0.447 . . . . 0.0 111.787 -175.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 125' ' ' ILE . 9.2 pt-20 -156.45 145.04 20.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.177 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -140.71 151.2 44.33 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.518 ' HD2' ' CE2' ' A' ' 122' ' ' TYR . 45.8 mmtt -116.41 137.67 51.97 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 41.0 mm -112.74 120.83 63.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 175.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.483 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.9 mm? -89.71 -38.96 13.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 -177.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 50.4 m -76.72 84.5 3.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.066 0.46 . . . . 0.0 111.206 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 90.2 mt -126.38 133.21 51.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.75 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -102.49 124.57 38.87 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.031 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.44 124.8 15.86 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.656 2.237 . . . . 0.0 112.387 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 88.16 27.56 25.38 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.549 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -126.82 146.95 50.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.027 0.442 . . . . 0.0 111.038 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -85.42 131.71 34.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.577 177.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -121.13 136.17 55.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.888 0.375 . . . . 0.0 110.471 176.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 8.5 mp -103.65 126.62 50.91 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.428 HG21 HG21 ' A' ' 111' ' ' VAL . 27.3 m -123.2 142.71 38.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.147 0.499 . . . . 0.0 111.813 -177.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.557 ' NE2' ' HB2' ' A' ' 197' ' ' ALA . 89.4 mt-30 -143.25 157.91 44.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.899 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.46 144.39 24.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.142 178.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.657 ' HG2' ' CZ3' ' A' ' 194' ' ' TRP . 1.9 ptm180 -138.82 175.6 9.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.213 0.53 . . . . 0.0 110.673 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 10.6 p -160.78 -172.66 3.59 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.369 176.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.437 ' H ' HD11 ' A' ' 142' ' ' LEU . 17.7 ptmt . . . . . 0 C--N 1.324 -0.515 0 CA-C-O 121.199 0.523 . . . . 0.0 111.176 177.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.657 ' CZ3' ' HG2' ' A' ' 183' ' ' ARG . 14.4 m95 . . . . . 0 C--O 1.233 0.236 0 CA-C-O 120.577 0.227 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.552 ' OG ' ' HD3' ' A' ' 196' ' ' PRO . 3.5 p -103.75 -50.59 0.14 Allowed Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.552 ' HD3' ' OG ' ' A' ' 195' ' ' SER . 4.7 Cg_exo -78.97 80.53 3.06 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.085 1.857 . . . . 0.0 113.078 -173.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.557 ' HB2' ' NE2' ' A' ' 181' ' ' GLN . . . -83.96 101.08 11.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.324 0.583 . . . . 0.0 110.104 176.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 25.2 m -95.97 131.45 42.33 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.605 -176.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -95.58 114.82 26.61 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.571 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.3 tp -118.23 134.92 60.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.056 0.455 . . . . 0.0 110.153 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -102.37 134.78 45.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.987 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 40.4 mm -92.16 116.48 66.54 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.614 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.97 150.24 84.89 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.557 2.171 . . . . 0.0 112.074 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 30.2 p -67.84 -18.21 64.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.596 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -86.18 10.24 15.13 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.636 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.454 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 57.5 t80 -64.71 -37.98 89.42 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 173.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 C--N 1.321 -0.658 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.134 176.653 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 C--O 1.235 0.346 0 CA-C-O 121.301 0.459 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 pp -122.77 178.92 4.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.76 -175.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 53.07 46.17 27.26 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 123.659 0.599 . . . . 0.0 110.702 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.7 tp -70.28 99.17 1.49 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.909 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.94 130.22 46.09 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.342 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.464 HG21 HG21 ' A' ' 180' ' ' VAL . 6.1 t -123.8 127.07 73.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.812 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -143.41 159.17 42.88 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.976 0.417 . . . . 0.0 110.848 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.79 129.65 60.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.408 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -111.28 132.92 54.0 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -122.52 83.72 47.7 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.832 0.349 . . . . 0.0 111.448 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -83.43 163.78 14.7 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.334 2.689 . . . . 0.0 111.376 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -97.62 -31.09 12.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.078 0.466 . . . . 0.0 111.006 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -86.37 -22.12 26.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.615 0.722 . . . . 0.0 109.965 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -123.07 135.47 54.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.064 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -56.66 134.71 78.03 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -49.79 141.12 28.79 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.419 2.746 . . . . 0.0 112.445 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -144.55 162.22 37.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.931 -173.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.485 ' HB2' HD11 ' A' ' 172' ' ' LEU . 31.4 tp -95.77 128.49 42.69 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.582 176.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -105.75 114.37 28.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.373 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.3 mp -104.29 120.9 55.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -128.94 128.67 44.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.096 0.474 . . . . 0.0 110.913 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' TRP . . . . . 0.455 ' CH2' HD11 ' A' ' 146' ' ' ILE . 32.6 p90 -121.41 160.79 23.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.907 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.3 t -123.74 123.66 26.25 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.459 -0.521 0 C-N-CA 122.326 2.017 . . . . 0.0 111.181 175.478 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.4 pt? . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 121.435 0.636 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 56.4 mt -91.95 149.58 21.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.688 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -108.0 150.61 26.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.245 0.545 . . . . 0.0 111.575 -174.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -140.91 130.12 23.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.171 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.3 mp -110.73 129.12 66.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.962 0.41 . . . . 0.0 110.82 -173.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.497 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 15.9 ttp180 -111.15 120.08 41.11 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -146.22 161.11 40.98 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.621 0.248 . . . . 0.0 110.969 -177.384 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -167.84 147.46 4.3 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.684 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.446 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 38.7 Cg_endo -71.96 178.01 6.4 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.411 2.074 . . . . 0.0 112.339 172.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.453 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 11.0 pt-20 -70.5 -30.84 67.74 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -176.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.453 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 88.5 mttt -91.67 13.01 19.25 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.152 0.501 . . . . 0.0 110.825 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.446 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -98.71 119.79 38.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.719 178.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.79 -32.47 35.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.324 0.583 . . . . 0.0 110.43 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -101.28 156.99 17.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.604 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.497 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 81.5 m95 -96.15 139.93 31.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.076 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -94.97 115.14 27.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.54 175.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.69 119.02 40.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.516 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 34.8 m-70 -120.14 108.14 13.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.193 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -75.24 126.0 30.12 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -93.51 -43.43 8.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.017 0.437 . . . . 0.0 110.985 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 102.95 -134.94 12.03 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.098 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -94.97 60.95 2.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.267 0.556 . . . . 0.0 110.138 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -156.81 146.28 20.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.117 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 44.0 p -103.22 37.37 2.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.182 0.515 . . . . 0.0 111.26 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -149.09 140.96 23.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.936 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.516 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 22.0 t80 -142.09 145.18 34.0 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 174.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 0.7 OUTLIER -119.17 129.85 55.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.776 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 35.8 mm -101.46 126.46 55.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 174.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -100.16 -30.78 11.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.724 0.297 . . . . 0.0 110.763 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 13.3 m -79.65 81.44 5.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.466 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 123' ' ' LEU . 74.1 mt -126.36 140.97 52.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.954 0.407 . . . . 0.0 111.367 -176.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 13.7 m-70 -112.55 131.19 22.77 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.222 175.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 27.6 Cg_exo -61.11 130.01 30.81 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.608 2.205 . . . . 0.0 112.13 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.64 26.77 60.27 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.275 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.433 ' HB3' ' CE1' ' A' ' 178' ' ' TYR . 0.7 OUTLIER -115.4 138.23 51.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.763 0.316 . . . . 0.0 110.23 179.003 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -82.71 129.9 35.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.365 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 176' ' ' GLN . 66.5 m-85 -121.06 140.19 52.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.872 0.368 . . . . 0.0 110.311 177.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.7 mm? -107.78 129.38 55.05 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.464 HG21 HG21 ' A' ' 111' ' ' VAL . 29.4 m -127.46 138.08 55.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.059 0.457 . . . . 0.0 111.945 -175.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.513 ' OE1' ' HB3' ' A' ' 194' ' ' TRP . 78.6 mt-30 -144.0 153.2 41.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.727 177.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.19 137.99 45.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.888 0.375 . . . . 0.0 110.759 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.478 ' HD2' ' C ' ' A' ' 183' ' ' ARG . 6.1 ppt_? -126.45 164.02 22.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.127 177.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 20.1 p -146.69 175.34 10.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.003 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 C--N 1.325 -0.48 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 173.447 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.513 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 70.5 m95 . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.683 ' H ' ' HD2' ' A' ' 196' ' ' PRO . 20.3 m -137.21 -54.01 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.683 ' HD2' ' H ' ' A' ' 195' ' ' SER . 66.4 Cg_endo -74.25 82.99 1.73 Allowed 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 121.686 1.59 . . . . 0.0 113.208 -175.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.43 ' HB2' ' NE2' ' A' ' 181' ' ' GLN . . . -82.3 104.03 12.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.805 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 34.7 m -95.21 135.79 36.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.738 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -98.72 119.48 37.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.068 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.3 tp -125.71 138.56 54.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.026 0.441 . . . . 0.0 110.627 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -106.78 140.86 38.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.361 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 41.0 mm -96.87 124.51 49.81 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.837 177.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.0 149.12 81.64 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.853 2.369 . . . . 0.0 112.04 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 3.0 p -75.24 -15.19 60.55 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.856 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -95.99 18.07 14.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.084 175.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -55.47 -60.58 3.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.27 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.7 m . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.144 179.7 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.511 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 9.7 Cg_endo . . . . . 0 C--O 1.232 0.189 0 CA-C-O 120.843 0.268 . . . . 0.0 111.446 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.86 175.34 6.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.485 -172.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 55.97 47.13 20.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.849 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.6 tp -68.92 98.9 0.99 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.631 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.63 130.39 41.11 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.457 -176.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -125.13 120.41 58.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.087 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -138.0 157.7 45.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.723 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.3 p -107.53 131.19 58.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.136 0.493 . . . . 0.0 110.295 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -103.04 123.88 47.46 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -123.38 80.36 53.39 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.006 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.466 ' HG2' ' HB2' ' A' ' 119' ' ' ARG . 1.0 OUTLIER -86.69 163.86 9.2 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.562 2.841 . . . . 0.0 111.798 177.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -97.45 -30.27 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.054 0.454 . . . . 0.0 111.169 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -93.76 -25.48 17.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.434 0.635 . . . . 0.0 110.177 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.466 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 23.3 mmt180 -110.91 151.74 27.55 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 175.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -73.78 138.3 76.82 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.63 132.93 55.04 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.946 2.431 . . . . 0.0 111.804 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.445 ' CD2' ' HD2' ' A' ' 168' ' ' LYS . 53.1 p90 -145.8 157.62 43.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.974 0.416 . . . . 0.0 110.957 -174.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.453 ' HB3' ' HB ' ' A' ' 169' ' ' ILE . 26.3 tp -91.21 131.17 36.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.624 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.558 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 12.4 t90 -110.47 109.38 19.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.207 -175.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.2 mp -108.05 123.37 63.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.082 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -123.23 148.42 45.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.834 0.35 . . . . 0.0 110.622 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -138.87 152.2 47.6 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.916 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 m -113.26 138.02 22.24 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.705 -175.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo . . . . . 0 C--N 1.346 0.445 0 C-N-CA 122.945 2.43 . . . . 0.0 111.556 175.767 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 29.7 tp . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.699 HD11 ' HG2' ' A' ' 163' ' ' GLN . 8.3 mp -98.01 153.28 18.49 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.848 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.543 ' CD2' ' HB3' ' A' ' 184' ' ' CYS . 75.2 m-85 -128.99 147.56 50.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.301 -173.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -128.12 139.82 52.29 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.3 mp -117.44 129.52 73.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.039 0.447 . . . . 0.0 110.718 -175.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.481 HH22 ' NE2' ' A' ' 181' ' ' GLN . 7.7 ttp-105 -112.67 120.4 41.42 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.551 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -143.69 160.38 40.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.463 0.173 . . . . 0.0 110.821 -177.266 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -165.96 151.76 8.2 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.395 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.507 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 37.1 Cg_endo -70.54 157.12 59.8 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.52 2.147 . . . . 0.0 110.923 170.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.526 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 14.9 pt-20 -62.51 -27.64 69.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.473 -0.785 . . . . 0.0 113.013 -170.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.526 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 82.4 mttt -94.09 9.29 38.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.091 0.472 . . . . 0.0 110.777 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.507 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -90.21 131.71 35.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.263 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.96 -35.35 24.04 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.97 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -103.66 159.98 15.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.273 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.429 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 60.0 m95 -101.04 156.23 17.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.652 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -102.79 120.97 41.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.194 173.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.54 117.84 47.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.948 177.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -124.55 124.58 42.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.924 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -89.48 126.1 35.44 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.047 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.401 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -83.96 -47.67 10.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.159 0.504 . . . . 0.0 110.88 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.419 ' C ' ' HG ' ' A' ' 143' ' ' LEU . . . 107.57 -128.49 9.21 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.805 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.699 ' HG2' HD11 ' A' ' 143' ' ' LEU . 34.4 mt-30 -94.76 5.59 51.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.25 0.548 . . . . 0.0 110.464 -175.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -95.94 142.74 27.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.534 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.451 HG22 ' CE1' ' A' ' 144' ' ' TYR . 61.9 p -101.63 23.98 10.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.459 0.647 . . . . 0.0 111.0 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -148.69 137.74 21.61 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -130.1 149.52 51.78 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.71 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.558 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 42.5 mmtm -114.69 135.85 53.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.593 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 123' ' ' LEU . 31.9 mm -109.86 136.32 46.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 172.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -102.29 -31.39 10.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.925 0.393 . . . . 0.0 110.852 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 44.0 m -89.33 80.95 6.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.652 -177.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.8 mm? -112.97 131.23 55.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.978 174.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -88.68 116.84 67.42 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.542 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.42 116.09 3.18 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.577 2.185 . . . . 0.0 112.066 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 108.27 -2.05 33.02 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.992 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -110.22 144.27 39.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.447 0.641 . . . . 0.0 111.766 -175.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -85.29 128.75 34.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.877 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -109.98 146.65 34.9 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.077 0.465 . . . . 0.0 110.886 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.8 mp -111.17 127.83 55.71 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.88 142.99 40.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.913 0.387 . . . . 0.0 111.447 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.595 ' HG2' ' HA ' ' A' ' 197' ' ' ALA . 62.4 mt-30 -143.41 139.19 29.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.574 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 12.6 p -125.65 141.18 46.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.803 0.335 . . . . 0.0 110.165 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -136.82 150.99 48.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.005 0.431 . . . . 0.0 110.639 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' CYS . . . . . 0.543 ' HB3' ' CD2' ' A' ' 144' ' ' TYR . 18.5 p -128.89 155.98 44.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.947 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt . . . . . 0 C--N 1.328 -0.358 0 CA-C-O 121.399 0.619 . . . . 0.0 112.415 -172.726 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.532 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 44.6 m95 . . . . . 0 C--O 1.233 0.201 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.563 ' OG ' ' HD3' ' A' ' 196' ' ' PRO . 13.9 p -168.16 -50.07 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -177.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.563 ' HD3' ' OG ' ' A' ' 195' ' ' SER . 94.8 Cg_endo -85.46 86.73 1.02 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 121.69 1.593 . . . . 0.0 113.516 -171.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.595 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -83.76 114.17 21.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.146 0.498 . . . . 0.0 111.505 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 86.2 m -106.07 139.56 40.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.022 175.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -104.09 148.69 25.97 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.384 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.8 tp -154.29 134.56 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.248 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -97.58 125.53 42.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.681 0.277 . . . . 0.0 110.276 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 44.6 mm -80.59 117.7 69.04 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -59.07 145.69 96.81 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.551 2.167 . . . . 0.0 111.874 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 26.8 m -70.1 -8.22 47.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.474 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.71 -15.24 60.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.984 176.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 9.7 t80 -61.62 131.82 51.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.197 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 49.8 m . . . . . 0 CA--C 1.539 0.521 0 O-C-N 123.314 0.384 . . . . 0.0 111.223 -179.784 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.527 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 9.8 Cg_endo . . . . . 0 C--O 1.236 0.421 0 CA-C-O 121.08 0.367 . . . . 0.0 112.664 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.407 ' H ' HD23 ' A' ' 107' ' ' LEU . 2.1 pt? -136.97 171.89 13.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.777 -173.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 54.35 57.22 6.04 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 123.96 0.787 . . . . 0.0 111.236 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.431 HD23 ' OG1' ' A' ' 198' ' ' THR . 56.2 tp -80.29 94.33 6.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.004 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.29 129.72 35.79 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.216 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.402 HG12 HD22 ' A' ' 123' ' ' LEU . 2.9 t -120.06 114.45 44.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.956 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.499 ' OE1' ' HE3' ' A' ' 114' ' ' LYS . 38.9 tt0 -135.51 131.69 36.36 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.349 -175.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.31 133.48 31.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.996 0.427 . . . . 0.0 110.892 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.499 ' HE3' ' OE1' ' A' ' 112' ' ' GLU . 0.4 OUTLIER -108.57 131.43 54.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.45 178.175 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -124.54 85.45 56.24 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.688 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.21 156.16 65.59 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 123.27 2.647 . . . . 0.0 112.318 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.91 -17.7 56.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.233 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -117.05 -49.75 2.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.9 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.78 157.6 28.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.764 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -64.29 145.5 98.2 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.336 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.97 141.13 76.08 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.821 2.347 . . . . 0.0 111.971 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.525 ' HB3' HD13 ' A' ' 170' ' ' LEU . 21.4 p90 -148.5 151.11 34.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.607 -174.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 6.8 mt -79.07 134.04 36.77 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.059 173.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -111.6 100.58 9.1 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.151 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.415 ' H ' HD12 ' A' ' 125' ' ' ILE . 4.4 mp -90.16 123.47 42.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.494 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -132.56 119.55 20.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.044 0.449 . . . . 0.0 110.534 -176.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' TRP . . . . . 0.464 ' CH2' HD11 ' A' ' 146' ' ' ILE . 39.4 p90 -118.45 166.44 12.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.535 -176.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.6 t -101.15 118.32 60.51 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo . . . . . 0 N--CA 1.462 -0.371 0 C-N-CA 122.723 2.282 . . . . 0.0 112.322 -178.221 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 22.6 tp . . . . . 0 N--CA 1.451 -0.414 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.401 HD11 ' HG2' ' A' ' 163' ' ' GLN . 0.9 OUTLIER -99.48 141.44 32.27 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.914 0.388 . . . . 0.0 110.954 -176.618 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -107.64 139.55 42.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.138 -172.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -133.57 134.35 43.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.639 -175.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.464 HD11 ' CH2' ' A' ' 127' ' ' TRP . 4.5 mp -118.9 124.82 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.881 0.372 . . . . 0.0 110.681 -175.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.506 ' HB2' ' CZ2' ' A' ' 194' ' ' TRP . 25.4 ttp180 -113.46 126.35 55.24 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 4.1 pp -149.89 164.67 34.78 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.526 -176.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -169.33 148.9 3.64 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.588 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.433 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 30.8 Cg_endo -68.23 167.35 22.31 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.377 2.051 . . . . 0.0 111.812 172.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.463 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 11.3 pt-20 -64.02 -24.21 67.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.97 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.463 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 89.6 mttt -96.15 18.78 12.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.198 0.523 . . . . 0.0 110.753 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.433 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -103.99 128.73 51.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.718 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -95.0 -11.24 28.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.075 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.67 162.67 27.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.239 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.473 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 86.5 m95 -98.81 137.73 36.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.17 0.51 . . . . 0.0 112.278 -171.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -104.14 115.04 29.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.548 176.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 158' ' ' ILE . 2.5 mp -95.98 120.02 44.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.363 -178.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 65.5 m-70 -113.56 130.1 56.43 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.341 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -97.41 129.89 44.59 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.845 -176.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -95.27 -37.96 10.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.888 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.68 -125.13 8.24 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.854 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.401 ' HG2' HD11 ' A' ' 143' ' ' LEU . 29.6 mt-30 -98.92 9.05 44.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.008 0.433 . . . . 0.0 110.577 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -103.82 144.88 30.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.459 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.6 p -97.01 33.58 1.89 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.305 0.574 . . . . 0.0 111.731 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -154.64 149.99 27.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.592 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 31.9 t80 -145.12 149.44 35.02 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 49.4 mmtt -113.03 144.34 42.77 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.444 ' HB ' ' HB2' ' A' ' 123' ' ' LEU . 36.3 mm -127.18 123.18 61.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.593 0.235 . . . . 0.0 110.809 176.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.525 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.9 mm? -97.3 -28.74 13.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.184 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 9.7 t -81.65 79.46 8.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.095 0.474 . . . . 0.0 110.563 -176.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 67.5 mt -129.64 143.02 50.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.863 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 80.9 m80 -105.95 128.53 26.23 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.974 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 22.2 Cg_exo -63.77 133.62 40.02 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.741 2.294 . . . . 0.0 112.484 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 79.52 28.93 50.75 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.769 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 72.4 mm-40 -128.38 155.67 44.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.067 0.46 . . . . 0.0 110.91 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -92.78 133.38 36.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.388 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -120.32 144.47 47.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.869 0.366 . . . . 0.0 110.144 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.2 mm? -105.12 129.1 53.61 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.402 HG21 HG21 ' A' ' 111' ' ' VAL . 23.1 m -128.61 139.64 51.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.834 0.349 . . . . 0.0 110.865 -176.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.452 ' HG2' ' HA ' ' A' ' 197' ' ' ALA . 16.2 mt-30 -139.64 158.98 43.21 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.212 -178.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 12.6 p -136.29 138.45 46.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.208 0.527 . . . . 0.0 111.04 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -138.76 147.86 43.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.876 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' CYS . . . . . 0.527 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 25.5 p -137.93 154.61 49.4 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.453 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.506 ' CZ2' ' HB2' ' A' ' 147' ' ' ARG . 75.4 m95 . . . . . 0 N--CA 1.455 -0.191 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.475 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 7.4 m -131.41 -59.1 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -175.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 10.1 Cg_endo -90.08 95.11 0.29 Allowed 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.43 2.087 . . . . 0.0 113.16 -171.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.452 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -95.74 127.58 41.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.965 0.412 . . . . 0.0 110.567 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.431 ' OG1' HD23 ' A' ' 109' ' ' LEU . 30.9 m -121.77 144.21 48.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.639 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -104.08 127.5 51.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.204 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.7 tp -128.45 137.42 57.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.156 0.503 . . . . 0.0 110.985 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -99.59 124.98 45.3 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.686 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 51.0 mm -86.28 124.57 69.89 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 174.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.68 152.82 66.4 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.898 2.399 . . . . 0.0 112.226 -176.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 17.9 m -71.17 -23.92 62.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.7 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -100.46 54.71 0.88 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.344 176.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -87.95 -60.31 2.0 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.829 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 C--N 1.323 -0.581 0 CA-C-O 121.039 0.447 . . . . 0.0 110.976 -179.719 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.438 ' HG3' ' SG ' ' A' ' 184' ' ' CYS . 24.2 Cg_exo . . . . . 0 C--O 1.233 0.256 0 N-CA-C 111.162 -0.361 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 128' ' ' SER . 1.2 pp -133.38 177.06 7.98 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.717 0.294 . . . . 0.0 111.582 -175.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 55.41 50.28 15.12 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.584 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.5 tp -73.66 105.18 4.86 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -112.13 128.86 56.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.828 -175.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.6 t -113.32 129.82 68.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.032 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -129.78 129.84 44.6 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.878 0.37 . . . . 0.0 110.401 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 p -85.66 118.73 32.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.183 0.516 . . . . 0.0 109.846 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.507 ' O ' ' HD3' ' A' ' 116' ' ' PRO . 31.2 mmmt -113.38 108.45 17.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.1 0.476 . . . . 0.0 110.762 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -107.36 96.14 15.22 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.364 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 114' ' ' LYS . 15.3 Cg_exo -69.37 146.11 61.54 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.798 2.332 . . . . 0.0 111.687 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -80.01 -3.89 50.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.104 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -126.77 -40.86 1.87 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.196 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.418 ' H ' ' HB2' ' A' ' 116' ' ' PRO . 66.7 mtm-85 -99.44 165.58 11.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.41 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 120' ' ' LYS . 12.6 mptt -60.11 135.4 90.71 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.119 175.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.434 ' HA ' ' CD ' ' A' ' 116' ' ' PRO . 32.3 Cg_endo -64.18 136.86 53.79 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.909 2.406 . . . . 0.0 112.122 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.442 ' HB3' HD13 ' A' ' 170' ' ' LEU . 54.0 p90 -136.33 159.71 40.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.711 -175.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.5 tp -98.83 123.83 43.33 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.431 ' CZ2' ' HD3' ' A' ' 126' ' ' LYS . 21.6 t90 -104.62 115.24 30.0 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.401 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.7 mp -108.3 129.06 63.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.652 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.431 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 54.9 pttt -137.68 152.48 49.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.047 0.451 . . . . 0.0 110.347 175.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' TRP . . . . . 0.456 ' CD2' HG21 ' A' ' 182' ' ' VAL . 29.3 p90 -142.0 163.33 33.17 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.076 -174.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.446 ' HB2' HD12 ' A' ' 107' ' ' LEU . 42.4 m -106.94 105.59 55.83 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 121.004 0.43 . . . . 0.0 109.895 176.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.463 -0.278 0 C-N-CA 122.758 2.305 . . . . 0.0 112.013 -177.77 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 185' ' ' LYS . 30.1 tp . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 184' ' ' CYS . 2.0 mp -106.8 158.31 17.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.361 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -125.45 133.39 52.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.024 0.44 . . . . 0.0 111.247 -172.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -123.28 139.33 54.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.067 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.416 HG13 HG23 ' A' ' 182' ' ' VAL . 4.6 mp -126.99 122.34 60.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.679 0.276 . . . . 0.0 110.469 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -107.72 130.08 54.97 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 174.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.5 pp -144.25 157.71 44.13 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.724 -177.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -165.44 144.5 5.32 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.187 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.459 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 29.2 Cg_endo -67.88 168.84 17.61 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.406 2.071 . . . . 0.0 111.835 172.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.86 -18.86 65.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.934 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -100.96 17.79 21.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.121 0.486 . . . . 0.0 110.578 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.459 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -108.21 120.5 42.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.166 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -79.57 -28.55 41.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.583 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -109.71 154.25 23.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.755 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -90.53 144.78 25.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.146 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -98.59 110.18 22.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.254 172.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.17 113.47 24.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.198 0.523 . . . . 0.0 109.733 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 49.4 m-70 -116.35 118.99 34.26 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.685 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -88.31 126.38 35.15 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -86.6 -30.6 21.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.987 0.422 . . . . 0.0 110.729 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 95.25 -127.89 9.31 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.589 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -104.8 53.13 0.73 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.372 0.606 . . . . 0.0 110.241 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -144.64 143.86 30.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.283 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.5 p -96.66 24.35 6.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.18 0.514 . . . . 0.0 111.538 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -147.43 136.24 22.07 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.446 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 24.5 t80 -134.05 142.1 47.45 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.403 ' HE2' ' CD1' ' A' ' 124' ' ' TRP . 0.2 OUTLIER -120.4 136.38 54.74 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.689 0.281 . . . . 0.0 110.564 -178.362 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.442 HG22 ' H ' ' A' ' 171' ' ' SER . 43.2 mm -108.52 131.95 57.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.616 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.442 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.8 mm? -112.71 41.96 1.94 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.203 0.525 . . . . 0.0 110.117 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.442 ' H ' HG22 ' A' ' 169' ' ' ILE . 10.7 t -157.75 64.26 0.47 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.647 -177.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.8 mm? -109.27 151.84 26.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.991 0.424 . . . . 0.0 110.694 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -116.61 122.96 31.04 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.232 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -59.84 117.61 4.38 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.862 2.375 . . . . 0.0 112.35 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.23 -5.76 49.7 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.69 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -101.63 142.18 33.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.05 0.452 . . . . 0.0 111.015 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 199' ' ' PHE . 79.7 tttt -91.86 133.33 35.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.131 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -116.8 137.9 51.87 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.095 0.474 . . . . 0.0 110.496 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 7.6 mp -99.3 126.28 45.11 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 174.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.7 136.4 60.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.043 0.449 . . . . 0.0 111.226 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.581 ' HG2' ' HA ' ' A' ' 197' ' ' ALA . 55.4 mt-30 -138.3 139.06 38.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.0 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.456 HG21 ' CD2' ' A' ' 127' ' ' TRP . 12.6 p -125.08 152.69 31.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.857 0.36 . . . . 0.0 110.733 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -153.13 142.02 21.17 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.79 173.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' CYS . . . . . 0.438 ' SG ' ' HG3' ' A' ' 106' ' ' PRO . 25.1 p -105.09 157.08 17.5 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.659 174.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.43 ' O ' HD12 ' A' ' 142' ' ' LEU . 98.3 mttt . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 120.634 0.254 . . . . 0.0 111.441 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 23.6 m95 . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.515 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 3.3 m -134.84 -54.47 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.208 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 27.1 Cg_endo -95.36 131.69 0.51 Allowed 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 122.501 2.134 . . . . 0.0 112.969 -177.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.581 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -123.65 124.63 43.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.036 0.446 . . . . 0.0 110.705 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 61.0 m -117.02 144.02 45.08 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.629 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.474 ' HB3' ' HE2' ' A' ' 177' ' ' LYS . 55.7 m-85 -107.69 132.44 53.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.594 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.1 tp -133.28 135.31 56.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.1 0.476 . . . . 0.0 110.735 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.417 HE21 ' HB2' ' A' ' 177' ' ' LYS . 1.7 mm-40 -105.61 130.6 53.62 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.539 178.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 46.6 mm -85.9 124.64 70.48 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.913 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.41 156.73 61.84 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.908 2.405 . . . . 0.0 112.382 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 46.1 m -81.06 -3.67 52.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.15 0.5 . . . . 0.0 110.913 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -84.96 -15.09 45.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.039 174.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 30.0 t80 -58.92 141.31 53.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.722 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 206' ' ' PHE . 80.6 m . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 121.474 0.654 . . . . 0.0 111.626 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo . . . . . 0 C--O 1.233 0.236 0 N-CA-C 110.768 -0.512 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.445 ' H ' HD23 ' A' ' 107' ' ' LEU . 2.2 pt? -127.75 -178.32 4.45 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.917 -171.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 55.78 40.8 30.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.822 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.492 HD23 ' OG1' ' A' ' 198' ' ' THR . 54.0 tp -70.22 94.61 0.93 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.7 123.58 40.43 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.322 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.497 HG12 HD11 ' A' ' 123' ' ' LEU . 3.2 t -112.29 113.56 44.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -124.06 133.27 53.67 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.141 -172.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.6 p -85.78 116.9 29.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.388 0.613 . . . . 0.0 109.841 175.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -103.05 123.49 46.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.403 -177.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -121.04 84.68 39.77 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.436 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.98 146.87 42.5 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.736 2.29 . . . . 0.0 111.087 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -79.9 -16.77 54.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.351 -177.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -116.12 -39.55 3.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.581 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -91.37 163.07 14.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.634 176.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -72.97 141.52 81.78 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.012 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.38 138.68 67.13 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.944 2.429 . . . . 0.0 111.742 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -150.82 164.55 35.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.833 -174.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.566 ' HB2' HD11 ' A' ' 172' ' ' LEU . 29.7 tp -97.41 122.27 40.26 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.428 ' HE1' ' HB2' ' A' ' 166' ' ' GLU . 24.4 t90 -102.71 112.53 25.34 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.047 -178.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.8 mp -106.89 120.15 57.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.666 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -128.11 134.78 49.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.93 0.395 . . . . 0.0 110.293 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 36.0 p90 -128.05 155.56 44.15 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.573 -177.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.9 m -108.88 100.27 38.87 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.909 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 CA--C 1.532 0.395 0 C-N-CA 123.021 2.481 . . . . 0.0 112.547 178.889 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.418 HD11 ' H ' ' A' ' 185' ' ' LYS . 46.5 tp . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 121.068 0.461 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -91.62 166.04 13.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.456 174.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.4 ' HD1' ' HG ' ' A' ' 184' ' ' CYS . 71.8 m-85 -131.32 131.92 44.12 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -177.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -119.87 134.6 55.19 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.51 121.96 61.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.133 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.446 ' HE ' ' CD ' ' A' ' 181' ' ' GLN . 22.5 ptt180 -103.74 148.08 26.5 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.6 pp -165.05 161.79 19.95 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.175 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 153' ' ' ALA . 57.5 pttt -164.77 145.59 6.32 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-O 120.682 0.277 . . . . 0.0 110.484 176.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.418 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 36.6 Cg_endo -68.75 165.71 28.67 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.76 2.307 . . . . 0.0 111.746 174.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.46 -5.4 19.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.897 -174.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -111.3 6.7 20.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.292 0.568 . . . . 0.0 110.437 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.418 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -95.2 127.72 41.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.187 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.36 -38.86 29.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.723 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -104.16 162.92 12.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.955 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -91.4 140.89 29.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.034 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 148' ' ' LEU . 36.1 mt-10 -91.88 116.25 28.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.3 172.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.75 109.41 21.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.54 0.686 . . . . 0.0 109.363 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.486 ' HB3' ' CE2' ' A' ' 167' ' ' PHE . 35.0 m-70 -105.8 126.42 52.15 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.195 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -98.28 117.27 32.28 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.866 0.365 . . . . 0.0 110.648 -176.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -78.0 -51.11 10.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.143 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 76.19 89.9 0.25 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.072 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 75.34 -25.59 0.2 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.733 0.813 . . . . 0.0 113.033 170.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -89.41 142.59 27.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.91 0.386 . . . . 0.0 110.57 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.1 p -101.75 32.6 3.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.5 0.667 . . . . 0.0 111.047 -177.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.428 ' HB2' ' HE1' ' A' ' 124' ' ' TRP . 5.5 pt-20 -156.9 109.94 2.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.769 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.486 ' CE2' ' HB3' ' A' ' 159' ' ' HIS . 17.8 t80 -110.94 146.56 36.38 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.497 -174.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.463 ' HD2' ' N ' ' A' ' 168' ' ' LYS . 9.6 mptt -121.83 130.19 53.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.369 -178.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 34.7 mm -107.84 124.21 63.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.551 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.17 -27.14 15.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.957 0.408 . . . . 0.0 110.482 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 34.7 m -82.33 84.55 7.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.663 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' A' ' 123' ' ' LEU . 68.9 mt -130.99 145.85 52.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.124 0.488 . . . . 0.0 111.323 -177.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 63.6 m-70 -114.38 127.49 26.77 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.859 177.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 24.2 Cg_exo -62.88 129.53 26.36 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.836 2.357 . . . . 0.0 112.797 -178.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.14 33.34 32.86 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.487 176.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -126.21 145.53 50.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.318 0.58 . . . . 0.0 111.059 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -86.85 129.64 34.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.079 177.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -120.25 137.21 54.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.246 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.5 mm? -97.44 125.02 41.85 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 173.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.47 ' O ' ' HB ' ' A' ' 198' ' ' THR . 16.7 m -135.43 139.31 46.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.748 0.309 . . . . 0.0 110.788 -171.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.502 ' HB3' ' HA ' ' A' ' 197' ' ' ALA . 1.0 OUTLIER -166.63 142.95 4.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.907 0.384 . . . . 0.0 110.842 177.936 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 13.0 p -121.93 153.02 26.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.52 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -146.11 134.75 22.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.066 0.46 . . . . 0.0 109.76 173.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' CYS . . . . . 0.4 ' HG ' ' HD1' ' A' ' 144' ' ' TYR . 3.3 m -111.93 152.66 27.78 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.682 -176.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.418 ' H ' HD11 ' A' ' 142' ' ' LEU . 18.0 pttp . . . . . 0 C--N 1.327 -0.373 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 51.6 m95 . . . . . 0 C--O 1.232 0.15 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.431 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 16.1 m -92.2 -54.57 0.26 Allowed Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 94.9 Cg_endo -76.68 69.78 6.65 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.096 1.864 . . . . 0.0 113.762 -172.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.502 ' HA ' ' HB3' ' A' ' 181' ' ' GLN . . . -69.52 123.23 20.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.331 0.586 . . . . 0.0 111.128 178.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.492 ' OG1' HD23 ' A' ' 109' ' ' LEU . 90.4 m -108.07 148.02 30.37 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.566 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -111.86 133.14 54.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.362 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.9 tp -137.63 133.84 45.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.34 0.591 . . . . 0.0 111.017 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -100.7 121.17 41.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.517 176.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.4 mm -85.85 122.95 72.82 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.27 143.7 96.84 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.58 2.186 . . . . 0.0 112.384 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 14.9 m -66.28 -23.55 66.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.29 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.87 19.62 3.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.591 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -53.64 -48.86 68.97 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.095 0.474 . . . . 0.0 110.318 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.444 -0.746 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.776 174.779 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.423 ' HG3' ' SG ' ' A' ' 184' ' ' CYS . 18.3 Cg_endo . . . . . 0 N--CA 1.473 0.289 0 CA-C-O 120.884 0.285 . . . . 0.0 112.346 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.44 HD23 ' N ' ' A' ' 107' ' ' LEU . 2.4 pt? -146.82 -167.57 2.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.27 -174.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 59.14 57.16 3.59 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.241 0.543 . . . . 0.0 111.105 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.411 HD23 ' HB3' ' A' ' 127' ' ' TRP . 12.3 mt -72.37 99.95 2.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.796 177.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.53 122.9 37.58 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.416 HG12 HD11 ' A' ' 123' ' ' LEU . 4.9 t -114.64 122.64 69.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.14 -175.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -120.84 140.92 51.08 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.804 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 p -98.21 119.71 46.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.21 0.528 . . . . 0.0 110.145 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.557 ' HE2' ' HA ' ' A' ' 114' ' ' LYS . 9.9 mmpt? -111.51 126.69 55.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.652 -178.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -133.09 97.23 16.79 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.08 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.81 175.97 8.92 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.71 2.273 . . . . 0.0 112.7 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -59.76 -67.31 0.4 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.329 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -131.63 38.16 3.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.295 0.569 . . . . 0.0 111.017 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -122.23 154.6 37.31 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.189 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -55.33 118.38 18.34 Favored Pre-proline 0 C--N 1.328 -0.337 0 O-C-N 123.582 0.552 . . . . 0.0 111.071 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.91 144.57 83.36 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.628 2.219 . . . . 0.0 111.146 177.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -140.53 150.56 43.86 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.219 0.533 . . . . 0.0 111.215 -173.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.455 ' HB2' HD11 ' A' ' 172' ' ' LEU . 30.1 tp -91.52 126.27 36.54 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.288 175.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.438 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 22.5 t90 -102.98 105.89 16.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.195 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.7 mp -98.99 123.62 51.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -134.12 136.21 43.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.944 0.402 . . . . 0.0 110.555 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' TRP . . . . . 0.485 ' CH2' HD11 ' A' ' 146' ' ' ILE . 20.7 p90 -122.51 167.96 12.71 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.0 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.9 t -87.29 125.47 65.74 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo . . . . . 0 C--N 1.343 0.273 0 C-N-CA 122.652 2.235 . . . . 0.0 111.81 178.793 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 63.9 tp . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.99 148.27 26.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.2 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.487 ' CD2' ' HB3' ' A' ' 184' ' ' CYS . 92.6 m-85 -115.46 138.33 51.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.545 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -124.46 135.77 53.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.485 HD11 ' CH2' ' A' ' 127' ' ' TRP . 5.1 mp -118.73 130.84 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.043 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -111.79 134.26 53.48 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.552 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.5 pp -145.43 156.53 43.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.797 -177.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -165.66 151.05 8.08 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.419 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.491 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 36.7 Cg_endo -70.05 164.11 36.03 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.453 2.102 . . . . 0.0 111.685 173.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.44 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 14.4 pt-20 -64.15 -23.69 67.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.976 -172.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.44 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 86.9 mttt -98.55 9.94 42.09 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.189 0.518 . . . . 0.0 110.875 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.491 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -95.85 131.52 42.08 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.006 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -84.96 -43.03 14.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.542 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -82.78 150.56 26.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.036 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -98.09 142.85 29.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.811 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -103.35 116.28 32.13 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.957 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.06 132.17 38.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.189 0.519 . . . . 0.0 111.079 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 67.6 m-70 -127.08 125.97 42.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.332 175.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -86.43 119.86 27.15 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.432 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -85.11 -39.19 18.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.905 0.383 . . . . 0.0 111.026 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 100.51 -143.78 16.45 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.443 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.08 62.74 4.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.978 0.418 . . . . 0.0 110.366 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -155.24 147.92 24.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.377 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.8 p -98.0 27.8 4.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.975 0.416 . . . . 0.0 111.909 -176.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -151.82 144.86 24.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.893 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 26.4 t80 -140.07 148.51 41.86 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.992 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 10.5 mptt -120.39 142.77 48.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.644 0.259 . . . . 0.0 110.782 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 32.9 mm -119.64 129.92 74.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.572 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.68 -29.17 11.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.102 0.477 . . . . 0.0 110.294 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.0 m -79.27 83.71 5.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.285 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 123' ' ' LEU . 63.4 mt -132.12 172.19 12.7 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.958 -176.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -138.37 124.65 12.82 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.899 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.13 130.02 29.16 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.606 2.204 . . . . 0.0 112.08 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 79.65 39.69 17.11 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.839 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -133.24 146.39 51.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.957 0.408 . . . . 0.0 110.474 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 150' ' ' PRO . 34.9 tttp -98.1 128.1 44.42 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.836 177.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -119.85 140.98 49.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.193 0.52 . . . . 0.0 110.898 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 5.5 mp -103.73 130.66 51.27 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.97 139.73 51.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.81 0.338 . . . . 0.0 111.452 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.547 ' HG2' ' HA ' ' A' ' 197' ' ' ALA . 78.1 mt-30 -143.72 142.47 30.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.299 177.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 13.5 p -132.06 150.15 33.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.684 0.278 . . . . 0.0 110.798 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -159.06 147.44 18.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.254 172.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' CYS . . . . . 0.487 ' HB3' ' CD2' ' A' ' 144' ' ' TYR . 27.9 p -123.4 -172.96 2.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.67 177.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 121.183 0.516 . . . . 0.0 111.044 179.764 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.492 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 81.0 m95 . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.599 ' H ' ' HD2' ' A' ' 196' ' ' PRO . 5.3 m -153.71 -56.9 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.599 ' HD2' ' H ' ' A' ' 195' ' ' SER . 68.4 Cg_endo -72.69 80.81 1.68 Allowed 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 122.019 1.813 . . . . 0.0 113.354 -173.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.547 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -80.35 103.0 9.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.273 0.559 . . . . 0.0 110.812 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.9 m -100.44 135.45 41.85 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.158 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -104.92 126.51 52.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.103 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.9 tp -126.75 137.98 56.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.003 0.43 . . . . 0.0 110.832 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -100.19 120.98 40.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.751 177.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.1 121.02 76.96 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.1 151.58 65.46 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.925 2.417 . . . . 0.0 112.362 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 16.8 t -71.75 -23.63 61.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.895 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -98.33 43.76 1.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.795 0.807 . . . . 0.0 109.28 175.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -80.85 -18.42 47.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.536 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 57.4 m . . . . . 0 C--N 1.319 -0.738 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.565 -178.171 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.61 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 72.6 Cg_endo . . . . . 0 N--CA 1.459 -0.553 0 CA-C-O 121.784 0.66 . . . . 0.0 111.872 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 pp -109.43 174.47 5.85 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.317 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 52.45 60.22 3.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.259 0.552 . . . . 0.0 110.626 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.445 HD11 ' CG2' ' A' ' 125' ' ' ILE . 43.1 tp -73.17 108.88 6.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.675 -177.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -98.44 119.68 37.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.576 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.459 ' CG1' HD11 ' A' ' 123' ' ' LEU . 2.6 t -109.24 115.28 49.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.394 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -127.72 125.58 40.25 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.933 -173.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.5 126.41 39.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.15 177.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 57.0 mmtt -108.28 129.72 55.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.936 0.398 . . . . 0.0 110.853 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.584 ' OE1' ' HA ' ' A' ' 206' ' ' PHE . 47.3 mt-30 -133.89 86.75 37.22 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.433 -174.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.05 167.69 24.62 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.078 2.519 . . . . 0.0 111.547 175.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.482 ' H ' ' CD ' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -86.24 -46.28 10.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.779 0.323 . . . . 0.0 111.32 -178.429 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -88.53 -51.48 5.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.89 0.376 . . . . 0.0 110.24 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -72.65 138.72 46.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -66.52 144.84 98.84 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 120.732 0.301 . . . . 0.0 111.4 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.557 ' HG3' ' O ' ' A' ' 206' ' ' PHE . 36.1 Cg_endo -62.72 142.41 89.13 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 123.263 2.642 . . . . 0.0 112.56 -177.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -144.56 159.9 42.03 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.733 -176.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.459 HD11 ' CG1' ' A' ' 111' ' ' VAL . 2.7 tm? -98.22 126.38 43.67 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.417 ' HE1' ' HB2' ' A' ' 166' ' ' GLU . 21.7 t90 -111.68 109.25 19.03 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.703 -172.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.445 ' CG2' HD11 ' A' ' 109' ' ' LEU . 3.6 mp -96.67 132.56 40.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.45 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -146.91 143.17 28.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.313 0.578 . . . . 0.0 110.456 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 18.5 p90 -126.74 162.94 24.64 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.112 -173.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.1 t -102.9 112.98 66.16 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 120.852 0.358 . . . . 0.0 110.374 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo . . . . . 0 N--CA 1.456 -0.698 0 C-N-CA 122.436 2.091 . . . . 0.0 111.541 174.372 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 52.5 tp . . . . . 0 N--CA 1.451 -0.382 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.441 ' HG ' ' HA2' ' A' ' 162' ' ' GLY . 4.7 mp -99.95 139.13 36.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.049 -175.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -109.14 143.18 38.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.402 -175.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -127.64 135.17 49.87 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.544 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.4 mp -114.75 128.19 71.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.009 0.433 . . . . 0.0 110.428 -176.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.483 ' HB2' ' CH2' ' A' ' 194' ' ' TRP . 26.6 ttp180 -114.97 123.13 48.31 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -142.6 160.35 40.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.632 0.253 . . . . 0.0 111.437 -177.16 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -171.69 150.22 2.57 Favored Pre-proline 0 C--O 1.234 0.275 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.996 176.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.498 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 36.6 Cg_endo -69.18 160.32 50.32 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.282 1.988 . . . . 0.0 110.599 169.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -67.9 -21.37 65.14 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -173.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -86.04 -11.12 53.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.018 0.437 . . . . 0.0 110.289 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.498 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -82.12 131.26 35.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.57 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -86.03 -35.57 20.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.363 178.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -94.96 143.19 26.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.325 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.453 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 67.7 m95 -88.46 145.76 25.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.77 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -96.43 116.94 29.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.577 174.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mp -95.67 111.66 26.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.009 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 51.3 m-70 -117.87 119.7 35.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.159 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -85.38 137.3 33.03 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.14 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.412 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -102.22 -41.05 6.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.992 0.425 . . . . 0.0 110.937 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.441 ' HA2' ' HG ' ' A' ' 143' ' ' LEU . . . 91.41 -125.64 8.11 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.152 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -97.23 64.06 1.89 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.217 0.532 . . . . 0.0 110.366 -177.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -157.64 142.95 17.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.03 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.6 p -99.31 31.6 3.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.04 0.447 . . . . 0.0 111.608 -176.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.417 ' HB2' ' HE1' ' A' ' 124' ' ' TRP . 11.3 pt-20 -158.86 156.44 29.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.941 176.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 33.1 t80 -146.01 154.03 41.43 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.05 131.94 54.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.711 0.291 . . . . 0.0 110.996 -178.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.42 HG12 HD11 ' A' ' 125' ' ' ILE . 29.0 mm -106.88 138.55 32.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 170' ' ' LEU . 3.0 mm? -104.64 -28.15 11.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.965 0.412 . . . . 0.0 111.107 -176.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.9 m -90.59 75.15 6.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.928 -174.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 172' ' ' LEU . 2.7 mm? -114.56 142.66 46.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.84 0.352 . . . . 0.0 110.737 176.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 26.3 m-70 -111.35 134.36 21.17 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.924 174.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 39.7 Cg_exo -61.22 131.14 35.07 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.834 2.356 . . . . 0.0 112.325 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 73.36 43.57 37.62 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.118 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -134.0 148.0 51.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.872 0.368 . . . . 0.0 110.041 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -95.03 126.29 40.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.74 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -120.29 136.8 54.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.184 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 7.3 mp -102.24 129.67 48.7 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.22 141.84 43.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.069 0.462 . . . . 0.0 111.544 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 98.5 mt-30 -141.42 149.02 40.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.066 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.15 136.58 37.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.618 0.247 . . . . 0.0 110.338 175.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.441 ' HD2' ' HA ' ' A' ' 194' ' ' TRP . 65.7 mtp85 -143.47 160.93 39.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.354 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' CYS . . . . . 0.61 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 21.3 p -148.49 172.15 14.94 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 21.2 pttp . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 121.058 0.456 . . . . 0.0 111.907 -174.518 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.483 ' CH2' ' HB2' ' A' ' 147' ' ' ARG . 72.9 m95 . . . . . 0 N--CA 1.456 -0.165 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.455 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 13.1 m -148.69 -58.87 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.563 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 4.5 Cg_exo -79.56 75.69 4.93 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.332 2.021 . . . . 0.0 113.412 -168.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -77.91 103.02 7.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.988 0.423 . . . . 0.0 110.429 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.2 m -96.95 140.58 31.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.454 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -105.0 131.4 52.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.933 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.3 tp -126.49 140.06 49.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.121 0.486 . . . . 0.0 110.744 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -103.41 119.11 38.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.038 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 51.2 mm -83.29 124.31 76.14 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.636 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.99 164.92 25.57 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.211 2.608 . . . . 0.0 113.419 -174.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 10.3 p -68.63 -46.79 68.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.473 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -85.6 35.19 0.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.769 0.795 . . . . 0.0 110.609 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.584 ' HA ' ' OE1' ' A' ' 115' ' ' GLN . 89.2 t80 -68.76 -58.04 4.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 C--N 1.322 -0.626 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.814 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 0 N--CA 1.464 -0.226 0 CA-C-O 121.453 0.522 . . . . 0.0 112.179 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.663 ' H ' HD23 ' A' ' 107' ' ' LEU . 2.6 pt? -94.53 -173.21 2.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.021 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 54.7 43.04 30.76 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 123.563 0.54 . . . . 0.0 110.217 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.413 HD13 ' HB3' ' A' ' 127' ' ' TRP . 48.6 tp -68.76 94.77 0.63 Allowed 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.604 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.69 125.64 38.42 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.997 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.478 HG12 HD11 ' A' ' 123' ' ' LEU . 2.1 t -110.69 114.13 46.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -121.32 118.19 28.87 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.108 -173.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.518 HG22 ' CD1' ' A' ' 123' ' ' LEU . 7.1 t -80.39 123.84 37.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -102.73 120.5 40.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.956 0.408 . . . . 0.0 110.783 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -121.61 86.39 44.75 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.422 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.41 ' HB2' ' HB2' ' A' ' 119' ' ' ARG . 12.1 Cg_exo -71.62 -177.85 2.71 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 123.211 2.607 . . . . 0.0 113.327 -175.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -74.41 -64.71 0.97 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.17 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -119.32 15.26 13.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.096 0.474 . . . . 0.0 110.912 -176.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.41 ' HB2' ' HB2' ' A' ' 116' ' ' PRO . 98.9 mtt180 -110.29 150.19 29.09 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.556 177.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -61.71 138.22 95.22 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 123.634 0.584 . . . . 0.0 110.646 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.98 138.52 44.34 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.543 2.162 . . . . 0.0 111.47 178.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -148.39 157.25 43.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.624 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.518 ' CD1' HG22 ' A' ' 113' ' ' VAL . 30.7 tp -92.61 124.8 36.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.955 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.525 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 21.3 t90 -103.43 103.75 13.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.096 0.474 . . . . 0.0 110.429 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.2 mp -95.2 116.45 36.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.579 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.47 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 5.0 ttpm? -128.93 127.27 41.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.189 0.518 . . . . 0.0 110.566 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' TRP . . . . . 0.413 ' HB3' HD13 ' A' ' 109' ' ' LEU . 22.5 p90 -116.27 160.56 20.28 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.27 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 39.3 t -86.33 118.62 70.64 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo . . . . . 0 C--O 1.235 0.338 0 C-N-CA 122.709 2.273 . . . . 0.0 111.876 -178.423 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 60.0 mt -104.31 141.51 36.18 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.018 0.437 . . . . 0.0 110.941 -175.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.619 ' CE2' ' HB3' ' A' ' 184' ' ' CYS . 93.6 m-85 -104.29 141.24 36.64 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.477 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -126.84 136.57 52.53 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.41 ' CD1' ' HB2' ' A' ' 161' ' ' ALA . 4.9 mp -118.16 128.07 75.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.949 0.404 . . . . 0.0 110.782 -176.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.533 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 15.3 ttp180 -113.07 120.3 40.86 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.6 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -144.58 160.41 41.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.692 0.282 . . . . 0.0 111.596 -175.872 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.401 ' HE2' ' CE2' ' A' ' 156' ' ' TRP . 56.7 pttt -170.93 144.55 1.82 Allowed Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.489 176.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.5 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 43.4 Cg_endo -74.2 167.09 28.0 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.553 2.169 . . . . 0.0 111.444 167.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.453 ' HG2' ' HG3' ' A' ' 152' ' ' LYS . 1.4 pm0 -59.47 -39.6 84.21 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.925 0.393 . . . . 0.0 111.426 -177.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.453 ' HG3' ' HG2' ' A' ' 151' ' ' GLU . 91.7 mttt -87.8 16.25 6.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.499 -175.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.5 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -88.96 -38.99 14.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.262 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 70.33 -54.38 0.63 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.126 0.891 . . . . 0.0 111.19 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -85.41 151.89 23.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.248 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.533 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 77.1 m95 -90.45 135.51 33.64 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.216 178.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -99.95 123.48 44.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.505 175.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.4 mp -103.66 120.07 53.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.994 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 41.2 m-70 -123.35 122.91 39.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.872 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -85.8 131.4 34.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.548 -176.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.41 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -96.6 -41.56 8.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.331 . . . . 0.0 111.387 -179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.35 -141.09 15.18 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.292 -176.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.447 ' H ' ' CD ' ' A' ' 163' ' ' GLN . 0.4 OUTLIER -97.49 44.03 1.06 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.461 0.648 . . . . 0.0 111.08 -177.723 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -128.46 149.68 50.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.593 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.3 p -101.47 26.18 7.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -174.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -151.66 140.42 20.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.931 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 33.5 t80 -130.7 146.99 52.32 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.525 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 39.1 mmtm -112.1 132.5 54.81 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.736 0.303 . . . . 0.0 110.901 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 26.4 mm -112.34 136.85 47.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -104.93 -25.5 12.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.068 0.461 . . . . 0.0 110.441 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 25.6 t -86.18 70.02 10.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.287 -175.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.9 mm? -110.62 139.83 45.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.968 0.414 . . . . 0.0 110.435 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -101.03 122.51 48.4 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.051 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.449 ' HB3' ' HB3' ' A' ' 206' ' ' PHE . 10.0 Cg_endo -58.35 116.96 3.61 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.527 2.152 . . . . 0.0 112.605 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 91.35 32.46 8.77 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.636 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.562 HE21 ' HA ' ' A' ' 176' ' ' GLN . 0.1 OUTLIER -133.13 159.3 40.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.826 0.346 . . . . 0.0 110.911 -179.6 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -106.88 126.63 52.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.691 -174.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -112.82 137.95 50.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.048 0.451 . . . . 0.0 110.67 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.9 mp -99.84 124.21 44.89 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 26.3 m -121.8 140.27 46.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.229 0.538 . . . . 0.0 111.877 -176.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.611 HE21 ' HB2' ' A' ' 197' ' ' ALA . 82.7 mt-30 -136.08 147.68 47.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.333 175.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.18 142.44 22.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.869 0.366 . . . . 0.0 110.128 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 27.0 ttt-85 -146.69 149.31 33.2 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' CYS . . . . . 0.619 ' HB3' ' CE2' ' A' ' 144' ' ' TYR . 9.0 p -103.67 154.03 19.98 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.527 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 73.7 mttt . . . . . 0 C--N 1.32 -0.679 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.676 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 73.1 m95 . . . . . 0 C--O 1.235 0.299 0 N-CA-C 110.448 -0.204 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.506 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 2.0 m -133.54 -60.85 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -176.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 14.8 Cg_endo -94.9 111.47 0.15 Allowed 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.674 2.249 . . . . 0.0 113.308 -172.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.611 ' HB2' HE21 ' A' ' 181' ' ' GLN . . . -103.53 122.47 45.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.039 0.447 . . . . 0.0 110.858 177.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 90.7 m -117.03 147.04 42.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.709 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.403 ' CD2' ' HG ' ' A' ' 179' ' ' LEU . 68.2 m-85 -110.66 140.37 45.08 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.1 tp -136.23 138.07 47.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.145 0.498 . . . . 0.0 110.794 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -104.39 124.37 49.09 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.551 177.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 40.8 mm -88.56 124.55 65.66 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.343 178.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.49 146.61 96.88 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.605 2.203 . . . . 0.0 111.908 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 49.6 m -70.91 -11.56 61.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.288 0.566 . . . . 0.0 110.57 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -96.26 15.59 20.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.614 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.511 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 83.7 t80 -53.13 -43.91 67.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.523 177.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.449 -0.479 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.229 177.143 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.413 ' HG2' HG13 ' A' ' 182' ' ' VAL . 11.8 Cg_endo . . . . . 0 C--O 1.235 0.339 0 N-CA-C 110.87 -0.473 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.41 HD12 ' HB2' ' A' ' 128' ' ' SER . 0.6 OUTLIER -127.16 174.68 8.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.971 -172.059 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 57.07 60.63 2.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.343 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.426 HD23 ' HB3' ' A' ' 127' ' ' TRP . 9.7 mt -69.45 97.76 1.03 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.7 174.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.6 122.02 39.07 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.455 HG12 HD22 ' A' ' 123' ' ' LEU . 10.0 t -115.09 119.55 62.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.896 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -118.88 132.7 56.11 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.158 -176.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.495 ' HA ' HD23 ' A' ' 123' ' ' LEU . 12.9 p -86.78 128.26 39.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.19 0.519 . . . . 0.0 109.984 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -116.69 107.84 15.17 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.21 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.457 ' HG2' ' HB3' ' A' ' 121' ' ' PRO . 50.5 mt-30 -111.24 97.95 37.58 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.421 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.91 -179.88 4.68 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.775 2.316 . . . . 0.0 112.374 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.66 -68.44 0.45 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.884 0.373 . . . . 0.0 110.855 -177.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -107.24 -18.28 13.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.334 0.588 . . . . 0.0 110.97 -176.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -80.12 141.93 35.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.845 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -60.06 135.39 90.54 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.268 -175.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.457 ' HB3' ' HG2' ' A' ' 115' ' ' GLN . 38.0 Cg_endo -65.52 149.36 87.77 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.978 2.452 . . . . 0.0 112.282 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.428 ' HB3' HD13 ' A' ' 170' ' ' LEU . 49.2 p90 -150.81 167.98 25.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.941 -175.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 113' ' ' VAL . 11.1 mt -100.25 142.41 31.77 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 120.918 0.39 . . . . 0.0 110.822 176.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.523 ' CZ2' ' HD2' ' A' ' 126' ' ' LYS . 19.9 t90 -113.93 105.28 13.06 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.729 175.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.1 mp -94.87 118.48 41.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.523 ' HD2' ' CZ2' ' A' ' 124' ' ' TRP . 81.5 tttt -132.05 119.56 21.17 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.216 0.532 . . . . 0.0 110.866 -175.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' TRP . . . . . 0.491 ' CH2' HD11 ' A' ' 146' ' ' ILE . 35.5 p90 -116.08 162.46 17.39 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.829 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.41 ' HB2' HD12 ' A' ' 107' ' ' LEU . 17.6 m -102.9 134.94 19.54 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 C--N 1.347 0.464 0 C-N-CA 123.235 2.623 . . . . 0.0 112.279 -177.005 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.024 ' HG ' ' SG ' ' A' ' 184' ' ' CYS . 11.4 tp . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 120.889 0.376 . . . . 0.0 110.077 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -96.16 133.67 40.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.948 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -102.1 144.35 30.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.988 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 75.1 tt0 -136.64 137.35 39.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.926 -173.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 181' ' ' GLN . 4.7 mp -120.57 125.42 74.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.775 0.321 . . . . 0.0 110.858 -176.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.44 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 18.0 ttp180 -108.84 121.77 45.77 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 4.0 pp -145.25 159.28 43.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.79 0.328 . . . . 0.0 111.342 -176.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -168.61 149.33 4.34 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.54 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 31.3 Cg_endo -70.95 160.89 47.94 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.988 1.792 . . . . 0.0 112.311 174.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.455 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 6.0 pt-20 -50.93 -46.93 61.04 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.455 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 93.4 mttt -84.77 13.85 5.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.803 0.335 . . . . 0.0 111.59 -174.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.54 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -88.23 134.25 33.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.926 0.393 . . . . 0.0 111.185 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -89.95 -21.63 22.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.205 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -120.37 145.83 46.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.733 -177.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.44 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 66.4 m95 -84.06 137.7 33.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.433 176.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -109.9 116.7 32.1 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.423 0.63 . . . . 0.0 111.323 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.1 mp -91.03 130.79 39.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.935 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 67.6 m-70 -124.11 126.03 45.49 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.223 176.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -93.0 119.55 32.38 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.852 0.358 . . . . 0.0 110.836 -174.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.437 ' HB2' HD11 ' A' ' 146' ' ' ILE . . . -75.09 -51.5 13.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.054 177.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 77.8 81.76 0.63 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.368 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 74.3 -40.0 0.44 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.954 0.901 . . . . 0.0 112.563 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -68.56 145.65 53.78 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 55.5 p -104.94 30.31 5.63 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.26 0.552 . . . . 0.0 111.49 -176.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -154.14 144.76 22.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.639 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 32.4 t80 -142.27 146.14 34.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.081 -177.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.451 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 10.3 mptt -115.76 144.53 43.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.861 0.362 . . . . 0.0 110.661 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 35.8 mm -119.61 134.19 63.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.951 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.428 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.6 mm? -102.02 -29.52 11.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.878 0.371 . . . . 0.0 110.608 178.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 45.6 m -86.2 73.89 10.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.963 -175.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.25 144.3 41.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.854 0.359 . . . . 0.0 110.333 174.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 -110.16 122.11 39.72 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.887 175.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.25 124.35 15.96 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.984 2.456 . . . . 0.0 112.772 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 97.21 12.54 48.6 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.073 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -118.78 148.84 42.4 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.377 0.608 . . . . 0.0 111.873 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -89.47 129.97 35.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.547 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.435 ' HB2' HG23 ' A' ' 200' ' ' ILE . 22.7 m-85 -115.59 135.52 53.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.998 0.427 . . . . 0.0 110.455 177.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.6 mp -101.5 121.94 42.88 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.402 HG23 ' HB ' ' A' ' 198' ' ' THR . 29.8 m -119.49 137.56 52.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.175 0.512 . . . . 0.0 111.062 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.553 HE21 ' HB2' ' A' ' 197' ' ' ALA . 89.3 mt-30 -136.94 139.58 41.63 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.556 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 145' ' ' GLU . 10.4 p -123.55 137.35 57.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.206 0.527 . . . . 0.0 110.606 174.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -138.79 138.68 37.81 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.667 174.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' CYS . . . . . 1.024 ' SG ' ' HG ' ' A' ' 142' ' ' LEU . 4.6 t -125.53 156.23 39.36 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.424 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.22 -172.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.412 ' CZ2' ' HB2' ' A' ' 147' ' ' ARG . 83.0 m95 . . . . . 0 C--O 1.23 0.078 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.516 ' OG ' ' HD3' ' A' ' 196' ' ' PRO . 3.1 p -110.72 -50.24 0.06 OUTLIER Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -176.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.516 ' HD3' ' OG ' ' A' ' 195' ' ' SER . 9.3 Cg_endo -86.92 83.05 1.13 Allowed 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.019 1.813 . . . . 0.0 113.12 -172.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.553 ' HB2' HE21 ' A' ' 181' ' ' GLN . . . -87.41 107.1 18.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.043 0.449 . . . . 0.0 110.464 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.402 ' HB ' HG23 ' A' ' 180' ' ' VAL . 28.8 m -100.27 139.8 35.43 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.19 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -108.19 120.41 42.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.831 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.435 HG23 ' HB2' ' A' ' 178' ' ' TYR . 6.1 tp -119.99 133.56 66.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.167 0.508 . . . . 0.0 110.508 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -95.94 135.58 37.51 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.452 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.455 HD11 HD11 ' A' ' 123' ' ' LEU . 43.1 mm -95.83 121.51 60.94 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 175.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.01 149.13 86.11 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.923 2.415 . . . . 0.0 112.071 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 7.5 p -72.76 -18.75 61.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.037 0.446 . . . . 0.0 110.523 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -91.32 16.78 9.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.363 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.417 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 54.5 t80 -67.1 -32.41 73.54 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.451 -0.382 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.058 175.757 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.484 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 32.8 Cg_endo . . . . . 0 N--CA 1.461 -0.383 0 N-CA-C 111.131 -0.373 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.16 178.82 4.55 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.382 -174.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 54.16 58.07 5.33 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.894 -178.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.0 96.15 3.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.012 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.57 129.87 41.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.84 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.483 HG12 HD11 ' A' ' 123' ' ' LEU . 3.1 t -120.35 120.25 62.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.786 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -132.16 141.53 49.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.686 0.279 . . . . 0.0 110.616 -176.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.2 p -95.82 120.28 45.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.049 0.452 . . . . 0.0 110.029 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -111.18 126.82 55.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.904 0.383 . . . . 0.0 111.109 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.44 ' HG2' ' HB3' ' A' ' 121' ' ' PRO . 78.0 mt-30 -114.02 106.47 53.26 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.098 175.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.53 170.37 5.61 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.054 2.503 . . . . 0.0 112.561 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -78.29 -8.68 58.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.382 -176.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -159.71 -40.13 0.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.243 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -69.05 167.37 16.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.295 -178.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -63.02 141.68 97.69 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.853 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.44 ' HB3' ' HG2' ' A' ' 115' ' ' GLN . 60.3 Cg_endo -72.36 147.26 46.68 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.819 2.346 . . . . 0.0 111.602 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.496 ' HB3' HD13 ' A' ' 170' ' ' LEU . 34.8 p90 -147.92 154.77 40.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.14 0.495 . . . . 0.0 111.336 -175.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.616 ' HB2' HD11 ' A' ' 172' ' ' LEU . 28.9 tp -90.16 124.36 34.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.531 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.541 ' CZ2' ' HD3' ' A' ' 126' ' ' LYS . 21.9 t90 -100.32 103.76 15.19 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.224 0.535 . . . . 0.0 110.232 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.9 mp -97.66 119.82 46.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.195 177.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.541 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 25.4 pttm -132.0 139.59 48.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.51 0.672 . . . . 0.0 110.458 176.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 19.1 p90 -122.52 145.3 48.45 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.143 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.6 t -88.11 121.15 70.71 Favored Pre-proline 0 C--N 1.317 -0.828 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo . . . . . 0 C--N 1.347 0.497 0 C-N-CA 123.58 2.854 . . . . 0.0 112.951 -179.116 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 39.2 tp . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.24 142.03 28.15 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.936 0.398 . . . . 0.0 111.063 -175.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.475 ' CE2' HG22 ' A' ' 165' ' ' THR . 86.8 m-85 -119.37 141.51 48.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.123 -175.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -120.29 129.82 54.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.057 175.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.5 mp -106.6 125.38 62.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.005 0.431 . . . . 0.0 110.191 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.523 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 18.6 ttp180 -117.66 119.81 36.12 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.676 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -140.5 159.45 42.17 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.413 -176.32 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.45 ' HE2' ' CZ2' ' A' ' 156' ' ' TRP . 52.4 pttt -167.08 149.9 5.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.426 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.422 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 45.8 Cg_endo -71.97 161.69 44.1 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.547 2.165 . . . . 0.0 111.196 170.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -67.47 -16.74 64.38 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -172.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -94.04 -1.15 54.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.021 0.439 . . . . 0.0 110.427 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.422 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -91.23 125.78 36.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.381 -176.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.09 -35.32 25.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.706 0.765 . . . . 0.0 109.415 173.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -88.16 150.25 23.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.388 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.523 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 65.4 m95 -101.41 153.4 19.72 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.786 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -105.24 117.78 34.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.592 174.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -94.82 118.8 41.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.227 0.537 . . . . 0.0 110.044 175.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 22.8 m-70 -122.68 114.8 21.07 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.328 177.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -82.71 142.22 31.82 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.508 -176.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -82.37 -46.36 13.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.944 0.402 . . . . 0.0 111.448 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 163' ' ' GLN . . . 108.28 -39.44 2.9 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.987 177.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 162' ' ' GLY . 63.8 tt0 174.93 -28.28 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.295 0.569 . . . . 0.0 110.017 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -70.78 160.3 32.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.809 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.475 HG22 ' CE2' ' A' ' 144' ' ' TYR . 60.7 p -110.91 28.09 9.04 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.254 0.549 . . . . 0.0 111.273 -174.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.405 ' HB2' ' HE1' ' A' ' 124' ' ' TRP . 12.3 pt-20 -152.29 143.95 23.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.411 177.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 19.8 t80 -131.86 147.7 52.5 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.437 ' HD2' ' CE2' ' A' ' 122' ' ' TYR . 43.2 mmtt -117.68 131.69 56.59 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 34.9 mm -106.91 125.01 62.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.496 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.8 mm? -93.95 -38.2 11.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.508 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 14.7 m -76.51 87.23 3.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.822 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.616 HD11 ' HB2' ' A' ' 123' ' ' LEU . 49.1 mt -131.92 147.57 52.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.762 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -109.28 134.29 20.52 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.305 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.34 110.87 2.13 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.618 2.212 . . . . 0.0 111.852 178.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 90.17 46.61 4.08 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.6 -176.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -135.78 147.22 48.27 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.925 0.393 . . . . 0.0 110.29 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -98.29 129.1 45.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.028 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -122.38 138.82 54.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.93 0.395 . . . . 0.0 110.639 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 7.5 mp -97.09 132.97 42.36 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.467 ' CG2' ' HB ' ' A' ' 198' ' ' THR . 28.4 m -122.72 152.98 27.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.174 0.511 . . . . 0.0 110.988 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.581 ' NE2' ' HA ' ' A' ' 181' ' ' GLN . 0.8 OUTLIER -151.94 152.6 32.73 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.454 -177.871 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.9 p -135.85 139.91 45.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.029 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -136.49 133.59 36.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.449 176.852 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 184' ' ' CYS . . . . . 0.484 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 13.0 p -105.08 144.65 31.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.486 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 53.4 mttt . . . . . 0 C--N 1.327 -0.391 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.284 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.448 ' CE3' ' HB3' ' A' ' 181' ' ' GLN . 63.4 m95 . . . . . 0 C--O 1.231 0.126 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.527 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 6.9 m -102.0 -54.05 0.14 Allowed Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -176.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.527 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 73.5 Cg_endo -78.08 169.74 19.9 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.656 1.571 . . . . 0.0 112.333 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -154.93 117.89 4.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 172.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.467 ' HB ' ' CG2' ' A' ' 180' ' ' VAL . 7.0 m -99.01 134.57 41.65 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.312 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -104.91 130.07 53.15 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 8.4 tp -128.78 138.92 53.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.284 0.564 . . . . 0.0 111.124 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -100.14 123.29 44.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.936 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 50.6 mm -88.24 120.39 70.53 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 173.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.6 150.69 80.53 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.845 2.363 . . . . 0.0 112.425 -176.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 17.5 m -69.83 -12.53 61.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.52 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -91.6 17.31 8.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.711 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -67.3 -34.11 76.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.232 -178.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.191 -176.927 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.423 ' HG3' ' SG ' ' A' ' 184' ' ' CYS . 14.6 Cg_endo . . . . . 0 C--O 1.235 0.35 0 N-CA-C 111.446 -0.251 . . . . 0.0 111.446 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.01 -172.13 3.61 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.498 -173.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 58.53 51.24 8.18 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.699 0.625 . . . . 0.0 111.403 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.43 HD23 ' OG1' ' A' ' 198' ' ' THR . 52.9 tp -80.23 93.62 5.91 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.76 127.45 45.91 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.306 -177.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.7 t -112.27 123.8 68.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.877 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -132.59 140.07 48.09 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.585 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.69 113.46 32.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.383 0.611 . . . . 0.0 109.753 176.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -96.26 121.26 37.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.223 -176.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -120.7 76.13 27.48 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.101 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.91 160.61 40.2 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.74 2.293 . . . . 0.0 111.891 -178.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -83.2 -25.59 31.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.295 0.569 . . . . 0.0 110.374 176.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -92.75 -44.55 8.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.324 -175.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -105.07 153.64 21.21 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.414 ' O ' ' HD2' ' A' ' 122' ' ' TYR . 18.7 ptpt -64.7 152.43 90.05 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.413 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.55 134.34 44.02 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.754 2.303 . . . . 0.0 112.565 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.414 ' HD2' ' O ' ' A' ' 120' ' ' LYS . 46.1 p90 -146.4 163.93 34.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.443 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.472 ' HB3' ' HB ' ' A' ' 169' ' ' ILE . 33.7 tp -97.44 125.77 42.29 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.47 ' CZ2' ' HD2' ' A' ' 126' ' ' LYS . 24.3 t90 -107.67 114.66 28.79 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.296 -176.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.409 HD11 HG12 ' A' ' 169' ' ' ILE . 4.2 mp -102.85 123.08 55.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.47 ' HD2' ' CZ2' ' A' ' 124' ' ' TRP . 51.2 tttm -132.38 121.12 22.97 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.991 0.424 . . . . 0.0 110.848 -177.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' TRP . . . . . 0.414 ' CD2' HG21 ' A' ' 182' ' ' VAL . 42.8 p90 -119.61 166.42 13.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.995 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 61.2 m -109.02 126.47 29.27 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.293 177.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo . . . . . 0 C--O 1.233 0.257 0 C-N-CA 122.822 2.348 . . . . 0.0 111.647 179.446 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 54.1 tp . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.553 ' CD1' ' HG2' ' A' ' 163' ' ' GLN . 2.8 mm? -100.55 157.22 16.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 -176.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -120.84 136.98 54.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.801 -176.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.452 ' C ' HG13 ' A' ' 146' ' ' ILE . 27.4 tt0 -127.54 140.42 52.14 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -174.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.46 ' CD1' ' HB2' ' A' ' 161' ' ' ALA . 7.6 mt -132.65 150.15 32.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.98 0.419 . . . . 0.0 111.843 -166.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.48 ' HG3' ' CH2' ' A' ' 194' ' ' TRP . 43.6 mtm180 -126.75 154.71 43.82 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 174.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.629 HD12 ' NE2' ' A' ' 159' ' ' HIS . 0.0 OUTLIER -163.1 155.41 18.36 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 123.297 0.373 . . . . 0.0 110.255 170.773 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -173.43 141.38 0.91 Allowed Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.955 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.8 173.37 13.57 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.561 2.174 . . . . 0.0 112.108 173.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.408 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 9.0 pt-20 -65.78 -24.68 66.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.627 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.408 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 50.6 mttm -90.51 11.51 21.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.237 0.541 . . . . 0.0 110.467 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -111.52 130.6 55.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.751 178.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -92.92 -35.35 13.38 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.259 0.552 . . . . 0.0 110.341 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -91.92 149.46 21.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.002 -175.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -93.77 128.72 40.14 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.065 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -93.06 111.46 23.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.008 173.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.462 HG13 ' HG2' ' A' ' 147' ' ' ARG . 1.9 mp -88.72 126.21 41.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.629 ' NE2' HD12 ' A' ' 148' ' ' LEU . 3.2 p80 -130.36 132.96 46.06 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.828 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -97.72 116.57 30.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.199 -176.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.46 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -76.95 -48.74 17.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.191 0.52 . . . . 0.0 110.643 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 123.5 -125.61 5.96 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.257 -176.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.553 ' HG2' ' CD1' ' A' ' 143' ' ' LEU . 28.8 mt-30 -102.14 -7.0 22.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.921 0.391 . . . . 0.0 110.482 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -79.48 143.24 35.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.375 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 63.5 p -101.32 33.78 2.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.171 0.51 . . . . 0.0 111.76 -174.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -158.82 153.51 24.62 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.283 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -151.27 152.56 33.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.701 0.286 . . . . 0.0 110.547 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 168' ' ' LYS . 0.1 OUTLIER -118.33 128.92 55.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.437 -178.109 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 123' ' ' LEU . 23.6 mm -99.87 140.82 18.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.11 -19.82 13.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.777 0.323 . . . . 0.0 110.86 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 36.7 t -87.59 73.89 9.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.231 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.418 HD22 ' N ' ' A' ' 172' ' ' LEU . 2.7 mm? -117.7 143.26 46.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.995 0.426 . . . . 0.0 110.522 175.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 73.0 m80 -119.15 132.26 24.03 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.575 175.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 24.3 Cg_exo -62.09 124.33 14.2 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.791 2.327 . . . . 0.0 112.732 -177.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 85.67 28.37 29.64 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.751 177.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -123.75 149.74 45.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.14 0.495 . . . . 0.0 111.125 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -87.38 128.34 35.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.361 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -121.1 142.39 49.89 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.752 0.311 . . . . 0.0 110.329 175.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.8 mp -104.93 146.89 28.39 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 172.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.459 HG23 ' HB ' ' A' ' 198' ' ' THR . 19.4 m -134.53 152.74 34.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.983 0.42 . . . . 0.0 110.484 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.565 ' NE2' ' HA ' ' A' ' 181' ' ' GLN . 0.3 OUTLIER -151.66 146.27 25.67 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.035 179.522 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.414 HG21 ' CD2' ' A' ' 127' ' ' TRP . 12.0 p -138.17 149.82 24.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -158.34 139.25 13.02 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' CYS . . . . . 0.423 ' SG ' ' HG3' ' A' ' 106' ' ' PRO . 26.3 p -104.41 177.9 4.71 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 56.3 mttm . . . . . 0 C--N 1.327 -0.395 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.684 -178.391 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.48 ' CH2' ' HG3' ' A' ' 147' ' ' ARG . 50.9 m95 . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 120.796 0.331 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.447 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 12.9 m -74.48 -51.24 4.35 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.099 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.447 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 59.2 Cg_endo -74.78 165.27 31.84 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.667 1.578 . . . . 0.0 112.722 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -154.11 130.67 10.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.965 172.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.459 ' HB ' HG23 ' A' ' 180' ' ' VAL . 12.8 m -115.9 135.45 53.98 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.582 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -106.22 131.64 53.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.252 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.0 tp -128.53 130.27 69.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.283 0.563 . . . . 0.0 110.4 177.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -97.81 113.38 25.16 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.338 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 51.7 mm -74.27 122.05 86.64 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.14 155.05 71.63 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.776 2.318 . . . . 0.0 112.353 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 12.3 p -75.85 -5.18 44.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.299 0.571 . . . . 0.0 110.224 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -82.8 -6.43 59.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.148 177.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 36.2 t80 -53.32 -37.26 62.11 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.54 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.449 -0.506 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.231 174.176 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.664 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 73.4 Cg_endo . . . . . 0 N--CA 1.458 -0.609 0 N-CA-C 111.271 -0.319 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.405 HD23 ' N ' ' A' ' 107' ' ' LEU . 2.1 pt? -140.07 -174.61 3.97 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.094 -177.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 128' ' ' SER . 42.7 mt-10 54.99 55.97 7.12 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 123.704 0.628 . . . . 0.0 110.925 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.4 tp -75.5 96.85 3.56 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.21 0.528 . . . . 0.0 110.491 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.09 123.18 38.44 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.253 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.444 HG12 HD11 ' A' ' 123' ' ' LEU . 3.5 t -119.04 118.1 56.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.43 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -136.1 121.37 19.14 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.838 -174.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.475 HG22 HD13 ' A' ' 123' ' ' LEU . 48.2 t -74.48 129.44 36.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.312 -0.403 . . . . 0.0 109.971 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 114' ' ' LYS . 24.3 mmtp -118.59 125.17 49.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.14 0.495 . . . . 0.0 111.642 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -117.26 97.13 50.41 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.884 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.491 ' HB2' ' HB2' ' A' ' 119' ' ' ARG . 15.2 Cg_exo -68.74 171.48 13.24 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.429 2.086 . . . . 0.0 111.968 177.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -76.18 -66.2 0.83 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.953 0.406 . . . . 0.0 110.706 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -92.69 -33.6 14.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.666 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.491 ' HB2' ' HB2' ' A' ' 116' ' ' PRO . 71.8 mtp180 -72.41 154.9 40.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.806 176.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -75.54 149.39 83.79 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.53 146.15 48.97 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.975 2.45 . . . . 0.0 112.468 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.473 ' CD2' ' HD2' ' A' ' 168' ' ' LYS . 49.0 p90 -151.41 161.37 42.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.461 -176.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.623 ' HB2' HD11 ' A' ' 172' ' ' LEU . 44.5 tp -91.52 125.46 36.27 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 175.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.595 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 22.4 t90 -102.03 108.93 20.52 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.127 0.489 . . . . 0.0 110.421 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.03 122.22 52.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.337 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -131.09 120.5 23.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.946 0.403 . . . . 0.0 110.491 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' TRP . . . . . 0.437 ' CH2' HD11 ' A' ' 146' ' ' ILE . 37.1 p90 -115.83 165.84 12.63 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.466 -178.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.428 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 23.0 t -104.34 121.27 47.94 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.756 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo . . . . . 0 C--N 1.346 0.442 0 C-N-CA 123.377 2.718 . . . . 0.0 112.526 177.914 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.479 HD21 ' SG ' ' A' ' 184' ' ' CYS . 48.0 tp . . . . . 0 N--CA 1.448 -0.538 0 CA-C-O 120.962 0.411 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 3.5 mp -95.71 134.84 38.16 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.318 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -102.83 153.17 20.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.718 -172.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -131.62 134.24 45.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.953 -171.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.437 HD11 ' CH2' ' A' ' 127' ' ' TRP . 4.5 mp -125.68 125.2 68.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.549 ' HB3' ' HB2' ' A' ' 181' ' ' GLN . 46.6 ttp180 -118.01 119.86 36.06 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -141.5 162.59 35.12 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.848 -176.251 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -167.07 150.25 6.06 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.164 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.482 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 34.2 Cg_endo -68.32 159.48 53.13 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.282 1.988 . . . . 0.0 111.027 171.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.44 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 15.8 pt-20 -63.06 -20.66 65.54 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -171.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.44 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 84.7 mttt -100.28 7.35 44.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.091 0.472 . . . . 0.0 110.852 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.482 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -84.75 124.24 31.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.899 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.96 -22.99 39.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.535 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -115.32 154.45 29.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.393 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -94.7 141.58 28.45 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.324 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -103.92 108.58 19.97 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.989 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.43 HD12 ' N ' ' A' ' 158' ' ' ILE . 2.2 mp -87.99 133.4 30.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.033 0.444 . . . . 0.0 110.053 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -126.92 141.84 51.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.609 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 143' ' ' LEU . 5.3 t80 -106.14 124.66 49.93 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.073 -177.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -88.21 -44.06 11.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.138 0.494 . . . . 0.0 110.303 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 143' ' ' LEU . . . 103.71 -127.63 9.21 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.051 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -93.03 9.0 37.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.447 0.641 . . . . 0.0 110.519 -176.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -105.48 153.19 22.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.584 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.8 p -107.44 19.5 20.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.033 -175.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -146.57 140.66 26.27 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -133.87 151.39 51.51 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.595 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 40.7 mmtm -120.53 135.48 55.07 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.613 0.244 . . . . 0.0 110.66 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 33.9 mm -109.7 128.78 65.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.93 -25.06 12.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.368 . . . . 0.0 111.051 -178.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 13.8 m -80.62 65.4 5.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.712 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 123' ' ' LEU . 57.6 mt -114.55 157.59 22.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.949 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 75.3 m-70 -126.08 129.97 24.1 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.774 177.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 23.7 Cg_exo -63.75 121.85 9.73 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.615 2.21 . . . . 0.0 111.925 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 90.8 20.2 40.93 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.05 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -117.49 142.97 46.52 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 151' ' ' GLU . 30.3 ttmt -90.77 135.13 33.92 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.064 177.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -122.12 133.17 54.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.112 0.482 . . . . 0.0 110.606 176.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.3 mp -100.68 124.71 46.66 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.442 HG21 HG21 ' A' ' 111' ' ' VAL . 34.7 m -115.02 161.27 13.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.364 0.602 . . . . 0.0 111.723 -176.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.584 HE21 ' HB2' ' A' ' 197' ' ' ALA . 12.2 mm-40 -145.63 148.67 33.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.901 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 9.0 p -136.37 145.69 30.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 120.891 0.377 . . . . 0.0 110.184 175.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.56 ' HG2' ' CZ3' ' A' ' 194' ' ' TRP . 1.2 ptm180 -163.08 177.98 8.68 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.398 175.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' CYS . . . . . 0.664 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 27.9 p -155.25 170.46 21.81 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 21.7 pttm . . . . . 0 C--N 1.322 -0.619 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.797 -176.067 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.56 ' CZ3' ' HG2' ' A' ' 183' ' ' ARG . 71.9 m95 . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 120.717 0.294 . . . . 0.0 111.653 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.574 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 70.4 m -158.58 -63.97 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.574 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 76.9 Cg_endo -76.25 109.07 2.8 Favored 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 121.896 1.731 . . . . 0.0 113.456 -173.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.584 ' HB2' HE21 ' A' ' 181' ' ' GLN . . . -101.66 137.61 39.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.891 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 94.9 m -133.48 139.21 46.54 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.574 177.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -99.75 126.72 45.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.396 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.9 tp -129.25 137.68 56.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.029 0.443 . . . . 0.0 110.423 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -102.54 137.33 40.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.905 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 39.2 mm -96.98 113.08 62.39 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 176.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.8 147.44 72.39 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.921 2.414 . . . . 0.0 112.188 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 42.1 m -71.76 -7.51 48.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.974 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -95.16 7.77 45.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.773 175.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -59.77 -36.19 76.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.114 177.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 24.9 m . . . . . 0 C--N 1.319 -0.754 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.225 177.85 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo . . . . . 0 C--O 1.232 0.185 0 CA-C-O 120.684 0.202 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.93 174.26 5.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.154 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 54.74 47.53 22.25 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.694 0.621 . . . . 0.0 110.976 -178.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.445 HD23 ' OG1' ' A' ' 198' ' ' THR . 55.8 tp -70.34 94.39 0.94 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.002 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.17 130.79 43.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.541 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.431 HG13 HG13 ' A' ' 125' ' ' ILE . 5.0 t -117.38 113.88 43.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.667 178.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -111.94 148.43 33.76 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.18 -178.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.6 p -108.36 95.84 4.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 122.077 0.941 . . . . 0.0 109.92 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -87.36 122.06 30.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.456 -174.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -117.88 98.87 51.95 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.195 -173.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.6 155.39 49.83 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.977 2.451 . . . . 0.0 111.27 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.496 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -93.5 -4.93 50.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.958 0.408 . . . . 0.0 111.145 -176.317 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -132.49 -34.94 1.16 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.728 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -87.37 173.15 9.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.291 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -79.62 138.24 54.75 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.161 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.425 ' HG3' ' O ' ' A' ' 206' ' ' PHE . 38.3 Cg_endo -66.24 147.91 84.1 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.949 2.432 . . . . 0.0 111.847 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -149.09 156.99 43.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.958 0.408 . . . . 0.0 110.979 -174.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.417 HD12 HD11 ' A' ' 172' ' ' LEU . 16.3 mt -87.65 142.46 27.82 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.248 0.547 . . . . 0.0 110.602 174.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.491 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 19.5 t90 -117.03 102.1 9.05 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.701 177.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.431 HG13 HG13 ' A' ' 111' ' ' VAL . 4.2 mp -97.94 117.79 43.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -131.48 131.56 43.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.065 0.459 . . . . 0.0 110.897 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 29.0 p90 -123.48 151.92 42.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.897 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.2 m -127.54 78.09 75.18 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.4 -177.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo . . . . . 0 CA--C 1.541 0.854 0 C-N-CA 122.091 1.861 . . . . 0.0 113.395 177.997 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.45 HD21 ' HB2' ' A' ' 184' ' ' CYS . 13.5 tp . . . . . 0 N--CA 1.448 -0.544 0 CA-C-O 120.717 0.294 . . . . 0.0 110.414 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 4.1 mp -92.76 135.54 34.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.871 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.503 ' CE1' ' HB3' ' A' ' 184' ' ' CYS . 82.5 m-85 -122.61 144.42 49.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.17 -176.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -125.66 138.14 53.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.315 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 181' ' ' GLN . 4.4 mp -118.56 122.02 68.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.924 0.392 . . . . 0.0 110.148 -177.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.423 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 23.1 ttp180 -107.1 123.86 48.84 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.58 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.7 pp -143.18 162.09 36.52 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.161 -176.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -168.35 148.8 4.35 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.91 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.424 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 40.6 Cg_endo -71.08 161.11 47.08 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.306 2.004 . . . . 0.0 111.067 170.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.423 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 13.2 pt-20 -63.35 -19.94 65.07 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.247 -175.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.423 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 88.6 mttt -97.02 10.37 39.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.0 0.428 . . . . 0.0 110.9 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.424 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -98.55 131.01 45.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.641 178.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -86.23 -37.13 18.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.206 0.527 . . . . 0.0 110.469 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -98.23 159.29 15.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.912 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.423 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 69.9 m95 -96.88 146.03 25.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.078 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -105.39 111.82 24.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.007 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.48 130.08 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.082 0.468 . . . . 0.0 110.959 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -126.46 133.64 51.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.791 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -102.78 130.09 49.64 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -94.11 -29.96 14.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.859 0.362 . . . . 0.0 111.4 -177.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 143' ' ' LEU . . . 100.33 -133.28 11.24 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.149 -176.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -106.81 31.6 5.18 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.34 0.591 . . . . 0.0 110.96 -177.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -115.69 151.97 34.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.385 177.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 34.9 p -102.17 21.81 14.27 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -175.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 125' ' ' ILE . 8.5 pt-20 -147.74 138.83 23.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.109 174.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -129.51 150.22 50.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.892 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.491 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 42.9 mmtm -112.78 146.0 39.58 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.409 ' HB ' ' HB2' ' A' ' 123' ' ' LEU . 32.6 mm -125.04 132.62 71.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 173.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.75 -16.94 14.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.915 0.388 . . . . 0.0 110.969 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 8.7 t -96.33 69.95 2.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.828 0.347 . . . . 0.0 111.451 -173.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.1 mm? -115.98 159.8 21.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.815 0.34 . . . . 0.0 110.603 176.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 57.7 m-70 -126.52 136.36 28.56 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.548 178.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 24.6 Cg_exo -62.29 122.25 10.6 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.745 2.297 . . . . 0.0 111.986 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 83.98 38.34 10.42 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.81 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -133.38 144.43 49.57 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -101.83 132.66 47.46 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.635 177.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -120.66 142.64 49.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.63 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.1 mm? -103.85 127.39 51.35 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 174.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.2 m -122.36 141.46 42.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.182 0.515 . . . . 0.0 111.55 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 99.1 mt-30 -140.65 142.73 34.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.337 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.2 p -138.57 139.42 41.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -145.97 142.82 29.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' CYS . . . . . 0.503 ' HB3' ' CE1' ' A' ' 144' ' ' TYR . 23.5 p -108.14 163.4 13.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.98 -175.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 121.38 0.609 . . . . 0.0 111.516 -178.008 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.423 ' CZ2' ' HB2' ' A' ' 147' ' ' ARG . 61.0 m95 . . . . . 0 N--CA 1.456 -0.165 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.452 ' H ' ' CD ' ' A' ' 196' ' ' PRO . 18.2 m -140.5 -55.75 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -176.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.549 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 8.4 Cg_endo -87.64 88.71 0.58 Allowed 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.312 2.008 . . . . 0.0 113.273 -171.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.457 ' HB2' ' NE2' ' A' ' 181' ' ' GLN . . . -85.78 106.76 17.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.908 0.385 . . . . 0.0 110.47 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.445 ' OG1' HD23 ' A' ' 109' ' ' LEU . 17.4 m -92.33 136.32 33.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.814 -177.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -95.36 124.15 39.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.742 -177.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.2 tp -127.45 129.43 70.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.234 0.54 . . . . 0.0 110.464 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -101.11 132.79 46.4 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.409 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 36.5 mm -94.08 115.48 65.24 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.07 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.41 155.4 47.09 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.998 2.465 . . . . 0.0 112.562 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 18.7 m -70.06 -17.31 63.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.645 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -82.27 1.15 38.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.87 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 62.4 t80 -57.41 -51.24 70.24 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.109 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.807 176.805 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 C--O 1.232 0.195 0 CA-C-O 120.469 0.112 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.481 ' N ' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -134.91 -178.32 5.03 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -176.454 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 56.11 58.75 4.12 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.615 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.465 HD23 ' OG1' ' A' ' 198' ' ' THR . 33.9 tp -75.57 95.81 3.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.261 0.553 . . . . 0.0 109.735 175.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.72 128.83 40.13 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.01 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.9 t -125.7 122.09 61.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.04 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -139.21 155.35 47.86 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.176 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.506 HG22 ' CD1' ' A' ' 123' ' ' LEU . 21.8 t -100.18 94.21 3.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-O 121.375 0.607 . . . . 0.0 109.636 -177.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.446 ' O ' ' HD3' ' A' ' 116' ' ' PRO . 0.8 OUTLIER -78.86 108.14 12.09 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.794 -176.723 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -106.43 98.98 21.81 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.921 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 114' ' ' LYS . 14.6 Cg_exo -69.88 163.82 36.93 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.817 2.344 . . . . 0.0 112.881 -177.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -101.4 19.75 17.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.206 177.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -147.39 -55.25 0.23 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.673 -176.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -93.12 168.59 11.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.795 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.62 143.77 96.3 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.344 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.98 135.19 46.53 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.821 2.347 . . . . 0.0 112.024 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -139.44 160.49 39.71 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.047 0.451 . . . . 0.0 110.991 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.506 ' CD1' HG22 ' A' ' 113' ' ' VAL . 37.2 tp -91.12 123.76 34.82 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 176.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.526 ' CZ2' ' HD2' ' A' ' 126' ' ' LYS . 10.5 t90 -103.0 103.25 13.33 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.2 0.524 . . . . 0.0 110.49 -174.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.0 mp -95.73 113.61 30.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.081 178.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.526 ' HD2' ' CZ2' ' A' ' 124' ' ' TRP . 58.6 tttp -129.61 119.54 23.76 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.352 0.596 . . . . 0.0 110.656 -176.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' TRP . . . . . 0.427 ' CD2' HG21 ' A' ' 182' ' ' VAL . 29.2 p90 -109.76 163.61 13.35 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.752 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.1 t -103.25 122.81 43.93 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo . . . . . 0 C--N 1.347 0.452 0 C-N-CA 123.334 2.689 . . . . 0.0 112.202 177.899 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.3 tp . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.2 mt -101.29 150.39 23.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.297 -177.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.589 ' CD2' ' HB3' ' A' ' 184' ' ' CYS . 49.7 m-85 -116.54 143.98 44.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.178 -176.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -121.48 141.93 50.54 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.1 mp -117.95 124.94 73.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.024 0.44 . . . . 0.0 110.734 -175.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.454 ' HB2' ' CH2' ' A' ' 194' ' ' TRP . 14.3 ttp180 -109.01 120.32 42.2 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.062 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -145.69 161.49 39.75 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.471 -175.611 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -172.69 147.29 1.62 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.72 175.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -70.9 164.73 34.64 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.093 1.862 . . . . 0.0 111.067 170.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -64.29 -23.96 67.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.608 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.523 ' HE2' ' OE1' ' A' ' 176' ' ' GLN . 67.8 mmtt -81.7 -13.66 57.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.21 0.528 . . . . 0.0 110.512 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -83.97 129.61 34.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.746 -178.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -88.22 -26.39 22.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.409 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -107.12 144.66 33.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.791 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' TRP . . . . . 0.435 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 77.1 m95 -85.22 134.56 34.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.261 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -93.37 131.22 38.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.685 177.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.38 122.44 65.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.038 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 46.3 m-70 -130.57 113.45 14.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.202 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -79.09 132.71 36.68 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.988 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -99.12 -49.49 4.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 111.804 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 111.87 -137.75 14.49 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.02 13.58 22.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.066 0.46 . . . . 0.0 111.005 -177.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -68.75 -23.01 64.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.492 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 42.0 p 63.16 15.71 8.77 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.382 -1.281 . . . . 0.0 113.051 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -153.2 136.88 16.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 171.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 24.7 t80 -125.74 151.33 46.81 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.692 0.282 . . . . 0.0 110.525 -176.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.582 ' HD2' ' N ' ' A' ' 168' ' ' LYS . 0.0 OUTLIER -125.53 115.51 20.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.466 -175.087 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' A' ' 123' ' ' LEU . 34.5 mm -93.39 137.92 21.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 176.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -100.37 -32.53 10.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.851 0.358 . . . . 0.0 111.118 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 18.7 m -87.55 80.93 7.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.814 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.6 mm? -113.6 137.43 51.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 110.712 176.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 53.5 m-70 -100.05 125.93 38.31 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.18 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 22.9 Cg_exo -63.52 125.05 14.78 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.566 2.177 . . . . 0.0 112.448 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 86.6 26.93 31.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.409 178.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.523 ' OE1' ' HE2' ' A' ' 152' ' ' LYS . 77.4 mm-40 -125.18 152.47 44.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.294 0.568 . . . . 0.0 111.658 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -91.08 129.69 37.05 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.32 176.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.414 ' HB2' HG23 ' A' ' 200' ' ' ILE . 15.6 m-85 -117.58 137.74 52.4 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.43 177.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.5 mm? -102.31 128.74 48.74 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 175.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.414 HG23 ' HB ' ' A' ' 198' ' ' THR . 30.7 m -128.92 139.74 51.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 120.951 0.405 . . . . 0.0 111.33 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 98.9 mt-30 -139.19 136.58 35.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.355 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.427 HG21 ' CD2' ' A' ' 127' ' ' TRP . 13.5 p -120.05 137.42 53.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.99 0.424 . . . . 0.0 110.334 174.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -138.62 157.06 46.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.349 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' CYS . . . . . 0.589 ' HB3' ' CD2' ' A' ' 144' ' ' TYR . 24.3 p -136.34 174.75 10.27 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 121.17 0.509 . . . . 0.0 111.953 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' TRP . . . . . 0.454 ' CH2' ' HB2' ' A' ' 147' ' ' ARG . 72.2 m95 . . . . . 0 N--CA 1.457 -0.091 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.548 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 54.0 m -152.28 -63.77 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.548 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 97.5 Cg_endo -74.88 80.49 2.38 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 121.954 1.77 . . . . 0.0 113.952 -168.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ALA . . . . . 0.412 ' HB2' HE21 ' A' ' 181' ' ' GLN . . . -78.65 100.61 7.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.169 0.509 . . . . 0.0 110.312 178.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' THR . . . . . 0.465 ' OG1' HD23 ' A' ' 109' ' ' LEU . 20.0 m -94.17 138.9 31.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.713 -176.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -100.83 116.06 31.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.622 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.414 HG23 ' HB2' ' A' ' 178' ' ' TYR . 7.0 tp -123.73 137.49 56.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.061 0.458 . . . . 0.0 110.485 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -104.75 128.71 52.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.236 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 47.2 mm -87.09 124.39 68.66 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.86 151.47 80.81 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.049 2.499 . . . . 0.0 112.382 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 37.8 m -68.57 -30.12 68.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.757 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -92.56 39.8 1.04 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.681 0.753 . . . . 0.0 109.809 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' PHE . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 80.3 t80 -74.89 -35.19 62.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.863 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.514 -177.059 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.957 0.408 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.508 ' CE2' HG12 ' A' ' 101' ' ' VAL . 8.7 t80 -75.11 133.96 41.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.32 0.581 . . . . 0.0 109.912 175.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.3 mp -74.2 97.96 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.83 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.508 HG12 ' CE2' ' A' ' 99' ' ' TYR . 3.9 m -99.23 157.95 3.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -105.33 96.46 11.64 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.923 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -73.93 -82.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.033 1.822 . . . . 0.0 112.284 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 130' ' ' PRO . 14.0 m-20 -140.9 114.55 7.12 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 120.678 0.275 . . . . 0.0 110.573 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -75.93 169.22 22.6 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.848 2.366 . . . . 0.0 110.446 170.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.652 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 37.7 Cg_endo -69.11 92.19 0.45 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 121.923 1.749 . . . . 0.0 111.349 176.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.17 178.91 6.24 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.2 -175.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 57.34 49.09 13.72 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.665 -175.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.68 96.28 0.54 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.69 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.33 125.11 39.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.543 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.428 HG12 HD11 ' A' ' 123' ' ' LEU . 5.2 t -120.38 120.44 62.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.662 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -127.77 142.88 51.19 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.3 p -97.99 117.14 42.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.118 0.485 . . . . 0.0 109.839 176.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -107.16 128.09 54.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.584 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -120.68 89.28 44.7 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.494 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -72.93 152.15 51.55 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 123.196 2.597 . . . . 0.0 111.989 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -73.81 -33.78 64.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.075 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -104.52 -49.3 3.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.473 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -76.4 167.02 22.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.772 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -75.16 143.28 76.83 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.588 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.6 138.13 63.01 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.596 2.198 . . . . 0.0 111.251 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -145.17 160.23 41.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.015 0.436 . . . . 0.0 111.232 -173.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.546 ' HB2' HD11 ' A' ' 172' ' ' LEU . 29.5 tp -93.98 121.88 35.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -102.82 104.42 14.7 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.034 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.2 mp -98.58 121.37 49.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.88 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -134.27 144.13 48.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.425 0.631 . . . . 0.0 110.476 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TRP . . . . . 0.429 ' CH2' HD11 ' A' ' 146' ' ' ILE . 22.9 p90 -132.56 164.13 27.32 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.766 -173.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 52.3 m -97.44 131.36 27.37 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.73 149.27 87.12 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.458 2.106 . . . . 0.0 111.504 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' A' ' 104' ' ' ASP . 12.5 Cg_endo -55.76 138.69 82.19 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.097 2.532 . . . . 0.0 112.192 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.6 m -68.04 148.35 51.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.744 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 62.9 mt 64.04 -170.57 0.19 Allowed 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.105 0.562 . . . . 0.0 111.361 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 34.0 mt 64.7 -70.58 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 123.574 0.749 . . . . 0.0 112.473 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 57.93 87.1 0.07 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.243 0.544 . . . . 0.0 110.611 -174.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.418 ' H ' HD12 ' A' ' 135' ' ' LEU . 5.2 mp -77.77 47.12 0.6 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.702 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -100.0 -29.78 12.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.942 -176.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.2 t -81.1 132.2 35.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.998 0.428 . . . . 0.0 110.965 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.69 162.81 9.64 Favored Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.986 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 75.7 t-105 -79.76 71.87 6.43 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 122.119 0.961 . . . . 0.0 110.501 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -145.95 75.48 1.42 Allowed 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 169.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.8 t -86.3 155.45 20.65 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.321 -177.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.448 HD21 ' SG ' ' A' ' 184' ' ' CYS . 32.9 tp -92.88 110.68 22.14 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.013 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 43.5 mt -92.31 144.69 25.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.913 0.387 . . . . 0.0 110.576 -177.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.492 ' CD1' ' HB3' ' A' ' 184' ' ' CYS . 46.2 m-85 -115.45 146.0 42.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.942 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 36.2 tt0 -126.3 133.87 51.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.604 176.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 181' ' ' GLN . 4.6 mp -118.64 125.65 74.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.309 -176.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -113.16 137.18 51.85 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -148.38 159.9 43.56 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.702 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -170.17 145.53 2.35 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.453 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.465 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 37.4 Cg_endo -70.38 175.16 9.0 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.196 1.931 . . . . 0.0 112.537 173.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -62.16 -43.37 98.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -86.07 17.06 3.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.136 0.493 . . . . 0.0 111.298 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.465 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -94.11 121.97 36.15 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.056 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.09 -22.68 33.37 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.894 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -121.01 156.04 33.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.91 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -90.92 140.61 29.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.36 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -104.41 107.35 18.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.836 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.03 129.57 39.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.124 0.487 . . . . 0.0 110.576 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 66.6 m-70 -128.2 114.11 16.55 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.961 175.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -83.43 115.89 22.25 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.59 -44.42 19.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.767 0.317 . . . . 0.0 111.053 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 143' ' ' LEU . . . 102.93 -127.96 9.38 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.313 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -86.23 -19.74 29.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.983 0.42 . . . . 0.0 111.018 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -75.0 146.29 41.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.202 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.5 p -104.98 30.02 5.87 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.206 0.527 . . . . 0.0 111.658 -174.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -157.16 142.4 17.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.603 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 34.3 t80 -136.52 150.7 48.79 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 0.0 OUTLIER -122.8 136.65 54.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.766 0.317 . . . . 0.0 110.669 -177.404 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 29.0 mm -109.92 128.52 65.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 175.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.55 -34.97 9.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.025 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.0 m -80.15 82.81 6.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.836 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 123' ' ' LEU . 73.7 mt -125.87 147.56 49.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.224 0.535 . . . . 0.0 111.687 -176.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -105.25 119.09 54.16 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.11 176.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.39 126.3 20.39 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.858 2.372 . . . . 0.0 112.66 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.55 45.41 7.94 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.628 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -146.98 149.05 32.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.96 0.41 . . . . 0.0 111.15 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -80.82 134.24 35.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.948 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -123.47 142.66 50.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.616 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.8 mm? -106.9 132.54 52.73 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 175.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.409 HG23 ' HB ' ' A' ' 198' ' ' THR . 27.1 m -132.28 141.98 43.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.028 0.442 . . . . 0.0 111.521 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.638 ' OE1' ' HB3' ' A' ' 194' ' ' TRP . 36.9 mt-30 -143.77 139.37 29.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.526 175.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 145' ' ' GLU . 7.1 p -133.36 139.06 49.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 174.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.462 ' NH1' ' HB3' ' A' ' 191' ' ' TRP . 37.1 ttt-85 -146.76 147.11 30.59 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.8 177.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.652 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 21.9 p -109.57 169.39 8.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.328 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.467 ' HB3' ' CD1' ' A' ' 191' ' ' TRP . 17.2 ptpt -124.92 90.92 50.27 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.261 0.553 . . . . 0.0 111.502 -177.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 189' ' ' GLY . 31.6 Cg_exo -62.15 157.64 43.6 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.042 2.494 . . . . 0.0 112.549 176.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -54.1 -49.05 69.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.881 0.372 . . . . 0.0 111.992 -172.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -97.6 10.74 39.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.842 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.54 ' O ' ' HD2' ' A' ' 186' ' ' PRO . . . -149.32 75.79 0.25 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.145 -176.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -76.27 153.93 35.58 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.467 ' CD1' ' HB3' ' A' ' 185' ' ' LYS . 14.8 p-90 -117.29 156.2 28.21 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.14 0.495 . . . . 0.0 111.518 -175.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 43.7 m -146.38 14.8 1.27 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.515 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -149.09 158.27 44.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.437 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.638 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 81.9 m95 -106.88 -179.56 3.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.321 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.473 ' H ' ' HD2' ' A' ' 196' ' ' PRO . 48.1 t -171.43 -54.96 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -176.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.473 ' HD2' ' H ' ' A' ' 195' ' ' SER . 77.8 Cg_endo -75.52 69.92 5.79 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.114 1.876 . . . . 0.0 113.669 -174.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.45 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -74.48 105.85 5.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.872 0.368 . . . . 0.0 110.879 178.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.409 ' HB ' HG23 ' A' ' 180' ' ' VAL . 27.6 m -98.0 132.34 43.64 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.565 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -96.3 120.33 36.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.317 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.1 tp -126.91 131.84 70.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.207 0.527 . . . . 0.0 110.473 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -95.41 119.91 34.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.621 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.9 mm -79.98 117.99 70.21 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 172.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.91 149.59 91.03 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.529 2.153 . . . . 0.0 112.158 -176.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 39.1 m -69.92 -17.46 63.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.341 0.591 . . . . 0.0 109.639 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.87 9.58 7.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.529 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -57.76 -46.17 84.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.167 0.508 . . . . 0.0 110.359 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.1 p -88.48 137.88 31.93 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.617 174.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 63.7 mtt -77.4 63.33 2.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.327 0.584 . . . . 0.0 111.016 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -85.97 65.73 9.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.305 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 31.7 t70 . . . . . 0 C--O 1.247 0.951 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.481 -175.278 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 84.5 mtp . . . . . 0 N--CA 1.478 0.929 0 CA-C-O 121.117 0.484 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.503 ' HD1' ' O ' ' A' ' 101' ' ' VAL . 37.0 t80 -137.4 141.13 41.71 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.403 ' H ' HG13 ' A' ' 100' ' ' ILE . 46.1 mt -43.16 -53.62 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 123.869 0.731 . . . . 0.0 112.596 -175.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.503 ' O ' ' HD1' ' A' ' 99' ' ' TYR . 3.6 t -116.85 157.0 17.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.32 -174.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -118.77 74.35 12.44 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-O 121.484 0.659 . . . . 0.0 109.396 168.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.465 ' HD3' ' C ' ' A' ' 101' ' ' VAL . 54.0 Cg_endo -101.37 -161.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.637 2.891 . . . . 0.0 112.958 -174.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -144.71 99.29 4.79 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.84 174.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.28 170.4 4.12 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.457 2.771 . . . . 0.0 112.716 -176.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.539 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 7.9 Cg_endo -50.17 133.33 35.41 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.785 2.324 . . . . 0.0 111.906 178.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.41 ' H ' HD23 ' A' ' 107' ' ' LEU . 1.1 pt? -122.27 178.57 4.89 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.78 -176.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 56.51 47.34 18.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.071 0.462 . . . . 0.0 111.126 178.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.2 tp -74.05 95.94 2.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.035 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -102.65 125.36 49.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.346 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.438 HG21 HG21 ' A' ' 180' ' ' VAL . 8.1 t -110.39 118.86 58.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.904 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -128.62 145.97 50.99 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.134 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.0 p -101.9 117.71 47.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.296 0.57 . . . . 0.0 110.343 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -98.1 129.88 44.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.246 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -120.08 86.44 37.23 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.101 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.484 ' HG2' ' HG3' ' A' ' 119' ' ' ARG . 6.4 Cg_exo -76.04 164.47 31.41 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.432 2.755 . . . . 0.0 112.606 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -91.4 -36.45 13.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.384 -176.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -94.73 -51.79 4.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.712 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.484 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 10.5 ptm180 -90.77 162.52 14.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.289 177.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -79.71 152.04 74.65 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.387 -174.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.405 ' HG3' ' O ' ' A' ' 206' ' ' PHE . 28.9 Cg_endo -60.37 151.26 75.66 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.369 2.713 . . . . 0.0 113.188 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.449 ' CE2' ' HD2' ' A' ' 168' ' ' LYS . 35.7 p90 -161.58 158.67 26.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.711 -174.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 8.3 mt -82.93 139.7 33.23 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.214 173.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.56 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 10.2 t90 -118.06 94.31 4.46 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.14 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.406 ' H ' HD12 ' A' ' 125' ' ' ILE . 4.6 mp -88.81 119.35 35.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.648 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.487 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 9.9 mtmp? -122.84 141.31 52.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.045 0.45 . . . . 0.0 110.985 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 40.2 p90 -138.45 152.06 47.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.04 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.2 t -89.09 126.16 59.89 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.19 139.36 21.47 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.374 2.716 . . . . 0.0 112.803 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.415 ' HG3' ' SG ' ' A' ' 184' ' ' CYS . 9.6 Cg_endo -50.75 138.1 41.62 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.679 2.919 . . . . 0.0 112.674 -177.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.6 m -71.33 -39.49 71.33 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.708 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 72.8 mt -118.72 104.4 10.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.764 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.429 ' O ' ' HB3' ' A' ' 134' ' ' ASP . 20.2 mt -100.84 -20.97 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.025 -175.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 133' ' ' ILE . 26.8 t70 70.52 14.17 7.33 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.016 0.912 . . . . 0.0 110.534 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 71.8 mt -122.37 141.02 52.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.519 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -89.35 150.42 22.57 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 12.0 t -83.15 158.38 22.39 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 -174.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 143.28 -64.3 0.48 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.253 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 44.5 p-90 -139.01 1.11 2.02 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -77.56 157.36 30.36 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.959 0.409 . . . . 0.0 110.438 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.7 m -156.2 132.71 10.18 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.88 173.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.586 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.5 pt? -115.64 144.62 43.65 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -98.88 145.58 26.85 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.901 0.382 . . . . 0.0 110.334 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -102.43 148.73 25.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.567 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -132.57 133.55 43.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.832 -168.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.414 HD11 ' HB2' ' A' ' 161' ' ' ALA . 4.5 mp -126.85 120.42 55.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.877 0.37 . . . . 0.0 110.753 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.62 ' HB2' ' CZ2' ' A' ' 194' ' ' TRP . 5.4 ttp-105 -104.22 120.13 40.48 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.572 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.2 pp -143.3 159.34 42.52 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.937 0.399 . . . . 0.0 111.719 -175.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -169.54 148.33 3.35 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.305 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.472 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 35.0 Cg_endo -71.16 166.9 27.74 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.247 1.965 . . . . 0.0 112.187 172.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.514 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 11.1 pt-20 -57.98 -41.15 82.37 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.514 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 95.0 mttt -85.25 16.84 3.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.904 0.383 . . . . 0.0 111.595 -176.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.472 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -101.15 128.17 47.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.59 176.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -85.53 -34.11 21.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.269 0.557 . . . . 0.0 110.333 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -103.12 147.49 26.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.705 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.482 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 76.3 m95 -90.7 148.6 22.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.5 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -107.42 114.14 27.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.719 174.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.1 mp -91.29 112.05 24.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -106.79 148.64 28.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.253 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -109.48 123.23 49.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.62 -174.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.414 ' HB2' HD11 ' A' ' 146' ' ' ILE . . . -79.24 -51.63 9.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.615 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 82.04 79.98 0.95 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.651 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 72.6 -46.18 0.64 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.078 0.951 . . . . 0.0 112.595 175.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -66.5 148.28 52.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.003 0.43 . . . . 0.0 110.81 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 56.9 p -104.14 36.41 2.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.35 0.595 . . . . 0.0 111.308 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -157.77 140.36 14.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.186 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -131.88 149.72 52.36 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.56 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 42.1 mmtm -116.6 143.85 45.1 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 123' ' ' LEU . 29.8 mm -123.76 122.29 64.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 175.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.408 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.7 mm? -94.81 -32.82 13.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.311 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.6 m -77.96 83.81 4.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.838 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 86.9 mt -133.03 145.63 50.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.784 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -102.49 122.13 47.45 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.283 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.65 112.93 1.41 Allowed 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.468 2.112 . . . . 0.0 111.682 175.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 89.27 44.76 4.92 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.658 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -141.29 147.41 38.15 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.763 0.316 . . . . 0.0 110.17 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -91.55 137.82 32.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.469 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -125.19 140.49 52.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.023 0.44 . . . . 0.0 110.498 176.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.4 mp -104.64 132.1 51.29 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.438 HG21 HG21 ' A' ' 111' ' ' VAL . 34.5 m -135.62 147.23 28.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.948 0.404 . . . . 0.0 111.699 -175.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.591 ' HG2' ' HA ' ' A' ' 197' ' ' ALA . 53.6 mt-30 -143.46 153.28 42.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.392 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.9 p -124.67 140.44 47.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.113 0.482 . . . . 0.0 111.012 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.624 ' HG3' ' CE3' ' A' ' 194' ' ' TRP . 26.2 mtp-105 -133.34 163.99 28.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.912 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.539 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 31.5 p -140.7 125.72 18.38 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 167.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.449 ' HD3' HH12 ' A' ' 183' ' ' ARG . 23.4 pttm -119.42 89.88 41.34 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 121.328 0.585 . . . . 0.0 110.984 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.41 166.85 18.22 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.769 2.313 . . . . 0.0 112.354 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.41 -24.37 65.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.281 -172.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 52.9 m170 -93.09 4.4 54.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.562 0.22 . . . . 0.0 111.111 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -132.57 174.29 20.48 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 119.927 -1.13 . . . . 0.0 113.535 -174.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.414 ' CG ' ' N ' ' A' ' 191' ' ' TRP . 66.6 t80 -129.53 178.95 6.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.609 ' HA ' ' NH2' ' A' ' 183' ' ' ARG . 50.7 m95 -48.24 142.02 5.84 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 174.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 17.7 p -119.4 9.61 11.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.903 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . 61.71 21.64 12.34 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.624 ' CE3' ' HG3' ' A' ' 183' ' ' ARG . 69.0 m95 69.2 171.96 0.3 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.624 172.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.47 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 42.0 m -159.64 -57.58 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -176.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.487 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 9.2 Cg_endo -90.03 91.9 0.31 Allowed 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.539 2.159 . . . . 0.0 113.595 -170.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.591 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -79.48 116.55 19.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.023 0.44 . . . . 0.0 111.0 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 27.0 m -109.48 140.96 42.6 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.812 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -115.61 127.82 55.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.731 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.9 tp -125.45 135.52 63.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.033 0.444 . . . . 0.0 111.141 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -96.67 118.9 34.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.404 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.401 HD11 HD11 ' A' ' 123' ' ' LEU . 50.8 mm -84.21 119.88 73.82 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.44 151.1 86.56 Favored 'Trans proline' 0 N--CA 1.466 -0.147 0 C-N-CA 122.558 2.172 . . . . 0.0 112.251 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 19.2 m -69.94 -20.4 63.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.047 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -88.2 26.82 1.32 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.775 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.405 ' O ' ' HG3' ' A' ' 121' ' ' PRO . 85.7 t80 -66.18 -43.98 85.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.635 176.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 28.8 m -112.84 141.39 46.71 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.922 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 21.4 ptm -72.29 122.16 20.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.202 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -101.24 57.47 0.86 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.968 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 C--O 1.246 0.882 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.952 177.403 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.7 0.286 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.403 ' CE2' HG12 ' A' ' 101' ' ' VAL . 16.9 t80 -122.23 137.59 54.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.442 0.639 . . . . 0.0 110.703 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 91.2 mt -81.34 111.87 18.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.951 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.585 ' O ' ' HD3' ' A' ' 103' ' ' PRO . 13.9 m -107.85 158.89 7.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.678 -176.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -98.66 91.74 1.36 Allowed Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 173.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.585 ' HD3' ' O ' ' A' ' 101' ' ' VAL . 93.8 Cg_endo -83.4 -9.84 10.14 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.514 2.142 . . . . 0.0 112.401 -175.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.482 ' HB3' ' HB3' ' A' ' 130' ' ' PRO . 26.1 m-20 -127.18 78.73 74.04 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.974 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -85.31 153.19 10.72 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.159 2.573 . . . . 0.0 111.481 177.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.685 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 39.4 Cg_endo -69.5 94.82 0.51 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.268 1.979 . . . . 0.0 111.44 176.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.683 ' H ' HD23 ' A' ' 107' ' ' LEU . 2.7 pt? -90.41 175.01 7.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.675 -177.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 53.38 51.96 14.39 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 123.556 0.535 . . . . 0.0 110.888 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 57.0 tp -78.84 96.37 5.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.148 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.83 128.71 45.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.387 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.448 HG21 HG21 ' A' ' 180' ' ' VAL . 2.4 t -116.62 115.74 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -125.0 130.18 51.83 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.965 0.412 . . . . 0.0 110.786 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.5 p -77.52 117.42 22.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.2 0.524 . . . . 0.0 109.874 176.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -102.23 122.38 44.09 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.282 0.563 . . . . 0.0 111.388 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -124.91 75.82 66.31 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.753 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.47 ' HG2' ' HB2' ' A' ' 119' ' ' ARG . 6.7 Cg_exo -76.03 -179.06 4.84 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 123.38 2.72 . . . . 0.0 112.782 -175.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -89.76 -64.21 1.17 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -71.96 -36.83 69.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.442 -177.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.47 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 56.9 mtt85 -88.01 156.35 19.36 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.592 -178.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.417 ' O ' ' HD1' ' A' ' 122' ' ' TYR . 50.6 mtmt -75.35 153.56 85.98 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.04 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.25 133.76 39.26 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.329 2.019 . . . . 0.0 111.503 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.417 ' HD1' ' O ' ' A' ' 120' ' ' LYS . 55.1 p90 -151.12 166.23 31.44 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.432 -176.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.437 ' HB3' ' HB ' ' A' ' 169' ' ' ILE . 38.9 tp -95.98 123.21 39.48 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 176.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.432 ' HE1' ' HB2' ' A' ' 166' ' ' GLU . 17.5 t90 -103.24 106.68 17.25 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.221 -176.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.4 mp -106.28 118.36 53.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.708 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -131.54 141.45 49.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.48 0.657 . . . . 0.0 111.24 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' TRP . . . . . 0.492 ' CH2' HD11 ' A' ' 146' ' ' ILE . 28.7 p90 -129.07 155.44 45.44 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.439 -176.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 22.6 t -83.36 130.53 56.17 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 128' ' ' SER . 50.4 Cg_exo -54.7 139.26 76.93 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.045 2.497 . . . . 0.0 112.492 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.482 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 76.8 Cg_exo -49.66 129.71 24.39 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.011 2.474 . . . . 0.0 111.899 176.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.99 -67.87 0.26 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -167.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 97.0 mt -101.75 80.58 2.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.486 0.66 . . . . 0.0 112.024 -173.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.3 mt -97.08 -58.53 3.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 172.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.0 t70 56.99 79.36 0.19 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.033 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.47 ' H ' HD12 ' A' ' 135' ' ' LEU . 4.0 mp -84.76 51.34 2.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.49 -175.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -101.04 -37.17 8.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.207 0.527 . . . . 0.0 110.034 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 19.3 p -81.8 -53.84 5.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.889 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.41 105.91 2.86 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.567 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -84.76 69.34 10.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.191 0.519 . . . . 0.0 110.592 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -103.42 178.95 4.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.372 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.3 m -117.9 129.4 55.61 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.596 HD11 ' H ' ' A' ' 185' ' ' LYS . 42.2 tp -91.69 116.47 28.91 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.967 0.413 . . . . 0.0 110.463 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.6 mp -106.18 144.8 32.37 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.557 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -113.61 165.31 12.64 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.151 -176.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.467 ' HB3' ' NE ' ' A' ' 183' ' ' ARG . 40.3 tt0 -154.07 139.37 17.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.527 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.531 ' CD1' ' HB2' ' A' ' 161' ' ' ALA . 4.3 mp -121.92 130.19 74.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.042 0.449 . . . . 0.0 110.968 -172.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.476 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 27.8 ttp180 -108.18 121.15 44.26 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 1.7 pp -146.98 166.0 28.13 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.9 0.381 . . . . 0.0 111.413 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -172.45 149.89 2.13 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.751 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.35 162.45 42.34 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.34 2.026 . . . . 0.0 111.153 172.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -67.31 -14.53 63.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.546 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -93.93 2.97 56.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.289 0.566 . . . . 0.0 110.06 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -102.76 130.93 49.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.272 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -88.22 -35.85 17.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.24 0.543 . . . . 0.0 110.315 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -95.84 150.44 20.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.333 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.476 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 84.3 m95 -85.91 148.02 25.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.238 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -115.82 119.23 35.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.947 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.0 mp -99.05 131.68 45.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.103 0.478 . . . . 0.0 110.847 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -125.54 126.41 44.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.976 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -83.28 124.79 30.93 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.531 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -82.3 -36.43 27.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.895 0.379 . . . . 0.0 111.286 -176.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 88.34 -136.97 14.08 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.487 -0.863 . . . . 0.0 110.965 -175.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -99.85 70.99 1.65 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.088 0.47 . . . . 0.0 110.353 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -160.24 147.17 15.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.821 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.2 p -102.43 13.62 34.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.35 0.595 . . . . 0.0 111.074 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.432 ' HB2' ' HE1' ' A' ' 124' ' ' TRP . 1.0 OUTLIER -140.08 113.41 8.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.89 175.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -109.03 152.08 25.48 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.519 -173.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 168' ' ' LYS . 10.4 mptt -123.23 129.11 50.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.276 -176.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.437 ' HB ' ' HB3' ' A' ' 123' ' ' LEU . 28.9 mm -108.54 137.58 39.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 175.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.77 -23.18 12.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.997 0.427 . . . . 0.0 110.58 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 7.0 m -87.17 67.5 9.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.78 -175.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.01 140.43 39.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.968 0.413 . . . . 0.0 110.887 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 32.5 m-70 -103.74 115.81 62.86 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.474 173.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 35.8 Cg_exo -59.02 126.09 20.06 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.822 2.348 . . . . 0.0 112.878 -177.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 88.86 29.45 18.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.752 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -133.95 145.51 49.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.095 0.474 . . . . 0.0 110.734 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -82.44 132.05 35.21 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.441 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -114.71 136.7 52.78 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.872 0.368 . . . . 0.0 110.532 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.9 mm? -101.36 129.26 47.32 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 174.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.448 HG21 HG21 ' A' ' 111' ' ' VAL . 35.8 m -125.24 141.7 44.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.176 0.512 . . . . 0.0 111.655 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 94.4 mt-30 -144.59 134.06 23.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.959 177.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 6.5 p -117.71 135.73 57.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.467 ' NE ' ' HB3' ' A' ' 145' ' ' GLU . 7.8 ppt_? -116.12 155.73 27.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.83 0.348 . . . . 0.0 110.731 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.685 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 26.4 p -136.77 175.26 9.78 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.794 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.596 ' H ' HD11 ' A' ' 142' ' ' LEU . 37.1 mtmt -124.72 83.85 58.47 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.337 174.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.493 ' HD2' ' O ' ' A' ' 190' ' ' TYR . 50.6 Cg_exo -56.48 146.97 71.69 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.079 2.52 . . . . 0.0 112.528 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -70.91 -29.25 65.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.401 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -92.49 24.04 3.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.503 177.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -170.17 -133.1 1.55 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.493 ' O ' ' HD2' ' A' ' 186' ' ' PRO . 31.5 p90 -163.17 -164.83 1.0 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -30.03 129.35 0.1 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.299 1.0 . . . . 0.0 112.717 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 35.8 p -98.17 -2.52 39.67 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.457 -177.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . 58.09 -157.83 0.3 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.785 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.404 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 29.9 m95 -117.73 106.32 12.93 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.56 -176.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.495 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 36.4 t -116.0 -59.67 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 195' ' ' SER . 95.4 Cg_endo -76.8 87.37 1.48 Allowed 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.857 1.705 . . . . 0.0 113.397 -173.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.61 101.75 5.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.101 0.477 . . . . 0.0 109.927 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 18.6 m -91.03 131.26 36.73 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.917 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -94.33 132.46 38.91 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.458 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.653 HG12 ' N ' ' A' ' 201' ' ' GLN . 0.0 OUTLIER -147.49 150.24 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.367 0.603 . . . . 0.0 111.297 174.67 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.653 ' N ' HG12 ' A' ' 200' ' ' ILE . 7.6 mm-40 -91.81 136.01 33.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.741 176.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 49.0 mm -100.89 114.75 65.83 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 165.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.64 148.95 79.51 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.905 2.403 . . . . 0.0 112.555 -175.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 17.1 m -69.79 -23.98 63.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.856 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -92.21 32.92 1.11 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.202 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -65.93 -32.44 73.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.135 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 8.3 t -100.86 141.84 33.17 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.119 0.485 . . . . 0.0 110.662 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -114.12 -71.13 0.76 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.733 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.3 t30 53.72 67.72 0.96 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.831 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.382 -0.818 . . . . 0.0 109.678 178.085 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.4 mmm . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 120.915 0.388 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.58 ' HD2' ' O ' ' A' ' 101' ' ' VAL . 83.2 t80 -135.26 161.02 36.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.58 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.608 HG22 HG23 ' A' ' 101' ' ' VAL . 4.4 mp -49.0 -48.31 16.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 123.53 0.732 . . . . 0.0 112.42 -177.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.608 HG23 HG22 ' A' ' 100' ' ' ILE . 63.4 t -124.33 137.12 58.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.163 -176.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -62.91 135.74 96.22 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.8 99.19 0.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.563 2.175 . . . . 0.0 112.013 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -119.6 91.02 44.08 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.949 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.86 145.64 32.26 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.88 2.387 . . . . 0.0 111.618 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.486 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 7.1 Cg_endo -49.68 112.46 0.7 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.271 2.647 . . . . 0.0 111.692 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.517 ' H ' HD23 ' A' ' 107' ' ' LEU . 2.7 pt? -73.15 163.02 28.74 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.384 -173.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 60.61 54.46 3.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.382 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -75.58 93.92 3.1 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -97.21 131.46 43.92 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.407 -176.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.467 HG12 HD22 ' A' ' 123' ' ' LEU . 2.6 t -120.57 114.39 43.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -129.39 140.36 51.37 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.367 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.9 p -87.16 115.56 28.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.413 0.625 . . . . 0.0 109.351 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.515 ' O ' ' HD3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -102.06 113.2 26.24 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.4 -174.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.463 ' HB3' ' SD ' ' A' ' 208' ' ' MET . 20.0 mp0 -105.49 98.89 18.4 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.316 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 114' ' ' LYS . 5.5 Cg_exo -80.79 146.08 16.36 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.295 2.663 . . . . 0.0 112.092 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.0 -23.99 58.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.831 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -118.15 3.27 12.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.774 0.321 . . . . 0.0 111.376 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -137.86 151.64 48.26 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' A' ' 120' ' ' LYS . 12.7 mptt -63.42 139.04 97.52 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.236 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.18 145.12 98.78 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.476 2.784 . . . . 0.0 112.752 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.524 ' CE1' ' HD2' ' A' ' 168' ' ' LYS . 35.4 p90 -149.28 155.04 39.93 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.26 -176.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 9.3 mt -80.43 127.41 32.38 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 173.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.569 ' CZ2' ' HD2' ' A' ' 126' ' ' LYS . 14.4 t90 -101.69 102.18 12.8 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.789 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.5 mp -93.62 114.27 29.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.569 ' HD2' ' CZ2' ' A' ' 124' ' ' TRP . 64.1 tttm -127.84 126.56 41.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.568 -175.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 39.9 p90 -126.04 158.98 33.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.338 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.451 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 37.7 m -99.61 131.74 24.26 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.195 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.567 ' HG3' HG21 ' A' ' 165' ' ' THR . 33.5 Cg_exo -62.23 141.92 89.72 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.664 2.243 . . . . 0.0 111.725 176.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.7 86.9 0.17 Allowed 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.986 2.457 . . . . 0.0 113.22 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.472 HG22 ' HG ' ' A' ' 132' ' ' LEU . 9.6 m 56.86 -95.22 0.05 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.243 176.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.472 ' HG ' HG22 ' A' ' 131' ' ' THR . 95.0 mt -117.12 -9.09 11.1 Favored 'General case' 0 CA--C 1.518 -0.255 0 O-C-N 122.409 -0.182 . . . . 0.0 111.125 -176.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.424 HD11 ' HB3' ' A' ' 129' ' ' PRO . 3.6 mp 67.9 -76.65 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 123.654 0.596 . . . . 0.0 110.137 -177.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.3 t70 45.91 62.06 2.4 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.977 0.911 . . . . 0.0 112.552 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.423 HD13 HG23 ' A' ' 133' ' ' ILE . 7.5 mp -79.19 -43.31 24.15 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 169.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -151.7 111.33 3.99 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.653 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.9 m -61.64 108.73 1.03 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.208 -174.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 165.22 -105.16 0.24 Allowed Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -128.1 7.92 6.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.844 0.354 . . . . 0.0 110.49 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -73.81 99.3 3.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.011 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 15.5 p -87.2 147.29 25.65 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.396 -178.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.524 HD21 ' SG ' ' A' ' 184' ' ' CYS . 56.7 tp -80.0 132.67 36.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.145 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -93.88 152.7 18.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.035 0.445 . . . . 0.0 111.141 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.596 ' CD1' ' HB3' ' A' ' 184' ' ' CYS . 63.7 m-85 -129.78 149.84 51.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.012 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -128.73 139.7 52.09 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.404 HD11 ' HB2' ' A' ' 161' ' ' ALA . 4.0 mp -113.42 124.34 69.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.847 0.356 . . . . 0.0 110.448 -176.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.514 ' HB2' ' CZ2' ' A' ' 194' ' ' TRP . 16.3 ttp180 -113.76 120.18 39.91 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.414 HD22 ' C ' ' A' ' 148' ' ' LEU . 0.0 OUTLIER -143.42 160.22 40.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.542 0.211 . . . . 0.0 110.786 -177.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -165.23 148.65 7.21 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.241 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 178' ' ' TYR . 56.9 Cg_endo -73.47 169.37 22.47 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.57 2.18 . . . . 0.0 111.946 172.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -68.9 -11.54 60.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.667 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -93.76 -1.57 54.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.289 0.566 . . . . 0.0 110.004 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -100.19 122.6 43.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.771 -173.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -84.45 -28.38 26.87 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.562 0.696 . . . . 0.0 109.437 173.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -106.85 146.32 31.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.173 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.476 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 80.0 m95 -86.69 155.22 20.47 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.08 0.466 . . . . 0.0 111.582 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -111.62 127.39 55.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.74 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.87 126.99 67.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.164 0.507 . . . . 0.0 111.222 -176.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -125.26 137.98 54.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -96.57 138.21 34.49 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.404 ' HB2' HD11 ' A' ' 146' ' ' ILE . . . -77.4 -23.16 50.73 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.514 -177.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 83.86 -46.06 3.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.994 177.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -179.52 -33.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.128 0.489 . . . . 0.0 109.895 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -72.28 160.08 32.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.385 -177.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.567 HG21 ' HG3' ' A' ' 129' ' ' PRO . 67.5 p -110.03 30.33 6.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.401 -174.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -153.19 140.6 19.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.711 175.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -135.65 153.25 51.69 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.672 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 22.5 mmtt -118.86 140.98 49.07 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 31.8 mm -114.89 123.79 70.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.691 0.281 . . . . 0.0 110.561 176.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.479 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.8 mm? -95.72 -16.76 21.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.5 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.8 m -80.8 71.15 7.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.709 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 59.4 mt -129.63 137.22 50.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.98 0.419 . . . . 0.0 111.34 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -111.7 125.19 30.8 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.263 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.84 122.52 11.35 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.742 2.295 . . . . 0.0 112.46 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 95.43 22.26 22.34 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.749 177.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -131.24 148.73 52.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.935 0.398 . . . . 0.0 110.895 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -90.26 134.18 34.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.116 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 150' ' ' PRO . 12.1 m-85 -119.9 149.59 41.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.021 0.438 . . . . 0.0 110.652 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.9 mp -112.49 136.21 52.27 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.3 m -132.6 148.12 31.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.056 0.455 . . . . 0.0 111.372 -177.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 93.2 mt-30 -150.29 144.33 25.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.384 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.459 HG13 ' HG2' ' A' ' 106' ' ' PRO . 12.0 p -138.83 145.01 28.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 171.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.477 ' HD3' ' CZ3' ' A' ' 191' ' ' TRP . 7.6 ptm180 -155.53 161.22 40.93 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.223 0.535 . . . . 0.0 110.182 171.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.596 ' HB3' ' CD1' ' A' ' 144' ' ' TYR . 5.7 p -116.69 -174.45 2.57 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.077 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.43 134.96 6.47 Favored Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.955 -177.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.02 141.16 47.45 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.953 2.435 . . . . 0.0 111.446 177.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -71.92 -24.73 61.68 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.55 -176.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -84.15 10.21 10.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.58 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -151.36 -158.18 8.23 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.484 -0.647 . . . . 0.0 111.484 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -138.66 -171.44 3.07 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.024 0.44 . . . . 0.0 111.162 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.477 ' CZ3' ' HD3' ' A' ' 183' ' ' ARG . 17.8 m95 -70.65 157.63 37.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.571 176.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 15.6 t -142.63 41.05 1.57 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.392 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . 67.62 -172.27 0.19 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.917 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.514 ' CZ2' ' HB2' ' A' ' 147' ' ' ARG . 61.8 m95 -100.36 178.45 4.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.014 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.424 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 50.7 m -156.07 -53.89 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.539 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 1.1 Cg_endo -82.95 81.27 2.44 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.128 1.886 . . . . 0.0 113.057 -173.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.409 ' HA ' ' CG ' ' A' ' 181' ' ' GLN . . . -82.83 103.94 12.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.115 0.484 . . . . 0.0 110.66 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 53.9 m -96.7 138.06 34.83 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.257 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -102.76 130.87 49.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.495 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.2 tp -135.91 137.09 49.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.207 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -102.46 147.05 27.22 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.93 0.395 . . . . 0.0 111.566 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 21.8 mm -96.47 118.16 65.52 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.789 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.51 153.28 72.35 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.968 2.445 . . . . 0.0 112.11 -177.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 28.0 m -70.81 -23.03 62.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.889 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -94.2 34.56 1.25 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.643 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -69.66 -50.97 38.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.838 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 6.4 t -65.51 144.03 57.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.371 0.605 . . . . 0.0 111.098 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.463 ' SD ' ' HB3' ' A' ' 115' ' ' GLN . 85.8 mtp -115.55 8.78 15.22 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.679 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -135.33 86.16 2.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.698 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 34.8 t70 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.409 -0.805 . . . . 0.0 110.404 -177.352 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 14.6 t80 68.82 127.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 O-C-N 124.065 0.853 . . . . 0.0 111.671 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.0 mm -71.38 92.44 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.765 174.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.2 m -67.47 146.41 13.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.422 0.63 . . . . 0.0 111.243 -176.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.4 pm0 -83.17 139.42 42.22 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.796 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -78.78 -174.72 2.4 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.977 2.451 . . . . 0.0 111.749 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -105.03 106.75 56.73 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.48 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 28.1 Cg_exo -64.47 147.81 90.55 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 123.224 2.616 . . . . 0.0 112.775 -176.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 105' ' ' PRO . 35.8 Cg_exo -58.48 132.94 51.41 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.068 2.512 . . . . 0.0 111.672 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.462 ' H ' HD23 ' A' ' 107' ' ' LEU . 1.6 pt? -122.3 -179.45 4.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.427 -172.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 54.78 41.22 32.08 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 123.576 0.548 . . . . 0.0 110.731 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.6 tt -64.53 103.97 0.74 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.792 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -109.74 132.42 54.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.705 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.3 t -114.42 126.35 71.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.84 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -126.52 132.61 51.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.947 0.404 . . . . 0.0 110.615 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.8 p -87.22 126.36 41.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.1 0.476 . . . . 0.0 110.196 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 114' ' ' LYS . 55.1 mmtt -106.68 127.29 53.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.032 0.444 . . . . 0.0 110.957 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -132.94 85.09 47.22 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.158 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.71 168.7 22.99 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.982 2.455 . . . . 0.0 111.5 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.451 ' HA ' ' OD1' ' A' ' 209' ' ' ASN . 0.4 OUTLIER -102.17 -6.24 23.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.859 0.362 . . . . 0.0 111.354 -177.811 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -132.88 2.62 3.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.481 0.658 . . . . 0.0 110.534 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -136.82 149.14 47.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.531 -176.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -56.97 130.63 79.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 O-C-N 123.513 0.508 . . . . 0.0 111.289 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.27 137.04 63.41 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.573 2.182 . . . . 0.0 111.361 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -140.9 163.89 31.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.468 -175.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.417 ' HB3' ' HB ' ' A' ' 169' ' ' ILE . 28.0 tp -100.19 124.99 46.26 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.457 ' CZ2' ' HD3' ' A' ' 126' ' ' LYS . 25.9 t90 -107.49 115.94 31.05 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.418 -177.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.4 mp -101.06 122.55 53.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.735 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.457 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 39.7 ttpt -129.72 120.36 24.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.189 0.519 . . . . 0.0 110.555 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' TRP . . . . . 0.45 ' CE2' HG21 ' A' ' 182' ' ' VAL . 40.3 p90 -116.28 160.78 19.98 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.931 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.3 m -95.61 129.37 34.86 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.51 162.72 29.74 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.905 2.404 . . . . 0.0 111.945 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -38.57 135.63 0.72 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.862 3.041 . . . . 0.0 113.57 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.5 p -68.01 -30.09 69.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.374 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 73.8 mt -99.07 -178.91 4.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.945 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.4 mt 70.39 -53.03 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 123.143 0.577 . . . . 0.0 111.801 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 54.49 65.33 1.53 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.299 0.571 . . . . 0.0 110.422 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.97 54.42 2.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.355 -176.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -79.38 -20.29 48.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.941 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 16.6 p -84.96 -178.36 6.81 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.866 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -88.42 -159.55 35.01 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.534 175.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 70.9 t90 69.34 -65.92 0.28 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.285 0.634 . . . . 0.0 111.363 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -71.09 100.14 1.97 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.4 m -96.42 132.23 42.17 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.188 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 41.8 tp -128.5 116.89 20.38 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.6 mp -99.84 143.19 30.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.01 0.434 . . . . 0.0 110.872 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -115.3 133.78 55.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.662 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -116.75 139.35 50.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 181' ' ' GLN . 4.7 mp -120.26 119.72 60.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.088 0.47 . . . . 0.0 110.859 -176.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.422 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 21.4 ttp180 -104.18 121.68 43.78 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.533 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.2 pp -143.88 162.75 35.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.678 0.275 . . . . 0.0 111.316 -176.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -171.51 150.42 2.71 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.416 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.474 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 45.6 Cg_endo -72.16 156.37 55.57 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.096 1.864 . . . . 0.0 110.904 170.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -61.95 -18.57 60.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.246 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -91.62 -3.85 55.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.984 0.421 . . . . 0.0 110.553 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.474 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -87.6 127.12 35.27 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.099 -177.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.72 -14.27 52.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.285 0.564 . . . . 0.0 110.475 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -119.95 139.02 53.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.794 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.422 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 78.2 m95 -81.4 147.98 29.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.354 177.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -116.08 117.62 30.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.279 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mp -93.05 123.18 45.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.392 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 59.8 m-70 -119.04 155.87 30.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.524 176.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -122.6 129.79 52.29 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.518 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -97.88 -34.74 10.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.943 0.401 . . . . 0.0 110.953 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.58 -140.93 15.24 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.49 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -91.67 52.99 2.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.211 0.529 . . . . 0.0 109.906 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -150.1 149.92 30.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.329 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.422 ' HA ' ' CE2' ' A' ' 127' ' ' TRP . 61.3 p -101.4 33.08 3.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.954 -174.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -146.59 134.09 20.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.975 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 39.9 t80 -136.89 149.33 47.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.105 176.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.97 140.84 49.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.945 0.402 . . . . 0.0 111.224 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' A' ' 123' ' ' LEU . 34.7 mm -117.67 136.41 54.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.886 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -103.84 -23.85 13.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.833 0.349 . . . . 0.0 110.67 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 69.5 m -89.54 80.53 6.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.867 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.7 mm? -116.57 132.16 56.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.982 0.42 . . . . 0.0 110.691 176.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 52.9 m170 -100.09 118.62 61.17 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.657 176.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 32.5 Cg_exo -57.02 118.46 5.33 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.875 2.383 . . . . 0.0 112.813 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 97.22 5.64 58.06 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.96 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -109.03 151.4 26.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.157 0.503 . . . . 0.0 110.66 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.441 ' HE3' ' HB3' ' A' ' 199' ' ' PHE . 37.8 tttp -93.51 136.72 33.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.07 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -120.88 139.42 53.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.879 0.371 . . . . 0.0 110.21 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.7 mp -104.08 126.06 50.9 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.9 m -123.76 139.15 51.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.117 0.484 . . . . 0.0 111.312 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.533 ' HG3' ' HA ' ' A' ' 197' ' ' ALA . 0.0 OUTLIER -141.63 134.64 29.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.14 179.415 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.45 HG21 ' CE2' ' A' ' 127' ' ' TRP . 7.8 p -129.45 137.65 56.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -143.39 149.56 37.85 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.478 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 28.3 p -118.21 158.85 24.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.638 -174.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.485 ' HB3' ' CD1' ' A' ' 191' ' ' TRP . 20.8 ptmt -145.72 114.65 4.74 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.137 0.494 . . . . 0.0 111.279 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -89.57 -170.95 0.47 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.123 2.549 . . . . 0.0 111.472 176.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -88.51 10.72 19.31 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.145 0.498 . . . . 0.0 110.221 177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -98.72 -21.65 16.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.04 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -168.13 -163.34 21.91 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.382 -175.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -156.83 178.75 9.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.71 0.29 . . . . 0.0 110.341 -175.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.485 ' CD1' ' HB3' ' A' ' 185' ' ' LYS . 49.1 p-90 -139.5 137.18 35.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.195 176.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 12.5 p -113.5 6.48 17.11 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.232 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -155.99 167.02 31.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.207 0.527 . . . . 0.0 111.61 -176.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -106.99 148.17 29.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.416 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.613 ' H ' ' HD2' ' A' ' 196' ' ' PRO . 20.0 m -137.02 -57.88 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.569 0 CA-C-O 119.242 -0.409 . . . . 0.0 111.947 -177.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.613 ' HD2' ' H ' ' A' ' 195' ' ' SER . 59.3 Cg_endo -71.42 83.06 1.05 Allowed 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.627 1.551 . . . . 0.0 112.874 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.533 ' HA ' ' HG3' ' A' ' 181' ' ' GLN . . . -88.24 115.14 25.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.143 0.497 . . . . 0.0 110.662 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 85.7 m -107.12 138.39 43.39 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.053 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.441 ' HB3' ' HE3' ' A' ' 177' ' ' LYS . 62.1 m-85 -106.61 140.04 40.11 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.347 -176.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.9 tp -136.54 134.06 49.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.147 0.499 . . . . 0.0 110.533 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -101.81 123.1 45.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.25 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.9 mm -79.34 123.52 84.51 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.96 149.63 87.85 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.904 2.402 . . . . 0.0 112.371 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 13.3 m -66.03 -26.48 67.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.94 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -91.91 27.78 2.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.55 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 82.6 t80 -62.71 -46.93 85.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.137 0.494 . . . . 0.0 110.433 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.4 m -97.36 115.49 27.8 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.9 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 93.8 mmm -139.28 -61.65 0.55 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.908 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' A' ' 117' ' ' GLU . 8.9 p30 -147.62 154.28 40.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.625 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 C--O 1.252 1.191 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.139 179.535 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.1 ptm . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 120.767 0.318 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -99.45 137.22 38.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.269 0.556 . . . . 0.0 110.259 175.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.41 HG21 ' O ' ' A' ' 188' ' ' HIS . 88.2 mt -77.36 111.05 13.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.596 177.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 31.2 m -103.5 139.42 24.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.6 -174.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.561 ' CD ' ' HA3' ' A' ' 189' ' ' GLY . 3.1 mp0 -112.3 89.85 13.08 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.162 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -72.79 -81.33 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.888 1.725 . . . . 0.0 111.921 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -135.46 87.69 26.48 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 174.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.524 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 38.1 Cg_exo -53.38 -46.45 33.75 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.547 2.165 . . . . 0.0 113.279 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' A' ' 105' ' ' PRO . 20.8 Cg_endo -96.66 104.54 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.128 1.885 . . . . 0.0 111.412 171.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.5 mp -91.52 178.24 6.0 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.835 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 128' ' ' SER . 39.6 mt-10 50.2 47.41 23.68 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 124.839 1.337 . . . . 0.0 111.727 165.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.2 tp -64.86 112.94 3.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.92 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -114.16 128.12 56.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.407 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.497 HG12 HD22 ' A' ' 123' ' ' LEU . 4.5 t -116.44 126.34 73.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.82 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -141.38 126.44 18.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.913 0.387 . . . . 0.0 110.609 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.31 133.96 28.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.318 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -124.19 117.71 25.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.356 0.598 . . . . 0.0 111.088 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.454 ' NE2' ' HA ' ' A' ' 206' ' ' PHE . 46.6 mt-30 -108.59 99.64 34.52 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.476 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.1 -83.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.769 2.313 . . . . 0.0 112.66 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -175.17 -77.44 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 120.704 0.288 . . . . 0.0 110.64 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -87.27 -34.89 18.76 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -66.92 134.79 52.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.923 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -58.35 135.11 85.15 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.004 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.435 ' HB3' ' HG2' ' A' ' 115' ' ' GLN . 28.1 Cg_endo -62.12 140.37 83.5 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.654 2.236 . . . . 0.0 111.367 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.518 ' CE2' ' HD2' ' A' ' 168' ' ' LYS . 23.2 p90 -144.03 155.85 44.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.064 0.459 . . . . 0.0 111.594 -172.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.497 HD22 HG12 ' A' ' 111' ' ' VAL . 6.6 mt -83.12 130.51 35.12 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.839 172.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -107.91 106.65 17.01 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.706 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 166' ' ' GLU . 4.0 mp -100.88 131.17 49.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.776 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -138.87 156.72 47.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.965 0.412 . . . . 0.0 110.577 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 20.1 p90 -143.53 156.21 44.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.911 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 15.0 m -114.22 105.38 54.12 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.076 -178.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.75 167.72 23.63 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.496 2.13 . . . . 0.0 111.033 173.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 105' ' ' PRO . 73.3 Cg_exo -50.6 154.06 6.99 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.573 2.182 . . . . 0.0 112.562 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.7 m -46.32 -62.71 1.23 Allowed 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 122.901 0.48 . . . . 0.0 111.917 -175.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.479 ' O ' HD12 ' A' ' 132' ' ' LEU . 3.5 pp -147.28 125.16 11.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.249 0.547 . . . . 0.0 110.333 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 49.0 mt -111.18 -50.21 6.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.225 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.7 t70 58.69 79.52 0.21 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.527 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.529 HD22 ' H ' ' A' ' 187' ' ' ASP . 40.9 mt -70.49 -65.38 0.74 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.567 ' HB2' ' HB3' ' A' ' 140' ' ' PHE . 99.5 mttt -142.89 118.89 10.65 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.372 170.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.6 m -61.07 107.73 0.78 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.757 -166.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.18 -56.77 4.58 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.451 173.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.528 ' NE1' ' HB3' ' A' ' 136' ' ' LYS . 24.2 p90 -81.27 11.25 4.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -173.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.567 ' HB3' ' HB2' ' A' ' 136' ' ' LYS . 43.7 t80 -153.18 138.74 17.75 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 173.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.404 ' CG2' ' HB2' ' A' ' 163' ' ' GLN . 7.4 m -135.66 149.64 49.35 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 176.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.437 HD11 ' H ' ' A' ' 185' ' ' LYS . 55.5 tp -78.53 124.86 28.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.984 0.421 . . . . 0.0 110.535 -176.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.3 mp -89.4 139.84 30.11 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.786 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -114.49 149.68 35.98 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.914 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -133.22 133.42 42.71 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.37 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.2 mp -113.72 131.5 65.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.749 0.309 . . . . 0.0 110.632 -174.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.506 ' HB2' ' CH2' ' A' ' 194' ' ' TRP . 18.6 ttp180 -118.23 120.18 36.92 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.421 HD22 ' C ' ' A' ' 148' ' ' LEU . 0.0 OUTLIER -145.58 160.41 41.7 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.798 -178.128 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -169.72 147.66 3.06 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.532 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.426 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 39.3 Cg_endo -70.08 167.37 25.04 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.102 1.868 . . . . 0.0 111.789 173.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -61.78 -29.65 70.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.221 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -86.53 7.03 27.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -177.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.426 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -94.72 130.95 41.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.113 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -87.32 -26.63 23.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.842 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -123.69 150.08 44.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.294 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.454 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 77.6 m95 -82.34 145.83 29.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.542 -177.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 148' ' ' LEU . 43.2 mt-10 -98.71 118.96 36.62 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.445 175.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mp -98.16 116.18 40.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -119.84 114.66 22.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.12 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -81.28 133.68 35.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.854 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -101.11 -51.64 3.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.876 0.37 . . . . 0.0 111.481 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 127.59 -142.39 13.47 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -175.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.404 ' HB2' ' CG2' ' A' ' 141' ' ' THR . 0.0 OUTLIER -97.3 20.3 11.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.322 0.561 . . . . 0.0 111.127 179.604 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -103.41 143.75 32.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.806 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 38.8 p -96.48 36.49 1.36 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.039 0.447 . . . . 0.0 111.787 -175.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 125' ' ' ILE . 9.2 pt-20 -156.45 145.04 20.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.177 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -140.71 151.2 44.33 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.518 ' HD2' ' CE2' ' A' ' 122' ' ' TYR . 45.8 mmtt -116.41 137.67 51.97 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 41.0 mm -112.74 120.83 63.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 175.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.483 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.9 mm? -89.71 -38.96 13.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 -177.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 50.4 m -76.72 84.5 3.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.066 0.46 . . . . 0.0 111.206 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 90.2 mt -126.38 133.21 51.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.75 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -102.49 124.57 38.87 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.031 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.44 124.8 15.86 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.656 2.237 . . . . 0.0 112.387 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 88.16 27.56 25.38 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.549 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -126.82 146.95 50.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.027 0.442 . . . . 0.0 111.038 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -85.42 131.71 34.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.577 177.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -121.13 136.17 55.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.888 0.375 . . . . 0.0 110.471 176.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 8.5 mp -103.65 126.62 50.91 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.428 HG21 HG21 ' A' ' 111' ' ' VAL . 27.3 m -123.2 142.71 38.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.147 0.499 . . . . 0.0 111.813 -177.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.557 ' NE2' ' HB2' ' A' ' 197' ' ' ALA . 89.4 mt-30 -143.25 157.91 44.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.899 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.46 144.39 24.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.142 178.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.657 ' HG2' ' CZ3' ' A' ' 194' ' ' TRP . 1.9 ptm180 -138.82 175.6 9.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.213 0.53 . . . . 0.0 110.673 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 105' ' ' PRO . 10.6 p -160.78 -172.66 3.59 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.369 176.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.437 ' H ' HD11 ' A' ' 142' ' ' LEU . 17.7 ptmt -142.56 91.4 7.56 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 121.199 0.523 . . . . 0.0 111.176 177.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -69.17 149.84 71.12 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.714 2.276 . . . . 0.0 112.034 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.529 ' H ' HD22 ' A' ' 135' ' ' LEU . 17.5 t70 -61.46 -25.23 67.1 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.823 -176.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.41 ' O ' HG21 ' A' ' 100' ' ' ILE . 20.8 m-70 -74.76 -39.42 61.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.997 0.427 . . . . 0.0 110.252 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.561 ' HA3' ' CD ' ' A' ' 102' ' ' GLN . . . -118.39 -134.22 4.98 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.969 -175.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -163.81 -168.53 1.65 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -51.98 139.53 22.35 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.831 0.348 . . . . 0.0 111.043 173.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 50.1 m -135.69 25.81 3.38 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.985 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . 58.32 -152.72 0.39 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.051 -178.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.657 ' CZ3' ' HG2' ' A' ' 183' ' ' ARG . 14.4 m95 -117.16 115.35 25.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.694 -174.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.552 ' OG ' ' HD3' ' A' ' 196' ' ' PRO . 3.5 p -103.75 -50.59 0.14 Allowed Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.552 ' HD3' ' OG ' ' A' ' 195' ' ' SER . 4.7 Cg_exo -78.97 80.53 3.06 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.085 1.857 . . . . 0.0 113.078 -173.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.557 ' HB2' ' NE2' ' A' ' 181' ' ' GLN . . . -83.96 101.08 11.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.324 0.583 . . . . 0.0 110.104 176.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 25.2 m -95.97 131.45 42.33 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.605 -176.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -95.58 114.82 26.61 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.571 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.3 tp -118.23 134.92 60.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.056 0.455 . . . . 0.0 110.153 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -102.37 134.78 45.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.987 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 40.4 mm -92.16 116.48 66.54 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.614 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.97 150.24 84.89 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.557 2.171 . . . . 0.0 112.074 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 30.2 p -67.84 -18.21 64.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.596 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -86.18 10.24 15.13 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.636 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.454 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 57.5 t80 -64.71 -37.98 89.42 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 173.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 23.6 m -155.8 140.98 17.48 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.134 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 86.8 mtp -60.7 -19.55 58.92 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -175.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -128.78 148.35 50.86 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 172.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 C--O 1.246 0.897 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.242 179.46 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 89.5 mmm . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -67.33 133.74 50.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.12 0.486 . . . . 0.0 110.802 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.1 mt -69.08 105.24 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.192 175.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.42 134.38 31.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.565 -175.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -100.59 105.87 39.75 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.426 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -90.17 -171.42 0.47 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.742 2.294 . . . . 0.0 110.467 175.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.45 ' N ' ' HD3' ' A' ' 105' ' ' PRO . 2.1 p30 34.89 57.35 2.26 Favored Pre-proline 0 N--CA 1.468 0.442 0 O-C-N 124.181 0.925 . . . . 0.0 112.373 -177.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 104' ' ' ASP . 53.0 Cg_endo -91.94 175.97 1.99 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.204 2.603 . . . . 0.0 112.234 -173.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.01 111.44 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.414 2.076 . . . . 0.0 111.225 174.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 pp -122.77 178.92 4.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.76 -175.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 53.07 46.17 27.26 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 123.659 0.599 . . . . 0.0 110.702 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.7 tp -70.28 99.17 1.49 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.909 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.94 130.22 46.09 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.342 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.464 HG21 HG21 ' A' ' 180' ' ' VAL . 6.1 t -123.8 127.07 73.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.812 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -143.41 159.17 42.88 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.976 0.417 . . . . 0.0 110.848 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.79 129.65 60.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.408 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -111.28 132.92 54.0 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -122.52 83.72 47.7 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.832 0.349 . . . . 0.0 111.448 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -83.43 163.78 14.7 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.334 2.689 . . . . 0.0 111.376 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -97.62 -31.09 12.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.078 0.466 . . . . 0.0 111.006 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -86.37 -22.12 26.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.615 0.722 . . . . 0.0 109.965 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -123.07 135.47 54.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.064 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -56.66 134.71 78.03 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -49.79 141.12 28.79 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.419 2.746 . . . . 0.0 112.445 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -144.55 162.22 37.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.931 -173.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.485 ' HB2' HD11 ' A' ' 172' ' ' LEU . 31.4 tp -95.77 128.49 42.69 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.582 176.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -105.75 114.37 28.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.373 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.3 mp -104.29 120.9 55.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -128.94 128.67 44.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.096 0.474 . . . . 0.0 110.913 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' TRP . . . . . 0.455 ' CH2' HD11 ' A' ' 146' ' ' ILE . 32.6 p90 -121.41 160.79 23.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.907 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.3 t -123.74 123.66 26.25 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.78 171.63 17.05 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.326 2.017 . . . . 0.0 111.181 175.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -46.56 138.5 14.24 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.95 2.433 . . . . 0.0 111.683 175.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.8 m -57.49 -32.75 67.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.183 -176.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 96.0 mt -126.32 108.24 11.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.869 176.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 26.7 mt -97.28 -65.18 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.097 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.7 t70 64.12 87.28 0.11 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.514 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 69.8 mt -112.02 13.88 20.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.718 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -72.95 111.76 8.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.455 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.9 t 178.26 -23.99 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.702 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 179.63 -158.7 22.7 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -81.32 75.91 8.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.096 0.474 . . . . 0.0 110.657 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -138.74 116.59 11.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.007 0.432 . . . . 0.0 110.372 176.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.3 m -132.73 136.03 46.12 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.264 176.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.537 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.4 pt? -82.62 111.73 18.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.435 0.636 . . . . 0.0 110.347 -177.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 56.4 mt -91.95 149.58 21.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.688 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -108.0 150.61 26.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.245 0.545 . . . . 0.0 111.575 -174.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -140.91 130.12 23.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.171 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.3 mp -110.73 129.12 66.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.962 0.41 . . . . 0.0 110.82 -173.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.497 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 15.9 ttp180 -111.15 120.08 41.11 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -146.22 161.11 40.98 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.621 0.248 . . . . 0.0 110.969 -177.384 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -167.84 147.46 4.3 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.684 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.446 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 38.7 Cg_endo -71.96 178.01 6.4 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.411 2.074 . . . . 0.0 112.339 172.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.453 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 11.0 pt-20 -70.5 -30.84 67.74 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -176.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.453 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 88.5 mttt -91.67 13.01 19.25 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.152 0.501 . . . . 0.0 110.825 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.446 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -98.71 119.79 38.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.719 178.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.79 -32.47 35.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.324 0.583 . . . . 0.0 110.43 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -101.28 156.99 17.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.604 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.497 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 81.5 m95 -96.15 139.93 31.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.076 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -94.97 115.14 27.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.54 175.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.69 119.02 40.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.516 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 34.8 m-70 -120.14 108.14 13.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.193 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -75.24 126.0 30.12 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -93.51 -43.43 8.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.017 0.437 . . . . 0.0 110.985 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 102.95 -134.94 12.03 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.098 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -94.97 60.95 2.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.267 0.556 . . . . 0.0 110.138 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -156.81 146.28 20.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.117 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 44.0 p -103.22 37.37 2.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.182 0.515 . . . . 0.0 111.26 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -149.09 140.96 23.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.936 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.516 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 22.0 t80 -142.09 145.18 34.0 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 174.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 0.7 OUTLIER -119.17 129.85 55.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.776 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 35.8 mm -101.46 126.46 55.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 174.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -100.16 -30.78 11.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.724 0.297 . . . . 0.0 110.763 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 13.3 m -79.65 81.44 5.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.466 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 123' ' ' LEU . 74.1 mt -126.36 140.97 52.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.954 0.407 . . . . 0.0 111.367 -176.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 13.7 m-70 -112.55 131.19 22.77 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.222 175.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 27.6 Cg_exo -61.11 130.01 30.81 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.608 2.205 . . . . 0.0 112.13 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.64 26.77 60.27 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.275 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.433 ' HB3' ' CE1' ' A' ' 178' ' ' TYR . 0.7 OUTLIER -115.4 138.23 51.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.763 0.316 . . . . 0.0 110.23 179.003 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -82.71 129.9 35.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.365 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 176' ' ' GLN . 66.5 m-85 -121.06 140.19 52.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.872 0.368 . . . . 0.0 110.311 177.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.7 mm? -107.78 129.38 55.05 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.464 HG21 HG21 ' A' ' 111' ' ' VAL . 29.4 m -127.46 138.08 55.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.059 0.457 . . . . 0.0 111.945 -175.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.513 ' OE1' ' HB3' ' A' ' 194' ' ' TRP . 78.6 mt-30 -144.0 153.2 41.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.727 177.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.19 137.99 45.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.888 0.375 . . . . 0.0 110.759 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.478 ' HD2' ' C ' ' A' ' 183' ' ' ARG . 6.1 ppt_? -126.45 164.02 22.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.127 177.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 186' ' ' PRO . 20.1 p -146.69 175.34 10.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.003 176.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -113.1 88.98 13.1 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.593 ' HD2' ' O ' ' A' ' 189' ' ' GLY . 2.3 Cg_endo -81.48 164.99 18.69 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.933 2.422 . . . . 0.0 111.955 177.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -82.44 -17.06 46.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.725 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -81.07 9.37 6.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.441 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.593 ' O ' ' HD2' ' A' ' 186' ' ' PRO . . . 143.59 109.88 0.71 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.429 ' O ' ' HB2' ' A' ' 191' ' ' TRP . 68.7 m-85 -64.77 135.03 55.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.462 0.173 . . . . 0.0 110.819 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.429 ' HB2' ' O ' ' A' ' 190' ' ' TYR . 84.1 m95 71.8 104.69 0.07 Allowed 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 124.261 0.976 . . . . 0.0 111.702 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 33.0 p -88.29 -1.87 58.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.517 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . 62.81 -169.57 0.18 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.744 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.513 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 70.5 m95 -110.96 112.69 24.7 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.13 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.683 ' H ' ' HD2' ' A' ' 196' ' ' PRO . 20.3 m -137.21 -54.01 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.683 ' HD2' ' H ' ' A' ' 195' ' ' SER . 66.4 Cg_endo -74.25 82.99 1.73 Allowed 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 121.686 1.59 . . . . 0.0 113.208 -175.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.43 ' HB2' ' NE2' ' A' ' 181' ' ' GLN . . . -82.3 104.03 12.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.805 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 34.7 m -95.21 135.79 36.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.738 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -98.72 119.48 37.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.068 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.3 tp -125.71 138.56 54.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.026 0.441 . . . . 0.0 110.627 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -106.78 140.86 38.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.361 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 41.0 mm -96.87 124.51 49.81 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.837 177.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.0 149.12 81.64 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.853 2.369 . . . . 0.0 112.04 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 3.0 p -75.24 -15.19 60.55 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.856 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -95.99 18.07 14.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.084 175.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -55.47 -60.58 3.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.27 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.7 m -72.75 131.4 42.3 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.144 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 20.5 ptp -90.44 54.87 2.86 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.869 0.842 . . . . 0.0 110.023 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -139.57 152.28 46.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.127 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.576 -0.726 . . . . 0.0 110.71 -179.152 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.862 0.363 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -146.28 132.58 19.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.26 0.553 . . . . 0.0 111.081 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 72.7 mt -72.24 95.64 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.63 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.1 p -114.56 133.37 60.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.427 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -71.82 127.83 90.27 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.27 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.66 -57.09 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.928 2.419 . . . . 0.0 112.217 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.467 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 6.1 t70 -165.14 128.5 1.65 Allowed Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 104' ' ' ASP . 11.4 Cg_exo -71.04 151.08 61.42 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.714 2.276 . . . . 0.0 112.249 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.511 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 9.7 Cg_endo -53.05 116.77 3.15 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.852 2.368 . . . . 0.0 111.446 177.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.86 175.34 6.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.485 -172.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 55.97 47.13 20.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.849 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.6 tp -68.92 98.9 0.99 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.631 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.63 130.39 41.11 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.457 -176.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -125.13 120.41 58.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.087 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -138.0 157.7 45.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.723 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.3 p -107.53 131.19 58.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.136 0.493 . . . . 0.0 110.295 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -103.04 123.88 47.46 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -123.38 80.36 53.39 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.006 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.466 ' HG2' ' HB2' ' A' ' 119' ' ' ARG . 1.0 OUTLIER -86.69 163.86 9.2 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.562 2.841 . . . . 0.0 111.798 177.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -97.45 -30.27 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.054 0.454 . . . . 0.0 111.169 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -93.76 -25.48 17.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.434 0.635 . . . . 0.0 110.177 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.466 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 23.3 mmt180 -110.91 151.74 27.55 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 175.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -73.78 138.3 76.82 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.63 132.93 55.04 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.946 2.431 . . . . 0.0 111.804 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.445 ' CD2' ' HD2' ' A' ' 168' ' ' LYS . 53.1 p90 -145.8 157.62 43.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.974 0.416 . . . . 0.0 110.957 -174.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.453 ' HB3' ' HB ' ' A' ' 169' ' ' ILE . 26.3 tp -91.21 131.17 36.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.624 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.558 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 12.4 t90 -110.47 109.38 19.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.207 -175.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.2 mp -108.05 123.37 63.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.082 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -123.23 148.42 45.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.834 0.35 . . . . 0.0 110.622 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -138.87 152.2 47.6 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.916 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 m -113.26 138.02 22.24 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.705 -175.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 51.4 Cg_exo -56.42 130.62 41.04 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.945 2.43 . . . . 0.0 111.556 175.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 129' ' ' PRO . 15.4 Cg_exo -67.47 174.38 7.4 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.777 2.318 . . . . 0.0 112.783 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.9 m -70.59 -33.57 71.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.352 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 39.2 mt -81.47 -179.38 7.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.295 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 27.1 mt 69.51 -58.04 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 123.173 0.589 . . . . 0.0 111.008 -173.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.9 t70 52.82 82.54 0.07 Allowed 'General case' 0 C--O 1.237 0.404 0 O-C-N 123.778 0.673 . . . . 0.0 110.581 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.419 ' H ' HD12 ' A' ' 135' ' ' LEU . 5.5 mp -73.03 67.86 0.89 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.397 -176.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -92.84 -14.66 27.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.43 0.633 . . . . 0.0 109.717 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.5 p -70.12 119.9 15.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.44 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -71.43 159.88 53.93 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.944 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 8.1 m-90 72.67 -44.26 0.59 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.7 0.8 . . . . 0.0 111.584 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -59.07 120.0 8.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.941 0.401 . . . . 0.0 110.489 176.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.0 m -118.74 128.81 54.84 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.612 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 29.7 tp -94.22 124.08 38.01 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.699 HD11 ' HG2' ' A' ' 163' ' ' GLN . 8.3 mp -98.01 153.28 18.49 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.848 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.543 ' CD2' ' HB3' ' A' ' 184' ' ' CYS . 75.2 m-85 -128.99 147.56 50.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.301 -173.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -128.12 139.82 52.29 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.3 mp -117.44 129.52 73.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.039 0.447 . . . . 0.0 110.718 -175.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.481 HH22 ' NE2' ' A' ' 181' ' ' GLN . 7.7 ttp-105 -112.67 120.4 41.42 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.551 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -143.69 160.38 40.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.463 0.173 . . . . 0.0 110.821 -177.266 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -165.96 151.76 8.2 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.395 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.507 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 37.1 Cg_endo -70.54 157.12 59.8 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.52 2.147 . . . . 0.0 110.923 170.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.526 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 14.9 pt-20 -62.51 -27.64 69.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.473 -0.785 . . . . 0.0 113.013 -170.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.526 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 82.4 mttt -94.09 9.29 38.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.091 0.472 . . . . 0.0 110.777 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.507 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -90.21 131.71 35.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.263 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.96 -35.35 24.04 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.97 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -103.66 159.98 15.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.273 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.429 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 60.0 m95 -101.04 156.23 17.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.652 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -102.79 120.97 41.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.194 173.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.54 117.84 47.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.948 177.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -124.55 124.58 42.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.924 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -89.48 126.1 35.44 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.047 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.401 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -83.96 -47.67 10.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.159 0.504 . . . . 0.0 110.88 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.419 ' C ' ' HG ' ' A' ' 143' ' ' LEU . . . 107.57 -128.49 9.21 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.805 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.699 ' HG2' HD11 ' A' ' 143' ' ' LEU . 34.5 mt-30 -94.76 5.59 51.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.25 0.548 . . . . 0.0 110.464 -175.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -95.94 142.74 27.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.534 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.451 HG22 ' CE1' ' A' ' 144' ' ' TYR . 61.9 p -101.63 23.98 10.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.459 0.647 . . . . 0.0 111.0 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -148.69 137.74 21.61 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -130.1 149.52 51.78 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.71 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.558 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 42.5 mmtm -114.69 135.85 53.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.593 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 123' ' ' LEU . 31.9 mm -109.86 136.32 46.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 172.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -102.29 -31.39 10.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.925 0.393 . . . . 0.0 110.852 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 44.0 m -89.33 80.95 6.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.652 -177.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.8 mm? -112.97 131.23 55.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.978 174.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -88.68 116.84 67.42 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.542 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.42 116.09 3.18 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.577 2.185 . . . . 0.0 112.066 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 108.27 -2.05 33.02 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.992 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -110.22 144.27 39.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.447 0.641 . . . . 0.0 111.766 -175.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -85.29 128.75 34.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.877 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -109.98 146.65 34.9 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.077 0.465 . . . . 0.0 110.886 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.8 mp -111.17 127.83 55.71 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.88 142.99 40.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.913 0.387 . . . . 0.0 111.447 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.595 ' HG2' ' HA ' ' A' ' 197' ' ' ALA . 62.4 mt-30 -143.41 139.19 29.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.574 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 12.6 p -125.65 141.18 46.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.803 0.335 . . . . 0.0 110.165 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -136.82 150.99 48.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.005 0.431 . . . . 0.0 110.639 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.543 ' HB3' ' CD2' ' A' ' 144' ' ' TYR . 18.5 p -128.89 155.98 44.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.947 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.53 ' HB3' ' CD1' ' A' ' 191' ' ' TRP . 17.9 ptpt -126.9 85.79 60.2 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.399 0.619 . . . . 0.0 112.415 -172.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.406 ' HD2' ' O ' ' A' ' 189' ' ' GLY . 6.5 Cg_exo -74.37 164.11 34.78 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.741 2.294 . . . . 0.0 110.77 172.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -72.28 -14.11 61.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.141 0.496 . . . . 0.0 110.775 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -86.37 -6.91 58.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.97 176.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.406 ' O ' ' HD2' ' A' ' 186' ' ' PRO . . . -172.73 100.37 0.15 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.0 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -88.93 119.08 29.12 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.53 ' CD1' ' HB3' ' A' ' 185' ' ' LYS . 30.1 p-90 -81.19 145.74 30.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.188 0.518 . . . . 0.0 111.263 -174.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 41.6 m -126.51 3.17 6.9 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.554 174.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.05 174.46 11.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.371 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.532 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 44.6 m95 -114.49 -176.73 2.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.781 -177.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.563 ' OG ' ' HD3' ' A' ' 196' ' ' PRO . 13.9 p -168.16 -50.07 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -177.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.563 ' HD3' ' OG ' ' A' ' 195' ' ' SER . 94.8 Cg_endo -85.46 86.73 1.02 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 121.69 1.593 . . . . 0.0 113.516 -171.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.595 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -83.76 114.17 21.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.146 0.498 . . . . 0.0 111.505 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 86.2 m -106.07 139.56 40.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.022 175.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -104.09 148.69 25.97 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.384 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.8 tp -154.29 134.56 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.248 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -97.58 125.53 42.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.681 0.277 . . . . 0.0 110.276 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 44.6 mm -80.59 117.7 69.04 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -59.07 145.69 96.81 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.551 2.167 . . . . 0.0 111.874 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 26.8 m -70.1 -8.22 47.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.474 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.71 -15.24 60.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.984 176.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 9.7 t80 -61.62 131.82 51.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.197 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 208' ' ' MET . 49.8 m 70.21 153.42 0.11 Allowed 'General case' 0 CA--C 1.539 0.521 0 O-C-N 123.314 0.384 . . . . 0.0 111.223 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 207' ' ' THR . 62.9 mtt 75.2 -69.53 0.17 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.494 0.717 . . . . 0.0 111.489 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -159.82 133.02 6.89 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -177.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.202 -179.939 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.841 0.353 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -120.45 141.4 50.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.411 0.624 . . . . 0.0 111.108 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.465 HD11 ' CZ ' ' A' ' 190' ' ' TYR . 83.9 mt -79.84 99.98 4.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.385 176.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.1 m -83.43 116.15 27.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.171 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -130.08 94.36 31.09 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.209 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -68.06 -59.15 0.11 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.38 2.053 . . . . 0.0 112.046 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -155.25 121.79 2.7 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.919 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -62.37 160.22 32.3 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.95 2.433 . . . . 0.0 112.385 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.527 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 9.8 Cg_endo -52.09 147.38 27.21 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.247 2.631 . . . . 0.0 112.664 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.407 ' H ' HD23 ' A' ' 107' ' ' LEU . 2.1 pt? -136.97 171.89 13.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.777 -173.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 54.35 57.22 6.04 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 123.96 0.787 . . . . 0.0 111.236 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.431 HD23 ' OG1' ' A' ' 198' ' ' THR . 56.2 tp -80.29 94.33 6.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.004 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.29 129.72 35.79 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.216 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.402 HG12 HD22 ' A' ' 123' ' ' LEU . 2.9 t -120.06 114.45 44.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.956 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.499 ' OE1' ' HE3' ' A' ' 114' ' ' LYS . 38.9 tt0 -135.51 131.69 36.36 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.349 -175.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.31 133.48 31.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.996 0.427 . . . . 0.0 110.892 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.499 ' HE3' ' OE1' ' A' ' 112' ' ' GLU . 0.4 OUTLIER -108.57 131.43 54.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.45 178.175 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -124.54 85.45 56.24 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.688 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.21 156.16 65.59 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 123.27 2.647 . . . . 0.0 112.318 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.91 -17.7 56.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.233 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -117.05 -49.75 2.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.9 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.78 157.6 28.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.764 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -64.29 145.5 98.2 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.336 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.97 141.13 76.08 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.821 2.347 . . . . 0.0 111.971 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.525 ' HB3' HD13 ' A' ' 170' ' ' LEU . 21.4 p90 -148.5 151.11 34.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.607 -174.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 6.8 mt -79.07 134.04 36.77 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.059 173.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -111.6 100.58 9.1 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.151 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.415 ' H ' HD12 ' A' ' 125' ' ' ILE . 4.4 mp -90.16 123.47 42.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.494 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -132.56 119.55 20.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.044 0.449 . . . . 0.0 110.534 -176.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' TRP . . . . . 0.464 ' CH2' HD11 ' A' ' 146' ' ' ILE . 39.4 p90 -118.45 166.44 12.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.535 -176.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.6 t -101.15 118.32 60.51 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.468 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 80.2 Cg_endo -76.67 136.96 17.64 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.723 2.282 . . . . 0.0 112.322 -178.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 129' ' ' PRO . 32.8 Cg_exo -61.6 91.53 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.628 2.219 . . . . 0.0 110.97 173.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.1 m -83.63 -22.51 32.18 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.042 -173.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 92.0 mt -84.87 13.45 5.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.453 0.644 . . . . 0.0 111.397 -175.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.547 ' HB ' HD11 ' A' ' 135' ' ' LEU . 59.2 mt -69.78 -20.31 23.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.241 -0.891 . . . . 0.0 108.869 166.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 t70 69.32 70.75 0.26 Allowed 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 114.44 -1.255 . . . . 0.0 109.913 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.547 HD11 ' HB ' ' A' ' 133' ' ' ILE . 1.0 OUTLIER -104.39 142.98 33.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.267 -176.731 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -133.44 165.74 24.15 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.99 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 13.6 p -82.85 43.6 0.86 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.152 0.501 . . . . 0.0 111.287 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.19 54.71 0.64 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 13.1 t90 66.13 62.62 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.598 0.713 . . . . 0.0 110.558 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -162.9 75.85 0.42 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.351 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 186' ' ' PRO . 4.2 m -98.93 136.12 39.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.393 -174.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 22.6 tp -99.9 110.89 23.23 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.401 HD11 ' HG2' ' A' ' 163' ' ' GLN . 0.9 OUTLIER -99.48 141.44 32.27 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.914 0.388 . . . . 0.0 110.954 -176.618 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -107.64 139.55 42.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.138 -172.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -133.57 134.35 43.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.639 -175.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.464 HD11 ' CH2' ' A' ' 127' ' ' TRP . 4.5 mp -118.9 124.82 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.881 0.372 . . . . 0.0 110.681 -175.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.506 ' HB2' ' CZ2' ' A' ' 194' ' ' TRP . 25.4 ttp180 -113.46 126.35 55.24 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 4.1 pp -149.89 164.67 34.78 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.526 -176.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -169.33 148.9 3.64 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.588 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.433 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 30.8 Cg_endo -68.23 167.35 22.31 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.377 2.051 . . . . 0.0 111.812 172.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.463 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 11.3 pt-20 -64.02 -24.21 67.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.97 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.463 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 89.6 mttt -96.15 18.78 12.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.198 0.523 . . . . 0.0 110.753 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.433 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -103.99 128.73 51.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.718 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -95.0 -11.24 28.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.075 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.67 162.67 27.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.239 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.473 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 86.5 m95 -98.81 137.73 36.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.17 0.51 . . . . 0.0 112.278 -171.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -104.14 115.04 29.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.548 176.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 158' ' ' ILE . 2.5 mp -95.98 120.02 44.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.363 -178.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 65.5 m-70 -113.56 130.1 56.43 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.341 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -97.41 129.89 44.59 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.845 -176.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -95.27 -37.96 10.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.888 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.68 -125.13 8.24 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.854 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.401 ' HG2' HD11 ' A' ' 143' ' ' LEU . 31.5 mt-30 -98.92 9.05 44.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.008 0.433 . . . . 0.0 110.577 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -103.82 144.88 30.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.459 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.6 p -97.01 33.58 1.89 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.305 0.574 . . . . 0.0 111.731 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -154.64 149.99 27.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.592 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 31.9 t80 -145.12 149.44 35.02 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 49.4 mmtt -113.03 144.34 42.77 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.444 ' HB ' ' HB2' ' A' ' 123' ' ' LEU . 36.3 mm -127.18 123.18 61.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.593 0.235 . . . . 0.0 110.809 176.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.525 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.9 mm? -97.3 -28.74 13.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.184 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 9.7 t -81.65 79.46 8.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.095 0.474 . . . . 0.0 110.563 -176.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 67.5 mt -129.64 143.02 50.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.863 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 80.9 m80 -105.95 128.53 26.23 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.974 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 22.2 Cg_exo -63.77 133.62 40.02 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.741 2.294 . . . . 0.0 112.484 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 79.52 28.93 50.75 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.769 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 72.4 mm-40 -128.38 155.67 44.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.067 0.46 . . . . 0.0 110.91 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -92.78 133.38 36.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.388 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -120.32 144.47 47.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.869 0.366 . . . . 0.0 110.144 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.2 mm? -105.12 129.1 53.61 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.402 HG21 HG21 ' A' ' 111' ' ' VAL . 23.1 m -128.61 139.64 51.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.834 0.349 . . . . 0.0 110.865 -176.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.452 ' HG2' ' HA ' ' A' ' 197' ' ' ALA . 16.2 mt-30 -139.64 158.98 43.21 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.212 -178.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 12.6 p -136.29 138.45 46.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.208 0.527 . . . . 0.0 111.04 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -138.76 147.86 43.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.876 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.527 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 25.5 p -137.93 154.61 49.4 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.31 138.82 5.97 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 141' ' ' THR . 89.8 Cg_endo -78.94 -165.64 0.35 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.761 2.307 . . . . 0.0 112.356 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -80.99 -35.49 31.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.72 0.295 . . . . 0.0 111.242 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -86.69 24.31 1.48 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -175.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -159.64 142.99 8.69 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.912 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.465 ' CZ ' HD11 ' A' ' 100' ' ' ILE . 37.6 p90 -119.23 153.3 35.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.135 0.493 . . . . 0.0 110.548 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -110.65 163.41 13.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.318 -174.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 20.6 p -148.58 10.36 0.84 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.518 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -162.25 160.81 27.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.146 0.498 . . . . 0.0 111.596 -177.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.506 ' CZ2' ' HB2' ' A' ' 147' ' ' ARG . 75.4 m95 -106.26 161.98 14.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.613 176.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.475 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 7.4 m -131.41 -59.1 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -175.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 10.1 Cg_endo -90.08 95.11 0.29 Allowed 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.43 2.087 . . . . 0.0 113.16 -171.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.452 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -95.74 127.58 41.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.965 0.412 . . . . 0.0 110.567 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.431 ' OG1' HD23 ' A' ' 109' ' ' LEU . 30.9 m -121.77 144.21 48.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.639 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -104.08 127.5 51.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.204 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.7 tp -128.45 137.42 57.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.156 0.503 . . . . 0.0 110.985 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -99.59 124.98 45.3 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.686 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 51.0 mm -86.28 124.57 69.89 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 174.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.68 152.82 66.4 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.898 2.399 . . . . 0.0 112.226 -176.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 17.9 m -71.17 -23.92 62.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.7 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -100.46 54.71 0.88 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.344 176.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -87.95 -60.31 2.0 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.829 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.8 p -89.86 106.37 18.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.039 0.447 . . . . 0.0 110.976 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.19 111.83 6.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.948 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -88.7 -23.59 22.93 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.825 0.821 . . . . 0.0 109.748 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 . . . . . 0 C--N 1.309 -1.185 0 CA-C-N 114.227 -1.351 . . . . 0.0 109.767 -178.333 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 93.3 mtp . . . . . 0 N--CA 1.485 1.282 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 76.9 t80 74.94 143.97 0.08 Allowed 'General case' 0 C--O 1.236 0.354 0 O-C-N 123.802 0.689 . . . . 0.0 111.595 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 58.5 mt -43.09 -56.75 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.578 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.0 t -85.12 97.61 5.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.405 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -63.42 154.82 77.69 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.93 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.426 ' O ' ' HD3' ' A' ' 105' ' ' PRO . 52.4 Cg_endo -70.36 1.71 4.57 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.129 2.553 . . . . 0.0 114.0 -174.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.4 ' OD2' ' HB3' ' A' ' 130' ' ' PRO . 19.2 t70 -110.27 95.14 20.64 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.797 0.332 . . . . 0.0 110.143 176.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 103' ' ' PRO . 72.9 Cg_endo -94.97 168.25 1.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.444 2.763 . . . . 0.0 112.616 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.438 ' HG3' ' SG ' ' A' ' 184' ' ' CYS . 24.2 Cg_exo -62.98 141.64 84.84 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.394 2.063 . . . . 0.0 111.162 174.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 128' ' ' SER . 1.2 pp -133.38 177.06 7.98 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.717 0.294 . . . . 0.0 111.582 -175.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 55.41 50.28 15.12 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.584 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.5 tp -73.66 105.18 4.86 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -112.13 128.86 56.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.828 -175.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.6 t -113.32 129.82 68.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.032 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -129.78 129.84 44.6 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.878 0.37 . . . . 0.0 110.401 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 p -85.66 118.73 32.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.183 0.516 . . . . 0.0 109.846 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.507 ' O ' ' HD3' ' A' ' 116' ' ' PRO . 31.2 mmmt -113.38 108.45 17.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.1 0.476 . . . . 0.0 110.762 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -107.36 96.14 15.22 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.364 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 114' ' ' LYS . 15.3 Cg_exo -69.37 146.11 61.54 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.798 2.332 . . . . 0.0 111.687 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -80.01 -3.89 50.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.104 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -126.77 -40.86 1.87 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.196 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.418 ' H ' ' HB2' ' A' ' 116' ' ' PRO . 66.7 mtm-85 -99.44 165.58 11.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.41 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 120' ' ' LYS . 12.6 mptt -60.11 135.4 90.71 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.119 175.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.434 ' HA ' ' CD ' ' A' ' 116' ' ' PRO . 32.3 Cg_endo -64.18 136.86 53.79 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.909 2.406 . . . . 0.0 112.122 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.442 ' HB3' HD13 ' A' ' 170' ' ' LEU . 54.0 p90 -136.33 159.71 40.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.711 -175.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.5 tp -98.83 123.83 43.33 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.431 ' CZ2' ' HD3' ' A' ' 126' ' ' LYS . 21.6 t90 -104.62 115.24 30.0 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.401 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.7 mp -108.3 129.06 63.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.652 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.431 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 54.9 pttt -137.68 152.48 49.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.047 0.451 . . . . 0.0 110.347 175.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' TRP . . . . . 0.456 ' CD2' HG21 ' A' ' 182' ' ' VAL . 29.3 p90 -142.0 163.33 33.17 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.076 -174.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.446 ' HB2' HD12 ' A' ' 107' ' ' LEU . 42.4 m -106.94 105.59 55.83 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 121.004 0.43 . . . . 0.0 109.895 176.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.83 148.68 65.14 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.758 2.305 . . . . 0.0 112.013 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.4 ' HB3' ' OD2' ' A' ' 104' ' ' ASP . 33.7 Cg_exo -57.26 136.85 78.77 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.439 2.093 . . . . 0.0 111.767 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 26.9 m -90.13 -18.5 25.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.422 0.63 . . . . 0.0 110.092 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 97.4 mt -114.3 98.25 6.82 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.378 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 94.1 mt -133.19 -43.01 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.359 -177.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 5.3 m-20 66.66 77.43 0.28 Allowed 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.621 0.576 . . . . 0.0 110.239 -172.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 135' ' ' LEU . 3.0 mm? -75.08 -25.92 58.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.934 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? 65.06 110.86 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 122.092 0.948 . . . . 0.0 111.745 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 40.9 m -59.17 133.88 56.49 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.787 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 171.66 -79.7 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.45 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -143.72 -35.0 0.39 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.739 0.304 . . . . 0.0 110.237 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -64.16 131.46 47.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.066 0.46 . . . . 0.0 110.294 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.0 m -125.35 154.86 41.19 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.342 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 185' ' ' LYS . 30.1 tp -78.12 109.18 11.99 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 184' ' ' CYS . 2.0 mp -106.8 158.31 17.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.361 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -125.45 133.39 52.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.024 0.44 . . . . 0.0 111.247 -172.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -123.28 139.33 54.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.067 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.416 HG13 HG23 ' A' ' 182' ' ' VAL . 4.6 mp -126.99 122.34 60.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.679 0.276 . . . . 0.0 110.469 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -107.72 130.08 54.97 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 174.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.5 pp -144.25 157.71 44.13 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.724 -177.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -165.44 144.5 5.32 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.187 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.459 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 29.2 Cg_endo -67.88 168.84 17.61 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.406 2.071 . . . . 0.0 111.835 172.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.86 -18.86 65.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.934 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -100.96 17.79 21.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.121 0.486 . . . . 0.0 110.578 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.459 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -108.21 120.5 42.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.166 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -79.57 -28.55 41.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.583 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -109.71 154.25 23.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.755 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -90.53 144.78 25.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.146 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -98.59 110.18 22.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.254 172.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.17 113.47 24.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.198 0.523 . . . . 0.0 109.733 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 49.4 m-70 -116.35 118.99 34.26 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.685 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -88.31 126.38 35.15 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -86.6 -30.6 21.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.987 0.422 . . . . 0.0 110.729 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 95.25 -127.89 9.31 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.589 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -104.8 53.13 0.73 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.372 0.606 . . . . 0.0 110.241 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -144.64 143.86 30.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.283 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.5 p -96.66 24.35 6.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.18 0.514 . . . . 0.0 111.538 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -147.43 136.24 22.07 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.446 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 24.5 t80 -134.05 142.1 47.45 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.403 ' HE2' ' CD1' ' A' ' 124' ' ' TRP . 0.2 OUTLIER -120.4 136.38 54.74 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.689 0.281 . . . . 0.0 110.564 -178.362 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.442 HG22 ' H ' ' A' ' 171' ' ' SER . 43.2 mm -108.52 131.95 57.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.616 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.442 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.8 mm? -112.71 41.96 1.94 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.203 0.525 . . . . 0.0 110.117 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.442 ' H ' HG22 ' A' ' 169' ' ' ILE . 10.7 t -157.75 64.26 0.47 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.647 -177.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.8 mm? -109.27 151.84 26.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.991 0.424 . . . . 0.0 110.694 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -116.61 122.96 31.04 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.232 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -59.84 117.61 4.38 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.862 2.375 . . . . 0.0 112.35 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.23 -5.76 49.7 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.69 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -101.63 142.18 33.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.05 0.452 . . . . 0.0 111.015 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 199' ' ' PHE . 79.7 tttt -91.86 133.33 35.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.131 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -116.8 137.9 51.87 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.095 0.474 . . . . 0.0 110.496 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 7.6 mp -99.3 126.28 45.11 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 174.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.7 136.4 60.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.043 0.449 . . . . 0.0 111.226 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.581 ' HG2' ' HA ' ' A' ' 197' ' ' ALA . 55.4 mt-30 -138.3 139.06 38.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.0 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.456 HG21 ' CD2' ' A' ' 127' ' ' TRP . 12.6 p -125.08 152.69 31.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.857 0.36 . . . . 0.0 110.733 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -153.13 142.02 21.17 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.79 173.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.438 ' SG ' ' HG3' ' A' ' 106' ' ' PRO . 25.1 p -105.09 157.08 17.5 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.659 174.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.43 ' O ' HD12 ' A' ' 142' ' ' LEU . 98.3 mttt -102.96 103.33 33.11 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.634 0.254 . . . . 0.0 111.441 -176.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.26 161.53 28.94 Favored 'Trans proline' 0 CA--C 1.529 0.275 0 C-N-CA 123.021 2.481 . . . . 0.0 112.192 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -66.97 -18.16 65.25 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.141 0.495 . . . . 0.0 111.013 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -85.73 -13.75 47.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.698 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -151.88 103.58 0.24 Allowed Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -75.36 17.97 0.24 Allowed 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -167.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -145.21 172.72 12.72 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.2 m -94.25 75.25 3.98 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.35 -1.75 . . . . 0.0 110.039 -171.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -88.57 112.02 22.55 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.543 0.687 . . . . 0.0 109.737 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 23.6 m95 -69.88 149.31 47.98 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.58 -1.191 . . . . 0.0 112.622 -163.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.515 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 3.3 m -134.84 -54.47 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.208 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 27.1 Cg_endo -95.36 131.69 0.51 Allowed 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 122.501 2.134 . . . . 0.0 112.969 -177.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.581 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -123.65 124.63 43.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.036 0.446 . . . . 0.0 110.705 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 61.0 m -117.02 144.02 45.08 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.629 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.474 ' HB3' ' HE2' ' A' ' 177' ' ' LYS . 55.7 m-85 -107.69 132.44 53.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.594 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.1 tp -133.28 135.31 56.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.1 0.476 . . . . 0.0 110.735 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.417 HE21 ' HB2' ' A' ' 177' ' ' LYS . 1.7 mm-40 -105.61 130.6 53.62 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.539 178.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 46.6 mm -85.9 124.64 70.48 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.913 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.41 156.73 61.84 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.908 2.405 . . . . 0.0 112.382 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 46.1 m -81.06 -3.67 52.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.15 0.5 . . . . 0.0 110.913 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -84.96 -15.09 45.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.039 174.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 30.0 t80 -58.92 141.31 53.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.722 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 206' ' ' PHE . 80.6 m 74.87 138.11 0.06 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.474 0.654 . . . . 0.0 111.626 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 96.3 mmm -119.15 -72.03 0.71 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.168 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -141.9 61.67 1.45 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 . . . . . 0 C--O 1.25 1.125 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.492 -169.734 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -163.82 176.08 9.85 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 62.6 mt -65.45 95.89 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.92 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.3 p -152.9 139.77 12.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.639 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -97.82 115.92 65.74 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 120.904 0.383 . . . . 0.0 111.259 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -74.18 -50.6 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.671 2.247 . . . . 0.0 111.977 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -120.25 99.78 48.13 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.435 0.636 . . . . 0.0 110.289 176.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -63.14 161.1 31.45 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.455 2.77 . . . . 0.0 112.716 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -54.55 121.15 9.26 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.521 2.147 . . . . 0.0 110.768 174.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.445 ' H ' HD23 ' A' ' 107' ' ' LEU . 2.2 pt? -127.75 -178.32 4.45 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.917 -171.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 55.78 40.8 30.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.822 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.492 HD23 ' OG1' ' A' ' 198' ' ' THR . 54.0 tp -70.22 94.61 0.93 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.7 123.58 40.43 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.322 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.497 HG12 HD11 ' A' ' 123' ' ' LEU . 3.2 t -112.29 113.56 44.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -124.06 133.27 53.67 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.141 -172.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.6 p -85.78 116.9 29.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.388 0.613 . . . . 0.0 109.841 175.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -103.05 123.49 46.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.403 -177.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -121.04 84.68 39.77 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.436 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.98 146.87 42.5 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.736 2.29 . . . . 0.0 111.087 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -79.9 -16.77 54.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.351 -177.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -116.12 -39.55 3.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.581 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -91.37 163.07 14.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.634 176.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -72.97 141.52 81.78 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.012 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.38 138.68 67.13 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.944 2.429 . . . . 0.0 111.742 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -150.82 164.55 35.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.833 -174.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.566 ' HB2' HD11 ' A' ' 172' ' ' LEU . 29.7 tp -97.41 122.27 40.26 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.428 ' HE1' ' HB2' ' A' ' 166' ' ' GLU . 24.4 t90 -102.71 112.53 25.34 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.047 -178.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.8 mp -106.89 120.15 57.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.666 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -128.11 134.78 49.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.93 0.395 . . . . 0.0 110.293 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 36.0 p90 -128.05 155.56 44.15 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.573 -177.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.9 m -108.88 100.27 38.87 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.909 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.13 161.82 18.44 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.021 2.481 . . . . 0.0 112.547 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -51.8 153.29 11.75 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.316 2.678 . . . . 0.0 113.238 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.4 p -57.42 -54.54 45.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.796 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 57.0 mt -102.57 100.02 10.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.246 0.546 . . . . 0.0 111.187 -175.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 75.1 mt -111.95 -69.05 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.604 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 57.9 55.36 5.41 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.797 0.685 . . . . 0.0 112.615 172.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.52 HD21 ' N ' ' A' ' 187' ' ' ASP . 3.4 mm? -99.56 74.54 1.89 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.14 0.495 . . . . 0.0 109.966 172.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -84.43 -84.12 0.15 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.326 -177.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 70.0 p 46.49 -92.12 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.0 0.92 . . . . 0.0 113.419 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 152.19 -53.5 0.47 Allowed Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -178.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 40.2 m95 -75.92 -17.45 59.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.008 0.432 . . . . 0.0 110.184 176.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -118.6 136.67 53.75 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.001 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.424 ' O ' HD22 ' A' ' 143' ' ' LEU . 22.0 m -141.64 147.35 37.42 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 175.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.418 HD11 ' H ' ' A' ' 185' ' ' LYS . 46.5 tp -80.09 111.16 16.17 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.002 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.424 HD22 ' O ' ' A' ' 141' ' ' THR . 2.6 mm? -91.62 166.04 13.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.456 174.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.4 ' HD1' ' HG ' ' A' ' 184' ' ' CYS . 71.8 m-85 -131.32 131.92 44.12 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -177.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -119.87 134.6 55.19 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.51 121.96 61.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.133 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.446 ' HE ' ' CD ' ' A' ' 181' ' ' GLN . 22.5 ptt180 -103.74 148.08 26.5 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.6 pp -165.05 161.79 19.95 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.175 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 153' ' ' ALA . 57.5 pttt -164.77 145.59 6.32 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-O 120.682 0.277 . . . . 0.0 110.484 176.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.418 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 36.6 Cg_endo -68.75 165.71 28.67 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.76 2.307 . . . . 0.0 111.746 174.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.46 -5.4 19.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.897 -174.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -111.3 6.7 20.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.292 0.568 . . . . 0.0 110.437 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.418 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -95.2 127.72 41.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.187 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.36 -38.86 29.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.723 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -104.16 162.92 12.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.955 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -91.4 140.89 29.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.034 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 148' ' ' LEU . 36.1 mt-10 -91.88 116.25 28.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.3 172.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.75 109.41 21.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.54 0.686 . . . . 0.0 109.363 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.486 ' HB3' ' CE2' ' A' ' 167' ' ' PHE . 35.0 m-70 -105.8 126.42 52.15 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.195 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -98.28 117.27 32.28 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.866 0.365 . . . . 0.0 110.648 -176.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -78.0 -51.11 10.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.143 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 76.19 89.9 0.25 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.072 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 75.34 -25.59 0.2 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.733 0.813 . . . . 0.0 113.033 170.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -89.41 142.59 27.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.91 0.386 . . . . 0.0 110.57 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.1 p -101.75 32.6 3.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.5 0.667 . . . . 0.0 111.047 -177.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.428 ' HB2' ' HE1' ' A' ' 124' ' ' TRP . 5.5 pt-20 -156.9 109.94 2.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.769 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.486 ' CE2' ' HB3' ' A' ' 159' ' ' HIS . 17.8 t80 -110.94 146.56 36.38 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.497 -174.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.463 ' HD2' ' N ' ' A' ' 168' ' ' LYS . 9.6 mptt -121.83 130.19 53.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.369 -178.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 34.7 mm -107.84 124.21 63.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.551 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.17 -27.14 15.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.957 0.408 . . . . 0.0 110.482 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 34.7 m -82.33 84.55 7.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.663 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' A' ' 123' ' ' LEU . 68.9 mt -130.99 145.85 52.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.124 0.488 . . . . 0.0 111.323 -177.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 63.6 m-70 -114.38 127.49 26.77 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.859 177.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 24.2 Cg_exo -62.88 129.53 26.36 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.836 2.357 . . . . 0.0 112.797 -178.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.14 33.34 32.86 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.487 176.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -126.21 145.53 50.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.318 0.58 . . . . 0.0 111.059 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -86.85 129.64 34.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.079 177.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -120.25 137.21 54.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.246 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.5 mm? -97.44 125.02 41.85 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 173.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.47 ' O ' ' HB ' ' A' ' 198' ' ' THR . 16.7 m -135.43 139.31 46.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.748 0.309 . . . . 0.0 110.788 -171.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.502 ' HB3' ' HA ' ' A' ' 197' ' ' ALA . 1.0 OUTLIER -166.63 142.95 4.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.907 0.384 . . . . 0.0 110.842 177.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 13.0 p -121.93 153.02 26.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.52 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -146.11 134.75 22.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.066 0.46 . . . . 0.0 109.76 173.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.4 ' HG ' ' HD1' ' A' ' 144' ' ' TYR . 3.3 m -111.93 152.66 27.78 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.682 -176.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.485 ' HB3' ' CD1' ' A' ' 191' ' ' TRP . 18.0 pttp -121.39 86.52 43.93 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.87 175.82 5.95 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.33 2.02 . . . . 0.0 111.842 172.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.52 ' N ' HD21 ' A' ' 135' ' ' LEU . 27.7 t70 -64.98 -28.31 69.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.186 0.517 . . . . 0.0 110.782 -178.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -92.5 1.94 56.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.308 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -164.9 113.88 0.57 Allowed Glycine 0 C--O 1.226 -0.375 0 C-N-CA 119.704 -1.236 . . . . 0.0 113.546 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -108.55 141.95 39.69 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.485 ' CD1' ' HB3' ' A' ' 185' ' ' LYS . 28.9 p-90 -106.8 149.54 27.26 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.058 0.456 . . . . 0.0 111.282 -176.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.4 p -128.74 7.62 5.69 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.202 177.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -155.4 171.28 20.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.99 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -114.67 103.31 10.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.843 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.431 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 16.1 m -92.2 -54.57 0.26 Allowed Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 94.9 Cg_endo -76.68 69.78 6.65 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.096 1.864 . . . . 0.0 113.762 -172.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.502 ' HA ' ' HB3' ' A' ' 181' ' ' GLN . . . -69.52 123.23 20.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.331 0.586 . . . . 0.0 111.128 178.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.492 ' OG1' HD23 ' A' ' 109' ' ' LEU . 90.4 m -108.07 148.02 30.37 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.566 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -111.86 133.14 54.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.362 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.9 tp -137.63 133.84 45.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.34 0.591 . . . . 0.0 111.017 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -100.7 121.17 41.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.517 176.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.4 mm -85.85 122.95 72.82 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.27 143.7 96.84 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.58 2.186 . . . . 0.0 112.384 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 14.9 m -66.28 -23.55 66.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.29 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.87 19.62 3.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.591 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -53.64 -48.86 68.97 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.095 0.474 . . . . 0.0 110.318 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.8 p -85.6 125.62 33.27 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.776 174.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -65.19 113.44 3.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.515 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -92.96 66.28 4.18 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 C--O 1.25 1.107 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.178 -178.403 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 120.258 0.075 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 26.4 t80 69.0 144.67 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.629 0.728 . . . . 0.0 111.751 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.421 HD12 ' N ' ' A' ' 100' ' ' ILE . 4.4 mp -78.78 86.47 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.82 178.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.9 m -73.32 140.84 17.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -82.23 121.64 78.79 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -52.75 -67.85 0.08 OUTLIER 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.81 2.34 . . . . 0.0 112.322 -172.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -154.22 90.03 3.27 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.903 176.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.28 132.5 52.59 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.717 2.278 . . . . 0.0 112.007 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.423 ' HG3' ' SG ' ' A' ' 184' ' ' CYS . 18.3 Cg_endo -56.67 132.61 52.79 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.201 2.6 . . . . 0.0 112.346 -176.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.44 HD23 ' N ' ' A' ' 107' ' ' LEU . 2.4 pt? -146.82 -167.57 2.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.27 -174.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 59.14 57.16 3.59 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.241 0.543 . . . . 0.0 111.105 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.411 HD23 ' HB3' ' A' ' 127' ' ' TRP . 12.3 mt -72.37 99.95 2.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.796 177.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.53 122.9 37.58 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.416 HG12 HD11 ' A' ' 123' ' ' LEU . 4.9 t -114.64 122.64 69.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.14 -175.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -120.84 140.92 51.08 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.804 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 p -98.21 119.71 46.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.21 0.528 . . . . 0.0 110.145 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.557 ' HE2' ' HA ' ' A' ' 114' ' ' LYS . 9.9 mmpt? -111.51 126.69 55.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.652 -178.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -133.09 97.23 16.79 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.08 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.81 175.97 8.92 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.71 2.273 . . . . 0.0 112.7 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -59.76 -67.31 0.4 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.329 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -131.63 38.16 3.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.295 0.569 . . . . 0.0 111.017 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -122.23 154.6 37.31 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.189 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -55.33 118.38 18.34 Favored Pre-proline 0 C--N 1.328 -0.337 0 O-C-N 123.582 0.552 . . . . 0.0 111.071 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.91 144.57 83.36 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.628 2.219 . . . . 0.0 111.146 177.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -140.53 150.56 43.86 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.219 0.533 . . . . 0.0 111.215 -173.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.455 ' HB2' HD11 ' A' ' 172' ' ' LEU . 30.1 tp -91.52 126.27 36.54 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.288 175.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.438 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 22.5 t90 -102.98 105.89 16.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.195 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.7 mp -98.99 123.62 51.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -134.12 136.21 43.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.944 0.402 . . . . 0.0 110.555 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' TRP . . . . . 0.485 ' CH2' HD11 ' A' ' 146' ' ' ILE . 20.7 p90 -122.51 167.96 12.71 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.0 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.9 t -87.29 125.47 65.74 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -62.64 150.75 86.83 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.652 2.235 . . . . 0.0 111.81 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.69 -162.48 0.11 Allowed 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.845 2.363 . . . . 0.0 112.399 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.0 p -60.81 151.0 30.95 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.771 0.319 . . . . 0.0 110.793 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 132' ' ' LEU . 2.7 pp -66.14 112.74 4.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.644 0.735 . . . . 0.0 111.243 -174.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 68.3 mt -94.18 -41.21 12.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.597 177.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.0 t70 62.85 86.6 0.11 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.569 -172.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.3 mt -78.97 59.11 2.56 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.787 -174.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -74.68 -30.15 61.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.285 0.564 . . . . 0.0 109.769 173.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.4 p -86.74 95.36 9.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.352 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.53 -16.07 48.95 Favored Glycine 0 C--N 1.33 0.237 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.93 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 27.7 m-90 -57.27 -33.79 67.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.065 0.46 . . . . 0.0 110.155 175.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -110.6 112.78 24.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 171.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.8 m -112.54 138.16 49.72 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 63.9 tp -97.14 110.58 23.1 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.99 148.27 26.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.2 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.487 ' CD2' ' HB3' ' A' ' 184' ' ' CYS . 92.6 m-85 -115.46 138.33 51.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.545 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -124.46 135.77 53.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.485 HD11 ' CH2' ' A' ' 127' ' ' TRP . 5.1 mp -118.73 130.84 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.043 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -111.79 134.26 53.48 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.552 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.5 pp -145.43 156.53 43.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.797 -177.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -165.66 151.05 8.08 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.419 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.491 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 36.7 Cg_endo -70.05 164.11 36.03 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.453 2.102 . . . . 0.0 111.685 173.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.44 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 14.4 pt-20 -64.15 -23.69 67.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.976 -172.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.44 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 86.9 mttt -98.55 9.94 42.09 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.189 0.518 . . . . 0.0 110.875 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.491 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -95.85 131.52 42.08 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.006 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -84.96 -43.03 14.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.542 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -82.78 150.56 26.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.036 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -98.09 142.85 29.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.811 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -103.35 116.28 32.13 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.957 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.06 132.17 38.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.189 0.519 . . . . 0.0 111.079 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 67.6 m-70 -127.08 125.97 42.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.332 175.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -86.43 119.86 27.15 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.432 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -85.11 -39.19 18.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.905 0.383 . . . . 0.0 111.026 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 100.51 -143.78 16.45 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.443 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.08 62.74 4.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.978 0.418 . . . . 0.0 110.366 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -155.24 147.92 24.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.377 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.8 p -98.0 27.8 4.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.975 0.416 . . . . 0.0 111.909 -176.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -151.82 144.86 24.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.893 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 26.4 t80 -140.07 148.51 41.86 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.992 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 10.5 mptt -120.39 142.77 48.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.644 0.259 . . . . 0.0 110.782 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 32.9 mm -119.64 129.92 74.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.572 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.68 -29.17 11.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.102 0.477 . . . . 0.0 110.294 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.0 m -79.27 83.71 5.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.285 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 123' ' ' LEU . 63.4 mt -132.12 172.19 12.7 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.958 -176.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -138.37 124.65 12.82 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.899 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.13 130.02 29.16 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.606 2.204 . . . . 0.0 112.08 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 79.65 39.69 17.11 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.839 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -133.24 146.39 51.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.957 0.408 . . . . 0.0 110.474 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 150' ' ' PRO . 34.9 tttp -98.1 128.1 44.42 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.836 177.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -119.85 140.98 49.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.193 0.52 . . . . 0.0 110.898 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 5.5 mp -103.73 130.66 51.27 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.97 139.73 51.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.81 0.338 . . . . 0.0 111.452 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.547 ' HG2' ' HA ' ' A' ' 197' ' ' ALA . 78.1 mt-30 -143.72 142.47 30.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.299 177.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 13.5 p -132.06 150.15 33.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.684 0.278 . . . . 0.0 110.798 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -159.06 147.44 18.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.254 172.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.487 ' HB3' ' CD2' ' A' ' 144' ' ' TYR . 27.9 p -123.4 -172.96 2.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.67 177.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -125.71 95.28 40.53 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.183 0.516 . . . . 0.0 111.044 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.23 159.23 19.57 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 123.435 2.756 . . . . 0.0 113.124 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -73.67 -39.61 64.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.456 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -94.18 24.07 4.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.252 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -160.85 -144.99 4.15 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -167.44 -166.12 0.74 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 9.3 m95 -54.85 115.58 2.26 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.405 0.622 . . . . 0.0 111.299 176.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.6 m -97.87 16.1 21.88 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.57 -175.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . 66.98 173.44 0.26 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.722 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.492 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 81.0 m95 -82.34 144.55 30.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.009 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.599 ' H ' ' HD2' ' A' ' 196' ' ' PRO . 5.3 m -153.71 -56.9 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.599 ' HD2' ' H ' ' A' ' 195' ' ' SER . 68.4 Cg_endo -72.69 80.81 1.68 Allowed 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 122.019 1.813 . . . . 0.0 113.354 -173.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.547 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -80.35 103.0 9.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.273 0.559 . . . . 0.0 110.812 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.9 m -100.44 135.45 41.85 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.158 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -104.92 126.51 52.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.103 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.9 tp -126.75 137.98 56.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.003 0.43 . . . . 0.0 110.832 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -100.19 120.98 40.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.751 177.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.1 121.02 76.96 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.1 151.58 65.46 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.925 2.417 . . . . 0.0 112.362 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 16.8 t -71.75 -23.63 61.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.895 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -98.33 43.76 1.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.795 0.807 . . . . 0.0 109.28 175.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -80.85 -18.42 47.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.536 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 57.4 m -145.23 149.15 34.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.565 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 95.0 mmm -77.33 40.87 0.29 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.061 0.458 . . . . 0.0 111.464 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -137.11 41.48 2.45 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.424 -178.101 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.5 mpp? . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.963 0.411 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -103.34 139.37 38.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.334 0.587 . . . . 0.0 110.772 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.5 mp -81.57 95.21 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.107 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.541 ' O ' ' HD3' ' A' ' 103' ' ' PRO . 13.6 p -103.62 154.12 5.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.686 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -85.14 102.76 2.6 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 101' ' ' VAL . 70.1 Cg_endo -91.7 155.9 3.49 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.762 2.308 . . . . 0.0 113.185 -172.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -127.14 65.32 64.28 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.809 174.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.476 ' HD3' ' C ' ' A' ' 103' ' ' PRO . 36.6 Cg_exo -60.07 -49.08 10.38 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.619 2.212 . . . . 0.0 114.386 -177.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.61 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 72.6 Cg_endo -78.37 95.9 1.08 Allowed 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.128 1.219 . . . . 0.0 111.872 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 pp -109.43 174.47 5.85 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.317 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 52.45 60.22 3.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.259 0.552 . . . . 0.0 110.626 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.445 HD11 ' CG2' ' A' ' 125' ' ' ILE . 43.1 tp -73.17 108.88 6.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.675 -177.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -98.44 119.68 37.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.576 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.459 ' CG1' HD11 ' A' ' 123' ' ' LEU . 2.6 t -109.24 115.28 49.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.394 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -127.72 125.58 40.25 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.933 -173.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.5 126.41 39.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.15 177.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 57.0 mmtt -108.28 129.72 55.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.936 0.398 . . . . 0.0 110.853 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.584 ' OE1' ' HA ' ' A' ' 206' ' ' PHE . 47.3 mt-30 -133.89 86.75 37.22 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.433 -174.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.05 167.69 24.62 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.078 2.519 . . . . 0.0 111.547 175.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.482 ' H ' ' CD ' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -86.24 -46.28 10.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.779 0.323 . . . . 0.0 111.32 -178.429 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -88.53 -51.48 5.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.89 0.376 . . . . 0.0 110.24 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -72.65 138.72 46.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -66.52 144.84 98.84 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 120.732 0.301 . . . . 0.0 111.4 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.557 ' HG3' ' O ' ' A' ' 206' ' ' PHE . 36.1 Cg_endo -62.72 142.41 89.13 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 123.263 2.642 . . . . 0.0 112.56 -177.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -144.56 159.9 42.03 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.733 -176.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.459 HD11 ' CG1' ' A' ' 111' ' ' VAL . 2.7 tm? -98.22 126.38 43.67 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.417 ' HE1' ' HB2' ' A' ' 166' ' ' GLU . 21.7 t90 -111.68 109.25 19.03 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.703 -172.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.445 ' CG2' HD11 ' A' ' 109' ' ' LEU . 3.6 mp -96.67 132.56 40.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.45 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -146.91 143.17 28.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.313 0.578 . . . . 0.0 110.456 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 18.5 p90 -126.74 162.94 24.64 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.112 -173.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.1 t -102.9 112.98 66.16 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 120.852 0.358 . . . . 0.0 110.374 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 97.0 Cg_endo -83.27 137.61 8.36 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.436 2.091 . . . . 0.0 111.541 174.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 105' ' ' PRO . 52.9 Cg_exo -55.48 136.03 71.97 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.788 2.325 . . . . 0.0 111.559 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.2 m -67.12 -36.63 82.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.439 -176.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 94.8 mt -108.03 94.58 5.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.552 0.691 . . . . 0.0 110.988 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 78.4 mt -114.16 -57.72 3.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.1 175.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.3 t70 56.41 83.99 0.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.68 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.16 -28.76 69.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.826 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp 71.43 -44.75 0.6 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.822 0.849 . . . . 0.0 112.964 173.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 17.0 p -58.48 -33.45 69.8 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.06 -60.98 4.79 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.716 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -82.54 35.86 0.47 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.201 0.524 . . . . 0.0 111.065 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.404 ' HZ ' ' O ' ' A' ' 185' ' ' LYS . 76.1 t80 -142.46 132.5 24.49 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.793 -178.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.2 m -116.98 141.63 48.0 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.862 0.363 . . . . 0.0 110.409 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 52.5 tp -81.05 110.54 16.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.441 ' HG ' ' HA2' ' A' ' 162' ' ' GLY . 4.7 mp -99.95 139.13 36.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.049 -175.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -109.14 143.18 38.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.402 -175.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -127.64 135.17 49.87 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.544 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.4 mp -114.75 128.19 71.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.009 0.433 . . . . 0.0 110.428 -176.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.483 ' HB2' ' CH2' ' A' ' 194' ' ' TRP . 26.6 ttp180 -114.97 123.13 48.31 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -142.6 160.35 40.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.632 0.253 . . . . 0.0 111.437 -177.16 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -171.69 150.22 2.57 Favored Pre-proline 0 C--O 1.234 0.275 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.996 176.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.498 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 36.6 Cg_endo -69.18 160.32 50.32 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.282 1.988 . . . . 0.0 110.599 169.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -67.9 -21.37 65.14 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -173.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -86.04 -11.12 53.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.018 0.437 . . . . 0.0 110.289 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.498 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -82.12 131.26 35.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.57 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -86.03 -35.57 20.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.363 178.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -94.96 143.19 26.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.325 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.453 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 67.7 m95 -88.46 145.76 25.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.77 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -96.43 116.94 29.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.577 174.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mp -95.67 111.66 26.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.009 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 51.3 m-70 -117.87 119.7 35.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.159 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -85.38 137.3 33.03 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.14 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.412 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -102.22 -41.05 6.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.992 0.425 . . . . 0.0 110.937 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.441 ' HA2' ' HG ' ' A' ' 143' ' ' LEU . . . 91.41 -125.64 8.11 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.152 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -97.23 64.06 1.89 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.217 0.532 . . . . 0.0 110.366 -177.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -157.64 142.95 17.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.03 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.6 p -99.31 31.6 3.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.04 0.447 . . . . 0.0 111.608 -176.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.417 ' HB2' ' HE1' ' A' ' 124' ' ' TRP . 11.3 pt-20 -158.86 156.44 29.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.941 176.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 33.1 t80 -146.01 154.03 41.43 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.05 131.94 54.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.711 0.291 . . . . 0.0 110.996 -178.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.42 HG12 HD11 ' A' ' 125' ' ' ILE . 29.0 mm -106.88 138.55 32.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 170' ' ' LEU . 3.0 mm? -104.64 -28.15 11.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.965 0.412 . . . . 0.0 111.107 -176.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.9 m -90.59 75.15 6.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.928 -174.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 172' ' ' LEU . 2.7 mm? -114.56 142.66 46.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.84 0.352 . . . . 0.0 110.737 176.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 26.3 m-70 -111.35 134.36 21.17 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.924 174.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 39.7 Cg_exo -61.22 131.14 35.07 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.834 2.356 . . . . 0.0 112.325 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 73.36 43.57 37.62 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.118 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -134.0 148.0 51.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.872 0.368 . . . . 0.0 110.041 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -95.03 126.29 40.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.74 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -120.29 136.8 54.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.184 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 7.3 mp -102.24 129.67 48.7 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.22 141.84 43.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.069 0.462 . . . . 0.0 111.544 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 98.5 mt-30 -141.42 149.02 40.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.066 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.15 136.58 37.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.618 0.247 . . . . 0.0 110.338 175.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.441 ' HD2' ' HA ' ' A' ' 194' ' ' TRP . 65.7 mtp85 -143.47 160.93 39.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.354 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.61 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 21.3 p -148.49 172.15 14.94 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.404 ' O ' ' HZ ' ' A' ' 140' ' ' PHE . 21.2 pttp -138.55 117.66 9.52 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.058 0.456 . . . . 0.0 111.907 -174.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.71 -160.87 0.13 Allowed 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 123.299 2.666 . . . . 0.0 112.586 175.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -79.9 -46.54 16.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.118 0.485 . . . . 0.0 111.343 -175.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -94.41 23.85 4.92 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -171.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -161.86 168.23 36.88 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.384 178.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -157.59 150.74 23.42 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 29.1 p-90 -124.94 144.22 50.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.82 0.343 . . . . 0.0 111.218 -177.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 49.0 m -133.08 12.5 4.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.429 176.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -145.6 163.56 34.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.332 -178.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.483 ' CH2' ' HB2' ' A' ' 147' ' ' ARG . 72.9 m95 -112.86 167.7 10.29 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.184 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.455 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 13.1 m -148.69 -58.87 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.563 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 4.5 Cg_exo -79.56 75.69 4.93 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.332 2.021 . . . . 0.0 113.412 -168.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -77.91 103.02 7.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.988 0.423 . . . . 0.0 110.429 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.2 m -96.95 140.58 31.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.454 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -105.0 131.4 52.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.933 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.3 tp -126.49 140.06 49.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.121 0.486 . . . . 0.0 110.744 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -103.41 119.11 38.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.038 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 51.2 mm -83.29 124.31 76.14 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.636 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.99 164.92 25.57 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.211 2.608 . . . . 0.0 113.419 -174.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 10.3 p -68.63 -46.79 68.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.473 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -85.6 35.19 0.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.769 0.795 . . . . 0.0 110.609 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.584 ' HA ' ' OE1' ' A' ' 115' ' ' GLN . 89.2 t80 -68.76 -58.04 4.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.5 t -155.62 157.16 36.28 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 20.2 ptp -114.03 -44.25 3.17 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.268 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 50.43 45.58 26.18 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.25 0.548 . . . . 0.0 110.582 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 27.0 t70 . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.167 -176.784 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 67.6 mtm . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -122.18 146.72 46.97 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.48 HG22 HG13 ' A' ' 101' ' ' VAL . 47.4 mt -41.76 -60.92 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 123.772 0.829 . . . . 0.0 113.177 -176.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.642 ' O ' ' HD3' ' A' ' 103' ' ' PRO . 1.5 m -129.76 157.41 42.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -174.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -92.51 88.2 0.3 Allowed Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 164.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.642 ' HD3' ' O ' ' A' ' 101' ' ' VAL . 90.1 Cg_endo -83.61 135.44 6.92 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.381 2.054 . . . . 0.0 113.28 -167.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -111.2 91.29 13.13 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.923 173.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 103' ' ' PRO . 37.5 Cg_exo -60.18 153.59 57.81 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.176 2.584 . . . . 0.0 112.088 -177.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.43 98.49 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.881 2.387 . . . . 0.0 112.179 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.663 ' H ' HD23 ' A' ' 107' ' ' LEU . 2.6 pt? -94.53 -173.21 2.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.021 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 54.7 43.04 30.76 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 123.563 0.54 . . . . 0.0 110.217 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.413 HD13 ' HB3' ' A' ' 127' ' ' TRP . 48.6 tp -68.76 94.77 0.63 Allowed 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.604 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.69 125.64 38.42 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.997 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.478 HG12 HD11 ' A' ' 123' ' ' LEU . 2.1 t -110.69 114.13 46.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -121.32 118.19 28.87 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.108 -173.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.518 HG22 ' CD1' ' A' ' 123' ' ' LEU . 7.1 t -80.39 123.84 37.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -102.73 120.5 40.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.956 0.408 . . . . 0.0 110.783 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -121.61 86.39 44.75 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.422 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.41 ' HB2' ' HB2' ' A' ' 119' ' ' ARG . 12.1 Cg_exo -71.62 -177.85 2.71 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 123.211 2.607 . . . . 0.0 113.327 -175.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -74.41 -64.71 0.97 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.17 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -119.32 15.26 13.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.096 0.474 . . . . 0.0 110.912 -176.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.41 ' HB2' ' HB2' ' A' ' 116' ' ' PRO . 98.9 mtt180 -110.29 150.19 29.09 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.556 177.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -61.71 138.22 95.22 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 123.634 0.584 . . . . 0.0 110.646 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.475 ' HD3' ' SD ' ' A' ' 208' ' ' MET . 43.2 Cg_endo -67.98 138.52 44.34 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.543 2.162 . . . . 0.0 111.47 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -148.39 157.25 43.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.624 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.518 ' CD1' HG22 ' A' ' 113' ' ' VAL . 30.7 tp -92.61 124.8 36.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.955 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.525 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 21.3 t90 -103.43 103.75 13.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.096 0.474 . . . . 0.0 110.429 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.2 mp -95.2 116.45 36.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.579 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.47 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 5.0 ttpm? -128.93 127.27 41.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.189 0.518 . . . . 0.0 110.566 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' TRP . . . . . 0.413 ' HB3' HD13 ' A' ' 109' ' ' LEU . 22.5 p90 -116.27 160.56 20.28 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.27 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 39.3 t -86.33 118.62 70.64 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 21.1 Cg_endo -61.33 148.74 92.12 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.709 2.273 . . . . 0.0 111.876 -178.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 129' ' ' PRO . 38.9 Cg_exo -57.03 163.15 8.1 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.965 2.444 . . . . 0.0 112.386 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 36.3 p -69.09 174.35 4.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.513 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 58.1 mt -63.83 112.84 3.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.854 -175.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 133' ' ' ILE . 41.0 mt -99.55 7.59 8.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 122.005 0.907 . . . . 0.0 109.37 177.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 61.23 53.11 3.64 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.84 -176.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.428 ' H ' HD23 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -91.73 70.0 5.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.391 -177.73 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -101.76 -4.32 26.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.985 -172.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.2 p -74.26 -175.72 2.38 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.473 174.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -108.18 13.03 37.2 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.555 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -133.84 38.48 3.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.633 0.73 . . . . 0.0 109.801 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -91.98 -1.43 57.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.368 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.28 106.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -168.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.656 ' H ' HD23 ' A' ' 142' ' ' LEU . 2.5 pt? -97.68 132.9 42.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.095 175.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 60.0 mt -104.31 141.51 36.18 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.018 0.437 . . . . 0.0 110.941 -175.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.619 ' CE2' ' HB3' ' A' ' 184' ' ' CYS . 93.6 m-85 -104.29 141.24 36.64 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.477 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -126.84 136.57 52.53 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.41 ' CD1' ' HB2' ' A' ' 161' ' ' ALA . 4.9 mp -118.16 128.07 75.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.949 0.404 . . . . 0.0 110.782 -176.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.533 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 15.3 ttp180 -113.07 120.3 40.86 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.6 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -144.58 160.41 41.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.692 0.282 . . . . 0.0 111.596 -175.872 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.401 ' HE2' ' CE2' ' A' ' 156' ' ' TRP . 56.7 pttt -170.93 144.55 1.82 Allowed Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.489 176.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.5 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 43.4 Cg_endo -74.2 167.09 28.0 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.553 2.169 . . . . 0.0 111.444 167.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.453 ' HG2' ' HG3' ' A' ' 152' ' ' LYS . 1.4 pm0 -59.47 -39.6 84.21 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.925 0.393 . . . . 0.0 111.426 -177.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.453 ' HG3' ' HG2' ' A' ' 151' ' ' GLU . 91.7 mttt -87.8 16.25 6.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.499 -175.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.5 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -88.96 -38.99 14.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.262 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 70.33 -54.38 0.63 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.126 0.891 . . . . 0.0 111.19 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -85.41 151.89 23.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.248 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.533 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 77.1 m95 -90.45 135.51 33.64 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.216 178.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -99.95 123.48 44.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.505 175.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.4 mp -103.66 120.07 53.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.994 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 41.2 m-70 -123.35 122.91 39.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.872 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -85.8 131.4 34.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.548 -176.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.41 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -96.6 -41.56 8.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.331 . . . . 0.0 111.387 -179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.35 -141.09 15.18 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.292 -176.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.447 ' H ' ' CD ' ' A' ' 163' ' ' GLN . 0.4 OUTLIER -97.49 44.03 1.06 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.461 0.648 . . . . 0.0 111.08 -177.723 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -128.46 149.68 50.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.593 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.3 p -101.47 26.18 7.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -174.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -151.66 140.42 20.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.931 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 33.5 t80 -130.7 146.99 52.32 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.525 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 39.1 mmtm -112.1 132.5 54.81 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.736 0.303 . . . . 0.0 110.901 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 26.4 mm -112.34 136.85 47.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -104.93 -25.5 12.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.068 0.461 . . . . 0.0 110.441 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 25.6 t -86.18 70.02 10.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.287 -175.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.9 mm? -110.62 139.83 45.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.968 0.414 . . . . 0.0 110.435 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -101.03 122.51 48.4 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.051 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.449 ' HB3' ' HB3' ' A' ' 206' ' ' PHE . 10.0 Cg_endo -58.35 116.96 3.61 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.527 2.152 . . . . 0.0 112.605 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 91.35 32.46 8.77 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.636 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.562 HE21 ' HA ' ' A' ' 176' ' ' GLN . 0.1 OUTLIER -133.13 159.3 40.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.826 0.346 . . . . 0.0 110.911 -179.6 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -106.88 126.63 52.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.691 -174.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -112.82 137.95 50.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.048 0.451 . . . . 0.0 110.67 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.9 mp -99.84 124.21 44.89 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 26.3 m -121.8 140.27 46.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.229 0.538 . . . . 0.0 111.877 -176.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.611 HE21 ' HB2' ' A' ' 197' ' ' ALA . 82.7 mt-30 -136.08 147.68 47.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.333 175.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.18 142.44 22.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.869 0.366 . . . . 0.0 110.128 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.459 ' HD2' ' O ' ' A' ' 193' ' ' ALA . 27.0 ttt-85 -146.69 149.31 33.2 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.619 ' HB3' ' CE2' ' A' ' 144' ' ' TYR . 9.0 p -103.67 154.03 19.98 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.527 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.474 ' HE2' ' CE2' ' A' ' 191' ' ' TRP . 73.7 mttt -112.54 95.14 30.81 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.25 145.96 89.5 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.926 2.417 . . . . 0.0 112.442 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -64.87 -23.12 67.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.745 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -96.6 16.55 18.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.963 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -167.41 -148.9 5.81 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.174 -1.012 . . . . 0.0 112.967 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -162.43 -178.03 6.02 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.474 ' CE2' ' HE2' ' A' ' 185' ' ' LYS . 1.2 p-90 -118.48 135.48 54.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.019 0.438 . . . . 0.0 110.479 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 12.1 p -85.08 -38.57 18.96 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.044 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.459 ' O ' ' HD2' ' A' ' 183' ' ' ARG . . . -177.35 -154.78 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.767 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -94.32 157.03 16.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.448 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.506 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 2.0 m -133.54 -60.85 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -176.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 14.8 Cg_endo -94.9 111.47 0.15 Allowed 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.674 2.249 . . . . 0.0 113.308 -172.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.611 ' HB2' HE21 ' A' ' 181' ' ' GLN . . . -103.53 122.47 45.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.039 0.447 . . . . 0.0 110.858 177.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 90.7 m -117.03 147.04 42.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.709 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.403 ' CD2' ' HG ' ' A' ' 179' ' ' LEU . 68.2 m-85 -110.66 140.37 45.08 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.1 tp -136.23 138.07 47.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.145 0.498 . . . . 0.0 110.794 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -104.39 124.37 49.09 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.551 177.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 40.8 mm -88.56 124.55 65.66 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.343 178.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.49 146.61 96.88 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.605 2.203 . . . . 0.0 111.908 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 49.6 m -70.91 -11.56 61.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.288 0.566 . . . . 0.0 110.57 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -96.26 15.59 20.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.614 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.511 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 83.7 t80 -53.13 -43.91 67.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.523 177.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.5 m -57.52 119.81 7.18 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.229 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.487 ' HG3' ' O ' ' A' ' 208' ' ' MET . 20.5 ptm -80.8 83.46 6.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.278 0.561 . . . . 0.0 110.571 -175.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 60.37 -156.96 0.34 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.291 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.331 -0.843 . . . . 0.0 110.596 178.141 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.733 ' N ' HE22 ' A' ' 102' ' ' GLN . 56.6 tpp . . . . . 0 N--CA 1.483 1.186 0 CA-C-O 120.536 0.208 . . . . 0.0 110.645 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.582 ' CE2' ' HB ' ' A' ' 101' ' ' VAL . 35.5 p90 -162.34 178.68 8.46 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 177.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.608 ' O ' ' HA2' ' A' ' 189' ' ' GLY . 13.9 mt -41.09 -44.29 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.213 0.946 . . . . 0.0 113.079 -176.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.582 ' HB ' ' CE2' ' A' ' 99' ' ' TYR . 17.5 t -104.16 94.19 3.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.174 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.733 HE22 ' N ' ' A' ' 98' ' ' MET . 23.0 mm-40 -60.45 129.22 89.04 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.475 -177.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -82.47 -161.22 0.14 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.325 2.683 . . . . 0.0 112.736 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 67.79 85.19 0.15 Allowed Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.319 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.7 147.93 8.42 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.517 2.145 . . . . 0.0 111.822 175.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.413 ' HG2' HG13 ' A' ' 182' ' ' VAL . 11.8 Cg_endo -58.43 141.06 96.83 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.341 2.028 . . . . 0.0 110.87 172.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.41 HD12 ' HB2' ' A' ' 128' ' ' SER . 0.6 OUTLIER -127.16 174.68 8.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.971 -172.059 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 57.07 60.63 2.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.343 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.426 HD23 ' HB3' ' A' ' 127' ' ' TRP . 9.7 mt -69.45 97.76 1.03 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.7 174.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.6 122.02 39.07 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.455 HG12 HD22 ' A' ' 123' ' ' LEU . 10.0 t -115.09 119.55 62.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.896 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -118.88 132.7 56.11 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.158 -176.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.495 ' HA ' HD23 ' A' ' 123' ' ' LEU . 12.9 p -86.78 128.26 39.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.19 0.519 . . . . 0.0 109.984 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -116.69 107.84 15.17 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.21 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.457 ' HG2' ' HB3' ' A' ' 121' ' ' PRO . 50.5 mt-30 -111.24 97.95 37.58 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.421 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.91 -179.88 4.68 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.775 2.316 . . . . 0.0 112.374 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.66 -68.44 0.45 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.884 0.373 . . . . 0.0 110.855 -177.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -107.24 -18.28 13.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.334 0.588 . . . . 0.0 110.97 -176.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -80.12 141.93 35.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.845 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -60.06 135.39 90.54 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.268 -175.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.457 ' HB3' ' HG2' ' A' ' 115' ' ' GLN . 38.0 Cg_endo -65.52 149.36 87.77 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.978 2.452 . . . . 0.0 112.282 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.428 ' HB3' HD13 ' A' ' 170' ' ' LEU . 49.2 p90 -150.81 167.98 25.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.941 -175.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 113' ' ' VAL . 11.1 mt -100.25 142.41 31.77 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 120.918 0.39 . . . . 0.0 110.822 176.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.523 ' CZ2' ' HD2' ' A' ' 126' ' ' LYS . 19.9 t90 -113.93 105.28 13.06 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.729 175.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.1 mp -94.87 118.48 41.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.523 ' HD2' ' CZ2' ' A' ' 124' ' ' TRP . 81.5 tttt -132.05 119.56 21.17 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.216 0.532 . . . . 0.0 110.866 -175.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' TRP . . . . . 0.491 ' CH2' HD11 ' A' ' 146' ' ' ILE . 35.5 p90 -116.08 162.46 17.39 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.829 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.41 ' HB2' HD12 ' A' ' 107' ' ' LEU . 17.6 m -102.9 134.94 19.54 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.95 148.69 28.81 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.235 2.623 . . . . 0.0 112.279 -177.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -48.25 -82.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.464 2.776 . . . . 0.0 113.267 -174.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.1 p -149.5 -74.99 0.16 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.972 0.415 . . . . 0.0 111.143 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 95.5 mt -117.68 102.93 9.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.369 0.604 . . . . 0.0 111.471 -176.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.478 HD12 ' N ' ' A' ' 133' ' ' ILE . 3.5 mp -99.92 87.07 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 122.487 1.137 . . . . 0.0 109.617 177.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.78 -3.83 40.34 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.167 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.7 mp -78.71 57.4 2.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.228 -172.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -85.5 100.92 12.23 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 175.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.7 t 169.11 147.7 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.749 -173.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -66.77 -54.21 23.34 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.489 177.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 19.3 m-90 -82.97 136.44 34.53 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.9 t80 67.03 59.87 0.53 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.836 0.827 . . . . 0.0 109.696 -173.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 13.3 t -106.91 170.43 7.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.87 174.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.024 ' HG ' ' SG ' ' A' ' 184' ' ' CYS . 11.4 tp -96.1 110.63 22.86 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.889 0.376 . . . . 0.0 110.077 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -96.16 133.67 40.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.948 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -102.1 144.35 30.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.988 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 75.1 tt0 -136.64 137.35 39.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.926 -173.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 181' ' ' GLN . 4.7 mp -120.57 125.42 74.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.775 0.321 . . . . 0.0 110.858 -176.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.44 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 18.0 ttp180 -108.84 121.77 45.77 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 4.0 pp -145.25 159.28 43.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.79 0.328 . . . . 0.0 111.342 -176.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -168.61 149.33 4.34 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.54 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 31.3 Cg_endo -70.95 160.89 47.94 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.988 1.792 . . . . 0.0 112.311 174.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.455 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 6.0 pt-20 -50.93 -46.93 61.04 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.455 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 93.4 mttt -84.77 13.85 5.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.803 0.335 . . . . 0.0 111.59 -174.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.54 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -88.23 134.25 33.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.926 0.393 . . . . 0.0 111.185 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -89.95 -21.63 22.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.205 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -120.37 145.83 46.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.733 -177.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.44 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 66.4 m95 -84.06 137.7 33.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.433 176.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -109.9 116.7 32.1 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.423 0.63 . . . . 0.0 111.323 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.1 mp -91.03 130.79 39.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.935 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 67.6 m-70 -124.11 126.03 45.49 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.223 176.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -93.0 119.55 32.38 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.852 0.358 . . . . 0.0 110.836 -174.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.437 ' HB2' HD11 ' A' ' 146' ' ' ILE . . . -75.09 -51.5 13.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.054 177.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 77.8 81.76 0.63 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.368 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 74.3 -40.0 0.44 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.954 0.901 . . . . 0.0 112.563 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -68.56 145.65 53.78 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 55.5 p -104.94 30.31 5.63 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.26 0.552 . . . . 0.0 111.49 -176.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -154.14 144.76 22.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.639 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 32.4 t80 -142.27 146.14 34.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.081 -177.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.451 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 10.3 mptt -115.76 144.53 43.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.861 0.362 . . . . 0.0 110.661 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 35.8 mm -119.61 134.19 63.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.951 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.428 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.6 mm? -102.02 -29.52 11.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.878 0.371 . . . . 0.0 110.608 178.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 45.6 m -86.2 73.89 10.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.963 -175.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.25 144.3 41.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.854 0.359 . . . . 0.0 110.333 174.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 -110.16 122.11 39.72 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.887 175.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.25 124.35 15.96 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.984 2.456 . . . . 0.0 112.772 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 97.21 12.54 48.6 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.073 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -118.78 148.84 42.4 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.377 0.608 . . . . 0.0 111.873 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -89.47 129.97 35.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.547 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.435 ' HB2' HG23 ' A' ' 200' ' ' ILE . 22.7 m-85 -115.59 135.52 53.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.998 0.427 . . . . 0.0 110.455 177.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.6 mp -101.5 121.94 42.88 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.402 HG23 ' HB ' ' A' ' 198' ' ' THR . 29.8 m -119.49 137.56 52.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.175 0.512 . . . . 0.0 111.062 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.553 HE21 ' HB2' ' A' ' 197' ' ' ALA . 89.3 mt-30 -136.94 139.58 41.63 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.556 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 145' ' ' GLU . 10.4 p -123.55 137.35 57.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.206 0.527 . . . . 0.0 110.606 174.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -138.79 138.68 37.81 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.667 174.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 1.024 ' SG ' ' HG ' ' A' ' 142' ' ' LEU . 4.6 t -125.53 156.23 39.36 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.07 126.16 1.57 Allowed Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.22 -172.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -55.44 163.74 4.71 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.799 2.333 . . . . 0.0 112.454 168.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -47.33 -51.45 19.39 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -172.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -74.57 -20.37 59.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -174.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.608 ' HA2' ' O ' ' A' ' 100' ' ' ILE . . . -75.61 99.15 1.21 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.487 -174.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -84.45 113.95 21.57 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.784 0.802 . . . . 0.0 110.46 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 14.4 p-90 -91.51 158.99 16.16 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.359 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 10.5 t -158.96 22.75 0.21 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.215 0.531 . . . . 0.0 109.722 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -160.99 166.3 28.51 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.823 -173.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.412 ' CZ2' ' HB2' ' A' ' 147' ' ' ARG . 83.0 m95 -132.96 135.14 45.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.943 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.516 ' OG ' ' HD3' ' A' ' 196' ' ' PRO . 3.1 p -110.72 -50.24 0.06 OUTLIER Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -176.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.516 ' HD3' ' OG ' ' A' ' 195' ' ' SER . 9.3 Cg_endo -86.92 83.05 1.13 Allowed 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.019 1.813 . . . . 0.0 113.12 -172.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.553 ' HB2' HE21 ' A' ' 181' ' ' GLN . . . -87.41 107.1 18.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.043 0.449 . . . . 0.0 110.464 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.402 ' HB ' HG23 ' A' ' 180' ' ' VAL . 28.8 m -100.27 139.8 35.43 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.19 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -108.19 120.41 42.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.831 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.435 HG23 ' HB2' ' A' ' 178' ' ' TYR . 6.1 tp -119.99 133.56 66.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.167 0.508 . . . . 0.0 110.508 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -95.94 135.58 37.51 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.452 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.455 HD11 HD11 ' A' ' 123' ' ' LEU . 43.1 mm -95.83 121.51 60.94 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 175.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.01 149.13 86.11 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.923 2.415 . . . . 0.0 112.071 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 7.5 p -72.76 -18.75 61.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.037 0.446 . . . . 0.0 110.523 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -91.32 16.78 9.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.363 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.417 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 54.5 t80 -67.1 -32.41 73.54 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.9 m -63.93 134.25 54.75 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.058 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 82.6 mtp -77.85 161.52 27.55 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -79.67 59.36 3.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.667 0.27 . . . . 0.0 111.374 -176.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 33.3 t70 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.803 174.845 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.949 0.404 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.639 ' CE1' HG22 ' A' ' 101' ' ' VAL . 53.1 t80 -167.31 152.55 7.33 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.4 mt -48.87 -70.32 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.639 HG22 ' CE1' ' A' ' 99' ' ' TYR . 3.2 m -75.36 132.91 32.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.327 -172.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -134.13 72.74 71.25 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.638 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -82.76 116.22 2.51 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.63 2.22 . . . . 0.0 113.151 -173.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -153.29 87.34 3.9 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 171.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -62.16 138.63 73.55 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.953 2.436 . . . . 0.0 112.988 -174.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.484 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 32.8 Cg_endo -65.26 123.91 12.19 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.624 2.216 . . . . 0.0 111.131 176.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.16 178.82 4.55 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.382 -174.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 54.16 58.07 5.33 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.894 -178.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.0 96.15 3.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.012 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.57 129.87 41.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.84 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.483 HG12 HD11 ' A' ' 123' ' ' LEU . 3.1 t -120.35 120.25 62.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.786 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -132.16 141.53 49.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.686 0.279 . . . . 0.0 110.616 -176.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.2 p -95.82 120.28 45.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.049 0.452 . . . . 0.0 110.029 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -111.18 126.82 55.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.904 0.383 . . . . 0.0 111.109 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.44 ' HG2' ' HB3' ' A' ' 121' ' ' PRO . 78.0 mt-30 -114.02 106.47 53.26 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.098 175.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.53 170.37 5.61 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.054 2.503 . . . . 0.0 112.561 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -78.29 -8.68 58.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.382 -176.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -159.71 -40.13 0.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.243 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -69.05 167.37 16.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.295 -178.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -63.02 141.68 97.69 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.853 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.464 ' HD3' ' SD ' ' A' ' 208' ' ' MET . 60.3 Cg_endo -72.36 147.26 46.68 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.819 2.346 . . . . 0.0 111.602 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.496 ' HB3' HD13 ' A' ' 170' ' ' LEU . 34.8 p90 -147.92 154.77 40.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.14 0.495 . . . . 0.0 111.336 -175.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.616 ' HB2' HD11 ' A' ' 172' ' ' LEU . 28.9 tp -90.16 124.36 34.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.531 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.541 ' CZ2' ' HD3' ' A' ' 126' ' ' LYS . 21.9 t90 -100.32 103.76 15.19 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.224 0.535 . . . . 0.0 110.232 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.9 mp -97.66 119.82 46.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.195 177.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.541 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 25.4 pttm -132.0 139.59 48.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.51 0.672 . . . . 0.0 110.458 176.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 19.1 p90 -122.52 145.3 48.45 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.143 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.6 t -88.11 121.15 70.71 Favored Pre-proline 0 C--N 1.317 -0.828 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.02 151.88 3.7 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.58 2.854 . . . . 0.0 112.951 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -46.28 151.71 1.6 Allowed 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 123.824 3.016 . . . . 0.0 113.591 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.4 m -74.4 -31.64 62.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.714 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.43 ' O ' ' HB ' ' A' ' 133' ' ' ILE . 96.1 mt -84.05 155.52 22.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.3 174.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.442 HG21 ' CE1' ' A' ' 140' ' ' PHE . 29.5 mt 70.45 -59.88 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.211 0 O-C-N 123.47 0.481 . . . . 0.0 111.526 -177.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.9 t70 56.05 54.75 7.57 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.672 0.748 . . . . 0.0 110.11 -177.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.499 ' H ' HD23 ' A' ' 135' ' ' LEU . 2.1 pt? -69.78 151.3 45.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.917 -178.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -135.31 -45.21 0.7 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.851 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 13.8 t -167.3 167.65 13.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.055 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 117.8 -160.13 13.87 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.798 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 56.1 t90 -74.63 -36.79 62.91 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.442 ' CE1' HG21 ' A' ' 133' ' ' ILE . 25.4 t80 -61.56 117.55 5.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.687 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 21.9 m -133.56 140.26 47.06 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.044 0.45 . . . . 0.0 111.014 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 39.2 tp -116.32 116.54 27.93 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.24 142.03 28.15 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.936 0.398 . . . . 0.0 111.063 -175.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.475 ' CE2' HG22 ' A' ' 165' ' ' THR . 86.8 m-85 -119.37 141.51 48.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.123 -175.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -120.29 129.82 54.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.057 175.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.5 mp -106.6 125.38 62.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.005 0.431 . . . . 0.0 110.191 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.523 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 18.6 ttp180 -117.66 119.81 36.12 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.676 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -140.5 159.45 42.17 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.413 -176.32 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.45 ' HE2' ' CZ2' ' A' ' 156' ' ' TRP . 52.4 pttt -167.08 149.9 5.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.426 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.422 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 45.8 Cg_endo -71.97 161.69 44.1 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.547 2.165 . . . . 0.0 111.196 170.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -67.47 -16.74 64.38 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -172.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -94.04 -1.15 54.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.021 0.439 . . . . 0.0 110.427 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.422 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -91.23 125.78 36.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.381 -176.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.09 -35.32 25.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.706 0.765 . . . . 0.0 109.415 173.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -88.16 150.25 23.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.388 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.523 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 65.4 m95 -101.41 153.4 19.72 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.786 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -105.24 117.78 34.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.592 174.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -94.82 118.8 41.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.227 0.537 . . . . 0.0 110.044 175.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 22.8 m-70 -122.68 114.8 21.07 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.328 177.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -82.71 142.22 31.82 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.508 -176.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -82.37 -46.36 13.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.944 0.402 . . . . 0.0 111.448 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 163' ' ' GLN . . . 108.28 -39.44 2.9 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.987 177.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 162' ' ' GLY . 63.8 tt0 174.93 -28.28 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.295 0.569 . . . . 0.0 110.017 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -70.78 160.3 32.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.809 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.475 HG22 ' CE2' ' A' ' 144' ' ' TYR . 60.7 p -110.91 28.09 9.04 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.254 0.549 . . . . 0.0 111.273 -174.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.405 ' HB2' ' HE1' ' A' ' 124' ' ' TRP . 12.3 pt-20 -152.29 143.95 23.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.411 177.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 19.8 t80 -131.86 147.7 52.5 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.437 ' HD2' ' CE2' ' A' ' 122' ' ' TYR . 43.2 mmtt -117.68 131.69 56.59 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 34.9 mm -106.91 125.01 62.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.496 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.8 mm? -93.95 -38.2 11.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.508 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 14.7 m -76.51 87.23 3.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.822 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.616 HD11 ' HB2' ' A' ' 123' ' ' LEU . 49.1 mt -131.92 147.57 52.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.762 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -109.28 134.29 20.52 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.305 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.34 110.87 2.13 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.618 2.212 . . . . 0.0 111.852 178.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 90.17 46.61 4.08 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.6 -176.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -135.78 147.22 48.27 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.925 0.393 . . . . 0.0 110.29 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -98.29 129.1 45.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.028 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -122.38 138.82 54.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.93 0.395 . . . . 0.0 110.639 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 7.5 mp -97.09 132.97 42.36 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.467 ' CG2' ' HB ' ' A' ' 198' ' ' THR . 28.4 m -122.72 152.98 27.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.174 0.511 . . . . 0.0 110.988 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.581 ' NE2' ' HA ' ' A' ' 181' ' ' GLN . 0.8 OUTLIER -151.94 152.6 32.73 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.454 -177.871 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.9 p -135.85 139.91 45.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.029 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -136.49 133.59 36.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.449 176.852 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.484 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 13.0 p -105.08 144.65 31.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.486 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -131.74 106.06 14.15 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -76.18 -163.86 0.22 Allowed 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.742 2.295 . . . . 0.0 112.888 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -84.75 -54.38 4.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.788 0.328 . . . . 0.0 111.294 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -78.37 -40.01 37.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.03 0.443 . . . . 0.0 110.357 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -96.38 159.89 21.93 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.667 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -140.16 -157.69 0.79 Allowed 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -177.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -43.46 134.78 3.85 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 4.8 t -130.81 29.59 4.73 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.303 171.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . 68.6 162.95 0.21 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.444 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.448 ' CE3' ' HB3' ' A' ' 181' ' ' GLN . 63.4 m95 -86.34 115.11 23.66 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 175.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.527 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 6.9 m -102.0 -54.05 0.14 Allowed Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -176.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.527 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 73.5 Cg_endo -78.08 169.74 19.9 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.656 1.571 . . . . 0.0 112.333 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -154.93 117.89 4.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 172.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.467 ' HB ' ' CG2' ' A' ' 180' ' ' VAL . 7.0 m -99.01 134.57 41.65 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.312 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -104.91 130.07 53.15 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 8.4 tp -128.78 138.92 53.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.284 0.564 . . . . 0.0 111.124 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -100.14 123.29 44.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.936 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 50.6 mm -88.24 120.39 70.53 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 173.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.6 150.69 80.53 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.845 2.363 . . . . 0.0 112.425 -176.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 17.5 m -69.83 -12.53 61.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.52 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -91.6 17.31 8.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.711 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -67.3 -34.11 76.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.232 -178.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.1 m -68.07 129.51 40.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.191 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.464 ' SD ' ' HD3' ' A' ' 121' ' ' PRO . 91.9 mtp -97.14 166.82 11.4 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 64.7 t30 58.91 37.18 24.76 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 122.137 0.97 . . . . 0.0 108.579 -171.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 16.7 t70 . . . . . 0 C--O 1.248 0.985 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.946 -174.581 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.1 ptm . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.607 0.242 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.473 ' CD2' ' HB ' ' A' ' 101' ' ' VAL . 24.1 t80 -148.1 136.85 21.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.117 0.484 . . . . 0.0 110.463 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 82.8 mt -67.4 106.22 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.697 176.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.473 ' HB ' ' CD2' ' A' ' 99' ' ' TYR . 14.4 p -149.44 148.73 15.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.177 -174.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -90.5 110.13 38.92 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.95 -39.97 22.65 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.241 1.961 . . . . 0.0 111.651 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 130' ' ' PRO . 36.2 t70 -135.42 89.35 22.89 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.616 176.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -65.07 141.28 69.32 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.59 2.193 . . . . 0.0 111.798 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.423 ' HG3' ' SG ' ' A' ' 184' ' ' CYS . 14.6 Cg_endo -57.89 141.57 96.01 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.779 2.319 . . . . 0.0 111.446 178.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.01 -172.13 3.61 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.498 -173.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 58.53 51.24 8.18 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.699 0.625 . . . . 0.0 111.403 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.43 HD23 ' OG1' ' A' ' 198' ' ' THR . 52.9 tp -80.23 93.62 5.91 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.76 127.45 45.91 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.306 -177.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.7 t -112.27 123.8 68.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.877 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -132.59 140.07 48.09 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.585 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.69 113.46 32.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.383 0.611 . . . . 0.0 109.753 176.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -96.26 121.26 37.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.223 -176.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.456 ' HB3' ' SD ' ' A' ' 208' ' ' MET . 22.5 mt-30 -120.7 76.13 27.48 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.101 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.91 160.61 40.2 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.74 2.293 . . . . 0.0 111.891 -178.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -83.2 -25.59 31.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.295 0.569 . . . . 0.0 110.374 176.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -92.75 -44.55 8.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.324 -175.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -105.07 153.64 21.21 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.414 ' O ' ' HD2' ' A' ' 122' ' ' TYR . 18.7 ptpt -64.7 152.43 90.05 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.413 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.55 134.34 44.02 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.754 2.303 . . . . 0.0 112.565 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.414 ' HD2' ' O ' ' A' ' 120' ' ' LYS . 46.1 p90 -146.4 163.93 34.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.443 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.472 ' HB3' ' HB ' ' A' ' 169' ' ' ILE . 33.7 tp -97.44 125.77 42.29 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.47 ' CZ2' ' HD2' ' A' ' 126' ' ' LYS . 24.3 t90 -107.67 114.66 28.79 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.296 -176.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.409 HD11 HG12 ' A' ' 169' ' ' ILE . 4.2 mp -102.85 123.08 55.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.47 ' HD2' ' CZ2' ' A' ' 124' ' ' TRP . 51.2 tttm -132.38 121.12 22.97 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.991 0.424 . . . . 0.0 110.848 -177.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' TRP . . . . . 0.414 ' CD2' HG21 ' A' ' 182' ' ' VAL . 42.8 p90 -119.61 166.42 13.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.995 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 61.2 m -109.02 126.47 29.27 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.293 177.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.79 152.99 79.46 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.822 2.348 . . . . 0.0 111.647 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.474 ' HB2' HD11 ' A' ' 133' ' ' ILE . 40.1 Cg_exo -56.81 146.02 80.42 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.716 2.277 . . . . 0.0 111.724 178.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.416 HG22 ' HG ' ' A' ' 132' ' ' LEU . 12.2 m -94.49 149.61 21.07 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.372 -173.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.416 ' HG ' HG22 ' A' ' 131' ' ' THR . 74.2 mt 63.34 82.27 0.19 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.478 0.711 . . . . 0.0 112.366 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 130' ' ' PRO . 77.0 mt -134.98 -59.57 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.995 176.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.2 t70 51.31 79.33 0.1 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.54 -174.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.592 HD12 ' HA ' ' A' ' 141' ' ' THR . 1.7 pt? -85.34 86.89 7.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 122.176 0.988 . . . . 0.0 111.168 -176.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -132.92 -62.47 0.8 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.945 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.8 t -72.6 -18.09 61.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.196 -175.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -83.47 -12.01 79.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.487 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 52.34 64.99 1.64 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 122.757 0.423 . . . . 0.0 111.496 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -151.47 173.69 14.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.192 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.592 ' HA ' HD12 ' A' ' 135' ' ' LEU . 29.8 m -137.45 141.63 41.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.489 176.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 54.1 tp -97.79 111.36 23.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.553 ' CD1' ' HG2' ' A' ' 163' ' ' GLN . 2.8 mm? -100.55 157.22 16.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 -176.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -120.84 136.98 54.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.801 -176.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.452 ' C ' HG13 ' A' ' 146' ' ' ILE . 27.4 tt0 -127.54 140.42 52.14 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -174.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.46 ' CD1' ' HB2' ' A' ' 161' ' ' ALA . 7.6 mt -132.65 150.15 32.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.98 0.419 . . . . 0.0 111.843 -166.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.48 ' HG3' ' CH2' ' A' ' 194' ' ' TRP . 43.6 mtm180 -126.75 154.71 43.82 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 174.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.629 HD12 ' NE2' ' A' ' 159' ' ' HIS . 0.0 OUTLIER -163.1 155.41 18.36 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 123.297 0.373 . . . . 0.0 110.255 170.773 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -173.43 141.38 0.91 Allowed Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.955 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.8 173.37 13.57 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.561 2.174 . . . . 0.0 112.108 173.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.408 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 9.0 pt-20 -65.78 -24.68 66.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.627 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.408 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 50.6 mttm -90.51 11.51 21.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.237 0.541 . . . . 0.0 110.467 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -111.52 130.6 55.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.751 178.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -92.92 -35.35 13.38 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.259 0.552 . . . . 0.0 110.341 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -91.92 149.46 21.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.002 -175.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -93.77 128.72 40.14 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.065 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -93.06 111.46 23.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.008 173.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.462 HG13 ' HG2' ' A' ' 147' ' ' ARG . 1.9 mp -88.72 126.21 41.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.629 ' NE2' HD12 ' A' ' 148' ' ' LEU . 3.2 p80 -130.36 132.96 46.06 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.828 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -97.72 116.57 30.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.199 -176.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.46 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -76.95 -48.74 17.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.191 0.52 . . . . 0.0 110.643 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 123.5 -125.61 5.96 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.257 -176.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.553 ' HG2' ' CD1' ' A' ' 143' ' ' LEU . 5.1 mt-30 -102.14 -7.0 22.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.921 0.391 . . . . 0.0 110.482 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -79.48 143.24 35.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.375 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 63.5 p -101.32 33.78 2.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.171 0.51 . . . . 0.0 111.76 -174.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -158.82 153.51 24.62 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.283 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -151.27 152.56 33.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.701 0.286 . . . . 0.0 110.547 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 168' ' ' LYS . 0.1 OUTLIER -118.33 128.92 55.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.437 -178.109 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 123' ' ' LEU . 23.6 mm -99.87 140.82 18.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.11 -19.82 13.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.777 0.323 . . . . 0.0 110.86 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 36.7 t -87.59 73.89 9.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.231 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.418 HD22 ' N ' ' A' ' 172' ' ' LEU . 2.7 mm? -117.7 143.26 46.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.995 0.426 . . . . 0.0 110.522 175.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 73.0 m80 -119.15 132.26 24.03 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.575 175.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 24.3 Cg_exo -62.09 124.33 14.2 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.791 2.327 . . . . 0.0 112.732 -177.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 85.67 28.37 29.64 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.751 177.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -123.75 149.74 45.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.14 0.495 . . . . 0.0 111.125 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -87.38 128.34 35.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.361 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -121.1 142.39 49.89 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.752 0.311 . . . . 0.0 110.329 175.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.8 mp -104.93 146.89 28.39 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 172.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.459 HG23 ' HB ' ' A' ' 198' ' ' THR . 19.4 m -134.53 152.74 34.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.983 0.42 . . . . 0.0 110.484 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.565 ' NE2' ' HA ' ' A' ' 181' ' ' GLN . 0.3 OUTLIER -151.66 146.27 25.67 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.035 179.522 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.414 HG21 ' CD2' ' A' ' 127' ' ' TRP . 12.0 p -138.17 149.82 24.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -158.34 139.25 13.02 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.423 ' SG ' ' HG3' ' A' ' 106' ' ' PRO . 26.3 p -104.41 177.9 4.71 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -125.65 84.68 60.1 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.684 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.9 158.0 59.62 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.955 2.437 . . . . 0.0 111.701 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -79.45 -8.93 59.47 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.764 -176.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -88.65 -7.15 56.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.544 175.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -179.74 94.71 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.592 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -75.25 125.53 29.16 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 176.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 85.1 m95 62.85 98.6 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 O-C-N 123.626 0.579 . . . . 0.0 111.245 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 10.2 p -107.47 13.98 26.32 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.753 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . 67.38 163.64 0.2 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.801 -1.09 . . . . 0.0 112.196 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.48 ' CH2' ' HG3' ' A' ' 147' ' ' ARG . 50.9 m95 -88.92 79.36 7.35 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.191 -177.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.447 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 12.9 m -74.48 -51.24 4.35 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.099 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.447 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 59.2 Cg_endo -74.78 165.27 31.84 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.667 1.578 . . . . 0.0 112.722 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -154.11 130.67 10.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.965 172.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.459 ' HB ' HG23 ' A' ' 180' ' ' VAL . 12.8 m -115.9 135.45 53.98 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.582 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -106.22 131.64 53.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.252 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.0 tp -128.53 130.27 69.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.283 0.563 . . . . 0.0 110.4 177.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -97.81 113.38 25.16 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.338 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 51.7 mm -74.27 122.05 86.64 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.14 155.05 71.63 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.776 2.318 . . . . 0.0 112.353 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 12.3 p -75.85 -5.18 44.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.299 0.571 . . . . 0.0 110.224 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -82.8 -6.43 59.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.148 177.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 36.2 t80 -53.32 -37.26 62.11 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.54 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.2 p -89.12 92.89 9.38 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.231 174.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' MET . . . . . 0.456 ' SD ' ' HB3' ' A' ' 115' ' ' GLN . 58.5 mtm -82.63 -26.32 32.31 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.011 -172.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 22.5 m120 46.51 65.1 1.28 Allowed 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.756 0.66 . . . . 0.0 112.514 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 34.2 t70 . . . . . 0 C--O 1.253 1.252 0 O-C-N 123.643 0.589 . . . . 0.0 110.745 179.437 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 83.1 mtp . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.95 0.405 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -101.53 134.07 45.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.271 0.558 . . . . 0.0 110.642 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 76.9 mt -73.86 89.14 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.213 175.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.537 ' O ' ' HD3' ' A' ' 103' ' ' PRO . 10.4 p -84.99 144.78 9.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.59 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -85.88 101.79 2.14 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 101' ' ' VAL . 38.5 Cg_endo -69.2 -39.6 7.36 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.108 1.872 . . . . 0.0 110.977 -178.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -112.79 86.02 8.3 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.288 172.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 103' ' ' PRO . 89.8 Cg_endo -97.1 156.43 1.08 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.675 2.916 . . . . 0.0 113.131 -176.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.664 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 73.4 Cg_endo -77.6 146.24 23.96 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.457 2.105 . . . . 0.0 111.271 175.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.405 HD23 ' N ' ' A' ' 107' ' ' LEU . 2.1 pt? -140.07 -174.61 3.97 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.094 -177.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 128' ' ' SER . 42.7 mt-10 54.99 55.97 7.12 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 123.704 0.628 . . . . 0.0 110.925 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.4 tp -75.5 96.85 3.56 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.21 0.528 . . . . 0.0 110.491 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.09 123.18 38.44 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.253 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.444 HG12 HD11 ' A' ' 123' ' ' LEU . 3.5 t -119.04 118.1 56.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.43 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -136.1 121.37 19.14 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.838 -174.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.475 HG22 HD13 ' A' ' 123' ' ' LEU . 48.2 t -74.48 129.44 36.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.312 -0.403 . . . . 0.0 109.971 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 114' ' ' LYS . 24.3 mmtp -118.59 125.17 49.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.14 0.495 . . . . 0.0 111.642 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -117.26 97.13 50.41 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.884 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.491 ' HB2' ' HB2' ' A' ' 119' ' ' ARG . 15.2 Cg_exo -68.74 171.48 13.24 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.429 2.086 . . . . 0.0 111.968 177.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -76.18 -66.2 0.83 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.953 0.406 . . . . 0.0 110.706 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -92.69 -33.6 14.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.666 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.491 ' HB2' ' HB2' ' A' ' 116' ' ' PRO . 71.8 mtp180 -72.41 154.9 40.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.806 176.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -75.54 149.39 83.79 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.53 146.15 48.97 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.975 2.45 . . . . 0.0 112.468 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.473 ' CD2' ' HD2' ' A' ' 168' ' ' LYS . 49.0 p90 -151.41 161.37 42.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.461 -176.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.623 ' HB2' HD11 ' A' ' 172' ' ' LEU . 44.5 tp -91.52 125.46 36.27 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 175.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.595 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 22.4 t90 -102.03 108.93 20.52 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.127 0.489 . . . . 0.0 110.421 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.03 122.22 52.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.337 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -131.09 120.5 23.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.946 0.403 . . . . 0.0 110.491 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' TRP . . . . . 0.437 ' CH2' HD11 ' A' ' 146' ' ' ILE . 37.1 p90 -115.83 165.84 12.63 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.466 -178.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.428 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 23.0 t -104.34 121.27 47.94 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.756 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.95 142.4 33.85 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.377 2.718 . . . . 0.0 112.526 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -43.6 106.56 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 124.034 3.156 . . . . 0.0 113.175 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.486 ' HB ' HD23 ' A' ' 132' ' ' LEU . 52.7 p 48.87 -98.48 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.715 0.806 . . . . 0.0 112.353 -176.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.486 HD23 ' HB ' ' A' ' 131' ' ' THR . 0.9 OUTLIER -143.68 124.1 13.92 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 176.033 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 59.3 mt -121.98 -66.32 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.742 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 52.75 57.99 5.81 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 123.713 0.633 . . . . 0.0 110.756 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.3 pp -71.92 138.61 48.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.791 -177.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -145.64 179.72 7.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.014 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 69.2 p 58.22 18.06 5.09 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.358 1.063 . . . . 0.0 113.123 176.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.87 -30.22 2.33 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.259 176.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.4 ' O ' ' HB3' ' A' ' 140' ' ' PHE . 94.2 m95 -62.58 112.78 2.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.698 0.249 . . . . 0.0 110.698 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.4 ' HB3' ' O ' ' A' ' 139' ' ' TRP . 88.4 t80 70.47 133.37 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 O-C-N 123.915 0.759 . . . . 0.0 111.41 -177.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.9 m -148.68 135.5 19.86 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.597 174.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.479 HD21 ' SG ' ' A' ' 184' ' ' CYS . 48.0 tp -107.94 117.19 33.48 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.159 -176.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 3.5 mp -95.71 134.84 38.16 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.318 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -102.83 153.17 20.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.718 -172.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -131.62 134.24 45.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.953 -171.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.437 HD11 ' CH2' ' A' ' 127' ' ' TRP . 4.5 mp -125.68 125.2 68.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.549 ' HB3' ' HB2' ' A' ' 181' ' ' GLN . 46.6 ttp180 -118.01 119.86 36.06 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -141.5 162.59 35.12 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.848 -176.251 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -167.07 150.25 6.06 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.164 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.482 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 34.2 Cg_endo -68.32 159.48 53.13 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.282 1.988 . . . . 0.0 111.027 171.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.44 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 15.8 pt-20 -63.06 -20.66 65.54 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -171.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.44 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 84.7 mttt -100.28 7.35 44.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.091 0.472 . . . . 0.0 110.852 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.482 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -84.75 124.24 31.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.899 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.96 -22.99 39.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.535 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -115.32 154.45 29.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.393 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -94.7 141.58 28.45 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.324 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -103.92 108.58 19.97 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.989 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.43 HD12 ' N ' ' A' ' 158' ' ' ILE . 2.2 mp -87.99 133.4 30.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.033 0.444 . . . . 0.0 110.053 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -126.92 141.84 51.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.609 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 143' ' ' LEU . 5.3 t80 -106.14 124.66 49.93 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.073 -177.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -88.21 -44.06 11.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.138 0.494 . . . . 0.0 110.303 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 143' ' ' LEU . . . 103.71 -127.63 9.21 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.051 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -93.03 9.0 37.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.447 0.641 . . . . 0.0 110.519 -176.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -105.48 153.19 22.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.584 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.8 p -107.44 19.5 20.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.033 -175.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -146.57 140.66 26.27 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -133.87 151.39 51.51 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.595 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 40.7 mmtm -120.53 135.48 55.07 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.613 0.244 . . . . 0.0 110.66 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 33.9 mm -109.7 128.78 65.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.93 -25.06 12.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.368 . . . . 0.0 111.051 -178.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 13.8 m -80.62 65.4 5.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.712 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 123' ' ' LEU . 57.6 mt -114.55 157.59 22.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.949 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 75.3 m-70 -126.08 129.97 24.1 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.774 177.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 23.7 Cg_exo -63.75 121.85 9.73 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.615 2.21 . . . . 0.0 111.925 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 90.8 20.2 40.93 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.05 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -117.49 142.97 46.52 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 151' ' ' GLU . 30.3 ttmt -90.77 135.13 33.92 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.064 177.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -122.12 133.17 54.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.112 0.482 . . . . 0.0 110.606 176.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.3 mp -100.68 124.71 46.66 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.442 HG21 HG21 ' A' ' 111' ' ' VAL . 34.7 m -115.02 161.27 13.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.364 0.602 . . . . 0.0 111.723 -176.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.584 HE21 ' HB2' ' A' ' 197' ' ' ALA . 12.2 mm-40 -145.63 148.67 33.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.901 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 9.0 p -136.37 145.69 30.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 120.891 0.377 . . . . 0.0 110.184 175.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.56 ' HG2' ' CZ3' ' A' ' 194' ' ' TRP . 1.2 ptm180 -163.08 177.98 8.68 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.398 175.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.664 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 27.9 p -155.25 170.46 21.81 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -147.35 89.69 5.44 Favored Pre-proline 0 C--N 1.322 -0.619 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.797 -176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.49 -169.33 0.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.721 2.28 . . . . 0.0 112.252 -178.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.5 -24.03 64.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.236 0.541 . . . . 0.0 110.259 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -61.51 -24.3 66.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.108 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -159.41 -147.64 4.95 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 119.979 -1.105 . . . . 0.0 113.539 -177.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -150.36 -141.22 0.11 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 -176.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 40.5 m95 -66.1 136.5 56.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.123 0.487 . . . . 0.0 111.709 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 16.5 m -120.94 10.79 10.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.881 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . 62.25 24.44 14.55 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.56 ' CZ3' ' HG2' ' A' ' 183' ' ' ARG . 71.9 m95 70.83 164.29 0.27 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.653 173.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.574 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 70.4 m -158.58 -63.97 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.574 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 76.9 Cg_endo -76.25 109.07 2.8 Favored 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 121.896 1.731 . . . . 0.0 113.456 -173.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.584 ' HB2' HE21 ' A' ' 181' ' ' GLN . . . -101.66 137.61 39.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.891 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 94.9 m -133.48 139.21 46.54 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.574 177.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -99.75 126.72 45.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.396 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.9 tp -129.25 137.68 56.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.029 0.443 . . . . 0.0 110.423 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -102.54 137.33 40.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.905 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 39.2 mm -96.98 113.08 62.39 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 176.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.8 147.44 72.39 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.921 2.414 . . . . 0.0 112.188 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 42.1 m -71.76 -7.51 48.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.974 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -95.16 7.77 45.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.773 175.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -59.77 -36.19 76.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.114 177.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 24.9 m -138.14 142.62 40.12 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.225 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 21.4 ptp -57.79 117.16 3.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.415 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -79.99 105.17 11.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.946 -177.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 C--O 1.252 1.198 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.406 -179.309 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 55.7 ttp . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 120.549 0.214 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -140.58 151.33 44.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.993 0.425 . . . . 0.0 110.805 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 188' ' ' HIS . 4.5 mp -75.0 88.5 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.364 177.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.0 p -154.04 143.63 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.381 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -109.23 98.87 33.48 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 173.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.61 -18.71 25.26 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.553 2.169 . . . . 0.0 112.438 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -131.26 76.69 75.66 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.686 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -69.7 159.5 53.22 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.878 2.386 . . . . 0.0 111.271 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -60.24 105.34 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.772 2.315 . . . . 0.0 112.415 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.93 174.26 5.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.154 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 54.74 47.53 22.25 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.694 0.621 . . . . 0.0 110.976 -178.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.445 HD23 ' OG1' ' A' ' 198' ' ' THR . 55.8 tp -70.34 94.39 0.94 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.002 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.17 130.79 43.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.541 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.431 HG13 HG13 ' A' ' 125' ' ' ILE . 5.0 t -117.38 113.88 43.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.667 178.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -111.94 148.43 33.76 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.18 -178.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.6 p -108.36 95.84 4.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 122.077 0.941 . . . . 0.0 109.92 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -87.36 122.06 30.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.456 -174.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -117.88 98.87 51.95 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.195 -173.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.6 155.39 49.83 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.977 2.451 . . . . 0.0 111.27 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.496 ' CD ' ' H ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -93.5 -4.93 50.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.958 0.408 . . . . 0.0 111.145 -176.317 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -132.49 -34.94 1.16 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.728 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -87.37 173.15 9.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.291 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -79.62 138.24 54.75 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.161 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.425 ' HG3' ' O ' ' A' ' 206' ' ' PHE . 38.3 Cg_endo -66.24 147.91 84.1 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.949 2.432 . . . . 0.0 111.847 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -149.09 156.99 43.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.958 0.408 . . . . 0.0 110.979 -174.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.417 HD12 HD11 ' A' ' 172' ' ' LEU . 16.3 mt -87.65 142.46 27.82 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.248 0.547 . . . . 0.0 110.602 174.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.491 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 19.5 t90 -117.03 102.1 9.05 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.701 177.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.431 HG13 HG13 ' A' ' 111' ' ' VAL . 4.2 mp -97.94 117.79 43.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -131.48 131.56 43.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.065 0.459 . . . . 0.0 110.897 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 29.0 p90 -123.48 151.92 42.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.897 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.2 m -127.54 78.09 75.18 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.4 -177.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.46 ' CB ' ' HD3' ' A' ' 130' ' ' PRO . 19.0 Cg_exo -61.88 -56.67 0.69 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.091 1.861 . . . . 0.0 113.395 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.561 ' HB2' ' HB ' ' A' ' 133' ' ' ILE . 28.9 Cg_endo -98.08 73.04 0.08 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.466 2.111 . . . . 0.0 112.196 -177.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.8 p -55.93 -53.47 56.42 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -174.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 89.9 mt -113.56 28.78 8.5 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.698 0.761 . . . . 0.0 111.452 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 130' ' ' PRO . 70.7 mt -102.64 -52.97 7.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.221 177.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.9 t70 55.33 29.88 13.8 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.388 0.613 . . . . 0.0 111.133 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.513 ' H ' HG22 ' A' ' 133' ' ' ILE . 2.6 mm? 42.1 46.35 3.67 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.549 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -73.53 -69.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 0.0 111.149 -178.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.4 p -84.21 74.78 10.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.365 0.602 . . . . 0.0 110.979 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 108.43 93.04 2.27 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.704 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.493 ' HA ' ' HB3' ' A' ' 135' ' ' LEU . 29.8 p90 -93.43 145.5 24.45 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.992 0.425 . . . . 0.0 110.624 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -162.84 148.85 12.31 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.553 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.12 105.46 17.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.607 0.718 . . . . 0.0 110.938 178.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.45 HD21 ' HB2' ' A' ' 184' ' ' CYS . 13.5 tp -83.56 136.73 34.14 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.414 -177.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 4.1 mp -92.76 135.54 34.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.871 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.503 ' CE1' ' HB3' ' A' ' 184' ' ' CYS . 82.5 m-85 -122.61 144.42 49.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.17 -176.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -125.66 138.14 53.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.315 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 181' ' ' GLN . 4.4 mp -118.56 122.02 68.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.924 0.392 . . . . 0.0 110.148 -177.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.423 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 23.1 ttp180 -107.1 123.86 48.84 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.58 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.7 pp -143.18 162.09 36.52 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.161 -176.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -168.35 148.8 4.35 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.91 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.424 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 40.6 Cg_endo -71.08 161.11 47.08 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.306 2.004 . . . . 0.0 111.067 170.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.423 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 13.2 pt-20 -63.35 -19.94 65.07 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.247 -175.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.423 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 88.6 mttt -97.02 10.37 39.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.0 0.428 . . . . 0.0 110.9 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.424 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -98.55 131.01 45.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.641 178.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -86.23 -37.13 18.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.206 0.527 . . . . 0.0 110.469 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -98.23 159.29 15.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.912 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.423 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 69.9 m95 -96.88 146.03 25.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.078 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -105.39 111.82 24.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.007 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.48 130.08 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.082 0.468 . . . . 0.0 110.959 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -126.46 133.64 51.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.791 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -102.78 130.09 49.64 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -94.11 -29.96 14.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.859 0.362 . . . . 0.0 111.4 -177.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 143' ' ' LEU . . . 100.33 -133.28 11.24 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.149 -176.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -106.81 31.6 5.18 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.34 0.591 . . . . 0.0 110.96 -177.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -115.69 151.97 34.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.385 177.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 34.9 p -102.17 21.81 14.27 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -175.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 125' ' ' ILE . 8.5 pt-20 -147.74 138.83 23.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.109 174.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -129.51 150.22 50.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.892 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.491 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 42.9 mmtm -112.78 146.0 39.58 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.409 ' HB ' ' HB2' ' A' ' 123' ' ' LEU . 32.6 mm -125.04 132.62 71.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 173.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.75 -16.94 14.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.915 0.388 . . . . 0.0 110.969 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 8.7 t -96.33 69.95 2.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.828 0.347 . . . . 0.0 111.451 -173.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.1 mm? -115.98 159.8 21.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.815 0.34 . . . . 0.0 110.603 176.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 57.7 m-70 -126.52 136.36 28.56 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.548 178.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 24.6 Cg_exo -62.29 122.25 10.6 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.745 2.297 . . . . 0.0 111.986 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 83.98 38.34 10.42 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.81 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -133.38 144.43 49.57 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -101.83 132.66 47.46 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.635 177.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -120.66 142.64 49.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.63 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.1 mm? -103.85 127.39 51.35 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 174.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.2 m -122.36 141.46 42.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.182 0.515 . . . . 0.0 111.55 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 99.1 mt-30 -140.65 142.73 34.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.337 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.2 p -138.57 139.42 41.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -145.97 142.82 29.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.503 ' HB3' ' CE1' ' A' ' 144' ' ' TYR . 23.5 p -108.14 163.4 13.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.98 -175.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.462 ' HB3' ' CD1' ' A' ' 191' ' ' TRP . 18.0 ptmt -147.61 87.83 5.84 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.38 0.609 . . . . 0.0 111.516 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -85.38 -162.59 0.16 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.925 2.416 . . . . 0.0 111.895 176.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -77.73 -21.21 52.2 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.168 0.508 . . . . 0.0 110.187 176.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.457 ' O ' ' HA ' ' A' ' 100' ' ' ILE . 38.7 m170 -74.89 -29.26 60.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.823 -177.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -163.8 163.54 35.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.026 -1.083 . . . . 0.0 113.101 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -136.07 -176.87 4.46 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' TRP . . . . . 0.462 ' CD1' ' HB3' ' A' ' 185' ' ' LYS . 42.4 p-90 -151.07 147.57 27.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.048 0.451 . . . . 0.0 111.441 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 22.9 t -121.35 -3.05 9.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.039 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -149.85 172.37 15.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.969 -176.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.423 ' CZ2' ' HB2' ' A' ' 147' ' ' ARG . 61.0 m95 -110.82 163.46 13.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.678 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.452 ' H ' ' CD ' ' A' ' 196' ' ' PRO . 18.2 m -140.5 -55.75 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -176.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.549 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 8.4 Cg_endo -87.64 88.71 0.58 Allowed 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.312 2.008 . . . . 0.0 113.273 -171.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.457 ' HB2' ' NE2' ' A' ' 181' ' ' GLN . . . -85.78 106.76 17.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.908 0.385 . . . . 0.0 110.47 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.445 ' OG1' HD23 ' A' ' 109' ' ' LEU . 17.4 m -92.33 136.32 33.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.814 -177.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -95.36 124.15 39.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.742 -177.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.2 tp -127.45 129.43 70.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.234 0.54 . . . . 0.0 110.464 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -101.11 132.79 46.4 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.409 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 36.5 mm -94.08 115.48 65.24 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.07 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.41 155.4 47.09 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.998 2.465 . . . . 0.0 112.562 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 18.7 m -70.06 -17.31 63.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.645 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -82.27 1.15 38.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.87 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 62.4 t80 -57.41 -51.24 70.24 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.109 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 28.7 m -153.46 134.99 14.33 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.807 176.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -116.23 -18.42 10.55 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.093 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -76.84 144.38 39.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.134 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 30.7 t70 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.834 -1.079 . . . . 0.0 110.873 -179.421 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.3 mmm . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.429 ' CE2' ' HB ' ' A' ' 101' ' ' VAL . 19.8 t80 -144.33 144.89 31.67 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.265 -178.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 43.5 mm -64.68 91.32 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.298 175.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.429 ' HB ' ' CE2' ' A' ' 99' ' ' TYR . 8.3 p -152.01 144.7 15.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.284 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.445 ' HG2' ' HD3' ' A' ' 186' ' ' PRO . 26.6 mt-30 -98.05 156.23 36.14 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.83 178.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.18 -42.23 44.69 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.173 1.915 . . . . 0.0 110.581 172.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 132' ' ' LEU . 0.3 OUTLIER -150.18 127.32 5.46 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.432 178.183 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 104' ' ' ASP . 5.3 Cg_exo -77.03 145.8 25.11 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.93 2.42 . . . . 0.0 111.908 174.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.11 144.84 43.08 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.704 2.269 . . . . 0.0 111.814 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.481 ' N ' HD13 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -134.91 -178.32 5.03 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -176.454 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 56.11 58.75 4.12 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.615 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.465 HD23 ' OG1' ' A' ' 198' ' ' THR . 33.9 tp -75.57 95.81 3.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.261 0.553 . . . . 0.0 109.735 175.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.72 128.83 40.13 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.01 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.9 t -125.7 122.09 61.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.04 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -139.21 155.35 47.86 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.176 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.506 HG22 ' CD1' ' A' ' 123' ' ' LEU . 21.8 t -100.18 94.21 3.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-O 121.375 0.607 . . . . 0.0 109.636 -177.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.446 ' O ' ' HD3' ' A' ' 116' ' ' PRO . 0.8 OUTLIER -78.86 108.14 12.09 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.794 -176.723 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -106.43 98.98 21.81 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.921 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 114' ' ' LYS . 14.6 Cg_exo -69.88 163.82 36.93 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.817 2.344 . . . . 0.0 112.881 -177.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -101.4 19.75 17.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.206 177.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -147.39 -55.25 0.23 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.673 -176.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -93.12 168.59 11.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.795 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.62 143.77 96.3 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.344 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.98 135.19 46.53 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.821 2.347 . . . . 0.0 112.024 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -139.44 160.49 39.71 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.047 0.451 . . . . 0.0 110.991 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.506 ' CD1' HG22 ' A' ' 113' ' ' VAL . 37.2 tp -91.12 123.76 34.82 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 176.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.526 ' CZ2' ' HD2' ' A' ' 126' ' ' LYS . 10.5 t90 -103.0 103.25 13.33 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.2 0.524 . . . . 0.0 110.49 -174.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.0 mp -95.73 113.61 30.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.081 178.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.526 ' HD2' ' CZ2' ' A' ' 124' ' ' TRP . 58.6 tttp -129.61 119.54 23.76 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.352 0.596 . . . . 0.0 110.656 -176.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' TRP . . . . . 0.427 ' CD2' HG21 ' A' ' 182' ' ' VAL . 29.2 p90 -109.76 163.61 13.35 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.752 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.1 t -103.25 122.81 43.93 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 82.8 Cg_exo -49.71 137.53 33.98 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.334 2.689 . . . . 0.0 112.202 177.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 129' ' ' PRO . 39.0 Cg_exo -57.59 152.12 50.2 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.006 2.471 . . . . 0.0 112.735 -178.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.6 m -54.16 -66.82 0.33 Allowed 'General case' 0 C--O 1.236 0.369 0 O-C-N 123.343 0.402 . . . . 0.0 111.669 -176.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 104' ' ' ASP . 99.6 mt -112.69 101.51 9.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.297 0.57 . . . . 0.0 111.3 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.415 HD11 ' HD2' ' A' ' 130' ' ' PRO . 11.4 mt -96.49 87.01 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.748 0.785 . . . . 0.0 109.153 175.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -69.22 84.65 0.37 Allowed 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.419 175.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.487 ' HB2' ' CZ ' ' A' ' 140' ' ' PHE . 1.6 pt? -129.55 153.14 48.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.8 177.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -72.5 113.2 9.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.09 0.471 . . . . 0.0 110.451 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 24.7 p -75.38 133.42 41.19 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.564 -175.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.29 -17.3 52.64 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.219 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -96.57 -47.49 5.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.686 0.243 . . . . 0.0 110.402 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.487 ' CZ ' ' HB2' ' A' ' 135' ' ' LEU . 22.2 p90 -151.73 162.42 41.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.786 0.327 . . . . 0.0 110.498 178.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.9 m -122.86 151.6 41.56 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.01 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.3 tp -79.42 110.63 14.9 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.2 mt -101.29 150.39 23.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.297 -177.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.589 ' CD2' ' HB3' ' A' ' 184' ' ' CYS . 49.7 m-85 -116.54 143.98 44.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.178 -176.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -121.48 141.93 50.54 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.1 mp -117.95 124.94 73.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.024 0.44 . . . . 0.0 110.734 -175.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.454 ' HB2' ' CH2' ' A' ' 194' ' ' TRP . 14.3 ttp180 -109.01 120.32 42.2 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.062 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -145.69 161.49 39.75 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.471 -175.611 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -172.69 147.29 1.62 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.72 175.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -70.9 164.73 34.64 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.093 1.862 . . . . 0.0 111.067 170.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -64.29 -23.96 67.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.608 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.523 ' HE2' ' OE1' ' A' ' 176' ' ' GLN . 67.8 mmtt -81.7 -13.66 57.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.21 0.528 . . . . 0.0 110.512 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -83.97 129.61 34.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.746 -178.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -88.22 -26.39 22.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.409 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -107.12 144.66 33.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.791 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' TRP . . . . . 0.435 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 77.1 m95 -85.22 134.56 34.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.261 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -93.37 131.22 38.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.685 177.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.38 122.44 65.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.038 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 46.3 m-70 -130.57 113.45 14.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.202 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -79.09 132.71 36.68 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.988 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -99.12 -49.49 4.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 111.804 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 111.87 -137.75 14.49 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.02 13.58 22.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.066 0.46 . . . . 0.0 111.005 -177.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -68.75 -23.01 64.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.492 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 42.0 p 63.16 15.71 8.77 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.382 -1.281 . . . . 0.0 113.051 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -153.2 136.88 16.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 171.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 24.7 t80 -125.74 151.33 46.81 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.692 0.282 . . . . 0.0 110.525 -176.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.582 ' HD2' ' N ' ' A' ' 168' ' ' LYS . 0.0 OUTLIER -125.53 115.51 20.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.466 -175.087 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' A' ' 123' ' ' LEU . 34.5 mm -93.39 137.92 21.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 176.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -100.37 -32.53 10.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.851 0.358 . . . . 0.0 111.118 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 18.7 m -87.55 80.93 7.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.814 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.6 mm? -113.6 137.43 51.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 110.712 176.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 53.5 m-70 -100.05 125.93 38.31 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.18 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 22.9 Cg_exo -63.52 125.05 14.78 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.566 2.177 . . . . 0.0 112.448 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 86.6 26.93 31.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.409 178.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.523 ' OE1' ' HE2' ' A' ' 152' ' ' LYS . 77.4 mm-40 -125.18 152.47 44.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.294 0.568 . . . . 0.0 111.658 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -91.08 129.69 37.05 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.32 176.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.414 ' HB2' HG23 ' A' ' 200' ' ' ILE . 15.6 m-85 -117.58 137.74 52.4 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.43 177.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.5 mm? -102.31 128.74 48.74 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 175.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.414 HG23 ' HB ' ' A' ' 198' ' ' THR . 30.7 m -128.92 139.74 51.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 120.951 0.405 . . . . 0.0 111.33 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 98.9 mt-30 -139.19 136.58 35.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.355 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.427 HG21 ' CD2' ' A' ' 127' ' ' TRP . 13.5 p -120.05 137.42 53.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.99 0.424 . . . . 0.0 110.334 174.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -138.62 157.06 46.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.349 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.589 ' HB3' ' CD2' ' A' ' 144' ' ' TYR . 24.3 p -136.34 174.75 10.27 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.31 132.86 3.11 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.17 0.509 . . . . 0.0 111.953 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.445 ' HD3' ' HG2' ' A' ' 102' ' ' GLN . 93.9 Cg_endo -86.33 -163.35 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.216 2.61 . . . . 0.0 110.493 168.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -91.24 -31.58 16.09 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.485 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -62.72 -39.27 93.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.318 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -118.16 102.92 1.0 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.494 -178.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -80.39 107.07 12.88 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 3.1 p-90 -67.4 158.8 30.86 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.068 -174.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 15.8 m -153.98 16.5 0.49 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.432 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -152.01 162.15 41.54 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.295 0.569 . . . . 0.0 112.499 -172.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' TRP . . . . . 0.454 ' CH2' ' HB2' ' A' ' 147' ' ' ARG . 72.2 m95 -120.22 173.05 7.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.946 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.548 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 54.0 m -152.28 -63.77 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.548 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 97.5 Cg_endo -74.88 80.49 2.38 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 121.954 1.77 . . . . 0.0 113.952 -168.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.412 ' HB2' HE21 ' A' ' 181' ' ' GLN . . . -78.65 100.61 7.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.169 0.509 . . . . 0.0 110.312 178.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' THR . . . . . 0.465 ' OG1' HD23 ' A' ' 109' ' ' LEU . 20.0 m -94.17 138.9 31.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.713 -176.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -100.83 116.06 31.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.622 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.414 HG23 ' HB2' ' A' ' 178' ' ' TYR . 7.0 tp -123.73 137.49 56.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.061 0.458 . . . . 0.0 110.485 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -104.75 128.71 52.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.236 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 47.2 mm -87.09 124.39 68.66 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.86 151.47 80.81 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.049 2.499 . . . . 0.0 112.382 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 37.8 m -68.57 -30.12 68.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.757 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -92.56 39.8 1.04 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.681 0.753 . . . . 0.0 109.809 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' PHE . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 80.3 t80 -74.89 -35.19 62.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.863 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 12.8 t -73.89 152.49 40.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.514 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -70.26 129.86 40.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.36 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -95.53 -4.1 45.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.373 0.606 . . . . 0.0 111.143 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 . . . . . 0 C--O 1.248 0.994 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.078 179.431 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.652 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 37.7 Cg_endo . . . . . 0 N--CA 1.461 -0.384 0 CA-C-O 121.568 0.57 . . . . 0.0 111.349 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.17 178.91 6.24 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.2 -175.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 57.34 49.09 13.72 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.665 -175.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.68 96.28 0.54 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.69 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.33 125.11 39.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.543 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.428 HG12 HD11 ' A' ' 123' ' ' LEU . 5.2 t -120.38 120.44 62.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.662 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -127.77 142.88 51.19 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.3 p -97.99 117.14 42.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.118 0.485 . . . . 0.0 109.839 176.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -107.16 128.09 54.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.584 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -120.68 89.28 44.7 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.494 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -72.93 152.15 51.55 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 123.196 2.597 . . . . 0.0 111.989 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -73.81 -33.78 64.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.075 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -104.52 -49.3 3.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.473 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -76.4 167.02 22.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.772 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -75.16 143.28 76.83 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.588 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.6 138.13 63.01 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.596 2.198 . . . . 0.0 111.251 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -145.17 160.23 41.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.015 0.436 . . . . 0.0 111.232 -173.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.546 ' HB2' HD11 ' A' ' 172' ' ' LEU . 29.5 tp -93.98 121.88 35.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -102.82 104.42 14.7 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.034 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.2 mp -98.58 121.37 49.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.88 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -134.27 144.13 48.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.425 0.631 . . . . 0.0 110.476 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . 0.429 ' CH2' HD11 ' A' ' 146' ' ' ILE . 22.9 p90 -132.56 164.13 27.32 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.766 -173.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 52.3 m -97.44 131.36 27.37 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 C--O 1.235 0.343 0 C-N-CA 122.458 2.106 . . . . 0.0 111.504 177.583 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.448 HD21 ' SG ' ' A' ' 184' ' ' CYS . 32.9 tp . . . . . 0 N--CA 1.445 -0.684 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 43.5 mt -92.31 144.69 25.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.913 0.387 . . . . 0.0 110.576 -177.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.492 ' CD1' ' HB3' ' A' ' 184' ' ' CYS . 46.2 m-85 -115.45 146.0 42.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.942 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 36.2 tt0 -126.3 133.87 51.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.604 176.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 181' ' ' GLN . 4.6 mp -118.64 125.65 74.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.309 -176.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -113.16 137.18 51.85 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -148.38 159.9 43.56 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.702 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -170.17 145.53 2.35 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.453 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.465 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 37.4 Cg_endo -70.38 175.16 9.0 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.196 1.931 . . . . 0.0 112.537 173.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -62.16 -43.37 98.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -86.07 17.06 3.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.136 0.493 . . . . 0.0 111.298 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.465 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -94.11 121.97 36.15 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.056 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.09 -22.68 33.37 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.894 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -121.01 156.04 33.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.91 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -90.92 140.61 29.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.36 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -104.41 107.35 18.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.836 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.03 129.57 39.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.124 0.487 . . . . 0.0 110.576 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 66.6 m-70 -128.2 114.11 16.55 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.961 175.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -83.43 115.89 22.25 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.59 -44.42 19.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.767 0.317 . . . . 0.0 111.053 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 143' ' ' LEU . . . 102.93 -127.96 9.38 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.313 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -86.23 -19.74 29.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.983 0.42 . . . . 0.0 111.018 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -75.0 146.29 41.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.202 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.5 p -104.98 30.02 5.87 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.206 0.527 . . . . 0.0 111.658 -174.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -157.16 142.4 17.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.603 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 34.3 t80 -136.52 150.7 48.79 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 0.0 OUTLIER -122.8 136.65 54.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.766 0.317 . . . . 0.0 110.669 -177.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 29.0 mm -109.92 128.52 65.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 175.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.55 -34.97 9.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.025 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.0 m -80.15 82.81 6.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.836 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 123' ' ' LEU . 73.7 mt -125.87 147.56 49.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.224 0.535 . . . . 0.0 111.687 -176.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -105.25 119.09 54.16 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.11 176.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.39 126.3 20.39 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.858 2.372 . . . . 0.0 112.66 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.55 45.41 7.94 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.628 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -146.98 149.05 32.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.96 0.41 . . . . 0.0 111.15 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -80.82 134.24 35.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.948 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -123.47 142.66 50.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.616 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.8 mm? -106.9 132.54 52.73 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 175.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.409 HG23 ' HB ' ' A' ' 198' ' ' THR . 27.1 m -132.28 141.98 43.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.028 0.442 . . . . 0.0 111.521 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.638 ' OE1' ' HB3' ' A' ' 194' ' ' TRP . 36.9 mt-30 -143.77 139.37 29.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.526 175.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 145' ' ' GLU . 7.1 p -133.36 139.06 49.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 174.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 37.1 ttt-85 -146.76 147.11 30.59 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.8 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . 0.652 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 21.9 p -109.57 169.39 8.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.328 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.261 0.553 . . . . 0.0 111.502 -177.398 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.638 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 81.9 m95 . . . . . 0 C--O 1.233 0.23 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.473 ' H ' ' HD2' ' A' ' 196' ' ' PRO . 48.1 t -171.43 -54.96 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -176.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.473 ' HD2' ' H ' ' A' ' 195' ' ' SER . 77.8 Cg_endo -75.52 69.92 5.79 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.114 1.876 . . . . 0.0 113.669 -174.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.45 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -74.48 105.85 5.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.872 0.368 . . . . 0.0 110.879 178.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.409 ' HB ' HG23 ' A' ' 180' ' ' VAL . 27.6 m -98.0 132.34 43.64 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.565 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -96.3 120.33 36.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.317 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.1 tp -126.91 131.84 70.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.207 0.527 . . . . 0.0 110.473 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -95.41 119.91 34.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.621 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.9 mm -79.98 117.99 70.21 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 172.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.91 149.59 91.03 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.529 2.153 . . . . 0.0 112.158 -176.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 39.1 m -69.92 -17.46 63.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.341 0.591 . . . . 0.0 109.639 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.87 9.58 7.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.529 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -57.76 -46.17 84.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.167 0.508 . . . . 0.0 110.359 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.445 -0.723 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.617 174.482 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.539 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 7.9 Cg_endo . . . . . 0 C--O 1.235 0.354 0 CA-C-O 121.22 0.425 . . . . 0.0 111.906 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.41 HD23 ' H ' ' A' ' 107' ' ' LEU . 1.1 pt? -122.27 178.57 4.89 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.78 -176.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 56.51 47.34 18.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.071 0.462 . . . . 0.0 111.126 178.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.2 tp -74.05 95.94 2.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.035 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -102.65 125.36 49.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.346 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.438 HG21 HG21 ' A' ' 180' ' ' VAL . 8.1 t -110.39 118.86 58.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.904 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -128.62 145.97 50.99 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.134 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.0 p -101.9 117.71 47.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.296 0.57 . . . . 0.0 110.343 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -98.1 129.88 44.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.246 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -120.08 86.44 37.23 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.101 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.484 ' HG2' ' HG3' ' A' ' 119' ' ' ARG . 6.4 Cg_exo -76.04 164.47 31.41 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.432 2.755 . . . . 0.0 112.606 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -91.4 -36.45 13.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.384 -176.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -94.73 -51.79 4.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.712 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.484 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 10.5 ptm180 -90.77 162.52 14.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.289 177.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -79.71 152.04 74.65 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.387 -174.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.405 ' HG3' ' O ' ' A' ' 206' ' ' PHE . 28.9 Cg_endo -60.37 151.26 75.66 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.369 2.713 . . . . 0.0 113.188 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.449 ' CE2' ' HD2' ' A' ' 168' ' ' LYS . 35.7 p90 -161.58 158.67 26.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.711 -174.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 8.3 mt -82.93 139.7 33.23 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.214 173.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.56 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 10.2 t90 -118.06 94.31 4.46 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.14 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.406 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.6 mp -88.81 119.35 35.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.648 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.487 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 9.9 mtmp? -122.84 141.31 52.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.045 0.45 . . . . 0.0 110.985 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 40.2 p90 -138.45 152.06 47.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.04 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.2 t -89.09 126.16 59.89 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo . . . . . 0 C--N 1.346 0.438 0 C-N-CA 123.374 2.716 . . . . 0.0 112.803 -178.949 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 N--CA 1.454 -0.254 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -98.88 145.58 26.85 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.901 0.382 . . . . 0.0 110.334 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -102.43 148.73 25.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.567 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -132.57 133.55 43.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.832 -168.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.414 HD11 ' HB2' ' A' ' 161' ' ' ALA . 4.5 mp -126.85 120.42 55.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.877 0.37 . . . . 0.0 110.753 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.62 ' HB2' ' CZ2' ' A' ' 194' ' ' TRP . 5.4 ttp-105 -104.22 120.13 40.48 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.572 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.2 pp -143.3 159.34 42.52 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.937 0.399 . . . . 0.0 111.719 -175.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -169.54 148.33 3.35 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.305 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.472 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 35.0 Cg_endo -71.16 166.9 27.74 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.247 1.965 . . . . 0.0 112.187 172.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.514 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 11.1 pt-20 -57.98 -41.15 82.37 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.514 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 95.0 mttt -85.25 16.84 3.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.904 0.383 . . . . 0.0 111.595 -176.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.472 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -101.15 128.17 47.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.59 176.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -85.53 -34.11 21.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.269 0.557 . . . . 0.0 110.333 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -103.12 147.49 26.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.705 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.482 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 76.3 m95 -90.7 148.6 22.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.5 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -107.42 114.14 27.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.719 174.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.1 mp -91.29 112.05 24.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -106.79 148.64 28.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.253 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -109.48 123.23 49.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.62 -174.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.414 ' HB2' HD11 ' A' ' 146' ' ' ILE . . . -79.24 -51.63 9.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.615 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 82.04 79.98 0.95 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.651 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 72.6 -46.18 0.64 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.078 0.951 . . . . 0.0 112.595 175.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -66.5 148.28 52.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.003 0.43 . . . . 0.0 110.81 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 56.9 p -104.14 36.41 2.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.35 0.595 . . . . 0.0 111.308 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -157.77 140.36 14.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.186 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -131.88 149.72 52.36 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.56 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 42.1 mmtm -116.6 143.85 45.1 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 123' ' ' LEU . 29.8 mm -123.76 122.29 64.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 175.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.408 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.7 mm? -94.81 -32.82 13.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.311 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.6 m -77.96 83.81 4.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.838 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 86.9 mt -133.03 145.63 50.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.784 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -102.49 122.13 47.45 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.283 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.65 112.93 1.41 Allowed 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.468 2.112 . . . . 0.0 111.682 175.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 89.27 44.76 4.92 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.658 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -141.29 147.41 38.15 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.763 0.316 . . . . 0.0 110.17 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -91.55 137.82 32.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.469 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -125.19 140.49 52.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.023 0.44 . . . . 0.0 110.498 176.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.4 mp -104.64 132.1 51.29 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.438 HG21 HG21 ' A' ' 111' ' ' VAL . 34.5 m -135.62 147.23 28.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.948 0.404 . . . . 0.0 111.699 -175.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.591 ' HG2' ' HA ' ' A' ' 197' ' ' ALA . 53.6 mt-30 -143.46 153.28 42.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.392 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.9 p -124.67 140.44 47.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.113 0.482 . . . . 0.0 111.012 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.624 ' HG3' ' CE3' ' A' ' 194' ' ' TRP . 26.2 mtp-105 -133.34 163.99 28.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.912 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . 0.539 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 31.5 p -140.7 125.72 18.38 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 167.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.449 ' HD3' HH12 ' A' ' 183' ' ' ARG . 23.4 pttm . . . . . 0 C--N 1.318 -0.781 0 CA-C-O 121.328 0.585 . . . . 0.0 110.984 -177.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.624 ' CE3' ' HG3' ' A' ' 183' ' ' ARG . 69.0 m95 . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 120.726 0.298 . . . . 0.0 111.624 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.47 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 42.0 m -159.64 -57.58 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -176.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.487 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 9.2 Cg_endo -90.03 91.9 0.31 Allowed 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.539 2.159 . . . . 0.0 113.595 -170.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.591 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -79.48 116.55 19.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.023 0.44 . . . . 0.0 111.0 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 27.0 m -109.48 140.96 42.6 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.812 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -115.61 127.82 55.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.731 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.9 tp -125.45 135.52 63.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.033 0.444 . . . . 0.0 111.141 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -96.67 118.9 34.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.404 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.401 HD11 HD11 ' A' ' 123' ' ' LEU . 50.8 mm -84.21 119.88 73.82 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.44 151.1 86.56 Favored 'Trans proline' 0 N--CA 1.466 -0.147 0 C-N-CA 122.558 2.172 . . . . 0.0 112.251 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 19.2 m -69.94 -20.4 63.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.047 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -88.2 26.82 1.32 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.775 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.405 ' O ' ' HG3' ' A' ' 121' ' ' PRO . 85.7 t80 -66.18 -43.98 85.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.635 176.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 28.8 m . . . . . 0 C--N 1.319 -0.723 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.922 178.602 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.685 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 39.4 Cg_endo . . . . . 0 N--CA 1.461 -0.414 0 CA-C-O 121.545 0.56 . . . . 0.0 111.44 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.683 HD23 ' H ' ' A' ' 107' ' ' LEU . 2.7 pt? -90.41 175.01 7.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.675 -177.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 53.38 51.96 14.39 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 123.556 0.535 . . . . 0.0 110.888 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 57.0 tp -78.84 96.37 5.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.148 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.83 128.71 45.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.387 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.448 HG21 HG21 ' A' ' 180' ' ' VAL . 2.4 t -116.62 115.74 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -125.0 130.18 51.83 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.965 0.412 . . . . 0.0 110.786 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.5 p -77.52 117.42 22.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.2 0.524 . . . . 0.0 109.874 176.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -102.23 122.38 44.09 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.282 0.563 . . . . 0.0 111.388 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -124.91 75.82 66.31 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.753 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.47 ' HG2' ' HB2' ' A' ' 119' ' ' ARG . 6.7 Cg_exo -76.03 -179.06 4.84 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 123.38 2.72 . . . . 0.0 112.782 -175.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -89.76 -64.21 1.17 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -71.96 -36.83 69.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.442 -177.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.47 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 56.9 mtt85 -88.01 156.35 19.36 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.592 -178.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.417 ' O ' ' HD1' ' A' ' 122' ' ' TYR . 50.6 mtmt -75.35 153.56 85.98 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.04 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.25 133.76 39.26 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.329 2.019 . . . . 0.0 111.503 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.417 ' HD1' ' O ' ' A' ' 120' ' ' LYS . 55.1 p90 -151.12 166.23 31.44 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.432 -176.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.437 ' HB3' ' HB ' ' A' ' 169' ' ' ILE . 38.9 tp -95.98 123.21 39.48 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 176.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.432 ' HE1' ' HB2' ' A' ' 166' ' ' GLU . 17.5 t90 -103.24 106.68 17.25 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.221 -176.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.4 mp -106.28 118.36 53.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.708 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -131.54 141.45 49.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.48 0.657 . . . . 0.0 111.24 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . 0.492 ' CH2' HD11 ' A' ' 146' ' ' ILE . 28.7 p90 -129.07 155.44 45.44 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.439 -176.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 22.6 t -83.36 130.53 56.17 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 128' ' ' SER . 50.4 Cg_exo . . . . . 0 C--N 1.346 0.432 0 C-N-CA 123.045 2.497 . . . . 0.0 112.492 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.596 HD11 ' H ' ' A' ' 185' ' ' LYS . 42.2 tp . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 120.967 0.413 . . . . 0.0 110.463 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.6 mp -106.18 144.8 32.37 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.557 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -113.61 165.31 12.64 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.151 -176.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.467 ' HB3' ' NE ' ' A' ' 183' ' ' ARG . 40.3 tt0 -154.07 139.37 17.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.527 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.531 ' CD1' ' HB2' ' A' ' 161' ' ' ALA . 4.3 mp -121.92 130.19 74.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.042 0.449 . . . . 0.0 110.968 -172.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.476 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 27.8 ttp180 -108.18 121.15 44.26 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 1.7 pp -146.98 166.0 28.13 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.9 0.381 . . . . 0.0 111.413 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -172.45 149.89 2.13 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.751 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.35 162.45 42.34 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.34 2.026 . . . . 0.0 111.153 172.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -67.31 -14.53 63.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.546 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -93.93 2.97 56.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.289 0.566 . . . . 0.0 110.06 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -102.76 130.93 49.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.272 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -88.22 -35.85 17.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.24 0.543 . . . . 0.0 110.315 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -95.84 150.44 20.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.333 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.476 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 84.3 m95 -85.91 148.02 25.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.238 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -115.82 119.23 35.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.947 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.0 mp -99.05 131.68 45.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.103 0.478 . . . . 0.0 110.847 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -125.54 126.41 44.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.976 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -83.28 124.79 30.93 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.531 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -82.3 -36.43 27.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.895 0.379 . . . . 0.0 111.286 -176.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 88.34 -136.97 14.08 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.487 -0.863 . . . . 0.0 110.965 -175.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -99.85 70.99 1.65 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.088 0.47 . . . . 0.0 110.353 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -160.24 147.17 15.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.821 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.2 p -102.43 13.62 34.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.35 0.595 . . . . 0.0 111.074 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.432 ' HB2' ' HE1' ' A' ' 124' ' ' TRP . 1.0 OUTLIER -140.08 113.41 8.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.89 175.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -109.03 152.08 25.48 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.519 -173.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 168' ' ' LYS . 10.4 mptt -123.23 129.11 50.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.276 -176.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.437 ' HB ' ' HB3' ' A' ' 123' ' ' LEU . 28.9 mm -108.54 137.58 39.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 175.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.77 -23.18 12.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.997 0.427 . . . . 0.0 110.58 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 7.0 m -87.17 67.5 9.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.78 -175.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.01 140.43 39.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.968 0.413 . . . . 0.0 110.887 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 32.5 m-70 -103.74 115.81 62.86 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.474 173.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 35.8 Cg_exo -59.02 126.09 20.06 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.822 2.348 . . . . 0.0 112.878 -177.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 88.86 29.45 18.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.752 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -133.95 145.51 49.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.095 0.474 . . . . 0.0 110.734 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -82.44 132.05 35.21 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.441 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -114.71 136.7 52.78 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.872 0.368 . . . . 0.0 110.532 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.9 mm? -101.36 129.26 47.32 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 174.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.448 HG21 HG21 ' A' ' 111' ' ' VAL . 35.8 m -125.24 141.7 44.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.176 0.512 . . . . 0.0 111.655 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 94.4 mt-30 -144.59 134.06 23.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.959 177.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 6.5 p -117.71 135.73 57.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.467 ' NE ' ' HB3' ' A' ' 145' ' ' GLU . 7.8 ppt_? -116.12 155.73 27.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.83 0.348 . . . . 0.0 110.731 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . 0.685 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 26.4 p -136.77 175.26 9.78 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.794 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.596 ' H ' HD11 ' A' ' 142' ' ' LEU . 37.1 mtmt . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.337 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.404 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 29.9 m95 . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.516 0.198 . . . . 0.0 110.56 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.495 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 36.4 t -116.0 -59.67 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 195' ' ' SER . 95.4 Cg_endo -76.8 87.37 1.48 Allowed 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.857 1.705 . . . . 0.0 113.397 -173.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.61 101.75 5.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.101 0.477 . . . . 0.0 109.927 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 18.6 m -91.03 131.26 36.73 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.917 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -94.33 132.46 38.91 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.458 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.653 HG12 ' N ' ' A' ' 201' ' ' GLN . 0.0 OUTLIER -147.49 150.24 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.367 0.603 . . . . 0.0 111.297 174.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.653 ' N ' HG12 ' A' ' 200' ' ' ILE . 7.6 mm-40 -91.81 136.01 33.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.741 176.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 49.0 mm -100.89 114.75 65.83 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 165.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.64 148.95 79.51 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.905 2.403 . . . . 0.0 112.555 -175.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 17.1 m -69.79 -23.98 63.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.856 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -92.21 32.92 1.11 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.202 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -65.93 -32.44 73.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.135 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 C--N 1.321 -0.637 0 CA-C-O 121.119 0.485 . . . . 0.0 110.662 -178.829 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.486 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 7.1 Cg_endo . . . . . 0 C--O 1.233 0.24 0 CA-C-O 121.18 0.409 . . . . 0.0 111.692 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.517 HD23 ' H ' ' A' ' 107' ' ' LEU . 2.7 pt? -73.15 163.02 28.74 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.384 -173.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 60.61 54.46 3.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.382 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -75.58 93.92 3.1 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -97.21 131.46 43.92 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.407 -176.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.467 HG12 HD22 ' A' ' 123' ' ' LEU . 2.6 t -120.57 114.39 43.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -129.39 140.36 51.37 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.367 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.9 p -87.16 115.56 28.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.413 0.625 . . . . 0.0 109.351 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.515 ' O ' ' HD3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -102.06 113.2 26.24 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.4 -174.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -105.49 98.89 18.4 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.316 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 114' ' ' LYS . 5.5 Cg_exo -80.79 146.08 16.36 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.295 2.663 . . . . 0.0 112.092 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.0 -23.99 58.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.831 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -118.15 3.27 12.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.774 0.321 . . . . 0.0 111.376 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -137.86 151.64 48.26 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' A' ' 120' ' ' LYS . 12.7 mptt -63.42 139.04 97.52 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.236 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.18 145.12 98.78 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.476 2.784 . . . . 0.0 112.752 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.524 ' CE1' ' HD2' ' A' ' 168' ' ' LYS . 35.4 p90 -149.28 155.04 39.93 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.26 -176.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 9.3 mt -80.43 127.41 32.38 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 173.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.569 ' CZ2' ' HD2' ' A' ' 126' ' ' LYS . 14.4 t90 -101.69 102.18 12.8 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.789 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.5 mp -93.62 114.27 29.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.569 ' HD2' ' CZ2' ' A' ' 124' ' ' TRP . 64.1 tttm -127.84 126.56 41.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.568 -175.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 39.9 p90 -126.04 158.98 33.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.338 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.451 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 37.7 m -99.61 131.74 24.26 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.195 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.567 ' HG3' HG21 ' A' ' 165' ' ' THR . 33.5 Cg_exo . . . . . 0 C--O 1.233 0.267 0 C-N-CA 122.664 2.243 . . . . 0.0 111.725 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.524 HD21 ' SG ' ' A' ' 184' ' ' CYS . 56.7 tp . . . . . 0 C--O 1.233 0.189 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -93.88 152.7 18.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.035 0.445 . . . . 0.0 111.141 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.596 ' CD1' ' HB3' ' A' ' 184' ' ' CYS . 63.7 m-85 -129.78 149.84 51.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.012 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -128.73 139.7 52.09 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.404 HD11 ' HB2' ' A' ' 161' ' ' ALA . 4.0 mp -113.42 124.34 69.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.847 0.356 . . . . 0.0 110.448 -176.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.514 ' HB2' ' CZ2' ' A' ' 194' ' ' TRP . 16.3 ttp180 -113.76 120.18 39.91 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.414 ' C ' HD22 ' A' ' 148' ' ' LEU . 0.0 OUTLIER -143.42 160.22 40.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.542 0.211 . . . . 0.0 110.786 -177.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -165.23 148.65 7.21 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.241 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 178' ' ' TYR . 56.9 Cg_endo -73.47 169.37 22.47 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.57 2.18 . . . . 0.0 111.946 172.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -68.9 -11.54 60.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.667 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -93.76 -1.57 54.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.289 0.566 . . . . 0.0 110.004 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -100.19 122.6 43.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.771 -173.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -84.45 -28.38 26.87 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.562 0.696 . . . . 0.0 109.437 173.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -106.85 146.32 31.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.173 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.476 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 80.0 m95 -86.69 155.22 20.47 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.08 0.466 . . . . 0.0 111.582 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -111.62 127.39 55.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.74 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.87 126.99 67.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.164 0.507 . . . . 0.0 111.222 -176.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -125.26 137.98 54.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -96.57 138.21 34.49 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.404 ' HB2' HD11 ' A' ' 146' ' ' ILE . . . -77.4 -23.16 50.73 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.514 -177.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 83.86 -46.06 3.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.994 177.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -179.52 -33.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.128 0.489 . . . . 0.0 109.895 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -72.28 160.08 32.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.385 -177.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.567 HG21 ' HG3' ' A' ' 129' ' ' PRO . 67.5 p -110.03 30.33 6.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.401 -174.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -153.19 140.6 19.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.711 175.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -135.65 153.25 51.69 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.672 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 22.5 mmtt -118.86 140.98 49.07 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 31.8 mm -114.89 123.79 70.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.691 0.281 . . . . 0.0 110.561 176.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.479 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.8 mm? -95.72 -16.76 21.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.5 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.8 m -80.8 71.15 7.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.709 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 59.4 mt -129.63 137.22 50.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.98 0.419 . . . . 0.0 111.34 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -111.7 125.19 30.8 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.263 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.84 122.52 11.35 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.742 2.295 . . . . 0.0 112.46 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 95.43 22.26 22.34 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.749 177.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -131.24 148.73 52.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.935 0.398 . . . . 0.0 110.895 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -90.26 134.18 34.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.116 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 150' ' ' PRO . 12.1 m-85 -119.9 149.59 41.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.021 0.438 . . . . 0.0 110.652 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.9 mp -112.49 136.21 52.27 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.3 m -132.6 148.12 31.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.056 0.455 . . . . 0.0 111.372 -177.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 93.2 mt-30 -150.29 144.33 25.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.384 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.459 HG13 ' HG2' ' A' ' 106' ' ' PRO . 12.0 p -138.83 145.01 28.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 171.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -155.53 161.22 40.93 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.223 0.535 . . . . 0.0 110.182 171.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . 0.596 ' HB3' ' CD1' ' A' ' 144' ' ' TYR . 5.7 p -116.69 -174.45 2.57 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.077 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.412 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.955 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.514 ' CZ2' ' HB2' ' A' ' 147' ' ' ARG . 61.8 m95 . . . . . 0 C--O 1.236 0.346 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.424 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 50.7 m -156.07 -53.89 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.539 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 1.1 Cg_endo -82.95 81.27 2.44 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.128 1.886 . . . . 0.0 113.057 -173.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.409 ' HA ' ' CG ' ' A' ' 181' ' ' GLN . . . -82.83 103.94 12.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.115 0.484 . . . . 0.0 110.66 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 53.9 m -96.7 138.06 34.83 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.257 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -102.76 130.87 49.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.495 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.2 tp -135.91 137.09 49.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.207 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -102.46 147.05 27.22 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.93 0.395 . . . . 0.0 111.566 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 21.8 mm -96.47 118.16 65.52 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.789 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.51 153.28 72.35 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.968 2.445 . . . . 0.0 112.11 -177.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 28.0 m -70.81 -23.03 62.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.889 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -94.2 34.56 1.25 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.643 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -69.66 -50.97 38.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.838 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 6.4 t . . . . . 0 C--N 1.324 -0.502 0 CA-C-O 121.371 0.605 . . . . 0.0 111.098 -176.869 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.478 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 35.8 Cg_exo . . . . . 0 C--O 1.233 0.263 0 CA-C-O 120.867 0.278 . . . . 0.0 111.672 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.462 HD23 ' H ' ' A' ' 107' ' ' LEU . 1.6 pt? -122.3 -179.45 4.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.427 -172.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 54.78 41.22 32.08 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 123.576 0.548 . . . . 0.0 110.731 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.6 tt -64.53 103.97 0.74 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.792 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -109.74 132.42 54.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.705 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.3 t -114.42 126.35 71.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.84 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -126.52 132.61 51.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.947 0.404 . . . . 0.0 110.615 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.8 p -87.22 126.36 41.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.1 0.476 . . . . 0.0 110.196 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 114' ' ' LYS . 55.1 mmtt -106.68 127.29 53.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.032 0.444 . . . . 0.0 110.957 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -132.94 85.09 47.22 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.158 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.71 168.7 22.99 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.982 2.455 . . . . 0.0 111.5 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.17 -6.24 23.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.859 0.362 . . . . 0.0 111.354 -177.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -132.88 2.62 3.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.481 0.658 . . . . 0.0 110.534 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -136.82 149.14 47.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.531 -176.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -56.97 130.63 79.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 O-C-N 123.513 0.508 . . . . 0.0 111.289 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.27 137.04 63.41 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.573 2.182 . . . . 0.0 111.361 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -140.9 163.89 31.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.468 -175.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.417 ' HB3' ' HB ' ' A' ' 169' ' ' ILE . 28.0 tp -100.19 124.99 46.26 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.457 ' CZ2' ' HD3' ' A' ' 126' ' ' LYS . 25.9 t90 -107.49 115.94 31.05 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.418 -177.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.4 mp -101.06 122.55 53.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.735 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.457 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 39.7 ttpt -129.72 120.36 24.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.189 0.519 . . . . 0.0 110.555 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . 0.45 ' CE2' HG21 ' A' ' 182' ' ' VAL . 40.3 p90 -116.28 160.78 19.98 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.931 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.3 m -95.61 129.37 34.86 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo . . . . . 0 C--O 1.233 0.271 0 C-N-CA 122.905 2.404 . . . . 0.0 111.945 -178.884 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 41.8 tp . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.6 mp -99.84 143.19 30.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.01 0.434 . . . . 0.0 110.872 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -115.3 133.78 55.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.662 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -116.75 139.35 50.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 181' ' ' GLN . 4.7 mp -120.26 119.72 60.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.088 0.47 . . . . 0.0 110.859 -176.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.422 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 21.4 ttp180 -104.18 121.68 43.78 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.533 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.2 pp -143.88 162.75 35.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.678 0.275 . . . . 0.0 111.316 -176.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -171.51 150.42 2.71 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.416 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.474 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 45.6 Cg_endo -72.16 156.37 55.57 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.096 1.864 . . . . 0.0 110.904 170.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -61.95 -18.57 60.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.246 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -91.62 -3.85 55.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.984 0.421 . . . . 0.0 110.553 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.474 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -87.6 127.12 35.27 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.099 -177.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.72 -14.27 52.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.285 0.564 . . . . 0.0 110.475 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -119.95 139.02 53.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.794 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.422 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 78.2 m95 -81.4 147.98 29.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.354 177.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -116.08 117.62 30.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.279 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mp -93.05 123.18 45.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.392 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 59.8 m-70 -119.04 155.87 30.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.524 176.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -122.6 129.79 52.29 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.518 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -97.88 -34.74 10.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.943 0.401 . . . . 0.0 110.953 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.58 -140.93 15.24 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.49 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -91.67 52.99 2.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.211 0.529 . . . . 0.0 109.906 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -150.1 149.92 30.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.329 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.422 ' HA ' ' CE2' ' A' ' 127' ' ' TRP . 61.3 p -101.4 33.08 3.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.954 -174.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -146.59 134.09 20.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.975 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 39.9 t80 -136.89 149.33 47.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.105 176.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.97 140.84 49.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.945 0.402 . . . . 0.0 111.224 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' A' ' 123' ' ' LEU . 34.7 mm -117.67 136.41 54.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.886 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -103.84 -23.85 13.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.833 0.349 . . . . 0.0 110.67 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 69.5 m -89.54 80.53 6.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.867 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.7 mm? -116.57 132.16 56.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.982 0.42 . . . . 0.0 110.691 176.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 52.9 m170 -100.09 118.62 61.17 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.657 176.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 32.5 Cg_exo -57.02 118.46 5.33 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.875 2.383 . . . . 0.0 112.813 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 97.22 5.64 58.06 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.96 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -109.03 151.4 26.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.157 0.503 . . . . 0.0 110.66 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.441 ' HE3' ' HB3' ' A' ' 199' ' ' PHE . 37.8 tttp -93.51 136.72 33.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.07 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -120.88 139.42 53.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.879 0.371 . . . . 0.0 110.21 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.7 mp -104.08 126.06 50.9 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.9 m -123.76 139.15 51.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.117 0.484 . . . . 0.0 111.312 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.533 ' HG3' ' HA ' ' A' ' 197' ' ' ALA . 0.0 OUTLIER -141.63 134.64 29.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.14 179.415 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.45 HG21 ' CE2' ' A' ' 127' ' ' TRP . 7.8 p -129.45 137.65 56.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -143.39 149.56 37.85 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . 0.478 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 28.3 p -118.21 158.85 24.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.638 -174.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt . . . . . 0 C--N 1.328 -0.365 0 CA-C-O 121.137 0.494 . . . . 0.0 111.279 -178.856 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 80.4 m95 . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.613 ' H ' ' HD2' ' A' ' 196' ' ' PRO . 20.0 m -137.02 -57.88 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.569 0 CA-C-O 119.242 -0.409 . . . . 0.0 111.947 -177.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.613 ' HD2' ' H ' ' A' ' 195' ' ' SER . 59.3 Cg_endo -71.42 83.06 1.05 Allowed 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.627 1.551 . . . . 0.0 112.874 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.533 ' HA ' ' HG3' ' A' ' 181' ' ' GLN . . . -88.24 115.14 25.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.143 0.497 . . . . 0.0 110.662 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 85.7 m -107.12 138.39 43.39 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.053 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.441 ' HB3' ' HE3' ' A' ' 177' ' ' LYS . 62.1 m-85 -106.61 140.04 40.11 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.347 -176.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.9 tp -136.54 134.06 49.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.147 0.499 . . . . 0.0 110.533 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.413 ' HA ' HE21 ' A' ' 201' ' ' GLN . 0.0 OUTLIER -101.81 123.1 45.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.25 177.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.9 mm -79.34 123.52 84.51 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.96 149.63 87.85 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.904 2.402 . . . . 0.0 112.371 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 13.3 m -66.03 -26.48 67.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.94 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -91.91 27.78 2.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.55 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 82.6 t80 -62.71 -46.93 85.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.137 0.494 . . . . 0.0 110.433 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 C--N 1.32 -0.674 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.9 177.774 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo . . . . . 0 N--CA 1.449 -1.116 0 CA-C-O 121.009 0.337 . . . . 0.0 111.412 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.5 mp -91.52 178.24 6.0 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.835 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 128' ' ' SER . 39.6 mt-10 50.2 47.41 23.68 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 124.839 1.337 . . . . 0.0 111.727 165.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.2 tp -64.86 112.94 3.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.92 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -114.16 128.12 56.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.407 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.497 HG12 HD22 ' A' ' 123' ' ' LEU . 4.5 t -116.44 126.34 73.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.82 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -141.38 126.44 18.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.913 0.387 . . . . 0.0 110.609 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.31 133.96 28.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.318 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -124.19 117.71 25.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.356 0.598 . . . . 0.0 111.088 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.454 ' NE2' ' HA ' ' A' ' 206' ' ' PHE . 46.6 mt-30 -108.59 99.64 34.52 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.476 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.1 -83.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.769 2.313 . . . . 0.0 112.66 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -175.17 -77.44 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 120.704 0.288 . . . . 0.0 110.64 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -87.27 -34.89 18.76 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -66.92 134.79 52.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.923 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -58.35 135.11 85.15 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.004 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.435 ' HB3' ' HG2' ' A' ' 115' ' ' GLN . 28.1 Cg_endo -62.12 140.37 83.5 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.654 2.236 . . . . 0.0 111.367 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.518 ' CE2' ' HD2' ' A' ' 168' ' ' LYS . 23.2 p90 -144.03 155.85 44.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.064 0.459 . . . . 0.0 111.594 -172.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.497 HD22 HG12 ' A' ' 111' ' ' VAL . 6.6 mt -83.12 130.51 35.12 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.839 172.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -107.91 106.65 17.01 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.706 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 166' ' ' GLU . 4.0 mp -100.88 131.17 49.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.776 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -138.87 156.72 47.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.965 0.412 . . . . 0.0 110.577 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 20.1 p90 -143.53 156.21 44.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.911 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 15.0 m -114.22 105.38 54.12 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.076 -178.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo . . . . . 0 C--O 1.235 0.343 0 C-N-CA 122.496 2.13 . . . . 0.0 111.033 173.824 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.437 HD11 ' H ' ' A' ' 185' ' ' LYS . 55.5 tp . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.984 0.421 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.3 mp -89.4 139.84 30.11 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.786 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -114.49 149.68 35.98 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.914 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -133.22 133.42 42.71 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.37 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.2 mp -113.72 131.5 65.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.749 0.309 . . . . 0.0 110.632 -174.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.506 ' HB2' ' CH2' ' A' ' 194' ' ' TRP . 18.6 ttp180 -118.23 120.18 36.92 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.421 ' C ' HD22 ' A' ' 148' ' ' LEU . 0.0 OUTLIER -145.58 160.41 41.7 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.798 -178.128 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -169.72 147.66 3.06 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.532 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.426 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 39.3 Cg_endo -70.08 167.37 25.04 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.102 1.868 . . . . 0.0 111.789 173.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -61.78 -29.65 70.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.221 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -86.53 7.03 27.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -177.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.426 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -94.72 130.95 41.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.113 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -87.32 -26.63 23.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.842 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -123.69 150.08 44.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.294 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.454 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 77.6 m95 -82.34 145.83 29.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.542 -177.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 148' ' ' LEU . 43.2 mt-10 -98.71 118.96 36.62 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.445 175.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mp -98.16 116.18 40.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -119.84 114.66 22.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.12 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -81.28 133.68 35.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.854 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -101.11 -51.64 3.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.876 0.37 . . . . 0.0 111.481 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 127.59 -142.39 13.47 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -175.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.3 20.3 11.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.322 0.561 . . . . 0.0 111.127 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -103.41 143.75 32.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.806 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 38.8 p -96.48 36.49 1.36 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.039 0.447 . . . . 0.0 111.787 -175.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 125' ' ' ILE . 9.2 pt-20 -156.45 145.04 20.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.177 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -140.71 151.2 44.33 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.518 ' HD2' ' CE2' ' A' ' 122' ' ' TYR . 45.8 mmtt -116.41 137.67 51.97 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 41.0 mm -112.74 120.83 63.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 175.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.483 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.9 mm? -89.71 -38.96 13.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 -177.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 50.4 m -76.72 84.5 3.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.066 0.46 . . . . 0.0 111.206 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 90.2 mt -126.38 133.21 51.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.75 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -102.49 124.57 38.87 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.031 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.44 124.8 15.86 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.656 2.237 . . . . 0.0 112.387 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 88.16 27.56 25.38 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.549 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -126.82 146.95 50.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.027 0.442 . . . . 0.0 111.038 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -85.42 131.71 34.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.577 177.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -121.13 136.17 55.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.888 0.375 . . . . 0.0 110.471 176.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 8.5 mp -103.65 126.62 50.91 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.428 HG21 HG21 ' A' ' 111' ' ' VAL . 27.3 m -123.2 142.71 38.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.147 0.499 . . . . 0.0 111.813 -177.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.557 ' NE2' ' HB2' ' A' ' 197' ' ' ALA . 89.4 mt-30 -143.25 157.91 44.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.899 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.46 144.39 24.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.142 178.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.657 ' HG2' ' CZ3' ' A' ' 194' ' ' TRP . 1.9 ptm180 -138.82 175.6 9.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.213 0.53 . . . . 0.0 110.673 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 10.6 p -160.78 -172.66 3.59 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.369 176.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.437 ' H ' HD11 ' A' ' 142' ' ' LEU . 17.7 ptmt . . . . . 0 C--N 1.324 -0.515 0 CA-C-O 121.199 0.523 . . . . 0.0 111.176 177.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.657 ' CZ3' ' HG2' ' A' ' 183' ' ' ARG . 14.4 m95 . . . . . 0 C--O 1.233 0.236 0 CA-C-O 120.577 0.227 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.552 ' OG ' ' HD3' ' A' ' 196' ' ' PRO . 3.5 p -103.75 -50.59 0.14 Allowed Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.552 ' HD3' ' OG ' ' A' ' 195' ' ' SER . 4.7 Cg_exo -78.97 80.53 3.06 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.085 1.857 . . . . 0.0 113.078 -173.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.557 ' HB2' ' NE2' ' A' ' 181' ' ' GLN . . . -83.96 101.08 11.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.324 0.583 . . . . 0.0 110.104 176.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 25.2 m -95.97 131.45 42.33 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.605 -176.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -95.58 114.82 26.61 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.571 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.3 tp -118.23 134.92 60.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.056 0.455 . . . . 0.0 110.153 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -102.37 134.78 45.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.987 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 40.4 mm -92.16 116.48 66.54 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.614 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.97 150.24 84.89 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.557 2.171 . . . . 0.0 112.074 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 30.2 p -67.84 -18.21 64.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.596 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -86.18 10.24 15.13 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.636 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.454 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 57.5 t80 -64.71 -37.98 89.42 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 173.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 C--N 1.321 -0.658 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.134 176.653 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 C--O 1.235 0.346 0 CA-C-O 121.301 0.459 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 pp -122.77 178.92 4.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.76 -175.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 53.07 46.17 27.26 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 123.659 0.599 . . . . 0.0 110.702 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.7 tp -70.28 99.17 1.49 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.909 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.94 130.22 46.09 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.342 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.464 HG21 HG21 ' A' ' 180' ' ' VAL . 6.1 t -123.8 127.07 73.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.812 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -143.41 159.17 42.88 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.976 0.417 . . . . 0.0 110.848 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.79 129.65 60.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.408 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -111.28 132.92 54.0 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -122.52 83.72 47.7 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.832 0.349 . . . . 0.0 111.448 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -83.43 163.78 14.7 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.334 2.689 . . . . 0.0 111.376 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -97.62 -31.09 12.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.078 0.466 . . . . 0.0 111.006 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -86.37 -22.12 26.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.615 0.722 . . . . 0.0 109.965 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -123.07 135.47 54.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.064 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -56.66 134.71 78.03 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -49.79 141.12 28.79 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.419 2.746 . . . . 0.0 112.445 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -144.55 162.22 37.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.931 -173.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.485 ' HB2' HD11 ' A' ' 172' ' ' LEU . 31.4 tp -95.77 128.49 42.69 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.582 176.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -105.75 114.37 28.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.373 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.3 mp -104.29 120.9 55.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -128.94 128.67 44.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.096 0.474 . . . . 0.0 110.913 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . 0.455 ' CH2' HD11 ' A' ' 146' ' ' ILE . 32.6 p90 -121.41 160.79 23.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.907 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.3 t -123.74 123.66 26.25 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.459 -0.521 0 C-N-CA 122.326 2.017 . . . . 0.0 111.181 175.478 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.4 pt? . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 121.435 0.636 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 56.4 mt -91.95 149.58 21.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.688 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -108.0 150.61 26.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.245 0.545 . . . . 0.0 111.575 -174.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -140.91 130.12 23.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.171 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.3 mp -110.73 129.12 66.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.962 0.41 . . . . 0.0 110.82 -173.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.497 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 15.9 ttp180 -111.15 120.08 41.11 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -146.22 161.11 40.98 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.621 0.248 . . . . 0.0 110.969 -177.384 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -167.84 147.46 4.3 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.684 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.446 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 38.7 Cg_endo -71.96 178.01 6.4 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.411 2.074 . . . . 0.0 112.339 172.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.453 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 11.0 pt-20 -70.5 -30.84 67.74 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -176.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.453 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 88.5 mttt -91.67 13.01 19.25 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.152 0.501 . . . . 0.0 110.825 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.446 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -98.71 119.79 38.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.719 178.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.79 -32.47 35.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.324 0.583 . . . . 0.0 110.43 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -101.28 156.99 17.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.604 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.497 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 81.5 m95 -96.15 139.93 31.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.076 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -94.97 115.14 27.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.54 175.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.69 119.02 40.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.516 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 34.8 m-70 -120.14 108.14 13.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.193 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -75.24 126.0 30.12 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -93.51 -43.43 8.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.017 0.437 . . . . 0.0 110.985 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 102.95 -134.94 12.03 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.098 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -94.97 60.95 2.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.267 0.556 . . . . 0.0 110.138 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -156.81 146.28 20.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.117 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 44.0 p -103.22 37.37 2.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.182 0.515 . . . . 0.0 111.26 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -149.09 140.96 23.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.936 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.516 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 22.0 t80 -142.09 145.18 34.0 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 174.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 0.7 OUTLIER -119.17 129.85 55.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.776 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 35.8 mm -101.46 126.46 55.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 174.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -100.16 -30.78 11.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.724 0.297 . . . . 0.0 110.763 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 13.3 m -79.65 81.44 5.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.466 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 123' ' ' LEU . 74.1 mt -126.36 140.97 52.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.954 0.407 . . . . 0.0 111.367 -176.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 13.7 m-70 -112.55 131.19 22.77 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.222 175.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 27.6 Cg_exo -61.11 130.01 30.81 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.608 2.205 . . . . 0.0 112.13 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.64 26.77 60.27 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.275 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.433 ' HB3' ' CE1' ' A' ' 178' ' ' TYR . 0.6 OUTLIER -115.4 138.23 51.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.763 0.316 . . . . 0.0 110.23 179.003 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -82.71 129.9 35.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.365 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 176' ' ' GLN . 66.5 m-85 -121.06 140.19 52.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.872 0.368 . . . . 0.0 110.311 177.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.7 mm? -107.78 129.38 55.05 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.464 HG21 HG21 ' A' ' 111' ' ' VAL . 29.4 m -127.46 138.08 55.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.059 0.457 . . . . 0.0 111.945 -175.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.513 ' OE1' ' HB3' ' A' ' 194' ' ' TRP . 78.6 mt-30 -144.0 153.2 41.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.727 177.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.19 137.99 45.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.888 0.375 . . . . 0.0 110.759 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.478 ' HD2' ' C ' ' A' ' 183' ' ' ARG . 6.1 ppt_? -126.45 164.02 22.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.127 177.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 20.1 p -146.69 175.34 10.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.003 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 C--N 1.325 -0.48 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 173.447 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.513 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 70.5 m95 . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.683 ' H ' ' HD2' ' A' ' 196' ' ' PRO . 20.3 m -137.21 -54.01 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.683 ' HD2' ' H ' ' A' ' 195' ' ' SER . 66.4 Cg_endo -74.25 82.99 1.73 Allowed 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 121.686 1.59 . . . . 0.0 113.208 -175.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.43 ' HB2' ' NE2' ' A' ' 181' ' ' GLN . . . -82.3 104.03 12.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.805 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 34.7 m -95.21 135.79 36.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.738 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -98.72 119.48 37.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.068 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.3 tp -125.71 138.56 54.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.026 0.441 . . . . 0.0 110.627 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -106.78 140.86 38.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.361 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 41.0 mm -96.87 124.51 49.81 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.837 177.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.0 149.12 81.64 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.853 2.369 . . . . 0.0 112.04 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 3.0 p -75.24 -15.19 60.55 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.856 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -95.99 18.07 14.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.084 175.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -55.47 -60.58 3.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.27 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.7 m . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.144 179.7 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.511 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 9.7 Cg_endo . . . . . 0 C--O 1.232 0.189 0 CA-C-O 120.843 0.268 . . . . 0.0 111.446 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.86 175.34 6.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.485 -172.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 55.97 47.13 20.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.849 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.6 tp -68.92 98.9 0.99 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.631 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.63 130.39 41.11 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.457 -176.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -125.13 120.41 58.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.087 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -138.0 157.7 45.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.723 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.3 p -107.53 131.19 58.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.136 0.493 . . . . 0.0 110.295 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -103.04 123.88 47.46 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -123.38 80.36 53.39 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.006 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.466 ' HG2' ' HB2' ' A' ' 119' ' ' ARG . 1.0 OUTLIER -86.69 163.86 9.2 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.562 2.841 . . . . 0.0 111.798 177.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -97.45 -30.27 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.054 0.454 . . . . 0.0 111.169 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -93.76 -25.48 17.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.434 0.635 . . . . 0.0 110.177 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.466 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 23.3 mmt180 -110.91 151.74 27.55 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 175.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -73.78 138.3 76.82 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.63 132.93 55.04 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.946 2.431 . . . . 0.0 111.804 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.445 ' CD2' ' HD2' ' A' ' 168' ' ' LYS . 53.1 p90 -145.8 157.62 43.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.974 0.416 . . . . 0.0 110.957 -174.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.453 ' HB3' ' HB ' ' A' ' 169' ' ' ILE . 26.3 tp -91.21 131.17 36.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.624 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.558 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 12.4 t90 -110.47 109.38 19.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.207 -175.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.2 mp -108.05 123.37 63.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.082 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -123.23 148.42 45.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.834 0.35 . . . . 0.0 110.622 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -138.87 152.2 47.6 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.916 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 m -113.26 138.02 22.24 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.705 -175.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo . . . . . 0 C--N 1.346 0.445 0 C-N-CA 122.945 2.43 . . . . 0.0 111.556 175.767 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 29.7 tp . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.699 HD11 ' HG2' ' A' ' 163' ' ' GLN . 8.3 mp -98.01 153.28 18.49 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.848 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.543 ' CD2' ' HB3' ' A' ' 184' ' ' CYS . 75.2 m-85 -128.99 147.56 50.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.301 -173.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -128.12 139.82 52.29 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.3 mp -117.44 129.52 73.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.039 0.447 . . . . 0.0 110.718 -175.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.481 HH22 ' NE2' ' A' ' 181' ' ' GLN . 7.7 ttp-105 -112.67 120.4 41.42 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.551 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -143.69 160.38 40.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.463 0.173 . . . . 0.0 110.821 -177.266 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -165.96 151.76 8.2 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.395 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.507 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 37.1 Cg_endo -70.54 157.12 59.8 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.52 2.147 . . . . 0.0 110.923 170.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.526 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 14.9 pt-20 -62.51 -27.64 69.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.473 -0.785 . . . . 0.0 113.013 -170.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.526 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 82.4 mttt -94.09 9.29 38.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.091 0.472 . . . . 0.0 110.777 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.507 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -90.21 131.71 35.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.263 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.96 -35.35 24.04 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.97 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -103.66 159.98 15.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.273 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.429 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 60.0 m95 -101.04 156.23 17.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.652 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -102.79 120.97 41.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.194 173.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.54 117.84 47.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.948 177.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -124.55 124.58 42.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.924 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -89.48 126.1 35.44 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.047 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.401 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -83.96 -47.67 10.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.159 0.504 . . . . 0.0 110.88 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.419 ' C ' ' HG ' ' A' ' 143' ' ' LEU . . . 107.57 -128.49 9.21 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.805 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.699 ' HG2' HD11 ' A' ' 143' ' ' LEU . 34.4 mt-30 -94.76 5.59 51.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.25 0.548 . . . . 0.0 110.464 -175.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -95.94 142.74 27.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.534 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.451 HG22 ' CE1' ' A' ' 144' ' ' TYR . 61.9 p -101.63 23.98 10.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.459 0.647 . . . . 0.0 111.0 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -148.69 137.74 21.61 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -130.1 149.52 51.78 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.71 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.558 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 42.5 mmtm -114.69 135.85 53.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.593 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 123' ' ' LEU . 31.9 mm -109.86 136.32 46.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 172.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -102.29 -31.39 10.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.925 0.393 . . . . 0.0 110.852 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 44.0 m -89.33 80.95 6.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.652 -177.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.8 mm? -112.97 131.23 55.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.978 174.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -88.68 116.84 67.42 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.542 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.42 116.09 3.18 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.577 2.185 . . . . 0.0 112.066 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 108.27 -2.05 33.02 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.992 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -110.22 144.27 39.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.447 0.641 . . . . 0.0 111.766 -175.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -85.29 128.75 34.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.877 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -109.98 146.65 34.9 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.077 0.465 . . . . 0.0 110.886 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.8 mp -111.17 127.83 55.71 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.88 142.99 40.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.913 0.387 . . . . 0.0 111.447 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.595 ' HG2' ' HA ' ' A' ' 197' ' ' ALA . 62.4 mt-30 -143.41 139.19 29.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.574 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 12.6 p -125.65 141.18 46.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.803 0.335 . . . . 0.0 110.165 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -136.82 150.99 48.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.005 0.431 . . . . 0.0 110.639 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . 0.543 ' HB3' ' CD2' ' A' ' 144' ' ' TYR . 18.5 p -128.89 155.98 44.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.947 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt . . . . . 0 C--N 1.328 -0.358 0 CA-C-O 121.399 0.619 . . . . 0.0 112.415 -172.726 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.532 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 44.6 m95 . . . . . 0 C--O 1.233 0.201 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.563 ' OG ' ' HD3' ' A' ' 196' ' ' PRO . 13.9 p -168.16 -50.07 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -177.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.563 ' HD3' ' OG ' ' A' ' 195' ' ' SER . 94.8 Cg_endo -85.46 86.73 1.02 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 121.69 1.593 . . . . 0.0 113.516 -171.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.595 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -83.76 114.17 21.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.146 0.498 . . . . 0.0 111.505 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 86.2 m -106.07 139.56 40.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.022 175.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -104.09 148.69 25.97 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.384 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.8 tp -154.29 134.56 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.248 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -97.58 125.53 42.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.681 0.277 . . . . 0.0 110.276 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 44.6 mm -80.59 117.7 69.04 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -59.07 145.69 96.81 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.551 2.167 . . . . 0.0 111.874 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 26.8 m -70.1 -8.22 47.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.474 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.71 -15.24 60.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.984 176.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 9.7 t80 -61.62 131.82 51.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.197 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 49.8 m . . . . . 0 CA--C 1.539 0.521 0 O-C-N 123.314 0.384 . . . . 0.0 111.223 -179.784 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.527 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 9.8 Cg_endo . . . . . 0 C--O 1.236 0.421 0 CA-C-O 121.08 0.367 . . . . 0.0 112.664 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.407 HD23 ' H ' ' A' ' 107' ' ' LEU . 2.1 pt? -136.97 171.89 13.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.777 -173.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 54.35 57.22 6.04 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 123.96 0.787 . . . . 0.0 111.236 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.431 HD23 ' OG1' ' A' ' 198' ' ' THR . 56.2 tp -80.29 94.33 6.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.004 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.29 129.72 35.79 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.216 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.402 HG12 HD22 ' A' ' 123' ' ' LEU . 2.9 t -120.06 114.45 44.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.956 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.499 ' OE1' ' HE3' ' A' ' 114' ' ' LYS . 38.9 tt0 -135.51 131.69 36.36 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.349 -175.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.31 133.48 31.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.996 0.427 . . . . 0.0 110.892 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.499 ' HE3' ' OE1' ' A' ' 112' ' ' GLU . 0.4 OUTLIER -108.57 131.43 54.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.45 178.175 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -124.54 85.45 56.24 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.688 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.21 156.16 65.59 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 123.27 2.647 . . . . 0.0 112.318 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.91 -17.7 56.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.233 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -117.05 -49.75 2.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.9 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.78 157.6 28.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.764 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -64.29 145.5 98.2 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.336 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.97 141.13 76.08 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.821 2.347 . . . . 0.0 111.971 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.525 ' HB3' HD13 ' A' ' 170' ' ' LEU . 21.4 p90 -148.5 151.11 34.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.607 -174.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 6.8 mt -79.07 134.04 36.77 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.059 173.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -111.6 100.58 9.1 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.151 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.415 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.4 mp -90.16 123.47 42.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.494 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -132.56 119.55 20.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.044 0.449 . . . . 0.0 110.534 -176.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . 0.464 ' CH2' HD11 ' A' ' 146' ' ' ILE . 39.4 p90 -118.45 166.44 12.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.535 -176.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.6 t -101.15 118.32 60.51 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo . . . . . 0 N--CA 1.462 -0.371 0 C-N-CA 122.723 2.282 . . . . 0.0 112.322 -178.221 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 22.6 tp . . . . . 0 N--CA 1.451 -0.414 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.401 HD11 ' HG2' ' A' ' 163' ' ' GLN . 0.9 OUTLIER -99.48 141.44 32.27 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.914 0.388 . . . . 0.0 110.954 -176.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -107.64 139.55 42.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.138 -172.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -133.57 134.35 43.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.639 -175.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.464 HD11 ' CH2' ' A' ' 127' ' ' TRP . 4.5 mp -118.9 124.82 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.881 0.372 . . . . 0.0 110.681 -175.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.506 ' HB2' ' CZ2' ' A' ' 194' ' ' TRP . 25.4 ttp180 -113.46 126.35 55.24 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 4.1 pp -149.89 164.67 34.78 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.526 -176.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -169.33 148.9 3.64 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.588 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.433 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 30.8 Cg_endo -68.23 167.35 22.31 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.377 2.051 . . . . 0.0 111.812 172.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.463 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 11.3 pt-20 -64.02 -24.21 67.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.97 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.463 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 89.6 mttt -96.15 18.78 12.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.198 0.523 . . . . 0.0 110.753 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.433 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -103.99 128.73 51.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.718 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -95.0 -11.24 28.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.075 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.67 162.67 27.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.239 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.473 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 86.5 m95 -98.81 137.73 36.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.17 0.51 . . . . 0.0 112.278 -171.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -104.14 115.04 29.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.548 176.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.408 ' N ' HD12 ' A' ' 158' ' ' ILE . 2.5 mp -95.98 120.02 44.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.363 -178.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 65.5 m-70 -113.56 130.1 56.43 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.341 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -97.41 129.89 44.59 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.845 -176.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -95.27 -37.96 10.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.888 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.68 -125.13 8.24 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.854 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.401 ' HG2' HD11 ' A' ' 143' ' ' LEU . 29.6 mt-30 -98.92 9.05 44.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.008 0.433 . . . . 0.0 110.577 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -103.82 144.88 30.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.459 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.6 p -97.01 33.58 1.89 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.305 0.574 . . . . 0.0 111.731 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -154.64 149.99 27.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.592 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 31.9 t80 -145.12 149.44 35.02 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 49.4 mmtt -113.03 144.34 42.77 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.444 ' HB ' ' HB2' ' A' ' 123' ' ' LEU . 36.3 mm -127.18 123.18 61.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.593 0.235 . . . . 0.0 110.809 176.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.525 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.9 mm? -97.3 -28.74 13.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.184 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 9.7 t -81.65 79.46 8.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.095 0.474 . . . . 0.0 110.563 -176.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 67.5 mt -129.64 143.02 50.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.863 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 79.1 m-70 -105.95 128.53 26.23 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.974 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 22.2 Cg_exo -63.77 133.62 40.02 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.741 2.294 . . . . 0.0 112.484 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 79.52 28.93 50.75 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.769 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -128.38 155.67 44.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.067 0.46 . . . . 0.0 110.91 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -92.78 133.38 36.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.388 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -120.32 144.47 47.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.869 0.366 . . . . 0.0 110.144 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.2 mm? -105.12 129.1 53.61 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.402 HG21 HG21 ' A' ' 111' ' ' VAL . 23.1 m -128.61 139.64 51.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.834 0.349 . . . . 0.0 110.865 -176.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.452 ' HG2' ' HA ' ' A' ' 197' ' ' ALA . 16.2 mt-30 -139.64 158.98 43.21 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.212 -178.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 12.6 p -136.29 138.45 46.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.208 0.527 . . . . 0.0 111.04 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -138.76 147.86 43.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.876 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . 0.527 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 25.5 p -137.93 154.61 49.4 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.453 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.506 ' CZ2' ' HB2' ' A' ' 147' ' ' ARG . 75.4 m95 . . . . . 0 N--CA 1.455 -0.191 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.475 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 7.4 m -131.41 -59.1 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -175.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 10.1 Cg_endo -90.08 95.11 0.29 Allowed 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.43 2.087 . . . . 0.0 113.16 -171.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.452 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -95.74 127.58 41.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.965 0.412 . . . . 0.0 110.567 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.431 ' OG1' HD23 ' A' ' 109' ' ' LEU . 30.9 m -121.77 144.21 48.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.639 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -104.08 127.5 51.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.204 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.7 tp -128.45 137.42 57.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.156 0.503 . . . . 0.0 110.985 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -99.59 124.98 45.3 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.686 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 51.0 mm -86.28 124.57 69.89 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 174.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.68 152.82 66.4 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.898 2.399 . . . . 0.0 112.226 -176.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 17.9 m -71.17 -23.92 62.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.7 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -100.46 54.71 0.88 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.344 176.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -87.95 -60.31 2.0 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.829 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 C--N 1.323 -0.581 0 CA-C-O 121.039 0.447 . . . . 0.0 110.976 -179.719 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.438 ' HG3' ' SG ' ' A' ' 184' ' ' CYS . 24.2 Cg_exo . . . . . 0 C--O 1.233 0.256 0 N-CA-C 111.162 -0.361 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 128' ' ' SER . 1.2 pp -133.38 177.06 7.98 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.717 0.294 . . . . 0.0 111.582 -175.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 55.41 50.28 15.12 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.584 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.5 tp -73.66 105.18 4.86 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -112.13 128.86 56.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.828 -175.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.6 t -113.32 129.82 68.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.032 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -129.78 129.84 44.6 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.878 0.37 . . . . 0.0 110.401 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 p -85.66 118.73 32.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.183 0.516 . . . . 0.0 109.846 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.507 ' O ' ' HD3' ' A' ' 116' ' ' PRO . 31.2 mmmt -113.38 108.45 17.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.1 0.476 . . . . 0.0 110.762 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -107.36 96.14 15.22 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.364 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 114' ' ' LYS . 15.3 Cg_exo -69.37 146.11 61.54 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.798 2.332 . . . . 0.0 111.687 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -80.01 -3.89 50.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.104 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -126.77 -40.86 1.87 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.196 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.418 ' H ' ' HB2' ' A' ' 116' ' ' PRO . 66.7 mtm-85 -99.44 165.58 11.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.41 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 120' ' ' LYS . 12.6 mptt -60.11 135.4 90.71 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.119 175.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.434 ' HA ' ' CD ' ' A' ' 116' ' ' PRO . 32.3 Cg_endo -64.18 136.86 53.79 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.909 2.406 . . . . 0.0 112.122 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.442 ' HB3' HD13 ' A' ' 170' ' ' LEU . 54.0 p90 -136.33 159.71 40.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.711 -175.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.5 tp -98.83 123.83 43.33 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.431 ' CZ2' ' HD3' ' A' ' 126' ' ' LYS . 21.6 t90 -104.62 115.24 30.0 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.401 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.7 mp -108.3 129.06 63.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.652 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.431 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 54.9 pttt -137.68 152.48 49.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.047 0.451 . . . . 0.0 110.347 175.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . 0.456 ' CD2' HG21 ' A' ' 182' ' ' VAL . 29.3 p90 -142.0 163.33 33.17 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.076 -174.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.446 ' HB2' HD12 ' A' ' 107' ' ' LEU . 42.4 m -106.94 105.59 55.83 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 121.004 0.43 . . . . 0.0 109.895 176.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.463 -0.278 0 C-N-CA 122.758 2.305 . . . . 0.0 112.013 -177.77 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 185' ' ' LYS . 30.1 tp . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 184' ' ' CYS . 2.0 mp -106.8 158.31 17.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.361 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -125.45 133.39 52.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.024 0.44 . . . . 0.0 111.247 -172.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -123.28 139.33 54.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.067 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.416 HG13 HG23 ' A' ' 182' ' ' VAL . 4.6 mp -126.99 122.34 60.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.679 0.276 . . . . 0.0 110.469 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -107.72 130.08 54.97 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 174.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.5 pp -144.25 157.71 44.13 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.724 -177.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -165.44 144.5 5.32 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.187 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.459 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 29.2 Cg_endo -67.88 168.84 17.61 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.406 2.071 . . . . 0.0 111.835 172.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.86 -18.86 65.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.934 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -100.96 17.79 21.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.121 0.486 . . . . 0.0 110.578 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.459 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -108.21 120.5 42.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.166 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -79.57 -28.55 41.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.583 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -109.71 154.25 23.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.755 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -90.53 144.78 25.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.146 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -98.59 110.18 22.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.254 172.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.17 113.47 24.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.198 0.523 . . . . 0.0 109.733 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 49.4 m-70 -116.35 118.99 34.26 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.685 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -88.31 126.38 35.15 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -86.6 -30.6 21.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.987 0.422 . . . . 0.0 110.729 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 95.25 -127.89 9.31 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.589 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -104.8 53.13 0.73 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.372 0.606 . . . . 0.0 110.241 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -144.64 143.86 30.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.283 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.5 p -96.66 24.35 6.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.18 0.514 . . . . 0.0 111.538 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -147.43 136.24 22.07 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.446 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 24.5 t80 -134.05 142.1 47.45 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.403 ' HE2' ' CD1' ' A' ' 124' ' ' TRP . 0.2 OUTLIER -120.4 136.38 54.74 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.689 0.281 . . . . 0.0 110.564 -178.362 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.442 HG22 ' H ' ' A' ' 171' ' ' SER . 43.2 mm -108.52 131.95 57.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.616 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.442 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.8 mm? -112.71 41.96 1.94 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.203 0.525 . . . . 0.0 110.117 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.442 ' H ' HG22 ' A' ' 169' ' ' ILE . 10.7 t -157.75 64.26 0.47 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.647 -177.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.8 mm? -109.27 151.84 26.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.991 0.424 . . . . 0.0 110.694 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -116.61 122.96 31.04 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.232 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -59.84 117.61 4.38 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.862 2.375 . . . . 0.0 112.35 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.23 -5.76 49.7 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.69 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -101.63 142.18 33.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.05 0.452 . . . . 0.0 111.015 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 199' ' ' PHE . 79.7 tttt -91.86 133.33 35.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.131 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -116.8 137.9 51.87 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.095 0.474 . . . . 0.0 110.496 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 7.6 mp -99.3 126.28 45.11 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 174.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.7 136.4 60.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.043 0.449 . . . . 0.0 111.226 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.581 ' HG2' ' HA ' ' A' ' 197' ' ' ALA . 55.4 mt-30 -138.3 139.06 38.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.0 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.456 HG21 ' CD2' ' A' ' 127' ' ' TRP . 12.6 p -125.08 152.69 31.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.857 0.36 . . . . 0.0 110.733 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -153.13 142.02 21.17 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.79 173.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . 0.438 ' SG ' ' HG3' ' A' ' 106' ' ' PRO . 25.1 p -105.09 157.08 17.5 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.659 174.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.43 ' O ' HD12 ' A' ' 142' ' ' LEU . 98.3 mttt . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 120.634 0.254 . . . . 0.0 111.441 -176.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 23.6 m95 . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.515 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 3.3 m -134.84 -54.47 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.208 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 27.1 Cg_endo -95.36 131.69 0.51 Allowed 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 122.501 2.134 . . . . 0.0 112.969 -177.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.581 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -123.65 124.63 43.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.036 0.446 . . . . 0.0 110.705 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 61.0 m -117.02 144.02 45.08 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.629 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.474 ' HB3' ' HE2' ' A' ' 177' ' ' LYS . 55.7 m-85 -107.69 132.44 53.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.594 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.1 tp -133.28 135.31 56.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.1 0.476 . . . . 0.0 110.735 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.417 HE21 ' HB2' ' A' ' 177' ' ' LYS . 1.7 mm-40 -105.61 130.6 53.62 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.539 178.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 46.6 mm -85.9 124.64 70.48 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.913 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.41 156.73 61.84 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.908 2.405 . . . . 0.0 112.382 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 46.1 m -81.06 -3.67 52.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.15 0.5 . . . . 0.0 110.913 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -84.96 -15.09 45.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.039 174.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 30.0 t80 -58.92 141.31 53.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.722 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 206' ' ' PHE . 80.6 m . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 121.474 0.654 . . . . 0.0 111.626 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo . . . . . 0 C--O 1.233 0.236 0 N-CA-C 110.768 -0.512 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.445 HD23 ' H ' ' A' ' 107' ' ' LEU . 2.2 pt? -127.75 -178.32 4.45 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.917 -171.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 55.78 40.8 30.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.822 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.492 HD23 ' OG1' ' A' ' 198' ' ' THR . 54.0 tp -70.22 94.61 0.93 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.7 123.58 40.43 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.322 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.497 HG12 HD11 ' A' ' 123' ' ' LEU . 3.2 t -112.29 113.56 44.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -124.06 133.27 53.67 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.141 -172.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.6 p -85.78 116.9 29.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.388 0.613 . . . . 0.0 109.841 175.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -103.05 123.49 46.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.403 -177.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -121.04 84.68 39.77 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.436 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.98 146.87 42.5 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.736 2.29 . . . . 0.0 111.087 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -79.9 -16.77 54.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.351 -177.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -116.12 -39.55 3.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.581 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -91.37 163.07 14.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.634 176.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -72.97 141.52 81.78 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.012 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.38 138.68 67.13 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.944 2.429 . . . . 0.0 111.742 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -150.82 164.55 35.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.833 -174.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.566 ' HB2' HD11 ' A' ' 172' ' ' LEU . 29.7 tp -97.41 122.27 40.26 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.428 ' HE1' ' HB2' ' A' ' 166' ' ' GLU . 24.4 t90 -102.71 112.53 25.34 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.047 -178.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.8 mp -106.89 120.15 57.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.666 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -128.11 134.78 49.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.93 0.395 . . . . 0.0 110.293 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 36.0 p90 -128.05 155.56 44.15 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.573 -177.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.9 m -108.88 100.27 38.87 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.909 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 CA--C 1.532 0.395 0 C-N-CA 123.021 2.481 . . . . 0.0 112.547 178.889 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.418 HD11 ' H ' ' A' ' 185' ' ' LYS . 46.5 tp . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 121.068 0.461 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -91.62 166.04 13.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.456 174.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.4 ' HD1' ' HG ' ' A' ' 184' ' ' CYS . 71.8 m-85 -131.32 131.92 44.12 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -177.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -119.87 134.6 55.19 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.51 121.96 61.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.133 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.584 ' HG3' ' NE2' ' A' ' 181' ' ' GLN . 22.5 ptt180 -103.74 148.08 26.5 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.6 pp -165.05 161.79 19.95 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.175 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 153' ' ' ALA . 57.5 pttt -164.77 145.59 6.32 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-O 120.682 0.277 . . . . 0.0 110.484 176.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.418 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 36.6 Cg_endo -68.75 165.71 28.67 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.76 2.307 . . . . 0.0 111.746 174.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.46 -5.4 19.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.897 -174.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -111.3 6.7 20.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.292 0.568 . . . . 0.0 110.437 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.418 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -95.2 127.72 41.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.187 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.36 -38.86 29.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.723 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -104.16 162.92 12.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.955 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -91.4 140.89 29.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.034 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 148' ' ' LEU . 36.1 mt-10 -91.88 116.25 28.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.3 172.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.75 109.41 21.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.54 0.686 . . . . 0.0 109.363 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.486 ' HB3' ' CE2' ' A' ' 167' ' ' PHE . 35.0 m-70 -105.8 126.42 52.15 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.195 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -98.28 117.27 32.28 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.866 0.365 . . . . 0.0 110.648 -176.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -78.0 -51.11 10.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.143 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 76.19 89.9 0.25 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.072 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 75.34 -25.59 0.2 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.733 0.813 . . . . 0.0 113.033 170.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -89.41 142.59 27.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.91 0.386 . . . . 0.0 110.57 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.1 p -101.75 32.6 3.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.5 0.667 . . . . 0.0 111.047 -177.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.428 ' HB2' ' HE1' ' A' ' 124' ' ' TRP . 5.5 pt-20 -156.9 109.94 2.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.769 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.486 ' CE2' ' HB3' ' A' ' 159' ' ' HIS . 17.8 t80 -110.94 146.56 36.38 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.497 -174.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.463 ' HD2' ' N ' ' A' ' 168' ' ' LYS . 9.6 mptt -121.83 130.19 53.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.369 -178.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 34.7 mm -107.84 124.21 63.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.551 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.17 -27.14 15.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.957 0.408 . . . . 0.0 110.482 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 34.7 m -82.33 84.55 7.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.663 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' A' ' 123' ' ' LEU . 68.9 mt -130.99 145.85 52.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.124 0.488 . . . . 0.0 111.323 -177.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 63.6 m-70 -114.38 127.49 26.77 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.859 177.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 24.2 Cg_exo -62.88 129.53 26.36 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.836 2.357 . . . . 0.0 112.797 -178.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.14 33.34 32.86 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.487 176.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -126.21 145.53 50.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.318 0.58 . . . . 0.0 111.059 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -86.85 129.64 34.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.079 177.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -120.25 137.21 54.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.246 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.5 mm? -97.44 125.02 41.85 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 173.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.47 ' O ' ' HB ' ' A' ' 198' ' ' THR . 16.7 m -135.43 139.31 46.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.748 0.309 . . . . 0.0 110.788 -171.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.584 ' NE2' ' HG3' ' A' ' 147' ' ' ARG . 0.2 OUTLIER -166.63 142.95 4.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.907 0.384 . . . . 0.0 110.842 177.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 13.0 p -121.93 153.02 26.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.52 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -146.11 134.75 22.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.066 0.46 . . . . 0.0 109.76 173.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . 0.4 ' HG ' ' HD1' ' A' ' 144' ' ' TYR . 3.3 m -111.93 152.66 27.78 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.682 -176.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.418 ' H ' HD11 ' A' ' 142' ' ' LEU . 18.0 pttp . . . . . 0 C--N 1.327 -0.373 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 51.6 m95 . . . . . 0 C--O 1.232 0.15 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.431 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 16.1 m -92.2 -54.57 0.26 Allowed Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 94.9 Cg_endo -76.68 69.78 6.65 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.096 1.864 . . . . 0.0 113.762 -172.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.502 ' HA ' ' HB3' ' A' ' 181' ' ' GLN . . . -69.52 123.23 20.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.331 0.586 . . . . 0.0 111.128 178.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.492 ' OG1' HD23 ' A' ' 109' ' ' LEU . 90.4 m -108.07 148.02 30.37 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.566 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -111.86 133.14 54.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.362 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.9 tp -137.63 133.84 45.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.34 0.591 . . . . 0.0 111.017 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -100.7 121.17 41.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.517 176.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.4 mm -85.85 122.95 72.82 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.27 143.7 96.84 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.58 2.186 . . . . 0.0 112.384 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 14.9 m -66.28 -23.55 66.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.29 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.87 19.62 3.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.591 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -53.64 -48.86 68.97 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.095 0.474 . . . . 0.0 110.318 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.444 -0.746 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.776 174.779 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.423 ' HG3' ' SG ' ' A' ' 184' ' ' CYS . 18.3 Cg_endo . . . . . 0 N--CA 1.473 0.289 0 CA-C-O 120.884 0.285 . . . . 0.0 112.346 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.44 ' N ' HD23 ' A' ' 107' ' ' LEU . 2.4 pt? -146.82 -167.57 2.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.27 -174.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 59.14 57.16 3.59 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.241 0.543 . . . . 0.0 111.105 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.411 HD23 ' HB3' ' A' ' 127' ' ' TRP . 12.3 mt -72.37 99.95 2.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.796 177.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.53 122.9 37.58 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.416 HG12 HD11 ' A' ' 123' ' ' LEU . 4.9 t -114.64 122.64 69.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.14 -175.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -120.84 140.92 51.08 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.804 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 p -98.21 119.71 46.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.21 0.528 . . . . 0.0 110.145 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.557 ' HE2' ' HA ' ' A' ' 114' ' ' LYS . 9.9 mmpt? -111.51 126.69 55.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.652 -178.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -133.09 97.23 16.79 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.08 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.81 175.97 8.92 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.71 2.273 . . . . 0.0 112.7 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -59.76 -67.31 0.4 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.329 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -131.63 38.16 3.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.295 0.569 . . . . 0.0 111.017 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -122.23 154.6 37.31 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.189 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -55.33 118.38 18.34 Favored Pre-proline 0 C--N 1.328 -0.337 0 O-C-N 123.582 0.552 . . . . 0.0 111.071 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.91 144.57 83.36 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.628 2.219 . . . . 0.0 111.146 177.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -140.53 150.56 43.86 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.219 0.533 . . . . 0.0 111.215 -173.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.455 ' HB2' HD11 ' A' ' 172' ' ' LEU . 30.1 tp -91.52 126.27 36.54 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.288 175.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.438 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 22.5 t90 -102.98 105.89 16.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.195 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.7 mp -98.99 123.62 51.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -134.12 136.21 43.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.944 0.402 . . . . 0.0 110.555 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . 0.485 ' CH2' HD11 ' A' ' 146' ' ' ILE . 20.7 p90 -122.51 167.96 12.71 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.0 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.9 t -87.29 125.47 65.74 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo . . . . . 0 C--N 1.343 0.273 0 C-N-CA 122.652 2.235 . . . . 0.0 111.81 178.793 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 63.9 tp . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.99 148.27 26.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.2 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.487 ' CD2' ' HB3' ' A' ' 184' ' ' CYS . 92.6 m-85 -115.46 138.33 51.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.545 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -124.46 135.77 53.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.485 HD11 ' CH2' ' A' ' 127' ' ' TRP . 5.1 mp -118.73 130.84 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.043 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -111.79 134.26 53.48 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.552 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.5 pp -145.43 156.53 43.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.797 -177.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -165.66 151.05 8.08 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.419 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.491 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 36.7 Cg_endo -70.05 164.11 36.03 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.453 2.102 . . . . 0.0 111.685 173.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.44 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 14.4 pt-20 -64.15 -23.69 67.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.976 -172.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.44 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 86.9 mttt -98.55 9.94 42.09 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.189 0.518 . . . . 0.0 110.875 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.491 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -95.85 131.52 42.08 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.006 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -84.96 -43.03 14.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.542 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -82.78 150.56 26.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.036 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -98.09 142.85 29.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.811 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -103.35 116.28 32.13 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.957 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.06 132.17 38.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.189 0.519 . . . . 0.0 111.079 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 67.6 m-70 -127.08 125.97 42.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.332 175.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -86.43 119.86 27.15 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.432 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -85.11 -39.19 18.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.905 0.383 . . . . 0.0 111.026 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 100.51 -143.78 16.45 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.443 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.08 62.74 4.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.978 0.418 . . . . 0.0 110.366 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -155.24 147.92 24.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.377 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.8 p -98.0 27.8 4.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.975 0.416 . . . . 0.0 111.909 -176.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -151.82 144.86 24.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.893 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 26.4 t80 -140.07 148.51 41.86 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.992 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 10.5 mptt -120.39 142.77 48.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.644 0.259 . . . . 0.0 110.782 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 32.9 mm -119.64 129.92 74.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.572 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.68 -29.17 11.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.102 0.477 . . . . 0.0 110.294 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.0 m -79.27 83.71 5.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.285 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 123' ' ' LEU . 63.4 mt -132.12 172.19 12.7 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.958 -176.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -138.37 124.65 12.82 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.899 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.13 130.02 29.16 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.606 2.204 . . . . 0.0 112.08 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 79.65 39.69 17.11 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.839 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -133.24 146.39 51.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.957 0.408 . . . . 0.0 110.474 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 150' ' ' PRO . 34.9 tttp -98.1 128.1 44.42 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.836 177.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -119.85 140.98 49.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.193 0.52 . . . . 0.0 110.898 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 5.5 mp -103.73 130.66 51.27 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.97 139.73 51.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.81 0.338 . . . . 0.0 111.452 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.547 ' HG2' ' HA ' ' A' ' 197' ' ' ALA . 78.1 mt-30 -143.72 142.47 30.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.299 177.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 13.5 p -132.06 150.15 33.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.684 0.278 . . . . 0.0 110.798 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -159.06 147.44 18.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.254 172.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . 0.487 ' HB3' ' CD2' ' A' ' 144' ' ' TYR . 27.9 p -123.4 -172.96 2.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.67 177.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 121.183 0.516 . . . . 0.0 111.044 179.764 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.492 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 81.0 m95 . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.599 ' H ' ' HD2' ' A' ' 196' ' ' PRO . 5.3 m -153.71 -56.9 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.599 ' HD2' ' H ' ' A' ' 195' ' ' SER . 68.4 Cg_endo -72.69 80.81 1.68 Allowed 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 122.019 1.813 . . . . 0.0 113.354 -173.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.547 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -80.35 103.0 9.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.273 0.559 . . . . 0.0 110.812 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.9 m -100.44 135.45 41.85 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.158 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -104.92 126.51 52.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.103 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.9 tp -126.75 137.98 56.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.003 0.43 . . . . 0.0 110.832 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -100.19 120.98 40.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.751 177.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.1 121.02 76.96 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.1 151.58 65.46 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.925 2.417 . . . . 0.0 112.362 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 16.8 t -71.75 -23.63 61.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.895 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -98.33 43.76 1.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.795 0.807 . . . . 0.0 109.28 175.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -80.85 -18.42 47.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.536 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 57.4 m . . . . . 0 C--N 1.319 -0.738 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.565 -178.171 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.61 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 72.6 Cg_endo . . . . . 0 N--CA 1.459 -0.553 0 CA-C-O 121.784 0.66 . . . . 0.0 111.872 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 pp -109.43 174.47 5.85 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.317 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 52.45 60.22 3.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.259 0.552 . . . . 0.0 110.626 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.445 HD11 ' CG2' ' A' ' 125' ' ' ILE . 43.1 tp -73.17 108.88 6.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.675 -177.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -98.44 119.68 37.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.576 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.459 ' CG1' HD11 ' A' ' 123' ' ' LEU . 2.6 t -109.24 115.28 49.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.394 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -127.72 125.58 40.25 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.933 -173.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.5 126.41 39.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.15 177.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 57.0 mmtt -108.28 129.72 55.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.936 0.398 . . . . 0.0 110.853 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.584 ' OE1' ' HA ' ' A' ' 206' ' ' PHE . 47.3 mt-30 -133.89 86.75 37.22 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.433 -174.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.05 167.69 24.62 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.078 2.519 . . . . 0.0 111.547 175.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.482 ' H ' ' CD ' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -86.24 -46.28 10.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.779 0.323 . . . . 0.0 111.32 -178.429 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -88.53 -51.48 5.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.89 0.376 . . . . 0.0 110.24 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -72.65 138.72 46.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -66.52 144.84 98.84 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 120.732 0.301 . . . . 0.0 111.4 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.557 ' HG3' ' O ' ' A' ' 206' ' ' PHE . 36.1 Cg_endo -62.72 142.41 89.13 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 123.263 2.642 . . . . 0.0 112.56 -177.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -144.56 159.9 42.03 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.733 -176.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.459 HD11 ' CG1' ' A' ' 111' ' ' VAL . 2.7 tm? -98.22 126.38 43.67 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.417 ' HE1' ' HB2' ' A' ' 166' ' ' GLU . 21.7 t90 -111.68 109.25 19.03 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.703 -172.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.445 ' CG2' HD11 ' A' ' 109' ' ' LEU . 3.6 mp -96.67 132.56 40.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.45 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -146.91 143.17 28.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.313 0.578 . . . . 0.0 110.456 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 18.5 p90 -126.74 162.94 24.64 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.112 -173.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.1 t -102.9 112.98 66.16 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 120.852 0.358 . . . . 0.0 110.374 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo . . . . . 0 N--CA 1.456 -0.698 0 C-N-CA 122.436 2.091 . . . . 0.0 111.541 174.372 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 52.5 tp . . . . . 0 N--CA 1.451 -0.382 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.441 ' HG ' ' HA2' ' A' ' 162' ' ' GLY . 4.7 mp -99.95 139.13 36.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.049 -175.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -109.14 143.18 38.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.402 -175.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -127.64 135.17 49.87 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.544 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.4 mp -114.75 128.19 71.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.009 0.433 . . . . 0.0 110.428 -176.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.483 ' HB2' ' CH2' ' A' ' 194' ' ' TRP . 26.6 ttp180 -114.97 123.13 48.31 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -142.6 160.35 40.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.632 0.253 . . . . 0.0 111.437 -177.16 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -171.69 150.22 2.57 Favored Pre-proline 0 C--O 1.234 0.275 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.996 176.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.498 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 36.6 Cg_endo -69.18 160.32 50.32 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.282 1.988 . . . . 0.0 110.599 169.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -67.9 -21.37 65.14 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -173.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -86.04 -11.12 53.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.018 0.437 . . . . 0.0 110.289 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.498 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -82.12 131.26 35.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.57 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -86.03 -35.57 20.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.363 178.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -94.96 143.19 26.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.325 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.453 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 67.7 m95 -88.46 145.76 25.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.77 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -96.43 116.94 29.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.577 174.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mp -95.67 111.66 26.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.009 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 51.3 m-70 -117.87 119.7 35.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.159 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -85.38 137.3 33.03 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.14 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.412 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -102.22 -41.05 6.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.992 0.425 . . . . 0.0 110.937 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.441 ' HA2' ' HG ' ' A' ' 143' ' ' LEU . . . 91.41 -125.64 8.11 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.152 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -97.23 64.06 1.89 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.217 0.532 . . . . 0.0 110.366 -177.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -157.64 142.95 17.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.03 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.6 p -99.31 31.6 3.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.04 0.447 . . . . 0.0 111.608 -176.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.417 ' HB2' ' HE1' ' A' ' 124' ' ' TRP . 11.3 pt-20 -158.86 156.44 29.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.941 176.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 33.1 t80 -146.01 154.03 41.43 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.05 131.94 54.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.711 0.291 . . . . 0.0 110.996 -178.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.42 HG12 HD11 ' A' ' 125' ' ' ILE . 29.0 mm -106.88 138.55 32.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 170' ' ' LEU . 3.0 mm? -104.64 -28.15 11.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.965 0.412 . . . . 0.0 111.107 -176.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.9 m -90.59 75.15 6.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.928 -174.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 172' ' ' LEU . 2.7 mm? -114.56 142.66 46.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.84 0.352 . . . . 0.0 110.737 176.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 26.3 m-70 -111.35 134.36 21.17 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.924 174.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 39.7 Cg_exo -61.22 131.14 35.07 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.834 2.356 . . . . 0.0 112.325 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 73.36 43.57 37.62 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.118 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -134.0 148.0 51.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.872 0.368 . . . . 0.0 110.041 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -95.03 126.29 40.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.74 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -120.29 136.8 54.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.184 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 7.3 mp -102.24 129.67 48.7 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.22 141.84 43.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.069 0.462 . . . . 0.0 111.544 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 98.5 mt-30 -141.42 149.02 40.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.066 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.15 136.58 37.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.618 0.247 . . . . 0.0 110.338 175.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.441 ' HD2' ' HA ' ' A' ' 194' ' ' TRP . 65.7 mtp85 -143.47 160.93 39.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.354 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . 0.61 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 21.3 p -148.49 172.15 14.94 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 21.2 pttp . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 121.058 0.456 . . . . 0.0 111.907 -174.518 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.483 ' CH2' ' HB2' ' A' ' 147' ' ' ARG . 72.9 m95 . . . . . 0 N--CA 1.456 -0.165 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.455 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 13.1 m -148.69 -58.87 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.563 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 4.5 Cg_exo -79.56 75.69 4.93 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.332 2.021 . . . . 0.0 113.412 -168.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -77.91 103.02 7.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.988 0.423 . . . . 0.0 110.429 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.2 m -96.95 140.58 31.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.454 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -105.0 131.4 52.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.933 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.3 tp -126.49 140.06 49.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.121 0.486 . . . . 0.0 110.744 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -103.41 119.11 38.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.038 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 51.2 mm -83.29 124.31 76.14 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.636 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.99 164.92 25.57 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.211 2.608 . . . . 0.0 113.419 -174.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 10.3 p -68.63 -46.79 68.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.473 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -85.6 35.19 0.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.769 0.795 . . . . 0.0 110.609 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.584 ' HA ' ' OE1' ' A' ' 115' ' ' GLN . 89.2 t80 -68.76 -58.04 4.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 C--N 1.322 -0.626 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.814 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 0 N--CA 1.464 -0.226 0 CA-C-O 121.453 0.522 . . . . 0.0 112.179 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.663 HD23 ' H ' ' A' ' 107' ' ' LEU . 2.6 pt? -94.53 -173.21 2.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.021 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 54.7 43.04 30.76 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 123.563 0.54 . . . . 0.0 110.217 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.413 HD13 ' HB3' ' A' ' 127' ' ' TRP . 48.6 tp -68.76 94.77 0.63 Allowed 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.604 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.69 125.64 38.42 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.997 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.478 HG12 HD11 ' A' ' 123' ' ' LEU . 2.1 t -110.69 114.13 46.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -121.32 118.19 28.87 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.108 -173.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.518 HG22 ' CD1' ' A' ' 123' ' ' LEU . 7.1 t -80.39 123.84 37.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -102.73 120.5 40.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.956 0.408 . . . . 0.0 110.783 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -121.61 86.39 44.75 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.422 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.41 ' HB2' ' HB2' ' A' ' 119' ' ' ARG . 12.1 Cg_exo -71.62 -177.85 2.71 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 123.211 2.607 . . . . 0.0 113.327 -175.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -74.41 -64.71 0.97 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.17 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -119.32 15.26 13.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.096 0.474 . . . . 0.0 110.912 -176.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.41 ' HB2' ' HB2' ' A' ' 116' ' ' PRO . 98.9 mtt180 -110.29 150.19 29.09 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.556 177.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -61.71 138.22 95.22 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 123.634 0.584 . . . . 0.0 110.646 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.98 138.52 44.34 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.543 2.162 . . . . 0.0 111.47 178.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -148.39 157.25 43.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.624 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.518 ' CD1' HG22 ' A' ' 113' ' ' VAL . 30.7 tp -92.61 124.8 36.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.955 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.525 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 21.3 t90 -103.43 103.75 13.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.096 0.474 . . . . 0.0 110.429 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.2 mp -95.2 116.45 36.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.579 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.47 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 5.0 ttpm? -128.93 127.27 41.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.189 0.518 . . . . 0.0 110.566 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . 0.413 ' HB3' HD13 ' A' ' 109' ' ' LEU . 22.5 p90 -116.27 160.56 20.28 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.27 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 39.3 t -86.33 118.62 70.64 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo . . . . . 0 C--O 1.235 0.338 0 C-N-CA 122.709 2.273 . . . . 0.0 111.876 -178.423 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 60.0 mt -104.31 141.51 36.18 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.018 0.437 . . . . 0.0 110.941 -175.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.619 ' CE2' ' HB3' ' A' ' 184' ' ' CYS . 93.6 m-85 -104.29 141.24 36.64 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.477 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -126.84 136.57 52.53 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.41 ' CD1' ' HB2' ' A' ' 161' ' ' ALA . 4.9 mp -118.16 128.07 75.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.949 0.404 . . . . 0.0 110.782 -176.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.533 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 15.3 ttp180 -113.07 120.3 40.86 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.6 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -144.58 160.41 41.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.692 0.282 . . . . 0.0 111.596 -175.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.401 ' HE2' ' CE2' ' A' ' 156' ' ' TRP . 56.7 pttt -170.93 144.55 1.82 Allowed Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.489 176.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.5 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 43.4 Cg_endo -74.2 167.09 28.0 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.553 2.169 . . . . 0.0 111.444 167.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.453 ' HG2' ' HG3' ' A' ' 152' ' ' LYS . 1.4 pm0 -59.47 -39.6 84.21 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.925 0.393 . . . . 0.0 111.426 -177.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.453 ' HG3' ' HG2' ' A' ' 151' ' ' GLU . 91.7 mttt -87.8 16.25 6.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.499 -175.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.5 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -88.96 -38.99 14.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.262 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 70.33 -54.38 0.63 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.126 0.891 . . . . 0.0 111.19 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -85.41 151.89 23.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.248 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.533 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 77.1 m95 -90.45 135.51 33.64 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.216 178.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -99.95 123.48 44.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.505 175.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.4 mp -103.66 120.07 53.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.994 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 41.2 m-70 -123.35 122.91 39.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.872 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -85.8 131.4 34.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.548 -176.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.41 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -96.6 -41.56 8.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.331 . . . . 0.0 111.387 -179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.35 -141.09 15.18 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.292 -176.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.447 ' H ' ' CD ' ' A' ' 163' ' ' GLN . 0.4 OUTLIER -97.49 44.03 1.06 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.461 0.648 . . . . 0.0 111.08 -177.723 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -128.46 149.68 50.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.593 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.3 p -101.47 26.18 7.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -174.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -151.66 140.42 20.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.931 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 33.5 t80 -130.7 146.99 52.32 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.525 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 39.1 mmtm -112.1 132.5 54.81 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.736 0.303 . . . . 0.0 110.901 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 26.4 mm -112.34 136.85 47.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -104.93 -25.5 12.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.068 0.461 . . . . 0.0 110.441 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 25.6 t -86.18 70.02 10.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.287 -175.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.9 mm? -110.62 139.83 45.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.968 0.414 . . . . 0.0 110.435 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -101.03 122.51 48.4 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.051 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.449 ' HB3' ' HB3' ' A' ' 206' ' ' PHE . 10.0 Cg_endo -58.35 116.96 3.61 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.527 2.152 . . . . 0.0 112.605 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 91.35 32.46 8.77 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.636 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.562 HE21 ' HA ' ' A' ' 176' ' ' GLN . 0.1 OUTLIER -133.13 159.3 40.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.826 0.346 . . . . 0.0 110.911 -179.6 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -106.88 126.63 52.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.691 -174.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -112.82 137.95 50.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.048 0.451 . . . . 0.0 110.67 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.9 mp -99.84 124.21 44.89 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 26.3 m -121.8 140.27 46.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.229 0.538 . . . . 0.0 111.877 -176.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.611 HE21 ' HB2' ' A' ' 197' ' ' ALA . 82.7 mt-30 -136.08 147.68 47.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.333 175.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.18 142.44 22.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.869 0.366 . . . . 0.0 110.128 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 27.0 ttt-85 -146.69 149.31 33.2 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . 0.619 ' HB3' ' CE2' ' A' ' 144' ' ' TYR . 9.0 p -103.67 154.03 19.98 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.527 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 73.7 mttt . . . . . 0 C--N 1.32 -0.679 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.676 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 73.1 m95 . . . . . 0 C--O 1.235 0.299 0 N-CA-C 110.448 -0.204 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.506 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 2.0 m -133.54 -60.85 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -176.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 14.8 Cg_endo -94.9 111.47 0.15 Allowed 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.674 2.249 . . . . 0.0 113.308 -172.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.611 ' HB2' HE21 ' A' ' 181' ' ' GLN . . . -103.53 122.47 45.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.039 0.447 . . . . 0.0 110.858 177.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 90.7 m -117.03 147.04 42.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.709 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.403 ' CD2' ' HG ' ' A' ' 179' ' ' LEU . 68.2 m-85 -110.66 140.37 45.08 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.1 tp -136.23 138.07 47.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.145 0.498 . . . . 0.0 110.794 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -104.39 124.37 49.09 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.551 177.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 40.8 mm -88.56 124.55 65.66 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.343 178.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.49 146.61 96.88 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.605 2.203 . . . . 0.0 111.908 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 49.6 m -70.91 -11.56 61.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.288 0.566 . . . . 0.0 110.57 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -96.26 15.59 20.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.614 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.511 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 83.7 t80 -53.13 -43.91 67.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.523 177.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.449 -0.479 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.229 177.143 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.413 ' HG2' HG13 ' A' ' 182' ' ' VAL . 11.8 Cg_endo . . . . . 0 C--O 1.235 0.339 0 N-CA-C 110.87 -0.473 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.41 HD12 ' HB2' ' A' ' 128' ' ' SER . 0.6 OUTLIER -127.16 174.68 8.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.971 -172.059 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 57.07 60.63 2.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.343 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.426 HD23 ' HB3' ' A' ' 127' ' ' TRP . 9.7 mt -69.45 97.76 1.03 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.7 174.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.6 122.02 39.07 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.455 HG12 HD22 ' A' ' 123' ' ' LEU . 10.0 t -115.09 119.55 62.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.896 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -118.88 132.7 56.11 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.158 -176.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.495 ' HA ' HD23 ' A' ' 123' ' ' LEU . 12.9 p -86.78 128.26 39.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.19 0.519 . . . . 0.0 109.984 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -116.69 107.84 15.17 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.21 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.457 ' HG2' ' HB3' ' A' ' 121' ' ' PRO . 50.5 mt-30 -111.24 97.95 37.58 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.421 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.91 -179.88 4.68 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.775 2.316 . . . . 0.0 112.374 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.66 -68.44 0.45 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.884 0.373 . . . . 0.0 110.855 -177.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -107.24 -18.28 13.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.334 0.588 . . . . 0.0 110.97 -176.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -80.12 141.93 35.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.845 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -60.06 135.39 90.54 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.268 -175.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.457 ' HB3' ' HG2' ' A' ' 115' ' ' GLN . 38.0 Cg_endo -65.52 149.36 87.77 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.978 2.452 . . . . 0.0 112.282 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.428 ' HB3' HD13 ' A' ' 170' ' ' LEU . 49.2 p90 -150.81 167.98 25.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.941 -175.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 113' ' ' VAL . 11.1 mt -100.25 142.41 31.77 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 120.918 0.39 . . . . 0.0 110.822 176.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.523 ' CZ2' ' HD2' ' A' ' 126' ' ' LYS . 19.9 t90 -113.93 105.28 13.06 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.729 175.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.1 mp -94.87 118.48 41.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.523 ' HD2' ' CZ2' ' A' ' 124' ' ' TRP . 81.5 tttt -132.05 119.56 21.17 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.216 0.532 . . . . 0.0 110.866 -175.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . 0.491 ' CH2' HD11 ' A' ' 146' ' ' ILE . 35.5 p90 -116.08 162.46 17.39 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.829 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.41 ' HB2' HD12 ' A' ' 107' ' ' LEU . 17.6 m -102.9 134.94 19.54 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 C--N 1.347 0.464 0 C-N-CA 123.235 2.623 . . . . 0.0 112.279 -177.005 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.024 ' HG ' ' SG ' ' A' ' 184' ' ' CYS . 11.4 tp . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 120.889 0.376 . . . . 0.0 110.077 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -96.16 133.67 40.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.948 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -102.1 144.35 30.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.988 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 75.1 tt0 -136.64 137.35 39.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.926 -173.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 181' ' ' GLN . 4.7 mp -120.57 125.42 74.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.775 0.321 . . . . 0.0 110.858 -176.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.44 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 18.0 ttp180 -108.84 121.77 45.77 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 4.0 pp -145.25 159.28 43.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.79 0.328 . . . . 0.0 111.342 -176.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -168.61 149.33 4.34 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.54 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 31.3 Cg_endo -70.95 160.89 47.94 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.988 1.792 . . . . 0.0 112.311 174.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.455 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 6.0 pt-20 -50.93 -46.93 61.04 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.455 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 93.4 mttt -84.77 13.85 5.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.803 0.335 . . . . 0.0 111.59 -174.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.54 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -88.23 134.25 33.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.926 0.393 . . . . 0.0 111.185 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -89.95 -21.63 22.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.205 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -120.37 145.83 46.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.733 -177.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.44 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 66.4 m95 -84.06 137.7 33.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.433 176.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -109.9 116.7 32.1 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.423 0.63 . . . . 0.0 111.323 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.1 mp -91.03 130.79 39.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.935 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 67.6 m-70 -124.11 126.03 45.49 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.223 176.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -93.0 119.55 32.38 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.852 0.358 . . . . 0.0 110.836 -174.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.437 ' HB2' HD11 ' A' ' 146' ' ' ILE . . . -75.09 -51.5 13.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.054 177.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 77.8 81.76 0.63 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.368 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 74.3 -40.0 0.44 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.954 0.901 . . . . 0.0 112.563 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -68.56 145.65 53.78 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 55.5 p -104.94 30.31 5.63 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.26 0.552 . . . . 0.0 111.49 -176.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -154.14 144.76 22.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.639 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 32.4 t80 -142.27 146.14 34.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.081 -177.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.451 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 10.3 mptt -115.76 144.53 43.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.861 0.362 . . . . 0.0 110.661 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 35.8 mm -119.61 134.19 63.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.951 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.428 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.6 mm? -102.02 -29.52 11.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.878 0.371 . . . . 0.0 110.608 178.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 45.6 m -86.2 73.89 10.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.963 -175.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.25 144.3 41.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.854 0.359 . . . . 0.0 110.333 174.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 -110.16 122.11 39.72 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.887 175.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.25 124.35 15.96 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.984 2.456 . . . . 0.0 112.772 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 97.21 12.54 48.6 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.073 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -118.78 148.84 42.4 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.377 0.608 . . . . 0.0 111.873 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -89.47 129.97 35.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.547 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.435 ' HB2' HG23 ' A' ' 200' ' ' ILE . 22.7 m-85 -115.59 135.52 53.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.998 0.427 . . . . 0.0 110.455 177.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.6 mp -101.5 121.94 42.88 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.402 HG23 ' HB ' ' A' ' 198' ' ' THR . 29.8 m -119.49 137.56 52.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.175 0.512 . . . . 0.0 111.062 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.553 HE21 ' HB2' ' A' ' 197' ' ' ALA . 89.3 mt-30 -136.94 139.58 41.63 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.556 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 145' ' ' GLU . 10.4 p -123.55 137.35 57.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.206 0.527 . . . . 0.0 110.606 174.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -138.79 138.68 37.81 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.667 174.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . 1.024 ' SG ' ' HG ' ' A' ' 142' ' ' LEU . 4.6 t -125.53 156.23 39.36 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.424 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.22 -172.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.412 ' CZ2' ' HB2' ' A' ' 147' ' ' ARG . 83.0 m95 . . . . . 0 C--O 1.23 0.078 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.516 ' OG ' ' HD3' ' A' ' 196' ' ' PRO . 3.1 p -110.72 -50.24 0.06 OUTLIER Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -176.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.516 ' HD3' ' OG ' ' A' ' 195' ' ' SER . 9.3 Cg_endo -86.92 83.05 1.13 Allowed 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.019 1.813 . . . . 0.0 113.12 -172.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.553 ' HB2' HE21 ' A' ' 181' ' ' GLN . . . -87.41 107.1 18.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.043 0.449 . . . . 0.0 110.464 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.402 ' HB ' HG23 ' A' ' 180' ' ' VAL . 28.8 m -100.27 139.8 35.43 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.19 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -108.19 120.41 42.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.831 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.435 HG23 ' HB2' ' A' ' 178' ' ' TYR . 6.1 tp -119.99 133.56 66.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.167 0.508 . . . . 0.0 110.508 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -95.94 135.58 37.51 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.452 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.455 HD11 HD11 ' A' ' 123' ' ' LEU . 43.1 mm -95.83 121.51 60.94 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 175.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.01 149.13 86.11 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.923 2.415 . . . . 0.0 112.071 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 7.5 p -72.76 -18.75 61.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.037 0.446 . . . . 0.0 110.523 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -91.32 16.78 9.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.363 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.417 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 54.5 t80 -67.1 -32.41 73.54 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.451 -0.382 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.058 175.757 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.484 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 32.8 Cg_endo . . . . . 0 N--CA 1.461 -0.383 0 N-CA-C 111.131 -0.373 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.16 178.82 4.55 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.382 -174.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 54.16 58.07 5.33 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.894 -178.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.0 96.15 3.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.012 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.57 129.87 41.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.84 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.483 HG12 HD11 ' A' ' 123' ' ' LEU . 3.1 t -120.35 120.25 62.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.786 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -132.16 141.53 49.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.686 0.279 . . . . 0.0 110.616 -176.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.2 p -95.82 120.28 45.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.049 0.452 . . . . 0.0 110.029 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -111.18 126.82 55.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.904 0.383 . . . . 0.0 111.109 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.44 ' HG2' ' HB3' ' A' ' 121' ' ' PRO . 78.0 mt-30 -114.02 106.47 53.26 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.098 175.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.53 170.37 5.61 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.054 2.503 . . . . 0.0 112.561 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -78.29 -8.68 58.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.382 -176.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -159.71 -40.13 0.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.243 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -69.05 167.37 16.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.295 -178.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -63.02 141.68 97.69 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.853 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.44 ' HB3' ' HG2' ' A' ' 115' ' ' GLN . 60.3 Cg_endo -72.36 147.26 46.68 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.819 2.346 . . . . 0.0 111.602 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.496 ' HB3' HD13 ' A' ' 170' ' ' LEU . 34.8 p90 -147.92 154.77 40.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.14 0.495 . . . . 0.0 111.336 -175.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.616 ' HB2' HD11 ' A' ' 172' ' ' LEU . 28.9 tp -90.16 124.36 34.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.531 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.541 ' CZ2' ' HD3' ' A' ' 126' ' ' LYS . 21.9 t90 -100.32 103.76 15.19 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.224 0.535 . . . . 0.0 110.232 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.9 mp -97.66 119.82 46.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.195 177.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.541 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 25.4 pttm -132.0 139.59 48.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.51 0.672 . . . . 0.0 110.458 176.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 19.1 p90 -122.52 145.3 48.45 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.143 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.6 t -88.11 121.15 70.71 Favored Pre-proline 0 C--N 1.317 -0.828 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo . . . . . 0 C--N 1.347 0.497 0 C-N-CA 123.58 2.854 . . . . 0.0 112.951 -179.116 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 39.2 tp . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.24 142.03 28.15 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.936 0.398 . . . . 0.0 111.063 -175.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.475 ' CE2' HG22 ' A' ' 165' ' ' THR . 86.8 m-85 -119.37 141.51 48.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.123 -175.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -120.29 129.82 54.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.057 175.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.5 mp -106.6 125.38 62.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.005 0.431 . . . . 0.0 110.191 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.523 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 18.6 ttp180 -117.66 119.81 36.12 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.676 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -140.5 159.45 42.17 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.413 -176.32 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.45 ' HE2' ' CZ2' ' A' ' 156' ' ' TRP . 52.4 pttt -167.08 149.9 5.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.426 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.422 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 45.8 Cg_endo -71.97 161.69 44.1 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.547 2.165 . . . . 0.0 111.196 170.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -67.47 -16.74 64.38 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -172.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -94.04 -1.15 54.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.021 0.439 . . . . 0.0 110.427 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.422 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -91.23 125.78 36.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.381 -176.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.09 -35.32 25.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.706 0.765 . . . . 0.0 109.415 173.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -88.16 150.25 23.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.388 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.523 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 65.4 m95 -101.41 153.4 19.72 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.786 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -105.24 117.78 34.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.592 174.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -94.82 118.8 41.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.227 0.537 . . . . 0.0 110.044 175.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 22.8 m-70 -122.68 114.8 21.07 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.328 177.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -82.71 142.22 31.82 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.508 -176.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -82.37 -46.36 13.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.944 0.402 . . . . 0.0 111.448 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 163' ' ' GLN . . . 108.28 -39.44 2.9 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.987 177.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 162' ' ' GLY . 63.8 tt0 174.93 -28.28 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.295 0.569 . . . . 0.0 110.017 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -70.78 160.3 32.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.809 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.475 HG22 ' CE2' ' A' ' 144' ' ' TYR . 60.7 p -110.91 28.09 9.04 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.254 0.549 . . . . 0.0 111.273 -174.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.405 ' HB2' ' HE1' ' A' ' 124' ' ' TRP . 12.3 pt-20 -152.29 143.95 23.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.411 177.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 19.8 t80 -131.86 147.7 52.5 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.437 ' HD2' ' CE2' ' A' ' 122' ' ' TYR . 43.2 mmtt -117.68 131.69 56.59 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 34.9 mm -106.91 125.01 62.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.496 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.8 mm? -93.95 -38.2 11.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.508 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 14.7 m -76.51 87.23 3.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.822 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.616 HD11 ' HB2' ' A' ' 123' ' ' LEU . 49.1 mt -131.92 147.57 52.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.762 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -109.28 134.29 20.52 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.305 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.34 110.87 2.13 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.618 2.212 . . . . 0.0 111.852 178.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 90.17 46.61 4.08 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.6 -176.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -135.78 147.22 48.27 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.925 0.393 . . . . 0.0 110.29 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -98.29 129.1 45.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.028 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -122.38 138.82 54.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.93 0.395 . . . . 0.0 110.639 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 7.5 mp -97.09 132.97 42.36 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.467 ' CG2' ' HB ' ' A' ' 198' ' ' THR . 28.4 m -122.72 152.98 27.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.174 0.511 . . . . 0.0 110.988 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.581 ' NE2' ' HA ' ' A' ' 181' ' ' GLN . 0.8 OUTLIER -151.94 152.6 32.73 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.454 -177.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.9 p -135.85 139.91 45.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.029 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -136.49 133.59 36.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.449 176.852 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . 0.484 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 13.0 p -105.08 144.65 31.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.486 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 53.4 mttt . . . . . 0 C--N 1.327 -0.391 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.284 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.448 ' CE3' ' HB3' ' A' ' 181' ' ' GLN . 63.4 m95 . . . . . 0 C--O 1.231 0.126 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.527 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 6.9 m -102.0 -54.05 0.14 Allowed Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -176.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.527 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 73.5 Cg_endo -78.08 169.74 19.9 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.656 1.571 . . . . 0.0 112.333 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -154.93 117.89 4.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 172.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.467 ' HB ' ' CG2' ' A' ' 180' ' ' VAL . 7.0 m -99.01 134.57 41.65 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.312 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -104.91 130.07 53.15 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 8.4 tp -128.78 138.92 53.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.284 0.564 . . . . 0.0 111.124 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -100.14 123.29 44.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.936 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 50.6 mm -88.24 120.39 70.53 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 173.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.6 150.69 80.53 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.845 2.363 . . . . 0.0 112.425 -176.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 17.5 m -69.83 -12.53 61.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.52 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -91.6 17.31 8.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.711 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -67.3 -34.11 76.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.232 -178.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.191 -176.927 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.423 ' HG3' ' SG ' ' A' ' 184' ' ' CYS . 14.6 Cg_endo . . . . . 0 C--O 1.235 0.35 0 N-CA-C 111.446 -0.251 . . . . 0.0 111.446 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.01 -172.13 3.61 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.498 -173.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 58.53 51.24 8.18 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.699 0.625 . . . . 0.0 111.403 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.43 HD23 ' OG1' ' A' ' 198' ' ' THR . 52.9 tp -80.23 93.62 5.91 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.76 127.45 45.91 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.306 -177.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.7 t -112.27 123.8 68.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.877 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -132.59 140.07 48.09 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.585 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.69 113.46 32.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.383 0.611 . . . . 0.0 109.753 176.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -96.26 121.26 37.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.223 -176.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -120.7 76.13 27.48 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.101 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.91 160.61 40.2 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.74 2.293 . . . . 0.0 111.891 -178.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -83.2 -25.59 31.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.295 0.569 . . . . 0.0 110.374 176.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -92.75 -44.55 8.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.324 -175.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -105.07 153.64 21.21 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.414 ' O ' ' HD2' ' A' ' 122' ' ' TYR . 18.7 ptpt -64.7 152.43 90.05 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.413 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.55 134.34 44.02 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.754 2.303 . . . . 0.0 112.565 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.414 ' HD2' ' O ' ' A' ' 120' ' ' LYS . 46.1 p90 -146.4 163.93 34.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.443 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.472 ' HB3' ' HB ' ' A' ' 169' ' ' ILE . 33.7 tp -97.44 125.77 42.29 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.47 ' CZ2' ' HD2' ' A' ' 126' ' ' LYS . 24.3 t90 -107.67 114.66 28.79 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.296 -176.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.409 HD11 HG12 ' A' ' 169' ' ' ILE . 4.2 mp -102.85 123.08 55.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.47 ' HD2' ' CZ2' ' A' ' 124' ' ' TRP . 51.2 tttm -132.38 121.12 22.97 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.991 0.424 . . . . 0.0 110.848 -177.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . 0.414 ' CD2' HG21 ' A' ' 182' ' ' VAL . 42.8 p90 -119.61 166.42 13.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.995 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 61.2 m -109.02 126.47 29.27 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.293 177.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo . . . . . 0 C--O 1.233 0.257 0 C-N-CA 122.822 2.348 . . . . 0.0 111.647 179.446 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 54.1 tp . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.553 ' CD1' ' HG2' ' A' ' 163' ' ' GLN . 2.8 mm? -100.55 157.22 16.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 -176.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -120.84 136.98 54.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.801 -176.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.452 ' C ' HG13 ' A' ' 146' ' ' ILE . 27.4 tt0 -127.54 140.42 52.14 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -174.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.46 ' CD1' ' HB2' ' A' ' 161' ' ' ALA . 7.6 mt -132.65 150.15 32.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.98 0.419 . . . . 0.0 111.843 -166.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.48 ' HG3' ' CH2' ' A' ' 194' ' ' TRP . 43.6 mtm180 -126.75 154.71 43.82 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 174.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.629 HD12 ' NE2' ' A' ' 159' ' ' HIS . 0.0 OUTLIER -163.1 155.41 18.36 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 123.297 0.373 . . . . 0.0 110.255 170.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -173.43 141.38 0.91 Allowed Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.955 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.8 173.37 13.57 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.561 2.174 . . . . 0.0 112.108 173.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.408 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 9.0 pt-20 -65.78 -24.68 66.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.627 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.408 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 50.6 mttm -90.51 11.51 21.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.237 0.541 . . . . 0.0 110.467 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -111.52 130.6 55.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.751 178.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -92.92 -35.35 13.38 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.259 0.552 . . . . 0.0 110.341 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -91.92 149.46 21.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.002 -175.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -93.77 128.72 40.14 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.065 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -93.06 111.46 23.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.008 173.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.462 HG13 ' HG2' ' A' ' 147' ' ' ARG . 1.9 mp -88.72 126.21 41.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.629 ' NE2' HD12 ' A' ' 148' ' ' LEU . 3.2 p80 -130.36 132.96 46.06 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.828 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -97.72 116.57 30.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.199 -176.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.46 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -76.95 -48.74 17.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.191 0.52 . . . . 0.0 110.643 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 123.5 -125.61 5.96 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.257 -176.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.553 ' HG2' ' CD1' ' A' ' 143' ' ' LEU . 5.1 mt-30 -102.14 -7.0 22.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.921 0.391 . . . . 0.0 110.482 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -79.48 143.24 35.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.375 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 63.5 p -101.32 33.78 2.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.171 0.51 . . . . 0.0 111.76 -174.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -158.82 153.51 24.62 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.283 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -151.27 152.56 33.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.701 0.286 . . . . 0.0 110.547 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 168' ' ' LYS . 0.1 OUTLIER -118.33 128.92 55.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.437 -178.109 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 123' ' ' LEU . 23.6 mm -99.87 140.82 18.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.11 -19.82 13.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.777 0.323 . . . . 0.0 110.86 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 36.7 t -87.59 73.89 9.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.231 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.418 HD22 ' N ' ' A' ' 172' ' ' LEU . 2.7 mm? -117.7 143.26 46.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.995 0.426 . . . . 0.0 110.522 175.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 62.0 m-70 -119.15 132.26 24.03 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.575 175.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 24.3 Cg_exo -62.09 124.33 14.2 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.791 2.327 . . . . 0.0 112.732 -177.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 85.67 28.37 29.64 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.751 177.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -123.75 149.74 45.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.14 0.495 . . . . 0.0 111.125 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -87.38 128.34 35.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.361 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -121.1 142.39 49.89 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.752 0.311 . . . . 0.0 110.329 175.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.8 mp -104.93 146.89 28.39 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 172.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.459 HG23 ' HB ' ' A' ' 198' ' ' THR . 19.4 m -134.53 152.74 34.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.983 0.42 . . . . 0.0 110.484 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.565 ' NE2' ' HA ' ' A' ' 181' ' ' GLN . 0.3 OUTLIER -151.66 146.27 25.67 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.035 179.522 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.414 HG21 ' CD2' ' A' ' 127' ' ' TRP . 12.0 p -138.17 149.82 24.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -158.34 139.25 13.02 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . 0.423 ' SG ' ' HG3' ' A' ' 106' ' ' PRO . 26.3 p -104.41 177.9 4.71 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 56.3 mttm . . . . . 0 C--N 1.327 -0.395 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.684 -178.391 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.48 ' CH2' ' HG3' ' A' ' 147' ' ' ARG . 50.9 m95 . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 120.796 0.331 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.447 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 12.9 m -74.48 -51.24 4.35 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.099 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.447 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 59.2 Cg_endo -74.78 165.27 31.84 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.667 1.578 . . . . 0.0 112.722 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -154.11 130.67 10.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.965 172.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.459 ' HB ' HG23 ' A' ' 180' ' ' VAL . 12.8 m -115.9 135.45 53.98 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.582 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -106.22 131.64 53.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.252 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.0 tp -128.53 130.27 69.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.283 0.563 . . . . 0.0 110.4 177.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.449 HE21 ' HA ' ' A' ' 201' ' ' GLN . 0.0 OUTLIER -97.81 113.38 25.16 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.338 178.495 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 51.7 mm -74.27 122.05 86.64 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.14 155.05 71.63 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.776 2.318 . . . . 0.0 112.353 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 12.3 p -75.85 -5.18 44.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.299 0.571 . . . . 0.0 110.224 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -82.8 -6.43 59.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.148 177.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 36.2 t80 -53.32 -37.26 62.11 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.54 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.449 -0.506 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.231 174.176 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.664 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 73.4 Cg_endo . . . . . 0 N--CA 1.458 -0.609 0 N-CA-C 111.271 -0.319 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.405 ' N ' HD23 ' A' ' 107' ' ' LEU . 2.1 pt? -140.07 -174.61 3.97 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.094 -177.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 128' ' ' SER . 42.7 mt-10 54.99 55.97 7.12 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 123.704 0.628 . . . . 0.0 110.925 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.4 tp -75.5 96.85 3.56 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.21 0.528 . . . . 0.0 110.491 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.09 123.18 38.44 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.253 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.444 HG12 HD11 ' A' ' 123' ' ' LEU . 3.5 t -119.04 118.1 56.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.43 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -136.1 121.37 19.14 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.838 -174.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.475 HG22 HD13 ' A' ' 123' ' ' LEU . 48.2 t -74.48 129.44 36.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.312 -0.403 . . . . 0.0 109.971 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 114' ' ' LYS . 24.3 mmtp -118.59 125.17 49.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.14 0.495 . . . . 0.0 111.642 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -117.26 97.13 50.41 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.884 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.491 ' HB2' ' HB2' ' A' ' 119' ' ' ARG . 15.2 Cg_exo -68.74 171.48 13.24 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.429 2.086 . . . . 0.0 111.968 177.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -76.18 -66.2 0.83 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.953 0.406 . . . . 0.0 110.706 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -92.69 -33.6 14.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.666 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.491 ' HB2' ' HB2' ' A' ' 116' ' ' PRO . 71.8 mtp180 -72.41 154.9 40.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.806 176.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -75.54 149.39 83.79 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.53 146.15 48.97 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.975 2.45 . . . . 0.0 112.468 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.473 ' CD2' ' HD2' ' A' ' 168' ' ' LYS . 49.0 p90 -151.41 161.37 42.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.461 -176.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.623 ' HB2' HD11 ' A' ' 172' ' ' LEU . 44.5 tp -91.52 125.46 36.27 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 175.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.595 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 22.4 t90 -102.03 108.93 20.52 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.127 0.489 . . . . 0.0 110.421 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.03 122.22 52.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.337 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -131.09 120.5 23.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.946 0.403 . . . . 0.0 110.491 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . 0.437 ' CH2' HD11 ' A' ' 146' ' ' ILE . 37.1 p90 -115.83 165.84 12.63 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.466 -178.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.428 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 23.0 t -104.34 121.27 47.94 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.756 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo . . . . . 0 C--N 1.346 0.442 0 C-N-CA 123.377 2.718 . . . . 0.0 112.526 177.914 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.479 HD21 ' SG ' ' A' ' 184' ' ' CYS . 48.0 tp . . . . . 0 N--CA 1.448 -0.538 0 CA-C-O 120.962 0.411 . . . . 0.0 110.159 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 3.5 mp -95.71 134.84 38.16 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.318 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -102.83 153.17 20.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.718 -172.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -131.62 134.24 45.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.953 -171.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.437 HD11 ' CH2' ' A' ' 127' ' ' TRP . 4.5 mp -125.68 125.2 68.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.549 ' HB3' ' HB2' ' A' ' 181' ' ' GLN . 46.6 ttp180 -118.01 119.86 36.06 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -141.5 162.59 35.12 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.848 -176.251 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -167.07 150.25 6.06 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.164 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.482 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 34.2 Cg_endo -68.32 159.48 53.13 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.282 1.988 . . . . 0.0 111.027 171.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.44 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 15.8 pt-20 -63.06 -20.66 65.54 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -171.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.44 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 84.7 mttt -100.28 7.35 44.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.091 0.472 . . . . 0.0 110.852 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.482 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -84.75 124.24 31.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.899 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.96 -22.99 39.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.535 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -115.32 154.45 29.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.393 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -94.7 141.58 28.45 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.324 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -103.92 108.58 19.97 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.989 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 158' ' ' ILE . 2.2 mp -87.99 133.4 30.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.033 0.444 . . . . 0.0 110.053 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -126.92 141.84 51.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.609 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 143' ' ' LEU . 5.3 t80 -106.14 124.66 49.93 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.073 -177.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -88.21 -44.06 11.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.138 0.494 . . . . 0.0 110.303 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 143' ' ' LEU . . . 103.71 -127.63 9.21 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.051 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -93.03 9.0 37.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.447 0.641 . . . . 0.0 110.519 -176.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -105.48 153.19 22.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.584 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.8 p -107.44 19.5 20.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.033 -175.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -146.57 140.66 26.27 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -133.87 151.39 51.51 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.595 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 40.7 mmtm -120.53 135.48 55.07 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.613 0.244 . . . . 0.0 110.66 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 33.9 mm -109.7 128.78 65.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.93 -25.06 12.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.368 . . . . 0.0 111.051 -178.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 13.8 m -80.62 65.4 5.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.712 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 123' ' ' LEU . 57.6 mt -114.55 157.59 22.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.949 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 75.3 m-70 -126.08 129.97 24.1 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.774 177.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 23.7 Cg_exo -63.75 121.85 9.73 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.615 2.21 . . . . 0.0 111.925 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 90.8 20.2 40.93 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.05 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -117.49 142.97 46.52 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 151' ' ' GLU . 30.3 ttmt -90.77 135.13 33.92 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.064 177.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -122.12 133.17 54.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.112 0.482 . . . . 0.0 110.606 176.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.3 mp -100.68 124.71 46.66 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.442 HG21 HG21 ' A' ' 111' ' ' VAL . 34.7 m -115.02 161.27 13.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.364 0.602 . . . . 0.0 111.723 -176.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.584 HE21 ' HB2' ' A' ' 197' ' ' ALA . 12.2 mm-40 -145.63 148.67 33.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.901 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 9.0 p -136.37 145.69 30.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 120.891 0.377 . . . . 0.0 110.184 175.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.56 ' HG2' ' CZ3' ' A' ' 194' ' ' TRP . 1.2 ptm180 -163.08 177.98 8.68 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.398 175.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . 0.664 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 27.9 p -155.25 170.46 21.81 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 21.7 pttm . . . . . 0 C--N 1.322 -0.619 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.797 -176.067 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.56 ' CZ3' ' HG2' ' A' ' 183' ' ' ARG . 71.9 m95 . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 120.717 0.294 . . . . 0.0 111.653 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.574 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 70.4 m -158.58 -63.97 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.574 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 76.9 Cg_endo -76.25 109.07 2.8 Favored 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 121.896 1.731 . . . . 0.0 113.456 -173.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.584 ' HB2' HE21 ' A' ' 181' ' ' GLN . . . -101.66 137.61 39.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.891 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 94.9 m -133.48 139.21 46.54 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.574 177.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -99.75 126.72 45.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.396 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.9 tp -129.25 137.68 56.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.029 0.443 . . . . 0.0 110.423 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -102.54 137.33 40.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.905 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 39.2 mm -96.98 113.08 62.39 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 176.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.8 147.44 72.39 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.921 2.414 . . . . 0.0 112.188 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 42.1 m -71.76 -7.51 48.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.974 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -95.16 7.77 45.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.773 175.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -59.77 -36.19 76.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.114 177.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 24.9 m . . . . . 0 C--N 1.319 -0.754 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.225 177.85 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo . . . . . 0 C--O 1.232 0.185 0 CA-C-O 120.684 0.202 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.93 174.26 5.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.154 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 54.74 47.53 22.25 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.694 0.621 . . . . 0.0 110.976 -178.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.445 HD23 ' OG1' ' A' ' 198' ' ' THR . 55.8 tp -70.34 94.39 0.94 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.002 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.17 130.79 43.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.541 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.431 HG13 HG13 ' A' ' 125' ' ' ILE . 5.0 t -117.38 113.88 43.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.667 178.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -111.94 148.43 33.76 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.18 -178.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.6 p -108.36 95.84 4.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 122.077 0.941 . . . . 0.0 109.92 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -87.36 122.06 30.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.456 -174.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -117.88 98.87 51.95 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.195 -173.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.6 155.39 49.83 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.977 2.451 . . . . 0.0 111.27 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.496 ' H ' ' CD ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -93.5 -4.93 50.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.958 0.408 . . . . 0.0 111.145 -176.317 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -132.49 -34.94 1.16 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.728 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -87.37 173.15 9.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.291 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -79.62 138.24 54.75 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.161 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.425 ' HG3' ' O ' ' A' ' 206' ' ' PHE . 38.3 Cg_endo -66.24 147.91 84.1 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.949 2.432 . . . . 0.0 111.847 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -149.09 156.99 43.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.958 0.408 . . . . 0.0 110.979 -174.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.417 HD12 HD11 ' A' ' 172' ' ' LEU . 16.3 mt -87.65 142.46 27.82 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.248 0.547 . . . . 0.0 110.602 174.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.491 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 19.5 t90 -117.03 102.1 9.05 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.701 177.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.431 HG13 HG13 ' A' ' 111' ' ' VAL . 4.2 mp -97.94 117.79 43.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -131.48 131.56 43.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.065 0.459 . . . . 0.0 110.897 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 29.0 p90 -123.48 151.92 42.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.897 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.2 m -127.54 78.09 75.18 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.4 -177.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo . . . . . 0 CA--C 1.541 0.854 0 C-N-CA 122.091 1.861 . . . . 0.0 113.395 177.997 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.45 HD21 ' HB2' ' A' ' 184' ' ' CYS . 13.5 tp . . . . . 0 N--CA 1.448 -0.544 0 CA-C-O 120.717 0.294 . . . . 0.0 110.414 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 4.1 mp -92.76 135.54 34.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.871 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.503 ' CE1' ' HB3' ' A' ' 184' ' ' CYS . 82.5 m-85 -122.61 144.42 49.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.17 -176.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -125.66 138.14 53.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.315 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 181' ' ' GLN . 4.4 mp -118.56 122.02 68.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.924 0.392 . . . . 0.0 110.148 -177.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.423 ' HB2' ' CZ2' ' A' ' 194' ' ' TRP . 23.1 ttp180 -107.1 123.86 48.84 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.58 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.7 pp -143.18 162.09 36.52 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.161 -176.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -168.35 148.8 4.35 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.91 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.424 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 40.6 Cg_endo -71.08 161.11 47.08 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.306 2.004 . . . . 0.0 111.067 170.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.423 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 13.2 pt-20 -63.35 -19.94 65.07 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.247 -175.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.423 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 88.6 mttt -97.02 10.37 39.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.0 0.428 . . . . 0.0 110.9 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.424 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -98.55 131.01 45.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.641 178.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -86.23 -37.13 18.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.206 0.527 . . . . 0.0 110.469 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -98.23 159.29 15.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.912 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.423 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 69.9 m95 -96.88 146.03 25.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.078 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -105.39 111.82 24.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.007 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.48 130.08 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.082 0.468 . . . . 0.0 110.959 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -126.46 133.64 51.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.791 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -102.78 130.09 49.64 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -94.11 -29.96 14.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.859 0.362 . . . . 0.0 111.4 -177.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 143' ' ' LEU . . . 100.33 -133.28 11.24 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.149 -176.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -106.81 31.6 5.18 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.34 0.591 . . . . 0.0 110.96 -177.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -115.69 151.97 34.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.385 177.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 34.9 p -102.17 21.81 14.27 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -175.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 125' ' ' ILE . 8.5 pt-20 -147.74 138.83 23.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.109 174.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -129.51 150.22 50.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.892 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.491 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 42.9 mmtm -112.78 146.0 39.58 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.409 ' HB ' ' HB2' ' A' ' 123' ' ' LEU . 32.6 mm -125.04 132.62 71.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 173.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.75 -16.94 14.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.915 0.388 . . . . 0.0 110.969 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 8.7 t -96.33 69.95 2.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.828 0.347 . . . . 0.0 111.451 -173.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.1 mm? -115.98 159.8 21.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.815 0.34 . . . . 0.0 110.603 176.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 57.7 m-70 -126.52 136.36 28.56 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.548 178.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 24.6 Cg_exo -62.29 122.25 10.6 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.745 2.297 . . . . 0.0 111.986 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 83.98 38.34 10.42 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.81 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -133.38 144.43 49.57 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -101.83 132.66 47.46 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.635 177.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -120.66 142.64 49.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.63 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.1 mm? -103.85 127.39 51.35 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 174.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.2 m -122.36 141.46 42.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.182 0.515 . . . . 0.0 111.55 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 99.1 mt-30 -140.65 142.73 34.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.337 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.2 p -138.57 139.42 41.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -145.97 142.82 29.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . 0.503 ' HB3' ' CE1' ' A' ' 144' ' ' TYR . 23.5 p -108.14 163.4 13.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.98 -175.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 121.38 0.609 . . . . 0.0 111.516 -178.008 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.423 ' CZ2' ' HB2' ' A' ' 147' ' ' ARG . 61.0 m95 . . . . . 0 N--CA 1.456 -0.165 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.452 ' H ' ' CD ' ' A' ' 196' ' ' PRO . 18.2 m -140.5 -55.75 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -176.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.549 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 8.4 Cg_endo -87.64 88.71 0.58 Allowed 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.312 2.008 . . . . 0.0 113.273 -171.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.457 ' HB2' ' NE2' ' A' ' 181' ' ' GLN . . . -85.78 106.76 17.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.908 0.385 . . . . 0.0 110.47 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.445 ' OG1' HD23 ' A' ' 109' ' ' LEU . 17.4 m -92.33 136.32 33.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.814 -177.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -95.36 124.15 39.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.742 -177.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.2 tp -127.45 129.43 70.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.234 0.54 . . . . 0.0 110.464 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -101.11 132.79 46.4 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.409 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 36.5 mm -94.08 115.48 65.24 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.07 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.41 155.4 47.09 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.998 2.465 . . . . 0.0 112.562 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 18.7 m -70.06 -17.31 63.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.645 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -82.27 1.15 38.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.87 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 62.4 t80 -57.41 -51.24 70.24 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.109 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.807 176.805 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 C--O 1.232 0.195 0 CA-C-O 120.469 0.112 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.481 HD13 ' N ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -134.91 -178.32 5.03 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -176.454 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 56.11 58.75 4.12 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.615 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.465 HD23 ' OG1' ' A' ' 198' ' ' THR . 33.9 tp -75.57 95.81 3.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.261 0.553 . . . . 0.0 109.735 175.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.72 128.83 40.13 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.01 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.9 t -125.7 122.09 61.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.04 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -139.21 155.35 47.86 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.176 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.506 HG22 ' CD1' ' A' ' 123' ' ' LEU . 21.8 t -100.18 94.21 3.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-O 121.375 0.607 . . . . 0.0 109.636 -177.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.446 ' O ' ' HD3' ' A' ' 116' ' ' PRO . 0.8 OUTLIER -78.86 108.14 12.09 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.794 -176.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -106.43 98.98 21.81 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.921 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 114' ' ' LYS . 14.6 Cg_exo -69.88 163.82 36.93 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.817 2.344 . . . . 0.0 112.881 -177.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -101.4 19.75 17.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.206 177.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -147.39 -55.25 0.23 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.673 -176.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -93.12 168.59 11.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.795 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.62 143.77 96.3 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.344 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.98 135.19 46.53 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.821 2.347 . . . . 0.0 112.024 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -139.44 160.49 39.71 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.047 0.451 . . . . 0.0 110.991 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.506 ' CD1' HG22 ' A' ' 113' ' ' VAL . 37.2 tp -91.12 123.76 34.82 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 176.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.526 ' CZ2' ' HD2' ' A' ' 126' ' ' LYS . 10.5 t90 -103.0 103.25 13.33 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.2 0.524 . . . . 0.0 110.49 -174.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.0 mp -95.73 113.61 30.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.081 178.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.526 ' HD2' ' CZ2' ' A' ' 124' ' ' TRP . 58.6 tttp -129.61 119.54 23.76 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.352 0.596 . . . . 0.0 110.656 -176.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' TRP . . . . . 0.427 ' CD2' HG21 ' A' ' 182' ' ' VAL . 29.2 p90 -109.76 163.61 13.35 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.752 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.1 t -103.25 122.81 43.93 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo . . . . . 0 C--N 1.347 0.452 0 C-N-CA 123.334 2.689 . . . . 0.0 112.202 177.899 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.3 tp . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.2 mt -101.29 150.39 23.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.297 -177.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.589 ' CD2' ' HB3' ' A' ' 184' ' ' CYS . 49.7 m-85 -116.54 143.98 44.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.178 -176.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -121.48 141.93 50.54 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.1 mp -117.95 124.94 73.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.024 0.44 . . . . 0.0 110.734 -175.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.454 ' HB2' ' CH2' ' A' ' 194' ' ' TRP . 14.3 ttp180 -109.01 120.32 42.2 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.062 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -145.69 161.49 39.75 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.471 -175.611 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -172.69 147.29 1.62 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.72 175.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -70.9 164.73 34.64 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.093 1.862 . . . . 0.0 111.067 170.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -64.29 -23.96 67.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.608 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.523 ' HE2' ' OE1' ' A' ' 176' ' ' GLN . 67.8 mmtt -81.7 -13.66 57.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.21 0.528 . . . . 0.0 110.512 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -83.97 129.61 34.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.746 -178.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -88.22 -26.39 22.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.409 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -107.12 144.66 33.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.791 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' TRP . . . . . 0.435 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 77.1 m95 -85.22 134.56 34.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.261 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -93.37 131.22 38.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.685 177.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.38 122.44 65.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.038 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 46.3 m-70 -130.57 113.45 14.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.202 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -79.09 132.71 36.68 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.988 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -99.12 -49.49 4.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 111.804 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 111.87 -137.75 14.49 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.02 13.58 22.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.066 0.46 . . . . 0.0 111.005 -177.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -68.75 -23.01 64.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.492 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 42.0 p 63.16 15.71 8.77 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.382 -1.281 . . . . 0.0 113.051 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -153.2 136.88 16.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 171.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 24.7 t80 -125.74 151.33 46.81 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.692 0.282 . . . . 0.0 110.525 -176.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.582 ' HD2' ' N ' ' A' ' 168' ' ' LYS . 0.0 OUTLIER -125.53 115.51 20.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.466 -175.087 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' A' ' 123' ' ' LEU . 34.5 mm -93.39 137.92 21.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 176.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -100.37 -32.53 10.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.851 0.358 . . . . 0.0 111.118 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 18.7 m -87.55 80.93 7.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.814 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.6 mm? -113.6 137.43 51.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 110.712 176.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 53.5 m-70 -100.05 125.93 38.31 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.18 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 22.9 Cg_exo -63.52 125.05 14.78 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.566 2.177 . . . . 0.0 112.448 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 86.6 26.93 31.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.409 178.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.523 ' OE1' ' HE2' ' A' ' 152' ' ' LYS . 77.4 mm-40 -125.18 152.47 44.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.294 0.568 . . . . 0.0 111.658 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -91.08 129.69 37.05 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.32 176.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.414 ' HB2' HG23 ' A' ' 200' ' ' ILE . 15.6 m-85 -117.58 137.74 52.4 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.43 177.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.5 mm? -102.31 128.74 48.74 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 175.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.414 HG23 ' HB ' ' A' ' 198' ' ' THR . 30.7 m -128.92 139.74 51.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 120.951 0.405 . . . . 0.0 111.33 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 98.9 mt-30 -139.19 136.58 35.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.355 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.427 HG21 ' CD2' ' A' ' 127' ' ' TRP . 13.5 p -120.05 137.42 53.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.99 0.424 . . . . 0.0 110.334 174.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -138.62 157.06 46.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.349 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . 0.589 ' HB3' ' CD2' ' A' ' 144' ' ' TYR . 24.3 p -136.34 174.75 10.27 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 121.17 0.509 . . . . 0.0 111.953 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' TRP . . . . . 0.454 ' CH2' ' HB2' ' A' ' 147' ' ' ARG . 72.2 m95 . . . . . 0 N--CA 1.457 -0.091 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.548 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 54.0 m -152.28 -63.77 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.548 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 97.5 Cg_endo -74.88 80.49 2.38 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 121.954 1.77 . . . . 0.0 113.952 -168.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . 0.412 ' HB2' HE21 ' A' ' 181' ' ' GLN . . . -78.65 100.61 7.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.169 0.509 . . . . 0.0 110.312 178.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . 0.465 ' OG1' HD23 ' A' ' 109' ' ' LEU . 20.0 m -94.17 138.9 31.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.713 -176.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -100.83 116.06 31.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.622 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.414 HG23 ' HB2' ' A' ' 178' ' ' TYR . 7.0 tp -123.73 137.49 56.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.061 0.458 . . . . 0.0 110.485 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -104.75 128.71 52.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.236 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 47.2 mm -87.09 124.39 68.66 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.86 151.47 80.81 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.049 2.499 . . . . 0.0 112.382 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 37.8 m -68.57 -30.12 68.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.757 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -92.56 39.8 1.04 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.681 0.753 . . . . 0.0 109.809 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' PHE . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 80.3 t80 -74.89 -35.19 62.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.863 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 12.8 t . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.514 -177.059 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.957 0.408 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.508 ' CE2' HG12 ' A' ' 101' ' ' VAL . 8.7 t80 -75.11 133.96 41.42 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.32 0.581 . . . . 0.0 109.912 175.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.3 mp -74.2 97.96 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.83 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.508 HG12 ' CE2' ' A' ' 99' ' ' TYR . 3.9 m -99.23 157.95 3.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -105.33 96.46 11.64 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.923 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -73.93 -82.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.033 1.822 . . . . 0.0 112.284 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 130' ' ' PRO . 14.0 m-20 -140.9 114.55 7.12 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-O 120.678 0.275 . . . . 0.0 110.573 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -75.93 169.22 22.6 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.848 2.366 . . . . 0.0 110.446 170.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.652 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 37.7 Cg_endo -69.11 92.19 0.45 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 121.923 1.749 . . . . 0.0 111.349 176.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.17 178.91 6.24 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.2 -175.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 57.34 49.09 13.72 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.665 -175.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.68 96.28 0.54 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.294 -0.867 . . . . 0.0 109.69 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.33 125.11 39.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.543 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.428 HG12 HD11 ' A' ' 123' ' ' LEU . 5.2 t -120.38 120.44 62.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.662 -177.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -127.77 142.88 51.19 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.3 p -97.99 117.14 42.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.118 0.485 . . . . 0.0 109.839 176.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -107.16 128.09 54.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.584 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -120.68 89.28 44.7 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.494 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -72.93 152.15 51.55 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 123.196 2.597 . . . . 0.0 111.989 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -73.81 -33.78 64.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.075 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -104.52 -49.3 3.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.473 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -76.4 167.02 22.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.772 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -75.16 143.28 76.83 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.588 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.6 138.13 63.01 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.596 2.198 . . . . 0.0 111.251 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -145.17 160.23 41.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.015 0.436 . . . . 0.0 111.232 -173.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.546 ' HB2' HD11 ' A' ' 172' ' ' LEU . 29.5 tp -93.98 121.88 35.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -102.82 104.42 14.7 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.034 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.2 mp -98.58 121.37 49.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.88 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -134.27 144.13 48.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.425 0.631 . . . . 0.0 110.476 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . 0.429 ' CH2' HD11 ' A' ' 146' ' ' ILE . 22.9 p90 -132.56 164.13 27.32 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.766 -173.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 52.3 m -97.44 131.36 27.37 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.73 149.27 87.12 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.458 2.106 . . . . 0.0 111.504 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' A' ' 104' ' ' ASP . 12.5 Cg_endo -55.76 138.69 82.19 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.097 2.532 . . . . 0.0 112.192 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.6 m -68.04 148.35 51.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.744 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 62.9 mt 64.04 -170.57 0.19 Allowed 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.105 0.562 . . . . 0.0 111.361 -177.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 34.0 mt 64.7 -70.58 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 123.574 0.749 . . . . 0.0 112.473 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 57.93 87.1 0.07 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.243 0.544 . . . . 0.0 110.611 -174.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.418 ' H ' HD12 ' A' ' 135' ' ' LEU . 5.2 mp -77.77 47.12 0.6 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.702 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -100.0 -29.78 12.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.942 -176.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.2 t -81.1 132.2 35.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.998 0.428 . . . . 0.0 110.965 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.69 162.81 9.64 Favored Glycine 0 C--N 1.332 0.315 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.986 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 75.7 t-105 -79.76 71.87 6.43 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 122.119 0.961 . . . . 0.0 110.501 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -145.95 75.48 1.42 Allowed 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 169.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.8 t -86.3 155.45 20.65 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.321 -177.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.448 HD21 ' SG ' ' A' ' 184' ' ' CYS . 32.9 tp -92.88 110.68 22.14 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.013 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 43.5 mt -92.31 144.69 25.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.913 0.387 . . . . 0.0 110.576 -177.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.492 ' CD1' ' HB3' ' A' ' 184' ' ' CYS . 46.2 m-85 -115.45 146.0 42.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.942 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 36.2 tt0 -126.3 133.87 51.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.604 176.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 181' ' ' GLN . 4.6 mp -118.64 125.65 74.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.309 -176.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -113.16 137.18 51.85 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -148.38 159.9 43.56 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.702 -179.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -170.17 145.53 2.35 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.453 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.465 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 37.4 Cg_endo -70.38 175.16 9.0 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.196 1.931 . . . . 0.0 112.537 173.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -62.16 -43.37 98.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -86.07 17.06 3.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.136 0.493 . . . . 0.0 111.298 -176.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.465 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -94.11 121.97 36.15 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.056 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.09 -22.68 33.37 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.894 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -121.01 156.04 33.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.91 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -90.92 140.61 29.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.36 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -104.41 107.35 18.22 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.836 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.03 129.57 39.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.124 0.487 . . . . 0.0 110.576 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 66.6 m-70 -128.2 114.11 16.55 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.961 175.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -83.43 115.89 22.25 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -80.59 -44.42 19.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.767 0.317 . . . . 0.0 111.053 -178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 143' ' ' LEU . . . 102.93 -127.96 9.38 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.313 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -86.23 -19.74 29.53 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.983 0.42 . . . . 0.0 111.018 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -75.0 146.29 41.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.202 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 22.5 p -104.98 30.02 5.87 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.206 0.527 . . . . 0.0 111.658 -174.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -157.16 142.4 17.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.603 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 34.3 t80 -136.52 150.7 48.79 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 -178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 0.0 OUTLIER -122.8 136.65 54.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.766 0.317 . . . . 0.0 110.669 -177.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 29.0 mm -109.92 128.52 65.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 175.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.55 -34.97 9.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.025 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.0 m -80.15 82.81 6.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.836 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 123' ' ' LEU . 73.7 mt -125.87 147.56 49.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.224 0.535 . . . . 0.0 111.687 -176.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -105.25 119.09 54.16 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.11 176.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.39 126.3 20.39 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.858 2.372 . . . . 0.0 112.66 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.55 45.41 7.94 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.628 176.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -146.98 149.05 32.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.96 0.41 . . . . 0.0 111.15 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -80.82 134.24 35.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.948 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -123.47 142.66 50.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.616 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.8 mm? -106.9 132.54 52.73 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 175.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.409 HG23 ' HB ' ' A' ' 198' ' ' THR . 27.1 m -132.28 141.98 43.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.028 0.442 . . . . 0.0 111.521 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.638 ' OE1' ' HB3' ' A' ' 194' ' ' TRP . 36.9 mt-30 -143.77 139.37 29.36 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.526 175.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 145' ' ' GLU . 7.1 p -133.36 139.06 49.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 174.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.462 ' NH1' ' HB3' ' A' ' 191' ' ' TRP . 37.1 ttt-85 -146.76 147.11 30.59 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.8 177.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.652 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 21.9 p -109.57 169.39 8.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.328 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.467 ' HB3' ' CD1' ' A' ' 191' ' ' TRP . 17.2 ptpt -124.92 90.92 50.27 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.261 0.553 . . . . 0.0 111.502 -177.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 189' ' ' GLY . 31.6 Cg_exo -62.15 157.64 43.6 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.042 2.494 . . . . 0.0 112.549 176.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -54.1 -49.05 69.99 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.881 0.372 . . . . 0.0 111.992 -172.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -97.6 10.74 39.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.842 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.54 ' O ' ' HD2' ' A' ' 186' ' ' PRO . . . -149.32 75.79 0.25 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.067 -1.063 . . . . 0.0 113.145 -176.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -76.27 153.93 35.58 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.467 ' CD1' ' HB3' ' A' ' 185' ' ' LYS . 14.8 p-90 -117.29 156.2 28.21 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.14 0.495 . . . . 0.0 111.518 -175.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 43.7 m -146.38 14.8 1.27 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.515 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -149.09 158.27 44.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.437 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.638 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 81.9 m95 -106.88 -179.56 3.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.321 -177.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.473 ' H ' ' HD2' ' A' ' 196' ' ' PRO . 48.1 t -171.43 -54.96 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -176.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.473 ' HD2' ' H ' ' A' ' 195' ' ' SER . 77.8 Cg_endo -75.52 69.92 5.79 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 122.114 1.876 . . . . 0.0 113.669 -174.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.45 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -74.48 105.85 5.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.872 0.368 . . . . 0.0 110.879 178.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.409 ' HB ' HG23 ' A' ' 180' ' ' VAL . 27.6 m -98.0 132.34 43.64 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.565 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -96.3 120.33 36.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.317 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.1 tp -126.91 131.84 70.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.207 0.527 . . . . 0.0 110.473 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -95.41 119.91 34.74 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.621 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.9 mm -79.98 117.99 70.21 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 172.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.91 149.59 91.03 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.529 2.153 . . . . 0.0 112.158 -176.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 39.1 m -69.92 -17.46 63.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.341 0.591 . . . . 0.0 109.639 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.87 9.58 7.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.529 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -57.76 -46.17 84.9 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.167 0.508 . . . . 0.0 110.359 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.1 p -88.48 137.88 31.93 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.617 174.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 63.7 mtt -77.4 63.33 2.56 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.327 0.584 . . . . 0.0 111.016 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -85.97 65.73 9.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.305 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 31.7 t70 . . . . . 0 C--O 1.247 0.951 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.481 -175.278 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 84.5 mtp . . . . . 0 N--CA 1.478 0.929 0 CA-C-O 121.117 0.484 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.503 ' HD1' ' O ' ' A' ' 101' ' ' VAL . 37.0 t80 -137.4 141.13 41.71 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.403 ' H ' HG13 ' A' ' 100' ' ' ILE . 46.1 mt -43.16 -53.62 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 123.869 0.731 . . . . 0.0 112.596 -175.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.503 ' O ' ' HD1' ' A' ' 99' ' ' TYR . 3.6 t -116.85 157.0 17.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.32 -174.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -118.77 74.35 12.44 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-O 121.484 0.659 . . . . 0.0 109.396 168.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.465 ' HD3' ' C ' ' A' ' 101' ' ' VAL . 54.0 Cg_endo -101.37 -161.19 0.04 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.637 2.891 . . . . 0.0 112.958 -174.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -144.71 99.29 4.79 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.84 174.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.28 170.4 4.12 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.457 2.771 . . . . 0.0 112.716 -176.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.539 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 7.9 Cg_endo -50.17 133.33 35.41 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.785 2.324 . . . . 0.0 111.906 178.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.41 HD23 ' H ' ' A' ' 107' ' ' LEU . 1.1 pt? -122.27 178.57 4.89 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.78 -176.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 56.51 47.34 18.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.071 0.462 . . . . 0.0 111.126 178.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 53.2 tp -74.05 95.94 2.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.035 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -102.65 125.36 49.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.346 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.438 HG21 HG21 ' A' ' 180' ' ' VAL . 8.1 t -110.39 118.86 58.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.904 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -128.62 145.97 50.99 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.134 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.0 p -101.9 117.71 47.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.296 0.57 . . . . 0.0 110.343 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -98.1 129.88 44.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.246 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -120.08 86.44 37.23 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.101 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.484 ' HG2' ' HG3' ' A' ' 119' ' ' ARG . 6.4 Cg_exo -76.04 164.47 31.41 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.432 2.755 . . . . 0.0 112.606 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -91.4 -36.45 13.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.384 -176.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -94.73 -51.79 4.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.712 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.484 ' HG3' ' HG2' ' A' ' 116' ' ' PRO . 10.5 ptm180 -90.77 162.52 14.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.289 177.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -79.71 152.04 74.65 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.387 -174.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.405 ' HG3' ' O ' ' A' ' 206' ' ' PHE . 28.9 Cg_endo -60.37 151.26 75.66 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.369 2.713 . . . . 0.0 113.188 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.449 ' CE2' ' HD2' ' A' ' 168' ' ' LYS . 35.7 p90 -161.58 158.67 26.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.711 -174.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 8.3 mt -82.93 139.7 33.23 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.214 173.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.56 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 10.2 t90 -118.06 94.31 4.46 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.14 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.406 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.6 mp -88.81 119.35 35.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.648 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.487 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 9.9 mtmp? -122.84 141.31 52.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.045 0.45 . . . . 0.0 110.985 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 40.2 p90 -138.45 152.06 47.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.04 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.2 t -89.09 126.16 59.89 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.19 139.36 21.47 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.374 2.716 . . . . 0.0 112.803 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.415 ' HG3' ' SG ' ' A' ' 184' ' ' CYS . 9.6 Cg_endo -50.75 138.1 41.62 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.679 2.919 . . . . 0.0 112.674 -177.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.6 m -71.33 -39.49 71.33 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.708 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 72.8 mt -118.72 104.4 10.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.764 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.429 ' O ' ' HB3' ' A' ' 134' ' ' ASP . 20.2 mt -100.84 -20.97 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.025 -175.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 133' ' ' ILE . 26.8 t70 70.52 14.17 7.33 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 122.016 0.912 . . . . 0.0 110.534 178.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 71.8 mt -122.37 141.02 52.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.519 -178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -89.35 150.42 22.57 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 12.0 t -83.15 158.38 22.39 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 -174.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 143.28 -64.3 0.48 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.253 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 44.5 p-90 -139.01 1.11 2.02 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -77.56 157.36 30.36 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.959 0.409 . . . . 0.0 110.438 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.7 m -156.2 132.71 10.18 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.88 173.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.586 HD23 ' H ' ' A' ' 142' ' ' LEU . 2.5 pt? -115.64 144.62 43.65 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -98.88 145.58 26.85 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.901 0.382 . . . . 0.0 110.334 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -102.43 148.73 25.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.567 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -132.57 133.55 43.83 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.832 -168.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.414 HD11 ' HB2' ' A' ' 161' ' ' ALA . 4.5 mp -126.85 120.42 55.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.877 0.37 . . . . 0.0 110.753 -177.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.62 ' HB2' ' CZ2' ' A' ' 194' ' ' TRP . 5.4 ttp-105 -104.22 120.13 40.48 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.572 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.2 pp -143.3 159.34 42.52 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.937 0.399 . . . . 0.0 111.719 -175.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -169.54 148.33 3.35 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.305 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.472 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 35.0 Cg_endo -71.16 166.9 27.74 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.247 1.965 . . . . 0.0 112.187 172.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.514 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 11.1 pt-20 -57.98 -41.15 82.37 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.514 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 95.0 mttt -85.25 16.84 3.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.904 0.383 . . . . 0.0 111.595 -176.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.472 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -101.15 128.17 47.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.59 176.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -85.53 -34.11 21.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.269 0.557 . . . . 0.0 110.333 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -103.12 147.49 26.93 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.705 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.482 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 76.3 m95 -90.7 148.6 22.49 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.5 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -107.42 114.14 27.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.719 174.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.1 mp -91.29 112.05 24.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -106.79 148.64 28.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.253 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -109.48 123.23 49.03 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.62 -174.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.414 ' HB2' HD11 ' A' ' 146' ' ' ILE . . . -79.24 -51.63 9.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.615 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 82.04 79.98 0.95 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.651 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 72.6 -46.18 0.64 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.078 0.951 . . . . 0.0 112.595 175.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -66.5 148.28 52.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.003 0.43 . . . . 0.0 110.81 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 56.9 p -104.14 36.41 2.37 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.35 0.595 . . . . 0.0 111.308 -176.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -157.77 140.36 14.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.186 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -131.88 149.72 52.36 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.56 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 42.1 mmtm -116.6 143.85 45.1 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 123' ' ' LEU . 29.8 mm -123.76 122.29 64.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 175.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.408 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.7 mm? -94.81 -32.82 13.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.311 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.6 m -77.96 83.81 4.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.838 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 86.9 mt -133.03 145.63 50.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.784 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -102.49 122.13 47.45 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.283 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.65 112.93 1.41 Allowed 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.468 2.112 . . . . 0.0 111.682 175.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 89.27 44.76 4.92 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.658 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -141.29 147.41 38.15 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.763 0.316 . . . . 0.0 110.17 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -91.55 137.82 32.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.469 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -125.19 140.49 52.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.023 0.44 . . . . 0.0 110.498 176.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.4 mp -104.64 132.1 51.29 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.438 HG21 HG21 ' A' ' 111' ' ' VAL . 34.5 m -135.62 147.23 28.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.948 0.404 . . . . 0.0 111.699 -175.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.591 ' HG2' ' HA ' ' A' ' 197' ' ' ALA . 53.6 mt-30 -143.46 153.28 42.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.392 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.9 p -124.67 140.44 47.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.113 0.482 . . . . 0.0 111.012 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.624 ' HG3' ' CE3' ' A' ' 194' ' ' TRP . 26.2 mtp-105 -133.34 163.99 28.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.912 175.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.539 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 31.5 p -140.7 125.72 18.38 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 167.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.449 ' HD3' HH12 ' A' ' 183' ' ' ARG . 23.4 pttm -119.42 89.88 41.34 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 121.328 0.585 . . . . 0.0 110.984 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.41 166.85 18.22 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.769 2.313 . . . . 0.0 112.354 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.41 -24.37 65.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.281 -172.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 52.9 m170 -93.09 4.4 54.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.562 0.22 . . . . 0.0 111.111 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -132.57 174.29 20.48 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 119.927 -1.13 . . . . 0.0 113.535 -174.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.414 ' CG ' ' N ' ' A' ' 191' ' ' TRP . 66.6 t80 -129.53 178.95 6.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.609 ' HA ' ' NH2' ' A' ' 183' ' ' ARG . 50.7 m95 -48.24 142.02 5.84 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 174.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 17.7 p -119.4 9.61 11.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.903 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . 61.71 21.64 12.34 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.624 ' CE3' ' HG3' ' A' ' 183' ' ' ARG . 69.0 m95 69.2 171.96 0.3 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.624 172.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.47 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 42.0 m -159.64 -57.58 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -176.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.487 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 9.2 Cg_endo -90.03 91.9 0.31 Allowed 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.539 2.159 . . . . 0.0 113.595 -170.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.591 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -79.48 116.55 19.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.023 0.44 . . . . 0.0 111.0 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 27.0 m -109.48 140.96 42.6 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.812 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -115.61 127.82 55.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.717 -0.22 . . . . 0.0 110.731 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.9 tp -125.45 135.52 63.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.033 0.444 . . . . 0.0 111.141 -178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -96.67 118.9 34.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.404 176.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.401 HD11 HD11 ' A' ' 123' ' ' LEU . 50.8 mm -84.21 119.88 73.82 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.44 151.1 86.56 Favored 'Trans proline' 0 N--CA 1.466 -0.147 0 C-N-CA 122.558 2.172 . . . . 0.0 112.251 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 19.2 m -69.94 -20.4 63.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.047 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -88.2 26.82 1.32 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.775 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.405 ' O ' ' HG3' ' A' ' 121' ' ' PRO . 85.7 t80 -66.18 -43.98 85.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.635 176.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 28.8 m -112.84 141.39 46.71 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.922 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 21.4 ptm -72.29 122.16 20.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.202 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -101.24 57.47 0.86 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.968 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 C--O 1.246 0.882 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.952 177.403 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.7 0.286 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.403 ' CE2' HG12 ' A' ' 101' ' ' VAL . 16.9 t80 -122.23 137.59 54.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.442 0.639 . . . . 0.0 110.703 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 91.2 mt -81.34 111.87 18.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.951 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.585 ' O ' ' HD3' ' A' ' 103' ' ' PRO . 13.9 m -107.85 158.89 7.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.678 -176.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -98.66 91.74 1.36 Allowed Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 173.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.585 ' HD3' ' O ' ' A' ' 101' ' ' VAL . 93.8 Cg_endo -83.4 -9.84 10.14 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.514 2.142 . . . . 0.0 112.401 -175.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.482 ' HB3' ' HB3' ' A' ' 130' ' ' PRO . 26.1 m-20 -127.18 78.73 74.04 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.974 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -85.31 153.19 10.72 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.159 2.573 . . . . 0.0 111.481 177.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.685 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 39.4 Cg_endo -69.5 94.82 0.51 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.268 1.979 . . . . 0.0 111.44 176.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.683 HD23 ' H ' ' A' ' 107' ' ' LEU . 2.7 pt? -90.41 175.01 7.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.675 -177.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 53.38 51.96 14.39 Favored 'General case' 0 C--O 1.233 0.193 0 O-C-N 123.556 0.535 . . . . 0.0 110.888 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 57.0 tp -78.84 96.37 5.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.148 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.83 128.71 45.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.387 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.448 HG21 HG21 ' A' ' 180' ' ' VAL . 2.4 t -116.62 115.74 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -125.0 130.18 51.83 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.965 0.412 . . . . 0.0 110.786 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.5 p -77.52 117.42 22.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.2 0.524 . . . . 0.0 109.874 176.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -102.23 122.38 44.09 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.282 0.563 . . . . 0.0 111.388 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -124.91 75.82 66.31 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.753 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.47 ' HG2' ' HB2' ' A' ' 119' ' ' ARG . 6.7 Cg_exo -76.03 -179.06 4.84 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 123.38 2.72 . . . . 0.0 112.782 -175.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -89.76 -64.21 1.17 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -71.96 -36.83 69.97 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.442 -177.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.47 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 56.9 mtt85 -88.01 156.35 19.36 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.592 -178.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.417 ' O ' ' HD1' ' A' ' 122' ' ' TYR . 50.6 mtmt -75.35 153.56 85.98 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.04 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.25 133.76 39.26 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.329 2.019 . . . . 0.0 111.503 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.417 ' HD1' ' O ' ' A' ' 120' ' ' LYS . 55.1 p90 -151.12 166.23 31.44 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.432 -176.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.437 ' HB3' ' HB ' ' A' ' 169' ' ' ILE . 38.9 tp -95.98 123.21 39.48 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 176.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.432 ' HE1' ' HB2' ' A' ' 166' ' ' GLU . 17.5 t90 -103.24 106.68 17.25 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.221 -176.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.4 mp -106.28 118.36 53.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.708 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -131.54 141.45 49.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.48 0.657 . . . . 0.0 111.24 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . 0.492 ' CH2' HD11 ' A' ' 146' ' ' ILE . 28.7 p90 -129.07 155.44 45.44 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.439 -176.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 22.6 t -83.36 130.53 56.17 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 128' ' ' SER . 50.4 Cg_exo -54.7 139.26 76.93 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.045 2.497 . . . . 0.0 112.492 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.482 ' HB3' ' HB3' ' A' ' 104' ' ' ASP . 76.8 Cg_exo -49.66 129.71 24.39 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.011 2.474 . . . . 0.0 111.899 176.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.99 -67.87 0.26 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -167.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 97.0 mt -101.75 80.58 2.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.486 0.66 . . . . 0.0 112.024 -173.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.3 mt -97.08 -58.53 3.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 172.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.0 t70 56.99 79.36 0.19 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.033 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.47 ' H ' HD12 ' A' ' 135' ' ' LEU . 4.0 mp -84.76 51.34 2.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.49 -175.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -101.04 -37.17 8.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.207 0.527 . . . . 0.0 110.034 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 19.3 p -81.8 -53.84 5.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.889 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -102.41 105.91 2.86 Favored Glycine 0 N--CA 1.442 -0.91 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.567 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -84.76 69.34 10.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.191 0.519 . . . . 0.0 110.592 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -103.42 178.95 4.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.372 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.3 m -117.9 129.4 55.61 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.596 HD11 ' H ' ' A' ' 185' ' ' LYS . 42.2 tp -91.69 116.47 28.91 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.967 0.413 . . . . 0.0 110.463 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.6 mp -106.18 144.8 32.37 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.557 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -113.61 165.31 12.64 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.151 -176.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.467 ' HB3' ' NE ' ' A' ' 183' ' ' ARG . 40.3 tt0 -154.07 139.37 17.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.527 -178.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.531 ' CD1' ' HB2' ' A' ' 161' ' ' ALA . 4.3 mp -121.92 130.19 74.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.042 0.449 . . . . 0.0 110.968 -172.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.476 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 27.8 ttp180 -108.18 121.15 44.26 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 1.7 pp -146.98 166.0 28.13 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.9 0.381 . . . . 0.0 111.413 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -172.45 149.89 2.13 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.751 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.35 162.45 42.34 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.34 2.026 . . . . 0.0 111.153 172.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -67.31 -14.53 63.0 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.546 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -93.93 2.97 56.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.289 0.566 . . . . 0.0 110.06 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -102.76 130.93 49.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.272 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -88.22 -35.85 17.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.24 0.543 . . . . 0.0 110.315 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -95.84 150.44 20.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.333 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.476 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 84.3 m95 -85.91 148.02 25.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.238 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -115.82 119.23 35.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.947 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.0 mp -99.05 131.68 45.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.103 0.478 . . . . 0.0 110.847 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -125.54 126.41 44.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.976 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -83.28 124.79 30.93 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.531 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -82.3 -36.43 27.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.895 0.379 . . . . 0.0 111.286 -176.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 88.34 -136.97 14.08 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.487 -0.863 . . . . 0.0 110.965 -175.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -99.85 70.99 1.65 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.088 0.47 . . . . 0.0 110.353 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -160.24 147.17 15.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.821 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.2 p -102.43 13.62 34.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.35 0.595 . . . . 0.0 111.074 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.432 ' HB2' ' HE1' ' A' ' 124' ' ' TRP . 1.0 OUTLIER -140.08 113.41 8.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.89 175.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -109.03 152.08 25.48 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.519 -173.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.446 ' HD2' ' N ' ' A' ' 168' ' ' LYS . 10.4 mptt -123.23 129.11 50.94 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.276 -176.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.437 ' HB ' ' HB3' ' A' ' 123' ' ' LEU . 28.9 mm -108.54 137.58 39.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 175.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.77 -23.18 12.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.997 0.427 . . . . 0.0 110.58 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 7.0 m -87.17 67.5 9.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.78 -175.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.01 140.43 39.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.968 0.413 . . . . 0.0 110.887 177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 32.5 m-70 -103.74 115.81 62.86 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.474 173.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 35.8 Cg_exo -59.02 126.09 20.06 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.822 2.348 . . . . 0.0 112.878 -177.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 88.86 29.45 18.14 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.752 177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -133.95 145.51 49.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.095 0.474 . . . . 0.0 110.734 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -82.44 132.05 35.21 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.441 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -114.71 136.7 52.78 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.872 0.368 . . . . 0.0 110.532 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.9 mm? -101.36 129.26 47.32 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 174.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.448 HG21 HG21 ' A' ' 111' ' ' VAL . 35.8 m -125.24 141.7 44.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.176 0.512 . . . . 0.0 111.655 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 94.4 mt-30 -144.59 134.06 23.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.959 177.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 6.5 p -117.71 135.73 57.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.467 ' NE ' ' HB3' ' A' ' 145' ' ' GLU . 7.8 ppt_? -116.12 155.73 27.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.83 0.348 . . . . 0.0 110.731 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.685 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 26.4 p -136.77 175.26 9.78 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.794 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.596 ' H ' HD11 ' A' ' 142' ' ' LEU . 37.1 mtmt -124.72 83.85 58.47 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.337 174.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.493 ' HD2' ' O ' ' A' ' 190' ' ' TYR . 50.6 Cg_exo -56.48 146.97 71.69 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.079 2.52 . . . . 0.0 112.528 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -70.91 -29.25 65.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.401 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -92.49 24.04 3.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.503 177.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -170.17 -133.1 1.55 Allowed Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.493 ' O ' ' HD2' ' A' ' 186' ' ' PRO . 31.5 p90 -163.17 -164.83 1.0 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 16.5 m95 -30.03 129.35 0.1 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.299 1.0 . . . . 0.0 112.717 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 35.8 p -98.17 -2.52 39.67 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.457 -177.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . 58.09 -157.83 0.3 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.785 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.404 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 29.9 m95 -117.73 106.32 12.93 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.56 -176.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.495 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 36.4 t -116.0 -59.67 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 195' ' ' SER . 95.4 Cg_endo -76.8 87.37 1.48 Allowed 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.857 1.705 . . . . 0.0 113.397 -173.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -75.61 101.75 5.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.101 0.477 . . . . 0.0 109.927 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 18.6 m -91.03 131.26 36.73 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.917 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -94.33 132.46 38.91 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.458 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.653 HG12 ' N ' ' A' ' 201' ' ' GLN . 0.0 OUTLIER -147.49 150.24 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.367 0.603 . . . . 0.0 111.297 174.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.653 ' N ' HG12 ' A' ' 200' ' ' ILE . 7.6 mm-40 -91.81 136.01 33.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.741 176.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 49.0 mm -100.89 114.75 65.83 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 165.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -58.64 148.95 79.51 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.905 2.403 . . . . 0.0 112.555 -175.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 17.1 m -69.79 -23.98 63.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.856 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -92.21 32.92 1.11 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.202 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -65.93 -32.44 73.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.135 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 8.3 t -100.86 141.84 33.17 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.119 0.485 . . . . 0.0 110.662 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -114.12 -71.13 0.76 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.733 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.3 t30 53.72 67.72 0.96 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.831 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.382 -0.818 . . . . 0.0 109.678 178.085 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.4 mmm . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 120.915 0.388 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.58 ' HD2' ' O ' ' A' ' 101' ' ' VAL . 83.2 t80 -135.26 161.02 36.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.58 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.608 HG22 HG23 ' A' ' 101' ' ' VAL . 4.4 mp -49.0 -48.31 16.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 123.53 0.732 . . . . 0.0 112.42 -177.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.608 HG23 HG22 ' A' ' 100' ' ' ILE . 63.4 t -124.33 137.12 58.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.163 -176.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -62.91 135.74 96.22 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.8 99.19 0.44 Allowed 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.563 2.175 . . . . 0.0 112.013 -176.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -119.6 91.02 44.08 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.949 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.86 145.64 32.26 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.88 2.387 . . . . 0.0 111.618 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.486 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 7.1 Cg_endo -49.68 112.46 0.7 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.271 2.647 . . . . 0.0 111.692 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.517 HD23 ' H ' ' A' ' 107' ' ' LEU . 2.7 pt? -73.15 163.02 28.74 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.384 -173.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 60.61 54.46 3.69 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.382 177.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -75.58 93.92 3.1 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -97.21 131.46 43.92 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.407 -176.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.467 HG12 HD22 ' A' ' 123' ' ' LEU . 2.6 t -120.57 114.39 43.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -129.39 140.36 51.37 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.367 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.9 p -87.16 115.56 28.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.413 0.625 . . . . 0.0 109.351 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.515 ' O ' ' HD3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -102.06 113.2 26.24 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.4 -174.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.463 ' HB3' ' SD ' ' A' ' 208' ' ' MET . 20.0 mp0 -105.49 98.89 18.4 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.316 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 114' ' ' LYS . 5.5 Cg_exo -80.79 146.08 16.36 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.295 2.663 . . . . 0.0 112.092 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -75.0 -23.99 58.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.831 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -118.15 3.27 12.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.774 0.321 . . . . 0.0 111.376 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -137.86 151.64 48.26 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' A' ' 120' ' ' LYS . 12.7 mptt -63.42 139.04 97.52 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.236 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.18 145.12 98.78 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.476 2.784 . . . . 0.0 112.752 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.524 ' CE1' ' HD2' ' A' ' 168' ' ' LYS . 35.4 p90 -149.28 155.04 39.93 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.26 -176.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 9.3 mt -80.43 127.41 32.38 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 173.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.569 ' CZ2' ' HD2' ' A' ' 126' ' ' LYS . 14.4 t90 -101.69 102.18 12.8 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.789 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.5 mp -93.62 114.27 29.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.569 ' HD2' ' CZ2' ' A' ' 124' ' ' TRP . 64.1 tttm -127.84 126.56 41.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.568 -175.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 39.9 p90 -126.04 158.98 33.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.338 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.451 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 37.7 m -99.61 131.74 24.26 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.195 179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.567 ' HG3' HG21 ' A' ' 165' ' ' THR . 33.5 Cg_exo -62.23 141.92 89.72 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.664 2.243 . . . . 0.0 111.725 176.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.7 86.9 0.17 Allowed 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.986 2.457 . . . . 0.0 113.22 -178.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.472 HG22 ' HG ' ' A' ' 132' ' ' LEU . 9.6 m 56.86 -95.22 0.05 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.243 176.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.472 ' HG ' HG22 ' A' ' 131' ' ' THR . 95.0 mt -117.12 -9.09 11.1 Favored 'General case' 0 CA--C 1.518 -0.255 0 O-C-N 122.409 -0.182 . . . . 0.0 111.125 -176.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.424 HD11 ' HB3' ' A' ' 129' ' ' PRO . 3.6 mp 67.9 -76.65 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 123.654 0.596 . . . . 0.0 110.137 -177.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.3 t70 45.91 62.06 2.4 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.977 0.911 . . . . 0.0 112.552 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.423 HD13 HG23 ' A' ' 133' ' ' ILE . 7.5 mp -79.19 -43.31 24.15 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 169.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -151.7 111.33 3.99 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.653 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.9 m -61.64 108.73 1.03 Allowed 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.208 -174.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 165.22 -105.16 0.24 Allowed Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -128.1 7.92 6.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.844 0.354 . . . . 0.0 110.49 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -73.81 99.3 3.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.011 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 15.5 p -87.2 147.29 25.65 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.396 -178.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.524 HD21 ' SG ' ' A' ' 184' ' ' CYS . 56.7 tp -80.0 132.67 36.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.145 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -93.88 152.7 18.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.035 0.445 . . . . 0.0 111.141 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.596 ' CD1' ' HB3' ' A' ' 184' ' ' CYS . 63.7 m-85 -129.78 149.84 51.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.012 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -128.73 139.7 52.09 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.404 HD11 ' HB2' ' A' ' 161' ' ' ALA . 4.0 mp -113.42 124.34 69.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.847 0.356 . . . . 0.0 110.448 -176.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.514 ' HB2' ' CZ2' ' A' ' 194' ' ' TRP . 16.3 ttp180 -113.76 120.18 39.91 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.414 ' C ' HD22 ' A' ' 148' ' ' LEU . 0.0 OUTLIER -143.42 160.22 40.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.542 0.211 . . . . 0.0 110.786 -177.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -165.23 148.65 7.21 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.241 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 178' ' ' TYR . 56.9 Cg_endo -73.47 169.37 22.47 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.57 2.18 . . . . 0.0 111.946 172.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -68.9 -11.54 60.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.667 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -93.76 -1.57 54.86 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.289 0.566 . . . . 0.0 110.004 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -100.19 122.6 43.27 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.771 -173.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -84.45 -28.38 26.87 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.562 0.696 . . . . 0.0 109.437 173.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -106.85 146.32 31.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.173 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.476 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 80.0 m95 -86.69 155.22 20.47 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.08 0.466 . . . . 0.0 111.582 -177.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -111.62 127.39 55.73 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.74 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.87 126.99 67.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.164 0.507 . . . . 0.0 111.222 -176.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -125.26 137.98 54.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -96.57 138.21 34.49 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.404 ' HB2' HD11 ' A' ' 146' ' ' ILE . . . -77.4 -23.16 50.73 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.514 -177.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 83.86 -46.06 3.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.994 177.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -179.52 -33.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.128 0.489 . . . . 0.0 109.895 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -72.28 160.08 32.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.385 -177.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.567 HG21 ' HG3' ' A' ' 129' ' ' PRO . 67.5 p -110.03 30.33 6.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.401 -174.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -153.19 140.6 19.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.711 175.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -135.65 153.25 51.69 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.672 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 22.5 mmtt -118.86 140.98 49.07 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 31.8 mm -114.89 123.79 70.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.691 0.281 . . . . 0.0 110.561 176.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.479 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.8 mm? -95.72 -16.76 21.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.5 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.8 m -80.8 71.15 7.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.709 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 59.4 mt -129.63 137.22 50.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.98 0.419 . . . . 0.0 111.34 -175.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -111.7 125.19 30.8 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.263 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.84 122.52 11.35 Favored 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.742 2.295 . . . . 0.0 112.46 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 95.43 22.26 22.34 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.749 177.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -131.24 148.73 52.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.935 0.398 . . . . 0.0 110.895 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -90.26 134.18 34.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.116 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 150' ' ' PRO . 12.1 m-85 -119.9 149.59 41.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.021 0.438 . . . . 0.0 110.652 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.9 mp -112.49 136.21 52.27 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.3 m -132.6 148.12 31.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.056 0.455 . . . . 0.0 111.372 -177.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 93.2 mt-30 -150.29 144.33 25.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.384 -179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.459 HG13 ' HG2' ' A' ' 106' ' ' PRO . 12.0 p -138.83 145.01 28.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 171.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.477 ' HD3' ' CZ3' ' A' ' 191' ' ' TRP . 7.6 ptm180 -155.53 161.22 40.93 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.223 0.535 . . . . 0.0 110.182 171.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.596 ' HB3' ' CD1' ' A' ' 144' ' ' TYR . 5.7 p -116.69 -174.45 2.57 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.077 178.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.43 134.96 6.47 Favored Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.955 -177.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.02 141.16 47.45 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.953 2.435 . . . . 0.0 111.446 177.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -71.92 -24.73 61.68 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.55 -176.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -84.15 10.21 10.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.58 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -151.36 -158.18 8.23 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.484 -0.647 . . . . 0.0 111.484 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -138.66 -171.44 3.07 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.024 0.44 . . . . 0.0 111.162 -177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.477 ' CZ3' ' HD3' ' A' ' 183' ' ' ARG . 17.8 m95 -70.65 157.63 37.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.571 176.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 15.6 t -142.63 41.05 1.57 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.392 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . 67.62 -172.27 0.19 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.917 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.514 ' CZ2' ' HB2' ' A' ' 147' ' ' ARG . 61.8 m95 -100.36 178.45 4.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.014 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.424 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 50.7 m -156.07 -53.89 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -178.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.539 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 1.1 Cg_endo -82.95 81.27 2.44 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.128 1.886 . . . . 0.0 113.057 -173.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.409 ' HA ' ' CG ' ' A' ' 181' ' ' GLN . . . -82.83 103.94 12.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.115 0.484 . . . . 0.0 110.66 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 53.9 m -96.7 138.06 34.83 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.257 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -102.76 130.87 49.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.495 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.2 tp -135.91 137.09 49.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.207 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -102.46 147.05 27.22 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.93 0.395 . . . . 0.0 111.566 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 21.8 mm -96.47 118.16 65.52 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.789 175.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.51 153.28 72.35 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.968 2.445 . . . . 0.0 112.11 -177.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 28.0 m -70.81 -23.03 62.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.889 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -94.2 34.56 1.25 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.643 176.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -69.66 -50.97 38.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.838 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 6.4 t -65.51 144.03 57.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.371 0.605 . . . . 0.0 111.098 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.463 ' SD ' ' HB3' ' A' ' 115' ' ' GLN . 85.8 mtp -115.55 8.78 15.22 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.679 177.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -135.33 86.16 2.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.698 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 34.8 t70 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.409 -0.805 . . . . 0.0 110.404 -177.352 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 14.6 t80 68.82 127.95 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 O-C-N 124.065 0.853 . . . . 0.0 111.671 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 48.0 mm -71.38 92.44 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.765 174.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.2 m -67.47 146.41 13.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.422 0.63 . . . . 0.0 111.243 -176.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.4 pm0 -83.17 139.42 42.22 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.796 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -78.78 -174.72 2.4 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.977 2.451 . . . . 0.0 111.749 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -105.03 106.75 56.73 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.48 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 28.1 Cg_exo -64.47 147.81 90.55 Favored 'Trans proline' 0 C--O 1.236 0.425 0 C-N-CA 123.224 2.616 . . . . 0.0 112.775 -176.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 105' ' ' PRO . 35.8 Cg_exo -58.48 132.94 51.41 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.068 2.512 . . . . 0.0 111.672 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.462 HD23 ' H ' ' A' ' 107' ' ' LEU . 1.6 pt? -122.3 -179.45 4.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.427 -172.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 54.78 41.22 32.08 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 123.576 0.548 . . . . 0.0 110.731 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.6 tt -64.53 103.97 0.74 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.792 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -109.74 132.42 54.16 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.705 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.3 t -114.42 126.35 71.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.84 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -126.52 132.61 51.33 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.947 0.404 . . . . 0.0 110.615 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.8 p -87.22 126.36 41.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.1 0.476 . . . . 0.0 110.196 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 114' ' ' LYS . 55.1 mmtt -106.68 127.29 53.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.032 0.444 . . . . 0.0 110.957 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -132.94 85.09 47.22 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.158 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.71 168.7 22.99 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.982 2.455 . . . . 0.0 111.5 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.451 ' HA ' ' OD1' ' A' ' 209' ' ' ASN . 0.4 OUTLIER -102.17 -6.24 23.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.859 0.362 . . . . 0.0 111.354 -177.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -132.88 2.62 3.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.481 0.658 . . . . 0.0 110.534 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -136.82 149.14 47.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.531 -176.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -56.97 130.63 79.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 O-C-N 123.513 0.508 . . . . 0.0 111.289 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.27 137.04 63.41 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.573 2.182 . . . . 0.0 111.361 176.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -140.9 163.89 31.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.468 -175.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.417 ' HB3' ' HB ' ' A' ' 169' ' ' ILE . 28.0 tp -100.19 124.99 46.26 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.457 ' CZ2' ' HD3' ' A' ' 126' ' ' LYS . 25.9 t90 -107.49 115.94 31.05 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.418 -177.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.4 mp -101.06 122.55 53.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.735 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.457 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 39.7 ttpt -129.72 120.36 24.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.189 0.519 . . . . 0.0 110.555 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . 0.45 ' CE2' HG21 ' A' ' 182' ' ' VAL . 40.3 p90 -116.28 160.78 19.98 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.931 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.3 m -95.61 129.37 34.86 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.51 162.72 29.74 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.905 2.404 . . . . 0.0 111.945 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -38.57 135.63 0.72 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.862 3.041 . . . . 0.0 113.57 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.5 p -68.01 -30.09 69.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.374 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 73.8 mt -99.07 -178.91 4.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.945 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.4 mt 70.39 -53.03 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 123.143 0.577 . . . . 0.0 111.801 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 54.49 65.33 1.53 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.299 0.571 . . . . 0.0 110.422 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.97 54.42 2.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.355 -176.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -79.38 -20.29 48.05 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.941 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 16.6 p -84.96 -178.36 6.81 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.866 177.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -88.42 -159.55 35.01 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.534 175.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 70.9 t90 69.34 -65.92 0.28 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.285 0.634 . . . . 0.0 111.363 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -71.09 100.14 1.97 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.4 m -96.42 132.23 42.17 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.188 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 41.8 tp -128.5 116.89 20.38 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.6 mp -99.84 143.19 30.36 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.01 0.434 . . . . 0.0 110.872 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -115.3 133.78 55.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.662 -176.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -116.75 139.35 50.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 181' ' ' GLN . 4.7 mp -120.26 119.72 60.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.088 0.47 . . . . 0.0 110.859 -176.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.422 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 21.4 ttp180 -104.18 121.68 43.78 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.533 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.2 pp -143.88 162.75 35.3 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.678 0.275 . . . . 0.0 111.316 -176.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -171.51 150.42 2.71 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.416 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.474 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 45.6 Cg_endo -72.16 156.37 55.57 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.096 1.864 . . . . 0.0 110.904 170.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -61.95 -18.57 60.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.246 -175.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -91.62 -3.85 55.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.984 0.421 . . . . 0.0 110.553 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.474 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -87.6 127.12 35.27 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.099 -177.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.72 -14.27 52.04 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.285 0.564 . . . . 0.0 110.475 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -119.95 139.02 53.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.794 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.422 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 78.2 m95 -81.4 147.98 29.53 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.354 177.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -116.08 117.62 30.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.279 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mp -93.05 123.18 45.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.392 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 59.8 m-70 -119.04 155.87 30.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.524 176.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -122.6 129.79 52.29 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.518 -176.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -97.88 -34.74 10.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.943 0.401 . . . . 0.0 110.953 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 99.58 -140.93 15.24 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.49 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -91.67 52.99 2.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.211 0.529 . . . . 0.0 109.906 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -150.1 149.92 30.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.329 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.422 ' HA ' ' CE2' ' A' ' 127' ' ' TRP . 61.3 p -101.4 33.08 3.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.954 -174.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -146.59 134.09 20.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.975 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 39.9 t80 -136.89 149.33 47.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.105 176.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.97 140.84 49.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.945 0.402 . . . . 0.0 111.224 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' A' ' 123' ' ' LEU . 34.7 mm -117.67 136.41 54.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.886 176.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -103.84 -23.85 13.35 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.833 0.349 . . . . 0.0 110.67 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 69.5 m -89.54 80.53 6.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.867 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.7 mm? -116.57 132.16 56.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.982 0.42 . . . . 0.0 110.691 176.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 52.9 m170 -100.09 118.62 61.17 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.657 176.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 32.5 Cg_exo -57.02 118.46 5.33 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.875 2.383 . . . . 0.0 112.813 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 97.22 5.64 58.06 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.96 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -109.03 151.4 26.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.157 0.503 . . . . 0.0 110.66 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.441 ' HE3' ' HB3' ' A' ' 199' ' ' PHE . 37.8 tttp -93.51 136.72 33.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.07 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -120.88 139.42 53.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.879 0.371 . . . . 0.0 110.21 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.533 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.7 mp -104.08 126.06 50.9 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.9 m -123.76 139.15 51.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.117 0.484 . . . . 0.0 111.312 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.533 ' HG3' ' HA ' ' A' ' 197' ' ' ALA . 0.0 OUTLIER -141.63 134.64 29.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.14 179.415 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.45 HG21 ' CE2' ' A' ' 127' ' ' TRP . 7.8 p -129.45 137.65 56.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -143.39 149.56 37.85 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.478 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 28.3 p -118.21 158.85 24.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.638 -174.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.485 ' HB3' ' CD1' ' A' ' 191' ' ' TRP . 20.8 ptmt -145.72 114.65 4.74 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.137 0.494 . . . . 0.0 111.279 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -89.57 -170.95 0.47 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.123 2.549 . . . . 0.0 111.472 176.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -88.51 10.72 19.31 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.145 0.498 . . . . 0.0 110.221 177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -98.72 -21.65 16.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.04 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -168.13 -163.34 21.91 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.382 -175.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -156.83 178.75 9.99 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.71 0.29 . . . . 0.0 110.341 -175.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.485 ' CD1' ' HB3' ' A' ' 185' ' ' LYS . 49.1 p-90 -139.5 137.18 35.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.195 176.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 12.5 p -113.5 6.48 17.11 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.232 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -155.99 167.02 31.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.207 0.527 . . . . 0.0 111.61 -176.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -106.99 148.17 29.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.416 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.613 ' H ' ' HD2' ' A' ' 196' ' ' PRO . 20.0 m -137.02 -57.88 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.569 0 CA-C-O 119.242 -0.409 . . . . 0.0 111.947 -177.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.613 ' HD2' ' H ' ' A' ' 195' ' ' SER . 59.3 Cg_endo -71.42 83.06 1.05 Allowed 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 121.627 1.551 . . . . 0.0 112.874 -178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.533 ' HA ' ' HG3' ' A' ' 181' ' ' GLN . . . -88.24 115.14 25.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.143 0.497 . . . . 0.0 110.662 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 85.7 m -107.12 138.39 43.39 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.053 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.441 ' HB3' ' HE3' ' A' ' 177' ' ' LYS . 62.1 m-85 -106.61 140.04 40.11 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.347 -176.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.9 tp -136.54 134.06 49.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.147 0.499 . . . . 0.0 110.533 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.413 HE21 ' HA ' ' A' ' 201' ' ' GLN . 0.0 OUTLIER -101.81 123.1 45.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.25 177.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.9 mm -79.34 123.52 84.51 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.96 149.63 87.85 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.904 2.402 . . . . 0.0 112.371 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 13.3 m -66.03 -26.48 67.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.94 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -91.91 27.78 2.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.55 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 82.6 t80 -62.71 -46.93 85.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.137 0.494 . . . . 0.0 110.433 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.4 m -97.36 115.49 27.8 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.9 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 93.8 mmm -139.28 -61.65 0.55 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.908 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . 0.451 ' OD1' ' HA ' ' A' ' 117' ' ' GLU . 8.9 p30 -147.62 154.28 40.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.625 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 C--O 1.252 1.191 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.139 179.535 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.1 ptm . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 120.767 0.318 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -99.45 137.22 38.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.269 0.556 . . . . 0.0 110.259 175.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.41 HG21 ' O ' ' A' ' 188' ' ' HIS . 88.2 mt -77.36 111.05 13.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.596 177.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 31.2 m -103.5 139.42 24.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.6 -174.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.561 ' CD ' ' HA3' ' A' ' 189' ' ' GLY . 3.1 mp0 -112.3 89.85 13.08 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.162 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -72.79 -81.33 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.888 1.725 . . . . 0.0 111.921 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -135.46 87.69 26.48 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 174.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.524 ' O ' ' HD3' ' A' ' 130' ' ' PRO . 38.1 Cg_exo -53.38 -46.45 33.75 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.547 2.165 . . . . 0.0 113.279 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' A' ' 105' ' ' PRO . 20.8 Cg_endo -96.66 104.54 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.128 1.885 . . . . 0.0 111.412 171.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.5 mp -91.52 178.24 6.0 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.835 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 128' ' ' SER . 39.6 mt-10 50.2 47.41 23.68 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 124.839 1.337 . . . . 0.0 111.727 165.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 37.2 tp -64.86 112.94 3.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.92 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -114.16 128.12 56.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.407 -178.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.497 HG12 HD22 ' A' ' 123' ' ' LEU . 4.5 t -116.44 126.34 73.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.82 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -141.38 126.44 18.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.913 0.387 . . . . 0.0 110.609 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.31 133.96 28.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.318 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -124.19 117.71 25.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.356 0.598 . . . . 0.0 111.088 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.454 ' NE2' ' HA ' ' A' ' 206' ' ' PHE . 46.6 mt-30 -108.59 99.64 34.52 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.476 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -68.1 -83.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.769 2.313 . . . . 0.0 112.66 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -175.17 -77.44 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 120.704 0.288 . . . . 0.0 110.64 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -87.27 -34.89 18.76 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -66.92 134.79 52.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.923 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -58.35 135.11 85.15 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.004 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.435 ' HB3' ' HG2' ' A' ' 115' ' ' GLN . 28.1 Cg_endo -62.12 140.37 83.5 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.654 2.236 . . . . 0.0 111.367 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.518 ' CE2' ' HD2' ' A' ' 168' ' ' LYS . 23.2 p90 -144.03 155.85 44.16 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.064 0.459 . . . . 0.0 111.594 -172.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.497 HD22 HG12 ' A' ' 111' ' ' VAL . 6.6 mt -83.12 130.51 35.12 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.839 172.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -107.91 106.65 17.01 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.706 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 166' ' ' GLU . 4.0 mp -100.88 131.17 49.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.776 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -138.87 156.72 47.07 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.965 0.412 . . . . 0.0 110.577 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 20.1 p90 -143.53 156.21 44.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.911 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 15.0 m -114.22 105.38 54.12 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.076 -178.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.75 167.72 23.63 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.496 2.13 . . . . 0.0 111.033 173.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 105' ' ' PRO . 73.3 Cg_exo -50.6 154.06 6.99 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.573 2.182 . . . . 0.0 112.562 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.7 m -46.32 -62.71 1.23 Allowed 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 122.901 0.48 . . . . 0.0 111.917 -175.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.479 ' O ' HD12 ' A' ' 132' ' ' LEU . 3.5 pp -147.28 125.16 11.95 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.249 0.547 . . . . 0.0 110.333 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 49.0 mt -111.18 -50.21 6.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.225 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.7 t70 58.69 79.52 0.21 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.527 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.529 HD22 ' H ' ' A' ' 187' ' ' ASP . 40.9 mt -70.49 -65.38 0.74 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.567 ' HB2' ' HB3' ' A' ' 140' ' ' PHE . 99.5 mttt -142.89 118.89 10.65 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.372 170.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.6 m -61.07 107.73 0.78 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.757 -166.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.18 -56.77 4.58 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.795 -0.639 . . . . 0.0 113.451 173.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.528 ' NE1' ' HB3' ' A' ' 136' ' ' LYS . 24.2 p90 -81.27 11.25 4.48 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -173.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.567 ' HB3' ' HB2' ' A' ' 136' ' ' LYS . 43.7 t80 -153.18 138.74 17.75 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 173.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.404 ' CG2' ' HB2' ' A' ' 163' ' ' GLN . 7.4 m -135.66 149.64 49.35 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 176.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.437 HD11 ' H ' ' A' ' 185' ' ' LYS . 55.5 tp -78.53 124.86 28.6 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.984 0.421 . . . . 0.0 110.535 -176.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.3 mp -89.4 139.84 30.11 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.786 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -114.49 149.68 35.98 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.914 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -133.22 133.42 42.71 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.37 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.2 mp -113.72 131.5 65.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.749 0.309 . . . . 0.0 110.632 -174.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.506 ' HB2' ' CH2' ' A' ' 194' ' ' TRP . 18.6 ttp180 -118.23 120.18 36.92 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.421 ' C ' HD22 ' A' ' 148' ' ' LEU . 0.0 OUTLIER -145.58 160.41 41.7 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.798 -178.128 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -169.72 147.66 3.06 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.532 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.426 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 39.3 Cg_endo -70.08 167.37 25.04 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.102 1.868 . . . . 0.0 111.789 173.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -61.78 -29.65 70.28 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.221 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -86.53 7.03 27.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -177.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.426 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -94.72 130.95 41.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.113 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -87.32 -26.63 23.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.842 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -123.69 150.08 44.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.294 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.454 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 77.6 m95 -82.34 145.83 29.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.542 -177.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 148' ' ' LEU . 43.2 mt-10 -98.71 118.96 36.62 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.445 175.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mp -98.16 116.18 40.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -119.84 114.66 22.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.12 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -81.28 133.68 35.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.854 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -101.11 -51.64 3.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.876 0.37 . . . . 0.0 111.481 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 127.59 -142.39 13.47 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -175.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.404 ' HB2' ' CG2' ' A' ' 141' ' ' THR . 0.0 OUTLIER -97.3 20.3 11.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.322 0.561 . . . . 0.0 111.127 179.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -103.41 143.75 32.29 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.806 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 38.8 p -96.48 36.49 1.36 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.039 0.447 . . . . 0.0 111.787 -175.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 125' ' ' ILE . 9.2 pt-20 -156.45 145.04 20.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.177 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -140.71 151.2 44.33 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.518 ' HD2' ' CE2' ' A' ' 122' ' ' TYR . 45.8 mmtt -116.41 137.67 51.97 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 41.0 mm -112.74 120.83 63.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 175.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.483 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.9 mm? -89.71 -38.96 13.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.086 -177.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 50.4 m -76.72 84.5 3.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.066 0.46 . . . . 0.0 111.206 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 90.2 mt -126.38 133.21 51.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.75 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -102.49 124.57 38.87 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.031 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.44 124.8 15.86 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.656 2.237 . . . . 0.0 112.387 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 88.16 27.56 25.38 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.549 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -126.82 146.95 50.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.027 0.442 . . . . 0.0 111.038 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -85.42 131.71 34.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.577 177.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -121.13 136.17 55.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.888 0.375 . . . . 0.0 110.471 176.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 8.5 mp -103.65 126.62 50.91 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.428 HG21 HG21 ' A' ' 111' ' ' VAL . 27.3 m -123.2 142.71 38.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.147 0.499 . . . . 0.0 111.813 -177.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.557 ' NE2' ' HB2' ' A' ' 197' ' ' ALA . 89.4 mt-30 -143.25 157.91 44.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.899 177.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 9.9 p -142.46 144.39 24.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.142 178.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.657 ' HG2' ' CZ3' ' A' ' 194' ' ' TRP . 1.9 ptm180 -138.82 175.6 9.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.213 0.53 . . . . 0.0 110.673 177.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 105' ' ' PRO . 10.6 p -160.78 -172.66 3.59 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.369 176.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.437 ' H ' HD11 ' A' ' 142' ' ' LEU . 17.7 ptmt -142.56 91.4 7.56 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 121.199 0.523 . . . . 0.0 111.176 177.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -69.17 149.84 71.12 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 122.714 2.276 . . . . 0.0 112.034 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.529 ' H ' HD22 ' A' ' 135' ' ' LEU . 17.5 t70 -61.46 -25.23 67.1 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.823 -176.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.41 ' O ' HG21 ' A' ' 100' ' ' ILE . 20.8 m-70 -74.76 -39.42 61.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.997 0.427 . . . . 0.0 110.252 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.561 ' HA3' ' CD ' ' A' ' 102' ' ' GLN . . . -118.39 -134.22 4.98 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.969 -175.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -163.81 -168.53 1.65 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -51.98 139.53 22.35 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.831 0.348 . . . . 0.0 111.043 173.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 50.1 m -135.69 25.81 3.38 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.985 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . 58.32 -152.72 0.39 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.051 -178.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.657 ' CZ3' ' HG2' ' A' ' 183' ' ' ARG . 14.4 m95 -117.16 115.35 25.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.694 -174.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.552 ' OG ' ' HD3' ' A' ' 196' ' ' PRO . 3.5 p -103.75 -50.59 0.14 Allowed Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.552 ' HD3' ' OG ' ' A' ' 195' ' ' SER . 4.7 Cg_exo -78.97 80.53 3.06 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.085 1.857 . . . . 0.0 113.078 -173.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.557 ' HB2' ' NE2' ' A' ' 181' ' ' GLN . . . -83.96 101.08 11.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.324 0.583 . . . . 0.0 110.104 176.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 25.2 m -95.97 131.45 42.33 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.605 -176.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -95.58 114.82 26.61 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.571 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.3 tp -118.23 134.92 60.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.056 0.455 . . . . 0.0 110.153 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -102.37 134.78 45.11 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.987 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 40.4 mm -92.16 116.48 66.54 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.614 177.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.97 150.24 84.89 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.557 2.171 . . . . 0.0 112.074 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 30.2 p -67.84 -18.21 64.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.596 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -86.18 10.24 15.13 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.636 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.454 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 57.5 t80 -64.71 -37.98 89.42 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 173.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 23.6 m -155.8 140.98 17.48 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.134 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 86.8 mtp -60.7 -19.55 58.92 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -175.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -128.78 148.35 50.86 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 172.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 C--O 1.246 0.897 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.242 179.46 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 89.5 mmm . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -67.33 133.74 50.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.12 0.486 . . . . 0.0 110.802 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.1 mt -69.08 105.24 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.192 175.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.42 134.38 31.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.565 -175.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -100.59 105.87 39.75 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.426 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -90.17 -171.42 0.47 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.742 2.294 . . . . 0.0 110.467 175.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.45 ' N ' ' HD3' ' A' ' 105' ' ' PRO . 2.1 p30 34.89 57.35 2.26 Favored Pre-proline 0 N--CA 1.468 0.442 0 O-C-N 124.181 0.925 . . . . 0.0 112.373 -177.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 104' ' ' ASP . 53.0 Cg_endo -91.94 175.97 1.99 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.204 2.603 . . . . 0.0 112.234 -173.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.01 111.44 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.414 2.076 . . . . 0.0 111.225 174.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 pp -122.77 178.92 4.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.76 -175.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 53.07 46.17 27.26 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 123.659 0.599 . . . . 0.0 110.702 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 51.7 tp -70.28 99.17 1.49 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.909 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.94 130.22 46.09 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.342 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.464 HG21 HG21 ' A' ' 180' ' ' VAL . 6.1 t -123.8 127.07 73.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.812 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -143.41 159.17 42.88 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.976 0.417 . . . . 0.0 110.848 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.79 129.65 60.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.408 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -111.28 132.92 54.0 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -122.52 83.72 47.7 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.832 0.349 . . . . 0.0 111.448 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -83.43 163.78 14.7 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.334 2.689 . . . . 0.0 111.376 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -97.62 -31.09 12.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.078 0.466 . . . . 0.0 111.006 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -86.37 -22.12 26.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.615 0.722 . . . . 0.0 109.965 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -123.07 135.47 54.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.064 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -56.66 134.71 78.03 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -49.79 141.12 28.79 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.419 2.746 . . . . 0.0 112.445 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -144.55 162.22 37.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.931 -173.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.485 ' HB2' HD11 ' A' ' 172' ' ' LEU . 31.4 tp -95.77 128.49 42.69 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.582 176.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -105.75 114.37 28.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.373 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.3 mp -104.29 120.9 55.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -128.94 128.67 44.22 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.096 0.474 . . . . 0.0 110.913 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . 0.455 ' CH2' HD11 ' A' ' 146' ' ' ILE . 32.6 p90 -121.41 160.79 23.38 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.907 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.3 t -123.74 123.66 26.25 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.78 171.63 17.05 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.326 2.017 . . . . 0.0 111.181 175.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -46.56 138.5 14.24 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.95 2.433 . . . . 0.0 111.683 175.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.8 m -57.49 -32.75 67.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.183 -176.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 96.0 mt -126.32 108.24 11.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.869 176.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 26.7 mt -97.28 -65.18 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.097 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.7 t70 64.12 87.28 0.11 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.514 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 69.8 mt -112.02 13.88 20.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.718 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -72.95 111.76 8.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.455 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.9 t 178.26 -23.99 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.702 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 179.63 -158.7 22.7 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 23.7 t90 -81.32 75.91 8.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.096 0.474 . . . . 0.0 110.657 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -138.74 116.59 11.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.007 0.432 . . . . 0.0 110.372 176.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.3 m -132.73 136.03 46.12 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.264 176.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.537 HD23 ' H ' ' A' ' 142' ' ' LEU . 2.4 pt? -82.62 111.73 18.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.435 0.636 . . . . 0.0 110.347 -177.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 56.4 mt -91.95 149.58 21.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.688 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -108.0 150.61 26.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.245 0.545 . . . . 0.0 111.575 -174.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -140.91 130.12 23.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.171 -178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.3 mp -110.73 129.12 66.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.962 0.41 . . . . 0.0 110.82 -173.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.497 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 15.9 ttp180 -111.15 120.08 41.11 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -146.22 161.11 40.98 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.621 0.248 . . . . 0.0 110.969 -177.384 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -167.84 147.46 4.3 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.684 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.446 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 38.7 Cg_endo -71.96 178.01 6.4 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.411 2.074 . . . . 0.0 112.339 172.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.453 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 11.0 pt-20 -70.5 -30.84 67.74 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -176.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.453 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 88.5 mttt -91.67 13.01 19.25 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.152 0.501 . . . . 0.0 110.825 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.446 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -98.71 119.79 38.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.719 178.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.79 -32.47 35.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.324 0.583 . . . . 0.0 110.43 178.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -101.28 156.99 17.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.604 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.497 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 81.5 m95 -96.15 139.93 31.59 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.076 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -94.97 115.14 27.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.54 175.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -93.69 119.02 40.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.516 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 34.8 m-70 -120.14 108.14 13.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.193 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -75.24 126.0 30.12 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -93.51 -43.43 8.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.017 0.437 . . . . 0.0 110.985 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 102.95 -134.94 12.03 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.098 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -94.97 60.95 2.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.267 0.556 . . . . 0.0 110.138 -176.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -156.81 146.28 20.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.117 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 44.0 p -103.22 37.37 2.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.182 0.515 . . . . 0.0 111.26 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -149.09 140.96 23.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.936 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.516 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 22.0 t80 -142.09 145.18 34.0 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 174.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 0.7 OUTLIER -119.17 129.85 55.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.776 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 35.8 mm -101.46 126.46 55.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 174.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -100.16 -30.78 11.74 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.724 0.297 . . . . 0.0 110.763 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 13.3 m -79.65 81.44 5.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.466 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 123' ' ' LEU . 74.1 mt -126.36 140.97 52.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.954 0.407 . . . . 0.0 111.367 -176.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 13.7 m-70 -112.55 131.19 22.77 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.222 175.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 27.6 Cg_exo -61.11 130.01 30.81 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.608 2.205 . . . . 0.0 112.13 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 77.64 26.77 60.27 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.275 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.433 ' HB3' ' CE1' ' A' ' 178' ' ' TYR . 0.6 OUTLIER -115.4 138.23 51.22 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.763 0.316 . . . . 0.0 110.23 179.003 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -82.71 129.9 35.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.365 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 176' ' ' GLN . 66.5 m-85 -121.06 140.19 52.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.872 0.368 . . . . 0.0 110.311 177.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.504 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.7 mm? -107.78 129.38 55.05 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 176.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.464 HG21 HG21 ' A' ' 111' ' ' VAL . 29.4 m -127.46 138.08 55.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.059 0.457 . . . . 0.0 111.945 -175.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.513 ' OE1' ' HB3' ' A' ' 194' ' ' TRP . 78.6 mt-30 -144.0 153.2 41.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.727 177.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.19 137.99 45.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.888 0.375 . . . . 0.0 110.759 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.478 ' HD2' ' C ' ' A' ' 183' ' ' ARG . 6.1 ppt_? -126.45 164.02 22.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.127 177.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 186' ' ' PRO . 20.1 p -146.69 175.34 10.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.003 176.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -113.1 88.98 13.1 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.593 ' HD2' ' O ' ' A' ' 189' ' ' GLY . 2.3 Cg_endo -81.48 164.99 18.69 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.933 2.422 . . . . 0.0 111.955 177.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -82.44 -17.06 46.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.725 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -81.07 9.37 6.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.441 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.593 ' O ' ' HD2' ' A' ' 186' ' ' PRO . . . 143.59 109.88 0.71 Allowed Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.429 ' O ' ' HB2' ' A' ' 191' ' ' TRP . 68.7 m-85 -64.77 135.03 55.37 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.462 0.173 . . . . 0.0 110.819 -178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.429 ' HB2' ' O ' ' A' ' 190' ' ' TYR . 84.1 m95 71.8 104.69 0.07 Allowed 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 124.261 0.976 . . . . 0.0 111.702 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 33.0 p -88.29 -1.87 58.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.517 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . 62.81 -169.57 0.18 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.744 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.513 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 70.5 m95 -110.96 112.69 24.7 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.13 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.683 ' H ' ' HD2' ' A' ' 196' ' ' PRO . 20.3 m -137.21 -54.01 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.683 ' HD2' ' H ' ' A' ' 195' ' ' SER . 66.4 Cg_endo -74.25 82.99 1.73 Allowed 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 121.686 1.59 . . . . 0.0 113.208 -175.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.43 ' HB2' ' NE2' ' A' ' 181' ' ' GLN . . . -82.3 104.03 12.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.805 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 34.7 m -95.21 135.79 36.36 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.738 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -98.72 119.48 37.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.068 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.3 tp -125.71 138.56 54.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.026 0.441 . . . . 0.0 110.627 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -106.78 140.86 38.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.361 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 41.0 mm -96.87 124.51 49.81 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.837 177.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.0 149.12 81.64 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.853 2.369 . . . . 0.0 112.04 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 3.0 p -75.24 -15.19 60.55 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.856 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -95.99 18.07 14.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.084 175.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -55.47 -60.58 3.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.27 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 3.7 m -72.75 131.4 42.3 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.144 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 20.5 ptp -90.44 54.87 2.86 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.869 0.842 . . . . 0.0 110.023 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -139.57 152.28 46.73 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.127 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 . . . . . 0 C--O 1.246 0.874 0 CA-C-O 118.576 -0.726 . . . . 0.0 110.71 -179.152 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.862 0.363 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -146.28 132.58 19.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.26 0.553 . . . . 0.0 111.081 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 72.7 mt -72.24 95.64 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.63 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.1 p -114.56 133.37 60.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.427 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -71.82 127.83 90.27 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.27 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.66 -57.09 0.61 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.928 2.419 . . . . 0.0 112.217 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.467 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 6.1 t70 -165.14 128.5 1.65 Allowed Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 104' ' ' ASP . 11.4 Cg_exo -71.04 151.08 61.42 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.714 2.276 . . . . 0.0 112.249 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.511 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 9.7 Cg_endo -53.05 116.77 3.15 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.852 2.368 . . . . 0.0 111.446 177.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.86 175.34 6.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.485 -172.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 55.97 47.13 20.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.849 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.6 tp -68.92 98.9 0.99 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.631 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.63 130.39 41.11 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.457 -176.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -125.13 120.41 58.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.087 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -138.0 157.7 45.82 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.723 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.3 p -107.53 131.19 58.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.136 0.493 . . . . 0.0 110.295 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -103.04 123.88 47.46 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 177.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -123.38 80.36 53.39 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.006 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.466 ' HG2' ' HB2' ' A' ' 119' ' ' ARG . 1.0 OUTLIER -86.69 163.86 9.2 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.562 2.841 . . . . 0.0 111.798 177.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -97.45 -30.27 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.054 0.454 . . . . 0.0 111.169 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -93.76 -25.48 17.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.434 0.635 . . . . 0.0 110.177 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.466 ' HB2' ' HG2' ' A' ' 116' ' ' PRO . 23.3 mmt180 -110.91 151.74 27.55 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 175.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -73.78 138.3 76.82 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.63 132.93 55.04 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.946 2.431 . . . . 0.0 111.804 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.445 ' CD2' ' HD2' ' A' ' 168' ' ' LYS . 53.1 p90 -145.8 157.62 43.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.974 0.416 . . . . 0.0 110.957 -174.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.453 ' HB3' ' HB ' ' A' ' 169' ' ' ILE . 26.3 tp -91.21 131.17 36.92 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.624 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.558 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 12.4 t90 -110.47 109.38 19.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.207 -175.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.2 mp -108.05 123.37 63.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.082 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -123.23 148.42 45.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.834 0.35 . . . . 0.0 110.622 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -138.87 152.2 47.6 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.916 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 m -113.26 138.02 22.24 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.705 -175.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 51.4 Cg_exo -56.42 130.62 41.04 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.945 2.43 . . . . 0.0 111.556 175.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 129' ' ' PRO . 15.4 Cg_exo -67.47 174.38 7.4 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.777 2.318 . . . . 0.0 112.783 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.9 m -70.59 -33.57 71.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.352 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 39.2 mt -81.47 -179.38 7.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.295 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 27.1 mt 69.51 -58.04 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 123.173 0.589 . . . . 0.0 111.008 -173.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.9 t70 52.82 82.54 0.07 Allowed 'General case' 0 C--O 1.237 0.404 0 O-C-N 123.778 0.673 . . . . 0.0 110.581 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.419 ' H ' HD12 ' A' ' 135' ' ' LEU . 5.5 mp -73.03 67.86 0.89 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.397 -176.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -92.84 -14.66 27.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.43 0.633 . . . . 0.0 109.717 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.5 p -70.12 119.9 15.01 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.44 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -71.43 159.88 53.93 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.944 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 8.1 m-90 72.67 -44.26 0.59 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.7 0.8 . . . . 0.0 111.584 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -59.07 120.0 8.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.941 0.401 . . . . 0.0 110.489 176.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.0 m -118.74 128.81 54.84 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.612 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 29.7 tp -94.22 124.08 38.01 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.699 HD11 ' HG2' ' A' ' 163' ' ' GLN . 8.3 mp -98.01 153.28 18.49 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.848 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.543 ' CD2' ' HB3' ' A' ' 184' ' ' CYS . 75.2 m-85 -128.99 147.56 50.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.301 -173.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -128.12 139.82 52.29 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.3 mp -117.44 129.52 73.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.039 0.447 . . . . 0.0 110.718 -175.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.481 HH22 ' NE2' ' A' ' 181' ' ' GLN . 7.7 ttp-105 -112.67 120.4 41.42 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.551 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -143.69 160.38 40.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.463 0.173 . . . . 0.0 110.821 -177.266 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -165.96 151.76 8.2 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.395 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.507 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 37.1 Cg_endo -70.54 157.12 59.8 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.52 2.147 . . . . 0.0 110.923 170.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.526 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 14.9 pt-20 -62.51 -27.64 69.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.473 -0.785 . . . . 0.0 113.013 -170.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.526 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 82.4 mttt -94.09 9.29 38.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.091 0.472 . . . . 0.0 110.777 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.507 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -90.21 131.71 35.89 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.263 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.96 -35.35 24.04 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.97 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -103.66 159.98 15.15 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.273 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.429 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 60.0 m95 -101.04 156.23 17.53 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.652 -176.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -102.79 120.97 41.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.194 173.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mp -101.54 117.84 47.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.948 177.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -124.55 124.58 42.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.924 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -89.48 126.1 35.44 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.047 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.401 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -83.96 -47.67 10.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.159 0.504 . . . . 0.0 110.88 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.419 ' C ' ' HG ' ' A' ' 143' ' ' LEU . . . 107.57 -128.49 9.21 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.523 -0.846 . . . . 0.0 111.805 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.699 ' HG2' HD11 ' A' ' 143' ' ' LEU . 34.4 mt-30 -94.76 5.59 51.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.25 0.548 . . . . 0.0 110.464 -175.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -95.94 142.74 27.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.534 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.451 HG22 ' CE1' ' A' ' 144' ' ' TYR . 61.9 p -101.63 23.98 10.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.459 0.647 . . . . 0.0 111.0 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -148.69 137.74 21.61 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -130.1 149.52 51.78 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.71 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.558 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 42.5 mmtm -114.69 135.85 53.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.593 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.453 ' HB ' ' HB3' ' A' ' 123' ' ' LEU . 31.9 mm -109.86 136.32 46.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 172.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -102.29 -31.39 10.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.925 0.393 . . . . 0.0 110.852 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 44.0 m -89.33 80.95 6.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.652 -177.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.8 mm? -112.97 131.23 55.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.978 174.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -88.68 116.84 67.42 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.542 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.42 116.09 3.18 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.577 2.185 . . . . 0.0 112.066 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 108.27 -2.05 33.02 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.992 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -110.22 144.27 39.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.447 0.641 . . . . 0.0 111.766 -175.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -85.29 128.75 34.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.877 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -109.98 146.65 34.9 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.077 0.465 . . . . 0.0 110.886 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.8 mp -111.17 127.83 55.71 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.88 142.99 40.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.913 0.387 . . . . 0.0 111.447 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.595 ' HG2' ' HA ' ' A' ' 197' ' ' ALA . 62.4 mt-30 -143.41 139.19 29.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.574 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 12.6 p -125.65 141.18 46.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.803 0.335 . . . . 0.0 110.165 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -136.82 150.99 48.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.005 0.431 . . . . 0.0 110.639 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.543 ' HB3' ' CD2' ' A' ' 144' ' ' TYR . 18.5 p -128.89 155.98 44.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.947 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.53 ' HB3' ' CD1' ' A' ' 191' ' ' TRP . 17.9 ptpt -126.9 85.79 60.2 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.399 0.619 . . . . 0.0 112.415 -172.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.406 ' HD2' ' O ' ' A' ' 189' ' ' GLY . 6.5 Cg_exo -74.37 164.11 34.78 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.741 2.294 . . . . 0.0 110.77 172.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -72.28 -14.11 61.68 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.141 0.496 . . . . 0.0 110.775 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -86.37 -6.91 58.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.97 176.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.406 ' O ' ' HD2' ' A' ' 186' ' ' PRO . . . -172.73 100.37 0.15 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.0 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -88.93 119.08 29.12 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.53 ' CD1' ' HB3' ' A' ' 185' ' ' LYS . 30.1 p-90 -81.19 145.74 30.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.188 0.518 . . . . 0.0 111.263 -174.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 41.6 m -126.51 3.17 6.9 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.554 174.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.05 174.46 11.53 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.371 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.532 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 44.6 m95 -114.49 -176.73 2.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.982 -0.553 . . . . 0.0 109.781 -177.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.563 ' OG ' ' HD3' ' A' ' 196' ' ' PRO . 13.9 p -168.16 -50.07 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -177.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.563 ' HD3' ' OG ' ' A' ' 195' ' ' SER . 94.8 Cg_endo -85.46 86.73 1.02 Allowed 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 121.69 1.593 . . . . 0.0 113.516 -171.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.595 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -83.76 114.17 21.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.146 0.498 . . . . 0.0 111.505 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 86.2 m -106.07 139.56 40.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.022 175.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -104.09 148.69 25.97 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.384 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.8 tp -154.29 134.56 4.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.248 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -97.58 125.53 42.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.681 0.277 . . . . 0.0 110.276 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 44.6 mm -80.59 117.7 69.04 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -59.07 145.69 96.81 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.551 2.167 . . . . 0.0 111.874 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 26.8 m -70.1 -8.22 47.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.474 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.71 -15.24 60.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.984 176.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 9.7 t80 -61.62 131.82 51.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.197 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 208' ' ' MET . 49.8 m 70.21 153.42 0.11 Allowed 'General case' 0 CA--C 1.539 0.521 0 O-C-N 123.314 0.384 . . . . 0.0 111.223 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 207' ' ' THR . 62.9 mtt 75.2 -69.53 0.17 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.494 0.717 . . . . 0.0 111.489 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -159.82 133.02 6.89 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -177.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.202 -179.939 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.841 0.353 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -120.45 141.4 50.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.411 0.624 . . . . 0.0 111.108 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.465 HD11 ' CZ ' ' A' ' 190' ' ' TYR . 83.9 mt -79.84 99.98 4.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.385 176.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.1 m -83.43 116.15 27.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.171 -177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -130.08 94.36 31.09 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.209 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -68.06 -59.15 0.11 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.38 2.053 . . . . 0.0 112.046 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -155.25 121.79 2.7 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.919 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -62.37 160.22 32.3 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.95 2.433 . . . . 0.0 112.385 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.527 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 9.8 Cg_endo -52.09 147.38 27.21 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.247 2.631 . . . . 0.0 112.664 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.407 HD23 ' H ' ' A' ' 107' ' ' LEU . 2.1 pt? -136.97 171.89 13.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.777 -173.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 54.35 57.22 6.04 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 123.96 0.787 . . . . 0.0 111.236 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.431 HD23 ' OG1' ' A' ' 198' ' ' THR . 56.2 tp -80.29 94.33 6.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.004 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -89.29 129.72 35.79 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.216 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.402 HG12 HD22 ' A' ' 123' ' ' LEU . 2.9 t -120.06 114.45 44.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.956 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.499 ' OE1' ' HE3' ' A' ' 114' ' ' LYS . 38.9 tt0 -135.51 131.69 36.36 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.349 -175.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.31 133.48 31.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.996 0.427 . . . . 0.0 110.892 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.499 ' HE3' ' OE1' ' A' ' 112' ' ' GLU . 0.4 OUTLIER -108.57 131.43 54.86 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.45 178.175 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -124.54 85.45 56.24 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.688 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.21 156.16 65.59 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 123.27 2.647 . . . . 0.0 112.318 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.91 -17.7 56.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.233 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -117.05 -49.75 2.6 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.9 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.78 157.6 28.41 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.764 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -64.29 145.5 98.2 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.336 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.97 141.13 76.08 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.821 2.347 . . . . 0.0 111.971 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.525 ' HB3' HD13 ' A' ' 170' ' ' LEU . 21.4 p90 -148.5 151.11 34.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.607 -174.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 168' ' ' LYS . 6.8 mt -79.07 134.04 36.77 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.059 173.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -111.6 100.58 9.1 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.151 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.415 HD12 ' H ' ' A' ' 125' ' ' ILE . 4.4 mp -90.16 123.47 42.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.494 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -132.56 119.55 20.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.044 0.449 . . . . 0.0 110.534 -176.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . 0.464 ' CH2' HD11 ' A' ' 146' ' ' ILE . 39.4 p90 -118.45 166.44 12.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.535 -176.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.6 t -101.15 118.32 60.51 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.468 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 80.2 Cg_endo -76.67 136.96 17.64 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.723 2.282 . . . . 0.0 112.322 -178.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 129' ' ' PRO . 32.8 Cg_exo -61.6 91.53 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.628 2.219 . . . . 0.0 110.97 173.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.1 m -83.63 -22.51 32.18 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.042 -173.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 92.0 mt -84.87 13.45 5.9 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.453 0.644 . . . . 0.0 111.397 -175.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.547 ' HB ' HD11 ' A' ' 135' ' ' LEU . 59.2 mt -69.78 -20.31 23.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.241 -0.891 . . . . 0.0 108.869 166.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 t70 69.32 70.75 0.26 Allowed 'General case' 0 CA--C 1.521 -0.145 0 CA-C-N 114.44 -1.255 . . . . 0.0 109.913 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.547 HD11 ' HB ' ' A' ' 133' ' ' ILE . 1.0 OUTLIER -104.39 142.98 33.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.267 -176.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -133.44 165.74 24.15 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.99 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 13.6 p -82.85 43.6 0.86 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.152 0.501 . . . . 0.0 111.287 -178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -120.19 54.71 0.64 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 13.1 t90 66.13 62.62 0.58 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.598 0.713 . . . . 0.0 110.558 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -162.9 75.85 0.42 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.351 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 186' ' ' PRO . 4.2 m -98.93 136.12 39.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.393 -174.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 22.6 tp -99.9 110.89 23.23 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.401 HD11 ' HG2' ' A' ' 163' ' ' GLN . 0.9 OUTLIER -99.48 141.44 32.27 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.914 0.388 . . . . 0.0 110.954 -176.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -107.64 139.55 42.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.138 -172.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -133.57 134.35 43.23 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.639 -175.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.464 HD11 ' CH2' ' A' ' 127' ' ' TRP . 4.5 mp -118.9 124.82 73.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.881 0.372 . . . . 0.0 110.681 -175.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.506 ' HB2' ' CZ2' ' A' ' 194' ' ' TRP . 25.4 ttp180 -113.46 126.35 55.24 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 4.1 pp -149.89 164.67 34.78 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.526 -176.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -169.33 148.9 3.64 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.588 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.433 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 30.8 Cg_endo -68.23 167.35 22.31 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.377 2.051 . . . . 0.0 111.812 172.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.463 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 11.3 pt-20 -64.02 -24.21 67.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.97 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.463 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 89.6 mttt -96.15 18.78 12.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.198 0.523 . . . . 0.0 110.753 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.433 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -103.99 128.73 51.56 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.718 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -95.0 -11.24 28.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.075 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.67 162.67 27.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.239 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.473 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 86.5 m95 -98.81 137.73 36.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.17 0.51 . . . . 0.0 112.278 -171.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -104.14 115.04 29.7 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.548 176.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.408 ' N ' HD12 ' A' ' 158' ' ' ILE . 2.5 mp -95.98 120.02 44.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.363 -178.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 65.5 m-70 -113.56 130.1 56.43 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.341 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -97.41 129.89 44.59 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.845 -176.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -95.27 -37.96 10.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.888 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 104.68 -125.13 8.24 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.854 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.401 ' HG2' HD11 ' A' ' 143' ' ' LEU . 29.6 mt-30 -98.92 9.05 44.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.008 0.433 . . . . 0.0 110.577 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -103.82 144.88 30.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.459 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.6 p -97.01 33.58 1.89 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.305 0.574 . . . . 0.0 111.731 -175.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -154.64 149.99 27.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.592 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 31.9 t80 -145.12 149.44 35.02 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 49.4 mmtt -113.03 144.34 42.77 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.444 ' HB ' ' HB2' ' A' ' 123' ' ' LEU . 36.3 mm -127.18 123.18 61.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.593 0.235 . . . . 0.0 110.809 176.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.525 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.9 mm? -97.3 -28.74 13.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.184 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 9.7 t -81.65 79.46 8.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.095 0.474 . . . . 0.0 110.563 -176.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 67.5 mt -129.64 143.02 50.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.863 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 79.1 m-70 -105.95 128.53 26.23 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.974 176.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 22.2 Cg_exo -63.77 133.62 40.02 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.741 2.294 . . . . 0.0 112.484 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 79.52 28.93 50.75 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.769 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -128.38 155.67 44.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.067 0.46 . . . . 0.0 110.91 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -92.78 133.38 36.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.388 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -120.32 144.47 47.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.869 0.366 . . . . 0.0 110.144 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.2 mm? -105.12 129.1 53.61 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.402 HG21 HG21 ' A' ' 111' ' ' VAL . 23.1 m -128.61 139.64 51.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.834 0.349 . . . . 0.0 110.865 -176.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.452 ' HG2' ' HA ' ' A' ' 197' ' ' ALA . 16.2 mt-30 -139.64 158.98 43.21 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.212 -178.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 12.6 p -136.29 138.45 46.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.208 0.527 . . . . 0.0 111.04 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.6 mmt180 -138.76 147.86 43.15 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.876 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.527 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 25.5 p -137.93 154.61 49.4 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.31 138.82 5.97 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 141' ' ' THR . 89.8 Cg_endo -78.94 -165.64 0.35 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.761 2.307 . . . . 0.0 112.356 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -80.99 -35.49 31.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.72 0.295 . . . . 0.0 111.242 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 38.6 m170 -86.69 24.31 1.48 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -175.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -159.64 142.99 8.69 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.912 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.465 ' CZ ' HD11 ' A' ' 100' ' ' ILE . 37.6 p90 -119.23 153.3 35.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.135 0.493 . . . . 0.0 110.548 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -110.65 163.41 13.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.318 -174.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 20.6 p -148.58 10.36 0.84 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.518 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -162.25 160.81 27.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.146 0.498 . . . . 0.0 111.596 -177.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.506 ' CZ2' ' HB2' ' A' ' 147' ' ' ARG . 75.4 m95 -106.26 161.98 14.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.613 176.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.475 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 7.4 m -131.41 -59.1 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.52 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -175.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 10.1 Cg_endo -90.08 95.11 0.29 Allowed 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.43 2.087 . . . . 0.0 113.16 -171.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.452 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -95.74 127.58 41.9 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.965 0.412 . . . . 0.0 110.567 176.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.431 ' OG1' HD23 ' A' ' 109' ' ' LEU . 30.9 m -121.77 144.21 48.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.639 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -104.08 127.5 51.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.204 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.7 tp -128.45 137.42 57.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.156 0.503 . . . . 0.0 110.985 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -99.59 124.98 45.3 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.686 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 51.0 mm -86.28 124.57 69.89 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 174.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -60.68 152.82 66.4 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.898 2.399 . . . . 0.0 112.226 -176.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 17.9 m -71.17 -23.92 62.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.7 177.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -100.46 54.71 0.88 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.344 176.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -87.95 -60.31 2.0 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.829 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.8 p -89.86 106.37 18.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.039 0.447 . . . . 0.0 110.976 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -71.19 111.83 6.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.948 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -88.7 -23.59 22.93 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.825 0.821 . . . . 0.0 109.748 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 . . . . . 0 C--N 1.309 -1.185 0 CA-C-N 114.227 -1.351 . . . . 0.0 109.767 -178.333 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 93.3 mtp . . . . . 0 N--CA 1.485 1.282 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 76.9 t80 74.94 143.97 0.08 Allowed 'General case' 0 C--O 1.236 0.354 0 O-C-N 123.802 0.689 . . . . 0.0 111.595 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 58.5 mt -43.09 -56.75 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.578 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.0 t -85.12 97.61 5.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.405 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.615 HE21 ' HA ' ' A' ' 102' ' ' GLN . 0.1 OUTLIER -63.42 154.82 77.69 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.93 -177.305 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.426 ' O ' ' HD3' ' A' ' 105' ' ' PRO . 52.4 Cg_endo -70.36 1.71 4.57 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.129 2.553 . . . . 0.0 114.0 -174.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.4 ' OD2' ' HB3' ' A' ' 130' ' ' PRO . 19.2 t70 -110.27 95.14 20.64 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.797 0.332 . . . . 0.0 110.143 176.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 103' ' ' PRO . 72.9 Cg_endo -94.97 168.25 1.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.444 2.763 . . . . 0.0 112.616 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.438 ' HG3' ' SG ' ' A' ' 184' ' ' CYS . 24.2 Cg_exo -62.98 141.64 84.84 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.394 2.063 . . . . 0.0 111.162 174.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 128' ' ' SER . 1.2 pp -133.38 177.06 7.98 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.717 0.294 . . . . 0.0 111.582 -175.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 55.41 50.28 15.12 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.584 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 46.5 tp -73.66 105.18 4.86 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -112.13 128.86 56.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.828 -175.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.6 t -113.32 129.82 68.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.032 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -129.78 129.84 44.6 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.878 0.37 . . . . 0.0 110.401 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 p -85.66 118.73 32.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.183 0.516 . . . . 0.0 109.846 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.507 ' O ' ' HD3' ' A' ' 116' ' ' PRO . 31.2 mmmt -113.38 108.45 17.24 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.1 0.476 . . . . 0.0 110.762 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -107.36 96.14 15.22 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.364 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 114' ' ' LYS . 15.3 Cg_exo -69.37 146.11 61.54 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.798 2.332 . . . . 0.0 111.687 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -80.01 -3.89 50.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.104 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -126.77 -40.86 1.87 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.196 -177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.418 ' H ' ' HB2' ' A' ' 116' ' ' PRO . 66.7 mtm-85 -99.44 165.58 11.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.41 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 120' ' ' LYS . 12.6 mptt -60.11 135.4 90.71 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.119 175.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.434 ' HA ' ' CD ' ' A' ' 116' ' ' PRO . 32.3 Cg_endo -64.18 136.86 53.79 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.909 2.406 . . . . 0.0 112.122 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.442 ' HB3' HD13 ' A' ' 170' ' ' LEU . 54.0 p90 -136.33 159.71 40.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.711 -175.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.5 tp -98.83 123.83 43.33 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.431 ' CZ2' ' HD3' ' A' ' 126' ' ' LYS . 21.6 t90 -104.62 115.24 30.0 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.401 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.7 mp -108.3 129.06 63.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.652 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.431 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 54.9 pttt -137.68 152.48 49.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.047 0.451 . . . . 0.0 110.347 175.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . 0.456 ' CD2' HG21 ' A' ' 182' ' ' VAL . 29.3 p90 -142.0 163.33 33.17 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.076 -174.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.446 ' HB2' HD12 ' A' ' 107' ' ' LEU . 42.4 m -106.94 105.59 55.83 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 121.004 0.43 . . . . 0.0 109.895 176.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.83 148.68 65.14 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.758 2.305 . . . . 0.0 112.013 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.4 ' HB3' ' OD2' ' A' ' 104' ' ' ASP . 33.7 Cg_exo -57.26 136.85 78.77 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.439 2.093 . . . . 0.0 111.767 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 26.9 m -90.13 -18.5 25.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.422 0.63 . . . . 0.0 110.092 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 97.4 mt -114.3 98.25 6.82 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.378 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 94.1 mt -133.19 -43.01 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.359 -177.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 133' ' ' ILE . 5.3 m-20 66.66 77.43 0.28 Allowed 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.621 0.576 . . . . 0.0 110.239 -172.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 135' ' ' LEU . 3.0 mm? -75.08 -25.92 58.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.934 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? 65.06 110.86 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 122.092 0.948 . . . . 0.0 111.745 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 40.9 m -59.17 133.88 56.49 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.787 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 171.66 -79.7 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.45 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -143.72 -35.0 0.39 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.739 0.304 . . . . 0.0 110.237 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -64.16 131.46 47.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.066 0.46 . . . . 0.0 110.294 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.0 m -125.35 154.86 41.19 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.342 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 185' ' ' LYS . 30.1 tp -78.12 109.18 11.99 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 184' ' ' CYS . 2.0 mp -106.8 158.31 17.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.361 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -125.45 133.39 52.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.024 0.44 . . . . 0.0 111.247 -172.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -123.28 139.33 54.15 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.067 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.416 HG13 HG23 ' A' ' 182' ' ' VAL . 4.6 mp -126.99 122.34 60.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.679 0.276 . . . . 0.0 110.469 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -107.72 130.08 54.97 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 174.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.5 pp -144.25 157.71 44.13 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.724 -177.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -165.44 144.5 5.32 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.187 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.459 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 29.2 Cg_endo -67.88 168.84 17.61 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.406 2.071 . . . . 0.0 111.835 172.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.86 -18.86 65.63 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.934 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -100.96 17.79 21.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.121 0.486 . . . . 0.0 110.578 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.459 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -108.21 120.5 42.52 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.166 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -79.57 -28.55 41.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.583 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -109.71 154.25 23.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.755 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -90.53 144.78 25.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.146 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -98.59 110.18 22.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.254 172.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.17 113.47 24.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.198 0.523 . . . . 0.0 109.733 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 49.4 m-70 -116.35 118.99 34.26 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.685 178.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -88.31 126.38 35.15 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -86.6 -30.6 21.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.987 0.422 . . . . 0.0 110.729 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 95.25 -127.89 9.31 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.589 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -104.8 53.13 0.73 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.372 0.606 . . . . 0.0 110.241 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -144.64 143.86 30.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.283 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.5 p -96.66 24.35 6.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.18 0.514 . . . . 0.0 111.538 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -147.43 136.24 22.07 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.446 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 24.5 t80 -134.05 142.1 47.45 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.403 ' HE2' ' CD1' ' A' ' 124' ' ' TRP . 0.2 OUTLIER -120.4 136.38 54.74 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.689 0.281 . . . . 0.0 110.564 -178.362 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.442 HG22 ' H ' ' A' ' 171' ' ' SER . 43.2 mm -108.52 131.95 57.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.616 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.442 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.8 mm? -112.71 41.96 1.94 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.203 0.525 . . . . 0.0 110.117 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.442 ' H ' HG22 ' A' ' 169' ' ' ILE . 10.7 t -157.75 64.26 0.47 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.647 -177.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.8 mm? -109.27 151.84 26.01 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.991 0.424 . . . . 0.0 110.694 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -116.61 122.96 31.04 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.232 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -59.84 117.61 4.38 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.862 2.375 . . . . 0.0 112.35 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.23 -5.76 49.7 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.69 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -101.63 142.18 33.37 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.05 0.452 . . . . 0.0 111.015 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 199' ' ' PHE . 79.7 tttt -91.86 133.33 35.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.131 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -116.8 137.9 51.87 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.095 0.474 . . . . 0.0 110.496 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 7.6 mp -99.3 126.28 45.11 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 174.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.7 136.4 60.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.043 0.449 . . . . 0.0 111.226 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.581 ' HG2' ' HA ' ' A' ' 197' ' ' ALA . 55.4 mt-30 -138.3 139.06 38.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.0 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.456 HG21 ' CD2' ' A' ' 127' ' ' TRP . 12.6 p -125.08 152.69 31.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.857 0.36 . . . . 0.0 110.733 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -153.13 142.02 21.17 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.79 173.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.438 ' SG ' ' HG3' ' A' ' 106' ' ' PRO . 25.1 p -105.09 157.08 17.5 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.659 174.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.43 ' O ' HD12 ' A' ' 142' ' ' LEU . 98.3 mttt -102.96 103.33 33.11 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.634 0.254 . . . . 0.0 111.441 -176.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.26 161.53 28.94 Favored 'Trans proline' 0 CA--C 1.529 0.275 0 C-N-CA 123.021 2.481 . . . . 0.0 112.192 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -66.97 -18.16 65.25 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.141 0.495 . . . . 0.0 111.013 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -85.73 -13.75 47.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.698 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -151.88 103.58 0.24 Allowed Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -75.36 17.97 0.24 Allowed 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -167.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -145.21 172.72 12.72 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.2 m -94.25 75.25 3.98 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.35 -1.75 . . . . 0.0 110.039 -171.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -88.57 112.02 22.55 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.543 0.687 . . . . 0.0 109.737 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 23.6 m95 -69.88 149.31 47.98 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.58 -1.191 . . . . 0.0 112.622 -163.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.515 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 3.3 m -134.84 -54.47 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.208 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 27.1 Cg_endo -95.36 131.69 0.51 Allowed 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 122.501 2.134 . . . . 0.0 112.969 -177.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.581 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -123.65 124.63 43.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.036 0.446 . . . . 0.0 110.705 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 61.0 m -117.02 144.02 45.08 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.629 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.474 ' HB3' ' HE2' ' A' ' 177' ' ' LYS . 55.7 m-85 -107.69 132.44 53.34 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.594 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.1 tp -133.28 135.31 56.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.1 0.476 . . . . 0.0 110.735 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.417 HE21 ' HB2' ' A' ' 177' ' ' LYS . 1.7 mm-40 -105.61 130.6 53.62 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.539 178.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 46.6 mm -85.9 124.64 70.48 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.913 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.41 156.73 61.84 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.908 2.405 . . . . 0.0 112.382 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 46.1 m -81.06 -3.67 52.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.15 0.5 . . . . 0.0 110.913 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -84.96 -15.09 45.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.039 174.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 30.0 t80 -58.92 141.31 53.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.722 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 206' ' ' PHE . 80.6 m 74.87 138.11 0.06 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.474 0.654 . . . . 0.0 111.626 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 96.3 mmm -119.15 -72.03 0.71 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.168 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -141.9 61.67 1.45 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 . . . . . 0 C--O 1.25 1.125 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.492 -169.734 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -163.82 176.08 9.85 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 62.6 mt -65.45 95.89 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.92 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.3 p -152.9 139.77 12.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.639 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -97.82 115.92 65.74 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 120.904 0.383 . . . . 0.0 111.259 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -74.18 -50.6 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.671 2.247 . . . . 0.0 111.977 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -120.25 99.78 48.13 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 121.435 0.636 . . . . 0.0 110.289 176.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -63.14 161.1 31.45 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.455 2.77 . . . . 0.0 112.716 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -54.55 121.15 9.26 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.521 2.147 . . . . 0.0 110.768 174.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.445 HD23 ' H ' ' A' ' 107' ' ' LEU . 2.2 pt? -127.75 -178.32 4.45 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.917 -171.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 55.78 40.8 30.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.822 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.492 HD23 ' OG1' ' A' ' 198' ' ' THR . 54.0 tp -70.22 94.61 0.93 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.7 123.58 40.43 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.322 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.497 HG12 HD11 ' A' ' 123' ' ' LEU . 3.2 t -112.29 113.56 44.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -124.06 133.27 53.67 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.141 -172.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.6 p -85.78 116.9 29.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.388 0.613 . . . . 0.0 109.841 175.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -103.05 123.49 46.72 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.403 -177.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -121.04 84.68 39.77 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.436 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.98 146.87 42.5 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.736 2.29 . . . . 0.0 111.087 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -79.9 -16.77 54.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.351 -177.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -116.12 -39.55 3.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.581 -177.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -91.37 163.07 14.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.634 176.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -72.97 141.52 81.78 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.012 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.38 138.68 67.13 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.944 2.429 . . . . 0.0 111.742 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -150.82 164.55 35.96 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.833 -174.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.566 ' HB2' HD11 ' A' ' 172' ' ' LEU . 29.7 tp -97.41 122.27 40.26 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.428 ' HE1' ' HB2' ' A' ' 166' ' ' GLU . 24.4 t90 -102.71 112.53 25.34 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.047 -178.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.8 mp -106.89 120.15 57.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.666 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -128.11 134.78 49.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.93 0.395 . . . . 0.0 110.293 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 36.0 p90 -128.05 155.56 44.15 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.573 -177.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.9 m -108.88 100.27 38.87 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.909 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.13 161.82 18.44 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.021 2.481 . . . . 0.0 112.547 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -51.8 153.29 11.75 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.316 2.678 . . . . 0.0 113.238 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.4 p -57.42 -54.54 45.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.796 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 57.0 mt -102.57 100.02 10.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.246 0.546 . . . . 0.0 111.187 -175.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 75.1 mt -111.95 -69.05 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.604 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 57.9 55.36 5.41 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.797 0.685 . . . . 0.0 112.615 172.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.52 HD21 ' N ' ' A' ' 187' ' ' ASP . 3.4 mm? -99.56 74.54 1.89 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.14 0.495 . . . . 0.0 109.966 172.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -84.43 -84.12 0.15 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.326 -177.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 70.0 p 46.49 -92.12 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.0 0.92 . . . . 0.0 113.419 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 152.19 -53.5 0.47 Allowed Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -178.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 40.2 m95 -75.92 -17.45 59.75 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.008 0.432 . . . . 0.0 110.184 176.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -118.6 136.67 53.75 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.001 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.424 ' O ' HD22 ' A' ' 143' ' ' LEU . 22.0 m -141.64 147.35 37.42 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 175.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.418 HD11 ' H ' ' A' ' 185' ' ' LYS . 46.5 tp -80.09 111.16 16.17 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.002 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.424 HD22 ' O ' ' A' ' 141' ' ' THR . 2.6 mm? -91.62 166.04 13.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.456 174.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.4 ' HD1' ' HG ' ' A' ' 184' ' ' CYS . 71.8 m-85 -131.32 131.92 44.12 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -177.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -119.87 134.6 55.19 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.51 121.96 61.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.133 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.584 ' HG3' ' NE2' ' A' ' 181' ' ' GLN . 22.5 ptt180 -103.74 148.08 26.5 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 174.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.6 pp -165.05 161.79 19.95 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.175 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 153' ' ' ALA . 57.5 pttt -164.77 145.59 6.32 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-O 120.682 0.277 . . . . 0.0 110.484 176.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.418 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 36.6 Cg_endo -68.75 165.71 28.67 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.76 2.307 . . . . 0.0 111.746 174.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -68.46 -5.4 19.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.897 -174.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -111.3 6.7 20.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.292 0.568 . . . . 0.0 110.437 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.418 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -95.2 127.72 41.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.187 -178.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.36 -38.86 29.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.723 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -104.16 162.92 12.76 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.955 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -91.4 140.89 29.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.034 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 148' ' ' LEU . 36.1 mt-10 -91.88 116.25 28.75 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.3 172.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.75 109.41 21.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-O 121.54 0.686 . . . . 0.0 109.363 175.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.486 ' HB3' ' CE2' ' A' ' 167' ' ' PHE . 35.0 m-70 -105.8 126.42 52.15 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.195 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -98.28 117.27 32.28 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.866 0.365 . . . . 0.0 110.648 -176.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -78.0 -51.11 10.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.143 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 76.19 89.9 0.25 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.463 -0.875 . . . . 0.0 113.072 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 75.34 -25.59 0.2 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.733 0.813 . . . . 0.0 113.033 170.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -89.41 142.59 27.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.91 0.386 . . . . 0.0 110.57 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 37.1 p -101.75 32.6 3.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.5 0.667 . . . . 0.0 111.047 -177.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.428 ' HB2' ' HE1' ' A' ' 124' ' ' TRP . 5.5 pt-20 -156.9 109.94 2.57 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.769 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.486 ' CE2' ' HB3' ' A' ' 159' ' ' HIS . 17.8 t80 -110.94 146.56 36.38 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.497 -174.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.463 ' HD2' ' N ' ' A' ' 168' ' ' LYS . 9.6 mptt -121.83 130.19 53.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.369 -178.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 34.7 mm -107.84 124.21 63.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.551 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -96.17 -27.14 15.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.957 0.408 . . . . 0.0 110.482 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 34.7 m -82.33 84.55 7.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.663 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' A' ' 123' ' ' LEU . 68.9 mt -130.99 145.85 52.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.124 0.488 . . . . 0.0 111.323 -177.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 63.6 m-70 -114.38 127.49 26.77 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.859 177.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 24.2 Cg_exo -62.88 129.53 26.36 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.836 2.357 . . . . 0.0 112.797 -178.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.14 33.34 32.86 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.487 176.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -126.21 145.53 50.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.318 0.58 . . . . 0.0 111.059 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -86.85 129.64 34.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.079 177.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -120.25 137.21 54.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.246 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 1.5 mm? -97.44 125.02 41.85 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 173.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.47 ' O ' ' HB ' ' A' ' 198' ' ' THR . 16.7 m -135.43 139.31 46.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.748 0.309 . . . . 0.0 110.788 -171.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.584 ' NE2' ' HG3' ' A' ' 147' ' ' ARG . 0.2 OUTLIER -166.63 142.95 4.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.907 0.384 . . . . 0.0 110.842 177.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 13.0 p -121.93 153.02 26.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.52 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -146.11 134.75 22.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.066 0.46 . . . . 0.0 109.76 173.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.4 ' HG ' ' HD1' ' A' ' 144' ' ' TYR . 3.3 m -111.93 152.66 27.78 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.682 -176.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.485 ' HB3' ' CD1' ' A' ' 191' ' ' TRP . 18.0 pttp -121.39 86.52 43.93 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.87 175.82 5.95 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.33 2.02 . . . . 0.0 111.842 172.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.52 ' N ' HD21 ' A' ' 135' ' ' LEU . 27.7 t70 -64.98 -28.31 69.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.186 0.517 . . . . 0.0 110.782 -178.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -92.5 1.94 56.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.308 -176.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -164.9 113.88 0.57 Allowed Glycine 0 C--O 1.226 -0.375 0 C-N-CA 119.704 -1.236 . . . . 0.0 113.546 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -108.55 141.95 39.69 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.485 ' CD1' ' HB3' ' A' ' 185' ' ' LYS . 28.9 p-90 -106.8 149.54 27.26 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.058 0.456 . . . . 0.0 111.282 -176.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.4 p -128.74 7.62 5.69 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.202 177.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -155.4 171.28 20.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.99 -177.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -114.67 103.31 10.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.843 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.431 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 16.1 m -92.2 -54.57 0.26 Allowed Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 94.9 Cg_endo -76.68 69.78 6.65 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.096 1.864 . . . . 0.0 113.762 -172.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.502 ' HA ' ' HB3' ' A' ' 181' ' ' GLN . . . -69.52 123.23 20.76 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.331 0.586 . . . . 0.0 111.128 178.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.492 ' OG1' HD23 ' A' ' 109' ' ' LEU . 90.4 m -108.07 148.02 30.37 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.566 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -111.86 133.14 54.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.362 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.9 tp -137.63 133.84 45.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.34 0.591 . . . . 0.0 111.017 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -100.7 121.17 41.21 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.517 176.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 48.4 mm -85.85 122.95 72.82 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 175.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.27 143.7 96.84 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.58 2.186 . . . . 0.0 112.384 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 14.9 m -66.28 -23.55 66.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.29 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.87 19.62 3.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.591 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -53.64 -48.86 68.97 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.095 0.474 . . . . 0.0 110.318 178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.8 p -85.6 125.62 33.27 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.776 174.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -65.19 113.44 3.99 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.515 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -92.96 66.28 4.18 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 C--O 1.25 1.107 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.178 -178.403 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 120.258 0.075 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 26.4 t80 69.0 144.67 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.629 0.728 . . . . 0.0 111.751 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 100' ' ' ILE . 4.4 mp -78.78 86.47 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.82 178.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.9 m -73.32 140.84 17.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -82.23 121.64 78.79 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -52.75 -67.85 0.08 OUTLIER 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.81 2.34 . . . . 0.0 112.322 -172.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -154.22 90.03 3.27 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.903 176.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.28 132.5 52.59 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.717 2.278 . . . . 0.0 112.007 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.423 ' HG3' ' SG ' ' A' ' 184' ' ' CYS . 18.3 Cg_endo -56.67 132.61 52.79 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.201 2.6 . . . . 0.0 112.346 -176.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.44 ' N ' HD23 ' A' ' 107' ' ' LEU . 2.4 pt? -146.82 -167.57 2.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.27 -174.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 59.14 57.16 3.59 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.241 0.543 . . . . 0.0 111.105 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.411 HD23 ' HB3' ' A' ' 127' ' ' TRP . 12.3 mt -72.37 99.95 2.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.796 177.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.53 122.9 37.58 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.416 HG12 HD11 ' A' ' 123' ' ' LEU . 4.9 t -114.64 122.64 69.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.14 -175.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -120.84 140.92 51.08 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.804 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 p -98.21 119.71 46.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.21 0.528 . . . . 0.0 110.145 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.557 ' HE2' ' HA ' ' A' ' 114' ' ' LYS . 9.9 mmpt? -111.51 126.69 55.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.652 -178.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -133.09 97.23 16.79 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.08 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.81 175.97 8.92 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.71 2.273 . . . . 0.0 112.7 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -59.76 -67.31 0.4 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.329 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -131.63 38.16 3.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.295 0.569 . . . . 0.0 111.017 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -122.23 154.6 37.31 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.189 175.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -55.33 118.38 18.34 Favored Pre-proline 0 C--N 1.328 -0.337 0 O-C-N 123.582 0.552 . . . . 0.0 111.071 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -64.91 144.57 83.36 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.628 2.219 . . . . 0.0 111.146 177.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -140.53 150.56 43.86 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.219 0.533 . . . . 0.0 111.215 -173.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.455 ' HB2' HD11 ' A' ' 172' ' ' LEU . 30.1 tp -91.52 126.27 36.54 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.288 175.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.438 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 22.5 t90 -102.98 105.89 16.31 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.195 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.7 mp -98.99 123.62 51.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.6 ttpp -134.12 136.21 43.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.944 0.402 . . . . 0.0 110.555 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . 0.485 ' CH2' HD11 ' A' ' 146' ' ' ILE . 20.7 p90 -122.51 167.96 12.71 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.0 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.9 t -87.29 125.47 65.74 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -62.64 150.75 86.83 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.652 2.235 . . . . 0.0 111.81 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.69 -162.48 0.11 Allowed 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.845 2.363 . . . . 0.0 112.399 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.0 p -60.81 151.0 30.95 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 120.771 0.319 . . . . 0.0 110.793 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 132' ' ' LEU . 2.7 pp -66.14 112.74 4.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.644 0.735 . . . . 0.0 111.243 -174.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 68.3 mt -94.18 -41.21 12.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.597 177.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.0 t70 62.85 86.6 0.11 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.569 -172.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.3 mt -78.97 59.11 2.56 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.787 -174.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -74.68 -30.15 61.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.285 0.564 . . . . 0.0 109.769 173.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.4 p -86.74 95.36 9.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.352 177.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -61.53 -16.07 48.95 Favored Glycine 0 C--N 1.33 0.237 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.93 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 27.7 m-90 -57.27 -33.79 67.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.065 0.46 . . . . 0.0 110.155 175.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -110.6 112.78 24.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 171.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 10.8 m -112.54 138.16 49.72 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 63.9 tp -97.14 110.58 23.1 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.99 148.27 26.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.2 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.487 ' CD2' ' HB3' ' A' ' 184' ' ' CYS . 92.6 m-85 -115.46 138.33 51.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.545 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -124.46 135.77 53.5 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.485 HD11 ' CH2' ' A' ' 127' ' ' TRP . 5.1 mp -118.73 130.84 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.043 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -111.79 134.26 53.48 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 173.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.552 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.5 pp -145.43 156.53 43.81 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.797 -177.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -165.66 151.05 8.08 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.419 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.491 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 36.7 Cg_endo -70.05 164.11 36.03 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.453 2.102 . . . . 0.0 111.685 173.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.44 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 14.4 pt-20 -64.15 -23.69 67.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.976 -172.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.44 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 86.9 mttt -98.55 9.94 42.09 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.189 0.518 . . . . 0.0 110.875 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.491 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -95.85 131.52 42.08 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.006 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -84.96 -43.03 14.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.542 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -82.78 150.56 26.56 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.036 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -98.09 142.85 29.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.811 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -103.35 116.28 32.13 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.957 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.06 132.17 38.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.189 0.519 . . . . 0.0 111.079 -176.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 67.6 m-70 -127.08 125.97 42.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.332 175.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -86.43 119.86 27.15 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.432 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -85.11 -39.19 18.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.905 0.383 . . . . 0.0 111.026 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 100.51 -143.78 16.45 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.443 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.08 62.74 4.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.978 0.418 . . . . 0.0 110.366 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -155.24 147.92 24.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.377 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 26.8 p -98.0 27.8 4.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.975 0.416 . . . . 0.0 111.909 -176.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -151.82 144.86 24.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.893 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 26.4 t80 -140.07 148.51 41.86 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.992 -179.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 10.5 mptt -120.39 142.77 48.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.644 0.259 . . . . 0.0 110.782 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 32.9 mm -119.64 129.92 74.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.572 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.68 -29.17 11.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.102 0.477 . . . . 0.0 110.294 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.0 m -79.27 83.71 5.29 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.285 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 123' ' ' LEU . 63.4 mt -132.12 172.19 12.7 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.958 -176.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -138.37 124.65 12.82 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.899 -179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.13 130.02 29.16 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.606 2.204 . . . . 0.0 112.08 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 79.65 39.69 17.11 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.898 -0.667 . . . . 0.0 111.839 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -133.24 146.39 51.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.957 0.408 . . . . 0.0 110.474 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 150' ' ' PRO . 34.9 tttp -98.1 128.1 44.42 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.836 177.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -119.85 140.98 49.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.193 0.52 . . . . 0.0 110.898 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 5.5 mp -103.73 130.66 51.27 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.8 m -126.97 139.73 51.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.81 0.338 . . . . 0.0 111.452 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.547 ' HG2' ' HA ' ' A' ' 197' ' ' ALA . 78.1 mt-30 -143.72 142.47 30.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.299 177.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 13.5 p -132.06 150.15 33.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.684 0.278 . . . . 0.0 110.798 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -159.06 147.44 18.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.254 172.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.487 ' HB3' ' CD2' ' A' ' 144' ' ' TYR . 27.9 p -123.4 -172.96 2.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.67 177.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -125.71 95.28 40.53 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.183 0.516 . . . . 0.0 111.044 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.23 159.23 19.57 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 123.435 2.756 . . . . 0.0 113.124 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -73.67 -39.61 64.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.456 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -94.18 24.07 4.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.252 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -160.85 -144.99 4.15 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -167.44 -166.12 0.74 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 9.3 m95 -54.85 115.58 2.26 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.405 0.622 . . . . 0.0 111.299 176.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.6 m -97.87 16.1 21.88 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.57 -175.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . 66.98 173.44 0.26 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.722 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.492 ' HB3' ' OE1' ' A' ' 181' ' ' GLN . 81.0 m95 -82.34 144.55 30.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.009 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.599 ' H ' ' HD2' ' A' ' 196' ' ' PRO . 5.3 m -153.71 -56.9 0.02 OUTLIER Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.599 ' HD2' ' H ' ' A' ' 195' ' ' SER . 68.4 Cg_endo -72.69 80.81 1.68 Allowed 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 122.019 1.813 . . . . 0.0 113.354 -173.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.547 ' HA ' ' HG2' ' A' ' 181' ' ' GLN . . . -80.35 103.0 9.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.273 0.559 . . . . 0.0 110.812 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.9 m -100.44 135.45 41.85 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.158 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -104.92 126.51 52.07 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.103 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.9 tp -126.75 137.98 56.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.003 0.43 . . . . 0.0 110.832 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -100.19 120.98 40.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.751 177.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 49.0 mm -83.1 121.02 76.96 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.1 151.58 65.46 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.925 2.417 . . . . 0.0 112.362 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 16.8 t -71.75 -23.63 61.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.895 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -98.33 43.76 1.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.795 0.807 . . . . 0.0 109.28 175.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -80.85 -18.42 47.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.536 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 57.4 m -145.23 149.15 34.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.565 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 95.0 mmm -77.33 40.87 0.29 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.061 0.458 . . . . 0.0 111.464 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -137.11 41.48 2.45 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 26.1 t70 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.424 -178.101 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.5 mpp? . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.963 0.411 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -103.34 139.37 38.85 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.334 0.587 . . . . 0.0 110.772 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.5 mp -81.57 95.21 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.107 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.541 ' O ' ' HD3' ' A' ' 103' ' ' PRO . 13.6 p -103.62 154.12 5.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.686 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -85.14 102.76 2.6 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 174.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 101' ' ' VAL . 70.1 Cg_endo -91.7 155.9 3.49 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.762 2.308 . . . . 0.0 113.185 -172.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -127.14 65.32 64.28 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.809 174.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.476 ' HD3' ' C ' ' A' ' 103' ' ' PRO . 36.6 Cg_exo -60.07 -49.08 10.38 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.619 2.212 . . . . 0.0 114.386 -177.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.61 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 72.6 Cg_endo -78.37 95.9 1.08 Allowed 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.128 1.219 . . . . 0.0 111.872 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 pp -109.43 174.47 5.85 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.317 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 52.45 60.22 3.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.259 0.552 . . . . 0.0 110.626 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.445 HD11 ' CG2' ' A' ' 125' ' ' ILE . 43.1 tp -73.17 108.88 6.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.675 -177.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -98.44 119.68 37.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.576 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.459 ' CG1' HD11 ' A' ' 123' ' ' LEU . 2.6 t -109.24 115.28 49.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.394 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -127.72 125.58 40.25 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.933 -173.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.5 126.41 39.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.15 177.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 57.0 mmtt -108.28 129.72 55.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.936 0.398 . . . . 0.0 110.853 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.584 ' OE1' ' HA ' ' A' ' 206' ' ' PHE . 47.3 mt-30 -133.89 86.75 37.22 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.433 -174.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.05 167.69 24.62 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.078 2.519 . . . . 0.0 111.547 175.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.482 ' H ' ' CD ' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -86.24 -46.28 10.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.779 0.323 . . . . 0.0 111.32 -178.429 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -88.53 -51.48 5.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.89 0.376 . . . . 0.0 110.24 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -72.65 138.72 46.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -66.52 144.84 98.84 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 120.732 0.301 . . . . 0.0 111.4 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.557 ' HG3' ' O ' ' A' ' 206' ' ' PHE . 36.1 Cg_endo -62.72 142.41 89.13 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 123.263 2.642 . . . . 0.0 112.56 -177.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -144.56 159.9 42.03 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.733 -176.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.459 HD11 ' CG1' ' A' ' 111' ' ' VAL . 2.7 tm? -98.22 126.38 43.67 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.417 ' HE1' ' HB2' ' A' ' 166' ' ' GLU . 21.7 t90 -111.68 109.25 19.03 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.703 -172.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.445 ' CG2' HD11 ' A' ' 109' ' ' LEU . 3.6 mp -96.67 132.56 40.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.45 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -146.91 143.17 28.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.313 0.578 . . . . 0.0 110.456 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 18.5 p90 -126.74 162.94 24.64 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.112 -173.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.1 t -102.9 112.98 66.16 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 120.852 0.358 . . . . 0.0 110.374 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 97.0 Cg_endo -83.27 137.61 8.36 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.436 2.091 . . . . 0.0 111.541 174.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 105' ' ' PRO . 52.9 Cg_exo -55.48 136.03 71.97 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.788 2.325 . . . . 0.0 111.559 177.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.2 m -67.12 -36.63 82.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.439 -176.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 94.8 mt -108.03 94.58 5.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.552 0.691 . . . . 0.0 110.988 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 78.4 mt -114.16 -57.72 3.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.1 175.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 38.3 t70 56.41 83.99 0.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.68 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.16 -28.76 69.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.826 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp 71.43 -44.75 0.6 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.822 0.849 . . . . 0.0 112.964 173.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 17.0 p -58.48 -33.45 69.8 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.06 -60.98 4.79 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.716 177.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -82.54 35.86 0.47 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.201 0.524 . . . . 0.0 111.065 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.404 ' HZ ' ' O ' ' A' ' 185' ' ' LYS . 76.1 t80 -142.46 132.5 24.49 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.793 -178.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 22.2 m -116.98 141.63 48.0 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.862 0.363 . . . . 0.0 110.409 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 52.5 tp -81.05 110.54 16.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.441 ' HG ' ' HA2' ' A' ' 162' ' ' GLY . 4.7 mp -99.95 139.13 36.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.049 -175.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -109.14 143.18 38.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.402 -175.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -127.64 135.17 49.87 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.544 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.4 mp -114.75 128.19 71.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.009 0.433 . . . . 0.0 110.428 -176.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.483 ' HB2' ' CH2' ' A' ' 194' ' ' TRP . 26.6 ttp180 -114.97 123.13 48.31 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -142.6 160.35 40.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.632 0.253 . . . . 0.0 111.437 -177.16 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -171.69 150.22 2.57 Favored Pre-proline 0 C--O 1.234 0.275 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.996 176.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.498 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 36.6 Cg_endo -69.18 160.32 50.32 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.282 1.988 . . . . 0.0 110.599 169.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -67.9 -21.37 65.14 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -173.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -86.04 -11.12 53.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.018 0.437 . . . . 0.0 110.289 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.498 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -82.12 131.26 35.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.57 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -86.03 -35.57 20.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.363 178.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -94.96 143.19 26.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.325 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.453 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 67.7 m95 -88.46 145.76 25.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.77 178.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -96.43 116.94 29.87 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.577 174.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.9 mp -95.67 111.66 26.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.009 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 51.3 m-70 -117.87 119.7 35.66 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.159 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -85.38 137.3 33.03 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.14 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.412 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -102.22 -41.05 6.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.992 0.425 . . . . 0.0 110.937 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.441 ' HA2' ' HG ' ' A' ' 143' ' ' LEU . . . 91.41 -125.64 8.11 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.152 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -97.23 64.06 1.89 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.217 0.532 . . . . 0.0 110.366 -177.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -157.64 142.95 17.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.03 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.6 p -99.31 31.6 3.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.04 0.447 . . . . 0.0 111.608 -176.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.417 ' HB2' ' HE1' ' A' ' 124' ' ' TRP . 11.3 pt-20 -158.86 156.44 29.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.941 176.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 33.1 t80 -146.01 154.03 41.43 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.05 131.94 54.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.711 0.291 . . . . 0.0 110.996 -178.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.42 HG12 HD11 ' A' ' 125' ' ' ILE . 29.0 mm -106.88 138.55 32.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 170' ' ' LEU . 3.0 mm? -104.64 -28.15 11.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.965 0.412 . . . . 0.0 111.107 -176.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.9 m -90.59 75.15 6.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.928 -174.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 172' ' ' LEU . 2.7 mm? -114.56 142.66 46.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.84 0.352 . . . . 0.0 110.737 176.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 26.3 m-70 -111.35 134.36 21.17 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.924 174.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 39.7 Cg_exo -61.22 131.14 35.07 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.834 2.356 . . . . 0.0 112.325 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 73.36 43.57 37.62 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.118 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -134.0 148.0 51.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.872 0.368 . . . . 0.0 110.041 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -95.03 126.29 40.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.74 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -120.29 136.8 54.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.184 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 7.3 mp -102.24 129.67 48.7 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 28.2 m -125.22 141.84 43.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.069 0.462 . . . . 0.0 111.544 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 98.5 mt-30 -141.42 149.02 40.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.066 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.15 136.58 37.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.618 0.247 . . . . 0.0 110.338 175.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.441 ' HD2' ' HA ' ' A' ' 194' ' ' TRP . 65.7 mtp85 -143.47 160.93 39.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.354 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.61 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 21.3 p -148.49 172.15 14.94 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.404 ' O ' ' HZ ' ' A' ' 140' ' ' PHE . 21.2 pttp -138.55 117.66 9.52 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.058 0.456 . . . . 0.0 111.907 -174.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.71 -160.87 0.13 Allowed 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 123.299 2.666 . . . . 0.0 112.586 175.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -79.9 -46.54 16.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.118 0.485 . . . . 0.0 111.343 -175.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -94.41 23.85 4.92 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -171.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -161.86 168.23 36.88 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.384 178.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -157.59 150.74 23.42 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 29.1 p-90 -124.94 144.22 50.47 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.82 0.343 . . . . 0.0 111.218 -177.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 49.0 m -133.08 12.5 4.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.429 176.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -145.6 163.56 34.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.332 -178.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.483 ' CH2' ' HB2' ' A' ' 147' ' ' ARG . 72.9 m95 -112.86 167.7 10.29 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.184 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.455 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 13.1 m -148.69 -58.87 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.563 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 4.5 Cg_exo -79.56 75.69 4.93 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.332 2.021 . . . . 0.0 113.412 -168.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -77.91 103.02 7.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.988 0.423 . . . . 0.0 110.429 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 23.2 m -96.95 140.58 31.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.454 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -105.0 131.4 52.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.933 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.3 tp -126.49 140.06 49.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.121 0.486 . . . . 0.0 110.744 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -103.41 119.11 38.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.038 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 51.2 mm -83.29 124.31 76.14 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.636 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.99 164.92 25.57 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.211 2.608 . . . . 0.0 113.419 -174.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 10.3 p -68.63 -46.79 68.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.473 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -85.6 35.19 0.6 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.769 0.795 . . . . 0.0 110.609 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.584 ' HA ' ' OE1' ' A' ' 115' ' ' GLN . 89.2 t80 -68.76 -58.04 4.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 174.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 9.5 t -155.62 157.16 36.28 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 20.2 ptp -114.03 -44.25 3.17 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.268 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 50.43 45.58 26.18 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.25 0.548 . . . . 0.0 110.582 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 27.0 t70 . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.167 -176.784 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 67.6 mtm . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -122.18 146.72 46.97 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.48 HG22 HG13 ' A' ' 101' ' ' VAL . 47.4 mt -41.76 -60.92 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 123.772 0.829 . . . . 0.0 113.177 -176.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.642 ' O ' ' HD3' ' A' ' 103' ' ' PRO . 1.5 m -129.76 157.41 42.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -174.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -92.51 88.2 0.3 Allowed Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 164.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.642 ' HD3' ' O ' ' A' ' 101' ' ' VAL . 90.1 Cg_endo -83.61 135.44 6.92 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.381 2.054 . . . . 0.0 113.28 -167.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -111.2 91.29 13.13 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.923 173.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 103' ' ' PRO . 37.5 Cg_exo -60.18 153.59 57.81 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.176 2.584 . . . . 0.0 112.088 -177.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.43 98.49 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.881 2.387 . . . . 0.0 112.179 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.663 HD23 ' H ' ' A' ' 107' ' ' LEU . 2.6 pt? -94.53 -173.21 2.97 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.021 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 54.7 43.04 30.76 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 123.563 0.54 . . . . 0.0 110.217 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.413 HD13 ' HB3' ' A' ' 127' ' ' TRP . 48.6 tp -68.76 94.77 0.63 Allowed 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.604 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.69 125.64 38.42 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.997 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.478 HG12 HD11 ' A' ' 123' ' ' LEU . 2.1 t -110.69 114.13 46.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -121.32 118.19 28.87 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.108 -173.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.518 HG22 ' CD1' ' A' ' 123' ' ' LEU . 7.1 t -80.39 123.84 37.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 -179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -102.73 120.5 40.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.956 0.408 . . . . 0.0 110.783 -175.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -121.61 86.39 44.75 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.422 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.41 ' HB2' ' HB2' ' A' ' 119' ' ' ARG . 12.1 Cg_exo -71.62 -177.85 2.71 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 123.211 2.607 . . . . 0.0 113.327 -175.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -74.41 -64.71 0.97 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.17 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -119.32 15.26 13.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.096 0.474 . . . . 0.0 110.912 -176.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.41 ' HB2' ' HB2' ' A' ' 116' ' ' PRO . 98.9 mtt180 -110.29 150.19 29.09 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.556 177.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -61.71 138.22 95.22 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 123.634 0.584 . . . . 0.0 110.646 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.475 ' HD3' ' SD ' ' A' ' 208' ' ' MET . 43.2 Cg_endo -67.98 138.52 44.34 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.543 2.162 . . . . 0.0 111.47 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -148.39 157.25 43.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.624 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.518 ' CD1' HG22 ' A' ' 113' ' ' VAL . 30.7 tp -92.61 124.8 36.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.955 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.525 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 21.3 t90 -103.43 103.75 13.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.096 0.474 . . . . 0.0 110.429 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.2 mp -95.2 116.45 36.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.579 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.47 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 5.0 ttpm? -128.93 127.27 41.41 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.189 0.518 . . . . 0.0 110.566 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . 0.413 ' HB3' HD13 ' A' ' 109' ' ' LEU . 22.5 p90 -116.27 160.56 20.28 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.27 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 39.3 t -86.33 118.62 70.64 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.469 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 21.1 Cg_endo -61.33 148.74 92.12 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.709 2.273 . . . . 0.0 111.876 -178.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 129' ' ' PRO . 38.9 Cg_exo -57.03 163.15 8.1 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.965 2.444 . . . . 0.0 112.386 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 36.3 p -69.09 174.35 4.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.513 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 58.1 mt -63.83 112.84 3.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.854 -175.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.45 ' O ' HG22 ' A' ' 133' ' ' ILE . 41.0 mt -99.55 7.59 8.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 122.005 0.907 . . . . 0.0 109.37 177.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 61.23 53.11 3.64 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.84 -176.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.428 HD23 ' H ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -91.73 70.0 5.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.391 -177.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -101.76 -4.32 26.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.985 -172.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.2 p -74.26 -175.72 2.38 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.473 174.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -108.18 13.03 37.2 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.555 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -133.84 38.48 3.21 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.633 0.73 . . . . 0.0 109.801 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -91.98 -1.43 57.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.368 -176.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.28 106.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -168.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.656 HD23 ' H ' ' A' ' 142' ' ' LEU . 2.5 pt? -97.68 132.9 42.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.095 175.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 60.0 mt -104.31 141.51 36.18 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.018 0.437 . . . . 0.0 110.941 -175.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.619 ' CE2' ' HB3' ' A' ' 184' ' ' CYS . 93.6 m-85 -104.29 141.24 36.64 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.477 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -126.84 136.57 52.53 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.41 ' CD1' ' HB2' ' A' ' 161' ' ' ALA . 4.9 mp -118.16 128.07 75.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.949 0.404 . . . . 0.0 110.782 -176.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.533 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 15.3 ttp180 -113.07 120.3 40.86 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.6 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -144.58 160.41 41.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.692 0.282 . . . . 0.0 111.596 -175.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.401 ' HE2' ' CE2' ' A' ' 156' ' ' TRP . 56.7 pttt -170.93 144.55 1.82 Allowed Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.489 176.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.5 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 43.4 Cg_endo -74.2 167.09 28.0 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.553 2.169 . . . . 0.0 111.444 167.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.453 ' HG2' ' HG3' ' A' ' 152' ' ' LYS . 1.4 pm0 -59.47 -39.6 84.21 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.925 0.393 . . . . 0.0 111.426 -177.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.453 ' HG3' ' HG2' ' A' ' 151' ' ' GLU . 91.7 mttt -87.8 16.25 6.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.499 -175.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.5 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -88.96 -38.99 14.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.262 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . 70.33 -54.38 0.63 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.126 0.891 . . . . 0.0 111.19 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -85.41 151.89 23.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.248 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.533 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 77.1 m95 -90.45 135.51 33.64 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.216 178.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -99.95 123.48 44.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.505 175.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.4 mp -103.66 120.07 53.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.994 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 41.2 m-70 -123.35 122.91 39.51 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.872 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -85.8 131.4 34.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.548 -176.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.41 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -96.6 -41.56 8.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.796 0.331 . . . . 0.0 111.387 -179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 101.35 -141.09 15.18 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.292 -176.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.447 ' H ' ' CD ' ' A' ' 163' ' ' GLN . 0.4 OUTLIER -97.49 44.03 1.06 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.461 0.648 . . . . 0.0 111.08 -177.723 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -128.46 149.68 50.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.593 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 17.3 p -101.47 26.18 7.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -174.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -151.66 140.42 20.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.075 -0.512 . . . . 0.0 109.931 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 33.5 t80 -130.7 146.99 52.32 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.525 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 39.1 mmtm -112.1 132.5 54.81 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.736 0.303 . . . . 0.0 110.901 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 26.4 mm -112.34 136.85 47.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -104.93 -25.5 12.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.068 0.461 . . . . 0.0 110.441 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 25.6 t -86.18 70.02 10.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.287 -175.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.9 mm? -110.62 139.83 45.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.968 0.414 . . . . 0.0 110.435 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -101.03 122.51 48.4 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.051 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.449 ' HB3' ' HB3' ' A' ' 206' ' ' PHE . 10.0 Cg_endo -58.35 116.96 3.61 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.527 2.152 . . . . 0.0 112.605 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 91.35 32.46 8.77 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.636 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.562 HE21 ' HA ' ' A' ' 176' ' ' GLN . 0.1 OUTLIER -133.13 159.3 40.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.826 0.346 . . . . 0.0 110.911 -179.6 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -106.88 126.63 52.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.691 -174.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -112.82 137.95 50.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.048 0.451 . . . . 0.0 110.67 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 4.9 mp -99.84 124.21 44.89 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 175.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 26.3 m -121.8 140.27 46.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.229 0.538 . . . . 0.0 111.877 -176.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.611 HE21 ' HB2' ' A' ' 197' ' ' ALA . 82.7 mt-30 -136.08 147.68 47.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.333 175.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.8 p -145.18 142.44 22.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.869 0.366 . . . . 0.0 110.128 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.459 ' HD2' ' O ' ' A' ' 193' ' ' ALA . 27.0 ttt-85 -146.69 149.31 33.2 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 174.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.619 ' HB3' ' CE2' ' A' ' 144' ' ' TYR . 9.0 p -103.67 154.03 19.98 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.527 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.474 ' HE2' ' CE2' ' A' ' 191' ' ' TRP . 73.7 mttt -112.54 95.14 30.81 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 176.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -64.25 145.96 89.5 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.926 2.417 . . . . 0.0 112.442 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -64.87 -23.12 67.13 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.745 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -96.6 16.55 18.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.963 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -167.41 -148.9 5.81 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.174 -1.012 . . . . 0.0 112.967 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -162.43 -178.03 6.02 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.474 ' CE2' ' HE2' ' A' ' 185' ' ' LYS . 1.2 p-90 -118.48 135.48 54.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.019 0.438 . . . . 0.0 110.479 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 12.1 p -85.08 -38.57 18.96 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.044 176.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.459 ' O ' ' HD2' ' A' ' 183' ' ' ARG . . . -177.35 -154.78 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.767 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . . . . . . . . . 73.1 m95 -94.32 157.03 16.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.448 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.506 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 2.0 m -133.54 -60.85 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -176.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 14.8 Cg_endo -94.9 111.47 0.15 Allowed 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.674 2.249 . . . . 0.0 113.308 -172.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.611 ' HB2' HE21 ' A' ' 181' ' ' GLN . . . -103.53 122.47 45.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.039 0.447 . . . . 0.0 110.858 177.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 90.7 m -117.03 147.04 42.69 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.709 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.403 ' CD2' ' HG ' ' A' ' 179' ' ' LEU . 68.2 m-85 -110.66 140.37 45.08 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.1 tp -136.23 138.07 47.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.145 0.498 . . . . 0.0 110.794 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -104.39 124.37 49.09 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.551 177.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 40.8 mm -88.56 124.55 65.66 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.343 178.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.49 146.61 96.88 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.605 2.203 . . . . 0.0 111.908 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 49.6 m -70.91 -11.56 61.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.288 0.566 . . . . 0.0 110.57 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -96.26 15.59 20.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.614 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.511 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 83.7 t80 -53.13 -43.91 67.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.523 177.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.5 m -57.52 119.81 7.18 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.229 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.487 ' O ' ' HG3' ' A' ' 208' ' ' MET . 20.5 ptm -80.8 83.46 6.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.278 0.561 . . . . 0.0 110.571 -175.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 60.37 -156.96 0.34 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.291 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.331 -0.843 . . . . 0.0 110.596 178.141 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 56.6 tpp . . . . . 0 N--CA 1.483 1.186 0 CA-C-O 120.536 0.208 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.582 ' CE2' ' HB ' ' A' ' 101' ' ' VAL . 35.5 p90 -162.34 178.68 8.46 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 177.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.608 ' O ' ' HA2' ' A' ' 189' ' ' GLY . 13.9 mt -41.09 -44.29 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.213 0.946 . . . . 0.0 113.079 -176.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.582 ' HB ' ' CE2' ' A' ' 99' ' ' TYR . 17.5 t -104.16 94.19 3.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.174 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -60.45 129.22 89.04 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.475 -177.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -82.47 -161.22 0.14 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.325 2.683 . . . . 0.0 112.736 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 67.79 85.19 0.15 Allowed Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.319 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.7 147.93 8.42 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.517 2.145 . . . . 0.0 111.822 175.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.413 ' HG2' HG13 ' A' ' 182' ' ' VAL . 11.8 Cg_endo -58.43 141.06 96.83 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.341 2.028 . . . . 0.0 110.87 172.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.41 HD12 ' HB2' ' A' ' 128' ' ' SER . 0.6 OUTLIER -127.16 174.68 8.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.971 -172.059 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 57.07 60.63 2.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.343 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.426 HD23 ' HB3' ' A' ' 127' ' ' TRP . 9.7 mt -69.45 97.76 1.03 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.7 174.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.6 122.02 39.07 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.455 HG12 HD22 ' A' ' 123' ' ' LEU . 10.0 t -115.09 119.55 62.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.896 -177.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -118.88 132.7 56.11 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.158 -176.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.495 ' HA ' HD23 ' A' ' 123' ' ' LEU . 12.9 p -86.78 128.26 39.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.19 0.519 . . . . 0.0 109.984 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -116.69 107.84 15.17 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.21 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.457 ' HG2' ' HB3' ' A' ' 121' ' ' PRO . 50.5 mt-30 -111.24 97.95 37.58 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.421 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.91 -179.88 4.68 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.775 2.316 . . . . 0.0 112.374 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -71.66 -68.44 0.45 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.884 0.373 . . . . 0.0 110.855 -177.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -107.24 -18.28 13.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.334 0.588 . . . . 0.0 110.97 -176.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -80.12 141.93 35.3 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.845 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -60.06 135.39 90.54 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.268 -175.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.457 ' HB3' ' HG2' ' A' ' 115' ' ' GLN . 38.0 Cg_endo -65.52 149.36 87.77 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.978 2.452 . . . . 0.0 112.282 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.428 ' HB3' HD13 ' A' ' 170' ' ' LEU . 49.2 p90 -150.81 167.98 25.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.941 -175.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 113' ' ' VAL . 11.1 mt -100.25 142.41 31.77 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 120.918 0.39 . . . . 0.0 110.822 176.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.523 ' CZ2' ' HD2' ' A' ' 126' ' ' LYS . 19.9 t90 -113.93 105.28 13.06 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.729 175.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.1 mp -94.87 118.48 41.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.523 ' HD2' ' CZ2' ' A' ' 124' ' ' TRP . 81.5 tttt -132.05 119.56 21.17 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.216 0.532 . . . . 0.0 110.866 -175.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . 0.491 ' CH2' HD11 ' A' ' 146' ' ' ILE . 35.5 p90 -116.08 162.46 17.39 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.829 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.41 ' HB2' HD12 ' A' ' 107' ' ' LEU . 17.6 m -102.9 134.94 19.54 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.95 148.69 28.81 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.235 2.623 . . . . 0.0 112.279 -177.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -48.25 -82.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.464 2.776 . . . . 0.0 113.267 -174.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.1 p -149.5 -74.99 0.16 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.972 0.415 . . . . 0.0 111.143 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 95.5 mt -117.68 102.93 9.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.369 0.604 . . . . 0.0 111.471 -176.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.478 HD12 ' N ' ' A' ' 133' ' ' ILE . 3.5 mp -99.92 87.07 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 122.487 1.137 . . . . 0.0 109.617 177.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.78 -3.83 40.34 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 113.414 -1.721 . . . . 0.0 111.167 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.7 mp -78.71 57.4 2.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.228 -172.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -85.5 100.92 12.23 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 175.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.7 t 169.11 147.7 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.749 -173.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -66.77 -54.21 23.34 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.489 177.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 19.3 m-90 -82.97 136.44 34.53 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 3.9 t80 67.03 59.87 0.53 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.836 0.827 . . . . 0.0 109.696 -173.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 13.3 t -106.91 170.43 7.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.87 174.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.024 ' HG ' ' SG ' ' A' ' 184' ' ' CYS . 11.4 tp -96.1 110.63 22.86 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.889 0.376 . . . . 0.0 110.077 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -96.16 133.67 40.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.948 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -102.1 144.35 30.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.988 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 182' ' ' VAL . 75.1 tt0 -136.64 137.35 39.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.926 -173.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 181' ' ' GLN . 4.7 mp -120.57 125.42 74.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.775 0.321 . . . . 0.0 110.858 -176.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.44 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 18.0 ttp180 -108.84 121.77 45.77 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 4.0 pp -145.25 159.28 43.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.79 0.328 . . . . 0.0 111.342 -176.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -168.61 149.33 4.34 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 174.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.54 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 31.3 Cg_endo -70.95 160.89 47.94 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.988 1.792 . . . . 0.0 112.311 174.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.455 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 6.0 pt-20 -50.93 -46.93 61.04 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.455 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 93.4 mttt -84.77 13.85 5.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.803 0.335 . . . . 0.0 111.59 -174.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.54 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -88.23 134.25 33.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.926 0.393 . . . . 0.0 111.185 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -89.95 -21.63 22.35 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.205 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -120.37 145.83 46.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.733 -177.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.44 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 66.4 m95 -84.06 137.7 33.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.433 176.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -109.9 116.7 32.1 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.423 0.63 . . . . 0.0 111.323 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.1 mp -91.03 130.79 39.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.935 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 67.6 m-70 -124.11 126.03 45.49 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.223 176.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -93.0 119.55 32.38 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.852 0.358 . . . . 0.0 110.836 -174.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.437 ' HB2' HD11 ' A' ' 146' ' ' ILE . . . -75.09 -51.5 13.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.054 177.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 77.8 81.76 0.63 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.368 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 74.3 -40.0 0.44 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.954 0.901 . . . . 0.0 112.563 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -68.56 145.65 53.78 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 55.5 p -104.94 30.31 5.63 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.26 0.552 . . . . 0.0 111.49 -176.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -154.14 144.76 22.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.639 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 32.4 t80 -142.27 146.14 34.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.081 -177.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.451 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 10.3 mptt -115.76 144.53 43.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.861 0.362 . . . . 0.0 110.661 179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 122' ' ' TYR . 35.8 mm -119.61 134.19 63.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.951 177.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.428 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.6 mm? -102.02 -29.52 11.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.878 0.371 . . . . 0.0 110.608 178.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 45.6 m -86.2 73.89 10.14 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.963 -175.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.25 144.3 41.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.854 0.359 . . . . 0.0 110.333 174.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 -110.16 122.11 39.72 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.887 175.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.25 124.35 15.96 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.984 2.456 . . . . 0.0 112.772 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 97.21 12.54 48.6 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.073 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -118.78 148.84 42.4 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.377 0.608 . . . . 0.0 111.873 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -89.47 129.97 35.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.547 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.435 ' HB2' HG23 ' A' ' 200' ' ' ILE . 22.7 m-85 -115.59 135.52 53.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.998 0.427 . . . . 0.0 110.455 177.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.6 mp -101.5 121.94 42.88 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.402 HG23 ' HB ' ' A' ' 198' ' ' THR . 29.8 m -119.49 137.56 52.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.175 0.512 . . . . 0.0 111.062 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.553 HE21 ' HB2' ' A' ' 197' ' ' ALA . 89.3 mt-30 -136.94 139.58 41.63 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.556 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 145' ' ' GLU . 10.4 p -123.55 137.35 57.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.206 0.527 . . . . 0.0 110.606 174.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -138.79 138.68 37.81 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.667 174.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 1.024 ' SG ' ' HG ' ' A' ' 142' ' ' LEU . 4.6 t -125.53 156.23 39.36 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.07 126.16 1.57 Allowed Pre-proline 0 C--N 1.326 -0.424 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.22 -172.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -55.44 163.74 4.71 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.799 2.333 . . . . 0.0 112.454 168.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -47.33 -51.45 19.39 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -172.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -74.57 -20.37 59.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -174.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.608 ' HA2' ' O ' ' A' ' 100' ' ' ILE . . . -75.61 99.15 1.21 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.487 -174.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -84.45 113.95 21.57 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.784 0.802 . . . . 0.0 110.46 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 14.4 p-90 -91.51 158.99 16.16 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.359 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 10.5 t -158.96 22.75 0.21 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.215 0.531 . . . . 0.0 109.722 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -160.99 166.3 28.51 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.823 -173.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.412 ' CZ2' ' HB2' ' A' ' 147' ' ' ARG . 83.0 m95 -132.96 135.14 45.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.943 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.516 ' OG ' ' HD3' ' A' ' 196' ' ' PRO . 3.1 p -110.72 -50.24 0.06 OUTLIER Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -176.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.516 ' HD3' ' OG ' ' A' ' 195' ' ' SER . 9.3 Cg_endo -86.92 83.05 1.13 Allowed 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.019 1.813 . . . . 0.0 113.12 -172.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.553 ' HB2' HE21 ' A' ' 181' ' ' GLN . . . -87.41 107.1 18.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.043 0.449 . . . . 0.0 110.464 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.402 ' HB ' HG23 ' A' ' 180' ' ' VAL . 28.8 m -100.27 139.8 35.43 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.19 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -108.19 120.41 42.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.831 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.435 HG23 ' HB2' ' A' ' 178' ' ' TYR . 6.1 tp -119.99 133.56 66.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.167 0.508 . . . . 0.0 110.508 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -95.94 135.58 37.51 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.452 177.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.455 HD11 HD11 ' A' ' 123' ' ' LEU . 43.1 mm -95.83 121.51 60.94 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 175.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.01 149.13 86.11 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.923 2.415 . . . . 0.0 112.071 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 7.5 p -72.76 -18.75 61.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.037 0.446 . . . . 0.0 110.523 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -91.32 16.78 9.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.363 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.417 ' HA ' ' NE2' ' A' ' 115' ' ' GLN . 54.5 t80 -67.1 -32.41 73.54 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.9 m -63.93 134.25 54.75 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.058 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 82.6 mtp -77.85 161.52 27.55 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -79.67 59.36 3.02 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.667 0.27 . . . . 0.0 111.374 -176.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 33.3 t70 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.803 174.845 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.949 0.404 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.639 ' CE1' HG22 ' A' ' 101' ' ' VAL . 53.1 t80 -167.31 152.55 7.33 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.4 mt -48.87 -70.32 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.639 HG22 ' CE1' ' A' ' 99' ' ' TYR . 3.2 m -75.36 132.91 32.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.327 -172.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -134.13 72.74 71.25 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.638 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -82.76 116.22 2.51 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.63 2.22 . . . . 0.0 113.151 -173.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -153.29 87.34 3.9 Favored Pre-proline 0 C--N 1.32 -0.683 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 171.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -62.16 138.63 73.55 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.953 2.436 . . . . 0.0 112.988 -174.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.484 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 32.8 Cg_endo -65.26 123.91 12.19 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.624 2.216 . . . . 0.0 111.131 176.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.16 178.82 4.55 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.382 -174.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 54.16 58.07 5.33 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.894 -178.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.0 96.15 3.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.012 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.57 129.87 41.22 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.84 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.483 HG12 HD11 ' A' ' 123' ' ' LEU . 3.1 t -120.35 120.25 62.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.786 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -132.16 141.53 49.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.686 0.279 . . . . 0.0 110.616 -176.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.2 p -95.82 120.28 45.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.049 0.452 . . . . 0.0 110.029 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -111.18 126.82 55.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.904 0.383 . . . . 0.0 111.109 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.44 ' HG2' ' HB3' ' A' ' 121' ' ' PRO . 78.0 mt-30 -114.02 106.47 53.26 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.098 175.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.53 170.37 5.61 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.054 2.503 . . . . 0.0 112.561 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -78.29 -8.68 58.67 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.382 -176.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -159.71 -40.13 0.05 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.243 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -69.05 167.37 16.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.295 -178.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -63.02 141.68 97.69 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.853 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.464 ' HD3' ' SD ' ' A' ' 208' ' ' MET . 60.3 Cg_endo -72.36 147.26 46.68 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.819 2.346 . . . . 0.0 111.602 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.496 ' HB3' HD13 ' A' ' 170' ' ' LEU . 34.8 p90 -147.92 154.77 40.8 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.14 0.495 . . . . 0.0 111.336 -175.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.616 ' HB2' HD11 ' A' ' 172' ' ' LEU . 28.9 tp -90.16 124.36 34.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.531 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.541 ' CZ2' ' HD3' ' A' ' 126' ' ' LYS . 21.9 t90 -100.32 103.76 15.19 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.224 0.535 . . . . 0.0 110.232 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.9 mp -97.66 119.82 46.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.195 177.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.541 ' HD3' ' CZ2' ' A' ' 124' ' ' TRP . 25.4 pttm -132.0 139.59 48.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.51 0.672 . . . . 0.0 110.458 176.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 19.1 p90 -122.52 145.3 48.45 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.143 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 6.6 t -88.11 121.15 70.71 Favored Pre-proline 0 C--N 1.317 -0.828 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -48.02 151.88 3.7 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.58 2.854 . . . . 0.0 112.951 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -46.28 151.71 1.6 Allowed 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 123.824 3.016 . . . . 0.0 113.591 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.4 m -74.4 -31.64 62.4 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.714 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.43 ' O ' ' HB ' ' A' ' 133' ' ' ILE . 96.1 mt -84.05 155.52 22.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.3 174.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.442 HG21 ' CE1' ' A' ' 140' ' ' PHE . 29.5 mt 70.45 -59.88 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.211 0 O-C-N 123.47 0.481 . . . . 0.0 111.526 -177.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 28.9 t70 56.05 54.75 7.57 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.672 0.748 . . . . 0.0 110.11 -177.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.499 HD23 ' H ' ' A' ' 135' ' ' LEU . 2.1 pt? -69.78 151.3 45.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.917 -178.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -135.31 -45.21 0.7 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.851 -178.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 13.8 t -167.3 167.65 13.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.055 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 117.8 -160.13 13.87 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.798 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 56.1 t90 -74.63 -36.79 62.91 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.442 ' CE1' HG21 ' A' ' 133' ' ' ILE . 25.4 t80 -61.56 117.55 5.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.687 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 21.9 m -133.56 140.26 47.06 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.044 0.45 . . . . 0.0 111.014 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 39.2 tp -116.32 116.54 27.93 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.24 142.03 28.15 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.936 0.398 . . . . 0.0 111.063 -175.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.475 ' CE2' HG22 ' A' ' 165' ' ' THR . 86.8 m-85 -119.37 141.51 48.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.123 -175.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -120.29 129.82 54.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.057 175.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.5 mp -106.6 125.38 62.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.005 0.431 . . . . 0.0 110.191 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.523 ' HG2' ' CE3' ' A' ' 156' ' ' TRP . 18.6 ttp180 -117.66 119.81 36.12 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.676 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -140.5 159.45 42.17 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.413 -176.32 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.45 ' HE2' ' CZ2' ' A' ' 156' ' ' TRP . 52.4 pttt -167.08 149.9 5.89 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.426 176.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.422 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 45.8 Cg_endo -71.97 161.69 44.1 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.547 2.165 . . . . 0.0 111.196 170.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -67.47 -16.74 64.38 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -172.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -94.04 -1.15 54.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.021 0.439 . . . . 0.0 110.427 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.422 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -91.23 125.78 36.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.381 -176.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -83.09 -35.32 25.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.706 0.765 . . . . 0.0 109.415 173.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -88.16 150.25 23.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.388 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.523 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 65.4 m95 -101.41 153.4 19.72 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.786 179.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -105.24 117.78 34.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.592 174.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -94.82 118.8 41.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.227 0.537 . . . . 0.0 110.044 175.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 22.8 m-70 -122.68 114.8 21.07 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.328 177.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -82.71 142.22 31.82 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.508 -176.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -82.37 -46.36 13.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.944 0.402 . . . . 0.0 111.448 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 163' ' ' GLN . . . 108.28 -39.44 2.9 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.987 177.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 162' ' ' GLY . 63.8 tt0 174.93 -28.28 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.295 0.569 . . . . 0.0 110.017 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -70.78 160.3 32.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.809 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.475 HG22 ' CE2' ' A' ' 144' ' ' TYR . 60.7 p -110.91 28.09 9.04 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.254 0.549 . . . . 0.0 111.273 -174.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.405 ' HB2' ' HE1' ' A' ' 124' ' ' TRP . 12.3 pt-20 -152.29 143.95 23.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.411 177.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 19.8 t80 -131.86 147.7 52.5 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.437 ' HD2' ' CE2' ' A' ' 122' ' ' TYR . 43.2 mmtt -117.68 131.69 56.59 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 34.9 mm -106.91 125.01 62.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.496 HD13 ' HB3' ' A' ' 122' ' ' TYR . 3.8 mm? -93.95 -38.2 11.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.508 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 14.7 m -76.51 87.23 3.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.822 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.616 HD11 ' HB2' ' A' ' 123' ' ' LEU . 49.1 mt -131.92 147.57 52.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.762 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -109.28 134.29 20.52 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.305 178.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.34 110.87 2.13 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.618 2.212 . . . . 0.0 111.852 178.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 90.17 46.61 4.08 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.6 -176.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -135.78 147.22 48.27 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.925 0.393 . . . . 0.0 110.29 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -98.29 129.1 45.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.028 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -122.38 138.82 54.4 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.93 0.395 . . . . 0.0 110.639 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 7.5 mp -97.09 132.97 42.36 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 172.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.467 ' CG2' ' HB ' ' A' ' 198' ' ' THR . 28.4 m -122.72 152.98 27.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.174 0.511 . . . . 0.0 110.988 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.581 ' NE2' ' HA ' ' A' ' 181' ' ' GLN . 0.8 OUTLIER -151.94 152.6 32.73 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.454 -177.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 7.9 p -135.85 139.91 45.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.029 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -136.49 133.59 36.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.449 176.852 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.484 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 13.0 p -105.08 144.65 31.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.486 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -131.74 106.06 14.15 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -76.18 -163.86 0.22 Allowed 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.742 2.295 . . . . 0.0 112.888 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -84.75 -54.38 4.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.788 0.328 . . . . 0.0 111.294 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -78.37 -40.01 37.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.03 0.443 . . . . 0.0 110.357 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -96.38 159.89 21.93 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.667 -178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -140.16 -157.69 0.79 Allowed 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -177.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 72.1 m95 -43.46 134.78 3.85 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 4.8 t -130.81 29.59 4.73 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.303 171.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . 68.6 162.95 0.21 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.444 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.448 ' CE3' ' HB3' ' A' ' 181' ' ' GLN . 63.4 m95 -86.34 115.11 23.66 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 175.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.527 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 6.9 m -102.0 -54.05 0.14 Allowed Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -176.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.527 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 73.5 Cg_endo -78.08 169.74 19.9 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.656 1.571 . . . . 0.0 112.333 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -154.93 117.89 4.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 172.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.467 ' HB ' ' CG2' ' A' ' 180' ' ' VAL . 7.0 m -99.01 134.57 41.65 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.312 -179.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -104.91 130.07 53.15 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 8.4 tp -128.78 138.92 53.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.284 0.564 . . . . 0.0 111.124 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -100.14 123.29 44.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.936 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 50.6 mm -88.24 120.39 70.53 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 173.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.6 150.69 80.53 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.845 2.363 . . . . 0.0 112.425 -176.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 17.5 m -69.83 -12.53 61.7 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.52 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -91.6 17.31 8.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.711 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -67.3 -34.11 76.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.232 -178.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.1 m -68.07 129.51 40.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.191 -176.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.464 ' SD ' ' HD3' ' A' ' 121' ' ' PRO . 91.9 mtp -97.14 166.82 11.4 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 174.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 64.7 t30 58.91 37.18 24.76 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 122.137 0.97 . . . . 0.0 108.579 -171.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 16.7 t70 . . . . . 0 C--O 1.248 0.985 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.946 -174.581 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.1 ptm . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.607 0.242 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.473 ' CD2' ' HB ' ' A' ' 101' ' ' VAL . 24.1 t80 -148.1 136.85 21.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.117 0.484 . . . . 0.0 110.463 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 82.8 mt -67.4 106.22 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.697 176.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.473 ' HB ' ' CD2' ' A' ' 99' ' ' TYR . 14.4 p -149.44 148.73 15.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.177 -174.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -90.5 110.13 38.92 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.95 -39.97 22.65 Favored 'Trans proline' 0 N--CA 1.464 -0.226 0 C-N-CA 122.241 1.961 . . . . 0.0 111.651 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 130' ' ' PRO . 36.2 t70 -135.42 89.35 22.89 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.616 176.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -65.07 141.28 69.32 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.59 2.193 . . . . 0.0 111.798 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.423 ' HG3' ' SG ' ' A' ' 184' ' ' CYS . 14.6 Cg_endo -57.89 141.57 96.01 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.779 2.319 . . . . 0.0 111.446 178.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.01 -172.13 3.61 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.498 -173.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 58.53 51.24 8.18 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.699 0.625 . . . . 0.0 111.403 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.43 HD23 ' OG1' ' A' ' 198' ' ' THR . 52.9 tp -80.23 93.62 5.91 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.76 127.45 45.91 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.306 -177.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.7 t -112.27 123.8 68.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.877 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -132.59 140.07 48.09 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.585 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.69 113.46 32.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.383 0.611 . . . . 0.0 109.753 176.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -96.26 121.26 37.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.223 -176.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.456 ' HB3' ' SD ' ' A' ' 208' ' ' MET . 22.5 mt-30 -120.7 76.13 27.48 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.101 178.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.91 160.61 40.2 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.74 2.293 . . . . 0.0 111.891 -178.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -83.2 -25.59 31.63 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.295 0.569 . . . . 0.0 110.374 176.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -92.75 -44.55 8.47 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.324 -175.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -105.07 153.64 21.21 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.414 ' O ' ' HD2' ' A' ' 122' ' ' TYR . 18.7 ptpt -64.7 152.43 90.05 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.413 178.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.55 134.34 44.02 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.754 2.303 . . . . 0.0 112.565 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.414 ' HD2' ' O ' ' A' ' 120' ' ' LYS . 46.1 p90 -146.4 163.93 34.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.443 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.472 ' HB3' ' HB ' ' A' ' 169' ' ' ILE . 33.7 tp -97.44 125.77 42.29 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.47 ' CZ2' ' HD2' ' A' ' 126' ' ' LYS . 24.3 t90 -107.67 114.66 28.79 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.296 -176.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.409 HD11 HG12 ' A' ' 169' ' ' ILE . 4.2 mp -102.85 123.08 55.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.47 ' HD2' ' CZ2' ' A' ' 124' ' ' TRP . 51.2 tttm -132.38 121.12 22.97 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.991 0.424 . . . . 0.0 110.848 -177.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . 0.414 ' CD2' HG21 ' A' ' 182' ' ' VAL . 42.8 p90 -119.61 166.42 13.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.995 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 61.2 m -109.02 126.47 29.27 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.293 177.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.79 152.99 79.46 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.822 2.348 . . . . 0.0 111.647 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.474 ' HB2' HD11 ' A' ' 133' ' ' ILE . 40.1 Cg_exo -56.81 146.02 80.42 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.716 2.277 . . . . 0.0 111.724 178.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.416 HG22 ' HG ' ' A' ' 132' ' ' LEU . 12.2 m -94.49 149.61 21.07 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.372 -173.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.416 ' HG ' HG22 ' A' ' 131' ' ' THR . 74.2 mt 63.34 82.27 0.19 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.478 0.711 . . . . 0.0 112.366 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.474 HD11 ' HB2' ' A' ' 130' ' ' PRO . 77.0 mt -134.98 -59.57 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.995 176.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.2 t70 51.31 79.33 0.1 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.54 -174.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.592 HD12 ' HA ' ' A' ' 141' ' ' THR . 1.7 pt? -85.34 86.89 7.34 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 122.176 0.988 . . . . 0.0 111.168 -176.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -132.92 -62.47 0.8 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.945 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.8 t -72.6 -18.09 61.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.196 -175.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -83.47 -12.01 79.11 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.487 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 52.34 64.99 1.64 Allowed 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 122.757 0.423 . . . . 0.0 111.496 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -151.47 173.69 14.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.192 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.592 ' HA ' HD12 ' A' ' 135' ' ' LEU . 29.8 m -137.45 141.63 41.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.489 176.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 54.1 tp -97.79 111.36 23.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.553 ' CD1' ' HG2' ' A' ' 163' ' ' GLN . 2.8 mm? -100.55 157.22 16.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 -176.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -120.84 136.98 54.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.801 -176.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.452 ' C ' HG13 ' A' ' 146' ' ' ILE . 27.4 tt0 -127.54 140.42 52.14 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -174.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.46 ' CD1' ' HB2' ' A' ' 161' ' ' ALA . 7.6 mt -132.65 150.15 32.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.98 0.419 . . . . 0.0 111.843 -166.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.48 ' HG3' ' CH2' ' A' ' 194' ' ' TRP . 43.6 mtm180 -126.75 154.71 43.82 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 174.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.629 HD12 ' NE2' ' A' ' 159' ' ' HIS . 0.0 OUTLIER -163.1 155.41 18.36 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 123.297 0.373 . . . . 0.0 110.255 170.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -173.43 141.38 0.91 Allowed Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.955 176.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.8 173.37 13.57 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.561 2.174 . . . . 0.0 112.108 173.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.408 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 9.0 pt-20 -65.78 -24.68 66.99 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.627 178.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.408 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 50.6 mttm -90.51 11.51 21.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.237 0.541 . . . . 0.0 110.467 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -111.52 130.6 55.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.751 178.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -92.92 -35.35 13.38 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.259 0.552 . . . . 0.0 110.341 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -91.92 149.46 21.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.002 -175.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 77.1 m95 -93.77 128.72 40.14 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.065 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -93.06 111.46 23.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.008 173.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.462 HG13 ' HG2' ' A' ' 147' ' ' ARG . 1.9 mp -88.72 126.21 41.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.629 ' NE2' HD12 ' A' ' 148' ' ' LEU . 3.2 p80 -130.36 132.96 46.06 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.828 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -97.72 116.57 30.19 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.199 -176.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.46 ' HB2' ' CD1' ' A' ' 146' ' ' ILE . . . -76.95 -48.74 17.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.191 0.52 . . . . 0.0 110.643 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 123.5 -125.61 5.96 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.257 -176.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.553 ' HG2' ' CD1' ' A' ' 143' ' ' LEU . 5.1 mt-30 -102.14 -7.0 22.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.921 0.391 . . . . 0.0 110.482 -177.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -79.48 143.24 35.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.375 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 63.5 p -101.32 33.78 2.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.171 0.51 . . . . 0.0 111.76 -174.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -158.82 153.51 24.62 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.283 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -151.27 152.56 33.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.701 0.286 . . . . 0.0 110.547 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 168' ' ' LYS . 0.1 OUTLIER -118.33 128.92 55.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.437 -178.109 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 123' ' ' LEU . 23.6 mm -99.87 140.82 18.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.11 -19.82 13.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.777 0.323 . . . . 0.0 110.86 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 36.7 t -87.59 73.89 9.34 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.231 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.418 HD22 ' N ' ' A' ' 172' ' ' LEU . 2.7 mm? -117.7 143.26 46.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.995 0.426 . . . . 0.0 110.522 175.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 62.0 m-70 -119.15 132.26 24.03 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.575 175.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 24.3 Cg_exo -62.09 124.33 14.2 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.791 2.327 . . . . 0.0 112.732 -177.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 85.67 28.37 29.64 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.751 177.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -123.75 149.74 45.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.14 0.495 . . . . 0.0 111.125 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.4 ttmm -87.38 128.34 35.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.361 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -121.1 142.39 49.89 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.752 0.311 . . . . 0.0 110.329 175.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.8 mp -104.93 146.89 28.39 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 172.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.459 HG23 ' HB ' ' A' ' 198' ' ' THR . 19.4 m -134.53 152.74 34.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.983 0.42 . . . . 0.0 110.484 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.565 ' NE2' ' HA ' ' A' ' 181' ' ' GLN . 0.3 OUTLIER -151.66 146.27 25.67 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.035 179.522 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.414 HG21 ' CD2' ' A' ' 127' ' ' TRP . 12.0 p -138.17 149.82 24.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -158.34 139.25 13.02 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.423 ' SG ' ' HG3' ' A' ' 106' ' ' PRO . 26.3 p -104.41 177.9 4.71 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 175.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -125.65 84.68 60.1 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.684 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.9 158.0 59.62 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.955 2.437 . . . . 0.0 111.701 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -79.45 -8.93 59.47 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.764 -176.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -88.65 -7.15 56.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.544 175.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -179.74 94.71 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.592 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -75.25 125.53 29.16 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 176.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 85.1 m95 62.85 98.6 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.134 0 O-C-N 123.626 0.579 . . . . 0.0 111.245 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 10.2 p -107.47 13.98 26.32 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.753 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . 67.38 163.64 0.2 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.801 -1.09 . . . . 0.0 112.196 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.48 ' CH2' ' HG3' ' A' ' 147' ' ' ARG . 50.9 m95 -88.92 79.36 7.35 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.191 -177.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.447 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 12.9 m -74.48 -51.24 4.35 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 116.2 -0.454 . . . . 0.0 112.099 -178.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.447 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 59.2 Cg_endo -74.78 165.27 31.84 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.667 1.578 . . . . 0.0 112.722 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -154.11 130.67 10.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.965 172.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.459 ' HB ' HG23 ' A' ' 180' ' ' VAL . 12.8 m -115.9 135.45 53.98 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.582 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -106.22 131.64 53.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.252 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.0 tp -128.53 130.27 69.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.283 0.563 . . . . 0.0 110.4 177.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.449 HE21 ' HA ' ' A' ' 201' ' ' GLN . 0.0 OUTLIER -97.81 113.38 25.16 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.338 178.495 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 51.7 mm -74.27 122.05 86.64 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.14 155.05 71.63 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.776 2.318 . . . . 0.0 112.353 -176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 12.3 p -75.85 -5.18 44.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.299 0.571 . . . . 0.0 110.224 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -82.8 -6.43 59.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.148 177.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.41 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 36.2 t80 -53.32 -37.26 62.11 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.54 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 2.2 p -89.12 92.89 9.38 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.231 174.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . 0.456 ' SD ' ' HB3' ' A' ' 115' ' ' GLN . 58.5 mtm -82.63 -26.32 32.31 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.011 -172.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 46.51 65.1 1.28 Allowed 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.756 0.66 . . . . 0.0 112.514 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 34.2 t70 . . . . . 0 C--O 1.253 1.252 0 O-C-N 123.643 0.589 . . . . 0.0 110.745 179.437 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 83.1 mtp . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.95 0.405 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -101.53 134.07 45.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.271 0.558 . . . . 0.0 110.642 177.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 76.9 mt -73.86 89.14 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.213 175.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.537 ' O ' ' HD3' ' A' ' 103' ' ' PRO . 10.4 p -84.99 144.78 9.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.59 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -85.88 101.79 2.14 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 101' ' ' VAL . 38.5 Cg_endo -69.2 -39.6 7.36 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.108 1.872 . . . . 0.0 110.977 -178.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -112.79 86.02 8.3 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.288 172.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 103' ' ' PRO . 89.8 Cg_endo -97.1 156.43 1.08 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.675 2.916 . . . . 0.0 113.131 -176.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.664 ' HD3' ' SG ' ' A' ' 184' ' ' CYS . 73.4 Cg_endo -77.6 146.24 23.96 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.457 2.105 . . . . 0.0 111.271 175.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.405 ' N ' HD23 ' A' ' 107' ' ' LEU . 2.1 pt? -140.07 -174.61 3.97 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.094 -177.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 128' ' ' SER . 42.7 mt-10 54.99 55.97 7.12 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 123.704 0.628 . . . . 0.0 110.925 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.4 tp -75.5 96.85 3.56 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.21 0.528 . . . . 0.0 110.491 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -95.09 123.18 38.44 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.253 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.444 HG12 HD11 ' A' ' 123' ' ' LEU . 3.5 t -119.04 118.1 56.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.43 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -136.1 121.37 19.14 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.838 -174.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.475 HG22 HD13 ' A' ' 123' ' ' LEU . 48.2 t -74.48 129.44 36.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.312 -0.403 . . . . 0.0 109.971 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 114' ' ' LYS . 24.3 mmtp -118.59 125.17 49.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.14 0.495 . . . . 0.0 111.642 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -117.26 97.13 50.41 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.884 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.491 ' HB2' ' HB2' ' A' ' 119' ' ' ARG . 15.2 Cg_exo -68.74 171.48 13.24 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.429 2.086 . . . . 0.0 111.968 177.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -76.18 -66.2 0.83 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.953 0.406 . . . . 0.0 110.706 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -92.69 -33.6 14.29 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.666 -177.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.491 ' HB2' ' HB2' ' A' ' 116' ' ' PRO . 71.8 mtp180 -72.41 154.9 40.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.806 176.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -75.54 149.39 83.79 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.53 146.15 48.97 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.975 2.45 . . . . 0.0 112.468 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.473 ' CD2' ' HD2' ' A' ' 168' ' ' LYS . 49.0 p90 -151.41 161.37 42.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.461 -176.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.623 ' HB2' HD11 ' A' ' 172' ' ' LEU . 44.5 tp -91.52 125.46 36.27 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 175.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.595 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 22.4 t90 -102.03 108.93 20.52 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.127 0.489 . . . . 0.0 110.421 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.1 mp -101.03 122.22 52.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.337 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -131.09 120.5 23.48 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.946 0.403 . . . . 0.0 110.491 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . 0.437 ' CH2' HD11 ' A' ' 146' ' ' ILE . 37.1 p90 -115.83 165.84 12.63 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.466 -178.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.428 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 23.0 t -104.34 121.27 47.94 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.756 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.95 142.4 33.85 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.377 2.718 . . . . 0.0 112.526 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -43.6 106.56 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 124.034 3.156 . . . . 0.0 113.175 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.486 ' HB ' HD23 ' A' ' 132' ' ' LEU . 52.7 p 48.87 -98.48 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.715 0.806 . . . . 0.0 112.353 -176.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.486 HD23 ' HB ' ' A' ' 131' ' ' THR . 0.9 OUTLIER -143.68 124.1 13.92 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 176.033 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 59.3 mt -121.98 -66.32 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.742 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 52.75 57.99 5.81 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 123.713 0.633 . . . . 0.0 110.756 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.3 pp -71.92 138.61 48.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.791 -177.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -145.64 179.72 7.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.014 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 69.2 p 58.22 18.06 5.09 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.358 1.063 . . . . 0.0 113.123 176.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 79.87 -30.22 2.33 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.259 176.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.4 ' O ' ' HB3' ' A' ' 140' ' ' PHE . 94.2 m95 -62.58 112.78 2.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.698 0.249 . . . . 0.0 110.698 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.4 ' HB3' ' O ' ' A' ' 139' ' ' TRP . 88.4 t80 70.47 133.37 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 O-C-N 123.915 0.759 . . . . 0.0 111.41 -177.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.9 m -148.68 135.5 19.86 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.597 174.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.479 HD21 ' SG ' ' A' ' 184' ' ' CYS . 48.0 tp -107.94 117.19 33.48 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.159 -176.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 3.5 mp -95.71 134.84 38.16 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.318 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -102.83 153.17 20.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.718 -172.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -131.62 134.24 45.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.953 -171.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.437 HD11 ' CH2' ' A' ' 127' ' ' TRP . 4.5 mp -125.68 125.2 68.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.549 ' HB3' ' HB2' ' A' ' 181' ' ' GLN . 46.6 ttp180 -118.01 119.86 36.06 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -141.5 162.59 35.12 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.848 -176.251 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -167.07 150.25 6.06 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.164 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.482 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 34.2 Cg_endo -68.32 159.48 53.13 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.282 1.988 . . . . 0.0 111.027 171.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.44 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 15.8 pt-20 -63.06 -20.66 65.54 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.053 0.761 . . . . 0.0 113.053 -171.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.44 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 84.7 mttt -100.28 7.35 44.47 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.091 0.472 . . . . 0.0 110.852 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.482 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -84.75 124.24 31.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.899 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -80.96 -22.99 39.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.535 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -115.32 154.45 29.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.393 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -94.7 141.58 28.45 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.324 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -103.92 108.58 19.97 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.989 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 158' ' ' ILE . 2.2 mp -87.99 133.4 30.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.033 0.444 . . . . 0.0 110.053 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -126.92 141.84 51.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.609 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 143' ' ' LEU . 5.3 t80 -106.14 124.66 49.93 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.073 -177.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -88.21 -44.06 11.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.138 0.494 . . . . 0.0 110.303 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 143' ' ' LEU . . . 103.71 -127.63 9.21 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.051 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -93.03 9.0 37.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.447 0.641 . . . . 0.0 110.519 -176.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -105.48 153.19 22.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.584 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.8 p -107.44 19.5 20.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.033 -175.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -146.57 140.66 26.27 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -133.87 151.39 51.51 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.595 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 40.7 mmtm -120.53 135.48 55.07 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.613 0.244 . . . . 0.0 110.66 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 33.9 mm -109.7 128.78 65.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.93 -25.06 12.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.368 . . . . 0.0 111.051 -178.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 13.8 m -80.62 65.4 5.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.712 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 123' ' ' LEU . 57.6 mt -114.55 157.59 22.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.949 -177.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 75.3 m-70 -126.08 129.97 24.1 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.774 177.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 23.7 Cg_exo -63.75 121.85 9.73 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.615 2.21 . . . . 0.0 111.925 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 90.8 20.2 40.93 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.05 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -117.49 142.97 46.52 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 151' ' ' GLU . 30.3 ttmt -90.77 135.13 33.92 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.064 177.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -122.12 133.17 54.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.112 0.482 . . . . 0.0 110.606 176.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 6.3 mp -100.68 124.71 46.66 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.442 HG21 HG21 ' A' ' 111' ' ' VAL . 34.7 m -115.02 161.27 13.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.364 0.602 . . . . 0.0 111.723 -176.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.584 HE21 ' HB2' ' A' ' 197' ' ' ALA . 12.2 mm-40 -145.63 148.67 33.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.901 -178.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 9.0 p -136.37 145.69 30.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 120.891 0.377 . . . . 0.0 110.184 175.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.56 ' HG2' ' CZ3' ' A' ' 194' ' ' TRP . 1.2 ptm180 -163.08 177.98 8.68 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.398 175.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.664 ' SG ' ' HD3' ' A' ' 106' ' ' PRO . 27.9 p -155.25 170.46 21.81 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -147.35 89.69 5.44 Favored Pre-proline 0 C--N 1.322 -0.619 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.797 -176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.49 -169.33 0.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.721 2.28 . . . . 0.0 112.252 -178.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.5 -24.03 64.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.236 0.541 . . . . 0.0 110.259 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -61.51 -24.3 66.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.108 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -159.41 -147.64 4.95 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 119.979 -1.105 . . . . 0.0 113.539 -177.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -150.36 -141.22 0.11 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 -176.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 40.5 m95 -66.1 136.5 56.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.123 0.487 . . . . 0.0 111.709 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 16.5 m -120.94 10.79 10.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.881 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . 62.25 24.44 14.55 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.56 ' CZ3' ' HG2' ' A' ' 183' ' ' ARG . 71.9 m95 70.83 164.29 0.27 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.653 173.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.574 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 70.4 m -158.58 -63.97 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.574 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 76.9 Cg_endo -76.25 109.07 2.8 Favored 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 121.896 1.731 . . . . 0.0 113.456 -173.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.584 ' HB2' HE21 ' A' ' 181' ' ' GLN . . . -101.66 137.61 39.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.891 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 94.9 m -133.48 139.21 46.54 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.574 177.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -99.75 126.72 45.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.396 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.9 tp -129.25 137.68 56.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.029 0.443 . . . . 0.0 110.423 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -102.54 137.33 40.91 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.905 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 39.2 mm -96.98 113.08 62.39 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 176.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.8 147.44 72.39 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.921 2.414 . . . . 0.0 112.188 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 42.1 m -71.76 -7.51 48.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.974 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -95.16 7.77 45.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.773 175.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -59.77 -36.19 76.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.114 177.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 24.9 m -138.14 142.62 40.12 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.225 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 21.4 ptp -57.79 117.16 3.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.415 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -79.99 105.17 11.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.946 -177.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 C--O 1.252 1.198 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.406 -179.309 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 55.7 ttp . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 120.549 0.214 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -140.58 151.33 44.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.993 0.425 . . . . 0.0 110.805 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 188' ' ' HIS . 4.5 mp -75.0 88.5 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.364 177.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.0 p -154.04 143.63 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.381 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -109.23 98.87 33.48 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 173.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.61 -18.71 25.26 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.553 2.169 . . . . 0.0 112.438 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -131.26 76.69 75.66 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.686 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -69.7 159.5 53.22 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.878 2.386 . . . . 0.0 111.271 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -60.24 105.34 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.772 2.315 . . . . 0.0 112.415 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.93 174.26 5.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.154 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 54.74 47.53 22.25 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 123.694 0.621 . . . . 0.0 110.976 -178.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.445 HD23 ' OG1' ' A' ' 198' ' ' THR . 55.8 tp -70.34 94.39 0.94 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.002 177.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.17 130.79 43.13 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.541 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.431 HG13 HG13 ' A' ' 125' ' ' ILE . 5.0 t -117.38 113.88 43.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.667 178.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -111.94 148.43 33.76 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.18 -178.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.6 p -108.36 95.84 4.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-O 122.077 0.941 . . . . 0.0 109.92 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -87.36 122.06 30.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.456 -174.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -117.88 98.87 51.95 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.195 -173.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.6 155.39 49.83 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.977 2.451 . . . . 0.0 111.27 173.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.496 ' H ' ' CD ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -93.5 -4.93 50.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.958 0.408 . . . . 0.0 111.145 -176.317 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -132.49 -34.94 1.16 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.728 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -87.37 173.15 9.32 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.291 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -79.62 138.24 54.75 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.161 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.425 ' HG3' ' O ' ' A' ' 206' ' ' PHE . 38.3 Cg_endo -66.24 147.91 84.1 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.949 2.432 . . . . 0.0 111.847 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -149.09 156.99 43.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.958 0.408 . . . . 0.0 110.979 -174.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.417 HD12 HD11 ' A' ' 172' ' ' LEU . 16.3 mt -87.65 142.46 27.82 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.248 0.547 . . . . 0.0 110.602 174.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.491 ' CD1' ' HE3' ' A' ' 168' ' ' LYS . 19.5 t90 -117.03 102.1 9.05 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.701 177.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.431 HG13 HG13 ' A' ' 111' ' ' VAL . 4.2 mp -97.94 117.79 43.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -131.48 131.56 43.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.065 0.459 . . . . 0.0 110.897 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . . . . . . . . . 29.0 p90 -123.48 151.92 42.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.897 -178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.2 m -127.54 78.09 75.18 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.4 -177.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.46 ' CB ' ' HD3' ' A' ' 130' ' ' PRO . 19.0 Cg_exo -61.88 -56.67 0.69 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.091 1.861 . . . . 0.0 113.395 177.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.561 ' HB2' ' HB ' ' A' ' 133' ' ' ILE . 28.9 Cg_endo -98.08 73.04 0.08 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.466 2.111 . . . . 0.0 112.196 -177.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 33.8 p -55.93 -53.47 56.42 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -174.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 89.9 mt -113.56 28.78 8.5 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.698 0.761 . . . . 0.0 111.452 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 130' ' ' PRO . 70.7 mt -102.64 -52.97 7.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.221 177.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.9 t70 55.33 29.88 13.8 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.388 0.613 . . . . 0.0 111.133 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.513 ' H ' HG22 ' A' ' 133' ' ' ILE . 2.6 mm? 42.1 46.35 3.67 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.549 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -73.53 -69.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.868 0.366 . . . . 0.0 111.149 -178.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.4 p -84.21 74.78 10.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.365 0.602 . . . . 0.0 110.979 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 108.43 93.04 2.27 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.704 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.493 ' HA ' ' HB3' ' A' ' 135' ' ' LEU . 29.8 p90 -93.43 145.5 24.45 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.992 0.425 . . . . 0.0 110.624 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -162.84 148.85 12.31 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.553 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.12 105.46 17.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.607 0.718 . . . . 0.0 110.938 178.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.45 HD21 ' HB2' ' A' ' 184' ' ' CYS . 13.5 tp -83.56 136.73 34.14 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.414 -177.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 162' ' ' GLY . 4.1 mp -92.76 135.54 34.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.871 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.503 ' CE1' ' HB3' ' A' ' 184' ' ' CYS . 82.5 m-85 -122.61 144.42 49.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.17 -176.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -125.66 138.14 53.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.315 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 181' ' ' GLN . 4.4 mp -118.56 122.02 68.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.924 0.392 . . . . 0.0 110.148 -177.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.423 ' HB2' ' CZ2' ' A' ' 194' ' ' TRP . 23.1 ttp180 -107.1 123.86 48.84 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.58 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 3.7 pp -143.18 162.09 36.52 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.161 -176.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -168.35 148.8 4.35 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.255 -0.43 . . . . 0.0 109.91 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.424 ' HG2' ' HB2' ' A' ' 153' ' ' ALA . 40.6 Cg_endo -71.08 161.11 47.08 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.306 2.004 . . . . 0.0 111.067 170.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.423 ' HG3' ' HG3' ' A' ' 152' ' ' LYS . 13.2 pt-20 -63.35 -19.94 65.07 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.247 -175.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.423 ' HG3' ' HG3' ' A' ' 151' ' ' GLU . 88.6 mttt -97.02 10.37 39.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.0 0.428 . . . . 0.0 110.9 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.424 ' HB2' ' HG2' ' A' ' 150' ' ' PRO . . . -98.55 131.01 45.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.641 178.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -86.23 -37.13 18.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.206 0.527 . . . . 0.0 110.469 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -98.23 159.29 15.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.912 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.423 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 69.9 m95 -96.88 146.03 25.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.078 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -105.39 111.82 24.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.007 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.48 130.08 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.082 0.468 . . . . 0.0 110.959 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -126.46 133.64 51.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.791 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -102.78 130.09 49.64 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -94.11 -29.96 14.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.859 0.362 . . . . 0.0 111.4 -177.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 143' ' ' LEU . . . 100.33 -133.28 11.24 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.149 -176.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -106.81 31.6 5.18 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.34 0.591 . . . . 0.0 110.96 -177.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -115.69 151.97 34.07 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.385 177.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 34.9 p -102.17 21.81 14.27 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -175.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 125' ' ' ILE . 8.5 pt-20 -147.74 138.83 23.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.109 174.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -129.51 150.22 50.94 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.892 -178.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.491 ' HE3' ' CD1' ' A' ' 124' ' ' TRP . 42.9 mmtm -112.78 146.0 39.58 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.409 ' HB ' ' HB2' ' A' ' 123' ' ' LEU . 32.6 mm -125.04 132.62 71.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 173.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.75 -16.94 14.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.915 0.388 . . . . 0.0 110.969 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 8.7 t -96.33 69.95 2.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.828 0.347 . . . . 0.0 111.451 -173.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.1 mm? -115.98 159.8 21.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.815 0.34 . . . . 0.0 110.603 176.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 57.7 m-70 -126.52 136.36 28.56 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.548 178.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 24.6 Cg_exo -62.29 122.25 10.6 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.745 2.297 . . . . 0.0 111.986 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 83.98 38.34 10.42 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.81 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -133.38 144.43 49.57 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -101.83 132.66 47.46 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.635 177.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -120.66 142.64 49.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.63 176.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.1 mm? -103.85 127.39 51.35 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 174.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 30.2 m -122.36 141.46 42.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.182 0.515 . . . . 0.0 111.55 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 99.1 mt-30 -140.65 142.73 34.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.337 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 14.2 p -138.57 139.42 41.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -145.97 142.82 29.04 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.503 ' HB3' ' CE1' ' A' ' 144' ' ' TYR . 23.5 p -108.14 163.4 13.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.98 -175.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.462 ' HB3' ' CD1' ' A' ' 191' ' ' TRP . 18.0 ptmt -147.61 87.83 5.84 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.38 0.609 . . . . 0.0 111.516 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -85.38 -162.59 0.16 Allowed 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.925 2.416 . . . . 0.0 111.895 176.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -77.73 -21.21 52.2 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.168 0.508 . . . . 0.0 110.187 176.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.457 ' O ' ' HA ' ' A' ' 100' ' ' ILE . 38.7 m170 -74.89 -29.26 60.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.823 -177.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -163.8 163.54 35.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.026 -1.083 . . . . 0.0 113.101 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -136.07 -176.87 4.46 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . 0.462 ' CD1' ' HB3' ' A' ' 185' ' ' LYS . 42.4 p-90 -151.07 147.57 27.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.048 0.451 . . . . 0.0 111.441 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 22.9 t -121.35 -3.05 9.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.039 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -149.85 172.37 15.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.969 -176.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.423 ' CZ2' ' HB2' ' A' ' 147' ' ' ARG . 61.0 m95 -110.82 163.46 13.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.678 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.452 ' H ' ' CD ' ' A' ' 196' ' ' PRO . 18.2 m -140.5 -55.75 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -176.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.549 ' O ' ' HG2' ' A' ' 181' ' ' GLN . 8.4 Cg_endo -87.64 88.71 0.58 Allowed 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.312 2.008 . . . . 0.0 113.273 -171.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.457 ' HB2' ' NE2' ' A' ' 181' ' ' GLN . . . -85.78 106.76 17.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.908 0.385 . . . . 0.0 110.47 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.445 ' OG1' HD23 ' A' ' 109' ' ' LEU . 17.4 m -92.33 136.32 33.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.814 -177.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -95.36 124.15 39.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.742 -177.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 7.2 tp -127.45 129.43 70.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.234 0.54 . . . . 0.0 110.464 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -101.11 132.79 46.4 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.409 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 36.5 mm -94.08 115.48 65.24 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.07 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.41 155.4 47.09 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.998 2.465 . . . . 0.0 112.562 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 18.7 m -70.06 -17.31 63.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.645 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -82.27 1.15 38.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.87 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 62.4 t80 -57.41 -51.24 70.24 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.109 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 28.7 m -153.46 134.99 14.33 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.807 176.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -116.23 -18.42 10.55 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.093 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -76.84 144.38 39.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.134 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 30.7 t70 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.834 -1.079 . . . . 0.0 110.873 -179.421 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.3 mmm . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.429 ' CE2' ' HB ' ' A' ' 101' ' ' VAL . 19.8 t80 -144.33 144.89 31.67 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.265 -178.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 43.5 mm -64.68 91.32 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.298 175.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.429 ' HB ' ' CE2' ' A' ' 99' ' ' TYR . 8.3 p -152.01 144.7 15.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.284 -178.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.445 ' HG2' ' HD3' ' A' ' 186' ' ' PRO . 26.6 mt-30 -98.05 156.23 36.14 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.83 178.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.18 -42.23 44.69 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.173 1.915 . . . . 0.0 110.581 172.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 132' ' ' LEU . 0.3 OUTLIER -150.18 127.32 5.46 Favored Pre-proline 0 N--CA 1.449 -0.491 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.432 178.183 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 104' ' ' ASP . 5.3 Cg_exo -77.03 145.8 25.11 Favored 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 122.93 2.42 . . . . 0.0 111.908 174.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.11 144.84 43.08 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.704 2.269 . . . . 0.0 111.814 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.481 HD13 ' N ' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -134.91 -178.32 5.03 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 -176.454 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 56.11 58.75 4.12 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.615 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.465 HD23 ' OG1' ' A' ' 198' ' ' THR . 33.9 tp -75.57 95.81 3.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.261 0.553 . . . . 0.0 109.735 175.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.72 128.83 40.13 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.01 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.9 t -125.7 122.09 61.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.04 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -139.21 155.35 47.86 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.176 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.506 HG22 ' CD1' ' A' ' 123' ' ' LEU . 21.8 t -100.18 94.21 3.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-O 121.375 0.607 . . . . 0.0 109.636 -177.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.446 ' O ' ' HD3' ' A' ' 116' ' ' PRO . 0.8 OUTLIER -78.86 108.14 12.09 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.794 -176.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -106.43 98.98 21.81 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.921 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 114' ' ' LYS . 14.6 Cg_exo -69.88 163.82 36.93 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.817 2.344 . . . . 0.0 112.881 -177.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -101.4 19.75 17.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.206 177.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -147.39 -55.25 0.23 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.673 -176.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -93.12 168.59 11.01 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.795 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.62 143.77 96.3 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.344 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.98 135.19 46.53 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.821 2.347 . . . . 0.0 112.024 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -139.44 160.49 39.71 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.047 0.451 . . . . 0.0 110.991 -176.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.506 ' CD1' HG22 ' A' ' 113' ' ' VAL . 37.2 tp -91.12 123.76 34.82 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 176.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.526 ' CZ2' ' HD2' ' A' ' 126' ' ' LYS . 10.5 t90 -103.0 103.25 13.33 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.2 0.524 . . . . 0.0 110.49 -174.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 4.0 mp -95.73 113.61 30.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.081 178.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.526 ' HD2' ' CZ2' ' A' ' 124' ' ' TRP . 58.6 tttp -129.61 119.54 23.76 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.352 0.596 . . . . 0.0 110.656 -176.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' TRP . . . . . 0.427 ' CD2' HG21 ' A' ' 182' ' ' VAL . 29.2 p90 -109.76 163.61 13.35 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.752 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.1 t -103.25 122.81 43.93 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.474 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . 82.8 Cg_exo -49.71 137.53 33.98 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.334 2.689 . . . . 0.0 112.202 177.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 129' ' ' PRO . 39.0 Cg_exo -57.59 152.12 50.2 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.006 2.471 . . . . 0.0 112.735 -178.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.6 m -54.16 -66.82 0.33 Allowed 'General case' 0 C--O 1.236 0.369 0 O-C-N 123.343 0.402 . . . . 0.0 111.669 -176.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 104' ' ' ASP . 99.6 mt -112.69 101.51 9.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.297 0.57 . . . . 0.0 111.3 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.415 HD11 ' HD2' ' A' ' 130' ' ' PRO . 11.4 mt -96.49 87.01 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.748 0.785 . . . . 0.0 109.153 175.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -69.22 84.65 0.37 Allowed 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.419 175.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.487 ' HB2' ' CZ ' ' A' ' 140' ' ' PHE . 1.6 pt? -129.55 153.14 48.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.8 177.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -72.5 113.2 9.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.09 0.471 . . . . 0.0 110.451 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 24.7 p -75.38 133.42 41.19 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.564 -175.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 89.29 -17.3 52.64 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.219 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -96.57 -47.49 5.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.686 0.243 . . . . 0.0 110.402 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.487 ' CZ ' ' HB2' ' A' ' 135' ' ' LEU . 22.2 p90 -151.73 162.42 41.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.786 0.327 . . . . 0.0 110.498 178.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.9 m -122.86 151.6 41.56 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.01 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.3 tp -79.42 110.63 14.9 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.2 mt -101.29 150.39 23.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.297 -177.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.589 ' CD2' ' HB3' ' A' ' 184' ' ' CYS . 49.7 m-85 -116.54 143.98 44.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.178 -176.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -121.48 141.93 50.54 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 146' ' ' ILE . 4.1 mp -117.95 124.94 73.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.024 0.44 . . . . 0.0 110.734 -175.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.454 ' HB2' ' CH2' ' A' ' 194' ' ' TRP . 14.3 ttp180 -109.01 120.32 42.2 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.062 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 179' ' ' LEU . 0.0 OUTLIER -145.69 161.49 39.75 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.946 -0.302 . . . . 0.0 111.471 -175.611 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -172.69 147.29 1.62 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.72 175.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -70.9 164.73 34.64 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.093 1.862 . . . . 0.0 111.067 170.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -64.29 -23.96 67.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.608 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.523 ' HE2' ' OE1' ' A' ' 176' ' ' GLN . 67.8 mmtt -81.7 -13.66 57.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.21 0.528 . . . . 0.0 110.512 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -83.97 129.61 34.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.746 -178.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -88.22 -26.39 22.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.409 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -107.12 144.66 33.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.791 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' TRP . . . . . 0.435 ' CE3' ' HG2' ' A' ' 147' ' ' ARG . 77.1 m95 -85.22 134.56 34.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.261 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -93.37 131.22 38.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.685 177.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -111.38 122.44 65.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.038 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 167' ' ' PHE . 46.3 m-70 -130.57 113.45 14.25 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.202 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -79.09 132.71 36.68 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.988 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -99.12 -49.49 4.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 111.804 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 111.87 -137.75 14.49 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.02 13.58 22.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.066 0.46 . . . . 0.0 111.005 -177.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -68.75 -23.01 64.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.492 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 42.0 p 63.16 15.71 8.77 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.382 -1.281 . . . . 0.0 113.051 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -153.2 136.88 16.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 171.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 159' ' ' HIS . 24.7 t80 -125.74 151.33 46.81 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.692 0.282 . . . . 0.0 110.525 -176.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.582 ' HD2' ' N ' ' A' ' 168' ' ' LYS . 0.0 OUTLIER -125.53 115.51 20.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.466 -175.087 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' A' ' 123' ' ' LEU . 34.5 mm -93.39 137.92 21.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 176.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -100.37 -32.53 10.79 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.851 0.358 . . . . 0.0 111.118 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 18.7 m -87.55 80.93 7.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.814 -174.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 206' ' ' PHE . 2.6 mm? -113.6 137.43 51.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 110.712 176.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 53.5 m-70 -100.05 125.93 38.31 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.18 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 173' ' ' HIS . 22.9 Cg_exo -63.52 125.05 14.78 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.566 2.177 . . . . 0.0 112.448 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 86.6 26.93 31.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.409 178.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.523 ' OE1' ' HE2' ' A' ' 152' ' ' LYS . 77.4 mm-40 -125.18 152.47 44.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.294 0.568 . . . . 0.0 111.658 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -91.08 129.69 37.05 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.32 176.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.414 ' HB2' HG23 ' A' ' 200' ' ' ILE . 15.6 m-85 -117.58 137.74 52.4 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.43 177.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.531 ' O ' ' HA ' ' A' ' 148' ' ' LEU . 2.5 mm? -102.31 128.74 48.74 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 175.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.414 HG23 ' HB ' ' A' ' 198' ' ' THR . 30.7 m -128.92 139.74 51.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 120.951 0.405 . . . . 0.0 111.33 -178.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 196' ' ' PRO . 98.9 mt-30 -139.19 136.58 35.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.355 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.427 HG21 ' CD2' ' A' ' 127' ' ' TRP . 13.5 p -120.05 137.42 53.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.99 0.424 . . . . 0.0 110.334 174.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -138.62 157.06 46.84 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.349 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.589 ' HB3' ' CD2' ' A' ' 144' ' ' TYR . 24.3 p -136.34 174.75 10.27 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.31 132.86 3.11 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.17 0.509 . . . . 0.0 111.953 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.445 ' HD3' ' HG2' ' A' ' 102' ' ' GLN . 93.9 Cg_endo -86.33 -163.35 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.216 2.61 . . . . 0.0 110.493 168.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -91.24 -31.58 16.09 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.485 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -62.72 -39.27 93.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.318 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -118.16 102.92 1.0 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.494 -178.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -80.39 107.07 12.88 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' TRP . . . . . . . . . . . . . 3.1 p-90 -67.4 158.8 30.86 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.068 -174.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 15.8 m -153.98 16.5 0.49 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.432 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -152.01 162.15 41.54 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.295 0.569 . . . . 0.0 112.499 -172.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' TRP . . . . . 0.454 ' CH2' ' HB2' ' A' ' 147' ' ' ARG . 72.2 m95 -120.22 173.05 7.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.946 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.548 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 54.0 m -152.28 -63.77 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.548 ' HD3' ' HB2' ' A' ' 195' ' ' SER . 97.5 Cg_endo -74.88 80.49 2.38 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 121.954 1.77 . . . . 0.0 113.952 -168.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.412 ' HB2' HE21 ' A' ' 181' ' ' GLN . . . -78.65 100.61 7.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.169 0.509 . . . . 0.0 110.312 178.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . 0.465 ' OG1' HD23 ' A' ' 109' ' ' LEU . 20.0 m -94.17 138.9 31.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.713 -176.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -100.83 116.06 31.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.622 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.414 HG23 ' HB2' ' A' ' 178' ' ' TYR . 7.0 tp -123.73 137.49 56.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.061 0.458 . . . . 0.0 110.485 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -104.75 128.71 52.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.236 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 47.2 mm -87.09 124.39 68.66 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -61.86 151.47 80.81 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 123.049 2.499 . . . . 0.0 112.382 -177.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . . . . . . . . . 37.8 m -68.57 -30.12 68.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.757 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -92.56 39.8 1.04 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.681 0.753 . . . . 0.0 109.809 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 172' ' ' LEU . 80.3 t80 -74.89 -35.19 62.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.863 178.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 12.8 t -73.89 152.49 40.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.514 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -70.26 129.86 40.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.36 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -95.53 -4.1 45.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.373 0.606 . . . . 0.0 111.143 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 . . . . . 0 C--O 1.248 0.994 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.078 179.431 . . . . . . . . 0 0 . 1 stop_ save_